data_6y4h_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6y4h _Structure_validation_residue.Date_analyzed 2020-07-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.854 0.359 . . . . 2.13 111.036 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.28 124.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.122 -0.695 . . . . 1.8 109.122 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.25 138.89 32.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.368 0.604 . . . . 1.36 110.417 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.61 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -104.62 140.44 38.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.461 -0.791 . . . . 2.73 109.88 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.83 -172.39 30.25 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.13 -0.788 . . . . 0.5 111.13 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 143.05 37.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.04 0.448 . . . . 0.75 111.307 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.502 HG22 ' SD ' ' A' ' 17' ' ' MET . 33.1 mm -65.83 125.79 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 1.14 110.869 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.86 -35.74 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 1.31 111.384 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.5 123.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 2.16 110.698 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.502 ' SD ' HG22 ' A' ' 14' ' ' ILE . 80.5 mmm -116.03 107.39 14.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 1.92 110.954 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.4 mmtt -103.26 179.2 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.437 -1.32 . . . . 2.53 107.437 167.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.68 -18.56 29.28 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.892 -0.723 . . . . 3.24 110.695 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -101.67 -48.51 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.028 0.442 . . . . 2.03 111.592 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.507 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 39.9 p90 -142.67 -177.56 5.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.274 -0.421 . . . . 1.47 110.084 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.62 -178.36 34.54 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.748 -0.739 . . . . 0.76 111.795 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.88 130.97 53.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 1.22 110.224 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 mt -101.66 129.27 53.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.622 -0.717 . . . . 1.15 109.674 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.63 131.98 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.751 -0.833 . . . . 2.3 108.751 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.5 p -64.3 151.99 42.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.494 -0.776 . . . . 1.36 111.705 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 7.2 tp -62.7 -40.65 97.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.673 -0.694 . . . . 2.15 110.924 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 8.1 m -100.36 24.78 8.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.277 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.427 ' HB3' ' NH1' ' A' ' 158' ' ' ARG . 23.1 p80 44.3 51.01 7.71 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.763 0.792 . . . . 4.08 111.709 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 15.8 m-20 -82.02 -51.29 8.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.196 -0.911 . . . . 2.89 109.438 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -175.93 -175.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.089 -0.96 . . . . 1.8 109.678 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.39 136.3 43.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.047 0.451 . . . . 3.37 110.238 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.44 126.93 57.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.697 -0.683 . . . . 1.43 110.963 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -68.8 119.38 13.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.19 0.519 . . . . 1.12 110.124 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -129.58 136.51 49.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.654 -0.703 . . . . 2.46 109.935 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.21 139.27 40.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.346 -0.613 . . . . 1.4 109.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 17' ' ' MET . 60.0 m-85 -69.79 -16.31 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.032 0.444 . . . . 0.82 111.201 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 t -63.39 -23.22 67.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.76 -0.655 . . . . 2.03 111.77 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.41 24.62 12.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 2.09 110.488 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CZ ' HD12 ' A' ' 47' ' ' LEU . 91.8 t80 -91.69 146.29 23.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.838 -0.619 . . . . 1.39 110.865 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.77 117.32 31.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 2.04 110.12 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.95 -157.04 20.97 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.748 -0.739 . . . . 1.05 112.042 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.22 107.36 57.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.932 -0.396 . . . . 2.51 109.932 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 -17.28 38.22 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.772 2.315 . . . . 1.14 113.095 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -64.99 -21.94 66.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.439 . . . . 2.29 110.8 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -103.53 12.77 34.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.033 -0.53 . . . . 2.45 111.268 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 14.5 mt -88.11 146.94 25.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.14 -0.482 . . . . 1.29 111.572 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -143.49 169.22 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.288 -0.869 . . . . 2.35 110.273 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.2 mt -76.77 116.65 17.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.924 -0.58 . . . . 2.01 110.757 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 2.35 27.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.922 -0.656 . . . . 0.82 112.506 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -78.34 127.37 32.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.792 0.329 . . . . 1.16 111.035 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.61 ' OE1' ' HD2' ' A' ' 11' ' ' ARG . 19.1 tt0 -70.81 130.92 42.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.745 -0.661 . . . . 2.51 110.28 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.59 154.52 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 1.12 110.839 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.83 141.63 47.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.003 -0.739 . . . . 1.49 109.003 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.34 161.73 27.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.401 0.62 . . . . 0.79 111.936 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 p -110.18 163.73 13.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.414 -0.812 . . . . 1.49 109.906 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.32 142.03 33.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.665 0.269 . . . . 1.55 110.571 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 2.04 111.079 -178.186 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.797 -0.075 . . . . 2.92 110.797 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.75 172.45 16.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.705 2.27 . . . . 1.58 113.293 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.65 171.62 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.149 -0.932 . . . . 1.33 109.993 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.15 155.23 40.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.469 0.176 . . . . 2.3 110.622 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.26 55.27 9.41 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.828 0.705 . . . . 2.67 112.099 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG21 ' CD2' ' A' ' 35' ' ' PHE . 40.5 t -86.41 116.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 1.46 110.186 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -122.15 159.63 26.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.739 -0.467 . . . . 4.04 109.739 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.442 ' HA ' HG11 ' A' ' 53' ' ' VAL . 62.4 mtt -79.53 152.37 30.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.85 0.357 . . . . 1.5 111.163 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -119.16 162.61 30.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 2.27 110.539 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 134.68 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.337 2.025 . . . . 2.54 111.95 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 38.8 ttmt -70.01 155.27 40.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.807 -0.633 . . . . 4.95 110.925 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 17.3 m120 74.76 15.9 3.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.219 0.608 . . . . 3.42 111.402 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.499 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 44.8 m -92.23 -19.87 21.75 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.929 -0.309 . . . . 2.12 111.023 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.44 126.52 92.31 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.315 -0.624 . . . . 1.37 109.315 171.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.24 154.83 61.49 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.576 2.184 . . . . 1.17 112.331 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -113.64 152.76 45.74 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.059 -0.519 . . . . 3.13 110.171 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.427 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 23.5 Cg_endo -60.63 143.5 99.43 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 1.39 112.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.16 91.72 8.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.302 0.572 . . . . 1.69 110.007 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -142.04 128.67 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.607 -0.886 . . . . 1.49 108.607 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.26 -63.64 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.555 -0.458 . . . . 3.44 112.056 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.58 -53.82 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.982 0.42 . . . . 2.84 111.887 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.2 t 174.74 159.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.108 -0.701 . . . . 2.07 109.108 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -106.22 -58.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 1.45 111.059 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -140.52 158.09 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.064 0.459 . . . . 1.73 110.725 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -122.94 175.9 6.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.467 -0.788 . . . . 1.86 109.045 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.64 -163.13 34.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.264 -0.97 . . . . 0.54 112.198 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.36 148.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.13 -0.693 . . . . 2.06 109.13 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 144' ' ' GLN . 49.1 t -63.91 116.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.601 -0.518 . . . . 1.31 109.601 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 99' ' ' ARG . . . -82.65 -68.84 0.67 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.178 -0.464 . . . . 1.31 111.697 -173.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 4.8 mtm180 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.573 -0.285 . . . . 4.44 111.18 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 112.088 0.403 . . . . 1.67 112.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.74 179.88 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.05 -0.523 . . . . 1.08 113.871 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 130' ' ' GLU . 60.9 mt -144.48 138.23 27.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 1.5 111.17 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.6 mt -103.7 139.47 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.233 -0.894 . . . . 1.06 109.237 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.44 116.02 27.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.56 0.695 . . . . 1.4 110.184 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.8 mm -91.52 140.57 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.229 -0.896 . . . . 1.26 109.946 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.66 143.34 29.28 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.953 -0.299 . . . . 1.72 110.238 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.64 -179.49 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 2.29 111.064 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' HG2' HD21 ' A' ' 121' ' ' LEU . 1.6 pm0 -66.64 -25.17 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.262 . . . . 2.78 111.442 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -90.3 -1.47 57.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.353 -0.61 . . . . 2.13 109.353 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 60.1 43.6 14.07 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.166 -0.924 . . . . 4.81 111.534 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.2 m -114.83 -50.0 2.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.028 0.381 . . . . 2.38 112.028 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.8 p -130.65 -179.5 5.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.964 0.411 . . . . 2.22 111.858 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -81.83 136.64 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.755 -0.657 . . . . 1.84 110.277 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.1 mt -75.09 -69.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 1.45 110.56 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -137.58 -83.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 1.86 111.813 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -174.98 134.37 0.34 Allowed 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 115.458 -0.792 . . . . 2.39 109.757 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 117' ' ' ILE . 15.8 m170 -120.38 130.66 54.48 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.608 -0.437 . . . . 0.7 110.692 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' HD23 ' A' ' 114' ' ' LEU . 11.6 tt0 -91.5 143.98 26.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.419 -0.81 . . . . 1.19 109.395 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CD1' HD23 ' A' ' 136' ' ' LEU . 32.5 p90 -116.98 140.72 49.13 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.059 -0.657 . . . . 0.82 111.056 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.39 152.38 18.37 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.42 -0.809 . . . . 0.59 112.539 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 tp -49.89 -33.38 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.248 0.462 . . . . 1.25 112.248 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.6 p -72.93 -33.75 66.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.438 0.637 . . . . 1.68 110.813 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 16.3 m -74.55 -26.58 60.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.172 -0.922 . . . . 1.46 110.433 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' A' ' 131' ' ' PHE . 32.1 mt -75.58 60.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.44 -0.8 . . . . 2.06 112.151 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -45.56 -42.5 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.497 0.665 . . . . 1.4 110.481 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 45.7 m-80 -92.11 35.13 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.204 -0.907 . . . . 2.83 111.302 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -58.22 -17.78 21.51 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.477 0.547 . . . . 1.92 112.477 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.39 -22.91 62.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.064 0.459 . . . . 2.83 110.696 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 161.64 27.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 1.89 111.98 -171.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.447 HD22 ' H ' ' A' ' 142' ' ' LEU . 2.6 pt? -89.75 30.66 1.02 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.202 -0.908 . . . . 3.33 109.295 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.95 107.83 0.1 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.492 -1.231 . . . . 1.26 110.548 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 13.8 pt20 -129.51 -175.6 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.531 . . . . 2.0 111.55 -170.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 77.8 tttt -59.65 118.19 5.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.587 -0.733 . . . . 1.9 109.929 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.43 -5.25 29.82 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.467 -0.873 . . . . 1.17 112.635 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.39 136.39 33.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.067 0.46 . . . . 1.94 111.079 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 148' ' ' LEU . 3.4 mm? -86.0 136.38 33.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.38 -0.827 . . . . 2.45 110.359 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.27 150.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.245 0.545 . . . . 1.77 112.04 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.7 m -125.82 134.98 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 1.86 108.926 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -146.72 -176.61 5.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.079 -0.51 . . . . 0.74 109.7 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 122.31 17.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.277 0.56 . . . . 2.72 110.722 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.6 tt -100.62 130.49 49.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.178 -0.919 . . . . 1.84 110.296 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 13.5 t70 -159.17 -92.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.465 -0.198 . . . . 1.92 110.465 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -83.09 -19.69 36.3 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.08 -0.388 . . . . 2.76 111.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 m -77.92 -16.47 58.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 2.5 110.58 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 53.25 30.89 40.88 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.705 -0.68 . . . . 1.27 113.745 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 29' ' ' HIS . 11.6 ptm180 -161.63 -167.61 1.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.454 -0.943 . . . . 4.13 108.454 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.92 107.66 17.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.294 -0.632 . . . . 1.09 109.294 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -122.18 153.22 39.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 1.2 110.437 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 t 60.72 45.3 10.26 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.367 -0.605 . . . . 2.15 109.367 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.62 109.33 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.496 -0.774 . . . . 1.93 110.798 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.489 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 54.2 t30 -111.59 120.96 43.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.384 -0.826 . . . . 2.63 110.222 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.6 103.79 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.171 0.51 . . . . 1.23 110.034 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.73 136.05 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.706 -0.679 . . . . 2.08 110.533 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 116.304 -0.407 . . . . 3.44 110.046 179.609 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.843 0.354 . . . . 2.13 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.7 121.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.253 -0.647 . . . . 1.8 109.253 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -93.23 138.0 32.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.122 0.487 . . . . 1.36 109.992 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.502 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -108.54 137.8 45.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 2.73 109.786 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.77 -178.39 30.81 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.396 -0.682 . . . . 0.5 111.396 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -132.22 143.44 49.93 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.124 0.488 . . . . 0.75 110.867 -177.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.591 HG22 ' SD ' ' A' ' 17' ' ' MET . 46.5 mm -65.91 129.03 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 1.14 111.145 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.95 -45.07 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 1.31 111.264 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.78 122.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 2.16 111.068 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.591 ' SD ' HG22 ' A' ' 14' ' ' ILE . 87.2 mmm -112.4 105.33 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 1.92 110.805 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 54.6 mttt -113.06 167.47 10.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.554 -0.906 . . . . 2.53 108.554 171.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -75.33 -18.98 59.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.796 -0.361 . . . . 3.24 111.849 -171.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -108.53 -47.05 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.46 . . . . 2.03 111.707 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 6.7 p90 -141.24 172.08 13.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.586 -0.279 . . . . 1.47 110.448 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.33 32.83 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.805 -0.712 . . . . 0.76 111.907 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -120.8 135.05 55.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.71 -0.478 . . . . 1.22 109.71 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -103.5 133.9 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.02 -0.536 . . . . 1.15 110.536 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -79.26 121.15 24.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.041 -1.096 . . . . 2.3 108.041 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.8 144.16 52.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.134 -0.484 . . . . 1.36 110.727 -175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tp -51.68 -43.35 62.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 2.15 111.026 -176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -107.42 27.16 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 2.51 110.731 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' A' ' 158' ' ' ARG . 16.8 p80 45.48 36.78 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.13 0.972 . . . . 4.08 111.28 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.877 -1.056 . . . . 2.89 111.464 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.23 -174.58 1.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.856 -0.611 . . . . 1.8 110.785 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -103.09 120.74 41.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 3.37 109.438 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.4 t -104.44 125.26 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.779 0.323 . . . . 1.43 111.287 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.56 119.04 21.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 1.12 110.578 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.54 144.08 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.667 -0.697 . . . . 2.46 109.431 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.466 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 7.4 t60 -119.31 135.66 54.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.708 -0.479 . . . . 1.4 109.708 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -74.61 -19.12 60.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.458 0.54 . . . . 0.82 112.458 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 t -68.81 -33.47 73.91 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.826 -0.35 . . . . 2.03 110.954 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 1.2 p-10 -103.9 33.76 3.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.693 0.759 . . . . 2.09 109.633 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -102.51 139.21 38.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.696 -1.138 . . . . 1.39 110.437 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.1 ttm -101.11 104.96 16.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.04 110.369 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.8 -154.32 25.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 1.05 111.541 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 99.14 41.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.849 -0.426 . . . . 2.51 109.849 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.3 -21.9 66.72 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.739 2.293 . . . . 1.14 113.494 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.85 -1.24 57.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.972 0.415 . . . . 2.29 111.043 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -112.7 15.68 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 2.45 110.389 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.92 146.4 23.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.585 -0.734 . . . . 1.29 111.161 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -128.88 172.39 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.602 -0.726 . . . . 2.35 110.241 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.99 123.27 29.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.165 -0.471 . . . . 2.01 110.52 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.25 59.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.674 -0.774 . . . . 0.82 111.976 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -69.94 129.44 39.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.692 0.282 . . . . 1.16 111.051 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 82' ' ' SER . 10.4 tt0 -73.11 127.51 32.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.654 -0.703 . . . . 2.51 110.501 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 77' ' ' MET . 31.4 m -139.93 153.86 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 1.12 110.166 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.413 ' HB3' HD11 ' A' ' 78' ' ' LEU . 10.3 pt-20 -114.15 147.18 39.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.101 -0.703 . . . . 1.49 109.101 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -166.72 166.18 16.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.396 0.617 . . . . 0.79 112.357 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.37 166.59 13.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.259 -0.882 . . . . 1.49 110.188 176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -101.96 143.2 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.303 -0.408 . . . . 1.55 110.644 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' O ' HD21 ' A' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.04 110.592 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 58' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.425 0.155 . . . . 2.92 111.021 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.2 150.1 88.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.069 2.513 . . . . 1.58 113.277 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.68 141.17 29.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.387 -0.824 . . . . 1.33 110.481 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 165.24 25.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.644 0.259 . . . . 2.3 111.268 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 61.93 27.26 16.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.758 -0.656 . . . . 2.67 111.339 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 t -71.56 120.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.066 -0.516 . . . . 1.46 111.076 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -129.42 161.7 29.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 4.04 110.222 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.465 ' HA ' HG13 ' A' ' 53' ' ' VAL . 60.2 mtt -80.84 143.93 32.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.5 111.473 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 54' ' ' GLU . 36.3 mt -112.61 162.53 21.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.828 -0.623 . . . . 2.27 110.196 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.37 149.49 80.72 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.685 2.256 . . . . 2.54 111.78 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 38.7 ttmt -79.41 152.17 30.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.247 -0.433 . . . . 4.95 110.734 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 4.9 m-20 70.66 35.19 1.91 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.934 0.494 . . . . 3.42 111.453 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.55 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 49.2 m -107.16 -9.87 16.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.807 0.337 . . . . 2.12 110.813 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mm -76.36 136.16 68.67 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.52 -0.309 . . . . 1.37 110.366 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.74 157.54 61.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.652 2.235 . . . . 1.17 112.182 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -131.55 157.27 78.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.191 -0.459 . . . . 3.13 110.61 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.459 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 20.0 Cg_exo -62.56 138.68 71.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.157 . . . . 1.39 112.094 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 93.17 9.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.221 0.534 . . . . 1.69 110.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t -141.8 133.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.337 -0.986 . . . . 1.49 108.337 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.4 -62.52 1.67 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 3.44 112.621 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -94.09 -54.3 3.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 2.84 111.692 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t 173.77 161.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.643 -0.873 . . . . 2.07 108.643 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.505 HG23 ' CD2' ' A' ' 93' ' ' HIS . 7.6 m -106.0 -59.01 1.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.724 -0.39 . . . . 1.45 110.91 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 92' ' ' THR . 98.2 m-70 -145.07 155.6 43.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.73 110.213 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -115.37 173.2 6.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.969 -0.752 . . . . 1.86 108.969 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.57 -166.08 35.15 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.125 -1.036 . . . . 0.54 111.88 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.72 147.89 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.106 -0.702 . . . . 2.06 109.106 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.82 112.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.784 -0.45 . . . . 1.31 109.784 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 -63.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.31 111.887 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.559 -0.291 . . . . 4.44 111.0 -173.48 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.175 0.435 . . . . 1.67 112.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.04 173.39 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 114.584 0.594 . . . . 1.08 114.584 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 130' ' ' GLU . 74.2 mt -143.87 136.33 26.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.473 0.654 . . . . 1.5 111.257 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.3 mt -103.35 138.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.935 -1.03 . . . . 1.06 109.5 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 125.23 33.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.396 0.617 . . . . 1.4 109.611 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.489 HG13 ' CD2' ' A' ' 129' ' ' HIS . 11.6 mm -102.07 126.33 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.498 -0.774 . . . . 1.26 109.048 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.8 pt? -87.07 152.52 22.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 1.72 110.745 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.67 173.75 9.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.614 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.433 ' HG2' HD21 ' A' ' 121' ' ' LEU . 1.5 pm0 -66.91 -23.26 65.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 2.78 111.09 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.433 HD21 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -86.8 -3.23 59.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.736 -0.468 . . . . 2.13 109.736 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 66.43 35.98 5.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.322 -0.854 . . . . 4.81 111.051 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m -81.24 -68.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.746 -0.661 . . . . 2.38 111.567 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p -155.28 -174.36 4.94 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.995 0.368 . . . . 2.22 111.995 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 p -67.12 133.2 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.688 -0.687 . . . . 1.84 111.211 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.21 -69.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.476 -0.329 . . . . 1.45 110.653 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 m -136.51 -84.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.81 -0.356 . . . . 1.86 111.758 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.43 ' HB2' HD21 ' A' ' 114' ' ' LEU . 11.4 pt20 -174.67 138.24 0.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.842 -0.617 . . . . 2.39 110.144 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.489 ' CD2' HG13 ' A' ' 117' ' ' ILE . 21.6 m170 -122.6 123.18 40.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.792 0.329 . . . . 0.7 110.359 170.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.492 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.0 tt0 -84.22 145.68 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.552 -0.749 . . . . 1.19 109.24 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.472 ' CD1' HD23 ' A' ' 136' ' ' LEU . 32.4 p90 -117.66 139.96 50.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 0.82 111.824 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.88 154.37 20.87 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 114.999 -1.0 . . . . 0.59 112.383 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.22 -32.56 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 1.25 111.564 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -74.68 -35.8 62.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.2 0.524 . . . . 1.68 110.705 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.474 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 36.9 m -62.82 -32.7 73.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.236 -0.893 . . . . 1.46 110.532 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.472 HD23 ' CD1' ' A' ' 131' ' ' PHE . 72.7 mt -75.42 58.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 2.06 112.031 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.0 t -46.3 -43.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.357 0.599 . . . . 1.4 110.318 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 46.2 m-80 -95.87 34.66 1.49 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.3 -0.863 . . . . 2.83 111.508 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -56.65 -21.21 25.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.145 0.498 . . . . 1.92 111.615 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -70.91 -23.1 62.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 2.83 111.414 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.27 164.03 14.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.681 0.623 . . . . 1.89 112.681 -166.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 HD21 ' H ' ' A' ' 142' ' ' LEU . 2.7 pt? -79.51 34.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.014 -0.994 . . . . 3.33 111.2 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.16 105.43 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.796 -0.638 . . . . 1.26 111.021 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -121.66 -178.03 3.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.755 -0.657 . . . . 2.0 110.811 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -62.99 136.48 57.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.691 -0.686 . . . . 1.9 110.323 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.3 70.72 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.545 -0.836 . . . . 1.17 112.926 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -92.11 142.28 27.68 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.215 0.508 . . . . 1.94 109.859 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 148' ' ' LEU . 3.2 mm? -83.95 138.51 33.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.194 0.521 . . . . 2.45 111.146 -172.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.77 153.35 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.366 0.603 . . . . 1.77 111.912 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.2 m -129.57 138.01 51.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.221 -0.9 . . . . 1.86 109.332 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -149.0 174.15 12.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.645 -0.502 . . . . 0.74 109.645 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -130.38 120.46 24.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.397 0.618 . . . . 2.72 110.205 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.55 130.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.823 -0.626 . . . . 1.84 110.354 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.463 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 18.8 t70 -155.87 -100.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.954 -0.298 . . . . 1.92 110.718 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.463 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 42.2 mt-10 -83.9 -7.59 59.39 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.08 0.4 . . . . 2.76 112.08 -175.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -12.08 49.24 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.749 -0.464 . . . . 2.5 109.749 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.09 24.21 49.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.127 -0.942 . . . . 1.27 114.308 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.415 ' HD3' ' CD2' ' A' ' 29' ' ' HIS . 15.1 ptt-85 -158.08 -177.94 6.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.829 -0.804 . . . . 4.13 108.829 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.14 108.65 16.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.367 -0.533 . . . . 1.09 110.698 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -119.12 159.49 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 1.2 110.442 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 39.7 t 63.07 38.08 11.09 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.673 0.608 . . . . 2.15 110.091 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.99 111.54 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.476 -0.784 . . . . 1.93 110.657 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.463 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 8.3 t30 -120.52 128.91 53.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.315 -0.402 . . . . 2.63 110.394 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.96 117.13 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 1.23 110.282 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.69 130.55 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.844 -0.617 . . . . 2.08 111.66 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 3.44 110.127 176.117 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 121.426 0.632 . . . . 2.13 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.55 116.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.956 -1.02 . . . . 1.8 109.073 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -87.63 138.61 31.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.931 -0.577 . . . . 1.36 110.004 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 22.7 ttm180 -113.55 141.04 47.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.71 -0.677 . . . . 2.73 110.04 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.08 -171.12 36.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.006 -0.838 . . . . 0.5 111.006 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.61 141.95 33.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.184 0.516 . . . . 0.75 111.141 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.34 119.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.296 -0.865 . . . . 1.14 110.823 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.38 -41.73 6.91 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.967 -0.293 . . . . 1.31 111.172 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.76 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.536 -0.542 . . . . 2.16 109.536 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.9 ttm -137.17 106.7 6.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 1.92 110.391 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.7 mmtt -100.71 172.37 7.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.865 -0.791 . . . . 2.53 108.865 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.62 -22.1 61.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.692 0.282 . . . . 3.24 111.668 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -111.14 -41.93 4.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.72 0.295 . . . . 2.03 111.701 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -145.12 176.71 9.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.617 -0.265 . . . . 1.47 110.487 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 -179.97 25.82 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.497 -0.859 . . . . 0.76 112.059 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' CD ' ' A' ' 32' ' ' GLU . 54.3 m-85 -127.11 151.74 48.24 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.525 -0.546 . . . . 1.22 109.525 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -125.57 115.34 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.17 -0.468 . . . . 1.15 111.058 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.34 126.47 29.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.288 -1.004 . . . . 2.3 108.288 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 164.57 25.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.229 0.537 . . . . 1.36 111.401 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' CD2' HD13 ' A' ' 83' ' ' ILE . 1.8 tm? -60.58 -48.43 81.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.532 -0.758 . . . . 2.15 111.724 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -98.69 13.65 31.4 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.087 -0.338 . . . . 2.51 110.087 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 55.85 50.27 14.4 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.429 -0.952 . . . . 4.08 108.429 -168.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.14 -48.55 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.993 -1.458 . . . . 2.89 110.275 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -173.26 179.38 2.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 1.8 110.704 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' CD ' ' HB3' ' A' ' 23' ' ' PHE . 10.0 tp10 -103.2 139.53 38.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.781 -0.452 . . . . 3.37 109.781 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.53 132.24 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.051 0.453 . . . . 1.43 111.224 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -87.19 118.39 26.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.802 -0.636 . . . . 1.12 110.426 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -120.01 151.3 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 2.46 108.918 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -115.84 133.0 56.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.476 -0.564 . . . . 1.4 109.476 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -62.47 -22.62 66.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.058 0.762 . . . . 0.82 113.058 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -61.29 -35.84 78.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.779 0.323 . . . . 2.03 111.076 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -96.09 22.54 7.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.259 0.552 . . . . 2.09 110.842 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.558 ' OH ' ' HG2' ' A' ' 77' ' ' MET . 39.6 t80 -91.51 136.6 33.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 1.39 110.212 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.33 97.74 7.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 2.04 110.142 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.19 -139.63 7.46 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.143 -0.783 . . . . 1.05 111.143 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -124.73 91.46 49.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 121.515 0.674 . . . . 2.51 110.703 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.93 -21.04 33.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.003 2.468 . . . . 1.14 113.841 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.41 -11.66 59.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.371 0.605 . . . . 2.29 110.154 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.45 20.31 19.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 2.45 110.248 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 29.3 mt -85.14 -179.6 7.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.794 -0.639 . . . . 1.29 111.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -151.22 161.17 43.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.386 -0.825 . . . . 2.35 110.126 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.51 113.99 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 2.01 108.98 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.25 5.05 35.13 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.872 -0.604 . . . . 0.82 112.019 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.34 131.13 40.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.91 0.386 . . . . 1.16 111.315 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' CD ' HG12 ' A' ' 83' ' ' ILE . 40.2 mt-10 -78.27 128.26 33.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.227 -0.897 . . . . 2.51 111.279 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.89 161.33 18.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.127 -0.488 . . . . 1.12 110.444 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.42 148.28 48.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.795 -0.446 . . . . 1.49 109.795 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 11.9 p90 -163.99 175.17 10.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.79 112.142 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 p -130.14 170.72 13.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.44 -0.8 . . . . 1.49 110.112 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.86 138.75 45.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.78 0.324 . . . . 1.55 111.145 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.863 -0.608 . . . . 2.04 110.124 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.022 -0.733 . . . . 2.92 109.022 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.74 150.35 88.29 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.312 2.008 . . . . 1.58 112.223 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.63 137.01 32.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.67 -0.696 . . . . 1.33 111.035 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -112.41 165.74 11.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.845 -0.616 . . . . 2.3 110.334 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 63.18 29.67 16.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.818 -0.628 . . . . 2.67 111.477 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 9.6 t -74.19 108.25 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 1.46 110.237 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -112.31 167.82 10.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.87 0.367 . . . . 4.04 110.339 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.558 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 84.8 mtp -98.58 136.04 39.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.944 -0.571 . . . . 1.5 111.195 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.0 mt -107.9 154.89 40.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 2.27 110.556 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.08 140.93 35.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.263 1.975 . . . . 2.54 110.372 169.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.32 164.68 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 4.95 111.034 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.09 25.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.172 -0.922 . . . . 3.42 109.999 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -95.59 -14.86 23.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.398 -0.819 . . . . 2.12 109.122 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.593 HD13 ' CD2' ' A' ' 27' ' ' LEU . 8.7 mm -92.01 128.99 43.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.441 -0.8 . . . . 1.37 109.783 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.07 154.48 47.33 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.348 2.032 . . . . 1.17 112.14 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 152.15 74.35 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.556 -0.293 . . . . 3.13 110.465 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 125.94 18.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 1.39 112.202 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.14 92.97 7.06 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.999 0.428 . . . . 1.69 111.17 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 26.0 t -142.43 107.33 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 1.49 109.713 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.85 -25.92 27.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.735 -0.386 . . . . 3.44 111.737 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 91' ' ' THR . 69.8 tt0 -73.42 -18.19 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.609 -0.269 . . . . 2.84 110.953 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.544 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 41.5 m 81.04 122.72 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.634 -0.712 . . . . 2.07 110.54 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -80.86 -57.64 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.45 112.337 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -141.35 174.73 10.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.232 0.539 . . . . 1.73 111.36 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -141.81 176.83 8.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.132 -0.94 . . . . 1.86 109.273 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.09 179.45 39.57 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 110.464 -1.055 . . . . 0.54 110.464 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.3 m -103.89 159.5 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 117.852 0.826 . . . . 2.06 110.161 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.37 121.57 19.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.196 -0.668 . . . . 1.31 109.196 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -66.86 -53.47 32.08 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.3 0.375 . . . . 1.31 110.731 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 4.44 110.551 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 120.59 0.233 . . . . 1.67 111.247 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.78 166.66 25.23 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.439 -0.665 . . . . 1.08 111.439 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.8 mt -142.71 138.13 30.34 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.627 0.727 . . . . 1.5 111.842 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.89 138.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.654 -1.157 . . . . 1.06 108.746 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.77 124.26 31.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.936 -0.765 . . . . 1.4 108.936 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 129' ' ' HIS . 5.6 mm -101.36 120.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.494 -0.928 . . . . 1.26 108.494 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -83.33 144.25 29.81 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.294 -0.562 . . . . 1.72 110.157 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.07 151.49 12.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 2.29 109.583 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.72 -21.66 64.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 2.78 111.912 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.03 10.26 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.692 0.282 . . . . 2.13 110.374 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 67.52 30.39 6.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.613 -0.721 . . . . 4.81 111.512 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -70.32 -80.37 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.463 -0.335 . . . . 2.38 111.167 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -149.23 -176.45 5.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.687 -0.233 . . . . 2.22 110.643 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -65.25 134.51 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 123.542 0.526 . . . . 1.84 110.234 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -72.71 -67.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.442 -0.344 . . . . 1.45 110.432 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.9 m -137.6 -84.3 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.159 0.504 . . . . 1.86 110.645 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -176.6 139.84 0.33 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.249 -0.887 . . . . 2.39 108.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.54 ' HB2' HD12 ' A' ' 117' ' ' ILE . 33.6 m170 -117.48 131.59 56.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.125 -0.63 . . . . 0.7 110.089 172.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -89.57 139.49 30.49 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.763 -1.108 . . . . 1.19 109.402 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.427 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 46.1 p90 -118.67 134.87 54.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 0.82 110.961 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.11 153.94 24.01 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.326 -0.852 . . . . 0.59 112.57 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.2 -27.72 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.01 0.433 . . . . 1.25 110.807 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.8 p -74.86 -36.48 62.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.317 0.58 . . . . 1.68 110.443 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.593 ' O ' HG21 ' A' ' 162' ' ' VAL . 23.9 m -65.66 -30.2 70.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.84 . . . . 1.46 110.87 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.4 mt -71.49 58.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.812 0.695 . . . . 2.06 112.67 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -45.59 -42.28 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.408 0.623 . . . . 1.4 111.045 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.48 34.01 2.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 2.83 111.014 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 16.3 ptpt -54.53 -21.08 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.01 0.524 . . . . 1.92 112.357 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -86.39 -11.95 50.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 2.83 112.12 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.56 166.66 23.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 1.89 110.687 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -86.96 24.49 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.458 -0.337 . . . . 3.33 110.492 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -44.92 117.39 1.32 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.22 -0.9 . . . . 1.26 111.536 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -118.86 -172.97 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 2.0 111.238 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 72.4 tttt -67.53 140.22 57.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.908 -0.587 . . . . 1.9 110.139 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.06 86.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.423 -0.894 . . . . 1.17 112.439 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 7.9 m-20 -82.73 132.37 35.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.559 0.219 . . . . 1.94 110.741 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.54 135.11 42.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.993 -0.549 . . . . 2.45 110.828 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.36 151.45 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 1.77 111.187 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 44.0 p -109.03 136.01 49.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.811 -0.811 . . . . 1.86 108.811 172.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.525 ' HB3' HG12 ' A' ' 162' ' ' VAL . 36.1 p90 -154.24 169.3 23.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.852 0.358 . . . . 0.74 110.327 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 3.7 mpt_? -131.77 123.2 27.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.4 -0.52 . . . . 2.72 110.63 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 129' ' ' HIS . 8.5 pt -100.14 146.77 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.736 -0.839 . . . . 1.84 108.736 166.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -175.1 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.366 -0.134 . . . . 1.92 110.969 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.25 -41.5 73.42 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 2.76 111.503 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 158' ' ' ARG . 42.3 t -84.9 -17.98 36.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.174 -0.466 . . . . 2.5 111.099 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.63 -25.36 1.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.797 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 156' ' ' SER . 67.2 mtt85 -93.02 175.68 6.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.317 0.247 . . . . 4.13 110.388 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.34 110.39 19.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.033 0.444 . . . . 1.09 110.219 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -123.25 160.2 27.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.722 -0.672 . . . . 1.2 110.84 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.6 m 59.93 42.84 15.61 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.944 0.778 . . . . 2.15 110.692 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 135' ' ' SER . 19.7 m -70.96 138.35 21.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.565 0.698 . . . . 1.93 110.892 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.04 123.71 22.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.328 -0.851 . . . . 2.63 109.74 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.25 125.73 24.82 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 123.372 0.42 . . . . 1.23 110.912 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.66 122.7 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.868 -0.606 . . . . 2.08 110.651 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 109.188 -0.671 . . . . 3.44 109.188 176.162 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.932 0.396 . . . . 2.13 111.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.19 119.9 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.074 -0.713 . . . . 1.8 109.074 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.19 0.519 . . . . 1.36 109.798 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -112.39 138.71 48.73 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.482 -0.781 . . . . 2.73 110.187 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.42 -163.29 13.5 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.441 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -152.06 156.86 40.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.062 0.458 . . . . 0.75 110.69 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.32 119.26 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.711 -0.677 . . . . 1.14 111.218 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.88 -38.16 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.49 -0.323 . . . . 1.31 111.34 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.75 131.71 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.85 0.357 . . . . 2.16 110.739 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.2 mtp -123.06 129.91 52.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 1.92 110.449 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -173.46 2.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.131 -1.063 . . . . 2.53 108.131 171.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -15.75 36.58 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.346 -0.542 . . . . 3.24 110.645 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.52 -47.13 3.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.429 0.529 . . . . 2.03 112.429 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -142.33 -175.42 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.127 0.489 . . . . 1.47 111.445 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.04 36.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.324 -0.71 . . . . 0.76 111.324 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -124.16 138.62 54.4 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.578 -0.527 . . . . 1.22 109.578 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -99.79 123.2 52.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.163 -0.471 . . . . 1.15 110.72 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 31.0 tt0 -76.15 118.92 19.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.056 -1.09 . . . . 2.3 108.056 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.18 160.27 31.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.391 -0.368 . . . . 1.36 111.501 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.483 ' CD1' HD13 ' A' ' 83' ' ' ILE . 9.1 tp -56.02 -48.57 75.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 2.15 111.616 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -118.56 40.68 3.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 2.51 109.789 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.8 p80 45.73 33.88 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.076 0.86 . . . . 4.08 111.032 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -52.63 -47.3 67.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.744 -1.116 . . . . 2.89 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -169.26 173.53 6.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.8 110.185 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.81 121.03 42.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 3.37 109.166 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -113.39 130.7 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.095 0.474 . . . . 1.43 111.69 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -89.02 120.23 30.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.404 -0.816 . . . . 1.12 110.14 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -121.08 147.33 45.68 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.122 -0.696 . . . . 2.46 109.122 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -109.03 133.16 53.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.572 -0.899 . . . . 1.4 108.572 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -57.67 -23.38 51.13 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.443 0.535 . . . . 0.82 112.443 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -68.97 -15.66 63.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.869 0.366 . . . . 2.03 111.929 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -104.44 8.15 35.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.479 0.657 . . . . 2.09 109.788 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.424 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 75.7 t80 -93.02 126.7 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.355 -0.839 . . . . 1.39 110.064 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.4 ttm -96.68 101.87 13.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.357 -0.383 . . . . 2.04 110.294 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.02 -150.95 23.23 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.102 -0.57 . . . . 1.05 111.697 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -105.73 105.34 52.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.778 -0.453 . . . . 2.51 109.778 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.04 -25.88 3.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.805 2.337 . . . . 1.14 113.702 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -69.77 -24.74 63.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.623 0.725 . . . . 2.29 109.523 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.71 20.68 12.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.358 -0.837 . . . . 2.45 111.132 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.51 149.29 25.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 1.29 110.515 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.55 158.11 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 2.35 109.761 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HB2' ' HZ2' ' A' ' 139' ' ' LYS . 79.3 mt -71.67 120.07 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.947 0.403 . . . . 2.01 110.274 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.07 -11.87 26.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.98 -0.629 . . . . 0.82 112.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.33 120.6 13.08 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.961 0.41 . . . . 1.16 111.409 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 5.0 mp0 -64.62 129.05 38.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 2.51 111.146 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 77' ' ' MET . 26.8 m -140.85 149.97 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 1.12 110.654 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -124.33 150.27 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.926 -0.398 . . . . 1.49 109.926 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 3.2 p90 -163.91 179.67 6.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.927 0.394 . . . . 0.79 111.308 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 p -128.45 166.93 17.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.091 -0.504 . . . . 1.49 110.742 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.06 147.4 30.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.359 -0.382 . . . . 1.55 110.97 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.397 0.618 . . . . 2.04 110.681 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.438 -0.578 . . . . 2.92 109.438 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.08 146.6 87.51 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.039 1.826 . . . . 1.58 112.274 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 144.64 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.179 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.02 163.73 18.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.721 0.296 . . . . 2.3 110.837 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.8 57.38 2.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.601 -0.727 . . . . 2.67 110.551 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 21.8 t -93.01 122.59 44.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 1.46 109.877 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -124.39 147.74 48.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.404 . . . . 4.04 110.106 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.424 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 48.9 mtt -70.92 154.12 42.09 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.866 0.365 . . . . 1.5 110.4 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.461 ' CD1' ' HD2' ' A' ' 79' ' ' PRO . 17.3 tp -125.61 144.13 47.1 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.009 -0.541 . . . . 2.27 110.023 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 78' ' ' LEU . 25.3 Cg_endo -61.65 142.9 95.94 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.265 1.977 . . . . 2.54 111.961 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 4.2 ttmp? -62.94 156.67 23.77 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.825 -0.625 . . . . 4.95 111.856 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m120 73.74 24.02 2.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.45 -0.796 . . . . 3.42 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -96.96 8.5 44.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.04 -0.527 . . . . 2.12 110.181 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.483 HD13 ' CD1' ' A' ' 27' ' ' LEU . 18.4 mm -108.75 133.06 20.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.636 -0.505 . . . . 1.37 109.636 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.89 149.84 66.59 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.593 2.195 . . . . 1.17 112.621 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.99 145.99 54.83 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.941 -0.572 . . . . 3.13 110.073 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 76.3 Cg_exo -52.31 132.53 44.63 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.592 2.861 . . . . 1.39 113.49 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.03 94.66 8.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.69 110.863 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.29 150.63 27.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.739 -0.838 . . . . 1.49 108.739 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.94 -64.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.076 -0.65 . . . . 3.44 111.37 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 91' ' ' THR . 30.8 tt0 -95.06 -58.63 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.302 -0.559 . . . . 2.84 111.027 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER 175.62 173.96 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.169 -0.923 . . . . 2.07 109.254 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -105.46 -58.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.45 110.73 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.31 178.45 6.87 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.023 -0.535 . . . . 1.73 110.815 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.96 -177.91 4.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.038 -0.528 . . . . 1.86 110.476 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.44 -163.32 29.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.085 -0.579 . . . . 0.54 111.867 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.47 146.36 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.667 -0.494 . . . . 2.06 109.667 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.28 121.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 1.31 110.301 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' O ' ' HE3' ' A' ' 145' ' ' LYS . . . -73.04 -60.18 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.572 0.582 . . . . 1.31 112.572 -172.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 . . . . . 0 C--N 1.33 -0.245 0 C-N-CA 120.495 -0.482 . . . . 4.44 111.647 -176.214 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.134 0 N-CA-C 112.178 0.436 . . . . 1.67 112.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.83 162.87 30.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.515 -0.85 . . . . 1.08 111.66 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 130' ' ' GLU . 82.6 mt -144.45 147.08 32.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.54 0.686 . . . . 1.5 112.287 -172.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.6 mt -112.48 137.8 43.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.514 -1.221 . . . . 1.06 109.513 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -89.89 120.72 31.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.458 0.647 . . . . 1.4 110.116 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.504 HG13 ' CD2' ' A' ' 129' ' ' HIS . 34.9 mm -97.8 129.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.26 109.582 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -87.35 156.71 19.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.535 -0.302 . . . . 1.72 110.311 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.05 167.57 9.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.392 -0.596 . . . . 2.29 109.392 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.426 ' HG2' HD23 ' A' ' 121' ' ' LEU . 2.3 pm0 -69.71 -17.07 63.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.042 0.449 . . . . 2.78 110.563 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -99.6 -2.42 35.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 2.13 109.821 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 54.22 80.66 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.505 -0.77 . . . . 4.81 110.731 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.61 -47.37 1.84 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.323 -0.398 . . . . 2.38 111.142 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 -177.75 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 2.22 111.021 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.31 130.68 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.543 -0.91 . . . . 1.84 108.543 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.61 -69.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.6 -0.44 . . . . 1.45 110.869 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -138.75 -85.23 0.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.498 0.666 . . . . 1.86 111.034 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -175.96 137.64 0.33 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.777 -1.101 . . . . 2.39 108.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.504 ' CD2' HG13 ' A' ' 117' ' ' ILE . 19.1 m170 -113.19 132.75 55.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.163 -0.615 . . . . 0.7 110.664 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.52 ' HA ' HD23 ' A' ' 114' ' ' LEU . 5.7 tt0 -92.54 140.46 29.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.626 -1.17 . . . . 1.19 109.42 -175.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CD1' HD21 ' A' ' 136' ' ' LEU . 40.7 p90 -118.51 141.41 48.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.82 111.021 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.09 152.93 20.18 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.468 -0.787 . . . . 0.59 112.209 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.73 -30.15 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.212 0.506 . . . . 1.25 111.001 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -78.07 -23.61 47.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.485 0.659 . . . . 1.68 110.542 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 62.9 m -78.74 -27.6 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.101 -0.954 . . . . 1.46 110.464 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 131' ' ' PHE . 69.4 mt -75.33 60.11 1.1 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.349 -0.841 . . . . 2.06 112.017 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.24 -45.59 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.931 0.396 . . . . 1.4 111.522 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 2.9 p-10 -92.27 33.9 1.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.753 0.311 . . . . 2.83 111.231 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HZ2' ' HB2' ' A' ' 49' ' ' LEU . 5.5 ptmm? -53.0 -22.56 5.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.467 0.707 . . . . 1.92 112.674 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.71 -19.04 49.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.364 -0.38 . . . . 2.83 111.26 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 162.86 27.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.625 0.726 . . . . 1.89 112.465 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -81.86 35.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.788 -1.096 . . . . 3.33 110.47 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.48 HD21 HD22 ' A' ' 138' ' ' ASN . 24.4 tp -63.72 127.09 29.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 1.26 110.692 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.61 -173.55 3.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 2.0 110.95 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 98' ' ' ALA . 83.8 tttt -66.18 138.53 57.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 1.9 109.9 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.19 66.99 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.738 -0.744 . . . . 1.17 112.626 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -90.62 140.36 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 1.94 110.728 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.03 140.91 33.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.709 -0.678 . . . . 2.45 110.742 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.15 143.91 38.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.508 . . . . 1.77 112.009 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -115.84 125.87 53.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 1.86 109.389 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.12 168.57 20.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.619 0.247 . . . . 0.74 110.404 -175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 121.35 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.34 -0.944 . . . . 2.72 110.469 172.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.5 130.46 52.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 1.84 110.324 174.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 22.7 t70 -149.0 -89.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.536 . . . . 1.92 111.862 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -33.52 40.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.379 0.511 . . . . 2.76 112.379 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.2 p -84.12 -17.15 41.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.477 -0.329 . . . . 2.5 111.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.67 23.15 70.46 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.728 -0.749 . . . . 1.27 113.065 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -126.43 173.53 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.679 -0.489 . . . . 4.13 109.679 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.86 18.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.269 -0.641 . . . . 1.09 109.269 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.44 158.18 38.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.196 -0.457 . . . . 1.2 110.438 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 45.6 m 55.4 30.72 15.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.512 0.673 . . . . 2.15 109.304 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.4 126.73 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.135 -0.939 . . . . 1.93 110.932 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 5.8 t30 -125.34 132.27 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.231 -0.895 . . . . 2.63 110.296 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.76 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 1.23 110.389 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.05 119.63 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.068 0.461 . . . . 2.08 111.617 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 3.44 110.691 177.835 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 15.7 mm100 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.111 0.481 . . . . 2.13 111.455 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.28 115.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.586 -0.734 . . . . 1.8 109.501 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 8' ' ' GLN . 49.5 m-85 -98.69 150.64 21.58 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.255 -0.884 . . . . 1.36 109.662 -176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.432 ' C ' HD21 ' A' ' 27' ' ' LEU . 35.2 ttm-85 -108.26 149.41 28.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.813 -0.63 . . . . 2.73 109.994 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.93 170.95 42.25 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.143 -0.783 . . . . 0.5 111.143 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.973 0.416 . . . . 0.75 111.312 -174.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.38 118.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.754 -0.657 . . . . 1.14 110.721 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.58 -43.13 3.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.938 0.399 . . . . 1.31 110.779 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.03 123.59 70.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 2.16 111.039 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.1 mtp -119.19 110.09 16.63 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.566 . . . . 1.92 109.473 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 69.6 mmtt -97.66 -167.92 1.6 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.447 -0.575 . . . . 2.53 109.447 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.93 -26.98 30.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.486 -0.324 . . . . 3.24 111.108 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.65 -44.4 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 2.03 111.227 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -137.95 -170.44 2.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.088 -0.505 . . . . 1.47 110.657 -174.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.66 174.96 34.36 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 0.76 112.234 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -122.82 139.36 54.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.78 131.71 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.781 -0.645 . . . . 1.15 110.438 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.86 107.15 8.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.126 -1.065 . . . . 2.3 108.126 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -62.57 149.56 42.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.533 -0.303 . . . . 1.36 110.657 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -51.45 -48.25 62.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 2.15 111.303 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -84.4 3.76 34.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 2.51 111.713 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.1 p80 39.96 39.97 0.67 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.124 0.97 . . . . 4.08 111.881 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -88.39 -39.52 14.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.364 -0.835 . . . . 2.89 110.073 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.15 162.8 34.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 1.8 110.107 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -104.31 127.82 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.611 -0.515 . . . . 3.37 109.611 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.49 128.6 57.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.302 0.572 . . . . 1.43 110.836 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -81.83 114.21 20.3 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.846 -1.07 . . . . 1.12 109.733 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -116.7 145.55 43.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.172 -0.677 . . . . 2.46 109.172 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.8 131.62 54.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.392 -0.596 . . . . 1.4 109.392 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.95 -20.27 56.59 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.972 0.415 . . . . 0.82 111.636 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -68.45 -23.28 64.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 2.03 111.118 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -106.76 14.1 27.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.057 0.456 . . . . 2.09 110.723 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.566 ' OH ' ' HE1' ' A' ' 77' ' ' MET . 71.7 t80 -88.45 132.77 34.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.044 -0.526 . . . . 1.39 110.728 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.9 ttm -94.96 109.36 21.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.189 -0.46 . . . . 2.04 110.39 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.39 -141.97 12.89 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.738 -0.744 . . . . 1.05 111.84 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -116.65 103.35 52.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.004 -0.369 . . . . 2.51 110.004 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.17 -23.44 39.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.256 . . . . 1.14 112.949 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -86.16 -4.85 59.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.438 0.637 . . . . 2.29 110.51 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -112.15 19.44 17.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.723 -0.671 . . . . 2.45 110.568 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.454 HD21 ' HH ' ' A' ' 40' ' ' TYR . 16.8 mt -87.97 157.33 18.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.643 -0.708 . . . . 1.29 111.091 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -131.2 157.37 43.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.783 -0.644 . . . . 2.35 111.166 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.45 121.87 22.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.117 0.484 . . . . 2.01 110.168 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.09 56.08 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.063 -0.589 . . . . 0.82 112.126 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -73.29 120.47 18.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 1.16 111.233 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.481 ' CD ' HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.25 129.0 39.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.96 -1.018 . . . . 2.51 111.535 174.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.77 142.44 30.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 1.12 110.315 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.71 135.42 53.96 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.082 -0.71 . . . . 1.49 109.082 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -156.8 159.64 38.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.063 -0.517 . . . . 0.79 111.134 -169.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.2 p -112.61 146.79 37.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.461 -0.336 . . . . 1.49 110.814 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.72 140.18 32.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.973 0.416 . . . . 1.55 110.861 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.887 -0.597 . . . . 2.04 110.693 178.45 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 110.032 -0.358 . . . . 2.92 110.032 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.07 147.81 94.38 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.779 2.32 . . . . 1.58 113.367 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.24 137.99 45.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.125 -0.943 . . . . 1.33 110.289 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -118.47 152.85 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.197 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.6 72.91 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.637 . . . . 2.67 110.356 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.18 111.09 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 1.46 110.204 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -121.82 141.56 51.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 4.04 110.927 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.566 ' HE1' ' OH ' ' A' ' 40' ' ' TYR . 53.6 mtm -74.94 144.74 43.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 1.5 110.912 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.5 pt? -128.04 162.87 47.34 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.961 -0.755 . . . . 2.27 108.961 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 21.8 Cg_endo -62.19 163.59 19.62 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.138 1.892 . . . . 2.54 113.127 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' H ' ' A' ' 81' ' ' ASN . 26.9 ttpp -79.93 -179.48 7.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.551 -0.749 . . . . 4.95 110.39 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 54.0 m-20 78.07 9.17 2.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.764 0.826 . . . . 3.42 111.218 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -79.61 -34.17 40.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.97 -0.559 . . . . 2.12 110.018 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.505 ' CD1' HD23 ' A' ' 27' ' ' LEU . 10.7 mm -82.76 127.39 70.22 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.603 -0.726 . . . . 1.37 109.771 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.59 144.67 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.486 2.124 . . . . 1.17 112.644 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -103.55 131.42 22.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.779 . . . . 3.13 108.895 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 91.7 Cg_exo -44.43 125.11 5.72 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.953 2.436 . . . . 1.39 113.018 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.1 92.4 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.74 . . . . 1.69 111.456 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -141.78 129.84 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.587 -1.264 . . . . 1.49 107.587 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.43 -63.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.568 0.581 . . . . 3.44 112.568 -169.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.5 tp10 -95.41 -55.11 3.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.111 0.481 . . . . 2.84 111.017 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.7 t 169.96 161.47 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.646 -0.706 . . . . 2.07 109.756 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.424 HG22 ' CD2' ' A' ' 93' ' ' HIS . 5.7 m -105.79 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 1.45 112.256 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.424 ' CD2' HG22 ' A' ' 92' ' ' THR . 89.6 m-70 -138.91 172.34 13.0 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.494 0.664 . . . . 1.73 112.268 -171.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.89 163.05 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.878 -1.056 . . . . 1.86 109.399 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.54 177.49 45.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.817 -0.706 . . . . 0.54 111.387 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 m -107.79 161.6 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.046 0.45 . . . . 2.06 110.28 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.13 126.9 26.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 1.31 110.133 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.74 -44.35 56.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 1.31 111.484 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.74 0.274 . . . . 4.44 111.74 177.268 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.204 0 N-CA-C 111.81 0.3 . . . . 1.67 111.81 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 65.21 -176.65 12.42 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.265 -0.493 . . . . 1.08 113.311 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' GLY . 48.4 mt -151.01 139.8 20.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.217 0.532 . . . . 1.5 110.917 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.4 135.22 41.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.06 109.308 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.03 112.43 21.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.858 0.837 . . . . 1.4 109.246 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 16.9 mm -85.27 141.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.895 -1.048 . . . . 1.26 110.285 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.484 ' CG ' ' HA ' ' A' ' 122' ' ' ARG . 34.9 tp -85.44 136.95 33.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 116.251 -0.431 . . . . 1.72 110.015 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.47 152.82 10.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.059 -0.973 . . . . 2.29 110.441 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.434 ' HG2' HD23 ' A' ' 121' ' ' LEU . 1.9 pm0 -58.4 -26.72 63.55 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.043 0.386 . . . . 2.78 112.043 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.93 15.43 22.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.029 -0.268 . . . . 2.13 110.444 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.494 ' O ' ' HD2' ' A' ' 122' ' ' ARG . 1.4 tmm_? 64.25 31.8 12.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.818 0.818 . . . . 4.81 109.484 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 m -77.18 -83.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.751 -0.659 . . . . 2.38 111.435 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 p -140.39 -169.76 2.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.737 -0.211 . . . . 2.22 110.779 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -67.97 137.62 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.903 -0.406 . . . . 1.84 109.903 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.9 mt -83.68 -70.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.282 -0.567 . . . . 1.45 110.739 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.8 p -135.88 -85.64 0.36 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.169 0.509 . . . . 1.86 111.714 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.442 ' O ' ' HD2' ' A' ' 129' ' ' HIS . 7.5 pt20 -176.48 137.43 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.247 -0.888 . . . . 2.39 109.489 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.485 ' CG ' HG13 ' A' ' 117' ' ' ILE . 33.8 m170 -124.49 132.97 53.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.7 110.254 171.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -86.41 150.3 24.4 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.644 -0.707 . . . . 1.19 110.158 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -123.33 140.81 52.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.289 0.566 . . . . 0.82 111.671 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.49 154.74 20.77 Favored Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 115.426 -0.806 . . . . 0.59 111.987 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.35 -23.75 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 117.154 0.477 . . . . 1.25 111.493 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.7 p -81.78 -26.06 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.341 0.591 . . . . 1.68 110.669 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 19.8 m -73.81 -30.0 62.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.41 -0.814 . . . . 1.46 110.001 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 73.1 mt -76.01 60.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.242 -0.89 . . . . 2.06 111.828 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.46 -48.2 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.825 0.345 . . . . 1.4 111.595 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.74 35.84 1.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 2.83 111.167 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 14.8 ptpt -48.23 -25.08 1.37 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.194 1.183 . . . . 1.92 114.194 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -82.24 -11.44 58.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.903 0.383 . . . . 2.83 110.915 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.94 147.34 48.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 1.89 109.904 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.99 87.28 6.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.701 0.762 . . . . 3.33 110.051 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.34 109.22 20.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.659 -1.155 . . . . 1.26 110.223 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -104.8 -177.49 3.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.918 -0.583 . . . . 2.0 110.916 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -66.62 141.46 57.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.9 110.104 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.99 -4.23 81.36 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.63 -0.795 . . . . 1.17 113.151 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.1 141.56 28.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.757 -0.777 . . . . 1.94 109.64 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mt -86.82 132.14 33.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.423 0.63 . . . . 2.45 111.746 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.42 152.74 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 1.77 110.875 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.0 p -112.1 140.33 46.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 1.86 109.389 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.88 168.09 19.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.809 -0.441 . . . . 0.74 109.809 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 124.12 25.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.695 -0.802 . . . . 2.72 111.438 173.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tt -99.44 140.31 19.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.785 -1.098 . . . . 1.84 110.435 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -166.57 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.765 -0.198 . . . . 1.92 110.759 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 12.4 pt-20 -74.36 -36.73 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 2.76 111.573 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.9 t -74.36 -17.44 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.876 0.37 . . . . 2.5 111.015 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.51 19.89 54.7 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.516 -0.849 . . . . 1.27 112.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -139.31 178.23 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.968 -0.753 . . . . 4.13 108.968 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.36 108.64 19.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.251 -0.277 . . . . 1.09 110.251 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -121.3 161.98 21.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.43 . . . . 1.2 110.964 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.5 m 63.84 37.07 9.93 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.712 0.633 . . . . 2.15 109.921 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.8 t -69.15 114.93 6.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.237 -0.892 . . . . 1.93 111.202 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -125.13 118.81 26.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.834 -0.621 . . . . 2.63 109.945 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.94 116.19 3.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 1.23 110.543 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.05 118.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.506 0.669 . . . . 2.08 111.585 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.702 -0.681 . . . . 3.44 109.923 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 18.9 mm-40 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.181 0.515 . . . . 2.13 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.11 122.52 44.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 1.8 108.896 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.09 137.59 32.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.204 -0.453 . . . . 1.36 110.304 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -106.62 142.24 36.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.096 -0.502 . . . . 2.73 109.676 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.24 -174.01 34.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.183 -0.767 . . . . 0.5 111.183 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.81 144.17 35.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.884 0.373 . . . . 0.75 110.8 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.01 115.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 1.14 111.021 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.42 -44.36 4.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 1.31 110.507 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 23' ' ' PHE . 86.9 t -117.35 123.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.036 -0.529 . . . . 2.16 110.801 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.8 ttm -124.12 110.96 15.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.579 . . . . 1.92 109.968 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.3 mmtt -100.68 -174.3 2.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.754 -0.462 . . . . 2.53 109.754 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.06 -20.3 38.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.931 -0.577 . . . . 3.24 110.485 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -111.78 -49.02 3.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.089 0.471 . . . . 2.03 111.457 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 12.4 p90 -141.23 -174.12 3.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 1.47 109.747 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.74 177.48 33.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.591 -0.814 . . . . 0.76 112.254 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' CZ ' ' HE1' ' A' ' 21' ' ' PHE . 63.5 m-85 -128.78 139.09 52.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.021 0.439 . . . . 1.22 109.954 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -112.47 125.9 69.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.844 -0.617 . . . . 1.15 110.914 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.8 132.01 43.04 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.776 -0.824 . . . . 2.3 108.776 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 p -84.0 150.13 25.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.219 -0.446 . . . . 1.36 110.199 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.535 ' CD1' HD11 ' A' ' 83' ' ' ILE . 6.9 tp -49.07 -46.85 45.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.788 -0.642 . . . . 2.15 111.828 -174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 m -109.14 30.14 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.028 -0.533 . . . . 2.51 110.74 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 p80 39.4 57.37 2.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.618 1.199 . . . . 4.08 111.389 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.16 -35.97 23.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.73 -1.577 . . . . 2.89 109.918 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -173.72 175.22 2.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.14 -0.936 . . . . 1.8 110.108 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.6 128.57 50.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.196 -1.039 . . . . 3.37 108.196 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 124.37 58.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.648 -0.421 . . . . 1.43 111.043 -174.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.2 112.47 4.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.811 -0.631 . . . . 1.12 109.572 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -121.64 121.61 37.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.624 0.726 . . . . 2.46 110.796 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.94 128.18 44.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.135 -0.939 . . . . 1.4 108.717 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -62.17 -18.56 61.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.981 0.363 . . . . 0.82 111.981 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -60.05 -34.04 72.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.38 . . . . 2.03 111.03 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -95.65 20.79 9.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.934 0.397 . . . . 2.09 111.215 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -94.07 139.62 30.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 1.39 110.871 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.33 106.16 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.054 -0.521 . . . . 2.04 110.444 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.56 -150.51 17.82 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.862 -0.685 . . . . 1.05 112.173 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -108.37 104.05 52.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.456 0.17 . . . . 2.51 110.729 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.22 -19.95 28.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 1.14 112.819 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -70.44 -22.71 62.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.437 0.637 . . . . 2.29 110.164 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -96.28 19.38 12.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.348 -0.842 . . . . 2.45 110.343 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.422 ' CD2' ' HE2' ' A' ' 77' ' ' MET . 55.4 mt -95.84 153.55 17.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.29 110.181 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 51' ' ' GLN . 6.0 pt-20 -126.24 162.25 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.969 -0.56 . . . . 2.35 109.935 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 114.58 10.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.017 -0.735 . . . . 2.01 109.017 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.37 4.54 40.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.506 -0.854 . . . . 0.82 112.183 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 57.9 tp60 -73.49 133.1 43.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.897 0.38 . . . . 1.16 110.612 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -86.27 128.24 34.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 2.51 110.799 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 77' ' ' MET . 35.7 m -139.51 160.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.088 -0.505 . . . . 1.12 110.921 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -120.88 140.02 52.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.234 -0.654 . . . . 1.49 109.234 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.78 172.62 15.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.088 0.47 . . . . 0.79 112.075 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 p -131.96 157.86 42.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.684 -0.689 . . . . 1.49 110.77 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.44 149.29 22.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 1.55 111.155 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.972 -0.558 . . . . 2.04 111.125 -179.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.49 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 120.709 0.29 . . . . 2.92 111.696 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.09 155.21 66.11 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.854 2.369 . . . . 1.58 112.378 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.03 30.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.994 -0.548 . . . . 1.33 110.668 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.79 169.32 17.23 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.507 -0.553 . . . . 2.3 109.507 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 t30 60.03 45.54 11.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.636 0.732 . . . . 2.67 109.871 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.32 114.05 29.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.73 . . . . 1.46 110.359 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 163.28 24.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 4.04 110.239 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.449 ' HA ' HG13 ' A' ' 53' ' ' VAL . 65.7 mtt -79.63 153.02 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.145 0.498 . . . . 1.5 111.369 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.8 mt -119.88 158.54 49.69 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.252 -0.885 . . . . 2.27 109.687 172.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.21 153.83 71.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.125 1.883 . . . . 2.54 111.93 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -78.94 148.68 32.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.077 -0.511 . . . . 4.95 110.839 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 72.01 30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 3.42 110.853 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.3 p -87.63 -11.71 47.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.39 0.614 . . . . 2.12 109.923 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 ' CD1' ' A' ' 27' ' ' LEU . 13.6 mm -84.98 131.56 48.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.315 -0.857 . . . . 1.37 109.627 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.18 150.58 65.85 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.483 2.122 . . . . 1.17 112.412 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -126.92 148.54 65.9 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.403 -0.362 . . . . 3.13 110.206 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.98 127.8 14.09 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.024 2.483 . . . . 1.39 113.625 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.94 94.49 4.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.659 -0.701 . . . . 1.69 110.895 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.86 120.94 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 1.49 109.087 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.05 -62.77 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.544 0.201 . . . . 3.44 111.544 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 91' ' ' THR . 6.0 mm-40 -92.98 -55.33 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 2.84 111.733 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 12.5 t 168.91 158.67 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.695 -0.854 . . . . 2.07 108.695 -176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.08 -58.92 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.454 -0.498 . . . . 1.45 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.44 163.61 34.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 1.73 110.803 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -120.87 174.09 6.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.457 -0.942 . . . . 1.86 108.457 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.35 -174.3 46.87 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.027 -1.083 . . . . 0.54 111.606 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.15 162.42 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.008 0.432 . . . . 2.06 110.028 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.39 122.43 17.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.94 -0.573 . . . . 1.31 109.869 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.65 -45.65 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.352 . . . . 1.31 111.61 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 4.44 110.835 179.469 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB3' ' CD ' ' A' ' 130' ' ' GLU . . . . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 112.301 0.482 . . . . 1.67 112.301 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.23 150.7 8.72 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.635 -0.793 . . . . 1.08 112.284 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 130' ' ' GLU . 67.3 mt -127.28 147.26 50.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.498 0.666 . . . . 1.5 112.597 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 82.3 mt -111.11 141.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.908 -1.042 . . . . 1.06 109.313 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.497 ' HG3' ' CG2' ' A' ' 125' ' ' VAL . 32.7 tt0 -93.11 109.24 20.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.148 0.499 . . . . 1.4 109.981 -176.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 129' ' ' HIS . 12.6 mm -91.74 132.52 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.713 . . . . 1.26 110.154 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -91.83 153.91 19.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.131 0.491 . . . . 1.72 111.008 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 123' ' ' THR . 2.8 t70 -55.12 146.88 17.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.32 -0.855 . . . . 2.29 109.063 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 121' ' ' LEU . 2.9 pm0 -62.75 -20.01 64.53 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.464 0.542 . . . . 2.78 112.464 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD23 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -102.25 13.46 34.6 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.936 -0.394 . . . . 2.13 109.936 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 58.1 80.89 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.652 -0.704 . . . . 4.81 110.378 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.462 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 32.5 m -116.33 -71.99 0.71 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.451 -0.795 . . . . 2.38 109.663 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -146.43 -176.58 5.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.82 -0.627 . . . . 2.22 110.189 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.497 ' CG2' ' HG3' ' A' ' 116' ' ' GLU . 3.6 p -72.38 137.86 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.281 -0.418 . . . . 1.84 110.105 175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.37 -70.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.431 -0.507 . . . . 1.45 110.086 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.2 p -138.48 -87.82 0.24 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.417 0.627 . . . . 1.86 111.193 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.98 139.1 0.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.647 -1.16 . . . . 2.39 108.224 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.518 ' HB2' HD12 ' A' ' 117' ' ' ILE . 25.9 m170 -117.32 121.06 40.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.455 -0.498 . . . . 0.7 110.448 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.433 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.3 tt0 -78.71 149.31 32.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.736 -0.665 . . . . 1.19 109.849 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -117.77 175.44 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.943 0.402 . . . . 0.82 111.007 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.46 153.09 21.44 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.797 -0.638 . . . . 0.59 111.616 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -51.03 -30.54 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.019 0.409 . . . . 1.25 111.516 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.4 p -74.44 -36.91 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 1.68 110.946 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 16.9 m -69.94 -23.15 63.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 1.46 110.145 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.88 59.78 1.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 2.06 111.846 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.2 t -48.28 -41.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.228 0.537 . . . . 1.4 110.563 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.95 33.88 1.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.652 -0.703 . . . . 2.83 110.722 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -52.93 -25.09 10.77 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.799 1.037 . . . . 1.92 113.799 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -84.07 -16.92 42.01 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.586 -0.446 . . . . 2.83 111.363 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -76.01 150.05 37.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 1.89 110.617 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 142' ' ' LEU . 2.1 mm? -84.96 71.37 10.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.935 -0.575 . . . . 3.33 109.745 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.72 122.88 24.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.775 -0.648 . . . . 1.26 110.028 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -108.32 172.12 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.024 0.44 . . . . 2.0 111.758 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 146' ' ' GLY . 13.5 tmtt? -70.93 132.82 45.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 1.9 110.366 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 145' ' ' LYS . . . 87.56 4.07 80.38 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.47 -0.871 . . . . 1.17 113.05 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.89 152.01 22.4 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.136 -0.626 . . . . 1.94 110.045 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 148' ' ' LEU . 3.3 mm? -77.32 123.47 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.529 0.681 . . . . 2.45 111.513 -172.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.169 -0.923 . . . . 1.77 110.339 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 73.4 m -121.57 152.8 38.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.057 -0.52 . . . . 1.86 110.558 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 162' ' ' VAL . 6.4 p90 -165.49 168.27 16.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.803 -0.635 . . . . 0.74 109.817 -173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.48 122.55 29.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.459 0.647 . . . . 2.72 110.805 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -100.7 137.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.886 . . . . 1.84 110.551 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.531 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 31.6 t70 -169.64 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.19 -0.3 . . . . 1.92 110.19 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 39.1 mt-10 -76.73 -18.61 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.618 . . . . 2.76 110.035 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.5 p -80.03 -18.68 49.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.542 -0.754 . . . . 2.5 110.643 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.77 2.73 2.69 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.61 -0.723 . . . . 1.27 114.082 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -154.89 -161.16 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.262 -0.644 . . . . 4.13 109.262 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.71 115.58 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.337 0.589 . . . . 1.09 110.842 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -128.79 148.81 50.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.497 -0.774 . . . . 1.2 109.861 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.0 m 55.27 55.17 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.038 0.836 . . . . 2.15 110.916 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 150' ' ' SER . 4.1 m -77.25 141.62 15.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.287 0.565 . . . . 1.93 110.277 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -138.56 119.95 14.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 2.63 110.286 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.16 103.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.115 -0.493 . . . . 1.23 110.958 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.97 118.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.381 0.61 . . . . 2.08 110.698 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 3.44 110.791 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 120.998 0.428 . . . . 2.13 110.977 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.412 ' HA ' HG23 ' A' ' 56' ' ' THR . 2.4 p -104.23 129.71 56.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.612 -0.722 . . . . 1.8 109.774 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -113.17 148.72 34.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.279 -0.873 . . . . 1.36 109.881 -174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -110.45 136.42 49.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.147 -0.479 . . . . 2.73 109.907 -177.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.44 -168.2 17.52 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.372 -0.691 . . . . 0.5 111.372 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 149.14 34.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.121 0.486 . . . . 0.75 111.178 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.77 118.99 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.442 -0.799 . . . . 1.14 110.497 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.21 -49.67 3.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.31 111.001 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 23' ' ' PHE . 6.3 p -123.51 139.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.032 -0.531 . . . . 2.16 110.272 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.7 ttm -131.76 122.05 25.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.42 . . . . 1.92 110.993 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -107.43 -170.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.653 -0.869 . . . . 2.53 108.653 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.96 -20.36 25.99 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.438 -0.801 . . . . 3.24 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.83 -48.44 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.063 0.459 . . . . 2.03 111.34 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.3 p90 -143.65 175.78 9.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.36 . . . . 1.47 110.947 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.27 173.23 33.51 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.435 -0.666 . . . . 0.76 111.435 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' H ' HG13 ' A' ' 16' ' ' VAL . 40.7 m-85 -114.16 126.17 54.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.661 -0.866 . . . . 1.22 108.661 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.69 125.66 46.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.243 -0.435 . . . . 1.15 110.527 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.74 119.7 15.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.172 -0.677 . . . . 2.3 109.172 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.45 160.55 24.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.328 -0.851 . . . . 1.36 110.315 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 13.9 tp -56.27 -46.4 79.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.341 -0.39 . . . . 2.15 111.929 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.8 t -99.58 13.02 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.59 -0.522 . . . . 2.51 109.59 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.539 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 84.5 m-70 61.22 35.56 18.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.42 -0.809 . . . . 4.08 109.599 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.94 -58.52 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.094 -1.412 . . . . 2.89 111.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.07 178.85 9.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 1.8 109.765 -173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 131.4 50.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 3.37 110.62 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.98 129.9 64.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.888 -0.597 . . . . 1.43 110.464 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -80.91 113.21 18.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.464 0.65 . . . . 1.12 110.446 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' CE2' HG22 ' A' ' 75' ' ' VAL . 26.3 t80 -121.95 132.49 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 2.46 110.13 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -102.26 124.32 47.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.159 -0.682 . . . . 1.4 109.159 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.97 -18.74 63.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.476 0.547 . . . . 0.82 112.476 -172.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -59.26 -23.28 62.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.007 0.432 . . . . 2.03 110.618 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.18 20.72 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.081 0.467 . . . . 2.09 110.458 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -85.99 140.95 29.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 1.39 110.336 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.7 ttm -111.47 89.32 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 2.04 110.425 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.27 -168.97 33.19 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.812 -0.631 . . . . 1.05 111.949 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.43 HD21 ' HB2' ' A' ' 46' ' ' TRP . 4.3 p-10 -98.37 102.75 15.21 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.344 0.593 . . . . 2.51 110.791 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.89 -17.99 13.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 1.14 113.513 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -64.32 -25.72 68.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 2.29 110.107 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.43 ' HB2' HD21 ' A' ' 43' ' ' ASN . 84.1 m95 -106.51 23.51 14.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.823 -0.626 . . . . 2.45 111.419 -176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' ' HE3' ' A' ' 77' ' ' MET . 23.9 mt -89.7 152.02 21.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.717 -0.674 . . . . 1.29 109.719 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.13 157.81 44.77 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 mm? -68.67 118.15 11.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.41 -0.359 . . . . 2.01 110.061 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.77 -5.47 16.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.82 112.296 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -76.31 122.96 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.669 0.271 . . . . 1.16 110.955 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 21.5 mt-10 -64.16 137.41 57.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.693 -0.685 . . . . 2.51 110.656 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.476 HG13 ' HA ' ' A' ' 77' ' ' MET . 22.5 m -143.09 148.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.508 -0.553 . . . . 1.12 109.508 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.33 144.48 43.19 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.931 -0.766 . . . . 1.49 108.931 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.451 ' CB ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -162.61 163.89 26.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.038 0.447 . . . . 0.79 111.939 -174.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 9' ' ' VAL . 56.9 p -120.94 153.51 37.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 1.49 109.742 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.67 156.74 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.745 0.307 . . . . 1.55 110.827 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 108.867 -0.79 . . . . 2.04 108.867 176.439 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.424 0.154 . . . . 2.92 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.17 153.16 67.29 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.532 2.155 . . . . 1.58 111.106 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.27 147.54 29.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.453 -0.34 . . . . 1.33 111.245 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -126.85 174.22 8.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.495 -0.321 . . . . 2.3 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 58.8 34.2 23.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.869 -0.605 . . . . 2.67 112.232 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' A' ' 35' ' ' PHE . 40.8 t -78.19 119.74 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.977 0.418 . . . . 1.46 110.899 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 76' ' ' ARG . 11.1 mmm180 -124.39 148.72 47.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.675 -0.693 . . . . 4.04 110.35 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.476 ' HA ' HG13 ' A' ' 53' ' ' VAL . 66.7 mtt -69.04 140.95 54.94 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.017 -0.364 . . . . 1.5 110.017 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 31.1 tp -130.61 82.69 64.16 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.389 -0.369 . . . . 2.27 111.502 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.06 116.58 3.97 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.524 1.483 . . . . 2.54 110.305 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -166.22 -21.45 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.904 0.383 . . . . 4.95 111.006 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t30 59.35 41.19 20.1 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.452 -0.944 . . . . 3.42 108.452 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 t -88.44 -5.97 57.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.626 -1.17 . . . . 2.12 110.924 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.23 119.65 54.65 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 1.37 109.236 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.68 158.98 53.27 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 122.44 2.094 . . . . 1.17 112.125 -172.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -98.2 139.72 21.4 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.942 -0.572 . . . . 3.13 110.413 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.457 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 76.6 Cg_exo -51.02 134.83 43.59 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.113 2.542 . . . . 1.39 112.261 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.76 91.83 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 1.69 110.226 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -142.82 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 1.49 109.531 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.92 -59.81 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.02 0.378 . . . . 3.44 112.02 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.554 ' O ' ' HB ' ' A' ' 91' ' ' THR . 16.7 mm-40 -90.76 -56.29 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.31 0.576 . . . . 2.84 111.145 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 13.1 t 151.01 164.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.431 -1.692 . . . . 2.07 106.431 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.4 HG23 HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -106.48 -58.21 1.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.28 -0.968 . . . . 1.45 111.536 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -140.87 158.37 44.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.028 0.442 . . . . 1.73 110.761 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -140.15 126.04 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.72 -0.673 . . . . 1.86 109.398 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.47 -140.45 3.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.986 -1.102 . . . . 0.54 112.379 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.92 152.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.611 0.243 . . . . 2.06 110.475 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.485 HG21 ' HG ' ' A' ' 143' ' ' LEU . 64.8 t -61.89 132.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 1.31 110.419 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -87.15 -49.11 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.238 0.458 . . . . 1.31 112.238 -173.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 . . . . . 0 C--N 1.327 -0.378 0 C-N-CA 120.257 -0.577 . . . . 4.44 111.823 -172.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 111.761 0.282 . . . . 1.67 111.761 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.53 170.01 46.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.529 -0.843 . . . . 1.08 111.969 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 130' ' ' GLU . 72.6 mt -145.31 144.21 30.61 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.309 0.576 . . . . 1.5 111.613 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.39 138.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.011 -0.995 . . . . 1.06 109.211 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.67 114.75 26.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.643 0.735 . . . . 1.4 110.312 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 14.8 mm -91.34 132.15 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.045 -0.98 . . . . 1.26 109.845 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.9 pt? -85.65 152.74 22.87 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.181 0.301 . . . . 1.72 110.438 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.438 ' OD1' ' HB ' ' A' ' 123' ' ' THR . 18.2 m-20 -56.75 151.67 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.669 -0.493 . . . . 2.29 109.669 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -62.59 -25.95 68.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.735 0.302 . . . . 2.78 110.699 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.49 5.78 43.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 2.13 109.987 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 60.94 78.92 0.27 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.547 -0.751 . . . . 4.81 110.643 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.438 ' HB ' ' OD1' ' A' ' 119' ' ' ASP . 22.0 m -121.13 -74.18 0.62 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 2.38 110.606 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.5 p -144.03 -174.71 4.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.148 -0.478 . . . . 2.22 110.75 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.1 p -70.92 134.54 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.676 -0.491 . . . . 1.84 109.676 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.68 -69.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 1.45 110.623 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -136.66 -84.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.261 0.553 . . . . 1.86 111.197 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -175.33 142.38 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.035 -0.984 . . . . 2.39 108.899 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' CD2' HG13 ' A' ' 117' ' ' ILE . 17.5 m170 -124.1 124.39 42.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.999 0.428 . . . . 0.7 110.678 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.0 tt0 -85.26 143.74 28.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.247 -0.888 . . . . 1.19 108.758 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -117.13 134.31 54.93 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.181 -0.608 . . . . 0.82 111.348 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.539 ' HA3' ' CE1' ' A' ' 29' ' ' HIS . . . -77.95 153.58 40.16 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 114.945 -1.025 . . . . 0.59 113.11 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.37 -37.52 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.545 0.338 . . . . 1.25 111.905 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.6 p -80.0 -32.89 39.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.322 0.582 . . . . 1.68 110.731 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 45.5 m -64.67 -32.81 74.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.263 -0.88 . . . . 1.46 109.934 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.9 tp -78.36 58.38 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.452 -0.795 . . . . 2.06 110.846 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -44.91 -40.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.64 0.733 . . . . 1.4 110.675 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.713 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 33.7 m-80 -87.87 33.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 2.83 111.283 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -61.9 -16.1 48.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.112 0.482 . . . . 1.92 111.064 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -92.15 -9.13 43.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.795 -0.639 . . . . 2.83 111.285 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.31 166.46 15.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 1.89 110.323 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -98.31 52.57 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.428 0.632 . . . . 3.33 109.753 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.485 ' HG ' HG21 ' A' ' 97' ' ' VAL . 13.0 tp -60.02 125.48 23.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.828 -1.078 . . . . 1.26 111.591 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -129.95 171.8 12.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 2.0 110.544 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 86.5 tttt -70.57 136.02 48.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.268 -0.573 . . . . 1.9 109.564 176.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.29 -9.12 57.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.486 -0.864 . . . . 1.17 111.398 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -91.81 123.34 35.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.334 -0.987 . . . . 1.94 108.334 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.94 146.87 47.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.049 0.452 . . . . 2.45 110.201 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.17 146.54 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.285 0.564 . . . . 1.77 111.504 -172.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 p -111.52 145.42 39.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.268 -0.878 . . . . 1.86 109.663 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -165.38 158.0 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.914 0.388 . . . . 0.74 110.175 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -125.65 125.26 42.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.399 -0.593 . . . . 2.72 109.399 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 92' ' ' THR . 9.2 tt -99.64 121.85 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 1.84 109.876 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.574 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 7.4 p-10 -145.71 -100.7 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.533 -0.303 . . . . 1.92 111.155 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.574 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 1.4 mt-10 -78.86 -29.0 44.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.026 0.441 . . . . 2.76 110.373 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.0 t -74.02 -17.51 60.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 2.5 110.915 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.72 21.99 58.97 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.719 -0.753 . . . . 1.27 112.37 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 158' ' ' ARG . 52.7 mtt180 -140.79 -171.4 3.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.997 -0.742 . . . . 4.13 108.997 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.86 107.74 18.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.606 -0.438 . . . . 1.09 109.862 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -110.33 161.48 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 1.2 110.109 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.71 36.93 19.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.24 0.543 . . . . 2.15 110.235 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.35 112.16 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.523 0.678 . . . . 1.93 111.12 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.713 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 53.2 t30 -131.14 114.52 15.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 2.63 110.476 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.41 131.18 49.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 1.23 111.057 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.54 107.28 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.959 -0.564 . . . . 2.08 110.501 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.362 -0.607 . . . . 3.44 109.362 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.952 0.406 . . . . 2.13 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -90.77 115.29 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.643 -0.873 . . . . 1.8 108.643 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.511 ' CD2' ' HG ' ' A' ' 57' ' ' LEU . 22.8 m-85 -87.79 139.17 30.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.404 0.621 . . . . 1.36 110.786 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 27.8 ttm180 -100.83 130.12 46.8 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.01 -0.995 . . . . 2.73 110.189 -176.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.63 -177.31 26.99 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.378 -0.689 . . . . 0.5 111.378 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -149.21 151.05 33.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.964 0.412 . . . . 0.75 111.064 -177.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.7 123.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.857 -0.61 . . . . 1.14 111.477 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . . . -106.26 -37.08 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 1.31 111.584 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 23' ' ' PHE . 6.4 p -144.82 149.65 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.074 -0.512 . . . . 2.16 109.953 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.6 mtp -130.71 107.5 9.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.77 -0.456 . . . . 1.92 109.77 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.22 -168.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.53 109.746 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.72 -44.2 43.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.159 0.504 . . . . 3.24 110.885 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -102.91 -27.93 12.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.545 . . . . 2.03 111.655 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.12 -177.91 6.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.895 0.379 . . . . 1.47 111.756 -172.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.95 160.82 28.54 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.931 -0.577 . . . . 0.76 111.719 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB2' HG12 ' A' ' 16' ' ' VAL . 25.9 m-85 -108.38 135.46 49.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.763 -0.458 . . . . 1.22 109.763 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -102.53 125.12 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.995 -0.548 . . . . 1.15 110.304 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.544 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 32.6 tt0 -72.34 117.79 14.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.968 -1.123 . . . . 2.3 107.968 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 p -66.07 157.44 31.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.036 -0.357 . . . . 1.36 110.036 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' HD12 ' A' ' 83' ' ' ILE . 17.2 tp -53.23 -36.05 60.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 2.15 111.785 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -110.7 12.61 22.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 2.51 110.054 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.2 p80 40.34 39.81 0.74 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.531 1.132 . . . . 4.08 113.086 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -95.37 -0.87 52.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 2.89 110.472 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -156.98 148.08 21.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 1.8 111.248 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.42 121.45 44.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.422 -0.584 . . . . 3.37 109.422 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.4 t -109.47 130.62 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 1.43 111.44 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 71' ' ' PRO . 14.0 t80 -84.56 120.56 26.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.814 -0.63 . . . . 1.12 110.385 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -124.23 144.96 49.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.828 -0.624 . . . . 2.46 110.367 177.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -116.84 126.92 53.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.716 -0.675 . . . . 1.4 110.101 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -63.93 -20.88 66.19 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.196 0.443 . . . . 0.82 112.196 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.7 t -67.02 -27.23 67.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.62 -0.263 . . . . 2.03 111.517 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -101.93 6.85 41.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.09 111.476 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' A' ' 47' ' ' LEU . 79.5 t80 -73.3 129.72 38.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.129 -0.487 . . . . 1.39 110.832 -175.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.5 ttp -98.9 93.09 5.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 2.04 110.389 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.27 -134.77 4.22 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.607 -0.724 . . . . 1.05 111.466 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -132.72 106.02 12.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.721 -0.474 . . . . 2.51 109.721 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.26 -17.85 16.55 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.36 2.04 . . . . 1.14 112.887 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -74.52 -17.01 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.338 0.59 . . . . 2.29 110.357 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -101.03 -2.13 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 2.45 110.844 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 13.1 mt -77.38 146.63 36.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 1.29 111.736 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.23 173.31 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 2.35 109.66 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.21 130.04 37.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.237 -0.438 . . . . 2.01 110.449 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.97 4.91 58.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.82 112.918 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.4 126.94 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.862 0.331 . . . . 1.16 111.042 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.57 129.97 39.53 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.577 -0.738 . . . . 2.51 110.551 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.92 156.54 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.932 0.396 . . . . 1.12 110.816 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HB3' HD11 ' A' ' 78' ' ' LEU . 12.9 pt-20 -114.3 138.64 50.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.086 -0.709 . . . . 1.49 109.086 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 72' ' ' ALA . 6.8 p90 -165.3 176.76 8.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.958 0.409 . . . . 0.79 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 p -125.67 145.45 50.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.1 -0.5 . . . . 1.49 110.973 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 10' ' ' TYR . 90.8 mt -73.02 135.39 44.91 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.621 -0.432 . . . . 1.55 110.371 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.065 0 CA-C-N 115.531 -0.759 . . . . 2.04 109.724 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.467 ' H ' HD11 ' A' ' 70' ' ' LEU . 1.7 mp . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 108.934 -0.765 . . . . 2.92 108.934 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 35.3 Cg_endo -66.01 140.66 61.06 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.019 1.813 . . . . 1.58 111.661 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . . . -58.25 121.22 10.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.493 -0.776 . . . . 1.33 110.593 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.3 148.44 28.99 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.361 0.413 . . . . 2.3 110.842 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.4 t30 59.12 82.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.23 -0.896 . . . . 2.67 110.708 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.49 121.95 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 1.46 110.253 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -125.97 156.47 39.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.837 -0.431 . . . . 4.04 109.837 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.3 mtt -76.91 138.99 40.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.5 110.613 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 54' ' ' GLU . 22.0 tp -113.88 146.0 34.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 2.27 109.255 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.07 155.84 17.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.54 113.152 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 84.4 tttt -73.35 154.2 40.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.389 -0.823 . . . . 4.95 111.308 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 93.7 m-20 77.36 23.56 0.87 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.622 0.769 . . . . 3.42 110.841 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 m -86.26 -13.08 47.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.863 -0.608 . . . . 2.12 109.512 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' A' ' 27' ' ' LEU . 3.5 mm -93.71 130.91 33.46 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.898 -0.778 . . . . 1.37 108.898 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.07 145.91 80.53 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.673 2.248 . . . . 1.17 112.56 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -124.0 137.54 29.1 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 3.13 110.835 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 82.6 Cg_exo -50.23 141.07 32.24 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.692 2.928 . . . . 1.39 113.352 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.58 95.29 5.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 1.69 111.393 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.455 HG11 ' OG1' ' A' ' 92' ' ' THR . 16.7 m -121.54 171.31 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.499 -0.556 . . . . 1.49 109.499 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.47 -63.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.308 -0.557 . . . . 3.44 111.124 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.03 -54.18 3.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.393 0.616 . . . . 2.84 111.269 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t 172.5 163.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.379 -0.971 . . . . 2.07 108.379 -174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.455 ' OG1' HG11 ' A' ' 88' ' ' VAL . 2.1 m -107.18 -59.06 1.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 1.45 111.84 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.418 ' CD2' HG21 ' A' ' 92' ' ' THR . 97.9 m-70 -148.34 178.04 8.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.573 0.701 . . . . 1.73 111.504 -173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.42 166.62 23.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.588 -1.264 . . . . 1.86 107.588 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.49 -165.79 30.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.707 -1.235 . . . . 0.54 112.695 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -135.7 141.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.547 0.339 . . . . 2.06 110.165 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 66.3 t -59.15 118.99 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.06 -0.348 . . . . 1.31 110.06 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.27 -64.15 1.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 1.31 111.917 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.336 . . . . 4.44 111.862 -174.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.985 0.421 . . . . 1.67 111.76 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.538 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 63.57 174.66 3.08 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.97 -0.559 . . . . 1.08 113.035 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 130' ' ' GLU . 55.8 mt -145.49 138.61 26.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.544 0.688 . . . . 1.5 111.715 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.48 138.02 37.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.686 -1.143 . . . . 1.06 109.767 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.62 121.39 29.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.628 . . . . 1.4 109.408 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 4.2 mm -103.36 120.45 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.45 -0.795 . . . . 1.26 109.238 -175.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD21 ' H ' ' A' ' 118' ' ' LEU . 2.5 pt? -85.18 139.41 31.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 1.72 110.29 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.73 160.9 3.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.147 -0.933 . . . . 2.29 110.218 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.1 -27.0 68.8 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.19 -0.319 . . . . 2.78 111.53 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.05 12.54 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.709 -0.478 . . . . 2.13 109.709 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 48.59 35.91 6.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.794 1.238 . . . . 4.81 111.854 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 20.3 p -75.47 -67.39 0.67 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.608 -0.723 . . . . 2.38 111.118 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.7 p -139.01 172.81 12.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.09 -0.505 . . . . 2.22 111.28 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.6 t -72.92 136.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 1.84 109.474 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -70.98 -69.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.43 -0.508 . . . . 1.45 111.1 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 61.2 m -140.4 -85.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.45 0.643 . . . . 1.86 111.341 172.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -176.5 123.9 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.646 -1.161 . . . . 2.39 108.653 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.447 ' CE1' HD12 ' A' ' 153' ' ' ILE . 31.5 m170 -111.91 126.93 55.64 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.631 -0.827 . . . . 0.7 110.618 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 114' ' ' LEU . 13.3 tt0 -88.1 149.06 24.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.462 -1.244 . . . . 1.19 109.629 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.538 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 38.3 p90 -123.7 175.71 6.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.82 110.837 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.44 153.58 22.06 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.625 -0.716 . . . . 0.59 111.564 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 tp -54.24 -23.26 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 117.154 0.477 . . . . 1.25 111.193 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -80.99 -34.4 33.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.323 0.582 . . . . 1.68 110.674 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 36.6 t -76.02 -26.0 56.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.231 -0.895 . . . . 1.46 110.377 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 80.1 mt -75.26 60.22 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.642 . . . . 2.06 112.27 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.5 t -41.41 -49.07 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.827 0.346 . . . . 1.4 111.863 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.46 HD22 HD23 ' A' ' 143' ' ' LEU . 2.7 p-10 -97.47 36.38 1.5 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.721 0.296 . . . . 2.83 111.53 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 13.9 ptpt -51.55 -22.54 3.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.244 0.831 . . . . 1.92 113.244 -177.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -81.66 -20.84 38.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.081 0.467 . . . . 2.83 111.005 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.24 163.36 18.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.641 -0.708 . . . . 1.89 111.431 -173.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.91 100.19 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.804 -0.635 . . . . 3.33 110.276 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 138' ' ' ASN . 7.1 tp -128.11 95.35 4.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.23 -0.655 . . . . 1.26 109.23 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.4 pt20 -130.35 -171.92 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.985 -0.552 . . . . 2.0 110.914 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.9 tttt -60.58 112.99 2.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.039 0.447 . . . . 1.9 110.833 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.02 -2.8 22.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.602 -0.809 . . . . 1.17 112.789 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.58 135.86 33.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.159 0.504 . . . . 1.94 111.095 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.07 135.96 35.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.043 -0.98 . . . . 2.45 110.147 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.61 151.09 27.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.11 0.481 . . . . 1.77 110.983 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.516 ' OG ' HG13 ' A' ' 165' ' ' VAL . 75.2 m -117.1 143.6 45.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.852 -0.613 . . . . 1.86 109.702 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CZ ' HD13 ' A' ' 117' ' ' ILE . 30.5 p90 -158.68 173.93 15.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.959 -0.564 . . . . 0.74 109.929 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 124.97 22.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.72 111.261 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.447 HD12 ' CE1' ' A' ' 129' ' ' HIS . 12.6 pt -97.2 151.66 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.348 -0.842 . . . . 1.84 109.621 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 35.3 t70 -173.26 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.055 0.222 . . . . 1.92 110.579 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -73.11 -36.5 66.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.957 0.408 . . . . 2.76 111.395 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -82.36 -16.67 48.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 2.5 111.187 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.36 2.08 13.24 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.021 -0.609 . . . . 1.27 112.814 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -130.18 -178.94 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.793 -0.447 . . . . 4.13 109.793 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.43 108.86 18.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 1.09 111.56 -169.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.552 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.4 156.39 27.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.714 -0.675 . . . . 1.2 109.873 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 64.64 41.1 5.51 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.691 0.619 . . . . 2.15 110.318 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.35 114.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.695 -0.684 . . . . 1.93 110.762 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.24 125.51 45.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.377 -0.374 . . . . 2.63 110.44 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.56 120.14 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 1.23 110.616 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.516 HG13 ' OG ' ' A' ' 150' ' ' SER . 13.6 p -136.37 139.94 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 2.08 111.139 -174.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.375 -0.375 . . . . 3.44 110.096 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.148 0.499 . . . . 2.13 111.732 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 123.47 41.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.536 -0.756 . . . . 1.8 109.319 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.62 151.06 22.79 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.649 -0.871 . . . . 1.36 108.649 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -132.54 153.25 51.15 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.726 -0.79 . . . . 2.73 110.828 177.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.44 -153.84 6.7 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.607 -1.397 . . . . 0.5 109.607 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.55 140.84 30.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.942 0.401 . . . . 0.75 111.1 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -64.76 108.42 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.487 -0.779 . . . . 1.14 110.501 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.49 9.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.079 0.466 . . . . 1.31 110.812 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.38 122.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 2.16 110.375 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 45.6 ttm -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.87 -0.419 . . . . 1.92 109.87 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 71.5 mmtt -101.66 -167.08 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.212 -0.449 . . . . 2.53 109.992 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' OE2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -83.34 -35.14 25.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 3.24 110.781 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.94 -36.91 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.244 0.461 . . . . 2.03 112.244 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 22.0 p90 -138.82 -170.36 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.791 0.329 . . . . 1.47 111.413 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.1 -169.45 31.6 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.399 -0.68 . . . . 0.76 111.399 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -136.46 142.7 43.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.766 -0.457 . . . . 1.22 109.766 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -114.15 120.58 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.086 -0.507 . . . . 1.15 110.237 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -70.65 119.58 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.976 -0.75 . . . . 2.3 108.976 171.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.436 HG23 ' HB3' ' A' ' 31' ' ' GLU . 7.5 p -62.16 155.67 23.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.247 -0.433 . . . . 1.36 110.274 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.01 -34.37 63.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.154 -0.475 . . . . 2.15 111.539 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 p -99.04 6.71 46.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 2.51 111.46 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 p80 40.18 42.28 1.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.147 0.979 . . . . 4.08 112.112 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -116.62 -16.13 10.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 2.89 110.137 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB3' HG23 ' A' ' 26' ' ' THR . 9.2 tp10 -132.18 148.51 52.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8 110.021 -175.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -109.37 128.66 55.29 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.731 -0.47 . . . . 3.37 109.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.61 116.55 48.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 120.847 0.356 . . . . 1.43 111.052 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -73.73 122.49 22.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.697 . . . . 1.12 110.184 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.69 124.11 40.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.732 -0.667 . . . . 2.46 110.675 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.407 ' ND1' ' HB3' ' A' ' 21' ' ' PHE . 5.3 t60 -101.56 142.35 33.05 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.668 -0.864 . . . . 1.4 108.668 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.42 -21.02 62.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.621 -0.432 . . . . 0.82 112.143 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.1 t -61.52 -29.63 70.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 2.03 111.246 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -99.95 17.01 22.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.024 0.44 . . . . 2.09 110.482 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -92.51 129.53 38.42 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.187 -0.46 . . . . 1.39 110.257 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.9 ttp -108.8 91.96 3.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 2.04 110.376 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.05 -130.13 1.83 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.332 -0.849 . . . . 1.05 111.073 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.469 ' ND2' ' HD1' ' A' ' 46' ' ' TRP . 36.4 t30 -150.12 111.07 3.28 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.328 . . . . 2.51 110.574 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HA ' HD13 ' A' ' 47' ' ' LEU . 59.5 Cg_endo -72.34 -16.31 27.89 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.859 2.373 . . . . 1.14 113.385 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.96 -16.47 63.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.686 0.279 . . . . 2.29 111.269 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HD1' ' ND2' ' A' ' 43' ' ' ASN . 69.6 m95 -115.04 17.52 16.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.539 . . . . 2.45 111.09 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 44' ' ' PRO . 44.5 mt -96.35 165.5 12.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 1.29 110.129 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -155.0 166.78 32.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.742 -0.663 . . . . 2.35 109.328 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.481 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.6 mm? -69.09 126.28 29.3 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.532 -0.544 . . . . 2.01 109.532 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.82 -0.34 62.71 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.749 -0.738 . . . . 0.82 112.438 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.43 120.42 13.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.007 0.432 . . . . 1.16 110.72 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.541 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 21.9 mt-10 -64.34 122.8 17.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.237 -0.892 . . . . 2.51 110.794 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.9 m -141.53 144.73 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.212 -0.449 . . . . 1.12 109.976 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -116.17 148.13 40.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.758 -0.377 . . . . 1.49 110.274 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -162.92 177.35 9.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.79 112.003 -171.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.69 166.55 16.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 1.49 111.021 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.15 137.68 35.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.55 111.194 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 2.04 111.064 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 110.6 -0.148 . . . . 2.92 110.6 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.8 155.8 52.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.929 2.42 . . . . 1.58 111.901 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.71 169.5 9.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.989 -0.551 . . . . 1.33 110.262 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HG3' HD21 ' A' ' 74' ' ' ASN . 9.9 pt-20 -158.73 172.2 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.768 -0.196 . . . . 2.3 110.607 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.471 HD21 ' HG3' ' A' ' 73' ' ' GLU . 50.2 m-80 60.51 26.6 16.24 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.674 0.609 . . . . 2.67 110.915 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.5 t -70.37 117.66 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.883 -0.599 . . . . 1.46 110.955 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -126.39 157.06 39.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 4.04 110.678 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.452 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.2 mtt -72.4 146.73 46.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.118 -0.492 . . . . 1.5 110.532 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 tp -119.97 131.23 24.49 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.876 -0.787 . . . . 2.27 108.876 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.42 146.13 64.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.001 1.801 . . . . 2.54 111.849 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 19.5 ptpt -59.47 162.83 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 4.95 110.625 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 8.8 t30 77.5 2.95 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.447 0.641 . . . . 3.42 110.919 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -81.05 -27.65 35.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 2.12 109.655 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.13 116.63 66.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.733 -0.84 . . . . 1.37 108.733 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.58 155.09 40.25 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.552 2.168 . . . . 1.17 112.377 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.97 155.03 45.89 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.527 -0.545 . . . . 3.13 109.527 178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.465 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 17.0 Cg_exo -65.67 143.12 73.4 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.27 1.98 . . . . 1.39 111.215 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.62 94.56 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 1.69 111.214 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 t -140.96 130.62 25.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.571 -0.74 . . . . 1.49 109.254 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.87 -60.51 1.84 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.131 0.419 . . . . 3.44 112.131 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 91' ' ' THR . 14.7 pt-20 -90.51 -52.43 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.92 -0.312 . . . . 2.84 111.569 -174.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.8 t 166.1 159.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.613 -0.884 . . . . 2.07 108.613 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.54 -52.02 2.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.196 0.522 . . . . 1.45 110.158 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.99 168.14 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 1.73 110.306 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -125.98 151.55 46.89 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.417 -1.327 . . . . 1.86 107.417 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.18 -173.31 25.45 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.385 -1.388 . . . . 0.54 112.506 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.44 143.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.465 -0.568 . . . . 2.06 109.465 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.24 123.51 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.604 0.24 . . . . 1.31 110.435 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.17 17.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 1.31 112.033 -173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 . . . . . 0 C--N 1.33 -0.281 0 C-N-CA 120.606 -0.437 . . . . 4.44 111.869 -176.532 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 112.407 0.521 . . . . 1.67 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.3 -178.72 9.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.345 -0.455 . . . . 1.08 113.193 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 130' ' ' GLU . 38.1 mt -152.24 141.01 20.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.292 0.567 . . . . 1.5 111.641 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.3 134.24 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.878 -1.055 . . . . 1.06 109.134 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -86.34 111.04 20.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.67 0.748 . . . . 1.4 109.413 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.503 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 5.4 mm -90.78 121.34 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.168 -0.924 . . . . 1.26 109.041 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.2 pt? -90.32 150.81 21.75 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.569 -0.453 . . . . 1.72 109.966 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.75 165.1 3.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.144 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.439 ' HG2' HD21 ' A' ' 121' ' ' LEU . 2.0 pm0 -65.12 -20.35 66.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 2.78 110.174 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.38 14.28 24.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 2.13 110.277 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 51.02 29.82 4.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.434 1.093 . . . . 4.81 112.118 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -67.53 0.66 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.392 -0.367 . . . . 2.38 111.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 7.3 p -138.24 -171.6 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.578 -0.283 . . . . 2.22 111.175 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 p -92.52 129.88 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.364 -0.606 . . . . 1.84 109.364 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.56 -69.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 1.45 110.629 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.4 m -139.01 -85.97 0.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.147 0.498 . . . . 1.86 110.46 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.5 143.49 0.48 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.873 -1.058 . . . . 2.39 108.596 173.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.452 ' CE1' HD12 ' A' ' 153' ' ' ILE . 33.3 m170 -116.34 124.46 50.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.7 110.335 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -81.94 140.59 33.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.996 . . . . 1.19 109.469 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.97 161.01 19.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.195 0.521 . . . . 0.82 111.27 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.43 152.24 17.25 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.813 -0.63 . . . . 0.59 111.663 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.9 tp -55.16 -29.42 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.96 0.409 . . . . 1.25 111.241 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -71.77 -33.7 68.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.451 0.643 . . . . 1.68 110.403 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.461 ' HG ' ' HA ' ' A' ' 160' ' ' ALA . 2.2 m -66.77 -33.11 74.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.287 -0.87 . . . . 1.46 109.983 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 10.9 mp -75.94 57.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.769 -0.65 . . . . 2.06 111.923 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.3 t -46.58 -48.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.239 0.543 . . . . 1.4 110.545 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -93.4 35.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.465 -0.789 . . . . 2.83 110.962 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 9.9 ptpp? -54.36 -23.69 16.53 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.754 1.02 . . . . 1.92 113.754 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -81.44 -6.26 58.76 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.202 -0.311 . . . . 2.83 111.33 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.45 174.93 4.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 1.89 110.471 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -88.94 17.2 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 3.33 110.507 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -46.2 117.73 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.921 -1.036 . . . . 1.26 111.756 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -135.59 -179.94 5.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 2.0 110.675 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.52 129.32 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 1.9 110.026 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.92 64.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.358 -0.925 . . . . 1.17 112.562 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.93 146.12 24.0 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.94 109.575 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.88 134.77 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.181 0.515 . . . . 2.45 111.513 -170.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 m -129.72 148.12 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.836 -0.62 . . . . 1.77 111.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 64.1 m -113.77 140.52 48.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.534 -0.757 . . . . 1.86 109.096 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.503 ' CZ ' HD13 ' A' ' 117' ' ' ILE . 25.7 p90 -151.06 165.75 32.86 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.144 -0.48 . . . . 0.74 109.794 -175.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 -126.91 119.65 27.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.063 -0.655 . . . . 2.72 110.423 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.5 HG21 ' O ' ' A' ' 158' ' ' ARG . 12.6 pt -102.46 149.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 109.184 -0.673 . . . . 1.84 109.184 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 6.4 t70 -160.69 -93.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.995 -0.282 . . . . 1.92 110.564 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.59 -34.82 27.54 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.767 -0.373 . . . . 2.76 111.519 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.2 t -77.63 -17.7 57.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.672 0.272 . . . . 2.5 110.699 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.61 -14.66 3.25 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.994 -0.622 . . . . 1.27 113.968 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 153' ' ' ILE . 11.0 ptm180 -103.41 175.48 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.296 0.548 . . . . 4.13 110.054 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.27 109.84 18.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.142 0.496 . . . . 1.09 110.423 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HA ' ' HG ' ' A' ' 135' ' ' SER . . . -119.67 154.8 33.49 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.464 -0.789 . . . . 1.2 110.354 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 37.6 m 57.82 47.22 15.71 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.932 0.77 . . . . 2.15 111.325 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 151' ' ' PHE . 19.3 m -70.89 128.3 33.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.642 0.734 . . . . 1.93 110.281 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -128.45 125.62 38.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.668 -0.696 . . . . 2.63 109.739 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.43 128.12 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.613 -0.721 . . . . 1.23 110.819 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.22 110.94 29.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.124 0.488 . . . . 2.08 111.468 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 2.8 mpt_? . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 108.747 -0.834 . . . . 3.44 108.747 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.338 0.59 . . . . 2.13 111.218 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.31 126.56 44.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.857 -1.065 . . . . 1.8 109.229 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -98.55 137.94 36.47 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.38 -0.6 . . . . 1.36 109.38 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 35.0 ttm180 -112.42 143.25 43.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.863 -0.421 . . . . 2.73 109.863 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.27 -170.24 22.74 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.67 -0.776 . . . . 0.5 111.591 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 139.74 42.29 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.662 0.268 . . . . 0.75 110.369 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.94 118.08 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.003 -0.544 . . . . 1.14 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.08 -56.65 2.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.614 0.245 . . . . 1.31 111.002 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.93 160.87 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.154 -0.313 . . . . 2.16 110.154 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.1 ttm -141.61 112.29 7.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.268 -0.424 . . . . 1.92 111.035 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 175.95 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.499 -0.556 . . . . 2.53 109.499 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.75 -34.76 76.4 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.581 0.551 . . . . 3.24 111.539 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -111.13 -47.45 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.205 0.446 . . . . 2.03 112.205 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -130.15 169.39 15.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.162 0.506 . . . . 1.47 111.627 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.72 -174.09 23.56 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.76 111.489 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB3' ' OE1' ' A' ' 32' ' ' GLU . 48.4 m-85 -129.04 154.4 46.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.119 -0.326 . . . . 1.22 110.119 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mt -133.79 122.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.316 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -69.0 119.5 13.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.817 -0.438 . . . . 2.3 109.817 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 p -57.6 141.47 48.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 1.36 109.911 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -50.0 -46.25 52.54 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.536 . . . . 2.15 110.708 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -85.81 18.05 3.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.656 . . . . 2.51 111.65 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 p80 43.13 36.2 0.93 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.128 0.971 . . . . 4.08 111.907 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -70.05 -50.99 35.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.274 -0.875 . . . . 2.89 110.382 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.43 -174.59 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 1.8 110.53 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' OE1' ' HB3' ' A' ' 23' ' ' PHE . 1.1 mm-40 -102.75 145.23 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.974 -0.557 . . . . 3.37 109.976 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.44 120.54 61.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.21 0.528 . . . . 1.43 111.21 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -74.2 116.91 15.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.364 -0.834 . . . . 1.12 110.392 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -121.99 151.18 41.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.281 -0.637 . . . . 2.46 109.281 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.31 128.86 55.75 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.349 -0.611 . . . . 1.4 109.349 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.06 -20.15 65.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 0.82 110.871 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -59.96 -34.83 73.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.555 . . . . 2.03 111.699 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -102.96 -0.54 30.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.028 0.442 . . . . 2.09 110.615 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.412 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 54.6 t80 -72.01 128.66 36.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 1.39 110.213 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.4 ttp -102.21 111.55 23.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.042 0.448 . . . . 2.04 110.239 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 44' ' ' PRO . . . 147.14 -171.87 27.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.687 -0.688 . . . . 1.05 111.429 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.69 105.25 19.66 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.22 -0.289 . . . . 2.51 110.22 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 42' ' ' GLY . 10.0 Cg_exo -66.99 -30.34 39.31 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.469 2.113 . . . . 1.14 112.354 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -70.43 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 2.29 111.19 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.95 7.32 44.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.114 0.483 . . . . 2.45 110.58 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.412 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 20.6 mt -88.16 141.61 28.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.183 0.516 . . . . 1.29 111.306 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -120.92 158.41 27.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.821 . . . . 2.35 109.274 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.78 114.76 12.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.184 -0.672 . . . . 2.01 109.184 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.72 32.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.027 -0.606 . . . . 0.82 112.226 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -65.8 137.39 57.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 1.16 110.67 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.497 ' HG3' HD13 ' A' ' 83' ' ' ILE . 12.9 tt0 -78.63 125.73 29.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.361 -0.836 . . . . 2.51 110.274 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -141.8 155.45 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 1.12 110.176 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.1 148.14 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.968 0.413 . . . . 1.49 110.308 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.487 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -159.34 173.66 15.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.975 -0.557 . . . . 0.79 110.81 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 p -127.96 142.81 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.488 -0.324 . . . . 1.49 110.961 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.53 121.92 20.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 120.881 0.372 . . . . 1.55 110.263 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.529 -0.759 . . . . 2.04 111.485 -175.193 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.599 0.238 . . . . 2.92 110.865 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.76 150.14 78.9 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.779 2.319 . . . . 1.58 113.357 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.94 147.72 25.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.114 -0.948 . . . . 1.33 109.292 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.98 176.43 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.108 -0.237 . . . . 2.3 110.508 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.41 28.08 15.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.627 0.727 . . . . 2.67 109.756 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.487 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 17.4 t -66.99 119.0 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.808 . . . . 1.46 109.841 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -133.2 140.3 47.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.998 -0.547 . . . . 4.04 111.644 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.435 ' HA ' HG13 ' A' ' 53' ' ' VAL . 41.3 mtt -71.6 149.46 45.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.5 110.485 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -145.9 163.31 31.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 2.27 109.445 170.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 24.7 Cg_exo -64.73 161.88 34.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.1 1.866 . . . . 2.54 112.216 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.45 -169.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 4.95 111.514 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t30 78.74 19.74 0.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.202 -0.908 . . . . 3.42 112.444 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -93.99 -39.27 10.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.199 -0.667 . . . . 2.12 109.199 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.497 HD13 ' HG3' ' A' ' 52' ' ' GLU . 2.3 mp -84.07 119.54 73.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.639 -0.71 . . . . 1.37 110.399 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.09 161.16 32.83 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.462 2.775 . . . . 1.17 112.565 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -93.12 153.97 41.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.414 -0.515 . . . . 3.13 110.188 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.16 164.1 23.7 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.649 2.233 . . . . 1.39 111.265 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.43 91.32 3.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.33 0.586 . . . . 1.69 111.627 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.47 153.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.953 -1.128 . . . . 1.49 107.953 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 -61.42 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.424 -0.511 . . . . 3.44 111.408 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' O ' ' HB ' ' A' ' 91' ' ' THR . 9.4 tp10 -92.17 -56.22 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 2.84 111.242 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t 167.17 165.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.283 -1.006 . . . . 2.07 108.283 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 m -106.79 -54.8 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.578 -0.449 . . . . 1.45 111.111 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -146.7 157.1 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 1.73 110.591 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.89 -179.53 3.72 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.558 -0.904 . . . . 1.86 108.558 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.99 -167.6 40.14 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.731 -1.223 . . . . 0.54 112.237 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.74 142.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.925 -0.768 . . . . 2.06 108.925 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 122.52 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.693 0.283 . . . . 1.31 110.712 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -72.94 -54.22 9.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.31 109.872 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 73.3 ttt180 . . . . . 0 CA--C 1.531 0.236 0 O-C-N 123.558 0.536 . . . . 4.44 111.8 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 112.663 0.616 . . . . 1.67 112.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.12 149.03 7.6 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.501 -0.857 . . . . 1.08 111.698 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 130' ' ' GLU . 54.2 mt -131.54 154.4 48.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.384 0.612 . . . . 1.5 111.743 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.84 136.6 53.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.981 -1.009 . . . . 1.06 108.82 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.04 110.72 19.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.574 0.702 . . . . 1.4 109.7 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 129' ' ' HIS . 11.0 mm -85.43 130.42 36.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.829 -1.078 . . . . 1.26 109.996 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.12 146.34 26.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.81 0.338 . . . . 1.72 110.333 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.19 165.06 9.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.29 110.429 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.25 -25.56 65.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.787 0.292 . . . . 2.78 111.787 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' C ' ' HD3' ' A' ' 122' ' ' ARG . 0.9 OUTLIER -96.67 13.92 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.906 -0.318 . . . . 2.13 110.604 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HD3' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 39.71 76.67 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.399 1.08 . . . . 4.81 112.318 -175.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.2 p -124.91 -68.55 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.144 -0.934 . . . . 2.38 111.237 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 m -124.17 166.64 15.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 2.22 110.477 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.7 p -73.39 133.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.156 -0.313 . . . . 1.84 110.156 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.48 -69.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.601 -0.272 . . . . 1.45 111.045 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -138.06 -85.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 1.86 110.918 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -175.75 137.09 0.34 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.328 -0.851 . . . . 2.39 108.865 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.511 ' HB2' HD12 ' A' ' 117' ' ' ILE . 35.3 m170 -121.32 133.89 55.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.58 -0.526 . . . . 0.7 109.58 172.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' HD22 ' A' ' 114' ' ' LEU . 12.8 tt0 -90.37 152.87 20.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.589 -0.732 . . . . 1.19 109.884 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -117.97 135.48 54.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.291 0.567 . . . . 0.82 110.838 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.29 151.34 21.42 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.396 -0.82 . . . . 0.59 111.734 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.45 -33.64 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 1.25 110.718 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.7 t -76.29 -30.22 57.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.481 -0.781 . . . . 1.68 110.203 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 162' ' ' VAL . 24.8 m -76.14 -24.18 54.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.753 -0.658 . . . . 1.46 110.159 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.5 mt -71.2 58.26 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.443 -0.798 . . . . 2.06 111.459 176.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.3 t -47.24 -47.13 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.436 0.636 . . . . 1.4 110.403 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 35.6 m-80 -92.38 34.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.563 -0.744 . . . . 2.83 111.622 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 8.9 ptpp? -61.21 -21.3 63.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.675 0.274 . . . . 1.92 111.726 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -89.06 -2.4 58.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 2.83 111.248 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.83 148.76 24.52 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.428 -0.953 . . . . 1.89 108.428 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.95 92.42 3.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.66 0.743 . . . . 3.33 110.077 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.31 105.71 13.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.675 -1.148 . . . . 1.26 110.064 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -128.45 -171.35 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.889 -0.324 . . . . 2.0 111.65 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 56.8 tttm -64.01 110.42 2.13 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.31 -0.405 . . . . 1.9 111.138 -175.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.47 -6.69 20.75 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.486 -0.864 . . . . 1.17 112.386 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.56 142.19 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 1.94 110.898 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.31 140.03 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 2.45 111.221 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.65 153.34 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.77 111.772 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -118.29 144.8 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.763 . . . . 1.86 108.983 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.483 ' HB3' HG13 ' A' ' 162' ' ' VAL . 33.8 p90 -158.47 176.86 11.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.016 0.436 . . . . 0.74 110.767 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -135.21 123.8 23.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 2.72 111.286 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.92 122.7 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.261 -0.881 . . . . 1.84 109.332 167.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 4.9 p-10 -152.9 -94.72 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.109 -0.237 . . . . 1.92 110.835 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.534 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 39.3 mm-40 -82.53 -17.32 45.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 2.76 109.233 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 -19.06 35.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.99 -1.004 . . . . 2.5 111.2 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.1 6.5 10.18 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.954 -0.566 . . . . 1.27 113.99 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.12 -167.51 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.852 -0.795 . . . . 4.13 108.852 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.6 18.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.415 -0.587 . . . . 1.09 109.415 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.43 155.21 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 1.2 111.188 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 70.4 m 58.7 37.89 25.06 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.833 0.708 . . . . 2.15 110.837 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 151' ' ' PHE . 33.1 m -65.02 117.76 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.766 0.793 . . . . 1.93 110.329 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 4.8 p30 -118.1 123.4 45.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.686 -0.688 . . . . 2.63 110.275 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.16 103.42 0.97 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.335 -0.848 . . . . 1.23 110.831 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.74 110.24 20.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.691 0.758 . . . . 2.08 110.86 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 7.5 mpt_? . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.776 -0.824 . . . . 3.44 108.776 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 120.98 0.419 . . . . 2.13 111.392 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.39 122.52 39.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.805 . . . . 1.8 109.163 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.23 137.52 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.12 -0.491 . . . . 1.36 110.005 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.507 HH11 ' CD2' ' A' ' 78' ' ' LEU . 21.6 ttm-85 -106.44 129.54 54.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.384 -0.825 . . . . 2.73 109.963 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.71 -171.33 22.75 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.795 -0.717 . . . . 0.5 111.765 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.7 148.51 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 0.75 111.075 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.41 118.68 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.513 -0.767 . . . . 1.14 110.791 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.85 -37.94 6.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 1.31 111.091 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.99 122.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.274 0.559 . . . . 2.16 110.861 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.99 106.24 18.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.429 -0.952 . . . . 1.92 108.429 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 14.7 tppt? -98.4 170.8 8.6 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.067 -0.716 . . . . 2.53 109.067 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 62.5 mt-10 -65.98 -38.64 89.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.169 0.433 . . . . 3.24 112.169 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -112.1 -41.32 3.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.088 0.47 . . . . 2.03 111.524 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 42.7 p90 -131.0 -161.53 1.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.052 -0.522 . . . . 1.47 110.195 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.91 -177.57 40.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.97 . . . . 0.76 112.245 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.26 130.3 51.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.598 -0.519 . . . . 1.22 109.598 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -102.9 134.08 44.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.267 -0.642 . . . . 1.15 109.267 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.71 143.33 30.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.933 -1.136 . . . . 2.3 107.933 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 p -67.66 -173.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.035 0.445 . . . . 1.36 110.523 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' CD2' HD13 ' A' ' 83' ' ' ILE . 2.3 tm? -81.96 -47.05 13.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.099 0.475 . . . . 2.15 110.658 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -102.68 22.54 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.445 0.535 . . . . 2.51 112.445 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 56.06 58.19 4.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.228 0.537 . . . . 4.08 109.785 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 -44.09 5.85 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.48 -0.782 . . . . 2.89 110.714 -172.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.91 167.34 20.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.04 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.6 127.81 50.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.062 0.458 . . . . 3.37 110.551 -175.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 t -110.27 131.5 61.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 1.43 111.245 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -89.9 123.81 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.566 -0.743 . . . . 1.12 110.081 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -124.06 153.8 40.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.214 -0.662 . . . . 2.46 109.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -116.11 131.96 56.79 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.939 -0.763 . . . . 1.4 108.939 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 25.8 m-85 -58.7 -27.82 65.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.537 0.569 . . . . 0.82 112.537 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.5 m -65.63 -36.5 83.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.541 0.21 . . . . 2.03 111.449 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -83.85 3.76 32.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.939 0.399 . . . . 2.09 110.981 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 64.9 t80 -83.59 140.44 32.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.891 -0.595 . . . . 1.39 110.091 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.5 ttp -116.52 116.43 27.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.122 0.487 . . . . 2.04 110.334 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.05 -151.49 22.9 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.655 . . . . 1.05 111.678 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -105.19 103.55 42.69 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.633 0.254 . . . . 2.51 110.855 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.03 -27.12 25.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.46 2.107 . . . . 1.14 113.119 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.82 1.0 45.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.975 0.416 . . . . 2.29 111.295 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -110.51 14.55 22.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.475 0.655 . . . . 2.45 109.674 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.5 mt -97.61 152.95 18.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.039 -0.982 . . . . 1.29 110.825 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.0 -178.32 6.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.754 -0.657 . . . . 2.35 109.238 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.7 mt -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.783 0.325 . . . . 2.01 111.414 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.0 -1.59 24.23 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.922 -0.656 . . . . 0.82 113.182 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -74.69 122.5 23.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.866 0.333 . . . . 1.16 110.98 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.0 mt-10 -61.59 132.86 54.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.609 -0.723 . . . . 2.51 110.373 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 77' ' ' MET . 25.9 m -140.83 148.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 1.12 110.207 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -114.63 142.71 46.1 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.268 -0.642 . . . . 1.49 109.268 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -162.13 170.82 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.103 0.478 . . . . 0.79 111.559 -175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 p -125.52 167.7 14.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 1.49 111.182 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.13 153.02 28.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 1.55 109.994 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 121.358 0.599 . . . . 2.04 110.969 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--O 1.232 0.149 0 N-CA-C 110.244 -0.28 . . . . 2.92 110.244 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.68 149.16 37.89 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.445 2.097 . . . . 1.58 111.823 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.48 36.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 1.33 111.116 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 79.8 mm-40 -119.59 143.78 47.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 2.3 110.436 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.5 t30 59.87 80.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 2.67 110.846 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.4 122.68 64.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.075 -0.512 . . . . 1.46 110.075 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.32 147.24 51.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.576 -0.283 . . . . 4.04 110.747 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.425 ' HA ' HG13 ' A' ' 53' ' ' VAL . 64.1 mtt -66.88 150.37 49.28 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.21 0.528 . . . . 1.5 111.467 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.507 ' CD2' HH11 ' A' ' 11' ' ' ARG . 19.1 tp -147.6 75.96 11.0 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.114 -0.948 . . . . 2.27 110.771 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -90.24 117.99 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.791 1.661 . . . . 2.54 112.716 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -174.05 6.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.117 0.414 . . . . 4.95 112.117 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 t30 57.7 50.56 10.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.027 0.917 . . . . 3.42 108.866 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.0 t -73.64 -10.44 59.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.554 -1.203 . . . . 2.12 109.937 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.591 HD13 ' CD2' ' A' ' 27' ' ' LEU . 6.2 mm -78.22 128.25 78.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.695 . . . . 1.37 109.469 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.1 159.66 48.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.083 2.522 . . . . 1.17 112.904 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -117.55 149.3 44.65 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.73 -0.668 . . . . 3.13 110.382 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.7 149.27 43.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 1.39 111.906 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.04 94.05 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.54 . . . . 1.69 110.603 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.24 144.37 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.715 -0.846 . . . . 1.49 108.715 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.2 mt -88.22 -64.12 1.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.476 -0.49 . . . . 3.44 111.872 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 91' ' ' THR . 33.5 mt-10 -95.25 -53.82 3.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.357 0.599 . . . . 2.84 110.676 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.2 t 172.0 166.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.769 -1.105 . . . . 2.07 108.114 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -105.66 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.295 -0.562 . . . . 1.45 111.424 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -141.71 171.76 13.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.281 0.562 . . . . 1.73 111.36 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.72 158.09 45.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.018 -1.105 . . . . 1.86 108.018 172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.43 -166.97 28.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.725 -1.226 . . . . 0.54 112.293 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.11 145.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.579 -0.526 . . . . 2.06 109.579 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 84.8 t -60.92 126.73 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.627 -0.26 . . . . 1.31 110.846 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.9 -48.59 17.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.31 -0.405 . . . . 1.31 110.344 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.018 0.437 . . . . 4.44 111.962 175.528 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.759 0.314 . . . . 1.67 111.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 161.08 36.03 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.499 -0.858 . . . . 1.08 111.508 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.44 141.47 30.84 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.628 0.727 . . . . 1.5 112.405 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.9 mt -114.16 139.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.494 -1.23 . . . . 1.06 108.817 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.46 136.35 33.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.173 -0.611 . . . . 1.4 110.206 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 129' ' ' HIS . 22.0 mm -105.75 131.81 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.803 -0.635 . . . . 1.26 109.541 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.55 150.13 24.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.559 -0.291 . . . . 1.72 110.559 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.42 166.85 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.468 . . . . 2.29 110.109 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.49 -26.89 63.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.78 110.648 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 1.1 mm? -91.3 11.87 22.21 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.163 -0.471 . . . . 2.13 110.632 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 4.2 ptp180 47.05 32.89 2.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.982 0.913 . . . . 4.81 112.537 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 p -95.59 -73.0 0.6 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 2.38 112.018 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -179.68 3.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.585 0.231 . . . . 2.22 111.488 -176.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -91.36 139.45 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.048 -0.523 . . . . 1.84 109.961 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mt -76.1 -69.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.579 -0.448 . . . . 1.45 110.675 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -138.02 -87.22 0.26 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.076 0.465 . . . . 1.86 110.426 168.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.74 146.85 0.46 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.084 -0.962 . . . . 2.39 109.109 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.452 ' HB2' HD13 ' A' ' 117' ' ' ILE . 27.7 m170 -118.8 136.79 53.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.317 0.58 . . . . 0.7 111.119 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.66 143.53 27.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.707 -1.133 . . . . 1.19 109.897 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -120.41 140.44 51.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.221 0.534 . . . . 0.82 110.713 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.29 154.04 22.1 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.616 -0.72 . . . . 0.59 112.187 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -55.38 -22.0 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.469 0.652 . . . . 1.25 111.013 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -79.19 -37.19 38.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.749 -0.659 . . . . 1.68 110.212 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.513 ' O ' HG22 ' A' ' 162' ' ' VAL . 14.5 m -68.61 -33.47 74.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.322 -0.854 . . . . 1.46 110.517 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.62 58.52 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 2.06 111.544 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -48.86 -39.11 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.178 0.514 . . . . 1.4 110.88 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.437 ' ND2' HD22 ' A' ' 143' ' ' LEU . 3.1 p-10 -84.99 33.16 0.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 2.83 111.283 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -61.95 -18.79 61.55 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.123 0.487 . . . . 1.92 111.418 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -76.58 -22.29 54.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 2.83 110.885 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.45 155.15 17.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.829 -0.623 . . . . 1.89 111.933 -169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.403 -0.817 . . . . 3.33 109.505 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' CG1' ' A' ' 149' ' ' VAL . 10.6 tp -145.46 119.52 9.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.644 -0.502 . . . . 1.26 109.644 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.6 pt20 -133.36 -173.23 3.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.839 0.352 . . . . 2.0 111.355 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 54.5 tttm -61.78 114.51 3.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.9 110.499 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.98 -10.34 15.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.856 -0.687 . . . . 1.17 112.256 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.4 133.12 33.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 1.94 110.508 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.9 142.02 28.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.963 -0.562 . . . . 2.45 111.186 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.504 ' CG1' HD23 ' A' ' 143' ' ' LEU . 30.7 m -139.02 158.52 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.315 0.579 . . . . 1.77 111.748 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 8.4 t -115.12 148.01 39.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.339 -0.986 . . . . 1.86 108.339 171.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.55 ' HB3' HG12 ' A' ' 162' ' ' VAL . 18.8 p90 -159.99 163.03 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.74 111.035 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -124.36 121.5 35.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.267 0.556 . . . . 2.72 110.71 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 tt -101.66 133.08 46.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.28 -0.873 . . . . 1.84 110.224 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.557 ' OD2' ' HG2' ' A' ' 155' ' ' GLU . 21.9 t70 -168.08 -88.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.366 -0.134 . . . . 1.92 111.25 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.557 ' HG2' ' OD2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -68.63 -32.27 72.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.866 0.365 . . . . 2.76 111.323 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 p -83.83 -16.38 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.011 -0.54 . . . . 2.5 111.147 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.3 15.05 60.57 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.988 -0.625 . . . . 1.27 112.752 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -151.14 -165.0 2.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.462 . . . . 4.13 109.754 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.29 116.27 24.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 1.09 111.204 -173.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.576 -0.738 . . . . 1.2 109.632 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 55.02 56.31 6.72 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.744 0.653 . . . . 2.15 111.128 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.55 HG12 ' HB3' ' A' ' 151' ' ' PHE . 10.3 m -80.92 146.1 7.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.984 -0.376 . . . . 1.93 109.984 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -148.1 141.6 25.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.907 0.384 . . . . 2.63 110.411 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.24 24.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 1.23 111.095 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.53 127.92 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.413 -0.358 . . . . 2.08 110.518 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 109.181 -0.674 . . . . 3.44 109.181 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.278 0.561 . . . . 2.13 112.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.92 118.02 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.178 -1.045 . . . . 1.8 108.178 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -87.43 138.28 31.61 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.948 -0.569 . . . . 1.36 110.162 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -106.56 131.62 53.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.533 -0.758 . . . . 2.73 109.286 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.09 -170.8 20.43 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.874 -0.891 . . . . 0.5 110.874 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.96 148.52 32.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.75 111.724 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.9 115.39 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.355 -0.838 . . . . 1.14 110.642 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.01 -26.92 12.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.873 -0.331 . . . . 1.31 110.891 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.29 140.15 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.687 -0.486 . . . . 2.16 109.687 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.9 tpp -125.43 106.09 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 1.92 110.32 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 63.3 mttt -112.08 172.45 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.284 -0.416 . . . . 2.53 110.99 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.14 -45.58 79.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.903 0.705 . . . . 3.24 112.903 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.02 -43.04 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.343 0.497 . . . . 2.03 112.343 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 43.5 p90 -132.44 168.2 18.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.789 0.328 . . . . 1.47 111.003 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.19 159.93 28.06 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.374 -0.69 . . . . 0.76 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.93 126.87 52.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.574 -0.528 . . . . 1.22 109.574 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.37 124.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.323 -0.621 . . . . 1.15 109.323 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 9.9 tp10 -82.3 133.3 35.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.968 -0.753 . . . . 2.3 108.968 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -62.82 154.69 29.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.358 -0.837 . . . . 1.36 110.648 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -47.66 -42.68 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 2.15 112.568 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -111.8 18.29 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.274 -0.421 . . . . 2.51 111.811 -174.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.547 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 15.6 m-70 57.46 58.78 3.62 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 4.08 110.415 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -96.87 -47.24 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.283 -0.871 . . . . 2.89 110.869 -174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -158.22 -174.39 4.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 1.8 111.009 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -102.29 123.68 46.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 3.37 110.753 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 t -111.82 107.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.933 0.397 . . . . 1.43 110.821 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.24 123.41 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.186 0.517 . . . . 1.12 109.759 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.499 ' CE2' HG23 ' A' ' 75' ' ' VAL . 30.0 t80 -128.13 134.38 49.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 2.46 110.9 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 125.02 47.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.888 -0.782 . . . . 1.4 108.888 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -60.24 -16.75 36.53 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.292 0.478 . . . . 0.82 112.292 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -59.71 -15.48 20.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.25 -0.432 . . . . 2.03 111.715 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -109.43 12.7 24.47 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.665 0.269 . . . . 2.09 111.401 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -82.11 133.42 35.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.722 0.296 . . . . 1.39 110.223 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 ttm -91.97 100.64 13.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.952 0.406 . . . . 2.04 110.613 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.32 -146.02 16.81 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.003 -0.618 . . . . 1.05 112.11 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -112.71 104.74 56.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.689 0.28 . . . . 2.51 110.602 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.82 -5.18 16.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.836 2.358 . . . . 1.14 112.292 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.21 -6.25 46.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.763 -0.653 . . . . 2.29 111.173 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.58 14.0 17.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.45 110.924 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.77 148.78 23.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.005 -0.543 . . . . 1.29 110.579 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -145.0 177.22 8.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.928 -0.578 . . . . 2.35 110.107 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 mm? -72.25 123.29 22.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.533 . . . . 2.01 110.944 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.1 1.59 48.31 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.955 -0.566 . . . . 0.82 112.551 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -79.13 123.74 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.812 0.339 . . . . 1.16 110.657 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.31 140.87 45.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.808 -0.633 . . . . 2.51 111.186 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.82 154.27 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 1.12 110.684 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.87 134.29 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.648 -0.871 . . . . 1.49 108.648 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CB ' HG22 ' A' ' 75' ' ' VAL . 3.5 p90 -164.9 175.89 9.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.527 0.566 . . . . 0.79 112.527 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 p -126.32 173.6 9.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.518 -0.764 . . . . 1.49 111.113 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -108.62 144.72 35.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 1.55 111.019 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 2.04 111.439 -178.128 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.48 0.181 . . . . 2.92 110.932 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.4 148.84 84.7 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.571 2.181 . . . . 1.58 111.762 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.04 156.68 20.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 1.33 110.566 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.17 166.53 24.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.696 -0.229 . . . . 2.3 110.807 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 55.55 76.53 0.27 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.892 0.745 . . . . 2.67 110.611 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.513 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.0 t -115.84 120.3 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.72 -0.673 . . . . 1.46 110.664 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -117.26 151.41 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.416 -0.587 . . . . 4.04 109.416 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtm -87.26 143.4 27.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.966 -0.294 . . . . 1.5 110.641 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -130.16 120.04 18.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.345 -0.983 . . . . 2.27 108.345 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.4 116.53 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.431 2.087 . . . . 2.54 116.002 -163.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 5.0 ttpm? 54.59 127.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.319 1.97 . . . . 4.95 116.319 162.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 t30 75.74 30.47 0.77 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.585 -1.189 . . . . 3.42 110.918 167.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 m -94.83 4.5 53.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 2.12 110.886 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.3 mm -108.21 136.16 19.85 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.299 -0.63 . . . . 1.37 109.299 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.49 156.2 67.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.527 2.151 . . . . 1.17 112.003 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.28 146.0 43.6 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.714 -0.221 . . . . 3.13 110.943 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HG3' ' HB3' ' A' ' 160' ' ' ALA . 36.5 Cg_endo -67.37 150.33 80.91 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.998 2.466 . . . . 1.39 112.139 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.34 94.14 6.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.052 0.453 . . . . 1.69 110.61 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.6 t -138.11 134.58 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.829 -0.804 . . . . 1.49 108.829 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 mt -74.83 -65.09 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.582 -0.447 . . . . 3.44 111.928 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 91' ' ' THR . 34.3 mt-10 -96.49 -56.12 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.19 0.519 . . . . 2.84 111.302 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 175.9 160.59 0.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.264 -1.334 . . . . 2.07 107.465 -174.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -101.53 -54.6 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.352 -0.539 . . . . 1.45 110.18 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -138.91 158.52 44.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.791 -0.448 . . . . 1.73 109.791 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -112.92 155.39 24.82 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.901 -1.148 . . . . 1.86 107.901 170.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.72 177.65 38.74 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 119.674 -1.251 . . . . 0.54 112.012 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.46 149.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.605 -0.517 . . . . 2.06 109.605 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.54 123.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.737 0.303 . . . . 1.31 111.276 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.97 4.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 1.31 111.722 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.522 -0.308 . . . . 4.44 111.01 -176.727 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.647 0.26 . . . . 1.67 111.648 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 87.04 157.61 31.18 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.473 -0.87 . . . . 1.08 112.176 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 130' ' ' GLU . 59.7 mt -144.03 135.33 25.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.402 0.62 . . . . 1.5 111.395 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 mt -106.22 138.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.793 -1.094 . . . . 1.06 109.726 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.59 117.15 28.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.593 0.711 . . . . 1.4 110.401 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.496 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 11.2 mm -96.48 132.31 41.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.008 -0.996 . . . . 1.26 109.502 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -86.45 152.79 22.39 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.91 -0.316 . . . . 1.72 110.56 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -59.83 161.39 6.46 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.124 -0.489 . . . . 2.29 111.265 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.41 -23.68 64.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.487 -0.779 . . . . 2.78 111.282 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.38 3.11 54.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.672 -0.24 . . . . 2.13 110.764 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 59.45 88.72 0.07 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.494 0.664 . . . . 4.81 109.759 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -144.5 -77.92 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 2.38 111.378 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 17.0 p -123.83 -166.45 1.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.682 0.277 . . . . 2.22 110.649 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.5 p -95.25 126.2 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.912 -0.585 . . . . 1.84 109.729 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.6 mt -65.31 -69.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 120.719 -0.392 . . . . 1.45 110.883 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -137.91 -85.93 0.28 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 1.86 110.485 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -176.43 139.71 0.35 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.649 -1.16 . . . . 2.39 108.151 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.459 ' HB2' HD11 ' A' ' 117' ' ' ILE . 19.4 m170 -117.88 130.19 56.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.69 -0.804 . . . . 0.7 111.277 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HA ' HD21 ' A' ' 114' ' ' LEU . 16.4 tt0 -85.55 142.67 28.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.476 -1.238 . . . . 1.19 109.435 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.405 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 43.1 p90 -117.91 136.09 53.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.31 0.576 . . . . 0.82 110.363 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.55 150.96 22.89 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.508 -0.769 . . . . 0.59 112.312 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.51 -27.95 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.226 0.536 . . . . 1.25 110.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.9 p -76.22 -39.81 53.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.661 -0.7 . . . . 1.68 111.034 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 15.1 p -82.51 -14.96 54.08 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.803 -0.635 . . . . 1.46 110.943 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -79.5 58.28 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 2.06 110.5 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.8 t -51.45 -35.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.591 . . . . 1.4 110.81 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.454 ' OD1' HD21 ' A' ' 143' ' ' LEU . 6.2 p30 -88.26 21.17 2.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.459 -0.791 . . . . 2.83 111.228 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -54.06 -23.61 14.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.833 0.679 . . . . 1.92 112.833 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -93.04 -1.57 56.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 2.83 111.819 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.17 175.75 9.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.204 -0.453 . . . . 1.89 110.202 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 mt -91.41 29.1 1.53 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.228 0.537 . . . . 3.33 109.828 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.454 HD21 ' OD1' ' A' ' 138' ' ' ASN . 18.9 tp -51.44 115.15 1.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.409 -1.269 . . . . 1.26 112.073 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -122.37 -176.31 3.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 2.0 110.544 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.69 130.96 43.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 1.9 109.612 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.67 43.65 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.662 -0.78 . . . . 1.17 112.196 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.99 134.88 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.678 -0.409 . . . . 1.94 110.218 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 165' ' ' VAL . 92.5 mt -80.19 141.28 35.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 2.45 110.258 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.85 142.81 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.124 -0.489 . . . . 1.77 110.738 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.6 p -100.83 121.81 42.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.784 -0.644 . . . . 1.86 109.455 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.496 ' CZ ' HD13 ' A' ' 117' ' ' ILE . 37.0 p90 -144.06 163.61 33.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.117 -0.492 . . . . 0.74 110.103 -176.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.512 ' NE ' ' HB2' ' A' ' 161' ' ' CYS . 0.9 OUTLIER -137.31 124.2 21.35 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.683 0.754 . . . . 2.72 111.247 176.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.4 tt -99.35 134.63 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.627 -1.17 . . . . 1.84 110.353 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 10.4 t70 -153.32 -97.34 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.515 0.191 . . . . 1.92 111.515 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.0 41.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.373 . . . . 2.76 111.683 -174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -80.58 -16.84 53.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 2.5 110.182 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.43 17.67 62.3 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.007 -0.542 . . . . 1.27 113.255 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.419 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 41.5 mtm180 -145.02 -170.65 3.47 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.994 -0.372 . . . . 4.13 109.994 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.14 124.23 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.402 0.62 . . . . 1.09 111.437 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 86' ' ' PRO . . . -135.64 157.91 45.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.443 -0.799 . . . . 1.2 110.091 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.512 ' HB2' ' NE ' ' A' ' 152' ' ' ARG . 59.4 m 49.27 61.91 2.89 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.772 0.67 . . . . 2.15 109.954 -171.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -90.89 121.83 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 1.93 110.33 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -136.21 132.75 36.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.964 -0.384 . . . . 2.63 109.964 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.33 120.43 9.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 1.23 111.472 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 148' ' ' LEU . 7.1 p -127.02 126.46 68.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 2.08 110.747 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.9 mpt_? . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 109.967 -0.383 . . . . 3.44 109.967 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.088 0.471 . . . . 2.13 111.524 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.88 123.38 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 1.8 109.32 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.83 139.76 37.98 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.917 -0.583 . . . . 1.36 109.798 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.426 HH11 ' CD1' ' A' ' 78' ' ' LEU . 37.8 ttm-85 -110.82 148.38 32.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.157 -0.683 . . . . 2.73 109.157 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.39 178.35 46.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.52 -0.847 . . . . 0.5 112.173 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 145.62 48.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.96 0.409 . . . . 0.75 111.17 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -65.96 117.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 1.14 110.419 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' HD22 ' A' ' 49' ' ' LEU . . . -97.9 -42.17 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.078 -0.249 . . . . 1.31 110.914 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 23' ' ' PHE . 2.4 m -124.84 148.63 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 109.949 -0.389 . . . . 2.16 109.949 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.4 mtp -133.79 110.07 9.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.973 -0.38 . . . . 1.92 109.973 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -92.69 170.69 9.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.272 -1.01 . . . . 2.53 108.272 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.66 -16.6 60.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.073 0.463 . . . . 3.24 110.034 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -104.31 -49.27 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.03 111.651 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -147.74 -179.84 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.796 -0.184 . . . . 1.47 110.621 -175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.69 165.28 28.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.275 -0.964 . . . . 0.76 112.389 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HB2' HG23 ' A' ' 16' ' ' VAL . 49.9 m-85 -118.79 128.71 54.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.894 0.378 . . . . 1.22 110.016 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.8 mt -97.77 125.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.956 -0.566 . . . . 1.15 109.493 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 139.16 36.35 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.806 -0.813 . . . . 2.3 108.806 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -66.34 156.87 33.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.176 0.512 . . . . 1.36 111.447 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -63.4 -42.46 98.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.786 -0.643 . . . . 2.15 111.143 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 p -97.2 12.27 33.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.868 0.692 . . . . 2.51 112.868 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 59.68 58.26 2.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.888 0.375 . . . . 4.08 111.332 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.54 -28.14 5.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.243 0.46 . . . . 2.89 112.243 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -169.55 170.61 8.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.953 0.342 . . . . 1.8 110.614 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.16 140.41 37.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.862 0.363 . . . . 3.37 110.349 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 127.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.043 0.449 . . . . 1.43 110.621 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -84.1 121.51 27.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.898 -0.592 . . . . 1.12 110.776 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -128.05 146.97 50.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.732 -0.84 . . . . 2.46 108.732 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.297 -0.631 . . . . 1.4 109.297 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -64.89 -19.58 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.027 0.441 . . . . 0.82 111.043 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.9 t -62.97 -36.58 83.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.599 -0.728 . . . . 2.03 111.08 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.91 16.85 23.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.865 0.364 . . . . 2.09 110.599 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.541 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 74.9 t80 -75.98 135.9 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.517 -0.549 . . . . 1.39 109.517 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.412 ' H ' HG23 ' A' ' 75' ' ' VAL . 60.4 mtp -98.09 105.93 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.264 0.554 . . . . 2.04 110.961 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.32 -134.59 7.77 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.025 -0.989 . . . . 1.05 111.999 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.1 100.83 51.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.339 . . . . 2.51 110.273 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.26 -12.6 21.02 Favored 'Trans proline' 0 N--CA 1.471 0.185 0 C-N-CA 122.976 2.45 . . . . 1.14 113.133 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.17 -13.44 59.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 2.29 110.37 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -102.84 14.63 31.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 2.45 111.359 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -88.67 141.73 28.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.219 -0.446 . . . . 1.29 110.211 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -136.06 170.56 15.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.673 -0.694 . . . . 2.35 109.934 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 15' ' ' ALA . 54.2 mt -74.68 114.59 13.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.01 -0.541 . . . . 2.01 110.488 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.7 26.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.898 -0.668 . . . . 0.82 112.764 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -81.16 116.41 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.048 0.451 . . . . 1.16 111.45 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.53 134.37 54.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.836 -1.075 . . . . 2.51 111.328 176.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 77' ' ' MET . 27.4 m -148.21 141.73 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.674 -0.491 . . . . 1.12 109.674 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HB3' HD13 ' A' ' 78' ' ' LEU . 11.5 pt-20 -114.82 145.17 42.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.506 -0.478 . . . . 1.49 109.922 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 5.7 p90 -166.64 179.71 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.79 111.651 -168.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 p -131.93 170.54 14.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 1.49 110.835 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.79 142.62 35.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.672 0.272 . . . . 1.55 111.157 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 121.317 0.579 . . . . 2.04 110.547 177.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 110.011 -0.366 . . . . 2.92 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.18 146.55 95.96 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.536 2.158 . . . . 1.58 112.457 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.83 146.5 23.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.696 -0.684 . . . . 1.33 111.043 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.58 176.48 5.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 2.3 110.937 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.5 32.41 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.635 0.731 . . . . 2.67 110.797 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 4.2 m -73.74 116.62 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.79 . . . . 1.46 111.693 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -123.27 144.66 49.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 4.04 110.302 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.541 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 50.8 mtt -74.07 147.06 43.16 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.097 0.475 . . . . 1.5 111.395 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 54' ' ' GLU . 75.7 mt -119.43 157.2 52.14 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.518 -0.765 . . . . 2.27 110.951 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.5 169.95 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.627 2.218 . . . . 2.54 111.847 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -78.08 175.16 10.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.0 -0.545 . . . . 4.95 111.297 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.03 3.04 4.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.307 -0.861 . . . . 3.42 112.234 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.0 m -71.92 -25.73 62.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.476 -0.329 . . . . 2.12 110.62 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.43 ' CD1' HD21 ' A' ' 27' ' ' LEU . 11.0 mm -105.99 120.99 47.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 1.37 109.954 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.19 158.99 17.74 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.007 2.471 . . . . 1.17 113.523 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -125.87 165.19 28.59 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.608 -0.724 . . . . 3.13 109.899 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 7.4 Cg_exo -69.47 156.16 64.86 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.668 2.246 . . . . 1.39 111.92 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.51 93.6 4.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.917 0.389 . . . . 1.69 111.373 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 t -141.88 92.29 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.771 -0.455 . . . . 1.49 109.771 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.82 -37.85 76.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.788 0.328 . . . . 3.44 110.718 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.14 -26.06 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 2.84 110.8 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.7 m 70.45 113.05 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.831 . . . . 2.07 111.23 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 t -93.66 -24.11 18.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.025 0.75 . . . . 1.45 113.025 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -138.84 160.87 38.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.909 0.862 . . . . 1.73 112.748 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -140.15 155.49 46.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.952 -1.476 . . . . 1.86 107.186 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.3 -165.69 23.03 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.33 -1.414 . . . . 0.54 112.762 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.85 146.7 24.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.807 -0.442 . . . . 2.06 109.807 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.11 122.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.382 -0.372 . . . . 1.31 110.8 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.3 -67.99 0.75 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.893 -0.594 . . . . 1.31 111.667 -175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 4.44 111.818 -177.665 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 130' ' ' GLU . . . . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.152 0.427 . . . . 1.67 112.152 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.39 158.16 16.28 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.078 -0.809 . . . . 1.08 111.078 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.35 147.41 34.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.028 0.914 . . . . 1.5 113.258 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.45 142.65 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.473 -1.239 . . . . 1.06 110.152 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.12 117.41 25.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 129' ' ' HIS . 8.6 mm -103.72 124.08 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 1.26 110.391 -174.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -97.91 153.47 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.229 -0.656 . . . . 1.72 109.229 175.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.07 177.43 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.274 0.559 . . . . 2.29 111.454 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.85 -25.71 67.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.417 -0.81 . . . . 2.78 111.851 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -94.23 -2.15 52.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.39 -0.596 . . . . 2.13 109.39 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.47 29.14 18.78 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.115 -0.948 . . . . 4.81 110.646 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.8 p -86.1 -38.17 18.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.903 0.334 . . . . 2.38 111.903 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -143.14 166.35 24.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.261 0.553 . . . . 2.22 112.042 -174.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.17 132.37 33.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.186 -0.915 . . . . 1.84 108.68 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -75.82 -71.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.017 -0.673 . . . . 1.45 111.242 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -142.56 -87.29 0.15 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.651 0.738 . . . . 1.86 110.427 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -178.11 133.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.03 -1.441 . . . . 2.39 107.984 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.503 ' HB2' HD13 ' A' ' 117' ' ' ILE . 35.6 m170 -109.21 132.77 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.264 -0.574 . . . . 0.7 110.792 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 23.9 tt0 -83.8 147.65 27.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.512 -0.767 . . . . 1.19 110.643 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -119.27 151.21 38.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 0.82 110.709 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.13 150.38 16.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.59 112.194 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -57.09 -26.96 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.217 0.532 . . . . 1.25 111.21 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.7 p -73.85 -32.49 63.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.751 -0.659 . . . . 1.68 110.469 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 14.7 m -87.64 -13.9 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 1.46 110.635 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -73.1 59.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.587 -0.733 . . . . 2.06 111.644 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.9 t -48.94 -42.46 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.247 0.546 . . . . 1.4 110.618 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 20.4 m120 -88.36 33.88 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.615 . . . . 2.83 111.727 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -62.32 -19.2 63.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.205 0.526 . . . . 1.92 110.9 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -81.66 -21.45 38.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 2.83 111.896 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.26 169.05 18.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.665 0.745 . . . . 1.89 112.788 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -85.66 27.94 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.631 -1.168 . . . . 3.33 110.509 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 113.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.492 -0.777 . . . . 1.26 111.146 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -128.83 -175.08 3.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.786 . . . . 2.0 110.207 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.27 136.22 49.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.075 -0.343 . . . . 1.9 110.075 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.69 -6.62 74.07 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.839 -0.696 . . . . 1.17 112.679 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.44 141.52 28.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.022 -0.671 . . . . 1.94 109.933 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.8 144.09 32.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.779 -0.646 . . . . 2.45 110.981 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 147.59 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.562 -0.745 . . . . 1.77 111.159 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 33.2 t -110.46 146.04 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 1.86 109.898 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -165.96 174.76 9.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.74 110.018 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 127.45 11.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.04 0.448 . . . . 2.72 111.217 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.434 HD11 ' CE1' ' A' ' 129' ' ' HIS . 8.7 pt -95.84 144.72 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.675 -0.693 . . . . 1.84 109.282 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 5.2 t70 -166.51 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.065 0.228 . . . . 1.92 111.103 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -82.41 -29.24 30.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.448 -0.501 . . . . 2.76 111.843 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.539 ' OG ' ' HG3' ' A' ' 86' ' ' PRO . 59.3 p -84.78 -17.01 39.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.742 0.306 . . . . 2.5 111.529 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.1 25.75 60.24 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.036 -0.602 . . . . 1.27 112.294 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -152.61 178.04 10.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.719 -0.474 . . . . 4.13 109.719 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.27 110.42 19.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 1.09 111.115 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.28 164.33 21.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.585 -0.734 . . . . 1.2 110.647 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.3 m 60.98 32.12 19.93 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.82 0.7 . . . . 2.15 111.336 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 150' ' ' SER . 10.0 m -64.35 122.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.529 0.68 . . . . 1.93 111.283 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.582 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 6.7 p30 -131.32 125.08 31.83 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.269 -0.878 . . . . 2.63 109.413 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.96 133.06 54.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 1.23 111.189 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 83.6 t -118.23 121.16 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.724 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 108.963 -0.755 . . . . 3.44 108.963 170.27 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.032 0.444 . . . . 2.13 110.772 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.89 120.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.454 -0.794 . . . . 1.8 109.432 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -90.65 158.67 16.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.34 -0.615 . . . . 1.36 109.34 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 30.8 ttm180 -129.1 143.02 50.72 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.307 -0.406 . . . . 2.73 110.485 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.32 -164.88 24.78 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.117 -0.793 . . . . 0.5 111.117 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.87 154.85 39.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.509 . . . . 0.75 111.276 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.6 mm -73.41 110.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 1.14 111.284 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.52 -49.98 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.101 0.477 . . . . 1.31 110.823 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.15 123.56 69.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.93 -0.577 . . . . 2.16 110.475 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.0 ttm -119.03 109.11 15.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.835 -0.62 . . . . 1.92 109.574 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 5.9 tppt? -98.23 -163.44 1.04 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.234 -1.024 . . . . 2.53 108.234 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 9.0 pt-20 -79.43 -39.13 33.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.13 0.419 . . . . 3.24 112.13 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.92 -35.06 5.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.008 0.432 . . . . 2.03 112.109 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -134.01 178.04 7.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.509 -0.314 . . . . 1.47 110.951 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.39 171.67 36.65 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.045 -0.598 . . . . 0.76 111.703 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -115.93 127.45 54.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.95 0.405 . . . . 1.22 110.085 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -98.28 127.33 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 1.15 110.976 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.5 117.81 22.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.653 -0.869 . . . . 2.3 108.653 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.7 p -68.94 156.41 38.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 1.36 111.818 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.7 OUTLIER -56.48 -47.25 79.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.533 -0.758 . . . . 2.15 110.976 -178.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.77 9.51 27.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.18 -0.463 . . . . 2.51 111.755 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p80 39.28 37.71 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.449 1.1 . . . . 4.08 112.599 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -98.91 -17.6 18.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 2.89 110.105 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.84 155.39 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.139 -0.937 . . . . 1.8 110.591 -166.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.188 -0.671 . . . . 3.37 109.188 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -108.95 108.56 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.784 -0.366 . . . . 1.43 110.1 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -68.58 121.22 15.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 1.12 109.723 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' A' ' 75' ' ' VAL . 23.3 t80 -121.28 128.35 52.27 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.066 -0.515 . . . . 2.46 110.827 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 122.99 41.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.521 -0.918 . . . . 1.4 108.521 174.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -62.18 -16.48 53.29 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.097 0.406 . . . . 0.82 112.097 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -57.14 -29.49 63.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.996 -0.547 . . . . 2.03 111.628 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -103.29 24.04 11.54 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.849 0.357 . . . . 2.09 111.638 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 77.6 t80 -86.22 139.06 31.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 1.39 110.768 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.4 ttm -96.77 97.09 9.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.098 0.475 . . . . 2.04 110.333 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.95 -136.25 8.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.768 -0.729 . . . . 1.05 112.066 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.5 104.94 33.7 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.25 -0.278 . . . . 2.51 110.25 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -17.36 27.0 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.215 . . . . 1.14 112.226 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -74.35 -8.1 55.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.923 -0.58 . . . . 2.29 110.459 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -107.06 10.5 30.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.728 -0.669 . . . . 2.45 110.597 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.9 142.29 27.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 1.29 110.306 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -116.1 161.95 18.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.464 -0.789 . . . . 2.35 109.969 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.78 120.22 19.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.59 -0.522 . . . . 2.01 109.59 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.9 59.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.964 -0.636 . . . . 0.82 112.01 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.09 129.09 38.91 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.956 0.408 . . . . 1.16 110.823 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.41 126.5 29.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.386 -0.825 . . . . 2.51 110.637 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.51 157.74 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.242 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -128.81 150.8 50.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.367 -0.605 . . . . 1.49 109.367 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.511 ' CB ' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -164.0 175.68 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.947 0.721 . . . . 0.79 112.947 -166.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -136.85 166.51 23.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.16 -0.927 . . . . 1.49 109.732 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.5 mt -94.71 147.51 23.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.003 0.43 . . . . 1.55 111.342 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.04 110.798 179.091 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.242 -0.281 . . . . 2.92 110.242 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.76 158.7 52.61 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.47 2.113 . . . . 1.58 113.057 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.55 155.5 19.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.618 -0.719 . . . . 1.33 110.378 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -134.84 164.26 27.97 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.513 -0.312 . . . . 2.3 111.03 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 62.12 29.27 17.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.488 -0.778 . . . . 2.67 111.095 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' A' ' 55' ' ' TYR . 39.3 t -73.9 122.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.945 -0.571 . . . . 1.46 110.843 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -126.46 156.91 39.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 4.04 110.442 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.429 ' HA ' HG13 ' A' ' 53' ' ' VAL . 61.9 mtt -72.3 143.24 48.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.5 110.814 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.86 143.33 27.36 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.0 -1.0 . . . . 2.27 109.178 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 135.33 69.86 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.768 1.645 . . . . 2.54 111.788 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 6.4 ttpm? -60.58 149.61 34.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.689 -0.687 . . . . 4.95 111.378 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 77.88 26.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.34 -0.845 . . . . 3.42 110.55 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.8 m -88.37 -30.66 19.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.24 -1.022 . . . . 2.12 108.24 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.25 123.54 73.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.318 -1.31 . . . . 1.37 108.868 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.48 158.17 48.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.816 2.344 . . . . 1.17 113.649 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.63 155.95 46.77 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.709 -0.678 . . . . 3.13 110.575 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 57.0 Cg_endo -69.16 133.94 27.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.729 2.286 . . . . 1.39 112.87 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.05 94.64 8.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 1.69 110.334 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.466 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 3.0 t -137.22 156.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.928 -1.138 . . . . 1.49 107.928 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.18 -64.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.131 -0.627 . . . . 3.44 111.195 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' THR . 78.7 mm-40 -95.06 -57.18 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.576 -0.45 . . . . 2.84 112.062 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -179.98 156.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 2.07 109.902 -171.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 153' ' ' ILE . 2.9 m -106.12 -54.24 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.968 0.413 . . . . 1.45 110.219 173.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -143.94 177.56 8.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.357 0.599 . . . . 1.73 110.931 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -145.25 168.37 20.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.323 -1.362 . . . . 1.86 107.323 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.8 -170.38 43.31 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.636 -1.269 . . . . 0.54 112.647 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.62 146.65 26.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.6 -0.519 . . . . 2.06 109.6 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.72 120.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.036 -0.357 . . . . 1.31 110.036 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -74.17 -65.54 0.83 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.055 -0.521 . . . . 1.31 111.391 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 4.44 110.349 -178.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 N-CA-C 112.856 0.688 . . . . 1.67 112.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.65 162.26 13.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.382 -0.913 . . . . 1.08 111.695 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 130' ' ' GLU . 18.3 mt -143.41 147.24 34.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 1.5 112.015 -171.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -107.3 141.14 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.089 -0.96 . . . . 1.06 109.289 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' A' ' 98' ' ' ALA . 8.0 pt-20 -88.86 113.18 24.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.542 0.686 . . . . 1.4 110.109 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 129' ' ' HIS . 6.7 mm -94.3 127.98 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.033 -0.985 . . . . 1.26 109.703 -174.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -85.84 159.61 19.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.162 -0.31 . . . . 1.72 110.162 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.84 164.04 8.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.623 . . . . 2.29 110.345 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.442 ' HG2' HD23 ' A' ' 121' ' ' LEU . 1.5 pm0 -68.31 -17.71 64.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.471 . . . . 2.78 109.744 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 1.0 OUTLIER -96.07 -17.19 21.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.612 -0.722 . . . . 2.13 110.462 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 20.9 ttm180 71.2 99.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.836 0.71 . . . . 4.81 111.653 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.0 t -154.75 -41.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.992 -0.283 . . . . 2.38 111.111 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 6.6 p -147.44 -171.95 3.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.742 0.306 . . . . 2.22 111.419 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.46 136.4 24.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.039 -0.528 . . . . 1.84 109.756 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.15 -69.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.67 -0.412 . . . . 1.45 110.925 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -138.61 -84.8 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.466 0.65 . . . . 1.86 110.841 171.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -175.33 141.25 0.53 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.877 -1.056 . . . . 2.39 108.726 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.495 ' HB2' HD13 ' A' ' 117' ' ' ILE . 32.7 m170 -116.46 133.57 55.86 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.67 -0.412 . . . . 0.7 110.161 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.431 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.2 tt0 -86.61 146.29 26.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.682 -0.69 . . . . 1.19 109.656 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -117.02 146.63 42.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.889 0.376 . . . . 0.82 110.155 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -108.83 150.05 17.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.757 -0.735 . . . . 0.59 111.744 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.73 -22.49 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.029 0.442 . . . . 1.25 111.369 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.2 p -73.23 -37.19 66.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.439 . . . . 1.68 110.682 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 11.2 p -90.65 -8.84 48.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.116 -0.493 . . . . 1.46 111.733 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.428 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 54.1 mt -73.45 59.97 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 2.06 111.225 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t -42.34 -47.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.287 0.477 . . . . 1.4 112.287 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.436 HD22 HD23 ' A' ' 143' ' ' LEU . 4.5 p-10 -93.15 34.36 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.737 0.273 . . . . 2.83 111.737 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -59.65 -14.81 15.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.274 0.472 . . . . 1.92 112.274 -176.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -79.86 -16.41 55.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 2.83 110.727 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.81 151.0 20.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.607 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.68 93.11 3.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.416 0.627 . . . . 3.33 110.076 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 HD22 ' A' ' 138' ' ' ASN . 11.7 tp -100.24 116.98 33.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.159 -0.928 . . . . 1.26 109.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.36 -176.35 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.335 0.588 . . . . 2.0 111.782 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 58.0 tttm -65.47 126.14 27.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.981 -1.009 . . . . 1.9 110.117 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 103.71 -1.57 45.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.448 -0.882 . . . . 1.17 113.133 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -91.69 141.35 28.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.094 0.447 . . . . 1.94 111.04 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.51 139.4 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 2.45 111.278 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.07 153.51 29.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.211 0.529 . . . . 1.77 111.073 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 22.9 t -112.72 142.34 45.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.771 -0.826 . . . . 1.86 108.771 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 27.1 p90 -158.45 158.21 33.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.74 110.354 -175.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.466 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 63.2 mtt180 -125.33 120.82 32.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.04 -0.355 . . . . 2.72 110.04 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.49 ' O ' HG22 ' A' ' 92' ' ' THR . 5.3 tt -102.29 120.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.072 -0.513 . . . . 1.84 110.794 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -159.75 -87.54 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.708 0.289 . . . . 1.92 110.478 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 6.0 mm-40 -75.07 -20.84 59.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.661 . . . . 2.76 109.822 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.8 p -83.79 -18.24 38.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.232 -0.895 . . . . 2.5 111.249 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.91 5.46 7.47 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.943 -0.571 . . . . 1.27 113.526 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -153.42 -164.12 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 4.13 108.426 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.1 109.14 17.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.407 0.622 . . . . 1.09 111.119 -172.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.558 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -120.18 165.16 15.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.26 -0.882 . . . . 1.2 109.944 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 73.7 m 59.02 36.37 24.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.995 0.426 . . . . 2.15 110.613 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 150' ' ' SER . 42.2 t -73.38 110.67 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 1.93 110.648 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.38 129.39 44.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.875 -0.602 . . . . 2.63 110.25 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 102.66 0.97 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.896 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.93 137.6 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.177 -0.465 . . . . 2.08 110.394 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.452 -0.34 . . . . 3.44 110.386 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 11.4 mm-40 . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.322 0.582 . . . . 2.13 111.316 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.29 114.5 30.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.11 -0.95 . . . . 1.8 108.868 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.93 138.22 31.71 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.057 -0.72 . . . . 1.36 109.057 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -129.04 151.52 49.64 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.439 -0.504 . . . . 2.73 110.385 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.25 -158.95 9.39 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.509 -1.036 . . . . 0.5 110.509 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 139.08 44.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.833 0.349 . . . . 0.75 110.629 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.6 mm -64.3 114.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 1.14 110.948 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -40.05 3.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.463 -0.335 . . . . 1.31 111.249 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.5 t -116.92 123.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.615 0.245 . . . . 2.16 110.713 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.5 mtp -123.21 108.14 12.48 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.05 -0.722 . . . . 1.92 109.05 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -106.76 -165.31 1.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.625 -0.509 . . . . 2.53 109.625 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.502 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 34.3 tt0 -76.24 -46.98 25.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 3.24 111.337 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -101.35 -32.67 10.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.466 . . . . 2.03 111.379 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -148.93 -169.82 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.4 -0.364 . . . . 1.47 111.18 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.37 -176.79 30.82 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.012 -0.613 . . . . 0.76 111.984 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -131.54 140.31 49.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 1.22 110.442 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.0 131.03 67.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.504 -0.771 . . . . 1.15 109.989 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' OE1' HG23 ' A' ' 133' ' ' ILE . 46.4 mt-10 -70.77 130.39 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.073 -0.714 . . . . 2.3 109.073 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.59 139.53 58.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.761 -0.459 . . . . 1.36 109.761 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.7 tp -52.22 -36.84 53.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 2.15 111.476 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.4 t -108.35 22.75 15.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 2.51 110.93 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 43.47 51.63 6.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.822 0.849 . . . . 4.08 111.856 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.95 -50.27 6.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.666 -1.152 . . . . 2.89 110.397 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.81 -173.04 3.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 1.8 110.576 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -101.53 129.65 47.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.895 0.379 . . . . 3.37 110.9 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.36 122.66 58.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.875 -0.602 . . . . 1.43 110.923 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.07 120.12 33.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 1.12 110.089 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.32 152.71 38.63 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.381 -0.599 . . . . 2.46 109.381 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -111.61 134.17 53.37 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.493 -0.558 . . . . 1.4 109.493 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 24.7 m-85 -63.91 -27.16 68.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.333 0.494 . . . . 0.82 112.333 -175.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -68.24 -36.42 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.783 0.325 . . . . 2.03 110.766 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -87.52 7.46 29.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.225 0.536 . . . . 2.09 110.894 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.492 ' OH ' ' HE1' ' A' ' 77' ' ' MET . 18.0 t80 -84.64 137.31 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.668 -0.697 . . . . 1.39 110.381 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttm -104.52 110.72 23.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 2.04 110.969 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.5 -138.01 6.58 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.842 -0.617 . . . . 1.05 111.787 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.34 101.96 14.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.955 -0.387 . . . . 2.51 109.955 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 -14.43 30.68 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.509 2.14 . . . . 1.14 112.294 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.74 -18.61 63.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.751 -0.659 . . . . 2.29 110.274 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -109.5 9.09 25.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 2.45 110.952 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.465 ' CD2' ' HE2' ' A' ' 77' ' ' MET . 13.3 mt -83.3 145.55 29.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 1.29 111.473 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -141.04 160.81 39.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.489 -0.778 . . . . 2.35 109.507 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.59 115.01 4.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.879 -0.6 . . . . 2.01 110.882 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.66 0.05 15.58 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.82 113.21 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -75.64 120.22 20.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.922 0.391 . . . . 1.16 110.638 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.83 128.44 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.474 -0.784 . . . . 2.51 109.858 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.79 144.4 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.707 -0.224 . . . . 1.12 110.904 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -118.19 149.18 41.51 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 1.49 109.809 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.601 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 20.6 p90 -168.57 179.67 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.051 0.453 . . . . 0.79 111.554 -173.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -133.95 141.9 47.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.575 . . . . 1.49 110.695 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.4 mt -72.52 156.39 39.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.357 -0.383 . . . . 1.55 111.14 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 2.04 110.559 177.318 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.819 -0.067 . . . . 2.92 110.819 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.85 152.38 80.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.858 2.372 . . . . 1.58 113.689 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -106.75 124.05 49.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.916 -1.038 . . . . 1.33 109.742 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.36 173.15 6.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.3 111.113 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 60.94 34.44 19.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.942 -0.572 . . . . 2.67 111.394 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 29.6 t -69.18 115.09 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.181 0.515 . . . . 1.46 111.181 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -119.36 146.55 45.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.199 -0.91 . . . . 4.04 111.151 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.492 ' HE1' ' OH ' ' A' ' 40' ' ' TYR . 63.0 mtt -78.91 139.09 38.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.566 -0.901 . . . . 1.5 108.566 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.1 pt? -131.87 161.98 59.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.638 -0.504 . . . . 2.27 109.638 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 10.8 Cg_endo -53.89 132.45 49.73 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.54 112.721 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 2.9 ttmp? -69.94 163.96 24.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.93 -1.032 . . . . 4.95 111.306 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 78.16 34.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.294 -0.866 . . . . 3.42 111.472 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -94.59 -16.9 22.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 2.12 109.057 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 27' ' ' LEU . 6.5 mm -73.07 135.66 79.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.297 -0.865 . . . . 1.37 109.854 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.81 159.65 50.05 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.496 2.131 . . . . 1.17 112.548 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -124.95 150.12 65.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.291 -0.413 . . . . 3.13 110.048 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.42 130.01 37.79 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.555 2.17 . . . . 1.39 111.578 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.95 90.99 5.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.472 0.653 . . . . 1.69 110.624 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.47 136.6 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.494 -0.928 . . . . 1.49 108.494 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.84 -60.95 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.552 -0.459 . . . . 3.44 112.009 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.0 tp10 -90.95 -54.47 3.95 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.875 -0.33 . . . . 2.84 110.81 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 169.16 155.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.187 -0.671 . . . . 2.07 109.187 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 -58.44 1.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 1.45 110.997 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -139.03 147.87 42.66 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.512 -0.313 . . . . 1.73 110.569 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.427 ' O ' HD21 ' A' ' 118' ' ' LEU . 8.7 p30 -108.05 125.51 51.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.41 -0.959 . . . . 1.86 108.41 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -133.1 -175.52 14.0 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.056 -1.069 . . . . 0.54 112.321 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.1 t -135.39 146.05 30.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.777 -0.453 . . . . 2.06 109.777 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' A' ' 143' ' ' LEU . 97.6 t -62.01 121.03 9.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 1.31 110.828 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.29 -53.22 17.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.277 -0.42 . . . . 1.31 111.871 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 . . . . . 0 N--CA 1.463 0.205 0 CA-C-N 116.677 -0.238 . . . . 4.44 111.089 -179.719 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.995 0.426 . . . . 1.67 110.807 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.09 145.96 11.43 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.459 -1.057 . . . . 1.08 110.459 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.12 138.83 50.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.69 0.757 . . . . 1.5 111.983 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.53 135.05 47.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.512 -1.222 . . . . 1.06 109.272 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.41 125.97 35.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4 110.263 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.1 mm -101.69 138.09 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.571 -0.741 . . . . 1.26 110.35 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.77 154.14 21.8 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.401 0.438 . . . . 1.72 110.016 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.94 -175.88 5.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.873 0.368 . . . . 2.29 110.365 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.59 -18.36 64.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.652 0.612 . . . . 2.78 112.652 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.19 -0.12 19.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.984 -0.286 . . . . 2.13 110.854 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.405 ' HB2' HD13 ' A' ' 118' ' ' LEU . 31.2 ttm-85 56.57 70.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 4.81 109.777 -172.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -118.69 -48.29 2.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.876 -0.602 . . . . 2.38 109.962 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -142.35 169.74 17.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.553 -0.749 . . . . 2.22 111.131 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.5 p -81.14 135.06 25.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.375 -0.602 . . . . 1.84 109.375 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.5 mt -71.12 -70.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.554 -0.458 . . . . 1.45 110.824 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -138.59 -85.45 0.26 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.04 0.447 . . . . 1.86 110.971 170.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -177.16 143.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.329 -0.85 . . . . 2.39 109.065 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.503 ' CE1' HD12 ' A' ' 153' ' ' ILE . 26.8 m170 -119.58 132.83 55.81 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.7 111.233 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -95.69 144.01 26.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.033 -0.985 . . . . 1.19 109.454 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -117.92 136.69 53.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.82 111.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.29 152.63 22.85 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.605 -0.725 . . . . 0.59 112.292 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.519 HG23 ' OE1' ' A' ' 25' ' ' GLU . 10.6 tp -55.71 -34.66 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.482 0.549 . . . . 1.25 112.482 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -78.32 -22.48 48.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.382 0.61 . . . . 1.68 110.545 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 3.5 m -89.21 -19.73 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.66 -0.7 . . . . 1.46 110.21 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -79.05 60.07 2.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.327 -0.851 . . . . 2.06 111.268 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.0 t -43.73 -41.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.241 0.544 . . . . 1.4 111.347 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.4 m120 -87.91 32.58 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.948 -0.569 . . . . 2.83 111.38 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -59.99 -26.97 66.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.355 0.598 . . . . 1.92 110.524 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -88.84 -13.8 38.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.193 -0.912 . . . . 2.83 111.392 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.97 175.1 8.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.077 -0.965 . . . . 1.89 111.294 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.73 16.51 17.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.991 -0.744 . . . . 3.33 108.991 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HG ' HG23 ' A' ' 97' ' ' VAL . 25.4 tp -43.6 107.53 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.188 -1.369 . . . . 1.26 111.448 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.59 -178.51 3.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.841 -0.618 . . . . 2.0 110.733 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -63.85 135.3 56.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 1.9 110.291 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.85 -7.31 67.59 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.365 -0.921 . . . . 1.17 112.931 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.19 146.42 23.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.205 -0.598 . . . . 1.94 109.585 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.56 140.77 29.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.684 -0.689 . . . . 2.45 110.768 -172.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.42 144.87 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 115.139 -0.937 . . . . 1.77 110.731 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.9 m -111.58 143.6 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.146 -0.479 . . . . 1.86 109.878 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 162' ' ' VAL . 7.0 p90 -157.14 166.6 32.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.146 -0.479 . . . . 0.74 110.116 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -119.22 119.61 34.61 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.003 -0.679 . . . . 2.72 109.517 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.503 HD12 ' CE1' ' A' ' 129' ' ' HIS . 3.7 tt -103.78 138.41 28.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.419 -0.586 . . . . 1.84 109.419 167.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.82 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.799 -0.36 . . . . 1.92 111.153 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -38.39 22.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.853 0.686 . . . . 2.76 112.853 -173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.9 t -81.45 -16.82 50.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.842 0.312 . . . . 2.5 111.842 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.15 71.76 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.428 -0.892 . . . . 1.27 112.519 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -133.27 -178.23 4.88 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.083 -0.339 . . . . 4.13 110.083 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.99 108.43 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 1.09 110.377 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -125.33 161.79 26.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.177 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.35 39.86 11.8 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 123.59 0.556 . . . . 2.15 110.045 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 151' ' ' PHE . 15.5 m -69.58 125.08 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 1.93 111.059 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 46.2 t30 -125.74 117.52 23.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.603 -0.726 . . . . 2.63 109.483 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.08 102.67 1.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 1.23 110.43 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.58 130.12 49.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.86 -0.609 . . . . 2.08 110.794 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.854 -0.612 . . . . 3.44 110.458 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 121.167 0.508 . . . . 2.13 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.25 116.01 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.436 -0.802 . . . . 1.8 109.13 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -89.09 138.17 31.66 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.822 -0.626 . . . . 1.36 109.564 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 39.9 ttm180 -116.19 132.37 56.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.616 -0.72 . . . . 2.73 109.462 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.73 -157.23 7.81 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.879 -0.677 . . . . 0.5 111.415 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CE2' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -146.04 152.92 40.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.989 0.423 . . . . 0.75 110.949 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.0 mm -71.68 114.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.691 -0.686 . . . . 1.14 110.287 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.83 -42.0 4.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.676 0.274 . . . . 1.31 111.45 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.19 123.12 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.453 . . . . 2.16 111.139 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.5 mtt -113.44 116.07 29.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.5 -0.773 . . . . 1.92 109.931 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 -177.8 3.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 2.53 108.444 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.19 -45.62 72.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.882 0.327 . . . . 3.24 111.882 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -110.92 -18.21 13.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.964 0.357 . . . . 2.03 111.964 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -153.73 -173.34 4.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.251 -0.278 . . . . 1.47 110.251 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.81 -169.99 30.14 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.718 -0.753 . . . . 0.76 111.496 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -130.18 130.54 44.84 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.959 -0.386 . . . . 1.22 109.959 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.445 HG13 ' CD1' ' A' ' 35' ' ' PHE . 63.9 mt -90.22 124.03 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.471 -0.566 . . . . 1.15 109.471 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.14 125.17 28.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 2.3 109.482 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.3 p -65.37 144.11 57.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.942 -0.392 . . . . 1.36 109.942 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -52.93 -46.31 68.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.057 0.456 . . . . 2.15 110.946 -174.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 t -92.94 6.57 47.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.105 -0.498 . . . . 2.51 111.542 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 54.46 56.95 6.25 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.013 0.911 . . . . 4.08 109.6 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.39 -33.4 7.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.683 -1.144 . . . . 2.89 110.759 -172.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -142.77 166.49 24.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.283 -0.417 . . . . 1.8 110.911 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.49 126.91 50.92 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.625 -0.879 . . . . 3.37 108.625 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.49 115.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 1.43 111.492 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -81.21 120.27 24.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.343 -0.844 . . . . 1.12 110.473 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.445 ' CD1' HG13 ' A' ' 24' ' ' ILE . 3.9 p90 -123.21 151.23 42.45 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -120.36 131.76 54.98 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.083 -0.71 . . . . 1.4 109.083 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -60.33 -24.73 65.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.537 0.569 . . . . 0.82 112.537 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -71.32 -12.2 61.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.668 0.27 . . . . 2.03 111.136 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -109.8 0.48 18.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.09 110.512 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.47 127.05 34.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.569 . . . . 1.39 109.998 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.0 ttp -101.02 97.77 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.186 0.517 . . . . 2.04 110.597 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.46 -160.34 30.14 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.619 -0.719 . . . . 1.05 111.331 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -102.98 102.94 30.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.805 0.302 . . . . 2.51 110.193 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.44 -24.05 9.47 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.45 2.1 . . . . 1.14 113.633 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.33 -4.28 50.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.531 0.205 . . . . 2.29 111.5 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -113.23 19.64 16.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.386 0.612 . . . . 2.45 110.704 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 mt -95.04 159.92 14.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.223 -0.899 . . . . 1.29 108.976 172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.13 164.88 28.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.821 -0.437 . . . . 2.35 109.821 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.32 113.28 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.28 0.562 . . . . 2.01 110.017 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.28 27.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.862 -0.685 . . . . 0.82 112.643 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.416 HE21 ' N ' ' A' ' 52' ' ' GLU . 28.2 tp60 -77.3 124.75 28.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.328 . . . . 1.16 110.41 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.416 ' N ' HE21 ' A' ' 51' ' ' GLN . 16.4 mp0 -67.97 126.8 30.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.312 -0.858 . . . . 2.51 111.257 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.2 m -142.9 149.86 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.036 -0.529 . . . . 1.12 109.925 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.02 156.28 42.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.24 -0.288 . . . . 1.49 110.401 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 2.4 p90 -170.16 179.42 3.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.877 0.37 . . . . 0.79 111.292 -169.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.4 p -120.8 172.3 7.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 1.49 110.683 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.67 146.12 49.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.55 111.528 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 2.04 110.091 174.539 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.544 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 110.238 -0.282 . . . . 2.92 110.238 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.29 150.98 42.71 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.57 2.18 . . . . 1.58 112.236 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.36 129.47 34.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.101 -0.499 . . . . 1.33 109.806 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -116.12 143.33 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.915 0.388 . . . . 2.3 111.123 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.1 70.92 0.58 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.362 -0.836 . . . . 2.67 111.21 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 25.3 t -96.14 125.17 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 1.46 109.821 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -127.89 149.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 4.04 111.13 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 66.8 mtt -79.23 154.17 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.5 109.935 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.3 147.96 32.99 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 2.27 109.658 169.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.93 162.83 27.41 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.54 2.16 . . . . 2.54 112.975 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.27 173.04 5.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 4.95 111.214 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 m120 73.72 3.18 4.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.496 -0.775 . . . . 3.42 110.989 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 m -89.46 -2.39 58.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 2.12 110.351 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 HD12 HD21 ' A' ' 27' ' ' LEU . 30.7 mm -110.72 123.39 35.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.203 -0.666 . . . . 1.37 109.203 176.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.49 139.27 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.048 1.832 . . . . 1.17 111.266 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.83 148.51 43.4 Favored Pre-proline 0 C--N 1.314 -0.941 0 C-N-CA 120.821 -0.352 . . . . 3.13 110.427 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.39 130.73 41.43 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.276 2.651 . . . . 1.39 111.932 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.09 93.0 9.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.188 0.518 . . . . 1.69 110.826 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.39 126.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.535 -0.913 . . . . 1.49 108.535 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -59.96 2.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.547 0.203 . . . . 3.44 111.547 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 91' ' ' THR . 57.5 mm-40 -91.21 -55.04 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.714 -0.394 . . . . 2.84 111.281 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 13.1 t 171.02 159.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 2.07 109.9 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.44 -54.93 2.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 1.45 109.788 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.577 ' CE1' ' HE2' ' A' ' 151' ' ' PHE . 23.7 p80 -162.93 168.23 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.73 109.623 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.38 -177.52 3.15 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.137 -0.32 . . . . 1.86 110.137 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.65 179.1 47.82 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.838 -0.696 . . . . 0.54 111.698 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.59 145.27 32.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.833 -0.432 . . . . 2.06 109.833 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.6 t -58.79 123.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.365 -0.235 . . . . 1.31 110.365 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.28 -65.96 0.82 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.388 -0.369 . . . . 1.31 111.888 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 110.331 -0.248 . . . . 4.44 110.331 179.081 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.639 0.257 . . . . 1.67 110.96 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 95.96 144.42 16.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.334 -0.46 . . . . 1.08 112.272 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 130' ' ' GLU . 54.5 mt -128.99 145.03 51.35 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.699 0.761 . . . . 1.5 112.148 -174.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.13 137.37 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.413 -1.267 . . . . 1.06 108.532 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.0 pt-20 -90.48 125.07 35.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.489 0.661 . . . . 1.4 110.505 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.457 HG13 ' CG ' ' A' ' 129' ' ' HIS . 44.0 mm -94.97 136.84 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.894 -1.048 . . . . 1.26 110.43 -174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD22 ' H ' ' A' ' 118' ' ' LEU . 2.5 pt? -100.73 144.39 29.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.282 -0.636 . . . . 1.72 109.282 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.63 167.29 9.27 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.104 0.252 . . . . 2.29 111.023 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.2 -29.44 68.71 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.575 0.35 . . . . 2.78 111.528 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.5 6.15 42.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 2.13 110.527 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 69.72 87.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 4.81 111.793 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.6 p -115.8 -159.07 0.7 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.928 -1.033 . . . . 2.38 109.639 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 p -85.84 -161.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.338 -0.392 . . . . 2.22 109.975 170.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.5 p -64.44 120.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 1.84 111.34 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.8 mt -69.1 -67.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 1.45 110.343 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 p -133.28 -86.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.75 -0.38 . . . . 1.86 111.335 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -178.1 129.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.685 . . . . 2.39 109.654 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.457 ' CG ' HG13 ' A' ' 117' ' ' ILE . 13.4 m170 -116.19 129.72 56.44 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.7 110.246 176.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 158' ' ' ARG . 10.4 tt0 -96.77 149.69 21.55 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.071 -0.968 . . . . 1.19 109.958 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 31.0 p90 -117.87 177.11 4.9 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.67 -0.412 . . . . 0.82 110.709 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -134.93 152.98 20.92 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.912 -0.585 . . . . 0.59 111.848 -176.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -52.86 -28.76 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.887 0.375 . . . . 1.25 111.897 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.0 p -77.53 -33.19 54.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.409 0.623 . . . . 1.68 110.436 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 47.9 t -72.03 -27.38 62.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.107 -0.951 . . . . 1.46 110.311 177.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.08 59.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.393 -0.821 . . . . 2.06 112.506 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -48.61 -41.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.234 0.54 . . . . 1.4 110.257 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.3 m120 -87.86 32.65 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.759 -0.655 . . . . 2.83 111.414 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -60.59 -21.66 62.88 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.156 0.503 . . . . 1.92 111.264 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -93.14 -6.28 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 2.83 111.371 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -88.51 158.06 18.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.76 -0.654 . . . . 1.89 111.188 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.4 mm? -81.36 49.06 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 3.33 110.43 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -76.4 122.84 25.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.603 -0.726 . . . . 1.26 109.937 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.441 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 11.7 pt20 -123.94 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.657 . . . . 2.0 111.732 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.39 121.79 15.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.907 -1.042 . . . . 1.9 109.905 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.33 1.81 44.31 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.322 -0.942 . . . . 1.17 112.53 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.441 ' OD1' ' HG2' ' A' ' 144' ' ' GLN . 13.3 m-20 -91.07 140.13 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.743 0.272 . . . . 1.94 110.393 173.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.78 138.99 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.918 0.39 . . . . 2.45 110.862 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 164' ' ' ALA . 15.6 m -135.97 146.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 1.77 110.823 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.3 p -104.67 133.38 49.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.505 -0.554 . . . . 1.86 109.505 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' HE2' ' CE1' ' A' ' 93' ' ' HIS . 5.5 p90 -146.42 163.57 35.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.116 0.26 . . . . 0.74 110.7 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 1.4 mpp_? -118.54 121.7 40.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.147 0.499 . . . . 2.72 110.194 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.423 HG23 ' NE2' ' A' ' 93' ' ' HIS . 12.9 tt -100.41 136.95 29.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.696 . . . . 1.84 109.788 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -169.61 -93.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.568 -0.16 . . . . 1.92 110.568 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.52 -19.97 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.826 0.346 . . . . 2.76 111.254 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.3 t -81.66 -17.01 49.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.927 -0.397 . . . . 2.5 109.927 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.32 23.22 57.54 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.791 -0.64 . . . . 1.27 113.51 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 11.4 ptp180 -156.93 -168.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.451 -0.574 . . . . 4.13 109.451 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.6 108.3 17.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.897 0.379 . . . . 1.09 110.319 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.12 144.85 44.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.154 -0.475 . . . . 1.2 111.368 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.9 m 66.17 43.6 2.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.633 -0.712 . . . . 2.15 110.352 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.07 118.7 7.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.622 0.725 . . . . 1.93 110.786 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.42 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.1 t-20 -120.86 124.4 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.48 -0.782 . . . . 2.63 109.882 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 149' ' ' VAL . . . -64.07 112.96 3.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 1.23 111.041 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.86 129.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.944 -0.571 . . . . 2.08 111.021 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 3.44 110.061 174.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.96 0.409 . . . . 2.13 110.788 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.45 114.65 25.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.631 . . . . 1.8 109.459 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.34 159.31 15.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.501 -0.772 . . . . 1.36 109.267 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' HG3' HD13 ' A' ' 27' ' ' LEU . 6.8 ptp180 -141.05 147.42 38.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.757 -0.46 . . . . 2.73 109.757 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.09 -169.77 22.06 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.172 -0.771 . . . . 0.5 111.172 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.19 140.26 52.69 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.785 0.326 . . . . 0.75 110.468 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.21 116.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.642 -0.708 . . . . 1.14 110.613 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.28 -48.55 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 1.31 111.355 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.45 124.03 70.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.676 0.274 . . . . 2.16 110.649 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.5 ttm -126.94 105.55 8.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.272 -0.422 . . . . 1.92 110.197 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -97.94 -161.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.715 -0.476 . . . . 2.53 109.715 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -50.63 38.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 3.24 111.912 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.4 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 50.8 m-80 -112.24 -34.47 5.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 2.03 111.571 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -124.82 173.74 8.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.15 -0.477 . . . . 1.47 110.709 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.32 165.74 35.56 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 111.076 -0.81 . . . . 0.76 111.076 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.44 126.64 54.53 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.183 0.516 . . . . 1.22 109.791 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -95.7 130.23 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.696 -0.853 . . . . 1.15 108.696 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -80.16 128.75 33.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.534 -0.913 . . . . 2.3 108.534 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.6 p -63.34 149.73 45.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.745 -0.661 . . . . 1.36 110.829 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 83' ' ' ILE . 11.4 tp -54.93 -34.12 62.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.305 0.574 . . . . 2.15 111.828 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -110.36 22.46 15.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 2.51 111.431 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 31.4 p80 43.63 45.73 5.9 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.016 0.912 . . . . 4.08 111.369 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.71 -44.72 9.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.919 -1.037 . . . . 2.89 111.337 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.82 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 1.8 112.07 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.21 121.75 46.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.53 -0.759 . . . . 3.37 110.367 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.19 127.32 64.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 1.43 111.536 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -91.83 120.62 32.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.95 -0.568 . . . . 1.12 110.053 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 75' ' ' VAL . 23.9 t80 -128.45 138.08 52.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.275 -0.42 . . . . 2.46 110.089 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 20' ' ' ASN . 3.3 t60 -107.6 124.29 49.73 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.174 -0.676 . . . . 1.4 109.174 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -63.18 -18.04 63.06 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.626 0.602 . . . . 0.82 112.626 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 -31.5 68.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.679 0.276 . . . . 2.03 110.841 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.05 5.95 46.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.982 0.42 . . . . 2.09 111.4 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.539 ' CZ ' HD12 ' A' ' 47' ' ' LEU . 47.4 t80 -75.34 132.09 40.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.313 -0.403 . . . . 1.39 110.047 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.3 ttp -114.63 91.06 3.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.959 0.409 . . . . 2.04 110.08 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.68 -136.65 4.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.987 -0.845 . . . . 1.05 110.987 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -121.25 96.6 48.04 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 117.023 0.411 . . . . 2.51 110.681 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.39 -22.94 12.03 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.791 2.328 . . . . 1.14 113.013 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -81.66 -5.91 58.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.295 0.569 . . . . 2.29 110.476 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -112.47 18.04 18.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.88 -0.6 . . . . 2.45 110.414 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.539 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 49.2 mt -92.32 143.72 26.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.841 -0.618 . . . . 1.29 110.716 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.0 157.96 42.73 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.993 -0.743 . . . . 2.35 108.993 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.7 mm? -60.84 134.43 57.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.966 0.412 . . . . 2.01 110.511 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.29 -15.55 50.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.716 -0.754 . . . . 0.82 113.032 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -66.0 133.32 50.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.997 0.427 . . . . 1.16 111.434 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 1.8 mp0 -81.36 137.39 35.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.889 . . . . 2.51 110.763 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 77' ' ' MET . 23.6 m -144.3 151.54 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 1.12 109.843 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' HD22 ' A' ' 78' ' ' LEU . 23.9 pt-20 -112.0 144.69 40.93 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.978 -0.378 . . . . 1.49 109.978 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -161.49 170.71 19.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.79 111.856 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -120.45 143.79 48.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.433 -0.803 . . . . 1.49 111.049 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.42 143.28 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 1.55 110.875 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.512 . . . . 2.04 110.018 176.621 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.886 -0.412 . . . . 2.92 109.886 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.53 165.72 31.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.331 2.021 . . . . 1.58 111.808 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.12 141.06 40.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.508 -0.315 . . . . 1.33 110.419 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.22 152.22 43.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 2.3 110.186 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.29 84.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.729 0.643 . . . . 2.67 111.511 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 35' ' ' PHE . 45.6 t -110.94 124.62 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.146 -0.479 . . . . 1.46 110.003 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -118.25 153.42 33.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.802 -0.635 . . . . 4.04 109.792 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.421 ' HA ' HG11 ' A' ' 53' ' ' VAL . 65.1 mtp -97.86 119.46 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.7 -0.227 . . . . 1.5 110.783 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -122.56 104.09 37.26 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-O 121.804 0.812 . . . . 2.27 111.401 176.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -88.95 129.49 2.04 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.27 1.98 . . . . 2.54 112.868 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.5 tttp 79.05 133.13 0.06 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.073 1.138 . . . . 4.95 114.073 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.3 t30 68.96 3.23 3.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.444 -1.253 . . . . 3.42 112.891 167.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -78.14 -25.93 47.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.2 -0.6 . . . . 2.12 109.439 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 27' ' ' LEU . 1.8 mm -108.33 128.21 26.09 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.392 -0.966 . . . . 1.37 108.392 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.16 152.08 50.16 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.297 1.998 . . . . 1.17 112.461 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -103.66 142.49 24.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 3.13 109.597 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.73 128.13 21.39 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.297 1.998 . . . . 1.39 111.977 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.26 95.0 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 1.69 111.502 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -137.54 135.01 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.113 -0.699 . . . . 1.49 109.113 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' C ' HD21 ' A' ' 89' ' ' LEU . 5.2 tt -85.18 -62.0 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.659 -0.416 . . . . 3.44 111.265 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -93.0 -56.93 2.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.534 0.568 . . . . 2.84 112.534 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m 169.12 140.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.866 -1.161 . . . . 2.07 107.866 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -93.21 -55.34 3.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.174 -0.61 . . . . 1.45 110.638 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -145.96 148.29 32.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 1.73 110.987 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -110.7 161.54 15.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.706 -1.22 . . . . 1.86 107.706 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.28 -176.88 41.38 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.429 -1.367 . . . . 0.54 112.838 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.56 146.69 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.828 -0.434 . . . . 2.06 109.828 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.5 t -58.79 119.47 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.316 -0.402 . . . . 1.31 110.575 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.554 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -74.4 -37.49 63.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 1.31 111.192 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 4.44 110.563 172.558 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 N-CA-C 112.049 0.389 . . . . 1.67 112.049 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.3 163.33 30.63 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.664 -0.779 . . . . 1.08 111.984 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.45 150.71 39.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 1.5 111.876 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.5 mt -116.3 136.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.981 -1.009 . . . . 1.06 109.748 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.57 114.67 24.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.678 0.751 . . . . 1.4 110.009 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 5.4 mm -91.0 132.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.994 -1.003 . . . . 1.26 109.076 -176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.02 146.01 27.4 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.779 -0.368 . . . . 1.72 110.438 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.81 -178.6 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 2.29 110.401 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG2' HD23 ' A' ' 121' ' ' LEU . 1.4 pm0 -68.11 -25.14 65.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.895 0.331 . . . . 2.78 111.895 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -93.35 0.71 57.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.904 -0.318 . . . . 2.13 110.476 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 62.95 39.57 10.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.043 -0.526 . . . . 4.81 110.789 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 m -104.38 -50.69 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 2.38 111.553 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 m -143.36 166.46 24.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.769 0.319 . . . . 2.22 110.794 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -68.72 137.27 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.356 -0.384 . . . . 1.84 110.995 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.16 -68.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 1.45 110.552 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -137.06 -86.41 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.017 0.436 . . . . 1.86 111.046 171.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -177.24 136.43 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.365 -0.834 . . . . 2.39 109.224 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.464 ' HB2' HD12 ' A' ' 117' ' ' ILE . 27.3 m170 -118.83 132.89 56.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.66 -0.416 . . . . 0.7 110.48 174.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.25 146.82 23.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.424 -0.807 . . . . 1.19 109.507 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -118.75 142.4 47.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.82 110.967 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.25 150.14 24.49 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.825 -0.625 . . . . 0.59 112.522 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.2 tp -54.39 -43.86 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.126 0.488 . . . . 1.25 111.624 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 t -71.99 -29.56 64.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.213 0.53 . . . . 1.68 110.124 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 6.0 m -73.07 -24.11 60.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.629 . . . . 1.46 110.495 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -77.17 60.05 1.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.947 -0.57 . . . . 2.06 110.486 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.8 t -39.96 -46.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.782 -0.644 . . . . 1.4 111.503 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 3.3 p30 -94.19 33.68 1.35 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 2.83 111.537 -173.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.54 -20.04 52.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.723 0.409 . . . . 1.92 111.765 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -75.74 -22.92 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 2.83 110.976 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -93.29 140.49 29.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.893 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 102.41 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.648 . . . . 3.33 110.788 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.04 118.44 32.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.824 -1.08 . . . . 1.26 109.93 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -120.24 -179.03 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.707 0.289 . . . . 2.0 111.117 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 75.2 tttt -65.17 126.94 29.68 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.699 -0.482 . . . . 1.9 109.699 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.74 -17.05 13.62 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.533 -0.758 . . . . 1.17 111.352 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -85.5 129.94 34.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 1.94 110.266 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -81.72 143.75 31.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 2.45 110.609 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.11 144.9 35.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.814 -0.63 . . . . 1.77 110.308 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.0 m -106.61 128.36 54.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.515 -0.55 . . . . 1.86 109.515 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.46 ' HB3' HG13 ' A' ' 162' ' ' VAL . 30.2 p90 -145.26 -178.61 6.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.481 . . . . 0.74 110.165 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -148.63 124.03 10.3 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.311 -0.556 . . . . 2.72 111.019 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 129' ' ' HIS . 7.5 pt -99.56 153.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.996 -0.547 . . . . 1.84 109.853 172.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.535 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 33.0 t70 -177.15 -88.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.277 0.361 . . . . 1.92 110.293 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 45.6 mt-10 -74.22 -28.6 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 2.76 110.535 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 158' ' ' ARG . 13.3 p -78.85 -17.34 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 2.5 110.602 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.93 -28.21 0.64 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.135 -0.484 . . . . 1.27 113.111 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 156' ' ' SER . 90.4 mtt180 -120.39 -169.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.994 -0.372 . . . . 4.13 109.994 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.62 22.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.341 0.591 . . . . 1.09 111.791 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -126.42 155.79 41.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.185 -0.916 . . . . 1.2 110.061 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.6 m 57.55 51.4 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 2.15 111.087 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 151' ' ' PHE . 29.0 m -79.05 145.13 9.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.854 -0.612 . . . . 1.93 110.437 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.522 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -149.04 128.8 13.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.359 -0.608 . . . . 2.63 109.359 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' N ' HD21 ' A' ' 163' ' ' ASN . . . -60.04 124.22 19.56 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.385 0.428 . . . . 1.23 111.094 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 99.9 t -132.54 142.11 43.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 2.08 110.342 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 3.44 110.258 177.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.144 0.497 . . . . 2.13 110.696 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.97 114.7 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.529 -0.915 . . . . 1.8 108.529 172.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -87.18 141.71 28.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.625 -0.716 . . . . 1.36 110.253 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 25.5 mmt85 -100.76 146.0 27.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.575 -0.738 . . . . 2.73 110.285 -177.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.69 -173.26 33.14 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.224 -1.15 . . . . 0.5 110.224 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.44 145.35 36.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.199 0.5 . . . . 0.75 111.196 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.54 101.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.561 -0.745 . . . . 1.14 110.61 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.41 -43.82 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.015 0.436 . . . . 1.31 110.733 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.74 122.6 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.208 -0.451 . . . . 2.16 110.665 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.0 ttm -117.58 107.33 14.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.92 109.788 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.21 170.36 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.159 -0.682 . . . . 2.53 109.159 176.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.728 0.299 . . . . 3.24 111.746 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -102.38 -34.85 9.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.147 0.425 . . . . 2.03 112.147 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.89 -172.79 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.61 0.243 . . . . 1.47 111.186 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.09 173.44 32.68 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.833 -0.699 . . . . 0.76 111.899 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.73 138.71 52.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.832 0.348 . . . . 1.22 110.262 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.09 129.91 58.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 1.15 109.807 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.48 130.98 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.013 -1.106 . . . . 2.3 108.013 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -65.86 145.22 56.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.89 -0.595 . . . . 1.36 111.382 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.504 HD23 HD11 ' A' ' 83' ' ' ILE . 2.3 tm? -52.36 -45.33 65.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 2.15 111.202 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -110.83 31.9 5.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.187 -0.46 . . . . 2.51 111.376 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 p80 43.89 45.38 6.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.785 0.834 . . . . 4.08 111.574 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.32 -48.21 62.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.8 -1.091 . . . . 2.89 110.608 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -172.46 -172.34 0.91 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 1.8 110.858 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.09 122.0 42.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 3.37 110.747 -168.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.58 136.29 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 121.116 0.484 . . . . 1.43 111.908 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.12 130.65 55.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 1.12 109.97 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -125.18 156.88 37.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.025 -0.732 . . . . 2.46 109.025 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -118.68 133.06 56.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.757 -0.46 . . . . 1.4 109.757 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.25 -24.04 66.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.867 0.691 . . . . 0.82 112.867 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -66.3 -33.37 75.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.762 0.315 . . . . 2.03 110.779 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.84 19.58 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.264 0.554 . . . . 2.09 110.564 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 75.0 t80 -92.98 139.69 30.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.654 -0.703 . . . . 1.39 110.304 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 38.0 ttm -119.5 100.42 7.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.04 110.108 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.88 -143.05 10.12 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.486 -0.646 . . . . 1.05 111.486 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -115.53 99.38 52.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.789 0.294 . . . . 2.51 110.732 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -81.9 -25.22 3.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.388 2.059 . . . . 1.14 111.918 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.34 -14.29 60.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.315 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -114.39 19.42 16.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.45 111.067 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 17.1 mt -82.29 169.31 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 1.29 112.202 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -130.77 164.76 24.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.014 -0.993 . . . . 2.35 110.337 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.18 114.87 22.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.6 -0.518 . . . . 2.01 109.6 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.67 3.05 46.67 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.742 -0.663 . . . . 0.82 112.192 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.401 HE21 ' N ' ' A' ' 52' ' ' GLU . 27.3 tp60 -68.3 122.46 18.41 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 1.16 111.574 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' OE2' ' HG2' ' A' ' 80' ' ' LYS . 26.0 mp0 -61.49 127.12 29.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.412 -0.813 . . . . 2.51 111.14 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.1 149.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.761 -0.654 . . . . 1.12 109.913 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 11' ' ' ARG . 21.6 pt-20 -121.22 137.32 54.73 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.344 -0.613 . . . . 1.49 109.344 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 4.3 p90 -155.39 178.05 10.67 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.684 -0.406 . . . . 0.79 111.411 -172.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -124.3 141.55 51.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.361 -0.381 . . . . 1.49 111.096 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.76 119.82 18.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.55 109.579 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.534 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 114.883 -1.053 . . . . 2.04 111.615 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 109.777 -0.453 . . . . 2.92 109.777 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.91 147.76 50.27 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.92 1.747 . . . . 1.58 112.233 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.4 142.07 27.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 1.33 110.421 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 53.8 mm-40 -113.02 156.66 22.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.061 -0.718 . . . . 2.3 109.061 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 58.07 50.68 9.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.576 0.703 . . . . 2.67 110.282 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 20.3 t -80.85 110.7 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.846 -0.616 . . . . 1.46 110.064 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -107.98 173.69 6.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.578 0.704 . . . . 4.04 111.821 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.44 ' CG ' ' HH ' ' A' ' 40' ' ' TYR . 48.1 mtp -117.46 144.05 45.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.859 -1.064 . . . . 1.5 109.301 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.4 pt? -131.56 160.27 68.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 C-N-CA 120.694 -0.403 . . . . 2.27 110.072 175.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 60.7 Cg_endo -73.55 160.97 43.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.833 1.689 . . . . 2.54 112.155 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HG2' ' OE2' ' A' ' 52' ' ' GLU . 41.6 mtmt -74.1 173.92 9.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.788 -0.642 . . . . 4.95 112.125 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.52 30.66 2.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.43 -1.259 . . . . 3.42 110.55 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 t -124.39 11.09 8.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.798 0.809 . . . . 2.12 109.324 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 27' ' ' LEU . 40.9 mm -113.12 125.25 30.04 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 1.37 109.157 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.78 158.33 57.73 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.875 2.383 . . . . 1.17 113.268 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -137.35 152.73 73.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 3.13 109.779 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 10.8 Cg_exo -69.93 150.19 66.82 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.542 2.161 . . . . 1.39 112.545 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.95 92.52 6.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.387 0.613 . . . . 1.69 111.38 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.79 119.3 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.009 -1.108 . . . . 1.49 108.009 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.82 -63.45 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.197 0.814 . . . . 3.44 113.197 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.19 -59.95 1.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.728 -0.789 . . . . 2.84 112.529 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -179.52 137.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.533 0.733 . . . . 2.07 109.525 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -106.3 -42.52 5.03 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.072 -0.251 . . . . 1.45 110.924 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -141.02 140.11 34.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.682 0.277 . . . . 1.73 110.422 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -116.97 110.14 17.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.239 -0.652 . . . . 1.86 109.239 173.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -114.53 -171.45 17.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.313 -0.946 . . . . 0.54 112.863 -172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -133.96 143.27 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.327 -0.249 . . . . 2.06 110.327 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.41 124.21 13.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.507 -0.315 . . . . 1.31 110.891 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.33 -59.11 2.65 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.31 111.172 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 120.859 0.361 . . . . 4.44 110.802 179.379 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 112.022 0.379 . . . . 1.67 112.022 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.77 164.46 38.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.485 -0.864 . . . . 1.08 111.284 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.445 HD13 ' NE2' ' A' ' 128' ' ' GLN . 26.1 mt -146.47 141.66 27.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.809 0.814 . . . . 1.5 112.214 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.13 132.94 55.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.181 -1.372 . . . . 1.06 108.988 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.93 112.42 21.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.883 0.849 . . . . 1.4 109.593 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.479 HG13 ' CG ' ' A' ' 129' ' ' HIS . 11.3 mm -87.56 134.85 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.694 -1.139 . . . . 1.26 110.249 -170.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.59 148.04 26.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.41 0.624 . . . . 1.72 110.731 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.64 150.89 14.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.994 -1.003 . . . . 2.29 109.116 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.8 -16.94 64.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.752 -0.379 . . . . 2.78 111.682 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.79 10.82 39.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.677 -0.49 . . . . 2.13 109.677 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 63.4 29.93 15.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.264 -0.88 . . . . 4.81 111.096 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 m -73.09 -76.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 2.38 110.988 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -143.94 -166.11 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.499 -0.126 . . . . 2.22 110.742 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 40.0 t -80.55 138.83 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 122.925 0.141 . . . . 1.84 110.689 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.7 mt -77.34 -70.68 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.908 -0.405 . . . . 1.45 109.908 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.4 m -138.52 -86.2 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.346 0.593 . . . . 1.86 110.457 167.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.445 ' NE2' HD13 ' A' ' 114' ' ' LEU . 10.9 pt20 -178.44 144.55 0.3 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.067 -0.97 . . . . 2.39 108.645 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.479 ' CG ' HG13 ' A' ' 117' ' ' ILE . 40.0 m170 -115.46 142.24 46.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.531 0.681 . . . . 0.7 111.282 176.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -89.87 140.76 29.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.263 -1.335 . . . . 1.19 109.176 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.532 ' CD1' HD22 ' A' ' 136' ' ' LEU . 30.9 p90 -118.07 154.97 31.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.82 0.343 . . . . 0.82 111.171 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.48 151.48 18.41 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.59 112.517 -173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.26 -32.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.008 0.432 . . . . 1.25 112.062 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 p -77.44 -38.02 50.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.438 -0.346 . . . . 1.68 111.106 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 42.2 p -80.49 -11.2 59.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 1.46 110.643 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 131' ' ' PHE . 29.4 mt -74.91 59.29 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 2.06 111.739 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -45.22 -41.38 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.537 . . . . 1.4 111.128 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.5 m120 -91.88 34.25 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.778 -0.646 . . . . 2.83 111.78 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 3.0 ptmt -64.39 -11.47 33.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.422 0.63 . . . . 1.92 110.832 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -87.52 -22.17 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.527 -0.761 . . . . 2.83 110.834 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 9.8 m-20 -92.86 162.54 14.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 1.89 111.726 -167.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.29 95.89 10.15 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.763 -0.653 . . . . 3.33 109.288 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.9 tp -114.78 107.45 15.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.901 -1.045 . . . . 1.26 109.04 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.92 -177.35 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 2.0 111.456 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -59.59 119.59 7.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 1.9 110.708 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.02 -3.55 31.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.564 -0.827 . . . . 1.17 112.904 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -89.7 137.07 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 1.94 110.655 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 148' ' ' LEU . 2.4 mm? -85.13 139.37 31.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 2.45 110.846 -174.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 141.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 1.77 111.461 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.0 p -105.72 123.37 47.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.771 -0.826 . . . . 1.86 108.771 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.5 p90 -139.94 164.36 30.2 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.585 -0.524 . . . . 0.74 109.585 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 6.8 mpt_? -123.65 119.25 29.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.018 -0.673 . . . . 2.72 110.136 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 tt -101.66 137.45 29.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.51 -0.768 . . . . 1.84 109.544 170.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -162.13 -99.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.915 -0.314 . . . . 1.92 110.731 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 8.8 pt-20 -83.0 -7.08 59.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.2 0.524 . . . . 2.76 111.071 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.4 t -93.26 -17.19 23.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.043 -0.526 . . . . 2.5 109.769 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.17 15.51 58.76 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 116.052 -0.522 . . . . 1.27 113.955 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -139.67 -177.32 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.44 . . . . 4.13 109.813 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.94 108.22 18.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.252 0.548 . . . . 1.09 110.107 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -118.03 155.74 29.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.86 -0.609 . . . . 1.2 110.557 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 t 56.37 49.3 15.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 2.15 109.699 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.23 110.74 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.038 -0.983 . . . . 1.93 110.608 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.11 124.4 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 2.63 110.126 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 121.21 14.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.208 -0.293 . . . . 1.23 110.208 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 96.3 t -128.31 140.88 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 2.08 111.091 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 3.44 109.922 176.651 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.212 0.529 . . . . 2.13 111.763 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 p -102.1 121.52 53.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.478 -0.934 . . . . 1.8 108.478 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -98.39 155.58 17.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.699 -0.682 . . . . 1.36 109.594 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.499 ' HG3' HD12 ' A' ' 27' ' ' LEU . 29.2 ptt-85 -128.82 143.91 51.03 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.104 0.478 . . . . 2.73 110.085 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.16 -171.88 21.57 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.356 -1.098 . . . . 0.5 110.356 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.32 140.34 48.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.271 0.557 . . . . 0.75 111.055 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.579 HG22 ' SD ' ' A' ' 17' ' ' MET . 45.7 mm -65.24 122.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.142 -0.935 . . . . 1.14 111.838 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.24 -18.0 10.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 1.31 111.321 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -135.54 123.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.395 0.141 . . . . 2.16 111.051 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.579 ' SD ' HG22 ' A' ' 14' ' ' ILE . 85.7 mmm -118.1 111.23 18.61 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.131 0.419 . . . . 1.92 112.131 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -112.4 172.23 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.514 -0.921 . . . . 2.53 108.514 165.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -82.89 -25.52 32.4 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.49 -0.484 . . . . 3.24 110.958 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -92.19 -50.23 5.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.724 0.297 . . . . 2.03 111.7 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.732 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.4 p90 -153.15 151.25 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.994 0.426 . . . . 1.47 111.292 -174.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.91 -178.8 15.71 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.891 -0.671 . . . . 0.76 111.817 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.88 141.83 49.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.345 -0.613 . . . . 1.22 109.345 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.61 119.78 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.081 0.467 . . . . 1.15 111.581 -170.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -70.83 128.59 36.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 2.3 108.934 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 p -81.2 153.12 27.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.192 -0.458 . . . . 1.36 111.161 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 83' ' ' ILE . 7.2 tp -50.14 -47.73 54.04 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.55 -0.75 . . . . 2.15 111.622 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -104.77 20.88 17.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 2.51 111.023 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 p80 41.48 47.56 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.88 0.872 . . . . 4.08 111.781 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.77 -40.49 22.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.451 -0.795 . . . . 2.89 110.068 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -159.99 179.98 8.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.418 -0.81 . . . . 1.8 109.78 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -114.74 133.3 56.01 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.429 -0.952 . . . . 3.37 108.429 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.22 112.17 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.461 0.648 . . . . 1.43 111.993 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -72.06 119.97 17.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.222 -0.899 . . . . 1.12 110.491 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -124.77 136.06 53.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.197 -0.456 . . . . 2.46 110.621 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -98.97 118.08 34.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.617 -0.883 . . . . 1.4 108.617 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.07 -17.38 39.14 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.26 0.467 . . . . 0.82 112.26 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 t -56.49 -24.98 49.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.191 -0.459 . . . . 2.03 111.114 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -107.14 24.24 13.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 2.09 111.021 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CZ ' HD13 ' A' ' 47' ' ' LEU . 70.9 t80 -87.41 152.05 22.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 1.39 111.297 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.6 ttm -116.47 110.88 19.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 2.04 109.89 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.05 -139.34 10.81 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.568 -0.825 . . . . 1.05 112.278 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -122.72 99.75 41.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.535 0.207 . . . . 2.51 110.468 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.53 -20.75 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.272 1.981 . . . . 1.14 112.372 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -74.88 -11.83 60.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 2.29 111.168 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -109.46 14.71 23.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 2.45 110.653 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.414 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 38.1 mt -93.83 158.66 15.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 1.29 111.048 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -162.06 175.13 12.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.597 -0.729 . . . . 2.35 109.571 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 mt -72.99 122.22 21.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.849 0.357 . . . . 2.01 111.039 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.08 -4.53 16.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.676 -0.773 . . . . 0.82 112.899 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -86.83 132.96 33.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.048 0.424 . . . . 1.16 111.237 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 3.4 mp0 -82.14 143.52 31.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.86 -0.609 . . . . 2.51 111.138 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.0 m -141.48 153.58 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.704 -0.68 . . . . 1.12 110.193 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -113.64 137.62 51.34 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.235 -0.654 . . . . 1.49 109.235 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.487 ' CB ' HG21 ' A' ' 75' ' ' VAL . 1.3 p90 -164.45 163.03 22.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.398 0.618 . . . . 0.79 112.372 -175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -113.3 147.72 37.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 1.49 110.025 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.2 135.73 46.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.647 -0.421 . . . . 1.55 110.327 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 2.04 111.002 -178.543 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.2 mt . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 110.333 -0.247 . . . . 2.92 110.333 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.33 174.98 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.586 2.19 . . . . 1.58 112.134 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.72 159.52 22.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.596 -0.275 . . . . 1.33 110.84 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -130.1 145.39 51.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.709 0.29 . . . . 2.3 111.566 -176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 55.17 85.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.047 -0.979 . . . . 2.67 111.823 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.487 HG21 ' CB ' ' A' ' 55' ' ' TYR . 43.5 t -115.86 119.38 61.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.056 -0.52 . . . . 1.46 110.623 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -120.22 164.74 15.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.636 -0.505 . . . . 4.04 109.636 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.4 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.9 mtt -81.12 144.27 31.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.815 0.34 . . . . 1.5 110.653 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 26.2 tp -121.68 129.43 25.19 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 2.27 110.183 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 28.2 Cg_exo -63.83 154.37 70.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.624 2.216 . . . . 2.54 112.476 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.585 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -64.07 168.82 4.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.915 -0.584 . . . . 4.95 111.248 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.9 t30 76.58 2.84 3.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.628 0.771 . . . . 3.42 110.735 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.7 p -86.99 -11.12 51.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.815 0.816 . . . . 2.12 109.191 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 27' ' ' LEU . 8.4 mm -100.52 132.51 22.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 114.463 -1.244 . . . . 1.37 108.565 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.05 142.04 66.42 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.159 1.906 . . . . 1.17 111.495 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.03 143.28 47.29 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.695 -0.402 . . . . 3.13 110.485 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.48 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 33.1 Cg_endo -63.84 141.46 78.32 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.117 2.545 . . . . 1.39 112.917 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.07 93.39 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.992 -0.549 . . . . 1.69 110.03 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.07 137.01 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.728 -0.842 . . . . 1.49 108.728 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -82.65 -61.06 1.98 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.911 -0.316 . . . . 3.44 111.73 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 91' ' ' THR . 39.1 mt-10 -91.45 -55.52 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.453 -0.499 . . . . 2.84 111.082 -175.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 166.43 161.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.716 -0.846 . . . . 2.07 108.716 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -105.5 -50.41 3.22 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.511 -0.476 . . . . 1.45 110.788 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.82 145.64 31.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.943 0.402 . . . . 1.73 111.04 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.64 ' O ' HD21 ' A' ' 118' ' ' LEU . 3.9 p-10 -113.41 148.1 36.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.774 -1.195 . . . . 1.86 107.774 171.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -163.43 -163.75 16.91 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 118.973 -1.584 . . . . 0.54 113.225 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 21.1 t -133.94 146.88 30.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.7 -0.482 . . . . 2.06 109.7 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.95 117.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.077 -0.342 . . . . 1.31 110.077 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.88 -57.0 3.14 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.159 0.429 . . . . 1.31 112.159 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 4.44 111.48 -176.766 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 111.532 0.197 . . . . 1.67 111.532 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.19 153.23 22.06 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.773 -0.727 . . . . 1.08 112.302 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 130' ' ' GLU . 89.3 mt -138.65 142.01 39.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.622 0.725 . . . . 1.5 112.419 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.48 143.88 18.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.521 -1.218 . . . . 1.06 109.964 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 96' ' ' VAL . 11.1 pt-20 -84.63 125.8 32.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.345 0.593 . . . . 1.4 109.586 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.56 HG13 ' CD2' ' A' ' 129' ' ' HIS . 14.6 mm -104.59 128.15 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.463 -0.789 . . . . 1.26 109.386 -173.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.64 HD21 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.18 156.93 20.79 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.299 0.374 . . . . 1.72 110.597 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.548 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m-20 -56.75 154.54 8.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.66 -0.496 . . . . 2.29 109.66 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.91 -22.42 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.06 0.457 . . . . 2.78 110.603 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.65 -3.82 45.5 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.145 -0.479 . . . . 2.13 110.221 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HG3' HD12 ' A' ' 118' ' ' LEU . 26.2 ttm180 64.23 89.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.272 -0.876 . . . . 4.81 111.004 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.9 m -133.34 -64.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 2.38 110.283 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -168.92 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.472 -0.785 . . . . 2.22 110.398 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 p -92.3 135.31 27.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.718 -0.475 . . . . 1.84 109.718 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -78.45 -70.87 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.566 -0.454 . . . . 1.45 110.767 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.6 m -139.89 -83.96 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.64 0.733 . . . . 1.86 111.43 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -175.36 138.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.575 -1.193 . . . . 2.39 109.695 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.56 ' CD2' HG13 ' A' ' 117' ' ' ILE . 35.6 m170 -118.76 140.48 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.252 -0.579 . . . . 0.7 109.703 168.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.536 ' HA ' HD21 ' A' ' 114' ' ' LEU . 19.8 tt0 -94.45 145.07 25.04 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.067 -0.97 . . . . 1.19 109.633 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.76 170.61 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.732 -0.387 . . . . 0.82 110.938 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.03 152.05 20.93 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.72 -0.552 . . . . 0.59 111.72 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.87 -29.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.966 0.412 . . . . 1.25 111.426 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.1 p -74.64 -37.36 62.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 1.68 111.271 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.565 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 47.3 p -86.46 -11.55 51.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.363 -0.38 . . . . 1.46 110.7 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.0 mt -73.93 59.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 2.06 111.107 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.68 -45.81 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.251 0.548 . . . . 1.4 110.839 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.528 HD22 HD23 ' A' ' 143' ' ' LEU . 2.9 p-10 -85.57 31.68 0.59 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 2.83 111.95 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -60.63 -20.01 59.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.023 0.439 . . . . 1.92 111.351 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -76.94 -21.43 54.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 2.83 111.591 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -89.8 175.6 7.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.148 -0.478 . . . . 1.89 110.677 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.0 mp -100.87 101.51 12.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.864 -0.607 . . . . 3.33 109.6 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.528 HD23 HD22 ' A' ' 138' ' ' ASN . 11.8 tp -115.48 114.43 25.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 1.26 110.094 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -124.98 -173.8 2.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.512 -0.313 . . . . 2.0 110.183 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -66.03 136.75 56.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.758 -0.377 . . . . 1.9 110.073 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.41 -9.48 57.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.675 -0.774 . . . . 1.17 111.722 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -89.49 147.57 23.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.099 0.952 . . . . 1.94 110.997 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.04 127.54 44.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.291 -1.777 . . . . 2.45 109.692 -168.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.1 152.57 37.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 1.77 111.768 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 p -118.98 135.71 54.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.214 -0.662 . . . . 1.86 109.214 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -153.94 161.98 41.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.74 110.948 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 123.96 30.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.781 0.8 . . . . 2.72 111.803 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tt -99.3 129.25 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.201 -1.363 . . . . 1.84 110.409 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 15.5 t70 -160.74 -88.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.976 -0.102 . . . . 1.92 110.913 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 4.6 mm-40 -81.66 -19.61 41.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 2.76 111.25 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.7 p -81.7 -17.57 47.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.238 -0.437 . . . . 2.5 110.496 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.73 18.18 16.48 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.808 -0.633 . . . . 1.27 112.842 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 62.8 mtm180 -147.46 -173.82 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.886 -1.153 . . . . 4.13 107.886 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.61 108.35 17.31 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.461 -0.496 . . . . 1.09 109.836 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -115.76 159.95 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 1.2 110.653 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.4 t 59.01 42.26 19.53 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.781 0.675 . . . . 2.15 109.766 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.77 108.81 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.348 -0.842 . . . . 1.93 110.442 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.75 111.33 20.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.387 -0.824 . . . . 2.63 110.143 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.68 120.26 9.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.869 -0.605 . . . . 1.23 110.675 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.84 110.26 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.855 -0.611 . . . . 2.08 110.614 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.439 -0.578 . . . . 3.44 109.439 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.341 0.591 . . . . 2.13 111.018 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.12 121.94 37.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.317 -0.856 . . . . 1.8 109.747 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.37 140.3 32.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.771 -0.65 . . . . 1.36 110.342 -173.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 37.5 ttm180 -101.77 152.85 20.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.776 -0.647 . . . . 2.73 110.002 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.97 -169.09 35.11 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.17 -0.772 . . . . 0.5 111.17 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.9 145.13 29.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.757 0.313 . . . . 0.75 110.581 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 112.16 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 1.14 110.589 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.82 -25.18 15.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.468 -0.333 . . . . 1.31 111.395 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.462 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 2.6 p -156.26 134.02 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.354 -0.384 . . . . 2.16 111.237 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.5 mtp -118.85 115.83 25.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.415 -0.587 . . . . 1.92 109.415 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HZ3' HG21 ' A' ' 16' ' ' VAL . 27.2 mmtm -96.25 -161.65 0.89 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.684 -0.487 . . . . 2.53 109.684 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.31 -46.53 27.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.899 -0.591 . . . . 3.24 111.134 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -111.49 -24.61 10.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 2.03 111.626 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 51.5 p90 -143.98 -173.72 4.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.938 0.399 . . . . 1.47 111.109 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.13 -178.36 35.03 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.001 -0.84 . . . . 0.76 111.001 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 67.7 m-85 -125.03 130.54 52.51 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.979 0.419 . . . . 1.22 109.958 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mt -100.03 126.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.976 -0.556 . . . . 1.15 109.542 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.78 127.46 32.45 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.959 -0.756 . . . . 2.3 108.959 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.1 p -63.62 139.72 58.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.34 -0.846 . . . . 1.36 110.729 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 2.3 tm? -57.2 -36.62 71.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.677 0.751 . . . . 2.15 109.468 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -82.72 6.92 16.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.718 -1.128 . . . . 2.51 112.253 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p80 42.71 53.02 4.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.73 0.812 . . . . 4.08 111.733 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.8 -42.66 3.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 2.89 111.444 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.14 174.5 14.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 1.8 111.303 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.24 126.16 50.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 3.37 109.43 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 90.7 t -105.28 121.41 57.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.282 -0.417 . . . . 1.43 111.86 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -82.15 114.57 20.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 1.12 109.691 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -118.15 137.45 52.96 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.179 -0.609 . . . . 2.46 109.424 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -100.79 127.64 47.14 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.174 -0.676 . . . . 1.4 109.174 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -56.99 -22.87 41.75 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.259 0.466 . . . . 0.82 112.259 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -70.55 -8.99 55.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.606 -0.27 . . . . 2.03 111.672 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -116.41 20.15 14.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 2.09 109.948 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -102.67 139.24 38.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 1.39 110.243 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -109.37 136.53 48.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.181 0.515 . . . . 2.04 110.717 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.6 -138.75 13.95 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.019 -0.833 . . . . 1.05 111.019 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -128.67 105.89 18.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.794 -0.447 . . . . 2.51 109.794 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.98 -30.7 38.87 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.843 2.362 . . . . 1.14 112.42 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.38 -18.1 65.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.66 -0.7 . . . . 2.29 111.528 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -98.36 10.65 40.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.079 0.466 . . . . 2.45 110.63 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.0 148.99 24.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.718 -0.673 . . . . 1.29 110.794 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 166.12 22.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 2.35 109.887 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.83 115.18 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 2.01 110.195 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -7.16 21.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.253 -0.499 . . . . 0.82 112.002 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.418 HE21 ' N ' ' A' ' 52' ' ' GLU . 24.8 tp60 -71.54 120.24 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 1.16 111.008 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG2' HG12 ' A' ' 83' ' ' ILE . 9.0 mp0 -65.13 134.09 53.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.294 -0.866 . . . . 2.51 111.371 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 77' ' ' MET . 18.6 m -145.2 166.42 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.751 -0.659 . . . . 1.12 110.108 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.62 150.02 48.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.03 -0.359 . . . . 1.49 110.03 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 12.1 p90 -164.09 -179.9 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.392 . . . . 0.79 111.649 -172.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -127.29 150.22 49.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 1.49 110.617 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.07 142.71 27.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 1.55 110.939 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.969 -0.56 . . . . 2.04 110.562 178.271 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.676 -0.49 . . . . 2.92 109.676 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.91 167.17 25.41 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.632 2.221 . . . . 1.58 112.91 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.19 146.59 31.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.377 -0.829 . . . . 1.33 110.747 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.09 154.55 27.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 2.3 111.027 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 61.87 41.22 11.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.627 -0.715 . . . . 2.67 111.515 170.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.9 t -71.01 118.59 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 1.46 110.092 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -118.44 154.99 31.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.57 . . . . 4.04 110.237 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.481 ' HA ' HG11 ' A' ' 53' ' ' VAL . 41.4 mtt -78.4 148.47 33.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.963 0.411 . . . . 1.5 110.485 173.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.46 HD13 ' HD2' ' A' ' 79' ' ' PRO . 20.0 tp -126.1 141.77 40.6 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.946 -0.57 . . . . 2.27 109.583 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HD2' HD13 ' A' ' 78' ' ' LEU . 15.0 Cg_endo -58.58 137.81 82.32 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.1 1.867 . . . . 2.54 111.279 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -66.85 164.48 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.694 -0.685 . . . . 4.95 111.861 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 70.44 21.7 5.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.91 -1.041 . . . . 3.42 110.41 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.4 t -89.76 5.14 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.606 0.717 . . . . 2.12 109.744 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 52' ' ' GLU . 28.9 mm -101.98 131.47 22.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 1.37 109.832 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.58 145.35 57.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.214 1.943 . . . . 1.17 111.735 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -120.71 149.8 51.24 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 120.866 -0.334 . . . . 3.13 110.851 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 43.0 Cg_endo -68.52 146.56 68.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.67 2.247 . . . . 1.39 112.195 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.57 95.27 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.332 -0.395 . . . . 1.69 110.338 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.08 136.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 1.49 109.021 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.7 -63.64 1.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.121 -0.631 . . . . 3.44 112.206 -171.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -94.22 -54.63 3.48 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.421 -0.512 . . . . 2.84 111.215 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 t 177.45 163.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.937 -0.764 . . . . 2.07 108.937 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -106.04 -52.72 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.087 0.47 . . . . 1.45 110.61 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.55 151.69 46.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 1.73 110.434 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.59 ' O ' HD22 ' A' ' 118' ' ' LEU . 4.4 p-10 -130.75 128.08 40.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.98 -0.748 . . . . 1.86 108.98 173.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.37 -146.32 4.31 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.859 -1.162 . . . . 0.54 112.723 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.453 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.0 p -142.14 148.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.802 -0.444 . . . . 2.06 109.802 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 ' HG ' ' A' ' 143' ' ' LEU . 86.2 t -59.95 126.76 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.495 0.188 . . . . 1.31 110.774 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -70.12 -52.46 23.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.377 -0.374 . . . . 1.31 110.765 -174.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 4.44 110.399 178.032 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.662 0.268 . . . . 1.67 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 157.74 33.46 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.569 -0.824 . . . . 1.08 111.834 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 128' ' ' GLN . 36.0 mt -141.81 148.06 38.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.467 0.651 . . . . 1.5 112.133 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.91 140.73 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.063 -0.971 . . . . 1.06 109.311 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 11.8 pt-20 -87.87 129.21 35.29 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.383 -0.599 . . . . 1.4 109.383 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 12.8 mm -104.43 140.67 21.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.827 -0.624 . . . . 1.26 110.614 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.7 pt? -84.08 146.48 27.89 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.987 -0.375 . . . . 1.72 109.987 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.9 165.47 17.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.71 -0.848 . . . . 2.29 108.71 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.74 -18.72 65.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.866 0.365 . . . . 2.78 111.0 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.95 6.47 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 2.13 110.18 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 55.87 77.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.526 -0.761 . . . . 4.81 111.208 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.9 p -117.73 -79.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 2.38 110.89 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.0 p -137.17 -174.5 3.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 2.22 110.793 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 4.7 p -65.17 129.87 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 1.84 110.721 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.1 -70.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.921 0.391 . . . . 1.45 110.791 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 p -135.97 -85.51 0.36 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.068 -0.514 . . . . 1.86 111.065 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.453 ' HB2' HD23 ' A' ' 114' ' ' LEU . 13.6 pt20 -176.51 137.4 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.573 -0.739 . . . . 2.39 109.763 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.529 ' CD2' HG13 ' A' ' 117' ' ' ILE . 32.1 m170 -121.62 125.83 47.62 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.809 -0.356 . . . . 0.7 110.086 171.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.44 149.42 24.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.639 -0.71 . . . . 1.19 109.9 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.465 ' CD1' HD23 ' A' ' 136' ' ' LEU . 20.9 p90 -117.74 146.86 43.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 0.82 111.294 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.8 150.43 18.33 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.59 112.494 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 134' ' ' THR . 9.2 tp -54.91 -43.02 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.236 0.458 . . . . 1.25 112.236 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.401 ' N ' HG23 ' A' ' 133' ' ' ILE . 3.1 t -77.58 -22.66 50.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.225 0.536 . . . . 1.68 110.203 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 15.2 m -80.66 -18.83 46.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.563 -0.744 . . . . 1.46 110.166 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.465 HD23 ' CD1' ' A' ' 131' ' ' PHE . 50.1 mt -76.53 60.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 2.06 111.419 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.2 t -41.09 -42.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.291 -0.413 . . . . 1.4 111.592 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -92.05 27.79 2.05 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.159 -0.473 . . . . 2.83 111.994 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -60.34 -18.19 48.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.07 0.396 . . . . 1.92 112.07 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -81.43 -19.24 42.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.309 -0.405 . . . . 2.83 111.478 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.48 175.41 9.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.941 -0.572 . . . . 1.89 110.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 pp -104.43 130.32 52.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.754 -0.832 . . . . 3.33 108.754 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.494 ' HG ' HG21 ' A' ' 97' ' ' VAL . 12.3 tp -139.97 109.7 6.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 1.26 109.372 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -122.73 -171.97 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 2.0 110.956 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 62.5 tttm -64.59 116.9 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.637 . . . . 1.9 110.44 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.71 33.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.603 -0.808 . . . . 1.17 112.877 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -91.49 127.64 37.01 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.106 0.453 . . . . 1.94 110.35 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.453 HD23 ' HB ' ' A' ' 96' ' ' VAL . 82.0 mt -73.73 144.24 45.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.34 0.591 . . . . 2.45 110.889 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.28 145.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.346 -0.843 . . . . 1.77 111.114 -173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.4 m -118.45 148.83 42.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.78 -0.645 . . . . 1.86 109.672 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -163.68 162.93 24.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.53 . . . . 0.74 109.808 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.7 122.05 35.21 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.779 0.799 . . . . 2.72 110.965 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.89 141.23 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.841 -1.072 . . . . 1.84 110.076 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 24.8 t70 -171.64 -93.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.625 -0.139 . . . . 1.92 110.625 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 41.9 mm-40 -74.01 -33.19 63.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 2.76 111.48 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -76.19 -15.51 60.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 2.5 110.753 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.65 20.6 39.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.968 -0.634 . . . . 1.27 112.948 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -140.49 -175.05 4.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.841 . . . . 4.13 108.728 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.47 108.38 18.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.216 -0.661 . . . . 1.09 109.216 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.26 158.77 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 1.2 111.218 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 36.8 t 59.34 39.59 22.11 Favored 'General case' 0 C--N 1.334 -0.071 0 N-CA-C 109.273 -0.64 . . . . 2.15 109.273 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -62.25 123.32 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.145 -0.934 . . . . 1.93 110.728 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -132.42 111.69 11.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.28 -0.418 . . . . 2.63 110.187 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.82 109.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 1.23 110.368 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 77.1 t -89.67 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 2.08 111.364 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.701 0 N-CA-C 109.125 -0.695 . . . . 3.44 109.125 172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.636 -0.586 . . . . 11.95 111.636 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.62 -31.14 2.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.876 0.369 . . . . 10.65 111.19 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.25 -13.73 30.95 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.058 -0.817 . . . . 8.95 111.058 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -105.1 15.46 27.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.92 0.867 . . . . 7.44 108.784 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.21 -168.27 1.44 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.8 -1.091 . . . . 5.59 110.747 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.04 161.1 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 3.46 110.702 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.0 24.47 5.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.49 -0.862 . . . . 1.76 112.052 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -112.93 122.09 46.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 2.13 111.036 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.28 124.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.122 -0.695 . . . . 1.8 109.122 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.25 138.89 32.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.368 0.604 . . . . 1.36 110.417 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.61 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -104.62 140.44 38.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.461 -0.791 . . . . 2.73 109.88 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.83 -172.39 30.25 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.13 -0.788 . . . . 0.5 111.13 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 143.05 37.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.04 0.448 . . . . 0.75 111.307 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.502 HG22 ' SD ' ' A' ' 17' ' ' MET . 33.1 mm -65.83 125.79 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 1.14 110.869 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.86 -35.74 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 1.31 111.384 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.5 123.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 2.16 110.698 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.502 ' SD ' HG22 ' A' ' 14' ' ' ILE . 80.5 mmm -116.03 107.39 14.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 1.92 110.954 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.4 mmtt -103.26 179.2 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.437 -1.32 . . . . 2.53 107.437 167.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.68 -18.56 29.28 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.892 -0.723 . . . . 3.24 110.695 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -101.67 -48.51 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.028 0.442 . . . . 2.03 111.592 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.507 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 39.9 p90 -142.67 -177.56 5.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.274 -0.421 . . . . 1.47 110.084 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.62 -178.36 34.54 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.748 -0.739 . . . . 0.76 111.795 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.88 130.97 53.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 1.22 110.224 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 mt -101.66 129.27 53.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.622 -0.717 . . . . 1.15 109.674 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.63 131.98 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.751 -0.833 . . . . 2.3 108.751 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.5 p -64.3 151.99 42.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.494 -0.776 . . . . 1.36 111.705 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 7.2 tp -62.7 -40.65 97.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.673 -0.694 . . . . 2.15 110.924 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 8.1 m -100.36 24.78 8.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.51 111.277 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.427 ' HB3' ' NH1' ' A' ' 158' ' ' ARG . 23.1 p80 44.3 51.01 7.71 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.763 0.792 . . . . 4.08 111.709 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 15.8 m-20 -82.02 -51.29 8.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.196 -0.911 . . . . 2.89 109.438 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -175.93 -175.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.089 -0.96 . . . . 1.8 109.678 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.39 136.3 43.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.047 0.451 . . . . 3.37 110.238 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.44 126.93 57.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.697 -0.683 . . . . 1.43 110.963 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -68.8 119.38 13.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.19 0.519 . . . . 1.12 110.124 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -129.58 136.51 49.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.654 -0.703 . . . . 2.46 109.935 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.21 139.27 40.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.346 -0.613 . . . . 1.4 109.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 17' ' ' MET . 60.0 m-85 -69.79 -16.31 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.032 0.444 . . . . 0.82 111.201 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 t -63.39 -23.22 67.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.76 -0.655 . . . . 2.03 111.77 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.41 24.62 12.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 2.09 110.488 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CZ ' HD12 ' A' ' 47' ' ' LEU . 91.8 t80 -91.69 146.29 23.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.838 -0.619 . . . . 1.39 110.865 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.77 117.32 31.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 2.04 110.12 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.95 -157.04 20.97 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.748 -0.739 . . . . 1.05 112.042 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.22 107.36 57.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.932 -0.396 . . . . 2.51 109.932 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 -17.28 38.22 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.772 2.315 . . . . 1.14 113.095 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -64.99 -21.94 66.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.439 . . . . 2.29 110.8 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -103.53 12.77 34.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.033 -0.53 . . . . 2.45 111.268 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 14.5 mt -88.11 146.94 25.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.14 -0.482 . . . . 1.29 111.572 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -143.49 169.22 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.288 -0.869 . . . . 2.35 110.273 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.2 mt -76.77 116.65 17.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.924 -0.58 . . . . 2.01 110.757 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 2.35 27.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.922 -0.656 . . . . 0.82 112.506 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -78.34 127.37 32.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.792 0.329 . . . . 1.16 111.035 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.61 ' OE1' ' HD2' ' A' ' 11' ' ' ARG . 19.1 tt0 -70.81 130.92 42.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.745 -0.661 . . . . 2.51 110.28 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.59 154.52 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 1.12 110.839 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.83 141.63 47.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.003 -0.739 . . . . 1.49 109.003 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.34 161.73 27.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.401 0.62 . . . . 0.79 111.936 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 p -110.18 163.73 13.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.414 -0.812 . . . . 1.49 109.906 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.32 142.03 33.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.665 0.269 . . . . 1.55 110.571 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.69 80.89 8.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 2.04 111.079 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HD3' HD22 ' A' ' 70' ' ' LEU . 17.5 mmt85 -96.3 7.6 46.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.628 -0.715 . . . . 5.95 110.34 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -92.59 114.08 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 6.03 110.867 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.61 -77.33 0.4 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.964 -0.636 . . . . 4.94 112.154 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -149.2 128.7 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.605 -0.517 . . . . 6.83 109.605 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -72.18 -22.55 61.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.104 0.478 . . . . 6.81 111.929 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -122.02 67.99 0.93 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.382 -0.599 . . . . 5.34 109.382 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.3 t -53.7 -71.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.98 -1.009 . . . . 7.41 110.885 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.4 p -121.31 -28.26 4.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 6.29 111.131 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.51 42.76 0.24 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.691 -0.766 . . . . 4.4 112.158 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.72 -46.61 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.003 0.921 . . . . 4.58 112.506 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 p -69.35 111.53 5.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.498 0.666 . . . . 2.58 110.643 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.455 HD22 ' HD3' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -111.29 164.23 15.49 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.774 -1.103 . . . . 2.92 110.797 -175.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.75 172.45 16.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.705 2.27 . . . . 1.58 113.293 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.65 171.62 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.149 -0.932 . . . . 1.33 109.993 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.15 155.23 40.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.469 0.176 . . . . 2.3 110.622 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.26 55.27 9.41 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.828 0.705 . . . . 2.67 112.099 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG21 ' CD2' ' A' ' 35' ' ' PHE . 40.5 t -86.41 116.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 1.46 110.186 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -122.15 159.63 26.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.739 -0.467 . . . . 4.04 109.739 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.442 ' HA ' HG11 ' A' ' 53' ' ' VAL . 62.4 mtt -79.53 152.37 30.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.85 0.357 . . . . 1.5 111.163 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -119.16 162.61 30.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 2.27 110.539 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 134.68 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.337 2.025 . . . . 2.54 111.95 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 38.8 ttmt -70.01 155.27 40.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.807 -0.633 . . . . 4.95 110.925 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 17.3 m120 74.76 15.9 3.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.219 0.608 . . . . 3.42 111.402 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.499 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 44.8 m -92.23 -19.87 21.75 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.929 -0.309 . . . . 2.12 111.023 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.44 126.52 92.31 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.315 -0.624 . . . . 1.37 109.315 171.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.24 154.83 61.49 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.576 2.184 . . . . 1.17 112.331 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -113.64 152.76 45.74 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.059 -0.519 . . . . 3.13 110.171 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.427 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 23.5 Cg_endo -60.63 143.5 99.43 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 1.39 112.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.16 91.72 8.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.302 0.572 . . . . 1.69 110.007 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -142.04 128.67 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.607 -0.886 . . . . 1.49 108.607 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.26 -63.64 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.555 -0.458 . . . . 3.44 112.056 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.58 -53.82 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.982 0.42 . . . . 2.84 111.887 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.2 t 174.74 159.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.108 -0.701 . . . . 2.07 109.108 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -106.22 -58.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 1.45 111.059 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -140.52 158.09 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.064 0.459 . . . . 1.73 110.725 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -122.94 175.9 6.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.467 -0.788 . . . . 1.86 109.045 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.64 -163.13 34.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.264 -0.97 . . . . 0.54 112.198 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.36 148.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.13 -0.693 . . . . 2.06 109.13 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 144' ' ' GLN . 49.1 t -63.91 116.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.601 -0.518 . . . . 1.31 109.601 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 99' ' ' ARG . . . -82.65 -68.84 0.67 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.178 -0.464 . . . . 1.31 111.697 -173.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 4.8 mtm180 -162.85 139.48 5.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.573 -0.285 . . . . 4.44 111.18 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.487 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -70.87 130.65 18.29 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.428 2.085 . . . . 2.49 110.684 171.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.73 89.76 2.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.699 0.762 . . . . 3.85 111.413 -177.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.29 -59.01 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.252 -0.885 . . . . 6.1 110.421 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 6.2 p -85.56 -5.58 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 4.3 111.491 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 mp -71.62 -28.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 3.76 110.008 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.709 ' ND2' ' HG3' ' A' ' 109' ' ' GLN . 60.6 t30 -116.34 125.78 28.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 5.3 109.739 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.08 -26.12 80.49 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.281 1.987 . . . . 4.95 111.981 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.69 8.49 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 3.94 111.801 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 64.72 81.11 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.141 0.793 . . . . 6.23 113.141 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.709 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 30.4 mt-30 -89.11 8.55 29.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.494 -0.775 . . . . 5.86 112.341 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.515 ' HA ' HD13 ' A' ' 101' ' ' LEU . 10.7 pt-20 -43.6 -19.34 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.2 1.555 . . . . 4.95 115.2 -166.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -39.02 16.37 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.403 0.281 . . . . 3.34 111.581 172.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 101' ' ' LEU . . . -76.17 -43.05 44.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.088 0.403 . . . . 1.67 112.088 -169.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 100' ' ' PRO . . . 58.74 179.88 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.05 -0.523 . . . . 1.08 113.871 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 130' ' ' GLU . 60.9 mt -144.48 138.23 27.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 1.5 111.17 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.6 mt -103.7 139.47 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.233 -0.894 . . . . 1.06 109.237 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.44 116.02 27.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.56 0.695 . . . . 1.4 110.184 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.8 mm -91.52 140.57 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.229 -0.896 . . . . 1.26 109.946 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.66 143.34 29.28 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.953 -0.299 . . . . 1.72 110.238 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.64 -179.49 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 2.29 111.064 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' HG2' HD21 ' A' ' 121' ' ' LEU . 1.6 pm0 -66.64 -25.17 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.262 . . . . 2.78 111.442 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -90.3 -1.47 57.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.353 -0.61 . . . . 2.13 109.353 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 60.1 43.6 14.07 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.166 -0.924 . . . . 4.81 111.534 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.2 m -114.83 -50.0 2.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.028 0.381 . . . . 2.38 112.028 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.8 p -130.65 -179.5 5.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.964 0.411 . . . . 2.22 111.858 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -81.83 136.64 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.755 -0.657 . . . . 1.84 110.277 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.1 mt -75.09 -69.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 1.45 110.56 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -137.58 -83.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 1.86 111.813 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -174.98 134.37 0.34 Allowed 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 115.458 -0.792 . . . . 2.39 109.757 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 117' ' ' ILE . 15.8 m170 -120.38 130.66 54.48 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.608 -0.437 . . . . 0.7 110.692 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' HD23 ' A' ' 114' ' ' LEU . 11.6 tt0 -91.5 143.98 26.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.419 -0.81 . . . . 1.19 109.395 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CD1' HD23 ' A' ' 136' ' ' LEU . 32.5 p90 -116.98 140.72 49.13 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.059 -0.657 . . . . 0.82 111.056 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.39 152.38 18.37 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.42 -0.809 . . . . 0.59 112.539 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 tp -49.89 -33.38 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.248 0.462 . . . . 1.25 112.248 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.6 p -72.93 -33.75 66.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.438 0.637 . . . . 1.68 110.813 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 16.3 m -74.55 -26.58 60.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.172 -0.922 . . . . 1.46 110.433 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' A' ' 131' ' ' PHE . 32.1 mt -75.58 60.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.44 -0.8 . . . . 2.06 112.151 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -45.56 -42.5 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.497 0.665 . . . . 1.4 110.481 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 45.7 m-80 -92.11 35.13 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.204 -0.907 . . . . 2.83 111.302 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -58.22 -17.78 21.51 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.477 0.547 . . . . 1.92 112.477 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.39 -22.91 62.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.064 0.459 . . . . 2.83 110.696 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 161.64 27.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 1.89 111.98 -171.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.447 HD22 ' H ' ' A' ' 142' ' ' LEU . 2.6 pt? -89.75 30.66 1.02 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.202 -0.908 . . . . 3.33 109.295 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.95 107.83 0.1 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.492 -1.231 . . . . 1.26 110.548 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 13.8 pt20 -129.51 -175.6 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.531 . . . . 2.0 111.55 -170.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 77.8 tttt -59.65 118.19 5.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.587 -0.733 . . . . 1.9 109.929 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.43 -5.25 29.82 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.467 -0.873 . . . . 1.17 112.635 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.39 136.39 33.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.067 0.46 . . . . 1.94 111.079 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 148' ' ' LEU . 3.4 mm? -86.0 136.38 33.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.38 -0.827 . . . . 2.45 110.359 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.27 150.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.245 0.545 . . . . 1.77 112.04 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.7 m -125.82 134.98 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 1.86 108.926 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -146.72 -176.61 5.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.079 -0.51 . . . . 0.74 109.7 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 122.31 17.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.277 0.56 . . . . 2.72 110.722 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.6 tt -100.62 130.49 49.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.178 -0.919 . . . . 1.84 110.296 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.427 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 13.5 t70 -159.17 -92.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.465 -0.198 . . . . 1.92 110.465 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -83.09 -19.69 36.3 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.08 -0.388 . . . . 2.76 111.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 m -77.92 -16.47 58.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 2.5 110.58 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 53.25 30.89 40.88 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.705 -0.68 . . . . 1.27 113.745 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 29' ' ' HIS . 11.6 ptm180 -161.63 -167.61 1.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.454 -0.943 . . . . 4.13 108.454 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.92 107.66 17.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.294 -0.632 . . . . 1.09 109.294 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -122.18 153.22 39.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 1.2 110.437 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 t 60.72 45.3 10.26 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.367 -0.605 . . . . 2.15 109.367 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.62 109.33 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.496 -0.774 . . . . 1.93 110.798 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.489 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 54.2 t30 -111.59 120.96 43.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.384 -0.826 . . . . 2.63 110.222 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.6 103.79 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.171 0.51 . . . . 1.23 110.034 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.73 136.05 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.706 -0.679 . . . . 2.08 110.533 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -108.63 120.62 42.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.304 -0.407 . . . . 3.44 110.046 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -88.17 141.84 28.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 4.38 110.281 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 115.768 -0.651 . . . . 4.41 110.912 176.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 111.688 -0.565 . . . . 11.95 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 -29.06 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.524 0.202 . . . . 10.65 111.467 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.26 -27.28 2.89 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.856 -0.687 . . . . 8.95 111.842 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 p -104.5 28.01 7.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.395 0.616 . . . . 7.44 109.894 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.45 156.54 28.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.298 -0.865 . . . . 5.59 110.367 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.45 174.26 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.167 -0.469 . . . . 3.46 110.928 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.07 -2.1 27.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.786 -0.721 . . . . 1.76 111.671 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.01 121.3 27.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 2.13 110.872 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.7 121.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.253 -0.647 . . . . 1.8 109.253 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -93.23 138.0 32.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.122 0.487 . . . . 1.36 109.992 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.502 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -108.54 137.8 45.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 2.73 109.786 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.77 -178.39 30.81 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.396 -0.682 . . . . 0.5 111.396 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -132.22 143.44 49.93 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.124 0.488 . . . . 0.75 110.867 -177.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.591 HG22 ' SD ' ' A' ' 17' ' ' MET . 46.5 mm -65.91 129.03 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 1.14 111.145 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.95 -45.07 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 1.31 111.264 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.78 122.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 2.16 111.068 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.591 ' SD ' HG22 ' A' ' 14' ' ' ILE . 87.2 mmm -112.4 105.33 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 1.92 110.805 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 54.6 mttt -113.06 167.47 10.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.554 -0.906 . . . . 2.53 108.554 171.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -75.33 -18.98 59.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.796 -0.361 . . . . 3.24 111.849 -171.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -108.53 -47.05 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.46 . . . . 2.03 111.707 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 6.7 p90 -141.24 172.08 13.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.586 -0.279 . . . . 1.47 110.448 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.33 32.83 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.805 -0.712 . . . . 0.76 111.907 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -120.8 135.05 55.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.71 -0.478 . . . . 1.22 109.71 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -103.5 133.9 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.02 -0.536 . . . . 1.15 110.536 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -79.26 121.15 24.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.041 -1.096 . . . . 2.3 108.041 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.8 144.16 52.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.134 -0.484 . . . . 1.36 110.727 -175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tp -51.68 -43.35 62.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 2.15 111.026 -176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -107.42 27.16 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 2.51 110.731 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' A' ' 158' ' ' ARG . 16.8 p80 45.48 36.78 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.13 0.972 . . . . 4.08 111.28 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.877 -1.056 . . . . 2.89 111.464 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.23 -174.58 1.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.856 -0.611 . . . . 1.8 110.785 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -103.09 120.74 41.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 3.37 109.438 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.4 t -104.44 125.26 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.779 0.323 . . . . 1.43 111.287 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.56 119.04 21.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 1.12 110.578 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.54 144.08 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.667 -0.697 . . . . 2.46 109.431 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.466 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 7.4 t60 -119.31 135.66 54.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.708 -0.479 . . . . 1.4 109.708 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -74.61 -19.12 60.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.458 0.54 . . . . 0.82 112.458 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 t -68.81 -33.47 73.91 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.826 -0.35 . . . . 2.03 110.954 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 1.2 p-10 -103.9 33.76 3.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.693 0.759 . . . . 2.09 109.633 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -102.51 139.21 38.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.696 -1.138 . . . . 1.39 110.437 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.1 ttm -101.11 104.96 16.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.04 110.369 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.8 -154.32 25.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 1.05 111.541 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 99.14 41.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.849 -0.426 . . . . 2.51 109.849 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.3 -21.9 66.72 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.739 2.293 . . . . 1.14 113.494 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.85 -1.24 57.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.972 0.415 . . . . 2.29 111.043 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -112.7 15.68 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 2.45 110.389 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.92 146.4 23.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.585 -0.734 . . . . 1.29 111.161 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -128.88 172.39 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.602 -0.726 . . . . 2.35 110.241 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.99 123.27 29.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.165 -0.471 . . . . 2.01 110.52 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.25 59.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.674 -0.774 . . . . 0.82 111.976 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -69.94 129.44 39.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.692 0.282 . . . . 1.16 111.051 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 82' ' ' SER . 10.4 tt0 -73.11 127.51 32.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.654 -0.703 . . . . 2.51 110.501 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 77' ' ' MET . 31.4 m -139.93 153.86 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 1.12 110.166 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.413 ' HB3' HD11 ' A' ' 78' ' ' LEU . 10.3 pt-20 -114.15 147.18 39.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.101 -0.703 . . . . 1.49 109.101 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -166.72 166.18 16.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.396 0.617 . . . . 0.79 112.357 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.37 166.59 13.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.259 -0.882 . . . . 1.49 110.188 176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -101.96 143.2 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.303 -0.408 . . . . 1.55 110.644 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' O ' HD21 ' A' ' 70' ' ' LEU . . . -79.76 84.3 5.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.04 110.592 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HD3' HD22 ' A' ' 70' ' ' LEU . 38.6 mmt180 -93.88 5.95 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.085 -0.507 . . . . 5.95 110.625 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -84.38 127.57 34.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 6.03 110.815 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.19 0.68 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.544 -0.836 . . . . 4.94 112.913 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -151.35 137.83 18.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 6.83 110.489 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.1 p -88.62 -26.94 21.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.173 0.511 . . . . 6.81 111.186 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.0 t -92.31 52.65 1.97 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.34 0.59 . . . . 5.34 110.396 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.28 -66.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 7.41 110.191 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 m -87.48 -7.77 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 6.29 110.797 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 69' ' ' CYS . . . 114.95 58.31 0.36 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.759 -0.655 . . . . 4.4 112.045 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 m120 71.14 -30.23 0.2 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.725 0.81 . . . . 4.58 112.373 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.429 ' H ' ' C ' ' A' ' 67' ' ' GLY . 4.7 p -82.37 128.08 33.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.665 -0.494 . . . . 2.58 109.665 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -126.37 152.18 73.59 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 2.92 111.021 -177.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.2 150.1 88.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.069 2.513 . . . . 1.58 113.277 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.68 141.17 29.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.387 -0.824 . . . . 1.33 110.481 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 165.24 25.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.644 0.259 . . . . 2.3 111.268 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 61.93 27.26 16.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.758 -0.656 . . . . 2.67 111.339 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 t -71.56 120.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.066 -0.516 . . . . 1.46 111.076 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -129.42 161.7 29.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 4.04 110.222 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.465 ' HA ' HG13 ' A' ' 53' ' ' VAL . 60.2 mtt -80.84 143.93 32.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.5 111.473 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 54' ' ' GLU . 36.3 mt -112.61 162.53 21.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.828 -0.623 . . . . 2.27 110.196 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.37 149.49 80.72 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.685 2.256 . . . . 2.54 111.78 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 38.7 ttmt -79.41 152.17 30.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.247 -0.433 . . . . 4.95 110.734 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 4.9 m-20 70.66 35.19 1.91 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.934 0.494 . . . . 3.42 111.453 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.55 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 49.2 m -107.16 -9.87 16.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.807 0.337 . . . . 2.12 110.813 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mm -76.36 136.16 68.67 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.52 -0.309 . . . . 1.37 110.366 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.74 157.54 61.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.652 2.235 . . . . 1.17 112.182 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -131.55 157.27 78.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.191 -0.459 . . . . 3.13 110.61 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.459 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 20.0 Cg_exo -62.56 138.68 71.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.157 . . . . 1.39 112.094 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 93.17 9.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.221 0.534 . . . . 1.69 110.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t -141.8 133.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.337 -0.986 . . . . 1.49 108.337 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.4 -62.52 1.67 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 3.44 112.621 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -94.09 -54.3 3.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 2.84 111.692 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t 173.77 161.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.643 -0.873 . . . . 2.07 108.643 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.505 HG23 ' CD2' ' A' ' 93' ' ' HIS . 7.6 m -106.0 -59.01 1.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.724 -0.39 . . . . 1.45 110.91 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 92' ' ' THR . 98.2 m-70 -145.07 155.6 43.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.73 110.213 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -115.37 173.2 6.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.969 -0.752 . . . . 1.86 108.969 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.57 -166.08 35.15 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.125 -1.036 . . . . 0.54 111.88 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.72 147.89 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.106 -0.702 . . . . 2.06 109.106 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.82 112.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.784 -0.45 . . . . 1.31 109.784 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 -63.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.31 111.887 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -169.8 146.63 2.77 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.559 -0.291 . . . . 4.44 111.0 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.52 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 64.0 Cg_endo -75.62 129.75 12.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.146 1.898 . . . . 2.49 111.225 172.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -72.81 86.86 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.716 . . . . 3.85 110.817 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -96.91 -61.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.733 -0.667 . . . . 6.1 111.02 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 6.0 p -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 4.3 111.958 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.98 -22.61 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.145 0.498 . . . . 3.76 110.932 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.468 ' HB3' ' H ' ' A' ' 109' ' ' GLN . 62.5 t30 -118.72 120.98 31.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.408 -0.59 . . . . 5.3 109.408 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 -10.51 25.67 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.318 2.012 . . . . 4.95 111.885 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.09 5.27 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 3.94 110.458 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 66.75 82.56 0.18 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.595 0.712 . . . . 6.23 112.33 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.468 ' H ' ' HB3' ' A' ' 105' ' ' ASN . 6.9 tt0 -88.4 6.11 39.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.48 -0.782 . . . . 5.86 111.354 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.548 ' HA ' HD13 ' A' ' 101' ' ' LEU . 9.9 pt-20 -43.63 -24.91 0.14 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.333 1.605 . . . . 4.95 115.333 -164.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -38.41 7.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.853 0.461 . . . . 3.34 112.026 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 101' ' ' LEU . . . -78.57 -27.93 45.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.175 0.435 . . . . 1.67 112.175 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 100' ' ' PRO . . . 58.04 173.39 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 114.584 0.594 . . . . 1.08 114.584 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 130' ' ' GLU . 74.2 mt -143.87 136.33 26.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.473 0.654 . . . . 1.5 111.257 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.3 mt -103.35 138.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.935 -1.03 . . . . 1.06 109.5 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.78 125.23 33.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.396 0.617 . . . . 1.4 109.611 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.489 HG13 ' CD2' ' A' ' 129' ' ' HIS . 11.6 mm -102.07 126.33 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.498 -0.774 . . . . 1.26 109.048 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.8 pt? -87.07 152.52 22.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 1.72 110.745 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.67 173.75 9.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.614 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.433 ' HG2' HD21 ' A' ' 121' ' ' LEU . 1.5 pm0 -66.91 -23.26 65.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 2.78 111.09 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.433 HD21 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -86.8 -3.23 59.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.736 -0.468 . . . . 2.13 109.736 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 66.43 35.98 5.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.322 -0.854 . . . . 4.81 111.051 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m -81.24 -68.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.746 -0.661 . . . . 2.38 111.567 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p -155.28 -174.36 4.94 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.995 0.368 . . . . 2.22 111.995 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 p -67.12 133.2 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.688 -0.687 . . . . 1.84 111.211 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.21 -69.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.476 -0.329 . . . . 1.45 110.653 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 m -136.51 -84.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.81 -0.356 . . . . 1.86 111.758 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.43 ' HB2' HD21 ' A' ' 114' ' ' LEU . 11.4 pt20 -174.67 138.24 0.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.842 -0.617 . . . . 2.39 110.144 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.489 ' CD2' HG13 ' A' ' 117' ' ' ILE . 21.6 m170 -122.6 123.18 40.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.792 0.329 . . . . 0.7 110.359 170.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.492 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.0 tt0 -84.22 145.68 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.552 -0.749 . . . . 1.19 109.24 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.472 ' CD1' HD23 ' A' ' 136' ' ' LEU . 32.4 p90 -117.66 139.96 50.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 0.82 111.824 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.88 154.37 20.87 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 114.999 -1.0 . . . . 0.59 112.383 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.22 -32.56 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 1.25 111.564 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -74.68 -35.8 62.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.2 0.524 . . . . 1.68 110.705 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.474 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 36.9 m -62.82 -32.7 73.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.236 -0.893 . . . . 1.46 110.532 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.472 HD23 ' CD1' ' A' ' 131' ' ' PHE . 72.7 mt -75.42 58.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 2.06 112.031 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.0 t -46.3 -43.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.357 0.599 . . . . 1.4 110.318 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 46.2 m-80 -95.87 34.66 1.49 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.3 -0.863 . . . . 2.83 111.508 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -56.65 -21.21 25.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.145 0.498 . . . . 1.92 111.615 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -70.91 -23.1 62.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 2.83 111.414 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.27 164.03 14.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.681 0.623 . . . . 1.89 112.681 -166.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 HD21 ' H ' ' A' ' 142' ' ' LEU . 2.7 pt? -79.51 34.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.014 -0.994 . . . . 3.33 111.2 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.16 105.43 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.796 -0.638 . . . . 1.26 111.021 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -121.66 -178.03 3.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.755 -0.657 . . . . 2.0 110.811 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -62.99 136.48 57.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.691 -0.686 . . . . 1.9 110.323 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.3 70.72 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.545 -0.836 . . . . 1.17 112.926 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -92.11 142.28 27.68 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.215 0.508 . . . . 1.94 109.859 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.404 ' N ' HD23 ' A' ' 148' ' ' LEU . 3.2 mm? -83.95 138.51 33.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.194 0.521 . . . . 2.45 111.146 -172.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.77 153.35 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.366 0.603 . . . . 1.77 111.912 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.2 m -129.57 138.01 51.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.221 -0.9 . . . . 1.86 109.332 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -149.0 174.15 12.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.645 -0.502 . . . . 0.74 109.645 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -130.38 120.46 24.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.397 0.618 . . . . 2.72 110.205 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.55 130.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.823 -0.626 . . . . 1.84 110.354 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.463 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 18.8 t70 -155.87 -100.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.954 -0.298 . . . . 1.92 110.718 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.463 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 42.2 mt-10 -83.9 -7.59 59.39 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.08 0.4 . . . . 2.76 112.08 -175.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -12.08 49.24 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.749 -0.464 . . . . 2.5 109.749 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.09 24.21 49.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.127 -0.942 . . . . 1.27 114.308 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.415 ' HD3' ' CD2' ' A' ' 29' ' ' HIS . 15.1 ptt-85 -158.08 -177.94 6.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.829 -0.804 . . . . 4.13 108.829 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.14 108.65 16.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.367 -0.533 . . . . 1.09 110.698 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -119.12 159.49 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 1.2 110.442 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 39.7 t 63.07 38.08 11.09 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.673 0.608 . . . . 2.15 110.091 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.99 111.54 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.476 -0.784 . . . . 1.93 110.657 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.463 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 8.3 t30 -120.52 128.91 53.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.315 -0.402 . . . . 2.63 110.394 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.96 117.13 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 1.23 110.282 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.69 130.55 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.844 -0.617 . . . . 2.08 111.66 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.17 133.55 51.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 3.44 110.127 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -105.47 131.02 53.41 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.965 -0.561 . . . . 4.38 110.592 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 116.093 -0.503 . . . . 4.41 110.295 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 111.995 -0.442 . . . . 11.95 111.995 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.7 -27.71 69.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 10.65 111.356 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.22 26.09 10.06 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.835 -0.621 . . . . 8.95 111.602 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -109.31 15.77 22.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 7.44 110.468 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.8 129.04 34.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.868 0.366 . . . . 5.59 110.361 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.08 9.08 30.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.007 -0.542 . . . . 3.46 110.949 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.03 -29.03 4.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 1.76 112.537 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -105.57 113.35 26.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.426 0.632 . . . . 2.13 111.374 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.55 116.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.956 -1.02 . . . . 1.8 109.073 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -87.63 138.61 31.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.931 -0.577 . . . . 1.36 110.004 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 22.7 ttm180 -113.55 141.04 47.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.71 -0.677 . . . . 2.73 110.04 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.08 -171.12 36.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.006 -0.838 . . . . 0.5 111.006 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.61 141.95 33.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.184 0.516 . . . . 0.75 111.141 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.34 119.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.296 -0.865 . . . . 1.14 110.823 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.38 -41.73 6.91 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.967 -0.293 . . . . 1.31 111.172 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.97 150.76 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.536 -0.542 . . . . 2.16 109.536 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.9 ttm -137.17 106.7 6.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 1.92 110.391 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.7 mmtt -100.71 172.37 7.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.865 -0.791 . . . . 2.53 108.865 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.62 -22.1 61.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.692 0.282 . . . . 3.24 111.668 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -111.14 -41.93 4.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.72 0.295 . . . . 2.03 111.701 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -145.12 176.71 9.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.617 -0.265 . . . . 1.47 110.487 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 -179.97 25.82 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.497 -0.859 . . . . 0.76 112.059 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' CD ' ' A' ' 32' ' ' GLU . 54.3 m-85 -127.11 151.74 48.24 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.525 -0.546 . . . . 1.22 109.525 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -125.57 115.34 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.17 -0.468 . . . . 1.15 111.058 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.34 126.47 29.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.288 -1.004 . . . . 2.3 108.288 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 164.57 25.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.229 0.537 . . . . 1.36 111.401 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' CD2' HD13 ' A' ' 83' ' ' ILE . 1.8 tm? -60.58 -48.43 81.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.532 -0.758 . . . . 2.15 111.724 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -98.69 13.65 31.4 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.087 -0.338 . . . . 2.51 110.087 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 55.85 50.27 14.4 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.429 -0.952 . . . . 4.08 108.429 -168.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.14 -48.55 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.993 -1.458 . . . . 2.89 110.275 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -173.26 179.38 2.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 1.8 110.704 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' CD ' ' HB3' ' A' ' 23' ' ' PHE . 10.0 tp10 -103.2 139.53 38.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.781 -0.452 . . . . 3.37 109.781 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.53 132.24 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.051 0.453 . . . . 1.43 111.224 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -87.19 118.39 26.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.802 -0.636 . . . . 1.12 110.426 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -120.01 151.3 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 2.46 108.918 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -115.84 133.0 56.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.476 -0.564 . . . . 1.4 109.476 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -62.47 -22.62 66.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.058 0.762 . . . . 0.82 113.058 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -61.29 -35.84 78.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.779 0.323 . . . . 2.03 111.076 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -96.09 22.54 7.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.259 0.552 . . . . 2.09 110.842 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.558 ' OH ' ' HG2' ' A' ' 77' ' ' MET . 39.6 t80 -91.51 136.6 33.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 1.39 110.212 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.33 97.74 7.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 2.04 110.142 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.19 -139.63 7.46 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.143 -0.783 . . . . 1.05 111.143 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -124.73 91.46 49.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 121.515 0.674 . . . . 2.51 110.703 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.93 -21.04 33.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.003 2.468 . . . . 1.14 113.841 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.41 -11.66 59.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.371 0.605 . . . . 2.29 110.154 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.45 20.31 19.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 2.45 110.248 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 29.3 mt -85.14 -179.6 7.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.794 -0.639 . . . . 1.29 111.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -151.22 161.17 43.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.386 -0.825 . . . . 2.35 110.126 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.51 113.99 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 2.01 108.98 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.25 5.05 35.13 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.872 -0.604 . . . . 0.82 112.019 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.34 131.13 40.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.91 0.386 . . . . 1.16 111.315 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' CD ' HG12 ' A' ' 83' ' ' ILE . 40.2 mt-10 -78.27 128.26 33.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.227 -0.897 . . . . 2.51 111.279 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.89 161.33 18.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.127 -0.488 . . . . 1.12 110.444 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.42 148.28 48.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.795 -0.446 . . . . 1.49 109.795 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 11.9 p90 -163.99 175.17 10.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.79 112.142 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 p -130.14 170.72 13.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.44 -0.8 . . . . 1.49 110.112 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.86 138.75 45.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.78 0.324 . . . . 1.55 111.145 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' HD23 ' A' ' 70' ' ' LEU . . . -89.08 85.19 6.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.863 -0.608 . . . . 2.04 110.124 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.512 HH11 HD11 ' A' ' 70' ' ' LEU . 9.8 tpt180 -126.63 6.82 6.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.393 0.616 . . . . 5.95 109.638 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -77.01 114.45 15.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.687 -0.688 . . . . 6.03 110.415 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.74 170.06 13.49 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.842 -0.617 . . . . 4.94 111.679 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -99.58 26.75 5.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.684 0.754 . . . . 6.83 109.744 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -80.1 -14.84 58.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 6.81 110.704 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -81.31 42.84 0.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.91 -0.586 . . . . 5.34 111.265 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.15 -64.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.022 0.439 . . . . 7.41 110.183 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -100.52 2.41 41.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 6.29 109.361 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.74 72.59 2.8 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.269 -0.878 . . . . 4.4 111.945 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -60.12 -49.73 76.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.254 0.549 . . . . 4.58 109.543 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.8 m -117.9 131.1 56.57 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.53 -0.759 . . . . 2.58 109.267 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.512 HD11 HH11 ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.61 153.73 59.65 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.022 -0.733 . . . . 2.92 109.022 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.74 150.35 88.29 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.312 2.008 . . . . 1.58 112.223 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.63 137.01 32.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.67 -0.696 . . . . 1.33 111.035 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -112.41 165.74 11.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.845 -0.616 . . . . 2.3 110.334 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 63.18 29.67 16.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.818 -0.628 . . . . 2.67 111.477 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 9.6 t -74.19 108.25 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 1.46 110.237 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -112.31 167.82 10.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.87 0.367 . . . . 4.04 110.339 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.558 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 84.8 mtp -98.58 136.04 39.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.944 -0.571 . . . . 1.5 111.195 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.0 mt -107.9 154.89 40.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 2.27 110.556 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.08 140.93 35.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.263 1.975 . . . . 2.54 110.372 169.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.32 164.68 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 4.95 111.034 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.09 25.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.172 -0.922 . . . . 3.42 109.999 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -95.59 -14.86 23.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.398 -0.819 . . . . 2.12 109.122 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.593 HD13 ' CD2' ' A' ' 27' ' ' LEU . 8.7 mm -92.01 128.99 43.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.441 -0.8 . . . . 1.37 109.783 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.07 154.48 47.33 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.348 2.032 . . . . 1.17 112.14 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 152.15 74.35 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.556 -0.293 . . . . 3.13 110.465 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 125.94 18.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 1.39 112.202 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.14 92.97 7.06 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.999 0.428 . . . . 1.69 111.17 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 26.0 t -142.43 107.33 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 1.49 109.713 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.85 -25.92 27.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.735 -0.386 . . . . 3.44 111.737 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 91' ' ' THR . 69.8 tt0 -73.42 -18.19 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.609 -0.269 . . . . 2.84 110.953 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.544 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 41.5 m 81.04 122.72 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.634 -0.712 . . . . 2.07 110.54 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -80.86 -57.64 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.45 112.337 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -141.35 174.73 10.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.232 0.539 . . . . 1.73 111.36 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -141.81 176.83 8.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.132 -0.94 . . . . 1.86 109.273 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.09 179.45 39.57 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 110.464 -1.055 . . . . 0.54 110.464 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.3 m -103.89 159.5 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 117.852 0.826 . . . . 2.06 110.161 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.37 121.57 19.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.196 -0.668 . . . . 1.31 109.196 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -66.86 -53.47 32.08 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.3 0.375 . . . . 1.31 110.731 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.71 146.89 0.88 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 4.44 110.551 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.42 121.46 6.05 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.426 1.418 . . . . 2.49 110.146 167.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.675 HD21 ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -82.81 97.86 8.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.096 0.95 . . . . 3.85 110.724 -177.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.68 -66.46 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.7 -0.682 . . . . 6.1 111.251 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 9.2 p -95.2 -10.19 31.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.519 0.563 . . . . 4.3 112.519 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 104' ' ' ILE . 4.9 mp -77.36 -45.47 29.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.797 0.666 . . . . 3.76 112.797 -166.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -164.08 91.94 1.06 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 121.072 0.463 . . . . 5.3 111.636 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.46 -40.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.792 2.328 . . . . 4.95 113.411 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.4 28.89 2.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 3.94 112.171 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 44.2 tp60 -122.91 150.65 42.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.459 -0.571 . . . . 6.23 109.459 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 111' ' ' TYR . 28.8 tp60 -51.41 -30.73 20.29 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.012 0.525 . . . . 5.86 112.077 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 50.7 mt-10 -73.38 14.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.914 0.388 . . . . 4.95 111.2 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.526 ' O ' HD13 ' A' ' 101' ' ' LEU . 15.1 t80 -66.03 -25.69 67.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.283 0.563 . . . . 3.34 110.82 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -65.1 -21.89 66.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.965 -0.561 . . . . 1.67 111.247 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.78 166.66 25.23 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.439 -0.665 . . . . 1.08 111.439 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.8 mt -142.71 138.13 30.34 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.627 0.727 . . . . 1.5 111.842 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.89 138.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.654 -1.157 . . . . 1.06 108.746 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.77 124.26 31.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.936 -0.765 . . . . 1.4 108.936 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 129' ' ' HIS . 5.6 mm -101.36 120.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.494 -0.928 . . . . 1.26 108.494 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -83.33 144.25 29.81 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.294 -0.562 . . . . 1.72 110.157 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.07 151.49 12.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 2.29 109.583 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.72 -21.66 64.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 2.78 111.912 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.03 10.26 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.692 0.282 . . . . 2.13 110.374 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 67.52 30.39 6.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.613 -0.721 . . . . 4.81 111.512 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -70.32 -80.37 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.463 -0.335 . . . . 2.38 111.167 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -149.23 -176.45 5.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.687 -0.233 . . . . 2.22 110.643 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -65.25 134.51 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 123.542 0.526 . . . . 1.84 110.234 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -72.71 -67.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.442 -0.344 . . . . 1.45 110.432 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.9 m -137.6 -84.3 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.159 0.504 . . . . 1.86 110.645 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -176.6 139.84 0.33 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.249 -0.887 . . . . 2.39 108.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.54 ' HB2' HD12 ' A' ' 117' ' ' ILE . 33.6 m170 -117.48 131.59 56.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.125 -0.63 . . . . 0.7 110.089 172.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 110' ' ' GLU . 9.8 tt0 -89.57 139.49 30.49 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.763 -1.108 . . . . 1.19 109.402 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.427 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 46.1 p90 -118.67 134.87 54.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 0.82 110.961 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.11 153.94 24.01 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.326 -0.852 . . . . 0.59 112.57 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.2 -27.72 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.01 0.433 . . . . 1.25 110.807 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.8 p -74.86 -36.48 62.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.317 0.58 . . . . 1.68 110.443 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.593 ' O ' HG21 ' A' ' 162' ' ' VAL . 23.9 m -65.66 -30.2 70.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.84 . . . . 1.46 110.87 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.4 mt -71.49 58.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.812 0.695 . . . . 2.06 112.67 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -45.59 -42.28 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.408 0.623 . . . . 1.4 111.045 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.48 34.01 2.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 2.83 111.014 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 16.3 ptpt -54.53 -21.08 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.01 0.524 . . . . 1.92 112.357 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -86.39 -11.95 50.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 2.83 112.12 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.56 166.66 23.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 1.89 110.687 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -86.96 24.49 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.458 -0.337 . . . . 3.33 110.492 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -44.92 117.39 1.32 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.22 -0.9 . . . . 1.26 111.536 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -118.86 -172.97 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 2.0 111.238 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 72.4 tttt -67.53 140.22 57.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.908 -0.587 . . . . 1.9 110.139 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.06 86.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.423 -0.894 . . . . 1.17 112.439 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 7.9 m-20 -82.73 132.37 35.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.559 0.219 . . . . 1.94 110.741 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.54 135.11 42.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.993 -0.549 . . . . 2.45 110.828 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.36 151.45 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 1.77 111.187 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 44.0 p -109.03 136.01 49.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.811 -0.811 . . . . 1.86 108.811 172.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.525 ' HB3' HG12 ' A' ' 162' ' ' VAL . 36.1 p90 -154.24 169.3 23.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.852 0.358 . . . . 0.74 110.327 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 3.7 mpt_? -131.77 123.2 27.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.4 -0.52 . . . . 2.72 110.63 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.403 HD11 ' CE1' ' A' ' 129' ' ' HIS . 8.5 pt -100.14 146.77 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.736 -0.839 . . . . 1.84 108.736 166.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -175.1 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.366 -0.134 . . . . 1.92 110.969 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.25 -41.5 73.42 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 2.76 111.503 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 158' ' ' ARG . 42.3 t -84.9 -17.98 36.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.174 -0.466 . . . . 2.5 111.099 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.63 -25.36 1.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.797 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 156' ' ' SER . 67.2 mtt85 -93.02 175.68 6.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.317 0.247 . . . . 4.13 110.388 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.34 110.39 19.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.033 0.444 . . . . 1.09 110.219 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -123.25 160.2 27.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.722 -0.672 . . . . 1.2 110.84 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.6 m 59.93 42.84 15.61 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.944 0.778 . . . . 2.15 110.692 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 135' ' ' SER . 19.7 m -70.96 138.35 21.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.565 0.698 . . . . 1.93 110.892 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.04 123.71 22.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.328 -0.851 . . . . 2.63 109.74 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.25 125.73 24.82 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 123.372 0.42 . . . . 1.23 110.912 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.66 122.7 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.868 -0.606 . . . . 2.08 110.651 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.6 118.49 36.36 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.188 -0.671 . . . . 3.44 109.188 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -102.06 160.68 14.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.486 0.66 . . . . 4.38 111.106 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 114.922 -1.035 . . . . 4.41 110.355 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 112.237 -0.345 . . . . 11.95 112.237 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.39 107.39 19.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.602 0.239 . . . . 10.65 110.828 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.01 46.95 0.94 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.604 -0.808 . . . . 8.95 112.666 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p -79.03 95.24 5.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.064 0.459 . . . . 7.44 111.005 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.64 123.87 42.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.446 . . . . 5.59 110.358 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.38 -29.44 47.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.898 -0.592 . . . . 3.46 111.142 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.56 -29.71 3.23 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.905 -0.588 . . . . 1.76 112.548 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -124.99 123.44 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.932 0.396 . . . . 2.13 111.039 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.19 119.9 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.074 -0.713 . . . . 1.8 109.074 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.19 0.519 . . . . 1.36 109.798 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -112.39 138.71 48.73 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.482 -0.781 . . . . 2.73 110.187 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.42 -163.29 13.5 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.441 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -152.06 156.86 40.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.062 0.458 . . . . 0.75 110.69 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.32 119.26 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.711 -0.677 . . . . 1.14 111.218 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.88 -38.16 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.49 -0.323 . . . . 1.31 111.34 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HB ' ' OH ' ' A' ' 111' ' ' TYR . 2.1 p -134.75 131.71 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.85 0.357 . . . . 2.16 110.739 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.2 mtp -123.06 129.91 52.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 1.92 110.449 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -173.46 2.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.131 -1.063 . . . . 2.53 108.131 171.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -15.75 36.58 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.346 -0.542 . . . . 3.24 110.645 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.52 -47.13 3.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.429 0.529 . . . . 2.03 112.429 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -142.33 -175.42 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.127 0.489 . . . . 1.47 111.445 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.04 36.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.324 -0.71 . . . . 0.76 111.324 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -124.16 138.62 54.4 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.578 -0.527 . . . . 1.22 109.578 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -99.79 123.2 52.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.163 -0.471 . . . . 1.15 110.72 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 31.0 tt0 -76.15 118.92 19.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.056 -1.09 . . . . 2.3 108.056 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.18 160.27 31.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.391 -0.368 . . . . 1.36 111.501 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' CD1' HD13 ' A' ' 83' ' ' ILE . 9.1 tp -56.02 -48.57 75.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 2.15 111.616 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -118.56 40.68 3.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 2.51 109.789 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.8 p80 45.73 33.88 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.076 0.86 . . . . 4.08 111.032 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -52.63 -47.3 67.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.744 -1.116 . . . . 2.89 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -169.26 173.53 6.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.8 110.185 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.81 121.03 42.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 3.37 109.166 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -113.39 130.7 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.095 0.474 . . . . 1.43 111.69 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -89.02 120.23 30.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.404 -0.816 . . . . 1.12 110.14 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -121.08 147.33 45.68 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.122 -0.696 . . . . 2.46 109.122 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -109.03 133.16 53.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.572 -0.899 . . . . 1.4 108.572 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -57.67 -23.38 51.13 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.443 0.535 . . . . 0.82 112.443 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -68.97 -15.66 63.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.869 0.366 . . . . 2.03 111.929 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -104.44 8.15 35.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.479 0.657 . . . . 2.09 109.788 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.424 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 75.7 t80 -93.02 126.7 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.355 -0.839 . . . . 1.39 110.064 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.4 ttm -96.68 101.87 13.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.357 -0.383 . . . . 2.04 110.294 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.02 -150.95 23.23 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.102 -0.57 . . . . 1.05 111.697 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -105.73 105.34 52.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.778 -0.453 . . . . 2.51 109.778 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.04 -25.88 3.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.805 2.337 . . . . 1.14 113.702 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -69.77 -24.74 63.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.623 0.725 . . . . 2.29 109.523 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.71 20.68 12.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.358 -0.837 . . . . 2.45 111.132 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.51 149.29 25.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 1.29 110.515 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.55 158.11 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 2.35 109.761 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HB2' ' HZ2' ' A' ' 139' ' ' LYS . 79.3 mt -71.67 120.07 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.947 0.403 . . . . 2.01 110.274 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.07 -11.87 26.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.98 -0.629 . . . . 0.82 112.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.33 120.6 13.08 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.961 0.41 . . . . 1.16 111.409 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 5.0 mp0 -64.62 129.05 38.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 2.51 111.146 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 77' ' ' MET . 26.8 m -140.85 149.97 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 1.12 110.654 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -124.33 150.27 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.926 -0.398 . . . . 1.49 109.926 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 3.2 p90 -163.91 179.67 6.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.927 0.394 . . . . 0.79 111.308 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 p -128.45 166.93 17.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.091 -0.504 . . . . 1.49 110.742 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.06 147.4 30.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.359 -0.382 . . . . 1.55 110.97 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 31.13 0.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.397 0.618 . . . . 2.04 110.681 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.61 36.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.712 -0.676 . . . . 5.95 110.823 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.36 99.37 12.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.357 0.503 . . . . 6.03 112.357 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.8 37.27 92.22 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.887 -0.597 . . . . 4.94 113.241 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -110.45 153.7 24.65 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.664 -0.495 . . . . 6.83 109.664 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -66.79 -23.2 66.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.103 0.478 . . . . 6.81 111.298 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 m -81.08 50.47 1.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.22 0.533 . . . . 5.34 109.965 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.01 -35.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 7.41 111.033 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.4 m -73.09 -29.83 63.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 6.29 110.467 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.52 -137.18 2.26 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.921 -0.872 . . . . 4.4 110.921 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.61 79.88 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 0.689 . . . . 4.58 110.826 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.9 p -45.55 132.15 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 2.58 112.103 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -122.91 154.43 64.22 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.418 -0.81 . . . . 2.92 109.438 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.08 146.6 87.51 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.039 1.826 . . . . 1.58 112.274 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 144.64 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.179 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.02 163.73 18.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.721 0.296 . . . . 2.3 110.837 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.8 57.38 2.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.601 -0.727 . . . . 2.67 110.551 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 21.8 t -93.01 122.59 44.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 1.46 109.877 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -124.39 147.74 48.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.404 . . . . 4.04 110.106 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.424 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 48.9 mtt -70.92 154.12 42.09 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.866 0.365 . . . . 1.5 110.4 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' CD1' ' HD2' ' A' ' 79' ' ' PRO . 17.3 tp -125.61 144.13 47.1 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.009 -0.541 . . . . 2.27 110.023 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 78' ' ' LEU . 25.3 Cg_endo -61.65 142.9 95.94 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.265 1.977 . . . . 2.54 111.961 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 4.2 ttmp? -62.94 156.67 23.77 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.825 -0.625 . . . . 4.95 111.856 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m120 73.74 24.02 2.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.45 -0.796 . . . . 3.42 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -96.96 8.5 44.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.04 -0.527 . . . . 2.12 110.181 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.483 HD13 ' CD1' ' A' ' 27' ' ' LEU . 18.4 mm -108.75 133.06 20.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.636 -0.505 . . . . 1.37 109.636 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.89 149.84 66.59 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.593 2.195 . . . . 1.17 112.621 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.99 145.99 54.83 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.941 -0.572 . . . . 3.13 110.073 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 76.3 Cg_exo -52.31 132.53 44.63 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.592 2.861 . . . . 1.39 113.49 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.03 94.66 8.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.69 110.863 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.29 150.63 27.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.739 -0.838 . . . . 1.49 108.739 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.94 -64.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.076 -0.65 . . . . 3.44 111.37 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 91' ' ' THR . 30.8 tt0 -95.06 -58.63 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.302 -0.559 . . . . 2.84 111.027 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER 175.62 173.96 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.169 -0.923 . . . . 2.07 109.254 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -105.46 -58.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.45 110.73 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.31 178.45 6.87 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.023 -0.535 . . . . 1.73 110.815 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.96 -177.91 4.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.038 -0.528 . . . . 1.86 110.476 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.44 -163.32 29.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.085 -0.579 . . . . 0.54 111.867 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.47 146.36 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.667 -0.494 . . . . 2.06 109.667 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.28 121.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 1.31 110.301 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' O ' ' HE3' ' A' ' 145' ' ' LYS . . . -73.04 -60.18 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.572 0.582 . . . . 1.31 112.572 -172.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -164.56 158.15 15.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.495 -0.482 . . . . 4.44 111.647 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.36 170.42 10.6 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.701 2.268 . . . . 2.49 112.028 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 101' ' ' LEU . 1.5 mm? -90.7 89.8 7.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.599 -0.273 . . . . 3.85 110.495 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -98.41 -65.23 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 6.1 111.434 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 4.4 p -92.89 3.35 55.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.678 -0.692 . . . . 4.3 111.277 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 HG23 ' HG3' ' A' ' 110' ' ' GLU . 1.4 mp -67.0 -34.12 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 3.76 111.788 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.521 HD22 ' HB3' ' A' ' 107' ' ' ASP . 9.8 t30 72.87 115.63 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.781 0.676 . . . . 5.3 110.707 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.53 1.99 3.8 Favored 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.458 2.772 . . . . 4.95 113.806 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' HB3' HD22 ' A' ' 105' ' ' ASN . 1.2 t70 -105.57 28.69 7.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.511 0.672 . . . . 3.94 109.388 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -144.24 142.33 30.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 6.23 109.859 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.09 -26.02 10.1 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.582 0.956 . . . . 5.86 113.582 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.476 ' HG3' HG23 ' A' ' 104' ' ' ILE . 12.9 pt-20 -74.44 2.97 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 4.95 110.801 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.466 ' OH ' ' HB ' ' A' ' 16' ' ' VAL . 8.7 t80 -61.39 -24.39 66.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.546 -0.752 . . . . 3.34 111.838 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -27.7 69.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.178 0.436 . . . . 1.67 112.178 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.83 162.87 30.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.515 -0.85 . . . . 1.08 111.66 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 130' ' ' GLU . 82.6 mt -144.45 147.08 32.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.54 0.686 . . . . 1.5 112.287 -172.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.6 mt -112.48 137.8 43.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.514 -1.221 . . . . 1.06 109.513 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -89.89 120.72 31.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.458 0.647 . . . . 1.4 110.116 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.504 HG13 ' CD2' ' A' ' 129' ' ' HIS . 34.9 mm -97.8 129.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 1.26 109.582 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -87.35 156.71 19.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.535 -0.302 . . . . 1.72 110.311 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.05 167.57 9.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.392 -0.596 . . . . 2.29 109.392 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.426 ' HG2' HD23 ' A' ' 121' ' ' LEU . 2.3 pm0 -69.71 -17.07 63.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.042 0.449 . . . . 2.78 110.563 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -99.6 -2.42 35.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 2.13 109.821 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 54.22 80.66 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.505 -0.77 . . . . 4.81 110.731 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.61 -47.37 1.84 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.323 -0.398 . . . . 2.38 111.142 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 -177.75 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 2.22 111.021 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.31 130.68 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.543 -0.91 . . . . 1.84 108.543 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.61 -69.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.6 -0.44 . . . . 1.45 110.869 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -138.75 -85.23 0.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.498 0.666 . . . . 1.86 111.034 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -175.96 137.64 0.33 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.777 -1.101 . . . . 2.39 108.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.504 ' CD2' HG13 ' A' ' 117' ' ' ILE . 19.1 m170 -113.19 132.75 55.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.163 -0.615 . . . . 0.7 110.664 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.52 ' HA ' HD23 ' A' ' 114' ' ' LEU . 5.7 tt0 -92.54 140.46 29.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.626 -1.17 . . . . 1.19 109.42 -175.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CD1' HD21 ' A' ' 136' ' ' LEU . 40.7 p90 -118.51 141.41 48.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.82 111.021 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.09 152.93 20.18 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.468 -0.787 . . . . 0.59 112.209 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.73 -30.15 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.212 0.506 . . . . 1.25 111.001 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -78.07 -23.61 47.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.485 0.659 . . . . 1.68 110.542 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 62.9 m -78.74 -27.6 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.101 -0.954 . . . . 1.46 110.464 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 131' ' ' PHE . 69.4 mt -75.33 60.11 1.1 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.349 -0.841 . . . . 2.06 112.017 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.24 -45.59 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.931 0.396 . . . . 1.4 111.522 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 2.9 p-10 -92.27 33.9 1.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.753 0.311 . . . . 2.83 111.231 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HZ2' ' HB2' ' A' ' 49' ' ' LEU . 5.5 ptmm? -53.0 -22.56 5.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.467 0.707 . . . . 1.92 112.674 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.71 -19.04 49.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.364 -0.38 . . . . 2.83 111.26 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 162.86 27.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.625 0.726 . . . . 1.89 112.465 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -81.86 35.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.788 -1.096 . . . . 3.33 110.47 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.48 HD21 HD22 ' A' ' 138' ' ' ASN . 24.4 tp -63.72 127.09 29.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 1.26 110.692 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.61 -173.55 3.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 2.0 110.95 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 98' ' ' ALA . 83.8 tttt -66.18 138.53 57.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 1.9 109.9 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.19 66.99 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.738 -0.744 . . . . 1.17 112.626 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -90.62 140.36 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 1.94 110.728 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.03 140.91 33.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.709 -0.678 . . . . 2.45 110.742 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.15 143.91 38.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.508 . . . . 1.77 112.009 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -115.84 125.87 53.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 1.86 109.389 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.12 168.57 20.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.619 0.247 . . . . 0.74 110.404 -175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 121.35 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.34 -0.944 . . . . 2.72 110.469 172.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.5 130.46 52.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 1.84 110.324 174.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 22.7 t70 -149.0 -89.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.536 . . . . 1.92 111.862 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -33.52 40.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.379 0.511 . . . . 2.76 112.379 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.2 p -84.12 -17.15 41.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.477 -0.329 . . . . 2.5 111.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.67 23.15 70.46 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.728 -0.749 . . . . 1.27 113.065 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -126.43 173.53 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.679 -0.489 . . . . 4.13 109.679 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.86 18.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.269 -0.641 . . . . 1.09 109.269 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.44 158.18 38.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.196 -0.457 . . . . 1.2 110.438 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 45.6 m 55.4 30.72 15.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.512 0.673 . . . . 2.15 109.304 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.4 126.73 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.135 -0.939 . . . . 1.93 110.932 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 5.8 t30 -125.34 132.27 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.231 -0.895 . . . . 2.63 110.296 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.76 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 1.23 110.389 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.05 119.63 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.068 0.461 . . . . 2.08 111.617 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -90.82 156.6 17.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 3.44 110.691 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -80.88 134.05 35.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.051 -0.522 . . . . 4.38 110.176 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.503 -0.771 . . . . 4.41 110.919 -179.49 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.15 -0.38 . . . . 11.95 112.15 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.38 131.66 54.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 10.65 110.687 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.15 90.83 2.07 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.617 -0.801 . . . . 8.95 111.764 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.9 m -148.82 117.55 6.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.972 0.415 . . . . 7.44 111.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -113.94 18.35 17.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.872 0.844 . . . . 5.59 109.242 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.55 -178.19 4.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.348 -1.297 . . . . 3.46 109.606 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.71 23.48 53.02 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.33 -0.938 . . . . 1.76 111.033 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 15.7 mm100 -61.25 119.74 9.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.063 -0.568 . . . . 2.13 111.455 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.28 115.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.586 -0.734 . . . . 1.8 109.501 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 8' ' ' GLN . 49.5 m-85 -98.69 150.64 21.58 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.255 -0.884 . . . . 1.36 109.662 -176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.432 ' C ' HD21 ' A' ' 27' ' ' LEU . 35.2 ttm-85 -108.26 149.41 28.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.813 -0.63 . . . . 2.73 109.994 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.93 170.95 42.25 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.143 -0.783 . . . . 0.5 111.143 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.973 0.416 . . . . 0.75 111.312 -174.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.38 118.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.754 -0.657 . . . . 1.14 110.721 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.58 -43.13 3.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.938 0.399 . . . . 1.31 110.779 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.03 123.59 70.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 2.16 111.039 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.1 mtp -119.19 110.09 16.63 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.566 . . . . 1.92 109.473 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 69.6 mmtt -97.66 -167.92 1.6 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.447 -0.575 . . . . 2.53 109.447 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.93 -26.98 30.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.486 -0.324 . . . . 3.24 111.108 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.65 -44.4 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 2.03 111.227 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -137.95 -170.44 2.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.088 -0.505 . . . . 1.47 110.657 -174.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.66 174.96 34.36 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 0.76 112.234 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -122.82 139.36 54.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.881 -0.415 . . . . 1.22 109.881 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.78 131.71 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.781 -0.645 . . . . 1.15 110.438 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.86 107.15 8.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.126 -1.065 . . . . 2.3 108.126 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -62.57 149.56 42.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.533 -0.303 . . . . 1.36 110.657 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -51.45 -48.25 62.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 2.15 111.303 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -84.4 3.76 34.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 2.51 111.713 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.1 p80 39.96 39.97 0.67 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.124 0.97 . . . . 4.08 111.881 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -88.39 -39.52 14.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.364 -0.835 . . . . 2.89 110.073 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.15 162.8 34.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 1.8 110.107 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 19.9 pt-20 -104.31 127.82 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.611 -0.515 . . . . 3.37 109.611 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.49 128.6 57.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.302 0.572 . . . . 1.43 110.836 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -81.83 114.21 20.3 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.846 -1.07 . . . . 1.12 109.733 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -116.7 145.55 43.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.172 -0.677 . . . . 2.46 109.172 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.8 131.62 54.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.392 -0.596 . . . . 1.4 109.392 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.95 -20.27 56.59 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.972 0.415 . . . . 0.82 111.636 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -68.45 -23.28 64.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 2.03 111.118 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -106.76 14.1 27.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.057 0.456 . . . . 2.09 110.723 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.566 ' OH ' ' HE1' ' A' ' 77' ' ' MET . 71.7 t80 -88.45 132.77 34.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.044 -0.526 . . . . 1.39 110.728 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.9 ttm -94.96 109.36 21.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.189 -0.46 . . . . 2.04 110.39 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.39 -141.97 12.89 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.738 -0.744 . . . . 1.05 111.84 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -116.65 103.35 52.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.004 -0.369 . . . . 2.51 110.004 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.17 -23.44 39.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.256 . . . . 1.14 112.949 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -86.16 -4.85 59.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.438 0.637 . . . . 2.29 110.51 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -112.15 19.44 17.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.723 -0.671 . . . . 2.45 110.568 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.454 HD21 ' HH ' ' A' ' 40' ' ' TYR . 16.8 mt -87.97 157.33 18.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.643 -0.708 . . . . 1.29 111.091 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -131.2 157.37 43.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.783 -0.644 . . . . 2.35 111.166 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.45 121.87 22.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.117 0.484 . . . . 2.01 110.168 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.09 56.08 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.063 -0.589 . . . . 0.82 112.126 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -73.29 120.47 18.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 1.16 111.233 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.481 ' CD ' HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.25 129.0 39.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.96 -1.018 . . . . 2.51 111.535 174.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.77 142.44 30.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 1.12 110.315 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.71 135.42 53.96 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.082 -0.71 . . . . 1.49 109.082 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -156.8 159.64 38.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.063 -0.517 . . . . 0.79 111.134 -169.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.2 p -112.61 146.79 37.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.461 -0.336 . . . . 1.49 110.814 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.72 140.18 32.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.973 0.416 . . . . 1.55 110.861 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 -79.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.887 -0.597 . . . . 2.04 110.693 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HD2' ' CD1' ' A' ' 70' ' ' LEU . 15.4 ptm180 32.11 63.94 0.25 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.311 1.007 . . . . 5.95 112.34 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -112.94 -69.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 6.03 111.196 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.23 127.28 4.85 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.292 -0.956 . . . . 4.94 113.073 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 55.11 25.95 7.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.583 0.753 . . . . 6.83 112.507 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.34 21.11 8.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.974 0.416 . . . . 6.81 111.707 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.2 m -90.73 24.84 2.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 5.34 111.232 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.22 -25.9 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.097 0.406 . . . . 7.41 112.097 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.8 t -108.99 14.44 24.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.322 0.582 . . . . 6.29 110.111 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.42 -84.83 1.06 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.594 -0.73 . . . . 4.4 112.551 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.94 -26.2 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.766 0.317 . . . . 4.58 110.742 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.1 m -72.8 114.47 10.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.065 -0.717 . . . . 2.58 109.065 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' CD1' ' HD2' ' A' ' 59' ' ' ARG . 58.8 mt -107.82 124.83 33.67 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 2.92 110.032 -174.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.07 147.81 94.38 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.779 2.32 . . . . 1.58 113.367 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.24 137.99 45.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.125 -0.943 . . . . 1.33 110.289 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -118.47 152.85 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.197 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.6 72.91 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.637 . . . . 2.67 110.356 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.18 111.09 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 1.46 110.204 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -121.82 141.56 51.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 4.04 110.927 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.566 ' HE1' ' OH ' ' A' ' 40' ' ' TYR . 53.6 mtm -74.94 144.74 43.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 1.5 110.912 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.5 pt? -128.04 162.87 47.34 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.961 -0.755 . . . . 2.27 108.961 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 21.8 Cg_endo -62.19 163.59 19.62 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.138 1.892 . . . . 2.54 113.127 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' H ' ' A' ' 81' ' ' ASN . 26.9 ttpp -79.93 -179.48 7.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.551 -0.749 . . . . 4.95 110.39 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.449 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 54.0 m-20 78.07 9.17 2.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.764 0.826 . . . . 3.42 111.218 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -79.61 -34.17 40.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.97 -0.559 . . . . 2.12 110.018 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.505 ' CD1' HD23 ' A' ' 27' ' ' LEU . 10.7 mm -82.76 127.39 70.22 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.603 -0.726 . . . . 1.37 109.771 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.59 144.67 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.486 2.124 . . . . 1.17 112.644 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -103.55 131.42 22.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.779 . . . . 3.13 108.895 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 91.7 Cg_exo -44.43 125.11 5.72 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.953 2.436 . . . . 1.39 113.018 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.1 92.4 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.74 . . . . 1.69 111.456 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -141.78 129.84 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.587 -1.264 . . . . 1.49 107.587 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.43 -63.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.568 0.581 . . . . 3.44 112.568 -169.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.5 tp10 -95.41 -55.11 3.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.111 0.481 . . . . 2.84 111.017 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.7 t 169.96 161.47 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.646 -0.706 . . . . 2.07 109.756 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.424 HG22 ' CD2' ' A' ' 93' ' ' HIS . 5.7 m -105.79 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 1.45 112.256 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.424 ' CD2' HG22 ' A' ' 92' ' ' THR . 89.6 m-70 -138.91 172.34 13.0 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.494 0.664 . . . . 1.73 112.268 -171.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.89 163.05 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.878 -1.056 . . . . 1.86 109.399 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.54 177.49 45.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.817 -0.706 . . . . 0.54 111.387 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 m -107.79 161.6 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.046 0.45 . . . . 2.06 110.28 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.13 126.9 26.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 1.31 110.133 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.74 -44.35 56.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 1.31 111.484 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -171.7 143.96 1.51 Allowed Pre-proline 0 N--CA 1.463 0.18 0 N-CA-C 111.74 0.274 . . . . 4.44 111.74 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.81 159.73 41.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.596 2.197 . . . . 2.49 110.71 170.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 104' ' ' ILE . 5.0 mp -114.06 91.49 3.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.246 0.546 . . . . 3.85 112.169 -173.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -96.36 -58.99 1.92 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.727 -0.669 . . . . 6.1 110.406 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 58.3 m -92.75 8.94 37.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.234 -0.439 . . . . 4.3 111.713 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.48 ' O ' HG21 ' A' ' 104' ' ' ILE . 4.1 mp -107.03 32.27 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.424 0.631 . . . . 3.76 110.784 -174.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.85 97.84 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.929 0.714 . . . . 5.3 112.929 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.65 -6.28 13.43 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.4 2.066 . . . . 4.95 112.606 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -113.3 27.73 9.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 3.94 111.365 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 6.9 tp-100 -135.78 160.67 37.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.986 -0.746 . . . . 6.23 108.986 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 32' ' ' GLU . 25.0 mm-40 -54.77 -24.1 21.01 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.251 0.463 . . . . 5.86 112.251 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.32 -18.42 65.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.553 -0.294 . . . . 4.95 110.878 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 108' ' ' GLN . 4.0 t80 -57.33 -21.34 34.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.532 0.733 . . . . 3.34 112.305 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.11 44.83 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.81 0.3 . . . . 1.67 111.81 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 65.21 -176.65 12.42 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.265 -0.493 . . . . 1.08 113.311 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' GLY . 48.4 mt -151.01 139.8 20.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.217 0.532 . . . . 1.5 110.917 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.4 135.22 41.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.06 109.308 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.03 112.43 21.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.858 0.837 . . . . 1.4 109.246 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 16.9 mm -85.27 141.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.895 -1.048 . . . . 1.26 110.285 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' CG ' ' HA ' ' A' ' 122' ' ' ARG . 34.9 tp -85.44 136.95 33.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 116.251 -0.431 . . . . 1.72 110.015 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.47 152.82 10.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.059 -0.973 . . . . 2.29 110.441 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.434 ' HG2' HD23 ' A' ' 121' ' ' LEU . 1.9 pm0 -58.4 -26.72 63.55 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.043 0.386 . . . . 2.78 112.043 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.93 15.43 22.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.029 -0.268 . . . . 2.13 110.444 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.494 ' O ' ' HD2' ' A' ' 122' ' ' ARG . 1.4 tmm_? 64.25 31.8 12.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.818 0.818 . . . . 4.81 109.484 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 m -77.18 -83.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.751 -0.659 . . . . 2.38 111.435 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 p -140.39 -169.76 2.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.737 -0.211 . . . . 2.22 110.779 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -67.97 137.62 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.903 -0.406 . . . . 1.84 109.903 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.9 mt -83.68 -70.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.282 -0.567 . . . . 1.45 110.739 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.8 p -135.88 -85.64 0.36 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.169 0.509 . . . . 1.86 111.714 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.442 ' O ' ' HD2' ' A' ' 129' ' ' HIS . 7.5 pt20 -176.48 137.43 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.247 -0.888 . . . . 2.39 109.489 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.485 ' CG ' HG13 ' A' ' 117' ' ' ILE . 33.8 m170 -124.49 132.97 53.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.7 110.254 171.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -86.41 150.3 24.4 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.644 -0.707 . . . . 1.19 110.158 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -123.33 140.81 52.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.289 0.566 . . . . 0.82 111.671 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.49 154.74 20.77 Favored Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 115.426 -0.806 . . . . 0.59 111.987 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.35 -23.75 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 117.154 0.477 . . . . 1.25 111.493 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.7 p -81.78 -26.06 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.341 0.591 . . . . 1.68 110.669 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 19.8 m -73.81 -30.0 62.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.41 -0.814 . . . . 1.46 110.001 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 73.1 mt -76.01 60.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.242 -0.89 . . . . 2.06 111.828 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.46 -48.2 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.825 0.345 . . . . 1.4 111.595 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.74 35.84 1.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 2.83 111.167 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 14.8 ptpt -48.23 -25.08 1.37 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.194 1.183 . . . . 1.92 114.194 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -82.24 -11.44 58.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.903 0.383 . . . . 2.83 110.915 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.94 147.34 48.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 1.89 109.904 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.99 87.28 6.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.701 0.762 . . . . 3.33 110.051 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.34 109.22 20.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.659 -1.155 . . . . 1.26 110.223 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -104.8 -177.49 3.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.918 -0.583 . . . . 2.0 110.916 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -66.62 141.46 57.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.9 110.104 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.99 -4.23 81.36 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.63 -0.795 . . . . 1.17 113.151 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.1 141.56 28.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.757 -0.777 . . . . 1.94 109.64 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.593 HD13 ' OE1' ' A' ' 167' ' ' GLN . 3.6 mt -86.82 132.14 33.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.423 0.63 . . . . 2.45 111.746 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.42 152.74 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 1.77 110.875 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.0 p -112.1 140.33 46.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 1.86 109.389 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -163.88 168.09 19.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.809 -0.441 . . . . 0.74 109.809 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 124.12 25.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.695 -0.802 . . . . 2.72 111.438 173.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tt -99.44 140.31 19.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.785 -1.098 . . . . 1.84 110.435 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -166.57 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.765 -0.198 . . . . 1.92 110.759 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 12.4 pt-20 -74.36 -36.73 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 2.76 111.573 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.9 t -74.36 -17.44 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.876 0.37 . . . . 2.5 111.015 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.51 19.89 54.7 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.516 -0.849 . . . . 1.27 112.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -139.31 178.23 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.968 -0.753 . . . . 4.13 108.968 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.36 108.64 19.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.251 -0.277 . . . . 1.09 110.251 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -121.3 161.98 21.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.43 . . . . 1.2 110.964 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.5 m 63.84 37.07 9.93 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.712 0.633 . . . . 2.15 109.921 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.8 t -69.15 114.93 6.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.237 -0.892 . . . . 1.93 111.202 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -125.13 118.81 26.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.834 -0.621 . . . . 2.63 109.945 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.94 116.19 3.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 1.23 110.543 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.05 118.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.506 0.669 . . . . 2.08 111.585 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.93 138.9 36.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.702 -0.681 . . . . 3.44 109.923 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.593 ' OE1' HD13 ' A' ' 148' ' ' LEU . 24.4 mp0 -99.88 150.98 21.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.603 0.716 . . . . 4.38 111.118 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 114.819 -1.082 . . . . 4.41 110.05 175.199 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 111.917 -0.473 . . . . 11.95 111.917 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.05 110.54 22.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.739 0.304 . . . . 10.65 110.898 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.04 -174.65 30.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.288 -0.958 . . . . 8.95 112.47 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 p -85.38 -43.93 13.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.957 0.408 . . . . 7.44 110.821 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -152.47 -178.12 6.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.875 -0.602 . . . . 5.59 110.654 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.72 -21.86 40.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 3.46 111.83 -175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.93 23.26 72.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.884 -0.674 . . . . 1.76 112.324 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 18.9 mm-40 -117.54 122.42 43.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 2.13 111.563 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.11 122.52 44.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 1.8 108.896 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.09 137.59 32.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.204 -0.453 . . . . 1.36 110.304 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -106.62 142.24 36.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.096 -0.502 . . . . 2.73 109.676 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.24 -174.01 34.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.183 -0.767 . . . . 0.5 111.183 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.81 144.17 35.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.884 0.373 . . . . 0.75 110.8 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.01 115.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 1.14 111.021 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.42 -44.36 4.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 1.31 110.507 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 23' ' ' PHE . 86.9 t -117.35 123.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.036 -0.529 . . . . 2.16 110.801 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.8 ttm -124.12 110.96 15.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.579 . . . . 1.92 109.968 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.3 mmtt -100.68 -174.3 2.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.754 -0.462 . . . . 2.53 109.754 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.06 -20.3 38.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.931 -0.577 . . . . 3.24 110.485 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -111.78 -49.02 3.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.089 0.471 . . . . 2.03 111.457 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 12.4 p90 -141.23 -174.12 3.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 1.47 109.747 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.74 177.48 33.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.591 -0.814 . . . . 0.76 112.254 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' CZ ' ' HE1' ' A' ' 21' ' ' PHE . 63.5 m-85 -128.78 139.09 52.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.021 0.439 . . . . 1.22 109.954 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -112.47 125.9 69.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.844 -0.617 . . . . 1.15 110.914 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.8 132.01 43.04 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.776 -0.824 . . . . 2.3 108.776 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 p -84.0 150.13 25.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.219 -0.446 . . . . 1.36 110.199 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' CD1' HD11 ' A' ' 83' ' ' ILE . 6.9 tp -49.07 -46.85 45.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.788 -0.642 . . . . 2.15 111.828 -174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 m -109.14 30.14 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.028 -0.533 . . . . 2.51 110.74 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 p80 39.4 57.37 2.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.618 1.199 . . . . 4.08 111.389 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.16 -35.97 23.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.73 -1.577 . . . . 2.89 109.918 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -173.72 175.22 2.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.14 -0.936 . . . . 1.8 110.108 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.519 ' OE2' ' HB2' ' A' ' 106' ' ' PRO . 35.1 tt0 -103.6 128.57 50.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.196 -1.039 . . . . 3.37 108.196 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 124.37 58.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.648 -0.421 . . . . 1.43 111.043 -174.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.2 112.47 4.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.811 -0.631 . . . . 1.12 109.572 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -121.64 121.61 37.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.624 0.726 . . . . 2.46 110.796 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.94 128.18 44.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.135 -0.939 . . . . 1.4 108.717 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -62.17 -18.56 61.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.981 0.363 . . . . 0.82 111.981 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -60.05 -34.04 72.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.38 . . . . 2.03 111.03 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -95.65 20.79 9.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.934 0.397 . . . . 2.09 111.215 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -94.07 139.62 30.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 1.39 110.871 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.33 106.16 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.054 -0.521 . . . . 2.04 110.444 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.56 -150.51 17.82 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.862 -0.685 . . . . 1.05 112.173 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -108.37 104.05 52.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.456 0.17 . . . . 2.51 110.729 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.22 -19.95 28.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 1.14 112.819 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -70.44 -22.71 62.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.437 0.637 . . . . 2.29 110.164 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -96.28 19.38 12.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.348 -0.842 . . . . 2.45 110.343 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.422 ' CD2' ' HE2' ' A' ' 77' ' ' MET . 55.4 mt -95.84 153.55 17.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.29 110.181 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 51' ' ' GLN . 6.0 pt-20 -126.24 162.25 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.969 -0.56 . . . . 2.35 109.935 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 114.58 10.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.017 -0.735 . . . . 2.01 109.017 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.37 4.54 40.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.506 -0.854 . . . . 0.82 112.183 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 57.9 tp60 -73.49 133.1 43.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.897 0.38 . . . . 1.16 110.612 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -86.27 128.24 34.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 2.51 110.799 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 77' ' ' MET . 35.7 m -139.51 160.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.088 -0.505 . . . . 1.12 110.921 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -120.88 140.02 52.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.234 -0.654 . . . . 1.49 109.234 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.78 172.62 15.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.088 0.47 . . . . 0.79 112.075 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 p -131.96 157.86 42.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.684 -0.689 . . . . 1.49 110.77 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.44 149.29 22.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 1.55 111.155 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.72 99.61 7.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.972 -0.558 . . . . 2.04 111.125 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -130.42 76.94 1.76 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.047 -0.723 . . . . 5.95 109.047 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.97 -14.91 57.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 6.03 111.254 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.7 172.08 29.7 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.929 -0.653 . . . . 4.94 111.722 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.45 50.81 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.179 0.514 . . . . 6.83 110.63 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -77.73 43.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.804 -0.635 . . . . 6.81 110.957 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -81.09 6.41 13.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.813 -0.631 . . . . 5.34 111.021 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.03 -37.77 10.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.176 -0.466 . . . . 7.41 110.926 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 p -105.07 20.12 19.4 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.913 0.338 . . . . 6.29 111.913 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.12 134.61 1.93 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.733 -0.746 . . . . 4.4 111.868 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.31 -46.41 27.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.002 0.43 . . . . 4.58 110.455 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -110.05 127.42 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 2.58 110.712 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.49 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.4 mm? -67.6 155.27 91.63 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.705 -0.68 . . . . 2.92 111.696 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.09 155.21 66.11 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.854 2.369 . . . . 1.58 112.378 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.03 30.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.994 -0.548 . . . . 1.33 110.668 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.79 169.32 17.23 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.507 -0.553 . . . . 2.3 109.507 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 t30 60.03 45.54 11.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.636 0.732 . . . . 2.67 109.871 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.32 114.05 29.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.73 . . . . 1.46 110.359 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 163.28 24.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 4.04 110.239 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.449 ' HA ' HG13 ' A' ' 53' ' ' VAL . 65.7 mtt -79.63 153.02 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.145 0.498 . . . . 1.5 111.369 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.8 mt -119.88 158.54 49.69 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.252 -0.885 . . . . 2.27 109.687 172.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.21 153.83 71.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.125 1.883 . . . . 2.54 111.93 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -78.94 148.68 32.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.077 -0.511 . . . . 4.95 110.839 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 72.01 30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 3.42 110.853 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.3 p -87.63 -11.71 47.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.39 0.614 . . . . 2.12 109.923 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 ' CD1' ' A' ' 27' ' ' LEU . 13.6 mm -84.98 131.56 48.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.315 -0.857 . . . . 1.37 109.627 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.18 150.58 65.85 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.483 2.122 . . . . 1.17 112.412 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -126.92 148.54 65.9 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.403 -0.362 . . . . 3.13 110.206 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.98 127.8 14.09 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.024 2.483 . . . . 1.39 113.625 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.94 94.49 4.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.659 -0.701 . . . . 1.69 110.895 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.86 120.94 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 1.49 109.087 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.05 -62.77 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.544 0.201 . . . . 3.44 111.544 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 91' ' ' THR . 6.0 mm-40 -92.98 -55.33 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 2.84 111.733 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 12.5 t 168.91 158.67 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.695 -0.854 . . . . 2.07 108.695 -176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.08 -58.92 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.454 -0.498 . . . . 1.45 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.44 163.61 34.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 1.73 110.803 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -120.87 174.09 6.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.457 -0.942 . . . . 1.86 108.457 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.35 -174.3 46.87 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.027 -1.083 . . . . 0.54 111.606 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.15 162.42 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.008 0.432 . . . . 2.06 110.028 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.39 122.43 17.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.94 -0.573 . . . . 1.31 109.869 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.65 -45.65 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.352 . . . . 1.31 111.61 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -172.98 124.98 0.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 4.44 110.835 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.12 147.03 16.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.548 2.165 . . . . 2.49 111.671 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.1 pt? -78.94 90.79 4.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 3.85 111.595 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -97.55 -65.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.14 -0.482 . . . . 6.1 110.588 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.04 1.49 56.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.998 -0.546 . . . . 4.3 110.794 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.19 -42.55 75.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.723 -0.671 . . . . 3.76 111.161 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 72.42 147.04 0.12 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.638 0.775 . . . . 5.3 111.381 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.519 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . 54.8 Cg_endo -68.56 -19.87 41.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.845 2.363 . . . . 4.95 111.962 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.88 -14.3 61.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.373 -0.83 . . . . 3.94 110.325 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -96.92 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.949 -0.569 . . . . 6.23 110.332 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.3 -22.63 66.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.846 0.684 . . . . 5.86 112.846 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -85.61 15.85 4.33 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.779 0.323 . . . . 4.95 111.268 -175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.517 ' O ' HD11 ' A' ' 101' ' ' LEU . 14.0 t80 -50.11 -42.9 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.169 0.803 . . . . 3.34 113.169 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB3' ' CD ' ' A' ' 130' ' ' GLU . . . -76.57 -11.31 59.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.301 0.482 . . . . 1.67 112.301 -169.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.23 150.7 8.72 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.635 -0.793 . . . . 1.08 112.284 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 130' ' ' GLU . 67.3 mt -127.28 147.26 50.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.498 0.666 . . . . 1.5 112.597 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 82.3 mt -111.11 141.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.908 -1.042 . . . . 1.06 109.313 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.497 ' HG3' ' CG2' ' A' ' 125' ' ' VAL . 32.7 tt0 -93.11 109.24 20.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.148 0.499 . . . . 1.4 109.981 -176.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 129' ' ' HIS . 12.6 mm -91.74 132.52 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.713 . . . . 1.26 110.154 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -91.83 153.91 19.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.131 0.491 . . . . 1.72 111.008 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 123' ' ' THR . 2.8 t70 -55.12 146.88 17.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.32 -0.855 . . . . 2.29 109.063 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 121' ' ' LEU . 2.9 pm0 -62.75 -20.01 64.53 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.464 0.542 . . . . 2.78 112.464 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD23 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -102.25 13.46 34.6 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.936 -0.394 . . . . 2.13 109.936 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 58.1 80.89 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.652 -0.704 . . . . 4.81 110.378 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.462 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 32.5 m -116.33 -71.99 0.71 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.451 -0.795 . . . . 2.38 109.663 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -146.43 -176.58 5.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.82 -0.627 . . . . 2.22 110.189 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.497 ' CG2' ' HG3' ' A' ' 116' ' ' GLU . 3.6 p -72.38 137.86 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.281 -0.418 . . . . 1.84 110.105 175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.37 -70.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.431 -0.507 . . . . 1.45 110.086 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.2 p -138.48 -87.82 0.24 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.417 0.627 . . . . 1.86 111.193 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.98 139.1 0.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.647 -1.16 . . . . 2.39 108.224 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.518 ' HB2' HD12 ' A' ' 117' ' ' ILE . 25.9 m170 -117.32 121.06 40.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.455 -0.498 . . . . 0.7 110.448 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.433 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.3 tt0 -78.71 149.31 32.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.736 -0.665 . . . . 1.19 109.849 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -117.77 175.44 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.943 0.402 . . . . 0.82 111.007 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.46 153.09 21.44 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.797 -0.638 . . . . 0.59 111.616 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -51.03 -30.54 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.019 0.409 . . . . 1.25 111.516 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.4 p -74.44 -36.91 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 1.68 110.946 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 16.9 m -69.94 -23.15 63.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 1.46 110.145 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.88 59.78 1.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 2.06 111.846 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.2 t -48.28 -41.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.228 0.537 . . . . 1.4 110.563 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.95 33.88 1.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.652 -0.703 . . . . 2.83 110.722 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -52.93 -25.09 10.77 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.799 1.037 . . . . 1.92 113.799 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -84.07 -16.92 42.01 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.586 -0.446 . . . . 2.83 111.363 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -76.01 150.05 37.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 1.89 110.617 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 142' ' ' LEU . 2.1 mm? -84.96 71.37 10.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.935 -0.575 . . . . 3.33 109.745 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.6 tp -75.72 122.88 24.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.775 -0.648 . . . . 1.26 110.028 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -108.32 172.12 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.024 0.44 . . . . 2.0 111.758 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 146' ' ' GLY . 13.5 tmtt? -70.93 132.82 45.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 1.9 110.366 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 145' ' ' LYS . . . 87.56 4.07 80.38 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.47 -0.871 . . . . 1.17 113.05 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.89 152.01 22.4 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.136 -0.626 . . . . 1.94 110.045 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 148' ' ' LEU . 3.3 mm? -77.32 123.47 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.529 0.681 . . . . 2.45 111.513 -172.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.169 -0.923 . . . . 1.77 110.339 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 73.4 m -121.57 152.8 38.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.057 -0.52 . . . . 1.86 110.558 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 162' ' ' VAL . 6.4 p90 -165.49 168.27 16.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.803 -0.635 . . . . 0.74 109.817 -173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.48 122.55 29.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.459 0.647 . . . . 2.72 110.805 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -100.7 137.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.886 . . . . 1.84 110.551 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.531 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 31.6 t70 -169.64 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.19 -0.3 . . . . 1.92 110.19 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 39.1 mt-10 -76.73 -18.61 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.618 . . . . 2.76 110.035 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.5 p -80.03 -18.68 49.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.542 -0.754 . . . . 2.5 110.643 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.77 2.73 2.69 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.61 -0.723 . . . . 1.27 114.082 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -154.89 -161.16 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.262 -0.644 . . . . 4.13 109.262 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.71 115.58 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.337 0.589 . . . . 1.09 110.842 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -128.79 148.81 50.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.497 -0.774 . . . . 1.2 109.861 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.0 m 55.27 55.17 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.038 0.836 . . . . 2.15 110.916 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 150' ' ' SER . 4.1 m -77.25 141.62 15.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.287 0.565 . . . . 1.93 110.277 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -138.56 119.95 14.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 2.63 110.286 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.16 103.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.115 -0.493 . . . . 1.23 110.958 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.97 118.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.381 0.61 . . . . 2.08 110.698 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 119.6 36.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 3.44 110.791 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -118.16 164.23 15.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.261 -0.644 . . . . 4.38 109.261 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 168' ' ' LYS . 9.7 mtmp? . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 4.41 110.71 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.336 -0.306 . . . . 11.95 112.336 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.8 -75.23 0.48 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.583 0.23 . . . . 10.65 111.07 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.46 -18.67 56.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.783 -0.722 . . . . 8.95 112.258 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 p -96.15 39.45 1.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.024 0.44 . . . . 7.44 110.602 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.66 97.67 0.22 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.781 -0.645 . . . . 5.59 111.728 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.9 -83.24 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.183 -0.917 . . . . 3.46 113.068 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.26 -4.17 58.47 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.495 -0.642 . . . . 1.76 111.495 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.54 133.52 35.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 2.13 110.977 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' HA ' HG23 ' A' ' 56' ' ' THR . 2.4 p -104.23 129.71 56.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.612 -0.722 . . . . 1.8 109.774 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -113.17 148.72 34.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.279 -0.873 . . . . 1.36 109.881 -174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -110.45 136.42 49.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.147 -0.479 . . . . 2.73 109.907 -177.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.44 -168.2 17.52 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.372 -0.691 . . . . 0.5 111.372 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 149.14 34.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.121 0.486 . . . . 0.75 111.178 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.77 118.99 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.442 -0.799 . . . . 1.14 110.497 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.21 -49.67 3.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 1.31 111.001 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 23' ' ' PHE . 6.3 p -123.51 139.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.032 -0.531 . . . . 2.16 110.272 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.7 ttm -131.76 122.05 25.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.42 . . . . 1.92 110.993 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -107.43 -170.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.653 -0.869 . . . . 2.53 108.653 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.96 -20.36 25.99 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.438 -0.801 . . . . 3.24 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.83 -48.44 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.063 0.459 . . . . 2.03 111.34 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.3 p90 -143.65 175.78 9.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.36 . . . . 1.47 110.947 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.27 173.23 33.51 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.435 -0.666 . . . . 0.76 111.435 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' H ' HG13 ' A' ' 16' ' ' VAL . 40.7 m-85 -114.16 126.17 54.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.661 -0.866 . . . . 1.22 108.661 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.69 125.66 46.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.243 -0.435 . . . . 1.15 110.527 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.74 119.7 15.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.172 -0.677 . . . . 2.3 109.172 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.45 160.55 24.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.328 -0.851 . . . . 1.36 110.315 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 13.9 tp -56.27 -46.4 79.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.341 -0.39 . . . . 2.15 111.929 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.8 t -99.58 13.02 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.59 -0.522 . . . . 2.51 109.59 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.539 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 84.5 m-70 61.22 35.56 18.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.42 -0.809 . . . . 4.08 109.599 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.94 -58.52 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.094 -1.412 . . . . 2.89 111.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.07 178.85 9.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 1.8 109.765 -173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 131.4 50.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 3.37 110.62 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.98 129.9 64.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.888 -0.597 . . . . 1.43 110.464 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -80.91 113.21 18.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.464 0.65 . . . . 1.12 110.446 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' CE2' HG22 ' A' ' 75' ' ' VAL . 26.3 t80 -121.95 132.49 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 2.46 110.13 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -102.26 124.32 47.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.159 -0.682 . . . . 1.4 109.159 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.97 -18.74 63.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.476 0.547 . . . . 0.82 112.476 -172.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -59.26 -23.28 62.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.007 0.432 . . . . 2.03 110.618 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.18 20.72 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.081 0.467 . . . . 2.09 110.458 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -85.99 140.95 29.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 1.39 110.336 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.7 ttm -111.47 89.32 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 2.04 110.425 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.27 -168.97 33.19 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.812 -0.631 . . . . 1.05 111.949 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.43 HD21 ' HB2' ' A' ' 46' ' ' TRP . 4.3 p-10 -98.37 102.75 15.21 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.344 0.593 . . . . 2.51 110.791 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.89 -17.99 13.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 1.14 113.513 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -64.32 -25.72 68.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 2.29 110.107 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.43 ' HB2' HD21 ' A' ' 43' ' ' ASN . 84.1 m95 -106.51 23.51 14.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.823 -0.626 . . . . 2.45 111.419 -176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' ' HE3' ' A' ' 77' ' ' MET . 23.9 mt -89.7 152.02 21.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.717 -0.674 . . . . 1.29 109.719 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.13 157.81 44.77 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.4 mm? -68.67 118.15 11.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.41 -0.359 . . . . 2.01 110.061 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.77 -5.47 16.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.82 112.296 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -76.31 122.96 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.669 0.271 . . . . 1.16 110.955 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 21.5 mt-10 -64.16 137.41 57.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.693 -0.685 . . . . 2.51 110.656 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.476 HG13 ' HA ' ' A' ' 77' ' ' MET . 22.5 m -143.09 148.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.508 -0.553 . . . . 1.12 109.508 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.33 144.48 43.19 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.931 -0.766 . . . . 1.49 108.931 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.451 ' CB ' HG21 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -162.61 163.89 26.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.038 0.447 . . . . 0.79 111.939 -174.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 9' ' ' VAL . 56.9 p -120.94 153.51 37.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 1.49 109.742 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.67 156.74 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.745 0.307 . . . . 1.55 110.827 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.89 -174.38 3.3 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.867 -0.79 . . . . 2.04 108.867 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.45 ' HD3' ' CD2' ' A' ' 70' ' ' LEU . 72.5 ttt180 61.01 41.11 14.41 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.997 0.811 . . . . 5.95 110.218 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -97.81 174.36 6.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.663 -0.699 . . . . 6.03 110.707 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.2 -152.13 17.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.905 -0.664 . . . . 4.94 112.306 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.75 20.3 3.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 6.83 110.422 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -99.76 12.51 36.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.599 -0.728 . . . . 6.81 110.898 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.36 6.3 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 5.34 112.332 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 m -92.27 -28.01 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.024 -0.534 . . . . 7.41 109.979 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 m -107.06 -28.4 10.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.911 -0.586 . . . . 6.29 110.246 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -94.32 78.21 0.96 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.354 -0.698 . . . . 4.4 111.354 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -72.62 -41.02 66.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.013 0.435 . . . . 4.58 110.553 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 m -122.37 128.46 51.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.584 -0.895 . . . . 2.58 108.584 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' CD2' ' HD3' ' A' ' 59' ' ' ARG . 31.7 mt -109.85 138.44 20.71 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 121.202 -0.199 . . . . 2.92 110.92 -173.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.17 153.16 67.29 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.532 2.155 . . . . 1.58 111.106 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.27 147.54 29.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.453 -0.34 . . . . 1.33 111.245 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -126.85 174.22 8.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.495 -0.321 . . . . 2.3 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 58.8 34.2 23.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.869 -0.605 . . . . 2.67 112.232 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' A' ' 35' ' ' PHE . 40.8 t -78.19 119.74 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.977 0.418 . . . . 1.46 110.899 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 76' ' ' ARG . 11.1 mmm180 -124.39 148.72 47.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.675 -0.693 . . . . 4.04 110.35 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.476 ' HA ' HG13 ' A' ' 53' ' ' VAL . 66.7 mtt -69.04 140.95 54.94 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.017 -0.364 . . . . 1.5 110.017 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 31.1 tp -130.61 82.69 64.16 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.389 -0.369 . . . . 2.27 111.502 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.06 116.58 3.97 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.524 1.483 . . . . 2.54 110.305 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -166.22 -21.45 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.904 0.383 . . . . 4.95 111.006 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t30 59.35 41.19 20.1 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.452 -0.944 . . . . 3.42 108.452 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 t -88.44 -5.97 57.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.626 -1.17 . . . . 2.12 110.924 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -63.23 119.65 54.65 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 1.37 109.236 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.68 158.98 53.27 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 122.44 2.094 . . . . 1.17 112.125 -172.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -98.2 139.72 21.4 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.942 -0.572 . . . . 3.13 110.413 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.457 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 76.6 Cg_exo -51.02 134.83 43.59 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.113 2.542 . . . . 1.39 112.261 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.76 91.83 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 1.69 110.226 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -142.82 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 1.49 109.531 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.92 -59.81 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.02 0.378 . . . . 3.44 112.02 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.554 ' O ' ' HB ' ' A' ' 91' ' ' THR . 16.7 mm-40 -90.76 -56.29 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.31 0.576 . . . . 2.84 111.145 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 13.1 t 151.01 164.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.431 -1.692 . . . . 2.07 106.431 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.4 HG23 HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -106.48 -58.21 1.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.28 -0.968 . . . . 1.45 111.536 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -140.87 158.37 44.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.028 0.442 . . . . 1.73 110.761 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -140.15 126.04 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.72 -0.673 . . . . 1.86 109.398 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.47 -140.45 3.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.986 -1.102 . . . . 0.54 112.379 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.92 152.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.611 0.243 . . . . 2.06 110.475 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.485 HG21 ' HG ' ' A' ' 143' ' ' LEU . 64.8 t -61.89 132.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 1.31 110.419 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -87.15 -49.11 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.238 0.458 . . . . 1.31 112.238 -173.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -157.76 126.19 2.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.257 -0.577 . . . . 4.44 111.823 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.15 145.87 24.86 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.802 2.335 . . . . 2.49 111.717 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -93.65 89.97 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.325 0.583 . . . . 3.85 112.162 -176.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -98.44 -62.62 1.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.328 0.585 . . . . 6.1 110.468 170.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.51 7.35 26.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.425 -0.807 . . . . 4.3 111.081 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -77.34 -42.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.047 -0.524 . . . . 3.76 110.675 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 73.13 146.9 0.12 Allowed Pre-proline 0 N--CA 1.472 0.653 0 O-C-N 123.682 0.614 . . . . 5.3 110.735 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 55.4 Cg_endo -71.19 0.25 6.98 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.736 2.29 . . . . 4.95 112.412 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.94 -14.52 23.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.039 0.447 . . . . 3.94 110.298 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.404 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 52.0 tp60 -89.45 148.12 23.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 6.23 110.129 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -63.47 -28.75 70.17 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.862 0.69 . . . . 5.86 112.862 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 108' ' ' GLN . 1.3 pt-20 -88.41 16.12 6.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.026 0.441 . . . . 4.95 111.17 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 6.8 t80 -49.58 -33.17 14.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.383 -0.826 . . . . 3.34 111.633 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.56 -16.63 63.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.207 -0.451 . . . . 1.67 111.761 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.53 170.01 46.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.529 -0.843 . . . . 1.08 111.969 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 130' ' ' GLU . 72.6 mt -145.31 144.21 30.61 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.309 0.576 . . . . 1.5 111.613 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.39 138.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.011 -0.995 . . . . 1.06 109.211 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.67 114.75 26.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.643 0.735 . . . . 1.4 110.312 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 14.8 mm -91.34 132.15 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.045 -0.98 . . . . 1.26 109.845 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.9 pt? -85.65 152.74 22.87 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.181 0.301 . . . . 1.72 110.438 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.438 ' OD1' ' HB ' ' A' ' 123' ' ' THR . 18.2 m-20 -56.75 151.67 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.669 -0.493 . . . . 2.29 109.669 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -62.59 -25.95 68.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.735 0.302 . . . . 2.78 110.699 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.49 5.78 43.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 2.13 109.987 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 60.94 78.92 0.27 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.547 -0.751 . . . . 4.81 110.643 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.438 ' HB ' ' OD1' ' A' ' 119' ' ' ASP . 22.0 m -121.13 -74.18 0.62 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 2.38 110.606 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.5 p -144.03 -174.71 4.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.148 -0.478 . . . . 2.22 110.75 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.1 p -70.92 134.54 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.676 -0.491 . . . . 1.84 109.676 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.68 -69.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 1.45 110.623 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -136.66 -84.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.261 0.553 . . . . 1.86 111.197 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -175.33 142.38 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.035 -0.984 . . . . 2.39 108.899 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' CD2' HG13 ' A' ' 117' ' ' ILE . 17.5 m170 -124.1 124.39 42.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.999 0.428 . . . . 0.7 110.678 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.0 tt0 -85.26 143.74 28.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.247 -0.888 . . . . 1.19 108.758 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -117.13 134.31 54.93 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.181 -0.608 . . . . 0.82 111.348 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.539 ' HA3' ' CE1' ' A' ' 29' ' ' HIS . . . -77.95 153.58 40.16 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 114.945 -1.025 . . . . 0.59 113.11 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.37 -37.52 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.545 0.338 . . . . 1.25 111.905 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.6 p -80.0 -32.89 39.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.322 0.582 . . . . 1.68 110.731 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 45.5 m -64.67 -32.81 74.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.263 -0.88 . . . . 1.46 109.934 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.9 tp -78.36 58.38 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.452 -0.795 . . . . 2.06 110.846 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -44.91 -40.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.64 0.733 . . . . 1.4 110.675 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.713 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 33.7 m-80 -87.87 33.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 2.83 111.283 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -61.9 -16.1 48.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.112 0.482 . . . . 1.92 111.064 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -92.15 -9.13 43.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.795 -0.639 . . . . 2.83 111.285 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.31 166.46 15.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 1.89 110.323 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -98.31 52.57 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.428 0.632 . . . . 3.33 109.753 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.485 ' HG ' HG21 ' A' ' 97' ' ' VAL . 13.0 tp -60.02 125.48 23.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.828 -1.078 . . . . 1.26 111.591 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -129.95 171.8 12.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 2.0 110.544 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 86.5 tttt -70.57 136.02 48.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.268 -0.573 . . . . 1.9 109.564 176.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.29 -9.12 57.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.486 -0.864 . . . . 1.17 111.398 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -91.81 123.34 35.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.334 -0.987 . . . . 1.94 108.334 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.94 146.87 47.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.049 0.452 . . . . 2.45 110.201 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.17 146.54 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.285 0.564 . . . . 1.77 111.504 -172.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 p -111.52 145.42 39.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.268 -0.878 . . . . 1.86 109.663 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -165.38 158.0 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.914 0.388 . . . . 0.74 110.175 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -125.65 125.26 42.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.399 -0.593 . . . . 2.72 109.399 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.4 HG23 HG23 ' A' ' 92' ' ' THR . 9.2 tt -99.64 121.85 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 1.84 109.876 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.574 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 7.4 p-10 -145.71 -100.7 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.533 -0.303 . . . . 1.92 111.155 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.574 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 1.4 mt-10 -78.86 -29.0 44.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.026 0.441 . . . . 2.76 110.373 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.0 t -74.02 -17.51 60.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 2.5 110.915 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.72 21.99 58.97 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.719 -0.753 . . . . 1.27 112.37 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 158' ' ' ARG . 52.7 mtt180 -140.79 -171.4 3.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.997 -0.742 . . . . 4.13 108.997 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.86 107.74 18.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.606 -0.438 . . . . 1.09 109.862 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -110.33 161.48 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 1.2 110.109 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.71 36.93 19.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.24 0.543 . . . . 2.15 110.235 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.35 112.16 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.523 0.678 . . . . 1.93 111.12 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.713 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 53.2 t30 -131.14 114.52 15.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 2.63 110.476 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.41 131.18 49.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 1.23 111.057 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.54 107.28 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.959 -0.564 . . . . 2.08 110.501 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? -87.08 115.05 24.21 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.362 -0.607 . . . . 3.44 109.362 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.873 -0.603 . . . . 4.38 111.553 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.421 ' H ' ' HG3' ' A' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.908 -1.042 . . . . 4.41 111.271 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 N-CA-C 112.04 -0.424 . . . . 11.95 112.04 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.48 80.45 8.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.057 0.456 . . . . 10.65 110.314 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.99 111.98 0.66 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.85 -0.614 . . . . 8.95 111.591 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 m -130.31 6.07 4.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.44 0.162 . . . . 7.44 110.979 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -115.79 162.21 17.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.836 0.351 . . . . 5.59 110.569 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.75 -18.34 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 3.46 110.586 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.04 22.04 70.26 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.148 -0.549 . . . . 1.76 112.693 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -106.53 124.17 49.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 2.13 111.451 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -90.77 115.29 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.643 -0.873 . . . . 1.8 108.643 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.511 ' CD2' ' HG ' ' A' ' 57' ' ' LEU . 22.8 m-85 -87.79 139.17 30.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.404 0.621 . . . . 1.36 110.786 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 27.8 ttm180 -100.83 130.12 46.8 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.01 -0.995 . . . . 2.73 110.189 -176.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.63 -177.31 26.99 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.378 -0.689 . . . . 0.5 111.378 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -149.21 151.05 33.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.964 0.412 . . . . 0.75 111.064 -177.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.7 123.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.857 -0.61 . . . . 1.14 111.477 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 25' ' ' GLU . . . -106.26 -37.08 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 1.31 111.584 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 23' ' ' PHE . 6.4 p -144.82 149.65 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.074 -0.512 . . . . 2.16 109.953 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.6 mtp -130.71 107.5 9.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.77 -0.456 . . . . 1.92 109.77 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.22 -168.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.53 109.746 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.72 -44.2 43.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.159 0.504 . . . . 3.24 110.885 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -102.91 -27.93 12.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.545 . . . . 2.03 111.655 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.12 -177.91 6.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.895 0.379 . . . . 1.47 111.756 -172.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.95 160.82 28.54 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.931 -0.577 . . . . 0.76 111.719 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB2' HG12 ' A' ' 16' ' ' VAL . 25.9 m-85 -108.38 135.46 49.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.763 -0.458 . . . . 1.22 109.763 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -102.53 125.12 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.995 -0.548 . . . . 1.15 110.304 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.544 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 32.6 tt0 -72.34 117.79 14.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.968 -1.123 . . . . 2.3 107.968 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 p -66.07 157.44 31.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.036 -0.357 . . . . 1.36 110.036 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' HD12 ' A' ' 83' ' ' ILE . 17.2 tp -53.23 -36.05 60.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 2.15 111.785 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -110.7 12.61 22.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 2.51 110.054 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.2 p80 40.34 39.81 0.74 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.531 1.132 . . . . 4.08 113.086 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -95.37 -0.87 52.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 2.89 110.472 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -156.98 148.08 21.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 1.8 111.248 -170.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.42 121.45 44.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.422 -0.584 . . . . 3.37 109.422 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.4 t -109.47 130.62 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 1.43 111.44 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 71' ' ' PRO . 14.0 t80 -84.56 120.56 26.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.814 -0.63 . . . . 1.12 110.385 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -124.23 144.96 49.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.828 -0.624 . . . . 2.46 110.367 177.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -116.84 126.92 53.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.716 -0.675 . . . . 1.4 110.101 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -63.93 -20.88 66.19 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.196 0.443 . . . . 0.82 112.196 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.7 t -67.02 -27.23 67.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.62 -0.263 . . . . 2.03 111.517 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -101.93 6.85 41.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.09 111.476 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' A' ' 47' ' ' LEU . 79.5 t80 -73.3 129.72 38.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.129 -0.487 . . . . 1.39 110.832 -175.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.5 ttp -98.9 93.09 5.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 2.04 110.389 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.27 -134.77 4.22 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.607 -0.724 . . . . 1.05 111.466 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -132.72 106.02 12.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.721 -0.474 . . . . 2.51 109.721 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.26 -17.85 16.55 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.36 2.04 . . . . 1.14 112.887 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -74.52 -17.01 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.338 0.59 . . . . 2.29 110.357 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -101.03 -2.13 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 2.45 110.844 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 13.1 mt -77.38 146.63 36.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 1.29 111.736 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.23 173.31 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 2.35 109.66 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.21 130.04 37.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.237 -0.438 . . . . 2.01 110.449 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.97 4.91 58.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.82 112.918 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.4 126.94 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.862 0.331 . . . . 1.16 111.042 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.57 129.97 39.53 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.577 -0.738 . . . . 2.51 110.551 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.92 156.54 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.932 0.396 . . . . 1.12 110.816 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HB3' HD11 ' A' ' 78' ' ' LEU . 12.9 pt-20 -114.3 138.64 50.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.086 -0.709 . . . . 1.49 109.086 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 72' ' ' ALA . 6.8 p90 -165.3 176.76 8.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.958 0.409 . . . . 0.79 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 p -125.67 145.45 50.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.1 -0.5 . . . . 1.49 110.973 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 10' ' ' TYR . 90.8 mt -73.02 135.39 44.91 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.621 -0.432 . . . . 1.55 110.371 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' LEU . . . -80.76 98.52 7.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.531 -0.759 . . . . 2.04 109.724 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HD2' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER 37.16 41.44 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.866 1.266 . . . . 5.95 114.318 171.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.78 91.23 4.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.243 0.544 . . . . 6.03 111.012 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.41 30.11 4.12 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.604 -0.726 . . . . 4.94 111.927 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.03 -175.43 3.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 6.83 109.935 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -79.92 -35.85 37.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.642 0.258 . . . . 6.81 111.439 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.1 m 64.69 8.58 4.57 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.049 0.539 . . . . 5.34 112.032 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.11 -23.7 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 7.41 111.488 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.516 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 7.2 m -93.42 2.76 56.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 6.29 110.439 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.53 9.18 57.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 4.4 112.35 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 66' ' ' SER . 17.5 m120 -80.88 54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.347 0.594 . . . . 4.58 111.269 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 p -103.5 143.74 32.33 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.448 -0.796 . . . . 2.58 110.279 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.467 ' H ' HD11 ' A' ' 70' ' ' LEU . 1.7 mp -94.01 136.65 23.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.934 -0.765 . . . . 2.92 108.934 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 35.3 Cg_endo -66.01 140.66 61.06 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.019 1.813 . . . . 1.58 111.661 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . . . -58.25 121.22 10.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.493 -0.776 . . . . 1.33 110.593 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.3 148.44 28.99 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.361 0.413 . . . . 2.3 110.842 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.4 t30 59.12 82.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.23 -0.896 . . . . 2.67 110.708 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.49 121.95 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 1.46 110.253 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -125.97 156.47 39.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.837 -0.431 . . . . 4.04 109.837 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.3 mtt -76.91 138.99 40.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.5 110.613 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 54' ' ' GLU . 22.0 tp -113.88 146.0 34.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 2.27 109.255 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.07 155.84 17.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.54 113.152 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 84.4 tttt -73.35 154.2 40.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.389 -0.823 . . . . 4.95 111.308 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 93.7 m-20 77.36 23.56 0.87 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.622 0.769 . . . . 3.42 110.841 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 m -86.26 -13.08 47.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.863 -0.608 . . . . 2.12 109.512 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' A' ' 27' ' ' LEU . 3.5 mm -93.71 130.91 33.46 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.898 -0.778 . . . . 1.37 108.898 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.07 145.91 80.53 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.673 2.248 . . . . 1.17 112.56 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -124.0 137.54 29.1 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 3.13 110.835 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 82.6 Cg_exo -50.23 141.07 32.24 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.692 2.928 . . . . 1.39 113.352 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.58 95.29 5.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 1.69 111.393 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.455 HG11 ' OG1' ' A' ' 92' ' ' THR . 16.7 m -121.54 171.31 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.499 -0.556 . . . . 1.49 109.499 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.47 -63.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.308 -0.557 . . . . 3.44 111.124 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.03 -54.18 3.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.393 0.616 . . . . 2.84 111.269 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t 172.5 163.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.379 -0.971 . . . . 2.07 108.379 -174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.455 ' OG1' HG11 ' A' ' 88' ' ' VAL . 2.1 m -107.18 -59.06 1.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 1.45 111.84 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.418 ' CD2' HG21 ' A' ' 92' ' ' THR . 97.9 m-70 -148.34 178.04 8.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.573 0.701 . . . . 1.73 111.504 -173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.42 166.62 23.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.588 -1.264 . . . . 1.86 107.588 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.49 -165.79 30.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.707 -1.235 . . . . 0.54 112.695 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 42.0 t -135.7 141.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.547 0.339 . . . . 2.06 110.165 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 66.3 t -59.15 118.99 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.06 -0.348 . . . . 1.31 110.06 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.27 -64.15 1.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 1.31 111.917 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -160.51 158.1 24.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.336 . . . . 4.44 111.862 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.64 177.24 7.09 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.966 2.444 . . . . 2.49 111.038 169.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.78 90.65 3.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.444 0.64 . . . . 3.85 112.029 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -80.01 -20.5 45.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 6.1 109.724 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 56.6 m -72.63 -21.27 61.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 4.3 111.084 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.09 -43.78 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.69 0.281 . . . . 3.76 110.352 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.04 114.94 34.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.404 . . . . 5.3 110.329 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.17 -41.25 0.66 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.509 2.139 . . . . 4.95 114.133 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.36 -37.8 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.774 -0.37 . . . . 3.94 110.94 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -124.7 87.98 2.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.138 0.494 . . . . 6.23 110.091 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -65.78 -12.8 57.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.453 0.644 . . . . 5.86 110.947 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.89 5.82 50.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.444 -0.798 . . . . 4.95 111.052 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -54.98 -52.15 63.98 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.789 0.681 . . . . 3.34 110.548 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.53 -46.05 2.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.38 -0.827 . . . . 1.67 111.76 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.538 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 63.57 174.66 3.08 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.97 -0.559 . . . . 1.08 113.035 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 130' ' ' GLU . 55.8 mt -145.49 138.61 26.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.544 0.688 . . . . 1.5 111.715 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.48 138.02 37.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.686 -1.143 . . . . 1.06 109.767 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.62 121.39 29.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.628 . . . . 1.4 109.408 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 4.2 mm -103.36 120.45 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.45 -0.795 . . . . 1.26 109.238 -175.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD21 ' H ' ' A' ' 118' ' ' LEU . 2.5 pt? -85.18 139.41 31.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 1.72 110.29 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.73 160.9 3.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.147 -0.933 . . . . 2.29 110.218 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.1 -27.0 68.8 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.19 -0.319 . . . . 2.78 111.53 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.05 12.54 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.709 -0.478 . . . . 2.13 109.709 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 48.59 35.91 6.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.794 1.238 . . . . 4.81 111.854 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 20.3 p -75.47 -67.39 0.67 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.608 -0.723 . . . . 2.38 111.118 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.7 p -139.01 172.81 12.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.09 -0.505 . . . . 2.22 111.28 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.6 t -72.92 136.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 1.84 109.474 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -70.98 -69.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.43 -0.508 . . . . 1.45 111.1 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 61.2 m -140.4 -85.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.45 0.643 . . . . 1.86 111.341 172.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -176.5 123.9 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.646 -1.161 . . . . 2.39 108.653 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.447 ' CE1' HD12 ' A' ' 153' ' ' ILE . 31.5 m170 -111.91 126.93 55.64 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.631 -0.827 . . . . 0.7 110.618 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 114' ' ' LEU . 13.3 tt0 -88.1 149.06 24.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.462 -1.244 . . . . 1.19 109.629 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.538 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 38.3 p90 -123.7 175.71 6.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.82 110.837 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -137.44 153.58 22.06 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.625 -0.716 . . . . 0.59 111.564 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 tp -54.24 -23.26 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 117.154 0.477 . . . . 1.25 111.193 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -80.99 -34.4 33.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.323 0.582 . . . . 1.68 110.674 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 36.6 t -76.02 -26.0 56.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.231 -0.895 . . . . 1.46 110.377 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 80.1 mt -75.26 60.22 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.642 . . . . 2.06 112.27 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.5 t -41.41 -49.07 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.827 0.346 . . . . 1.4 111.863 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.46 HD22 HD23 ' A' ' 143' ' ' LEU . 2.7 p-10 -97.47 36.38 1.5 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.721 0.296 . . . . 2.83 111.53 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 13.9 ptpt -51.55 -22.54 3.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.244 0.831 . . . . 1.92 113.244 -177.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -81.66 -20.84 38.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.081 0.467 . . . . 2.83 111.005 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.24 163.36 18.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.641 -0.708 . . . . 1.89 111.431 -173.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.91 100.19 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.804 -0.635 . . . . 3.33 110.276 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 138' ' ' ASN . 7.1 tp -128.11 95.35 4.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.23 -0.655 . . . . 1.26 109.23 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.4 pt20 -130.35 -171.92 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.985 -0.552 . . . . 2.0 110.914 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.9 tttt -60.58 112.99 2.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.039 0.447 . . . . 1.9 110.833 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.02 -2.8 22.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.602 -0.809 . . . . 1.17 112.789 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.58 135.86 33.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.159 0.504 . . . . 1.94 111.095 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.07 135.96 35.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.043 -0.98 . . . . 2.45 110.147 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.61 151.09 27.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.11 0.481 . . . . 1.77 110.983 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.516 ' OG ' HG13 ' A' ' 165' ' ' VAL . 75.2 m -117.1 143.6 45.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.852 -0.613 . . . . 1.86 109.702 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.447 ' CZ ' HD13 ' A' ' 117' ' ' ILE . 30.5 p90 -158.68 173.93 15.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.959 -0.564 . . . . 0.74 109.929 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 124.97 22.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.72 111.261 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.447 HD12 ' CE1' ' A' ' 129' ' ' HIS . 12.6 pt -97.2 151.66 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.348 -0.842 . . . . 1.84 109.621 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 35.3 t70 -173.26 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.055 0.222 . . . . 1.92 110.579 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -73.11 -36.5 66.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.957 0.408 . . . . 2.76 111.395 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -82.36 -16.67 48.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 2.5 111.187 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.36 2.08 13.24 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.021 -0.609 . . . . 1.27 112.814 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -130.18 -178.94 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.793 -0.447 . . . . 4.13 109.793 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.43 108.86 18.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 1.09 111.56 -169.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.552 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.4 156.39 27.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.714 -0.675 . . . . 1.2 109.873 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 64.64 41.1 5.51 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.691 0.619 . . . . 2.15 110.318 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.35 114.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.695 -0.684 . . . . 1.93 110.762 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.24 125.51 45.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.377 -0.374 . . . . 2.63 110.44 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.56 120.14 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 1.23 110.616 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.516 HG13 ' OG ' ' A' ' 150' ' ' SER . 13.6 p -136.37 139.94 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 2.08 111.139 -174.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 139.56 50.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.375 -0.375 . . . . 3.44 110.096 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -136.27 167.27 21.61 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 4.38 109.548 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 116.273 -0.421 . . . . 4.41 110.352 178.395 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 112.227 -0.349 . . . . 11.95 112.227 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.35 115.33 12.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 10.65 110.839 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.42 119.65 0.67 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.752 -0.737 . . . . 8.95 112.128 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -109.99 112.11 23.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.144 -0.317 . . . . 7.44 110.144 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.43 159.02 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.034 -0.53 . . . . 5.59 110.8 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.89 91.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.527 -0.76 . . . . 3.46 110.246 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.52 23.56 72.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.582 -0.735 . . . . 1.76 113.206 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -125.25 122.58 37.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.148 0.499 . . . . 2.13 111.732 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 123.47 41.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.536 -0.756 . . . . 1.8 109.319 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.62 151.06 22.79 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.649 -0.871 . . . . 1.36 108.649 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -132.54 153.25 51.15 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.726 -0.79 . . . . 2.73 110.828 177.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.44 -153.84 6.7 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.607 -1.397 . . . . 0.5 109.607 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.55 140.84 30.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.942 0.401 . . . . 0.75 111.1 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -64.76 108.42 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.487 -0.779 . . . . 1.14 110.501 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.49 9.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.079 0.466 . . . . 1.31 110.812 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.38 122.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 2.16 110.375 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 45.6 ttm -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.87 -0.419 . . . . 1.92 109.87 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 71.5 mmtt -101.66 -167.08 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.212 -0.449 . . . . 2.53 109.992 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' OE2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -83.34 -35.14 25.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 3.24 110.781 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.94 -36.91 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.244 0.461 . . . . 2.03 112.244 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 22.0 p90 -138.82 -170.36 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.791 0.329 . . . . 1.47 111.413 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.1 -169.45 31.6 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.399 -0.68 . . . . 0.76 111.399 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -136.46 142.7 43.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.766 -0.457 . . . . 1.22 109.766 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -114.15 120.58 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.086 -0.507 . . . . 1.15 110.237 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -70.65 119.58 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.976 -0.75 . . . . 2.3 108.976 171.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.436 HG23 ' HB3' ' A' ' 31' ' ' GLU . 7.5 p -62.16 155.67 23.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.247 -0.433 . . . . 1.36 110.274 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.01 -34.37 63.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.154 -0.475 . . . . 2.15 111.539 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 p -99.04 6.71 46.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 2.51 111.46 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 p80 40.18 42.28 1.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.147 0.979 . . . . 4.08 112.112 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -116.62 -16.13 10.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 2.89 110.137 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB3' HG23 ' A' ' 26' ' ' THR . 9.2 tp10 -132.18 148.51 52.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8 110.021 -175.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -109.37 128.66 55.29 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.731 -0.47 . . . . 3.37 109.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.61 116.55 48.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 120.847 0.356 . . . . 1.43 111.052 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -73.73 122.49 22.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.697 . . . . 1.12 110.184 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.69 124.11 40.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.732 -0.667 . . . . 2.46 110.675 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' ND1' ' HB3' ' A' ' 21' ' ' PHE . 5.3 t60 -101.56 142.35 33.05 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.668 -0.864 . . . . 1.4 108.668 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.42 -21.02 62.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.621 -0.432 . . . . 0.82 112.143 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.1 t -61.52 -29.63 70.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 2.03 111.246 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -99.95 17.01 22.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.024 0.44 . . . . 2.09 110.482 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -92.51 129.53 38.42 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.187 -0.46 . . . . 1.39 110.257 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.9 ttp -108.8 91.96 3.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 2.04 110.376 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.05 -130.13 1.83 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.332 -0.849 . . . . 1.05 111.073 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' ND2' ' HD1' ' A' ' 46' ' ' TRP . 36.4 t30 -150.12 111.07 3.28 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.328 . . . . 2.51 110.574 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HA ' HD13 ' A' ' 47' ' ' LEU . 59.5 Cg_endo -72.34 -16.31 27.89 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.859 2.373 . . . . 1.14 113.385 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.96 -16.47 63.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.686 0.279 . . . . 2.29 111.269 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HD1' ' ND2' ' A' ' 43' ' ' ASN . 69.6 m95 -115.04 17.52 16.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.539 . . . . 2.45 111.09 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 44' ' ' PRO . 44.5 mt -96.35 165.5 12.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 1.29 110.129 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -155.0 166.78 32.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.742 -0.663 . . . . 2.35 109.328 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.481 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.6 mm? -69.09 126.28 29.3 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.532 -0.544 . . . . 2.01 109.532 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.82 -0.34 62.71 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.749 -0.738 . . . . 0.82 112.438 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.43 120.42 13.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.007 0.432 . . . . 1.16 110.72 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.541 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 21.9 mt-10 -64.34 122.8 17.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.237 -0.892 . . . . 2.51 110.794 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.9 m -141.53 144.73 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.212 -0.449 . . . . 1.12 109.976 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -116.17 148.13 40.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.758 -0.377 . . . . 1.49 110.274 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -162.92 177.35 9.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.79 112.003 -171.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.69 166.55 16.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 1.49 111.021 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.15 137.68 35.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.55 111.194 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.62 34.65 0.59 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 2.04 111.064 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -88.85 61.18 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.797 0.808 . . . . 5.95 110.073 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -141.69 168.2 20.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.606 -1.179 . . . . 6.03 108.217 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.74 -68.37 3.55 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.881 -0.676 . . . . 4.94 112.608 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -78.93 168.69 19.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.694 0.283 . . . . 6.83 110.576 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 p -67.67 -31.21 71.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.148 -0.478 . . . . 6.81 111.171 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t 68.15 8.18 6.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.327 -0.851 . . . . 5.34 111.606 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.21 -33.01 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 7.41 110.264 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 p -96.55 5.9 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 6.29 110.464 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.32 90.59 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.965 -0.636 . . . . 4.4 111.713 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -60.79 -47.15 87.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.868 0.366 . . . . 4.58 110.62 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.99 139.49 52.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.591 . . . . 2.58 109.556 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.66 153.49 70.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.358 -0.383 . . . . 2.92 110.6 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.8 155.8 52.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.929 2.42 . . . . 1.58 111.901 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.71 169.5 9.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.989 -0.551 . . . . 1.33 110.262 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HG3' HD21 ' A' ' 74' ' ' ASN . 9.9 pt-20 -158.73 172.2 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.768 -0.196 . . . . 2.3 110.607 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.471 HD21 ' HG3' ' A' ' 73' ' ' GLU . 50.2 m-80 60.51 26.6 16.24 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.674 0.609 . . . . 2.67 110.915 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.5 t -70.37 117.66 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.883 -0.599 . . . . 1.46 110.955 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -126.39 157.06 39.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 4.04 110.678 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.452 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.2 mtt -72.4 146.73 46.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.118 -0.492 . . . . 1.5 110.532 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 tp -119.97 131.23 24.49 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.876 -0.787 . . . . 2.27 108.876 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.42 146.13 64.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.001 1.801 . . . . 2.54 111.849 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 19.5 ptpt -59.47 162.83 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 4.95 110.625 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 8.8 t30 77.5 2.95 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.447 0.641 . . . . 3.42 110.919 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -81.05 -27.65 35.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 2.12 109.655 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.13 116.63 66.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.733 -0.84 . . . . 1.37 108.733 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.58 155.09 40.25 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.552 2.168 . . . . 1.17 112.377 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.97 155.03 45.89 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.527 -0.545 . . . . 3.13 109.527 178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.465 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 17.0 Cg_exo -65.67 143.12 73.4 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.27 1.98 . . . . 1.39 111.215 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.62 94.56 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 1.69 111.214 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 t -140.96 130.62 25.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.571 -0.74 . . . . 1.49 109.254 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.87 -60.51 1.84 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.131 0.419 . . . . 3.44 112.131 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 91' ' ' THR . 14.7 pt-20 -90.51 -52.43 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.92 -0.312 . . . . 2.84 111.569 -174.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.8 t 166.1 159.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.613 -0.884 . . . . 2.07 108.613 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.54 -52.02 2.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.196 0.522 . . . . 1.45 110.158 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.99 168.14 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 1.73 110.306 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -125.98 151.55 46.89 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.417 -1.327 . . . . 1.86 107.417 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.18 -173.31 25.45 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.385 -1.388 . . . . 0.54 112.506 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.44 143.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.465 -0.568 . . . . 2.06 109.465 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.24 123.51 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.604 0.24 . . . . 1.31 110.435 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.17 17.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 1.31 112.033 -173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 12.1 ptm180 -154.23 139.8 12.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.606 -0.437 . . . . 4.44 111.869 -176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 4.8 Cg_exo -80.42 167.76 18.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.956 2.437 . . . . 2.49 111.133 170.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mt -118.82 86.68 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.935 -0.306 . . . . 3.85 111.307 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -102.7 -63.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 6.1 111.994 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 23.1 p -71.88 -26.97 62.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.468 -0.787 . . . . 4.3 112.913 -165.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' A' ' 110' ' ' GLU . 49.6 mt -67.67 -33.59 62.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.404 -0.362 . . . . 3.76 111.738 -173.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.411 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 9.2 t30 70.45 134.37 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 123.866 0.728 . . . . 5.3 110.73 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 105' ' ' ASN . 38.2 Cg_endo -64.9 0.78 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.727 2.952 . . . . 4.95 115.517 -171.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.91 -2.25 58.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 3.94 110.92 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 6.5 tp-100 -107.82 142.82 37.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.586 -0.524 . . . . 6.23 109.586 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -58.63 -23.08 58.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.256 0.551 . . . . 5.86 111.271 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.508 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 30.6 tp10 -61.26 -11.98 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.222 -0.899 . . . . 4.95 110.855 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.83 -20.99 25.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.812 0.845 . . . . 3.34 112.122 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.47 -14.53 61.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.407 0.521 . . . . 1.67 112.407 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.3 -178.72 9.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.345 -0.455 . . . . 1.08 113.193 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 130' ' ' GLU . 38.1 mt -152.24 141.01 20.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.292 0.567 . . . . 1.5 111.641 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.3 134.24 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.878 -1.055 . . . . 1.06 109.134 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -86.34 111.04 20.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.67 0.748 . . . . 1.4 109.413 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.503 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 5.4 mm -90.78 121.34 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.168 -0.924 . . . . 1.26 109.041 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.2 pt? -90.32 150.81 21.75 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.569 -0.453 . . . . 1.72 109.966 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.75 165.1 3.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.144 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.439 ' HG2' HD21 ' A' ' 121' ' ' LEU . 2.0 pm0 -65.12 -20.35 66.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 2.78 110.174 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.38 14.28 24.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 2.13 110.277 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 51.02 29.82 4.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.434 1.093 . . . . 4.81 112.118 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -67.53 0.66 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.392 -0.367 . . . . 2.38 111.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 7.3 p -138.24 -171.6 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.578 -0.283 . . . . 2.22 111.175 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 p -92.52 129.88 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.364 -0.606 . . . . 1.84 109.364 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.56 -69.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 1.45 110.629 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.4 m -139.01 -85.97 0.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.147 0.498 . . . . 1.86 110.46 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.5 143.49 0.48 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.873 -1.058 . . . . 2.39 108.596 173.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.452 ' CE1' HD12 ' A' ' 153' ' ' ILE . 33.3 m170 -116.34 124.46 50.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.7 110.335 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -81.94 140.59 33.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.996 . . . . 1.19 109.469 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -115.97 161.01 19.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.195 0.521 . . . . 0.82 111.27 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.43 152.24 17.25 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.813 -0.63 . . . . 0.59 111.663 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.9 tp -55.16 -29.42 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.96 0.409 . . . . 1.25 111.241 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -71.77 -33.7 68.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.451 0.643 . . . . 1.68 110.403 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.461 ' HG ' ' HA ' ' A' ' 160' ' ' ALA . 2.2 m -66.77 -33.11 74.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.287 -0.87 . . . . 1.46 109.983 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 10.9 mp -75.94 57.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.769 -0.65 . . . . 2.06 111.923 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.3 t -46.58 -48.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.239 0.543 . . . . 1.4 110.545 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -93.4 35.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.465 -0.789 . . . . 2.83 110.962 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 9.9 ptpp? -54.36 -23.69 16.53 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.754 1.02 . . . . 1.92 113.754 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -81.44 -6.26 58.76 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.202 -0.311 . . . . 2.83 111.33 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.45 174.93 4.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 1.89 110.471 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -88.94 17.2 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 3.33 110.507 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -46.2 117.73 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.921 -1.036 . . . . 1.26 111.756 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -135.59 -179.94 5.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 2.0 110.675 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.52 129.32 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 1.9 110.026 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.92 64.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.358 -0.925 . . . . 1.17 112.562 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.93 146.12 24.0 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.94 109.575 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.88 134.77 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.181 0.515 . . . . 2.45 111.513 -170.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 m -129.72 148.12 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.836 -0.62 . . . . 1.77 111.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 64.1 m -113.77 140.52 48.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.534 -0.757 . . . . 1.86 109.096 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.503 ' CZ ' HD13 ' A' ' 117' ' ' ILE . 25.7 p90 -151.06 165.75 32.86 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.144 -0.48 . . . . 0.74 109.794 -175.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 -126.91 119.65 27.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.063 -0.655 . . . . 2.72 110.423 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.5 HG21 ' O ' ' A' ' 158' ' ' ARG . 12.6 pt -102.46 149.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 109.184 -0.673 . . . . 1.84 109.184 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 6.4 t70 -160.69 -93.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.995 -0.282 . . . . 1.92 110.564 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.59 -34.82 27.54 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.767 -0.373 . . . . 2.76 111.519 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.2 t -77.63 -17.7 57.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.672 0.272 . . . . 2.5 110.699 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.61 -14.66 3.25 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.994 -0.622 . . . . 1.27 113.968 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 153' ' ' ILE . 11.0 ptm180 -103.41 175.48 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.296 0.548 . . . . 4.13 110.054 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.27 109.84 18.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.142 0.496 . . . . 1.09 110.423 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HA ' ' HG ' ' A' ' 135' ' ' SER . . . -119.67 154.8 33.49 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.464 -0.789 . . . . 1.2 110.354 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 37.6 m 57.82 47.22 15.71 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.932 0.77 . . . . 2.15 111.325 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 151' ' ' PHE . 19.3 m -70.89 128.3 33.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.642 0.734 . . . . 1.93 110.281 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -128.45 125.62 38.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.668 -0.696 . . . . 2.63 109.739 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.43 128.12 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.613 -0.721 . . . . 1.23 110.819 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.22 110.94 29.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.124 0.488 . . . . 2.08 111.468 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 2.8 mpt_? -94.07 126.49 39.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.747 -0.834 . . . . 3.44 108.747 174.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.72 167.59 20.56 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.0 -0.545 . . . . 4.38 110.924 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.578 ' O ' ' HD2' ' A' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 4.41 112.475 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.142 -0.383 . . . . 11.95 112.142 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.57 116.26 9.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.096 0.474 . . . . 10.65 111.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.13 105.3 1.55 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.534 -0.757 . . . . 8.95 111.474 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.0 p -113.07 112.42 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.859 0.361 . . . . 7.44 110.704 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -86.93 169.94 12.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.947 -0.569 . . . . 5.59 110.067 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.91 -21.15 40.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.984 -0.553 . . . . 3.46 110.021 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.84 -29.72 4.49 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.761 -0.654 . . . . 1.76 112.458 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -100.27 118.85 37.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.338 0.59 . . . . 2.13 111.218 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.31 126.56 44.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.857 -1.065 . . . . 1.8 109.229 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -98.55 137.94 36.47 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.38 -0.6 . . . . 1.36 109.38 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 35.0 ttm180 -112.42 143.25 43.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.863 -0.421 . . . . 2.73 109.863 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.27 -170.24 22.74 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.67 -0.776 . . . . 0.5 111.591 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 139.74 42.29 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.662 0.268 . . . . 0.75 110.369 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.94 118.08 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.003 -0.544 . . . . 1.14 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.08 -56.65 2.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.614 0.245 . . . . 1.31 111.002 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.93 160.87 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.154 -0.313 . . . . 2.16 110.154 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.1 ttm -141.61 112.29 7.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.268 -0.424 . . . . 1.92 111.035 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 175.95 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.499 -0.556 . . . . 2.53 109.499 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.75 -34.76 76.4 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.581 0.551 . . . . 3.24 111.539 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -111.13 -47.45 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.205 0.446 . . . . 2.03 112.205 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -130.15 169.39 15.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.162 0.506 . . . . 1.47 111.627 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.72 -174.09 23.56 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.76 111.489 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB3' ' OE1' ' A' ' 32' ' ' GLU . 48.4 m-85 -129.04 154.4 46.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.119 -0.326 . . . . 1.22 110.119 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mt -133.79 122.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.316 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -69.0 119.5 13.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.817 -0.438 . . . . 2.3 109.817 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 p -57.6 141.47 48.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 1.36 109.911 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -50.0 -46.25 52.54 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.536 . . . . 2.15 110.708 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -85.81 18.05 3.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.656 . . . . 2.51 111.65 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 p80 43.13 36.2 0.93 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.128 0.971 . . . . 4.08 111.907 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -70.05 -50.99 35.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.274 -0.875 . . . . 2.89 110.382 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.43 -174.59 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 1.8 110.53 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' OE1' ' HB3' ' A' ' 23' ' ' PHE . 1.1 mm-40 -102.75 145.23 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.974 -0.557 . . . . 3.37 109.976 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.44 120.54 61.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.21 0.528 . . . . 1.43 111.21 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -74.2 116.91 15.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.364 -0.834 . . . . 1.12 110.392 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -121.99 151.18 41.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.281 -0.637 . . . . 2.46 109.281 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.31 128.86 55.75 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.349 -0.611 . . . . 1.4 109.349 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.06 -20.15 65.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 0.82 110.871 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -59.96 -34.83 73.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.555 . . . . 2.03 111.699 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -102.96 -0.54 30.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.028 0.442 . . . . 2.09 110.615 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.412 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 54.6 t80 -72.01 128.66 36.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 1.39 110.213 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.4 ttp -102.21 111.55 23.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.042 0.448 . . . . 2.04 110.239 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 44' ' ' PRO . . . 147.14 -171.87 27.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.687 -0.688 . . . . 1.05 111.429 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.69 105.25 19.66 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.22 -0.289 . . . . 2.51 110.22 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 42' ' ' GLY . 10.0 Cg_exo -66.99 -30.34 39.31 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.469 2.113 . . . . 1.14 112.354 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -70.43 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 2.29 111.19 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.95 7.32 44.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.114 0.483 . . . . 2.45 110.58 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.412 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 20.6 mt -88.16 141.61 28.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.183 0.516 . . . . 1.29 111.306 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -120.92 158.41 27.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.821 . . . . 2.35 109.274 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.78 114.76 12.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.184 -0.672 . . . . 2.01 109.184 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.72 32.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.027 -0.606 . . . . 0.82 112.226 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -65.8 137.39 57.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 1.16 110.67 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.497 ' HG3' HD13 ' A' ' 83' ' ' ILE . 12.9 tt0 -78.63 125.73 29.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.361 -0.836 . . . . 2.51 110.274 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -141.8 155.45 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 1.12 110.176 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.1 148.14 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.968 0.413 . . . . 1.49 110.308 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.487 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -159.34 173.66 15.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.975 -0.557 . . . . 0.79 110.81 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 p -127.96 142.81 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.488 -0.324 . . . . 1.49 110.961 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.53 121.92 20.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 120.881 0.372 . . . . 1.55 110.263 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.21 -30.34 54.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.529 -0.759 . . . . 2.04 111.485 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HD3' HD22 ' A' ' 70' ' ' LEU . 7.5 tpp180 58.44 34.67 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.851 0.834 . . . . 5.95 109.552 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.7 97.1 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.211 -0.904 . . . . 6.03 109.921 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.52 -169.06 32.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.954 -0.641 . . . . 4.94 112.777 -176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 65.13 19.8 11.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 6.83 111.113 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -112.74 -0.75 14.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.408 -0.814 . . . . 6.81 109.871 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 14.1 m -70.24 1.04 5.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.649 -0.705 . . . . 5.34 112.246 -174.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.07 -23.6 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.48 . . . . 7.41 110.824 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 m -120.91 9.66 10.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 6.29 110.853 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 64' ' ' SER . . . 176.09 133.5 1.79 Allowed Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.512 -0.635 . . . . 4.4 111.512 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -61.39 -45.26 95.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.127 0.489 . . . . 4.58 110.659 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.4 m -97.64 144.11 27.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.829 -0.623 . . . . 2.58 110.301 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 59' ' ' ARG . 1.1 pp -88.28 151.93 49.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 2.92 110.865 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.76 150.14 78.9 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.779 2.319 . . . . 1.58 113.357 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.94 147.72 25.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.114 -0.948 . . . . 1.33 109.292 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.98 176.43 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.108 -0.237 . . . . 2.3 110.508 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.41 28.08 15.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.627 0.727 . . . . 2.67 109.756 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.487 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 17.4 t -66.99 119.0 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.808 . . . . 1.46 109.841 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -133.2 140.3 47.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.998 -0.547 . . . . 4.04 111.644 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.435 ' HA ' HG13 ' A' ' 53' ' ' VAL . 41.3 mtt -71.6 149.46 45.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.5 110.485 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -145.9 163.31 31.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 2.27 109.445 170.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 24.7 Cg_exo -64.73 161.88 34.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.1 1.866 . . . . 2.54 112.216 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.45 -169.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 4.95 111.514 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t30 78.74 19.74 0.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.202 -0.908 . . . . 3.42 112.444 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -93.99 -39.27 10.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.199 -0.667 . . . . 2.12 109.199 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.497 HD13 ' HG3' ' A' ' 52' ' ' GLU . 2.3 mp -84.07 119.54 73.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.639 -0.71 . . . . 1.37 110.399 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.09 161.16 32.83 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.462 2.775 . . . . 1.17 112.565 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -93.12 153.97 41.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.414 -0.515 . . . . 3.13 110.188 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.16 164.1 23.7 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.649 2.233 . . . . 1.39 111.265 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.43 91.32 3.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.33 0.586 . . . . 1.69 111.627 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.47 153.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.953 -1.128 . . . . 1.49 107.953 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 -61.42 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.424 -0.511 . . . . 3.44 111.408 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' O ' ' HB ' ' A' ' 91' ' ' THR . 9.4 tp10 -92.17 -56.22 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 2.84 111.242 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t 167.17 165.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.283 -1.006 . . . . 2.07 108.283 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 m -106.79 -54.8 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.578 -0.449 . . . . 1.45 111.111 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -146.7 157.1 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 1.73 110.591 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.89 -179.53 3.72 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.558 -0.904 . . . . 1.86 108.558 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.99 -167.6 40.14 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.731 -1.223 . . . . 0.54 112.237 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.74 142.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.925 -0.768 . . . . 2.06 108.925 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 122.52 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.693 0.283 . . . . 1.31 110.712 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -72.94 -54.22 9.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.31 109.872 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 73.3 ttt180 177.74 130.03 0.2 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.558 0.536 . . . . 4.44 111.8 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.67 130.51 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.149 2.566 . . . . 2.49 110.392 166.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' CD2' ' HA2' ' A' ' 113' ' ' GLY . 0.4 OUTLIER -128.55 102.48 6.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 112.491 0.552 . . . . 3.85 112.491 -172.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -97.55 -36.42 10.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.095 0.474 . . . . 6.1 111.116 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.3 p -92.66 -46.45 7.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.445 0.906 . . . . 4.3 113.445 -169.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.3 pt -68.9 -44.82 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 114.576 1.325 . . . . 3.76 114.576 -164.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -138.75 89.55 13.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.401 -0.52 . . . . 5.3 111.907 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.494 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 95.9 Cg_endo -88.85 -8.16 5.11 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.909 2.406 . . . . 4.95 112.437 175.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.01 7.19 43.6 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.128 -0.487 . . . . 3.94 110.879 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -114.76 142.36 46.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.297 -0.41 . . . . 6.23 110.812 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -47.35 -38.9 13.85 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.762 0.825 . . . . 5.86 112.508 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.09 16.0 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 4.95 112.295 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.494 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 49.1 t80 -47.93 -30.78 4.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.161 0.8 . . . . 3.34 113.161 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.44 -35.53 63.36 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.663 0.616 . . . . 1.67 112.663 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 101' ' ' LEU . . . 124.12 149.03 7.6 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.501 -0.857 . . . . 1.08 111.698 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 130' ' ' GLU . 54.2 mt -131.54 154.4 48.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.384 0.612 . . . . 1.5 111.743 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.84 136.6 53.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.981 -1.009 . . . . 1.06 108.82 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.04 110.72 19.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.574 0.702 . . . . 1.4 109.7 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 129' ' ' HIS . 11.0 mm -85.43 130.42 36.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.829 -1.078 . . . . 1.26 109.996 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.12 146.34 26.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.81 0.338 . . . . 1.72 110.333 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.19 165.06 9.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.29 110.429 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -60.25 -25.56 65.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.787 0.292 . . . . 2.78 111.787 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' C ' ' HD3' ' A' ' 122' ' ' ARG . 0.9 OUTLIER -96.67 13.92 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.906 -0.318 . . . . 2.13 110.604 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HD3' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 39.71 76.67 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.399 1.08 . . . . 4.81 112.318 -175.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.2 p -124.91 -68.55 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.144 -0.934 . . . . 2.38 111.237 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 m -124.17 166.64 15.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 2.22 110.477 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.7 p -73.39 133.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.156 -0.313 . . . . 1.84 110.156 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.48 -69.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.601 -0.272 . . . . 1.45 111.045 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -138.06 -85.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 1.86 110.918 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -175.75 137.09 0.34 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.328 -0.851 . . . . 2.39 108.865 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.511 ' HB2' HD12 ' A' ' 117' ' ' ILE . 35.3 m170 -121.32 133.89 55.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.58 -0.526 . . . . 0.7 109.58 172.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' HD22 ' A' ' 114' ' ' LEU . 12.8 tt0 -90.37 152.87 20.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.589 -0.732 . . . . 1.19 109.884 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -117.97 135.48 54.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.291 0.567 . . . . 0.82 110.838 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.29 151.34 21.42 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.396 -0.82 . . . . 0.59 111.734 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.45 -33.64 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 1.25 110.718 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.7 t -76.29 -30.22 57.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.481 -0.781 . . . . 1.68 110.203 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 162' ' ' VAL . 24.8 m -76.14 -24.18 54.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.753 -0.658 . . . . 1.46 110.159 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.5 mt -71.2 58.26 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.443 -0.798 . . . . 2.06 111.459 176.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.3 t -47.24 -47.13 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.436 0.636 . . . . 1.4 110.403 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 35.6 m-80 -92.38 34.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.563 -0.744 . . . . 2.83 111.622 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 8.9 ptpp? -61.21 -21.3 63.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.675 0.274 . . . . 1.92 111.726 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -89.06 -2.4 58.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 2.83 111.248 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.83 148.76 24.52 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.428 -0.953 . . . . 1.89 108.428 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.95 92.42 3.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.66 0.743 . . . . 3.33 110.077 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.31 105.71 13.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.675 -1.148 . . . . 1.26 110.064 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -128.45 -171.35 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.889 -0.324 . . . . 2.0 111.65 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 56.8 tttm -64.01 110.42 2.13 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.31 -0.405 . . . . 1.9 111.138 -175.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.47 -6.69 20.75 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.486 -0.864 . . . . 1.17 112.386 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.56 142.19 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 1.94 110.898 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.31 140.03 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 2.45 111.221 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.65 153.34 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.77 111.772 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -118.29 144.8 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.763 . . . . 1.86 108.983 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.483 ' HB3' HG13 ' A' ' 162' ' ' VAL . 33.8 p90 -158.47 176.86 11.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.016 0.436 . . . . 0.74 110.767 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -135.21 123.8 23.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 2.72 111.286 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.92 122.7 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.261 -0.881 . . . . 1.84 109.332 167.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 4.9 p-10 -152.9 -94.72 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.109 -0.237 . . . . 1.92 110.835 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.534 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 39.3 mm-40 -82.53 -17.32 45.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 2.76 109.233 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 -19.06 35.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.99 -1.004 . . . . 2.5 111.2 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.1 6.5 10.18 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.954 -0.566 . . . . 1.27 113.99 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.12 -167.51 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.852 -0.795 . . . . 4.13 108.852 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.6 18.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.415 -0.587 . . . . 1.09 109.415 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.43 155.21 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 1.2 111.188 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 70.4 m 58.7 37.89 25.06 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.833 0.708 . . . . 2.15 110.837 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 151' ' ' PHE . 33.1 m -65.02 117.76 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.766 0.793 . . . . 1.93 110.329 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 4.8 p30 -118.1 123.4 45.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.686 -0.688 . . . . 2.63 110.275 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.16 103.42 0.97 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.335 -0.848 . . . . 1.23 110.831 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.74 110.24 20.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.691 0.758 . . . . 2.08 110.86 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 7.5 mpt_? -83.13 114.39 21.29 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.776 -0.824 . . . . 3.44 108.776 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -106.84 167.7 9.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 4.38 110.981 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.884 -1.053 . . . . 4.41 110.376 176.701 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.12 -0.392 . . . . 11.95 112.12 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.92 178.26 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.466 -0.198 . . . . 10.65 110.466 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.63 138.78 27.83 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 8.95 112.415 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 m -140.6 137.28 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.787 -0.449 . . . . 7.44 109.787 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -70.41 118.09 12.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.3 0.572 . . . . 5.59 110.302 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.16 46.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.804 -0.635 . . . . 3.46 111.231 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.89 23.52 71.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 1.76 112.491 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -92.83 119.58 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 2.13 111.392 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.39 122.52 39.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.805 . . . . 1.8 109.163 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.23 137.52 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.12 -0.491 . . . . 1.36 110.005 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.507 HH11 ' CD2' ' A' ' 78' ' ' LEU . 21.6 ttm-85 -106.44 129.54 54.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.384 -0.825 . . . . 2.73 109.963 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.71 -171.33 22.75 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.795 -0.717 . . . . 0.5 111.765 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.7 148.51 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 0.75 111.075 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.41 118.68 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.513 -0.767 . . . . 1.14 110.791 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.85 -37.94 6.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 1.31 111.091 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.542 ' HB ' ' OH ' ' A' ' 111' ' ' TYR . 2.5 p -130.99 122.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.274 0.559 . . . . 2.16 110.861 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.99 106.24 18.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.429 -0.952 . . . . 1.92 108.429 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 14.7 tppt? -98.4 170.8 8.6 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.067 -0.716 . . . . 2.53 109.067 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 62.5 mt-10 -65.98 -38.64 89.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.169 0.433 . . . . 3.24 112.169 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -112.1 -41.32 3.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.088 0.47 . . . . 2.03 111.524 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 42.7 p90 -131.0 -161.53 1.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.052 -0.522 . . . . 1.47 110.195 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.91 -177.57 40.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.97 . . . . 0.76 112.245 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -125.26 130.3 51.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.598 -0.519 . . . . 1.22 109.598 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -102.9 134.08 44.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.267 -0.642 . . . . 1.15 109.267 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.71 143.33 30.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.933 -1.136 . . . . 2.3 107.933 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 p -67.66 -173.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.035 0.445 . . . . 1.36 110.523 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' CD2' HD13 ' A' ' 83' ' ' ILE . 2.3 tm? -81.96 -47.05 13.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.099 0.475 . . . . 2.15 110.658 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -102.68 22.54 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.445 0.535 . . . . 2.51 112.445 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 56.06 58.19 4.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.228 0.537 . . . . 4.08 109.785 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 -44.09 5.85 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.48 -0.782 . . . . 2.89 110.714 -172.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.91 167.34 20.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.04 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.6 127.81 50.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.062 0.458 . . . . 3.37 110.551 -175.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 t -110.27 131.5 61.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 1.43 111.245 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -89.9 123.81 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.566 -0.743 . . . . 1.12 110.081 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -124.06 153.8 40.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.214 -0.662 . . . . 2.46 109.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -116.11 131.96 56.79 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.939 -0.763 . . . . 1.4 108.939 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 25.8 m-85 -58.7 -27.82 65.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.537 0.569 . . . . 0.82 112.537 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.5 m -65.63 -36.5 83.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.541 0.21 . . . . 2.03 111.449 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -83.85 3.76 32.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.939 0.399 . . . . 2.09 110.981 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 64.9 t80 -83.59 140.44 32.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.891 -0.595 . . . . 1.39 110.091 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.5 ttp -116.52 116.43 27.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.122 0.487 . . . . 2.04 110.334 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.05 -151.49 22.9 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.655 . . . . 1.05 111.678 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -105.19 103.55 42.69 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.633 0.254 . . . . 2.51 110.855 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.03 -27.12 25.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.46 2.107 . . . . 1.14 113.119 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.82 1.0 45.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.975 0.416 . . . . 2.29 111.295 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -110.51 14.55 22.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.475 0.655 . . . . 2.45 109.674 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.5 mt -97.61 152.95 18.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.039 -0.982 . . . . 1.29 110.825 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.0 -178.32 6.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.754 -0.657 . . . . 2.35 109.238 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.7 mt -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.783 0.325 . . . . 2.01 111.414 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.0 -1.59 24.23 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.922 -0.656 . . . . 0.82 113.182 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -74.69 122.5 23.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.866 0.333 . . . . 1.16 110.98 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.0 mt-10 -61.59 132.86 54.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.609 -0.723 . . . . 2.51 110.373 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 77' ' ' MET . 25.9 m -140.83 148.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 1.12 110.207 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -114.63 142.71 46.1 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.268 -0.642 . . . . 1.49 109.268 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -162.13 170.82 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.103 0.478 . . . . 0.79 111.559 -175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 p -125.52 167.7 14.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 1.49 111.182 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.13 153.02 28.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 1.55 109.994 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -96.2 -33.54 11.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.358 0.599 . . . . 2.04 110.969 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' CB ' HD21 ' A' ' 70' ' ' LEU . 99.4 mtt180 -91.57 56.34 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.324 -0.853 . . . . 5.95 110.498 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.06 131.36 48.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 6.03 110.215 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.43 154.91 6.45 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.883 -0.887 . . . . 4.94 110.883 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -79.41 74.76 6.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.405 0.621 . . . . 6.83 110.823 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 65' ' ' VAL . 8.8 t -121.12 -0.04 10.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.33 -0.85 . . . . 6.81 110.277 177.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 34.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.626 0.727 . . . . 5.34 110.036 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 63' ' ' THR . 12.9 p -134.44 -24.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.527 -0.76 . . . . 7.41 110.332 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -85.81 -15.53 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 6.29 111.214 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.77 51.73 1.62 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.584 -0.817 . . . . 4.4 111.821 -175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -131.81 86.62 2.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.189 -0.671 . . . . 4.58 109.189 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.93 144.83 17.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.411 -0.813 . . . . 2.58 111.578 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 59' ' ' ARG . 17.9 mt -122.0 138.48 28.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.734 -0.666 . . . . 2.92 110.244 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.68 149.16 37.89 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.445 2.097 . . . . 1.58 111.823 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.48 36.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 1.33 111.116 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 79.8 mm-40 -119.59 143.78 47.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 2.3 110.436 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.5 t30 59.87 80.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 2.67 110.846 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.4 122.68 64.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.075 -0.512 . . . . 1.46 110.075 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.32 147.24 51.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.576 -0.283 . . . . 4.04 110.747 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.425 ' HA ' HG13 ' A' ' 53' ' ' VAL . 64.1 mtt -66.88 150.37 49.28 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.21 0.528 . . . . 1.5 111.467 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' CD2' HH11 ' A' ' 11' ' ' ARG . 19.1 tp -147.6 75.96 11.0 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.114 -0.948 . . . . 2.27 110.771 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -90.24 117.99 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.791 1.661 . . . . 2.54 112.716 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -174.05 6.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.117 0.414 . . . . 4.95 112.117 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 t30 57.7 50.56 10.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.027 0.917 . . . . 3.42 108.866 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.0 t -73.64 -10.44 59.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.554 -1.203 . . . . 2.12 109.937 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.591 HD13 ' CD2' ' A' ' 27' ' ' LEU . 6.2 mm -78.22 128.25 78.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.695 . . . . 1.37 109.469 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.1 159.66 48.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.083 2.522 . . . . 1.17 112.904 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -117.55 149.3 44.65 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.73 -0.668 . . . . 3.13 110.382 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.7 149.27 43.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 1.39 111.906 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.04 94.05 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.54 . . . . 1.69 110.603 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.24 144.37 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.715 -0.846 . . . . 1.49 108.715 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.2 mt -88.22 -64.12 1.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.476 -0.49 . . . . 3.44 111.872 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 91' ' ' THR . 33.5 mt-10 -95.25 -53.82 3.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.357 0.599 . . . . 2.84 110.676 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.2 t 172.0 166.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.769 -1.105 . . . . 2.07 108.114 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -105.66 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.295 -0.562 . . . . 1.45 111.424 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -141.71 171.76 13.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.281 0.562 . . . . 1.73 111.36 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.72 158.09 45.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.018 -1.105 . . . . 1.86 108.018 172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.43 -166.97 28.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.725 -1.226 . . . . 0.54 112.293 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.11 145.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.579 -0.526 . . . . 2.06 109.579 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 84.8 t -60.92 126.73 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.627 -0.26 . . . . 1.31 110.846 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.9 -48.59 17.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.31 -0.405 . . . . 1.31 110.344 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -174.61 143.82 0.86 Allowed Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 121.018 0.437 . . . . 4.44 111.962 175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.22 177.4 7.21 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.17 2.58 . . . . 2.49 110.659 167.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.94 90.14 3.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.291 0.478 . . . . 3.85 112.291 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -98.34 -62.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.362 0.601 . . . . 6.1 110.069 166.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 3.8 p -91.83 10.49 28.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 4.3 111.889 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 47.8 mm -79.38 -22.13 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 3.76 110.48 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 8.8 t-20 73.07 127.65 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 O-C-N 123.817 0.698 . . . . 5.3 111.229 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 -14.74 30.02 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.999 2.466 . . . . 4.95 113.224 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -80.46 -12.3 59.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.382 0.611 . . . . 3.94 109.699 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 6.6 tp-100 -83.06 141.36 32.09 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.609 -0.723 . . . . 6.23 109.385 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.77 1.74 14.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.352 . . . . 5.86 111.532 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 46.3 mt-10 -85.82 12.87 8.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.801 -0.444 . . . . 4.95 109.801 173.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.542 ' OH ' ' HB ' ' A' ' 16' ' ' VAL . 53.5 t80 -55.52 -34.14 64.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 3.34 112.894 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.79 -25.57 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.759 0.314 . . . . 1.67 111.844 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 161.08 36.03 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.499 -0.858 . . . . 1.08 111.508 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.44 141.47 30.84 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.628 0.727 . . . . 1.5 112.405 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.9 mt -114.16 139.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.494 -1.23 . . . . 1.06 108.817 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.46 136.35 33.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.173 -0.611 . . . . 1.4 110.206 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 129' ' ' HIS . 22.0 mm -105.75 131.81 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.803 -0.635 . . . . 1.26 109.541 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.55 150.13 24.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.559 -0.291 . . . . 1.72 110.559 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.42 166.85 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.468 . . . . 2.29 110.109 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.49 -26.89 63.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.78 110.648 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 1.1 mm? -91.3 11.87 22.21 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.163 -0.471 . . . . 2.13 110.632 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 4.2 ptp180 47.05 32.89 2.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.982 0.913 . . . . 4.81 112.537 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 p -95.59 -73.0 0.6 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 2.38 112.018 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -179.68 3.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.585 0.231 . . . . 2.22 111.488 -176.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -91.36 139.45 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.048 -0.523 . . . . 1.84 109.961 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mt -76.1 -69.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.579 -0.448 . . . . 1.45 110.675 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -138.02 -87.22 0.26 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.076 0.465 . . . . 1.86 110.426 168.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.74 146.85 0.46 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.084 -0.962 . . . . 2.39 109.109 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.452 ' HB2' HD13 ' A' ' 117' ' ' ILE . 27.7 m170 -118.8 136.79 53.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.317 0.58 . . . . 0.7 111.119 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.66 143.53 27.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.707 -1.133 . . . . 1.19 109.897 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -120.41 140.44 51.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.221 0.534 . . . . 0.82 110.713 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.29 154.04 22.1 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.616 -0.72 . . . . 0.59 112.187 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -55.38 -22.0 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.469 0.652 . . . . 1.25 111.013 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -79.19 -37.19 38.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.749 -0.659 . . . . 1.68 110.212 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.513 ' O ' HG22 ' A' ' 162' ' ' VAL . 14.5 m -68.61 -33.47 74.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.322 -0.854 . . . . 1.46 110.517 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.62 58.52 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 2.06 111.544 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -48.86 -39.11 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.178 0.514 . . . . 1.4 110.88 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.437 ' ND2' HD22 ' A' ' 143' ' ' LEU . 3.1 p-10 -84.99 33.16 0.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 2.83 111.283 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -61.95 -18.79 61.55 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.123 0.487 . . . . 1.92 111.418 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -76.58 -22.29 54.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 2.83 110.885 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.45 155.15 17.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.829 -0.623 . . . . 1.89 111.933 -169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.403 -0.817 . . . . 3.33 109.505 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' CG1' ' A' ' 149' ' ' VAL . 10.6 tp -145.46 119.52 9.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.644 -0.502 . . . . 1.26 109.644 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.6 pt20 -133.36 -173.23 3.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.839 0.352 . . . . 2.0 111.355 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 54.5 tttm -61.78 114.51 3.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.9 110.499 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.98 -10.34 15.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.856 -0.687 . . . . 1.17 112.256 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.4 133.12 33.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 1.94 110.508 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.9 142.02 28.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.963 -0.562 . . . . 2.45 111.186 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.504 ' CG1' HD23 ' A' ' 143' ' ' LEU . 30.7 m -139.02 158.52 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.315 0.579 . . . . 1.77 111.748 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 8.4 t -115.12 148.01 39.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.339 -0.986 . . . . 1.86 108.339 171.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.55 ' HB3' HG12 ' A' ' 162' ' ' VAL . 18.8 p90 -159.99 163.03 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.74 111.035 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -124.36 121.5 35.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.267 0.556 . . . . 2.72 110.71 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 tt -101.66 133.08 46.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.28 -0.873 . . . . 1.84 110.224 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.557 ' OD2' ' HG2' ' A' ' 155' ' ' GLU . 21.9 t70 -168.08 -88.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.366 -0.134 . . . . 1.92 111.25 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.557 ' HG2' ' OD2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -68.63 -32.27 72.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.866 0.365 . . . . 2.76 111.323 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 p -83.83 -16.38 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.011 -0.54 . . . . 2.5 111.147 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.3 15.05 60.57 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.988 -0.625 . . . . 1.27 112.752 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -151.14 -165.0 2.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.462 . . . . 4.13 109.754 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.29 116.27 24.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 1.09 111.204 -173.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.576 -0.738 . . . . 1.2 109.632 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 55.02 56.31 6.72 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.744 0.653 . . . . 2.15 111.128 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.55 HG12 ' HB3' ' A' ' 151' ' ' PHE . 10.3 m -80.92 146.1 7.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.984 -0.376 . . . . 1.93 109.984 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -148.1 141.6 25.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.907 0.384 . . . . 2.63 110.411 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.24 24.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 1.23 111.095 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.53 127.92 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.413 -0.358 . . . . 2.08 110.518 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? -95.65 114.99 26.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.181 -0.674 . . . . 3.44 109.181 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -98.21 114.5 26.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.084 -0.507 . . . . 4.38 110.715 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.45 -0.796 . . . . 4.41 110.423 -178.292 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 N-CA-C 112.027 -0.429 . . . . 11.95 112.027 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.87 106.28 3.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 10.65 110.673 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.57 14.24 62.12 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.152 -0.547 . . . . 8.95 112.475 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 t -84.48 99.7 10.87 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.319 -0.623 . . . . 7.44 109.319 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.1 122.13 37.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.004 -0.544 . . . . 5.59 111.239 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.92 -23.93 52.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.106 -0.701 . . . . 3.46 109.106 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.86 -29.24 8.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.167 -0.924 . . . . 1.76 113.116 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.85 119.8 40.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.278 0.561 . . . . 2.13 112.138 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.92 118.02 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.178 -1.045 . . . . 1.8 108.178 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -87.43 138.28 31.61 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.948 -0.569 . . . . 1.36 110.162 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -106.56 131.62 53.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.533 -0.758 . . . . 2.73 109.286 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.09 -170.8 20.43 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.874 -0.891 . . . . 0.5 110.874 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.96 148.52 32.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.75 111.724 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.9 115.39 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.355 -0.838 . . . . 1.14 110.642 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.01 -26.92 12.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.873 -0.331 . . . . 1.31 110.891 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.29 140.15 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.687 -0.486 . . . . 2.16 109.687 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.9 tpp -125.43 106.09 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 1.92 110.32 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 63.3 mttt -112.08 172.45 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.284 -0.416 . . . . 2.53 110.99 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.14 -45.58 79.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.903 0.705 . . . . 3.24 112.903 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.02 -43.04 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.343 0.497 . . . . 2.03 112.343 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 43.5 p90 -132.44 168.2 18.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.789 0.328 . . . . 1.47 111.003 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.19 159.93 28.06 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.374 -0.69 . . . . 0.76 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.93 126.87 52.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.574 -0.528 . . . . 1.22 109.574 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.37 124.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.323 -0.621 . . . . 1.15 109.323 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 9.9 tp10 -82.3 133.3 35.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.968 -0.753 . . . . 2.3 108.968 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -62.82 154.69 29.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.358 -0.837 . . . . 1.36 110.648 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -47.66 -42.68 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 2.15 112.568 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -111.8 18.29 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.274 -0.421 . . . . 2.51 111.811 -174.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.547 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 15.6 m-70 57.46 58.78 3.62 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 4.08 110.415 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -96.87 -47.24 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.283 -0.871 . . . . 2.89 110.869 -174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -158.22 -174.39 4.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 1.8 111.009 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -102.29 123.68 46.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 3.37 110.753 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 t -111.82 107.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.933 0.397 . . . . 1.43 110.821 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.24 123.41 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.186 0.517 . . . . 1.12 109.759 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.499 ' CE2' HG23 ' A' ' 75' ' ' VAL . 30.0 t80 -128.13 134.38 49.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 2.46 110.9 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 125.02 47.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.888 -0.782 . . . . 1.4 108.888 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -60.24 -16.75 36.53 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.292 0.478 . . . . 0.82 112.292 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -59.71 -15.48 20.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.25 -0.432 . . . . 2.03 111.715 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -109.43 12.7 24.47 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.665 0.269 . . . . 2.09 111.401 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -82.11 133.42 35.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.722 0.296 . . . . 1.39 110.223 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 ttm -91.97 100.64 13.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.952 0.406 . . . . 2.04 110.613 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.32 -146.02 16.81 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.003 -0.618 . . . . 1.05 112.11 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -112.71 104.74 56.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.689 0.28 . . . . 2.51 110.602 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.82 -5.18 16.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.836 2.358 . . . . 1.14 112.292 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.21 -6.25 46.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.763 -0.653 . . . . 2.29 111.173 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.58 14.0 17.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.45 110.924 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.77 148.78 23.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.005 -0.543 . . . . 1.29 110.579 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -145.0 177.22 8.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.928 -0.578 . . . . 2.35 110.107 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 mm? -72.25 123.29 22.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.533 . . . . 2.01 110.944 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.1 1.59 48.31 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.955 -0.566 . . . . 0.82 112.551 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -79.13 123.74 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.812 0.339 . . . . 1.16 110.657 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.31 140.87 45.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.808 -0.633 . . . . 2.51 111.186 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.82 154.27 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 1.12 110.684 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.87 134.29 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.648 -0.871 . . . . 1.49 108.648 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CB ' HG22 ' A' ' 75' ' ' VAL . 3.5 p90 -164.9 175.89 9.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.527 0.566 . . . . 0.79 112.527 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 p -126.32 173.6 9.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.518 -0.764 . . . . 1.49 111.113 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -108.62 144.72 35.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 1.55 111.019 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.86 37.34 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 2.04 111.439 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -90.39 61.23 4.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.322 -0.622 . . . . 5.95 109.322 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -74.14 -74.14 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.764 . . . . 6.03 110.929 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.52 146.89 9.46 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.876 -0.678 . . . . 4.94 111.42 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 179.92 173.62 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.338 -0.986 . . . . 6.83 108.338 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.9 p -70.29 -27.62 64.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.262 -0.644 . . . . 6.81 109.262 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t 68.45 7.1 5.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 114.714 -1.13 . . . . 5.34 111.216 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.2 m -75.46 -23.64 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.22 0.533 . . . . 7.41 110.079 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 p -104.28 5.2 34.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.564 -0.744 . . . . 6.29 110.902 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.62 101.73 0.2 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.694 -0.765 . . . . 4.4 112.577 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -87.86 -48.82 7.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.056 -0.72 . . . . 4.58 109.056 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.5 133.65 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.36 -0.836 . . . . 2.58 108.775 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.04 150.25 43.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.671 -0.241 . . . . 2.92 110.932 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.4 148.84 84.7 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.571 2.181 . . . . 1.58 111.762 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.04 156.68 20.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 1.33 110.566 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.17 166.53 24.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.696 -0.229 . . . . 2.3 110.807 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 55.55 76.53 0.27 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.892 0.745 . . . . 2.67 110.611 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.513 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.0 t -115.84 120.3 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.72 -0.673 . . . . 1.46 110.664 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -117.26 151.41 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.416 -0.587 . . . . 4.04 109.416 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtm -87.26 143.4 27.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.966 -0.294 . . . . 1.5 110.641 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -130.16 120.04 18.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.345 -0.983 . . . . 2.27 108.345 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.4 116.53 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.431 2.087 . . . . 2.54 116.002 -163.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 5.0 ttpm? 54.59 127.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.319 1.97 . . . . 4.95 116.319 162.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 t30 75.74 30.47 0.77 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.585 -1.189 . . . . 3.42 110.918 167.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 m -94.83 4.5 53.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 2.12 110.886 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.3 mm -108.21 136.16 19.85 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.299 -0.63 . . . . 1.37 109.299 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.49 156.2 67.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.527 2.151 . . . . 1.17 112.003 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.28 146.0 43.6 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.714 -0.221 . . . . 3.13 110.943 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HG3' ' HB3' ' A' ' 160' ' ' ALA . 36.5 Cg_endo -67.37 150.33 80.91 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.998 2.466 . . . . 1.39 112.139 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.34 94.14 6.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.052 0.453 . . . . 1.69 110.61 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.6 t -138.11 134.58 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.829 -0.804 . . . . 1.49 108.829 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 mt -74.83 -65.09 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.582 -0.447 . . . . 3.44 111.928 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 91' ' ' THR . 34.3 mt-10 -96.49 -56.12 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.19 0.519 . . . . 2.84 111.302 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 175.9 160.59 0.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.264 -1.334 . . . . 2.07 107.465 -174.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -101.53 -54.6 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.352 -0.539 . . . . 1.45 110.18 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -138.91 158.52 44.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.791 -0.448 . . . . 1.73 109.791 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -112.92 155.39 24.82 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.901 -1.148 . . . . 1.86 107.901 170.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.72 177.65 38.74 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 119.674 -1.251 . . . . 0.54 112.012 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.46 149.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.605 -0.517 . . . . 2.06 109.605 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.54 123.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.737 0.303 . . . . 1.31 111.276 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.97 4.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 1.31 111.722 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -151.69 120.79 3.44 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.522 -0.308 . . . . 4.44 111.01 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.08 151.44 67.26 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.059 2.506 . . . . 2.49 111.362 172.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 111' ' ' TYR . 1.7 mm? -86.12 89.17 7.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.266 . . . . 3.85 111.203 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -98.79 -63.98 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.355 -0.538 . . . . 6.1 110.814 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.3 p -92.65 10.66 29.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 4.3 111.807 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 105' ' ' ASN . 48.2 mm -83.63 -41.82 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.318 -0.401 . . . . 3.76 111.422 -173.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 111' ' ' TYR . 93.3 m-20 75.05 142.66 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.672 0 O-C-N 123.685 0.616 . . . . 5.3 111.903 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.644 ' HA ' ' CG ' ' A' ' 111' ' ' TYR . 38.4 Cg_endo -67.04 -16.65 49.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.274 2.649 . . . . 4.95 113.464 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -87.44 -5.43 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 3.94 110.786 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.492 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 5.9 tp-100 -87.39 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 6.23 109.656 172.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.05 0.04 22.84 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.786 0.662 . . . . 5.86 112.786 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' A' ' 108' ' ' GLN . 4.2 pt-20 -114.23 15.33 18.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.818 0.818 . . . . 4.95 110.166 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.644 ' CG ' ' HA ' ' A' ' 106' ' ' PRO . 7.7 t80 -66.05 -20.99 66.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.491 -1.231 . . . . 3.34 111.791 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.55 -10.79 55.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.023 -0.271 . . . . 1.67 111.648 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 87.04 157.61 31.18 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.473 -0.87 . . . . 1.08 112.176 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 130' ' ' GLU . 59.7 mt -144.03 135.33 25.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.402 0.62 . . . . 1.5 111.395 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 mt -106.22 138.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.793 -1.094 . . . . 1.06 109.726 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.59 117.15 28.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.593 0.711 . . . . 1.4 110.401 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.496 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 11.2 mm -96.48 132.31 41.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.008 -0.996 . . . . 1.26 109.502 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -86.45 152.79 22.39 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.91 -0.316 . . . . 1.72 110.56 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -59.83 161.39 6.46 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.124 -0.489 . . . . 2.29 111.265 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.41 -23.68 64.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.487 -0.779 . . . . 2.78 111.282 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.38 3.11 54.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.672 -0.24 . . . . 2.13 110.764 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 59.45 88.72 0.07 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.494 0.664 . . . . 4.81 109.759 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -144.5 -77.92 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 2.38 111.378 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 17.0 p -123.83 -166.45 1.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.682 0.277 . . . . 2.22 110.649 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.5 p -95.25 126.2 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.912 -0.585 . . . . 1.84 109.729 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.6 mt -65.31 -69.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 120.719 -0.392 . . . . 1.45 110.883 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -137.91 -85.93 0.28 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 1.86 110.485 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -176.43 139.71 0.35 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.649 -1.16 . . . . 2.39 108.151 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.459 ' HB2' HD11 ' A' ' 117' ' ' ILE . 19.4 m170 -117.88 130.19 56.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.69 -0.804 . . . . 0.7 111.277 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HA ' HD21 ' A' ' 114' ' ' LEU . 16.4 tt0 -85.55 142.67 28.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.476 -1.238 . . . . 1.19 109.435 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.405 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 43.1 p90 -117.91 136.09 53.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.31 0.576 . . . . 0.82 110.363 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.55 150.96 22.89 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.508 -0.769 . . . . 0.59 112.312 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.51 -27.95 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.226 0.536 . . . . 1.25 110.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.9 p -76.22 -39.81 53.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.661 -0.7 . . . . 1.68 111.034 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 15.1 p -82.51 -14.96 54.08 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.803 -0.635 . . . . 1.46 110.943 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -79.5 58.28 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 2.06 110.5 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.8 t -51.45 -35.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.591 . . . . 1.4 110.81 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.454 ' OD1' HD21 ' A' ' 143' ' ' LEU . 6.2 p30 -88.26 21.17 2.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.459 -0.791 . . . . 2.83 111.228 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -54.06 -23.61 14.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.833 0.679 . . . . 1.92 112.833 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -93.04 -1.57 56.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 2.83 111.819 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.17 175.75 9.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.204 -0.453 . . . . 1.89 110.202 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 mt -91.41 29.1 1.53 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.228 0.537 . . . . 3.33 109.828 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.454 HD21 ' OD1' ' A' ' 138' ' ' ASN . 18.9 tp -51.44 115.15 1.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.409 -1.269 . . . . 1.26 112.073 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -122.37 -176.31 3.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 2.0 110.544 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.69 130.96 43.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 1.9 109.612 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.67 43.65 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.662 -0.78 . . . . 1.17 112.196 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.99 134.88 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.678 -0.409 . . . . 1.94 110.218 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 165' ' ' VAL . 92.5 mt -80.19 141.28 35.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 2.45 110.258 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.85 142.81 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.124 -0.489 . . . . 1.77 110.738 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.6 p -100.83 121.81 42.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.784 -0.644 . . . . 1.86 109.455 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.496 ' CZ ' HD13 ' A' ' 117' ' ' ILE . 37.0 p90 -144.06 163.61 33.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.117 -0.492 . . . . 0.74 110.103 -176.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.512 ' NE ' ' HB2' ' A' ' 161' ' ' CYS . 0.9 OUTLIER -137.31 124.2 21.35 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.683 0.754 . . . . 2.72 111.247 176.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.4 tt -99.35 134.63 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.627 -1.17 . . . . 1.84 110.353 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 10.4 t70 -153.32 -97.34 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.515 0.191 . . . . 1.92 111.515 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.0 41.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.373 . . . . 2.76 111.683 -174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -80.58 -16.84 53.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 2.5 110.182 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.43 17.67 62.3 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.007 -0.542 . . . . 1.27 113.255 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.419 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 41.5 mtm180 -145.02 -170.65 3.47 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.994 -0.372 . . . . 4.13 109.994 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.14 124.23 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.402 0.62 . . . . 1.09 111.437 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 86' ' ' PRO . . . -135.64 157.91 45.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.443 -0.799 . . . . 1.2 110.091 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.512 ' HB2' ' NE ' ' A' ' 152' ' ' ARG . 59.4 m 49.27 61.91 2.89 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.772 0.67 . . . . 2.15 109.954 -171.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -90.89 121.83 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 1.93 110.33 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -136.21 132.75 36.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.964 -0.384 . . . . 2.63 109.964 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.33 120.43 9.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 1.23 111.472 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 148' ' ' LEU . 7.1 p -127.02 126.46 68.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 2.08 110.747 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.9 mpt_? -99.91 123.91 44.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.967 -0.383 . . . . 3.44 109.967 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -126.47 166.29 17.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.758 -0.655 . . . . 4.38 109.918 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.763 -0.653 . . . . 4.41 110.38 178.212 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 N-CA-C 112.307 -0.317 . . . . 11.95 112.307 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.92 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.603 0.24 . . . . 10.65 110.993 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.32 55.83 0.42 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.847 -0.692 . . . . 8.95 112.439 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 t -146.64 161.72 39.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.264 -0.643 . . . . 7.44 109.264 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.08 -166.28 0.89 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.829 -0.623 . . . . 5.59 109.384 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.48 -29.18 67.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.8 0.333 . . . . 3.46 111.212 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.36 -20.8 8.04 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.089 -0.577 . . . . 1.76 112.767 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -123.78 130.46 52.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.088 0.471 . . . . 2.13 111.524 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.88 123.38 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 1.8 109.32 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.83 139.76 37.98 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.917 -0.583 . . . . 1.36 109.798 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.426 HH11 ' CD1' ' A' ' 78' ' ' LEU . 37.8 ttm-85 -110.82 148.38 32.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.157 -0.683 . . . . 2.73 109.157 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.39 178.35 46.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.52 -0.847 . . . . 0.5 112.173 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 145.62 48.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.96 0.409 . . . . 0.75 111.17 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -65.96 117.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 1.14 110.419 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' HD22 ' A' ' 49' ' ' LEU . . . -97.9 -42.17 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.078 -0.249 . . . . 1.31 110.914 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 23' ' ' PHE . 2.4 m -124.84 148.63 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 109.949 -0.389 . . . . 2.16 109.949 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.4 mtp -133.79 110.07 9.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.973 -0.38 . . . . 1.92 109.973 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -92.69 170.69 9.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.272 -1.01 . . . . 2.53 108.272 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.66 -16.6 60.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.073 0.463 . . . . 3.24 110.034 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -104.31 -49.27 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.03 111.651 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -147.74 -179.84 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.796 -0.184 . . . . 1.47 110.621 -175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.69 165.28 28.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.275 -0.964 . . . . 0.76 112.389 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HB2' HG23 ' A' ' 16' ' ' VAL . 49.9 m-85 -118.79 128.71 54.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.894 0.378 . . . . 1.22 110.016 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.8 mt -97.77 125.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.956 -0.566 . . . . 1.15 109.493 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 139.16 36.35 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.806 -0.813 . . . . 2.3 108.806 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -66.34 156.87 33.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.176 0.512 . . . . 1.36 111.447 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -63.4 -42.46 98.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.786 -0.643 . . . . 2.15 111.143 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 p -97.2 12.27 33.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.868 0.692 . . . . 2.51 112.868 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 59.68 58.26 2.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.888 0.375 . . . . 4.08 111.332 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.54 -28.14 5.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.243 0.46 . . . . 2.89 112.243 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -169.55 170.61 8.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.953 0.342 . . . . 1.8 110.614 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.16 140.41 37.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.862 0.363 . . . . 3.37 110.349 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 127.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.043 0.449 . . . . 1.43 110.621 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -84.1 121.51 27.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.898 -0.592 . . . . 1.12 110.776 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -128.05 146.97 50.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.732 -0.84 . . . . 2.46 108.732 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.297 -0.631 . . . . 1.4 109.297 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -64.89 -19.58 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.027 0.441 . . . . 0.82 111.043 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.9 t -62.97 -36.58 83.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.599 -0.728 . . . . 2.03 111.08 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.91 16.85 23.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.865 0.364 . . . . 2.09 110.599 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.541 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 74.9 t80 -75.98 135.9 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.517 -0.549 . . . . 1.39 109.517 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.412 ' H ' HG23 ' A' ' 75' ' ' VAL . 60.4 mtp -98.09 105.93 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.264 0.554 . . . . 2.04 110.961 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.32 -134.59 7.77 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.025 -0.989 . . . . 1.05 111.999 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.1 100.83 51.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.339 . . . . 2.51 110.273 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.26 -12.6 21.02 Favored 'Trans proline' 0 N--CA 1.471 0.185 0 C-N-CA 122.976 2.45 . . . . 1.14 113.133 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.17 -13.44 59.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 2.29 110.37 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -102.84 14.63 31.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 2.45 111.359 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -88.67 141.73 28.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.219 -0.446 . . . . 1.29 110.211 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -136.06 170.56 15.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.673 -0.694 . . . . 2.35 109.934 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 15' ' ' ALA . 54.2 mt -74.68 114.59 13.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.01 -0.541 . . . . 2.01 110.488 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.7 26.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.898 -0.668 . . . . 0.82 112.764 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -81.16 116.41 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.048 0.451 . . . . 1.16 111.45 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.53 134.37 54.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.836 -1.075 . . . . 2.51 111.328 176.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 77' ' ' MET . 27.4 m -148.21 141.73 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.674 -0.491 . . . . 1.12 109.674 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HB3' HD13 ' A' ' 78' ' ' LEU . 11.5 pt-20 -114.82 145.17 42.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.506 -0.478 . . . . 1.49 109.922 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 5.7 p90 -166.64 179.71 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.79 111.651 -168.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 p -131.93 170.54 14.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 1.49 110.835 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.79 142.62 35.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.672 0.272 . . . . 1.55 111.157 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.64 70.92 10.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.317 0.579 . . . . 2.04 110.547 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HD2' HD22 ' A' ' 70' ' ' LEU . 2.2 tpm_? -88.56 16.82 6.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.917 0.865 . . . . 5.95 110.02 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -95.09 131.44 41.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.623 -0.717 . . . . 6.03 110.049 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 166.66 12.3 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.547 -0.835 . . . . 4.94 112.87 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -104.9 27.28 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.474 0.654 . . . . 6.83 110.451 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -87.37 12.61 11.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 6.81 111.474 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t -89.26 47.77 1.53 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 5.34 110.49 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.94 -38.18 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 7.41 110.541 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 t -114.99 -30.37 6.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.148 -0.686 . . . . 6.29 109.148 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.78 45.73 48.71 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.573 -0.739 . . . . 4.4 114.546 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -80.94 -62.41 1.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.486 0.643 . . . . 4.58 109.953 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.16 117.6 6.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 2.58 110.784 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' HD2' ' A' ' 59' ' ' ARG . 1.5 pp -99.75 154.45 37.25 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.479 -0.782 . . . . 2.92 110.011 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.18 146.55 95.96 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.536 2.158 . . . . 1.58 112.457 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.83 146.5 23.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.696 -0.684 . . . . 1.33 111.043 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.58 176.48 5.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 2.3 110.937 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.5 32.41 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.635 0.731 . . . . 2.67 110.797 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 4.2 m -73.74 116.62 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.79 . . . . 1.46 111.693 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -123.27 144.66 49.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 4.04 110.302 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.541 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 50.8 mtt -74.07 147.06 43.16 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.097 0.475 . . . . 1.5 111.395 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 54' ' ' GLU . 75.7 mt -119.43 157.2 52.14 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.518 -0.765 . . . . 2.27 110.951 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.5 169.95 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.627 2.218 . . . . 2.54 111.847 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -78.08 175.16 10.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.0 -0.545 . . . . 4.95 111.297 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.03 3.04 4.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.307 -0.861 . . . . 3.42 112.234 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.0 m -71.92 -25.73 62.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.476 -0.329 . . . . 2.12 110.62 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.43 ' CD1' HD21 ' A' ' 27' ' ' LEU . 11.0 mm -105.99 120.99 47.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 1.37 109.954 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.19 158.99 17.74 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.007 2.471 . . . . 1.17 113.523 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -125.87 165.19 28.59 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.608 -0.724 . . . . 3.13 109.899 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 7.4 Cg_exo -69.47 156.16 64.86 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.668 2.246 . . . . 1.39 111.92 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.51 93.6 4.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.917 0.389 . . . . 1.69 111.373 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 t -141.88 92.29 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.771 -0.455 . . . . 1.49 109.771 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.82 -37.85 76.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.788 0.328 . . . . 3.44 110.718 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.14 -26.06 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 2.84 110.8 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.7 m 70.45 113.05 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.831 . . . . 2.07 111.23 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 t -93.66 -24.11 18.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.025 0.75 . . . . 1.45 113.025 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -138.84 160.87 38.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.909 0.862 . . . . 1.73 112.748 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -140.15 155.49 46.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.952 -1.476 . . . . 1.86 107.186 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.3 -165.69 23.03 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.33 -1.414 . . . . 0.54 112.762 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.85 146.7 24.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.807 -0.442 . . . . 2.06 109.807 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.11 122.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.382 -0.372 . . . . 1.31 110.8 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.3 -67.99 0.75 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.893 -0.594 . . . . 1.31 111.667 -175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -157.34 124.53 2.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 4.44 111.818 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.34 158.64 44.49 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.72 2.28 . . . . 2.49 110.699 169.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 111' ' ' TYR . 2.0 pt? -79.53 88.12 5.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.988 0.899 . . . . 3.85 111.758 -174.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -98.31 -63.33 1.14 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.538 -0.755 . . . . 6.1 109.82 169.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.2 p -92.07 -7.79 47.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.688 -0.687 . . . . 4.3 111.454 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 101' ' ' LEU . 91.8 mt -67.76 -42.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 3.76 111.603 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 71.8 151.5 0.14 Allowed Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.294 0.637 . . . . 5.3 111.25 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -13.1 33.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 4.95 111.891 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.79 -20.54 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.621 -0.718 . . . . 3.94 110.266 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -85.34 152.83 22.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.745 -0.661 . . . . 6.23 109.581 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -70.2 -11.15 60.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.124 0.488 . . . . 5.86 111.19 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.58 16.92 5.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.319 0.581 . . . . 4.95 110.836 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.54 ' O ' HD11 ' A' ' 101' ' ' LEU . 22.8 t80 -50.35 -36.2 31.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 3.34 113.77 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 130' ' ' GLU . . . -72.82 -29.04 62.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.152 0.427 . . . . 1.67 112.152 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.39 158.16 16.28 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.078 -0.809 . . . . 1.08 111.078 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.35 147.41 34.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.028 0.914 . . . . 1.5 113.258 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.45 142.65 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.473 -1.239 . . . . 1.06 110.152 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.12 117.41 25.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 129' ' ' HIS . 8.6 mm -103.72 124.08 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 1.26 110.391 -174.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -97.91 153.47 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.229 -0.656 . . . . 1.72 109.229 175.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.07 177.43 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.274 0.559 . . . . 2.29 111.454 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.85 -25.71 67.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.417 -0.81 . . . . 2.78 111.851 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -94.23 -2.15 52.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.39 -0.596 . . . . 2.13 109.39 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.47 29.14 18.78 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.115 -0.948 . . . . 4.81 110.646 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.8 p -86.1 -38.17 18.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.903 0.334 . . . . 2.38 111.903 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -143.14 166.35 24.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.261 0.553 . . . . 2.22 112.042 -174.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.17 132.37 33.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.186 -0.915 . . . . 1.84 108.68 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -75.82 -71.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.017 -0.673 . . . . 1.45 111.242 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -142.56 -87.29 0.15 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.651 0.738 . . . . 1.86 110.427 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -178.11 133.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.03 -1.441 . . . . 2.39 107.984 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.503 ' HB2' HD13 ' A' ' 117' ' ' ILE . 35.6 m170 -109.21 132.77 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.264 -0.574 . . . . 0.7 110.792 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 23.9 tt0 -83.8 147.65 27.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.512 -0.767 . . . . 1.19 110.643 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -119.27 151.21 38.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 0.82 110.709 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.13 150.38 16.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.59 112.194 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -57.09 -26.96 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.217 0.532 . . . . 1.25 111.21 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.7 p -73.85 -32.49 63.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.751 -0.659 . . . . 1.68 110.469 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 14.7 m -87.64 -13.9 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 1.46 110.635 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -73.1 59.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.587 -0.733 . . . . 2.06 111.644 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.9 t -48.94 -42.46 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.247 0.546 . . . . 1.4 110.618 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 20.4 m120 -88.36 33.88 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.615 . . . . 2.83 111.727 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -62.32 -19.2 63.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.205 0.526 . . . . 1.92 110.9 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -81.66 -21.45 38.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 2.83 111.896 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.26 169.05 18.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.665 0.745 . . . . 1.89 112.788 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -85.66 27.94 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.631 -1.168 . . . . 3.33 110.509 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 113.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.492 -0.777 . . . . 1.26 111.146 -174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -128.83 -175.08 3.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.786 . . . . 2.0 110.207 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.27 136.22 49.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.075 -0.343 . . . . 1.9 110.075 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.69 -6.62 74.07 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.839 -0.696 . . . . 1.17 112.679 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.44 141.52 28.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.022 -0.671 . . . . 1.94 109.933 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.8 144.09 32.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.779 -0.646 . . . . 2.45 110.981 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 147.59 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.562 -0.745 . . . . 1.77 111.159 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 33.2 t -110.46 146.04 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 1.86 109.898 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -165.96 174.76 9.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.74 110.018 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 127.45 11.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.04 0.448 . . . . 2.72 111.217 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.434 HD11 ' CE1' ' A' ' 129' ' ' HIS . 8.7 pt -95.84 144.72 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.675 -0.693 . . . . 1.84 109.282 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 5.2 t70 -166.51 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.065 0.228 . . . . 1.92 111.103 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -82.41 -29.24 30.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.448 -0.501 . . . . 2.76 111.843 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.539 ' OG ' ' HG3' ' A' ' 86' ' ' PRO . 59.3 p -84.78 -17.01 39.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.742 0.306 . . . . 2.5 111.529 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.1 25.75 60.24 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.036 -0.602 . . . . 1.27 112.294 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -152.61 178.04 10.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.719 -0.474 . . . . 4.13 109.719 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.27 110.42 19.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 1.09 111.115 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.28 164.33 21.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.585 -0.734 . . . . 1.2 110.647 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.3 m 60.98 32.12 19.93 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.82 0.7 . . . . 2.15 111.336 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 150' ' ' SER . 10.0 m -64.35 122.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.529 0.68 . . . . 1.93 111.283 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.582 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 6.7 p30 -131.32 125.08 31.83 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.269 -0.878 . . . . 2.63 109.413 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.96 133.06 54.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 1.23 111.189 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 83.6 t -118.23 121.16 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.724 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -91.38 138.9 31.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.963 -0.755 . . . . 3.44 108.963 170.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -120.43 149.38 42.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.358 0.599 . . . . 4.38 111.221 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 115.447 -0.797 . . . . 4.41 109.928 172.697 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.161 -0.376 . . . . 11.95 112.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.21 127.33 37.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.558 0.218 . . . . 10.65 110.684 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.35 -78.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.684 -0.566 . . . . 8.95 111.684 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 137.27 7.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.895 -0.409 . . . . 7.44 109.895 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -85.29 172.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.849 0.357 . . . . 5.59 110.242 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 8' ' ' GLN . . . -81.57 -17.88 46.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.886 -0.597 . . . . 3.46 111.596 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.99 -29.42 1.59 Allowed Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.288 -0.415 . . . . 1.76 112.787 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 6' ' ' ALA . 17.6 mm-40 -127.21 126.26 42.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.032 0.444 . . . . 2.13 110.772 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.89 120.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.454 -0.794 . . . . 1.8 109.432 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -90.65 158.67 16.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.34 -0.615 . . . . 1.36 109.34 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 30.8 ttm180 -129.1 143.02 50.72 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.307 -0.406 . . . . 2.73 110.485 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.32 -164.88 24.78 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.117 -0.793 . . . . 0.5 111.117 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.87 154.85 39.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.509 . . . . 0.75 111.276 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.6 mm -73.41 110.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 1.14 111.284 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.52 -49.98 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.101 0.477 . . . . 1.31 110.823 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.15 123.56 69.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.93 -0.577 . . . . 2.16 110.475 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.0 ttm -119.03 109.11 15.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.835 -0.62 . . . . 1.92 109.574 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 5.9 tppt? -98.23 -163.44 1.04 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.234 -1.024 . . . . 2.53 108.234 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 9.0 pt-20 -79.43 -39.13 33.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.13 0.419 . . . . 3.24 112.13 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -111.92 -35.06 5.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.008 0.432 . . . . 2.03 112.109 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -134.01 178.04 7.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.509 -0.314 . . . . 1.47 110.951 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.39 171.67 36.65 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.045 -0.598 . . . . 0.76 111.703 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -115.93 127.45 54.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.95 0.405 . . . . 1.22 110.085 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -98.28 127.33 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 1.15 110.976 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.5 117.81 22.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.653 -0.869 . . . . 2.3 108.653 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.7 p -68.94 156.41 38.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 1.36 111.818 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.7 OUTLIER -56.48 -47.25 79.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.533 -0.758 . . . . 2.15 110.976 -178.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.77 9.51 27.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.18 -0.463 . . . . 2.51 111.755 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p80 39.28 37.71 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.449 1.1 . . . . 4.08 112.599 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HA ' ' NE2' ' A' ' 109' ' ' GLN . 5.7 t70 -98.91 -17.6 18.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 2.89 110.105 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.84 155.39 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.139 -0.937 . . . . 1.8 110.591 -166.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.188 -0.671 . . . . 3.37 109.188 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -108.95 108.56 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.784 -0.366 . . . . 1.43 110.1 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -68.58 121.22 15.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 1.12 109.723 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' A' ' 75' ' ' VAL . 23.3 t80 -121.28 128.35 52.27 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.066 -0.515 . . . . 2.46 110.827 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 122.99 41.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.521 -0.918 . . . . 1.4 108.521 174.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -62.18 -16.48 53.29 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.097 0.406 . . . . 0.82 112.097 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -57.14 -29.49 63.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.996 -0.547 . . . . 2.03 111.628 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -103.29 24.04 11.54 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.849 0.357 . . . . 2.09 111.638 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 77.6 t80 -86.22 139.06 31.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 1.39 110.768 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.4 ttm -96.77 97.09 9.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.098 0.475 . . . . 2.04 110.333 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.95 -136.25 8.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.768 -0.729 . . . . 1.05 112.066 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.5 104.94 33.7 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.25 -0.278 . . . . 2.51 110.25 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -17.36 27.0 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.215 . . . . 1.14 112.226 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -74.35 -8.1 55.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.923 -0.58 . . . . 2.29 110.459 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -107.06 10.5 30.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.728 -0.669 . . . . 2.45 110.597 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.9 142.29 27.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 1.29 110.306 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -116.1 161.95 18.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.464 -0.789 . . . . 2.35 109.969 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.78 120.22 19.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.59 -0.522 . . . . 2.01 109.59 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.34 3.9 59.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.964 -0.636 . . . . 0.82 112.01 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.09 129.09 38.91 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.956 0.408 . . . . 1.16 110.823 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -71.41 126.5 29.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.386 -0.825 . . . . 2.51 110.637 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.51 157.74 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.242 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -128.81 150.8 50.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.367 -0.605 . . . . 1.49 109.367 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.511 ' CB ' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -164.0 175.68 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.947 0.721 . . . . 0.79 112.947 -166.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -136.85 166.51 23.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.16 -0.927 . . . . 1.49 109.732 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.5 mt -94.71 147.51 23.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.003 0.43 . . . . 1.55 111.342 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.86 26.62 1.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.04 110.798 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -88.0 61.25 6.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.622 0.725 . . . . 5.95 110.056 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.005 -0.998 . . . . 6.03 110.074 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.41 -171.99 31.33 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.559 -0.617 . . . . 4.94 111.559 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -72.0 113.43 9.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.824 0.345 . . . . 6.83 110.281 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.4 m -141.78 -82.96 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 6.81 110.778 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 15.5 t -91.45 12.83 19.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.438 0.637 . . . . 5.34 110.317 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.59 -20.45 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.57 . . . . 7.41 111.018 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -81.71 -8.7 59.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.966 -0.561 . . . . 6.29 110.731 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.14 -66.67 0.92 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.887 -0.673 . . . . 4.4 111.714 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -166.72 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 4.58 110.274 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.96 171.95 17.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 2.58 110.191 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 1.1 pp -125.97 154.4 73.81 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.227 -0.442 . . . . 2.92 110.242 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.76 158.7 52.61 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.47 2.113 . . . . 1.58 113.057 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.55 155.5 19.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.618 -0.719 . . . . 1.33 110.378 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -134.84 164.26 27.97 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.513 -0.312 . . . . 2.3 111.03 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 62.12 29.27 17.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.488 -0.778 . . . . 2.67 111.095 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' A' ' 55' ' ' TYR . 39.3 t -73.9 122.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.945 -0.571 . . . . 1.46 110.843 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -126.46 156.91 39.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 4.04 110.442 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.429 ' HA ' HG13 ' A' ' 53' ' ' VAL . 61.9 mtt -72.3 143.24 48.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.5 110.814 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.86 143.33 27.36 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.0 -1.0 . . . . 2.27 109.178 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 135.33 69.86 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.768 1.645 . . . . 2.54 111.788 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 6.4 ttpm? -60.58 149.61 34.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.689 -0.687 . . . . 4.95 111.378 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 77.88 26.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.34 -0.845 . . . . 3.42 110.55 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.8 m -88.37 -30.66 19.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.24 -1.022 . . . . 2.12 108.24 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.25 123.54 73.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.318 -1.31 . . . . 1.37 108.868 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.48 158.17 48.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.816 2.344 . . . . 1.17 113.649 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.63 155.95 46.77 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.709 -0.678 . . . . 3.13 110.575 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 57.0 Cg_endo -69.16 133.94 27.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.729 2.286 . . . . 1.39 112.87 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.05 94.64 8.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 1.69 110.334 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.466 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 3.0 t -137.22 156.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.928 -1.138 . . . . 1.49 107.928 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.18 -64.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.131 -0.627 . . . . 3.44 111.195 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' THR . 78.7 mm-40 -95.06 -57.18 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.576 -0.45 . . . . 2.84 112.062 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -179.98 156.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 2.07 109.902 -171.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 153' ' ' ILE . 2.9 m -106.12 -54.24 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.968 0.413 . . . . 1.45 110.219 173.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -143.94 177.56 8.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.357 0.599 . . . . 1.73 110.931 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -145.25 168.37 20.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.323 -1.362 . . . . 1.86 107.323 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.8 -170.38 43.31 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.636 -1.269 . . . . 0.54 112.647 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.62 146.65 26.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.6 -0.519 . . . . 2.06 109.6 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.72 120.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.036 -0.357 . . . . 1.31 110.036 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -74.17 -65.54 0.83 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.055 -0.521 . . . . 1.31 111.391 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -169.51 109.39 0.48 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 4.44 110.349 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.56 122.58 7.02 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.687 2.258 . . . . 2.49 110.874 173.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -102.39 115.73 31.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 3.85 111.091 -176.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -98.51 -64.71 1.01 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 6.1 110.666 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.84 -7.35 40.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.727 -0.669 . . . . 4.3 112.397 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.36 -42.52 90.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.472 0.545 . . . . 3.76 112.472 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -170.73 103.53 0.41 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.473 -0.195 . . . . 5.3 110.473 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.45 -7.37 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.195 2.596 . . . . 4.95 112.801 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.74 23.98 9.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 3.94 110.554 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -128.04 163.85 23.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.797 -0.445 . . . . 6.23 109.797 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.476 ' NE2' ' HA ' ' A' ' 30' ' ' ASP . 39.6 tt0 -74.52 -28.71 61.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.623 0.249 . . . . 5.86 111.523 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.81 15.27 0.68 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.282 -0.417 . . . . 4.95 111.939 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 101' ' ' LEU . 63.0 t80 -48.9 -32.2 8.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.252 -0.886 . . . . 3.34 113.137 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.65 63.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.856 0.688 . . . . 1.67 112.856 -170.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.65 162.26 13.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.382 -0.913 . . . . 1.08 111.695 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 130' ' ' GLU . 18.3 mt -143.41 147.24 34.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 1.5 112.015 -171.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -107.3 141.14 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.089 -0.96 . . . . 1.06 109.289 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' A' ' 98' ' ' ALA . 8.0 pt-20 -88.86 113.18 24.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.542 0.686 . . . . 1.4 110.109 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 129' ' ' HIS . 6.7 mm -94.3 127.98 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.033 -0.985 . . . . 1.26 109.703 -174.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -85.84 159.61 19.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.162 -0.31 . . . . 1.72 110.162 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.84 164.04 8.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.623 . . . . 2.29 110.345 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.442 ' HG2' HD23 ' A' ' 121' ' ' LEU . 1.5 pm0 -68.31 -17.71 64.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.471 . . . . 2.78 109.744 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 1.0 OUTLIER -96.07 -17.19 21.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.612 -0.722 . . . . 2.13 110.462 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 20.9 ttm180 71.2 99.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.836 0.71 . . . . 4.81 111.653 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.0 t -154.75 -41.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.992 -0.283 . . . . 2.38 111.111 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 6.6 p -147.44 -171.95 3.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.742 0.306 . . . . 2.22 111.419 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.46 136.4 24.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.039 -0.528 . . . . 1.84 109.756 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.15 -69.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.67 -0.412 . . . . 1.45 110.925 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -138.61 -84.8 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.466 0.65 . . . . 1.86 110.841 171.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -175.33 141.25 0.53 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.877 -1.056 . . . . 2.39 108.726 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.495 ' HB2' HD13 ' A' ' 117' ' ' ILE . 32.7 m170 -116.46 133.57 55.86 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.67 -0.412 . . . . 0.7 110.161 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.431 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.2 tt0 -86.61 146.29 26.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.682 -0.69 . . . . 1.19 109.656 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -117.02 146.63 42.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.889 0.376 . . . . 0.82 110.155 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -108.83 150.05 17.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.757 -0.735 . . . . 0.59 111.744 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.73 -22.49 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.029 0.442 . . . . 1.25 111.369 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.2 p -73.23 -37.19 66.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.439 . . . . 1.68 110.682 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 11.2 p -90.65 -8.84 48.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.116 -0.493 . . . . 1.46 111.733 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.428 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 54.1 mt -73.45 59.97 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 2.06 111.225 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t -42.34 -47.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.287 0.477 . . . . 1.4 112.287 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.436 HD22 HD23 ' A' ' 143' ' ' LEU . 4.5 p-10 -93.15 34.36 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.737 0.273 . . . . 2.83 111.737 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -59.65 -14.81 15.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.274 0.472 . . . . 1.92 112.274 -176.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -79.86 -16.41 55.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 2.83 110.727 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.81 151.0 20.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.607 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.68 93.11 3.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.416 0.627 . . . . 3.33 110.076 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 HD22 ' A' ' 138' ' ' ASN . 11.7 tp -100.24 116.98 33.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.159 -0.928 . . . . 1.26 109.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.36 -176.35 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.335 0.588 . . . . 2.0 111.782 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 58.0 tttm -65.47 126.14 27.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.981 -1.009 . . . . 1.9 110.117 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 103.71 -1.57 45.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.448 -0.882 . . . . 1.17 113.133 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -91.69 141.35 28.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.094 0.447 . . . . 1.94 111.04 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.51 139.4 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 2.45 111.278 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.07 153.51 29.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.211 0.529 . . . . 1.77 111.073 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 22.9 t -112.72 142.34 45.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.771 -0.826 . . . . 1.86 108.771 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 27.1 p90 -158.45 158.21 33.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.74 110.354 -175.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.466 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 63.2 mtt180 -125.33 120.82 32.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.04 -0.355 . . . . 2.72 110.04 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.49 ' O ' HG22 ' A' ' 92' ' ' THR . 5.3 tt -102.29 120.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.072 -0.513 . . . . 1.84 110.794 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -159.75 -87.54 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.708 0.289 . . . . 1.92 110.478 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 6.0 mm-40 -75.07 -20.84 59.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.661 . . . . 2.76 109.822 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.8 p -83.79 -18.24 38.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.232 -0.895 . . . . 2.5 111.249 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.91 5.46 7.47 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.943 -0.571 . . . . 1.27 113.526 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -153.42 -164.12 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 4.13 108.426 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.1 109.14 17.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.407 0.622 . . . . 1.09 111.119 -172.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.558 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -120.18 165.16 15.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.26 -0.882 . . . . 1.2 109.944 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 73.7 m 59.02 36.37 24.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.995 0.426 . . . . 2.15 110.613 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 150' ' ' SER . 42.2 t -73.38 110.67 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 1.93 110.648 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.38 129.39 44.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.875 -0.602 . . . . 2.63 110.25 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 102.66 0.97 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.896 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.93 137.6 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.177 -0.465 . . . . 2.08 110.394 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 140.29 45.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.452 -0.34 . . . . 3.44 110.386 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 101.36 2.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.062 -0.718 . . . . 4.38 109.062 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.434 0 CA-C-N 116.061 -0.518 . . . . 4.41 111.046 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.162 -0.375 . . . . 11.95 112.162 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.64 41.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.409 -0.219 . . . . 10.65 110.409 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.23 -88.06 1.58 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.064 -0.589 . . . . 8.95 112.344 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -155.96 107.12 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.146 -0.316 . . . . 7.44 110.146 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -104.23 172.32 6.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.621 -0.511 . . . . 5.59 109.621 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.05 -17.31 47.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 3.46 111.312 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.42 18.11 67.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.047 -0.597 . . . . 1.76 112.148 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 11.4 mm-40 -130.52 119.8 23.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.322 0.582 . . . . 2.13 111.316 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.29 114.5 30.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.11 -0.95 . . . . 1.8 108.868 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.93 138.22 31.71 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.057 -0.72 . . . . 1.36 109.057 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -129.04 151.52 49.64 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.439 -0.504 . . . . 2.73 110.385 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.25 -158.95 9.39 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.509 -1.036 . . . . 0.5 110.509 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 139.08 44.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.833 0.349 . . . . 0.75 110.629 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.6 mm -64.3 114.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 1.14 110.948 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -40.05 3.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.463 -0.335 . . . . 1.31 111.249 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.5 t -116.92 123.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.615 0.245 . . . . 2.16 110.713 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.5 mtp -123.21 108.14 12.48 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.05 -0.722 . . . . 1.92 109.05 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -106.76 -165.31 1.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.625 -0.509 . . . . 2.53 109.625 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.502 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 34.3 tt0 -76.24 -46.98 25.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 3.24 111.337 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -101.35 -32.67 10.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.466 . . . . 2.03 111.379 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -148.93 -169.82 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.4 -0.364 . . . . 1.47 111.18 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.37 -176.79 30.82 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.012 -0.613 . . . . 0.76 111.984 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -131.54 140.31 49.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 1.22 110.442 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.0 131.03 67.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.504 -0.771 . . . . 1.15 109.989 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' OE1' HG23 ' A' ' 133' ' ' ILE . 46.4 mt-10 -70.77 130.39 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.073 -0.714 . . . . 2.3 109.073 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.59 139.53 58.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.761 -0.459 . . . . 1.36 109.761 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.7 tp -52.22 -36.84 53.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 2.15 111.476 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.4 t -108.35 22.75 15.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 2.51 110.93 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 43.47 51.63 6.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.822 0.849 . . . . 4.08 111.856 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.95 -50.27 6.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.666 -1.152 . . . . 2.89 110.397 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.81 -173.04 3.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 1.8 110.576 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -101.53 129.65 47.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.895 0.379 . . . . 3.37 110.9 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.36 122.66 58.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.875 -0.602 . . . . 1.43 110.923 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.07 120.12 33.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 1.12 110.089 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.32 152.71 38.63 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.381 -0.599 . . . . 2.46 109.381 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -111.61 134.17 53.37 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.493 -0.558 . . . . 1.4 109.493 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 24.7 m-85 -63.91 -27.16 68.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.333 0.494 . . . . 0.82 112.333 -175.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -68.24 -36.42 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.783 0.325 . . . . 2.03 110.766 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -87.52 7.46 29.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.225 0.536 . . . . 2.09 110.894 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.492 ' OH ' ' HE1' ' A' ' 77' ' ' MET . 18.0 t80 -84.64 137.31 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.668 -0.697 . . . . 1.39 110.381 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttm -104.52 110.72 23.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 2.04 110.969 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.5 -138.01 6.58 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.842 -0.617 . . . . 1.05 111.787 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.34 101.96 14.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.955 -0.387 . . . . 2.51 109.955 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 -14.43 30.68 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.509 2.14 . . . . 1.14 112.294 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.74 -18.61 63.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.751 -0.659 . . . . 2.29 110.274 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -109.5 9.09 25.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 2.45 110.952 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.465 ' CD2' ' HE2' ' A' ' 77' ' ' MET . 13.3 mt -83.3 145.55 29.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 1.29 111.473 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -141.04 160.81 39.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.489 -0.778 . . . . 2.35 109.507 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.59 115.01 4.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.879 -0.6 . . . . 2.01 110.882 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.66 0.05 15.58 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.82 113.21 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -75.64 120.22 20.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.922 0.391 . . . . 1.16 110.638 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.83 128.44 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.474 -0.784 . . . . 2.51 109.858 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.79 144.4 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.707 -0.224 . . . . 1.12 110.904 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -118.19 149.18 41.51 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 1.49 109.809 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.601 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 20.6 p90 -168.57 179.67 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.051 0.453 . . . . 0.79 111.554 -173.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -133.95 141.9 47.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.575 . . . . 1.49 110.695 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.4 mt -72.52 156.39 39.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.357 -0.383 . . . . 1.55 111.14 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.99 -92.93 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 2.04 110.559 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 55.35 60.2 3.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.548 -0.751 . . . . 5.95 110.608 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -79.86 99.58 7.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.178 -0.919 . . . . 6.03 110.321 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.35 -170.11 15.35 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.6 -0.727 . . . . 4.94 112.199 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -93.58 35.45 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.544 0.688 . . . . 6.83 110.069 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.7 p -80.67 10.26 5.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.246 -0.888 . . . . 6.81 111.913 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 m -71.77 -2.32 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 5.34 111.723 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.91 -24.16 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.82 -0.627 . . . . 7.41 110.937 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -116.87 -9.54 11.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 6.29 110.713 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.34 86.3 0.41 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.746 -0.74 . . . . 4.4 111.91 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.92 -45.32 93.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 4.58 110.061 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -127.69 125.45 40.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.794 -0.639 . . . . 2.58 109.573 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.6 162.81 42.61 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.293 -0.412 . . . . 2.92 110.819 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.85 152.38 80.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.858 2.372 . . . . 1.58 113.689 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -106.75 124.05 49.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.916 -1.038 . . . . 1.33 109.742 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.36 173.15 6.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.3 111.113 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 60.94 34.44 19.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.942 -0.572 . . . . 2.67 111.394 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 29.6 t -69.18 115.09 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.181 0.515 . . . . 1.46 111.181 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -119.36 146.55 45.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.199 -0.91 . . . . 4.04 111.151 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.492 ' HE1' ' OH ' ' A' ' 40' ' ' TYR . 63.0 mtt -78.91 139.09 38.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.566 -0.901 . . . . 1.5 108.566 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.1 pt? -131.87 161.98 59.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.638 -0.504 . . . . 2.27 109.638 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 10.8 Cg_endo -53.89 132.45 49.73 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.54 112.721 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 2.9 ttmp? -69.94 163.96 24.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.93 -1.032 . . . . 4.95 111.306 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 78.16 34.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.294 -0.866 . . . . 3.42 111.472 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -94.59 -16.9 22.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 2.12 109.057 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 27' ' ' LEU . 6.5 mm -73.07 135.66 79.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.297 -0.865 . . . . 1.37 109.854 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.81 159.65 50.05 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.496 2.131 . . . . 1.17 112.548 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -124.95 150.12 65.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.291 -0.413 . . . . 3.13 110.048 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.42 130.01 37.79 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.555 2.17 . . . . 1.39 111.578 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.95 90.99 5.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.472 0.653 . . . . 1.69 110.624 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.47 136.6 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.494 -0.928 . . . . 1.49 108.494 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.84 -60.95 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.552 -0.459 . . . . 3.44 112.009 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.0 tp10 -90.95 -54.47 3.95 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.875 -0.33 . . . . 2.84 110.81 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 169.16 155.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.187 -0.671 . . . . 2.07 109.187 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 -58.44 1.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 1.45 110.997 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -139.03 147.87 42.66 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.512 -0.313 . . . . 1.73 110.569 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.427 ' O ' HD21 ' A' ' 118' ' ' LEU . 8.7 p30 -108.05 125.51 51.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.41 -0.959 . . . . 1.86 108.41 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -133.1 -175.52 14.0 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.056 -1.069 . . . . 0.54 112.321 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.1 t -135.39 146.05 30.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.777 -0.453 . . . . 2.06 109.777 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG23 ' HG ' ' A' ' 143' ' ' LEU . 97.6 t -62.01 121.03 9.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 1.31 110.828 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.29 -53.22 17.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.277 -0.42 . . . . 1.31 111.871 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -172.85 154.51 2.84 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.677 -0.238 . . . . 4.44 111.089 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.69 172.24 16.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.062 2.508 . . . . 2.49 112.39 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -106.99 88.31 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.25 0.548 . . . . 3.85 111.767 -177.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -100.21 -63.32 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.111 0.482 . . . . 6.1 112.028 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.02 9.41 33.36 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.965 -0.561 . . . . 4.3 111.208 -173.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASN . 1.9 mp -81.63 -27.88 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.426 . . . . 3.76 111.762 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 111' ' ' TYR . 78.1 m-20 75.52 156.18 0.16 Allowed Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 123.228 0.611 . . . . 5.3 110.213 -173.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.503 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 72.3 Cg_endo -91.23 -0.2 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.32 2.014 . . . . 4.95 113.673 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.28 -5.74 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 3.94 111.389 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.545 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 67.4 mt-30 -93.67 165.36 12.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 6.23 110.813 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.47 -30.58 61.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.511 -0.551 . . . . 5.86 109.511 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' OE2' ' HB3' ' A' ' 108' ' ' GLN . 2.4 pm0 -68.2 -4.42 13.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.554 -0.748 . . . . 4.95 111.54 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.566 ' O ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.57 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.988 -0.551 . . . . 3.34 111.022 176.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.36 73.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 1.67 110.807 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.09 145.96 11.43 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.459 -1.057 . . . . 1.08 110.459 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.12 138.83 50.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.69 0.757 . . . . 1.5 111.983 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.53 135.05 47.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.512 -1.222 . . . . 1.06 109.272 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.41 125.97 35.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4 110.263 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.1 mm -101.69 138.09 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.571 -0.741 . . . . 1.26 110.35 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.77 154.14 21.8 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.401 0.438 . . . . 1.72 110.016 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.94 -175.88 5.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.873 0.368 . . . . 2.29 110.365 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.59 -18.36 64.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.652 0.612 . . . . 2.78 112.652 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.19 -0.12 19.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.984 -0.286 . . . . 2.13 110.854 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.405 ' HB2' HD13 ' A' ' 118' ' ' LEU . 31.2 ttm-85 56.57 70.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 4.81 109.777 -172.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -118.69 -48.29 2.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.876 -0.602 . . . . 2.38 109.962 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -142.35 169.74 17.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.553 -0.749 . . . . 2.22 111.131 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.5 p -81.14 135.06 25.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.375 -0.602 . . . . 1.84 109.375 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.5 mt -71.12 -70.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.554 -0.458 . . . . 1.45 110.824 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -138.59 -85.45 0.26 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.04 0.447 . . . . 1.86 110.971 170.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -177.16 143.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.329 -0.85 . . . . 2.39 109.065 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.503 ' CE1' HD12 ' A' ' 153' ' ' ILE . 26.8 m170 -119.58 132.83 55.81 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.7 111.233 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -95.69 144.01 26.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.033 -0.985 . . . . 1.19 109.454 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -117.92 136.69 53.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.82 111.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.29 152.63 22.85 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.605 -0.725 . . . . 0.59 112.292 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.519 HG23 ' OE1' ' A' ' 25' ' ' GLU . 10.6 tp -55.71 -34.66 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.482 0.549 . . . . 1.25 112.482 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -78.32 -22.48 48.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.382 0.61 . . . . 1.68 110.545 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 3.5 m -89.21 -19.73 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.66 -0.7 . . . . 1.46 110.21 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -79.05 60.07 2.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.327 -0.851 . . . . 2.06 111.268 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.0 t -43.73 -41.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.241 0.544 . . . . 1.4 111.347 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.4 m120 -87.91 32.58 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.948 -0.569 . . . . 2.83 111.38 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -59.99 -26.97 66.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.355 0.598 . . . . 1.92 110.524 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -88.84 -13.8 38.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.193 -0.912 . . . . 2.83 111.392 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.97 175.1 8.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.077 -0.965 . . . . 1.89 111.294 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.73 16.51 17.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.991 -0.744 . . . . 3.33 108.991 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HG ' HG23 ' A' ' 97' ' ' VAL . 25.4 tp -43.6 107.53 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.188 -1.369 . . . . 1.26 111.448 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.59 -178.51 3.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.841 -0.618 . . . . 2.0 110.733 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -63.85 135.3 56.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 1.9 110.291 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.85 -7.31 67.59 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.365 -0.921 . . . . 1.17 112.931 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.19 146.42 23.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.205 -0.598 . . . . 1.94 109.585 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.56 140.77 29.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.684 -0.689 . . . . 2.45 110.768 -172.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.42 144.87 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 115.139 -0.937 . . . . 1.77 110.731 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.9 m -111.58 143.6 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.146 -0.479 . . . . 1.86 109.878 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 162' ' ' VAL . 7.0 p90 -157.14 166.6 32.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.146 -0.479 . . . . 0.74 110.116 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -119.22 119.61 34.61 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.003 -0.679 . . . . 2.72 109.517 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.503 HD12 ' CE1' ' A' ' 129' ' ' HIS . 3.7 tt -103.78 138.41 28.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.419 -0.586 . . . . 1.84 109.419 167.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.82 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.799 -0.36 . . . . 1.92 111.153 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -38.39 22.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.853 0.686 . . . . 2.76 112.853 -173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.9 t -81.45 -16.82 50.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.842 0.312 . . . . 2.5 111.842 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.15 71.76 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.428 -0.892 . . . . 1.27 112.519 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -133.27 -178.23 4.88 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.083 -0.339 . . . . 4.13 110.083 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.99 108.43 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 1.09 110.377 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -125.33 161.79 26.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.177 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.35 39.86 11.8 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 123.59 0.556 . . . . 2.15 110.045 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 151' ' ' PHE . 15.5 m -69.58 125.08 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 1.93 111.059 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 46.2 t30 -125.74 117.52 23.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.603 -0.726 . . . . 2.63 109.483 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.08 102.67 1.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 1.23 110.43 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.58 130.12 49.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.86 -0.609 . . . . 2.08 110.794 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.56 115.33 27.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.854 -0.612 . . . . 3.44 110.458 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.78 167.91 20.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.568 -0.742 . . . . 4.38 109.215 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 120.934 0.397 . . . . 4.41 110.93 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.945 -0.462 . . . . 11.95 111.945 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.55 99.16 6.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 10.65 110.489 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 74.18 1.89 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.781 -0.723 . . . . 8.95 112.649 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -112.37 99.26 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.599 0.238 . . . . 7.44 110.642 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -124.99 124.1 41.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.598 -0.519 . . . . 5.59 109.598 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 8' ' ' GLN . . . -82.17 -39.8 22.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.341 -0.39 . . . . 3.46 110.981 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.14 -29.72 1.88 Allowed Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 116.142 -0.481 . . . . 1.76 112.759 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 6' ' ' ALA . 2.8 mm100 -119.87 116.86 26.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 2.13 111.171 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.25 116.01 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.436 -0.802 . . . . 1.8 109.13 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -89.09 138.17 31.66 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.822 -0.626 . . . . 1.36 109.564 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 39.9 ttm180 -116.19 132.37 56.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.616 -0.72 . . . . 2.73 109.462 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.73 -157.23 7.81 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.879 -0.677 . . . . 0.5 111.415 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CE2' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -146.04 152.92 40.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.989 0.423 . . . . 0.75 110.949 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.0 mm -71.68 114.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.691 -0.686 . . . . 1.14 110.287 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.83 -42.0 4.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.676 0.274 . . . . 1.31 111.45 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.19 123.12 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.453 . . . . 2.16 111.139 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.5 mtt -113.44 116.07 29.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.5 -0.773 . . . . 1.92 109.931 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 -177.8 3.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 2.53 108.444 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.19 -45.62 72.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.882 0.327 . . . . 3.24 111.882 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -110.92 -18.21 13.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.964 0.357 . . . . 2.03 111.964 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -153.73 -173.34 4.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.251 -0.278 . . . . 1.47 110.251 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.81 -169.99 30.14 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.718 -0.753 . . . . 0.76 111.496 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -130.18 130.54 44.84 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.959 -0.386 . . . . 1.22 109.959 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.445 HG13 ' CD1' ' A' ' 35' ' ' PHE . 63.9 mt -90.22 124.03 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.471 -0.566 . . . . 1.15 109.471 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.14 125.17 28.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 2.3 109.482 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.3 p -65.37 144.11 57.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.942 -0.392 . . . . 1.36 109.942 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -52.93 -46.31 68.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.057 0.456 . . . . 2.15 110.946 -174.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 t -92.94 6.57 47.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.105 -0.498 . . . . 2.51 111.542 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 54.46 56.95 6.25 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.013 0.911 . . . . 4.08 109.6 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.39 -33.4 7.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.683 -1.144 . . . . 2.89 110.759 -172.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -142.77 166.49 24.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.283 -0.417 . . . . 1.8 110.911 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.49 126.91 50.92 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.625 -0.879 . . . . 3.37 108.625 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.49 115.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 1.43 111.492 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -81.21 120.27 24.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.343 -0.844 . . . . 1.12 110.473 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.445 ' CD1' HG13 ' A' ' 24' ' ' ILE . 3.9 p90 -123.21 151.23 42.45 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -120.36 131.76 54.98 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.083 -0.71 . . . . 1.4 109.083 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -60.33 -24.73 65.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.537 0.569 . . . . 0.82 112.537 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -71.32 -12.2 61.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.668 0.27 . . . . 2.03 111.136 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -109.8 0.48 18.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.09 110.512 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.47 127.05 34.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.569 . . . . 1.39 109.998 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.0 ttp -101.02 97.77 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.186 0.517 . . . . 2.04 110.597 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.46 -160.34 30.14 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.619 -0.719 . . . . 1.05 111.331 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -102.98 102.94 30.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.805 0.302 . . . . 2.51 110.193 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.44 -24.05 9.47 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.45 2.1 . . . . 1.14 113.633 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.33 -4.28 50.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.531 0.205 . . . . 2.29 111.5 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -113.23 19.64 16.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.386 0.612 . . . . 2.45 110.704 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 mt -95.04 159.92 14.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.223 -0.899 . . . . 1.29 108.976 172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.13 164.88 28.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.821 -0.437 . . . . 2.35 109.821 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.32 113.28 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.28 0.562 . . . . 2.01 110.017 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.28 27.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.862 -0.685 . . . . 0.82 112.643 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.416 HE21 ' N ' ' A' ' 52' ' ' GLU . 28.2 tp60 -77.3 124.75 28.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.328 . . . . 1.16 110.41 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.416 ' N ' HE21 ' A' ' 51' ' ' GLN . 16.4 mp0 -67.97 126.8 30.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.312 -0.858 . . . . 2.51 111.257 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.2 m -142.9 149.86 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.036 -0.529 . . . . 1.12 109.925 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.02 156.28 42.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.24 -0.288 . . . . 1.49 110.401 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 2.4 p90 -170.16 179.42 3.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.877 0.37 . . . . 0.79 111.292 -169.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.4 p -120.8 172.3 7.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 1.49 110.683 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.67 146.12 49.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.55 111.528 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.0 80.85 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 2.04 110.091 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -130.85 19.44 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 5.95 110.68 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.35 -45.69 7.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.657 -0.702 . . . . 6.03 111.664 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.15 20.73 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.478 -0.868 . . . . 4.94 111.788 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -74.41 80.93 1.9 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 6.83 110.491 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -127.58 -5.0 5.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.403 -0.817 . . . . 6.81 109.495 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.5 m -83.76 28.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.481 -0.781 . . . . 5.34 111.372 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.66 -29.66 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.23 0.538 . . . . 7.41 110.206 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -121.2 -7.37 9.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.482 -0.781 . . . . 6.29 110.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.69 95.74 1.23 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.659 -0.701 . . . . 4.4 111.726 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -49.76 -65.23 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 122.972 0.509 . . . . 4.58 111.604 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 34.4 m -114.66 120.51 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.219 -0.446 . . . . 2.58 110.461 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.544 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -84.78 149.61 54.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.802 -0.635 . . . . 2.92 110.238 177.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.29 150.98 42.71 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.57 2.18 . . . . 1.58 112.236 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.36 129.47 34.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.101 -0.499 . . . . 1.33 109.806 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -116.12 143.33 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.915 0.388 . . . . 2.3 111.123 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.1 70.92 0.58 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.362 -0.836 . . . . 2.67 111.21 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 25.3 t -96.14 125.17 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 1.46 109.821 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -127.89 149.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 4.04 111.13 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 66.8 mtt -79.23 154.17 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.5 109.935 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.3 147.96 32.99 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 2.27 109.658 169.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.93 162.83 27.41 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.54 2.16 . . . . 2.54 112.975 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.27 173.04 5.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 4.95 111.214 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 m120 73.72 3.18 4.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.496 -0.775 . . . . 3.42 110.989 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 m -89.46 -2.39 58.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 2.12 110.351 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 HD12 HD21 ' A' ' 27' ' ' LEU . 30.7 mm -110.72 123.39 35.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.203 -0.666 . . . . 1.37 109.203 176.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.49 139.27 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.048 1.832 . . . . 1.17 111.266 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.83 148.51 43.4 Favored Pre-proline 0 C--N 1.314 -0.941 0 C-N-CA 120.821 -0.352 . . . . 3.13 110.427 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.39 130.73 41.43 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.276 2.651 . . . . 1.39 111.932 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.09 93.0 9.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.188 0.518 . . . . 1.69 110.826 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.39 126.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.535 -0.913 . . . . 1.49 108.535 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -59.96 2.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.547 0.203 . . . . 3.44 111.547 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 91' ' ' THR . 57.5 mm-40 -91.21 -55.04 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.714 -0.394 . . . . 2.84 111.281 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 13.1 t 171.02 159.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 2.07 109.9 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.44 -54.93 2.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 1.45 109.788 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.577 ' CE1' ' HE2' ' A' ' 151' ' ' PHE . 23.7 p80 -162.93 168.23 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.73 109.623 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.38 -177.52 3.15 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.137 -0.32 . . . . 1.86 110.137 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.65 179.1 47.82 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.838 -0.696 . . . . 0.54 111.698 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.59 145.27 32.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.833 -0.432 . . . . 2.06 109.833 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.6 t -58.79 123.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.365 -0.235 . . . . 1.31 110.365 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.28 -65.96 0.82 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.388 -0.369 . . . . 1.31 111.888 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.445 HH21 ' CD ' ' A' ' 110' ' ' GLU . 35.6 ptt180 -157.48 147.55 15.64 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.331 -0.248 . . . . 4.44 110.331 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 7.4 Cg_exo -74.97 154.59 42.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.003 2.469 . . . . 2.49 111.911 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.658 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -107.1 102.66 11.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.924 0.868 . . . . 3.85 111.628 -176.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -97.91 -64.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.735 -0.666 . . . . 6.1 111.068 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.7 m -93.86 9.84 35.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.154 -0.475 . . . . 4.3 111.803 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 101' ' ' LEU . 1.7 mp -68.78 -44.14 82.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.036 0.384 . . . . 3.76 112.036 -172.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.475 HD21 ' HB3' ' A' ' 107' ' ' ASP . 12.1 t30 65.75 138.36 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 122.673 0.389 . . . . 5.3 111.328 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HA ' ' CG ' ' A' ' 111' ' ' TYR . 14.7 Cg_endo -55.97 -12.24 6.84 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 123.911 3.074 . . . . 4.95 114.984 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 105' ' ' ASN . 7.2 t70 -69.23 -29.77 67.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.594 0.712 . . . . 3.94 109.634 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 110' ' ' GLU . 51.5 tp60 -93.01 119.46 32.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.661 -1.237 . . . . 6.23 107.661 168.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.586 ' HG2' ' OE1' ' A' ' 130' ' ' GLU . 1.4 pm0 -63.45 -14.46 50.92 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.213 0.53 . . . . 5.86 111.431 -171.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' HH21 ' A' ' 99' ' ' ARG . 47.1 tt0 -62.42 -11.69 17.33 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.698 -0.683 . . . . 4.95 110.549 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -56.34 -27.44 55.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.642 -0.708 . . . . 3.34 110.835 174.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.71 62.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.034 -0.53 . . . . 1.67 110.96 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 95.96 144.42 16.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.334 -0.46 . . . . 1.08 112.272 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 130' ' ' GLU . 54.5 mt -128.99 145.03 51.35 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.699 0.761 . . . . 1.5 112.148 -174.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.13 137.37 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.413 -1.267 . . . . 1.06 108.532 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.0 pt-20 -90.48 125.07 35.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.489 0.661 . . . . 1.4 110.505 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.457 HG13 ' CG ' ' A' ' 129' ' ' HIS . 44.0 mm -94.97 136.84 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.894 -1.048 . . . . 1.26 110.43 -174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD22 ' H ' ' A' ' 118' ' ' LEU . 2.5 pt? -100.73 144.39 29.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.282 -0.636 . . . . 1.72 109.282 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.63 167.29 9.27 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.104 0.252 . . . . 2.29 111.023 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.2 -29.44 68.71 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.575 0.35 . . . . 2.78 111.528 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.5 6.15 42.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 2.13 110.527 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 69.72 87.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 4.81 111.793 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.6 p -115.8 -159.07 0.7 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.928 -1.033 . . . . 2.38 109.639 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 p -85.84 -161.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.338 -0.392 . . . . 2.22 109.975 170.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.5 p -64.44 120.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 1.84 111.34 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.8 mt -69.1 -67.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 1.45 110.343 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 p -133.28 -86.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.75 -0.38 . . . . 1.86 111.335 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -178.1 129.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.685 . . . . 2.39 109.654 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.457 ' CG ' HG13 ' A' ' 117' ' ' ILE . 13.4 m170 -116.19 129.72 56.44 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.7 110.246 176.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.586 ' OE1' ' HG2' ' A' ' 109' ' ' GLN . 10.4 tt0 -96.77 149.69 21.55 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.071 -0.968 . . . . 1.19 109.958 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 31.0 p90 -117.87 177.11 4.9 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.67 -0.412 . . . . 0.82 110.709 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -134.93 152.98 20.92 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.912 -0.585 . . . . 0.59 111.848 -176.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -52.86 -28.76 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.887 0.375 . . . . 1.25 111.897 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.0 p -77.53 -33.19 54.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.409 0.623 . . . . 1.68 110.436 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 47.9 t -72.03 -27.38 62.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.107 -0.951 . . . . 1.46 110.311 177.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.08 59.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.393 -0.821 . . . . 2.06 112.506 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -48.61 -41.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.234 0.54 . . . . 1.4 110.257 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.3 m120 -87.86 32.65 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.759 -0.655 . . . . 2.83 111.414 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -60.59 -21.66 62.88 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.156 0.503 . . . . 1.92 111.264 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -93.14 -6.28 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 2.83 111.371 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -88.51 158.06 18.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.76 -0.654 . . . . 1.89 111.188 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.4 mm? -81.36 49.06 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 3.33 110.43 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -76.4 122.84 25.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.603 -0.726 . . . . 1.26 109.937 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.441 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 11.7 pt20 -123.94 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.657 . . . . 2.0 111.732 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.39 121.79 15.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.907 -1.042 . . . . 1.9 109.905 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.33 1.81 44.31 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.322 -0.942 . . . . 1.17 112.53 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.441 ' OD1' ' HG2' ' A' ' 144' ' ' GLN . 13.3 m-20 -91.07 140.13 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.743 0.272 . . . . 1.94 110.393 173.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.78 138.99 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.918 0.39 . . . . 2.45 110.862 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 164' ' ' ALA . 15.6 m -135.97 146.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 1.77 110.823 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.3 p -104.67 133.38 49.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.505 -0.554 . . . . 1.86 109.505 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' HE2' ' CE1' ' A' ' 93' ' ' HIS . 5.5 p90 -146.42 163.57 35.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.116 0.26 . . . . 0.74 110.7 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 1.4 mpp_? -118.54 121.7 40.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.147 0.499 . . . . 2.72 110.194 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.423 HG23 ' NE2' ' A' ' 93' ' ' HIS . 12.9 tt -100.41 136.95 29.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.696 . . . . 1.84 109.788 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -169.61 -93.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.568 -0.16 . . . . 1.92 110.568 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.52 -19.97 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.826 0.346 . . . . 2.76 111.254 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.3 t -81.66 -17.01 49.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.927 -0.397 . . . . 2.5 109.927 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.32 23.22 57.54 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.791 -0.64 . . . . 1.27 113.51 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 11.4 ptp180 -156.93 -168.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.451 -0.574 . . . . 4.13 109.451 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.6 108.3 17.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.897 0.379 . . . . 1.09 110.319 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.12 144.85 44.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.154 -0.475 . . . . 1.2 111.368 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.9 m 66.17 43.6 2.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.633 -0.712 . . . . 2.15 110.352 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.07 118.7 7.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.622 0.725 . . . . 1.93 110.786 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.42 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.1 t-20 -120.86 124.4 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.48 -0.782 . . . . 2.63 109.882 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 149' ' ' VAL . . . -64.07 112.96 3.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 1.23 111.041 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.86 129.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.944 -0.571 . . . . 2.08 111.021 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -98.47 116.78 31.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 3.44 110.061 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.01 148.59 51.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.184 0.516 . . . . 4.38 110.437 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 51.0 tttp . . . . . 0 N--CA 1.435 -1.196 0 CA-C-N 115.387 -0.824 . . . . 4.41 111.229 -178.148 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.96 -0.456 . . . . 11.95 111.96 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.21 -178.46 5.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.891 -0.411 . . . . 10.65 109.891 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.62 30.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.601 -0.809 . . . . 8.95 111.8 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -82.74 54.69 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.536 0.684 . . . . 7.44 110.657 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.78 78.98 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.464 -0.789 . . . . 5.59 110.964 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.93 -14.95 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.927 -0.579 . . . . 3.46 110.524 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -29.77 3.77 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.932 -0.576 . . . . 1.76 112.445 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -129.54 128.41 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.96 0.409 . . . . 2.13 110.788 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.45 114.65 25.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.631 . . . . 1.8 109.459 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.34 159.31 15.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.501 -0.772 . . . . 1.36 109.267 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' HG3' HD13 ' A' ' 27' ' ' LEU . 6.8 ptp180 -141.05 147.42 38.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.757 -0.46 . . . . 2.73 109.757 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.09 -169.77 22.06 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.172 -0.771 . . . . 0.5 111.172 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.19 140.26 52.69 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.785 0.326 . . . . 0.75 110.468 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.21 116.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.642 -0.708 . . . . 1.14 110.613 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.28 -48.55 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 1.31 111.355 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -114.45 124.03 70.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.676 0.274 . . . . 2.16 110.649 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.5 ttm -126.94 105.55 8.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.272 -0.422 . . . . 1.92 110.197 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -97.94 -161.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.715 -0.476 . . . . 2.53 109.715 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -50.63 38.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 3.24 111.912 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.4 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 50.8 m-80 -112.24 -34.47 5.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 2.03 111.571 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -124.82 173.74 8.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.15 -0.477 . . . . 1.47 110.709 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.32 165.74 35.56 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 111.076 -0.81 . . . . 0.76 111.076 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.44 126.64 54.53 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.183 0.516 . . . . 1.22 109.791 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -95.7 130.23 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.696 -0.853 . . . . 1.15 108.696 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -80.16 128.75 33.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.534 -0.913 . . . . 2.3 108.534 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.6 p -63.34 149.73 45.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.745 -0.661 . . . . 1.36 110.829 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 83' ' ' ILE . 11.4 tp -54.93 -34.12 62.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.305 0.574 . . . . 2.15 111.828 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -110.36 22.46 15.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 2.51 111.431 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 31.4 p80 43.63 45.73 5.9 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.016 0.912 . . . . 4.08 111.369 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.71 -44.72 9.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.919 -1.037 . . . . 2.89 111.337 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.82 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 1.8 112.07 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.21 121.75 46.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.53 -0.759 . . . . 3.37 110.367 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.19 127.32 64.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 1.43 111.536 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -91.83 120.62 32.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.95 -0.568 . . . . 1.12 110.053 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 75' ' ' VAL . 23.9 t80 -128.45 138.08 52.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.275 -0.42 . . . . 2.46 110.089 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.4 ' NE2' ' HB3' ' A' ' 20' ' ' ASN . 3.3 t60 -107.6 124.29 49.73 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.174 -0.676 . . . . 1.4 109.174 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -63.18 -18.04 63.06 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.626 0.602 . . . . 0.82 112.626 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 -31.5 68.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.679 0.276 . . . . 2.03 110.841 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.05 5.95 46.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.982 0.42 . . . . 2.09 111.4 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.539 ' CZ ' HD12 ' A' ' 47' ' ' LEU . 47.4 t80 -75.34 132.09 40.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.313 -0.403 . . . . 1.39 110.047 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.3 ttp -114.63 91.06 3.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.959 0.409 . . . . 2.04 110.08 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.68 -136.65 4.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.987 -0.845 . . . . 1.05 110.987 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -121.25 96.6 48.04 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 117.023 0.411 . . . . 2.51 110.681 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.39 -22.94 12.03 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.791 2.328 . . . . 1.14 113.013 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -81.66 -5.91 58.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.295 0.569 . . . . 2.29 110.476 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -112.47 18.04 18.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.88 -0.6 . . . . 2.45 110.414 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.539 HD12 ' CZ ' ' A' ' 40' ' ' TYR . 49.2 mt -92.32 143.72 26.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.841 -0.618 . . . . 1.29 110.716 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.0 157.96 42.73 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.993 -0.743 . . . . 2.35 108.993 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.496 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.7 mm? -60.84 134.43 57.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.966 0.412 . . . . 2.01 110.511 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.29 -15.55 50.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.716 -0.754 . . . . 0.82 113.032 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -66.0 133.32 50.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.997 0.427 . . . . 1.16 111.434 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 1.8 mp0 -81.36 137.39 35.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.889 . . . . 2.51 110.763 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 77' ' ' MET . 23.6 m -144.3 151.54 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 1.12 109.843 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' HD22 ' A' ' 78' ' ' LEU . 23.9 pt-20 -112.0 144.69 40.93 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.978 -0.378 . . . . 1.49 109.978 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -161.49 170.71 19.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.79 111.856 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -120.45 143.79 48.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.433 -0.803 . . . . 1.49 111.049 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.42 143.28 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 1.55 110.875 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.37 76.93 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.512 . . . . 2.04 110.018 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -91.12 57.68 3.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 5.95 109.614 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -64.35 133.38 52.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 6.03 110.279 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.89 76.77 1.56 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.956 -0.566 . . . . 4.94 113.425 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -90.28 -163.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 6.83 109.361 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 t -68.13 -22.13 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.09 -0.244 . . . . 6.81 110.749 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.4 m 64.96 16.36 10.5 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.101 0.778 . . . . 5.34 113.101 169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.25 -26.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 7.41 111.373 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -107.72 -4.32 18.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.008 0.433 . . . . 6.29 110.386 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.41 79.52 1.77 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.865 -0.683 . . . . 4.4 112.432 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -66.36 -44.09 84.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.865 0.364 . . . . 4.58 110.888 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -135.85 136.39 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 2.58 110.321 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.3 146.09 33.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.978 -0.555 . . . . 2.92 109.886 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.53 165.72 31.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.331 2.021 . . . . 1.58 111.808 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.12 141.06 40.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.508 -0.315 . . . . 1.33 110.419 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.22 152.22 43.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 2.3 110.186 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.29 84.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.729 0.643 . . . . 2.67 111.511 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 35' ' ' PHE . 45.6 t -110.94 124.62 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.146 -0.479 . . . . 1.46 110.003 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -118.25 153.42 33.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.802 -0.635 . . . . 4.04 109.792 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.421 ' HA ' HG11 ' A' ' 53' ' ' VAL . 65.1 mtp -97.86 119.46 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.7 -0.227 . . . . 1.5 110.783 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -122.56 104.09 37.26 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-O 121.804 0.812 . . . . 2.27 111.401 176.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -88.95 129.49 2.04 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.27 1.98 . . . . 2.54 112.868 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.5 tttp 79.05 133.13 0.06 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.073 1.138 . . . . 4.95 114.073 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.3 t30 68.96 3.23 3.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.444 -1.253 . . . . 3.42 112.891 167.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -78.14 -25.93 47.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.2 -0.6 . . . . 2.12 109.439 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 27' ' ' LEU . 1.8 mm -108.33 128.21 26.09 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.392 -0.966 . . . . 1.37 108.392 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.16 152.08 50.16 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.297 1.998 . . . . 1.17 112.461 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -103.66 142.49 24.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 3.13 109.597 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.73 128.13 21.39 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.297 1.998 . . . . 1.39 111.977 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.26 95.0 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 1.69 111.502 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -137.54 135.01 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.113 -0.699 . . . . 1.49 109.113 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' C ' HD21 ' A' ' 89' ' ' LEU . 5.2 tt -85.18 -62.0 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.659 -0.416 . . . . 3.44 111.265 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -93.0 -56.93 2.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.534 0.568 . . . . 2.84 112.534 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m 169.12 140.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.866 -1.161 . . . . 2.07 107.866 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -93.21 -55.34 3.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.174 -0.61 . . . . 1.45 110.638 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -145.96 148.29 32.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 1.73 110.987 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -110.7 161.54 15.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.706 -1.22 . . . . 1.86 107.706 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.28 -176.88 41.38 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.429 -1.367 . . . . 0.54 112.838 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.56 146.69 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.828 -0.434 . . . . 2.06 109.828 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.5 t -58.79 119.47 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.316 -0.402 . . . . 1.31 110.575 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.554 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -74.4 -37.49 63.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 1.31 111.192 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -177.66 131.46 0.33 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 4.44 110.563 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 144' ' ' GLN . 17.0 Cg_exo -70.96 169.29 20.79 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.437 2.091 . . . . 2.49 111.501 169.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.502 HD21 ' H ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -106.76 90.24 3.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.262 0.554 . . . . 3.85 111.629 -175.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -98.17 -62.99 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 6.1 110.212 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 m -91.71 5.21 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 4.3 111.19 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.26 -44.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.413 -0.358 . . . . 3.76 110.443 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 6.2 t30 67.89 153.23 0.13 Allowed Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.7 0.625 . . . . 5.3 111.515 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 105' ' ' ASN . 32.8 Cg_endo -65.36 -12.27 34.1 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.551 2.167 . . . . 4.95 112.764 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.75 1.72 25.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 3.94 111.329 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -117.46 149.56 40.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.79 0.328 . . . . 6.23 110.422 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -71.28 -0.25 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 5.86 111.773 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -103.8 13.09 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.271 0.558 . . . . 4.95 110.096 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.473 ' O ' HD11 ' A' ' 101' ' ' LEU . 10.4 t80 -57.3 -35.1 69.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.041 -0.981 . . . . 3.34 112.428 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.54 -22.96 64.47 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.049 0.389 . . . . 1.67 112.049 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.3 163.33 30.63 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.664 -0.779 . . . . 1.08 111.984 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.4 mt -143.45 150.71 39.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 1.5 111.876 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.5 mt -116.3 136.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.981 -1.009 . . . . 1.06 109.748 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.57 114.67 24.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.678 0.751 . . . . 1.4 110.009 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 5.4 mm -91.0 132.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.994 -1.003 . . . . 1.26 109.076 -176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.02 146.01 27.4 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.779 -0.368 . . . . 1.72 110.438 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.81 -178.6 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 2.29 110.401 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG2' HD23 ' A' ' 121' ' ' LEU . 1.4 pm0 -68.11 -25.14 65.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.895 0.331 . . . . 2.78 111.895 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -93.35 0.71 57.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.904 -0.318 . . . . 2.13 110.476 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 62.95 39.57 10.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.043 -0.526 . . . . 4.81 110.789 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 m -104.38 -50.69 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 2.38 111.553 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.2 m -143.36 166.46 24.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.769 0.319 . . . . 2.22 110.794 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -68.72 137.27 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.356 -0.384 . . . . 1.84 110.995 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.16 -68.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 1.45 110.552 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -137.06 -86.41 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.017 0.436 . . . . 1.86 111.046 171.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -177.24 136.43 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.365 -0.834 . . . . 2.39 109.224 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.464 ' HB2' HD12 ' A' ' 117' ' ' ILE . 27.3 m170 -118.83 132.89 56.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.66 -0.416 . . . . 0.7 110.48 174.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -91.25 146.82 23.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.424 -0.807 . . . . 1.19 109.507 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -118.75 142.4 47.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.82 110.967 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.25 150.14 24.49 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.825 -0.625 . . . . 0.59 112.522 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.2 tp -54.39 -43.86 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.126 0.488 . . . . 1.25 111.624 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 t -71.99 -29.56 64.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.213 0.53 . . . . 1.68 110.124 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 6.0 m -73.07 -24.11 60.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.629 . . . . 1.46 110.495 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -77.17 60.05 1.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.947 -0.57 . . . . 2.06 110.486 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.8 t -39.96 -46.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.782 -0.644 . . . . 1.4 111.503 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 3.3 p30 -94.19 33.68 1.35 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 2.83 111.537 -173.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.54 -20.04 52.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.723 0.409 . . . . 1.92 111.765 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -75.74 -22.92 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 2.83 110.976 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -93.29 140.49 29.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.893 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 102.41 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.648 . . . . 3.33 110.788 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.04 118.44 32.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.824 -1.08 . . . . 1.26 109.93 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.466 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 4.4 pt20 -120.24 -179.03 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.707 0.289 . . . . 2.0 111.117 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 75.2 tttt -65.17 126.94 29.68 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.699 -0.482 . . . . 1.9 109.699 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.74 -17.05 13.62 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.533 -0.758 . . . . 1.17 111.352 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -85.5 129.94 34.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 1.94 110.266 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -81.72 143.75 31.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 2.45 110.609 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.11 144.9 35.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.814 -0.63 . . . . 1.77 110.308 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.0 m -106.61 128.36 54.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.515 -0.55 . . . . 1.86 109.515 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.46 ' HB3' HG13 ' A' ' 162' ' ' VAL . 30.2 p90 -145.26 -178.61 6.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.481 . . . . 0.74 110.165 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -148.63 124.03 10.3 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.311 -0.556 . . . . 2.72 111.019 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 129' ' ' HIS . 7.5 pt -99.56 153.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.996 -0.547 . . . . 1.84 109.853 172.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.535 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 33.0 t70 -177.15 -88.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.277 0.361 . . . . 1.92 110.293 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 45.6 mt-10 -74.22 -28.6 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 2.76 110.535 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 158' ' ' ARG . 13.3 p -78.85 -17.34 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 2.5 110.602 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.93 -28.21 0.64 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.135 -0.484 . . . . 1.27 113.111 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 156' ' ' SER . 90.4 mtt180 -120.39 -169.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.994 -0.372 . . . . 4.13 109.994 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.62 22.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.341 0.591 . . . . 1.09 111.791 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -126.42 155.79 41.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.185 -0.916 . . . . 1.2 110.061 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.6 m 57.55 51.4 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 2.15 111.087 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 151' ' ' PHE . 29.0 m -79.05 145.13 9.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.854 -0.612 . . . . 1.93 110.437 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.522 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -149.04 128.8 13.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.359 -0.608 . . . . 2.63 109.359 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' N ' HD21 ' A' ' 163' ' ' ASN . . . -60.04 124.22 19.56 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.385 0.428 . . . . 1.23 111.094 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 99.9 t -132.54 142.11 43.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 2.08 110.342 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -101.31 145.26 29.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 3.44 110.258 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -96.22 120.64 36.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.159 -0.473 . . . . 4.38 110.495 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.139 -0.482 . . . . 4.41 110.934 177.261 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.663 -0.175 . . . . 11.95 112.663 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.36 173.89 9.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.264 -0.273 . . . . 10.65 110.264 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.37 83.11 0.55 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 121.022 -0.609 . . . . 8.95 112.375 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 p -134.51 110.63 9.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 7.44 111.361 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.27 48.05 20.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.601 -0.727 . . . . 5.59 111.973 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.41 67.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 3.46 110.786 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.61 -29.73 8.73 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.884 -0.598 . . . . 1.76 112.469 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -137.07 132.19 33.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.144 0.497 . . . . 2.13 110.696 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.97 114.7 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.529 -0.915 . . . . 1.8 108.529 172.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -87.18 141.71 28.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.625 -0.716 . . . . 1.36 110.253 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 25.5 mmt85 -100.76 146.0 27.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.575 -0.738 . . . . 2.73 110.285 -177.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.69 -173.26 33.14 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.224 -1.15 . . . . 0.5 110.224 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.44 145.35 36.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.199 0.5 . . . . 0.75 111.196 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.54 101.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.561 -0.745 . . . . 1.14 110.61 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.41 -43.82 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.015 0.436 . . . . 1.31 110.733 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.74 122.6 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.208 -0.451 . . . . 2.16 110.665 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.0 ttm -117.58 107.33 14.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.92 109.788 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.21 170.36 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.159 -0.682 . . . . 2.53 109.159 176.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.728 0.299 . . . . 3.24 111.746 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -102.38 -34.85 9.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.147 0.425 . . . . 2.03 112.147 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.89 -172.79 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.61 0.243 . . . . 1.47 111.186 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.09 173.44 32.68 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.833 -0.699 . . . . 0.76 111.899 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.73 138.71 52.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.832 0.348 . . . . 1.22 110.262 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.09 129.91 58.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 1.15 109.807 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.48 130.98 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.013 -1.106 . . . . 2.3 108.013 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -65.86 145.22 56.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.89 -0.595 . . . . 1.36 111.382 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.504 HD23 HD11 ' A' ' 83' ' ' ILE . 2.3 tm? -52.36 -45.33 65.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 2.15 111.202 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -110.83 31.9 5.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.187 -0.46 . . . . 2.51 111.376 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 p80 43.89 45.38 6.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.785 0.834 . . . . 4.08 111.574 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.32 -48.21 62.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.8 -1.091 . . . . 2.89 110.608 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -172.46 -172.34 0.91 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 1.8 110.858 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.09 122.0 42.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 3.37 110.747 -168.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.58 136.29 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 121.116 0.484 . . . . 1.43 111.908 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.12 130.65 55.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 1.12 109.97 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -125.18 156.88 37.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.025 -0.732 . . . . 2.46 109.025 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -118.68 133.06 56.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.757 -0.46 . . . . 1.4 109.757 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.25 -24.04 66.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.867 0.691 . . . . 0.82 112.867 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -66.3 -33.37 75.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.762 0.315 . . . . 2.03 110.779 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.84 19.58 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.264 0.554 . . . . 2.09 110.564 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 75.0 t80 -92.98 139.69 30.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.654 -0.703 . . . . 1.39 110.304 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 38.0 ttm -119.5 100.42 7.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 2.04 110.108 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.88 -143.05 10.12 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.486 -0.646 . . . . 1.05 111.486 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -115.53 99.38 52.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.789 0.294 . . . . 2.51 110.732 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -81.9 -25.22 3.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.388 2.059 . . . . 1.14 111.918 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.34 -14.29 60.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.315 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -114.39 19.42 16.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.45 111.067 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 17.1 mt -82.29 169.31 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 1.29 112.202 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -130.77 164.76 24.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.014 -0.993 . . . . 2.35 110.337 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.18 114.87 22.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.6 -0.518 . . . . 2.01 109.6 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.67 3.05 46.67 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.742 -0.663 . . . . 0.82 112.192 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.401 HE21 ' N ' ' A' ' 52' ' ' GLU . 27.3 tp60 -68.3 122.46 18.41 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 1.16 111.574 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' OE2' ' HG2' ' A' ' 80' ' ' LYS . 26.0 mp0 -61.49 127.12 29.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.412 -0.813 . . . . 2.51 111.14 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.1 149.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.761 -0.654 . . . . 1.12 109.913 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 11' ' ' ARG . 21.6 pt-20 -121.22 137.32 54.73 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.344 -0.613 . . . . 1.49 109.344 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 4.3 p90 -155.39 178.05 10.67 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.684 -0.406 . . . . 0.79 111.411 -172.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -124.3 141.55 51.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.361 -0.381 . . . . 1.49 111.096 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.76 119.82 18.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.55 109.579 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -77.64 -39.17 46.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.883 -1.053 . . . . 2.04 111.615 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' NH1' ' HG2' ' A' ' 71' ' ' PRO . 7.1 mpt_? -100.27 37.59 1.64 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.224 -0.898 . . . . 5.95 109.526 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.57 -24.26 67.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.417 -0.811 . . . . 6.03 111.067 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.91 17.01 35.93 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.716 -0.754 . . . . 4.94 112.642 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 15.2 m120 -115.74 121.44 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.787 -0.449 . . . . 6.83 109.787 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 p -88.34 87.16 7.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.409 0.623 . . . . 6.81 112.165 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 p 53.95 31.8 14.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.576 -1.193 . . . . 5.34 112.397 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.93 -30.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.142 0.496 . . . . 7.41 110.478 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 p -80.43 1.24 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.068 -0.514 . . . . 6.29 111.292 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.71 -91.52 1.49 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.934 -0.651 . . . . 4.4 112.072 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -105.98 -53.99 2.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.833 0.349 . . . . 4.58 110.939 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.2 m -134.07 152.35 51.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.136 -0.484 . . . . 2.58 110.676 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 59' ' ' ARG . 3.0 pp -126.89 148.41 65.3 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.789 -0.641 . . . . 2.92 109.777 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HG2' ' NH1' ' A' ' 59' ' ' ARG . 40.5 Cg_endo -71.91 147.76 50.27 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.92 1.747 . . . . 1.58 112.233 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.4 142.07 27.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 1.33 110.421 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 53.8 mm-40 -113.02 156.66 22.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.061 -0.718 . . . . 2.3 109.061 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 58.07 50.68 9.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.576 0.703 . . . . 2.67 110.282 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 20.3 t -80.85 110.7 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.846 -0.616 . . . . 1.46 110.064 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -107.98 173.69 6.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.578 0.704 . . . . 4.04 111.821 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.44 ' CG ' ' HH ' ' A' ' 40' ' ' TYR . 48.1 mtp -117.46 144.05 45.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.859 -1.064 . . . . 1.5 109.301 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.4 pt? -131.56 160.27 68.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 C-N-CA 120.694 -0.403 . . . . 2.27 110.072 175.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 60.7 Cg_endo -73.55 160.97 43.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.833 1.689 . . . . 2.54 112.155 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HG2' ' OE2' ' A' ' 52' ' ' GLU . 41.6 mtmt -74.1 173.92 9.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.788 -0.642 . . . . 4.95 112.125 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.52 30.66 2.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.43 -1.259 . . . . 3.42 110.55 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 t -124.39 11.09 8.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.798 0.809 . . . . 2.12 109.324 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 27' ' ' LEU . 40.9 mm -113.12 125.25 30.04 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 1.37 109.157 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.78 158.33 57.73 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.875 2.383 . . . . 1.17 113.268 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -137.35 152.73 73.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 3.13 109.779 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 10.8 Cg_exo -69.93 150.19 66.82 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.542 2.161 . . . . 1.39 112.545 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.95 92.52 6.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.387 0.613 . . . . 1.69 111.38 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.79 119.3 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.009 -1.108 . . . . 1.49 108.009 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.82 -63.45 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.197 0.814 . . . . 3.44 113.197 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.19 -59.95 1.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.728 -0.789 . . . . 2.84 112.529 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -179.52 137.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.533 0.733 . . . . 2.07 109.525 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -106.3 -42.52 5.03 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.072 -0.251 . . . . 1.45 110.924 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -141.02 140.11 34.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.682 0.277 . . . . 1.73 110.422 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -116.97 110.14 17.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.239 -0.652 . . . . 1.86 109.239 173.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -114.53 -171.45 17.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.313 -0.946 . . . . 0.54 112.863 -172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -133.96 143.27 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.327 -0.249 . . . . 2.06 110.327 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.41 124.21 13.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.507 -0.315 . . . . 1.31 110.891 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.33 -59.11 2.65 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.226 -0.443 . . . . 1.31 111.172 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -151.07 129.05 5.84 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.859 0.361 . . . . 4.44 110.802 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.18 141.4 18.41 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.675 2.25 . . . . 2.49 111.429 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 98.14 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.239 0.543 . . . . 3.85 112.075 -175.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -95.86 -63.99 1.1 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 6.1 110.828 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 35.0 t -94.2 10.43 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 4.3 111.714 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 47.8 mm -66.88 -39.43 83.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.703 0.26 . . . . 3.76 111.703 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' OD1' ' HD2' ' A' ' 106' ' ' PRO . 41.1 t30 71.35 123.73 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.764 0.665 . . . . 5.3 111.212 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 105' ' ' ASN . 32.6 Cg_endo -64.54 0.93 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.37 2.713 . . . . 4.95 114.335 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -88.27 3.34 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.572 0.701 . . . . 3.94 110.045 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -127.79 142.95 51.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.815 -0.63 . . . . 6.23 109.633 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -69.65 2.46 3.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.63 0.974 . . . . 5.86 113.63 -170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.87 6.01 30.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 4.95 109.767 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -56.31 -31.77 64.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.147 -0.933 . . . . 3.34 112.313 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.49 -28.83 69.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.022 0.379 . . . . 1.67 112.022 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.77 164.46 38.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.485 -0.864 . . . . 1.08 111.284 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.445 HD13 ' NE2' ' A' ' 128' ' ' GLN . 26.1 mt -146.47 141.66 27.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.809 0.814 . . . . 1.5 112.214 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.13 132.94 55.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.181 -1.372 . . . . 1.06 108.988 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.93 112.42 21.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.883 0.849 . . . . 1.4 109.593 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.479 HG13 ' CG ' ' A' ' 129' ' ' HIS . 11.3 mm -87.56 134.85 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.694 -1.139 . . . . 1.26 110.249 -170.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.59 148.04 26.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.41 0.624 . . . . 1.72 110.731 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.64 150.89 14.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.994 -1.003 . . . . 2.29 109.116 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.8 -16.94 64.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.752 -0.379 . . . . 2.78 111.682 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.79 10.82 39.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.677 -0.49 . . . . 2.13 109.677 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 63.4 29.93 15.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.264 -0.88 . . . . 4.81 111.096 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 m -73.09 -76.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 2.38 110.988 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -143.94 -166.11 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.499 -0.126 . . . . 2.22 110.742 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 40.0 t -80.55 138.83 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 122.925 0.141 . . . . 1.84 110.689 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.7 mt -77.34 -70.68 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.908 -0.405 . . . . 1.45 109.908 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.4 m -138.52 -86.2 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.346 0.593 . . . . 1.86 110.457 167.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.445 ' NE2' HD13 ' A' ' 114' ' ' LEU . 10.9 pt20 -178.44 144.55 0.3 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.067 -0.97 . . . . 2.39 108.645 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.479 ' CG ' HG13 ' A' ' 117' ' ' ILE . 40.0 m170 -115.46 142.24 46.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.531 0.681 . . . . 0.7 111.282 176.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -89.87 140.76 29.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.263 -1.335 . . . . 1.19 109.176 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.532 ' CD1' HD22 ' A' ' 136' ' ' LEU . 30.9 p90 -118.07 154.97 31.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.82 0.343 . . . . 0.82 111.171 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.48 151.48 18.41 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.59 112.517 -173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.26 -32.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.008 0.432 . . . . 1.25 112.062 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 p -77.44 -38.02 50.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.438 -0.346 . . . . 1.68 111.106 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 42.2 p -80.49 -11.2 59.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 1.46 110.643 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 131' ' ' PHE . 29.4 mt -74.91 59.29 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 2.06 111.739 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -45.22 -41.38 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.537 . . . . 1.4 111.128 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.5 m120 -91.88 34.25 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.778 -0.646 . . . . 2.83 111.78 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 3.0 ptmt -64.39 -11.47 33.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.422 0.63 . . . . 1.92 110.832 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -87.52 -22.17 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.527 -0.761 . . . . 2.83 110.834 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 9.8 m-20 -92.86 162.54 14.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 1.89 111.726 -167.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.29 95.89 10.15 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.763 -0.653 . . . . 3.33 109.288 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.9 tp -114.78 107.45 15.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.901 -1.045 . . . . 1.26 109.04 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.92 -177.35 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 2.0 111.456 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -59.59 119.59 7.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 1.9 110.708 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.02 -3.55 31.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.564 -0.827 . . . . 1.17 112.904 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -89.7 137.07 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 1.94 110.655 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 148' ' ' LEU . 2.4 mm? -85.13 139.37 31.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 2.45 110.846 -174.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 141.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 1.77 111.461 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.0 p -105.72 123.37 47.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.771 -0.826 . . . . 1.86 108.771 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.5 p90 -139.94 164.36 30.2 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.585 -0.524 . . . . 0.74 109.585 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 6.8 mpt_? -123.65 119.25 29.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.018 -0.673 . . . . 2.72 110.136 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 tt -101.66 137.45 29.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.51 -0.768 . . . . 1.84 109.544 170.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -162.13 -99.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.915 -0.314 . . . . 1.92 110.731 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 8.8 pt-20 -83.0 -7.08 59.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.2 0.524 . . . . 2.76 111.071 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.4 t -93.26 -17.19 23.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.043 -0.526 . . . . 2.5 109.769 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.17 15.51 58.76 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 116.052 -0.522 . . . . 1.27 113.955 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -139.67 -177.32 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.44 . . . . 4.13 109.813 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.94 108.22 18.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.252 0.548 . . . . 1.09 110.107 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -118.03 155.74 29.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.86 -0.609 . . . . 1.2 110.557 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 t 56.37 49.3 15.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 2.15 109.699 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.23 110.74 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.038 -0.983 . . . . 1.93 110.608 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.11 124.4 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 2.63 110.126 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 121.21 14.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.208 -0.293 . . . . 1.23 110.208 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 96.3 t -128.31 140.88 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 2.08 111.091 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -109.91 122.26 47.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 3.44 109.922 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -99.95 158.84 15.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.238 -0.653 . . . . 4.38 109.238 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 115.791 -0.64 . . . . 4.41 110.403 -176.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.38 -0.288 . . . . 11.95 112.38 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.89 136.93 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.986 -0.376 . . . . 10.65 109.986 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.46 49.6 0.1 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.417 -0.897 . . . . 8.95 111.708 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.4 m -149.12 120.87 8.09 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.765 -0.458 . . . . 7.44 109.765 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -113.51 99.34 7.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.242 -0.435 . . . . 5.59 109.927 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.5 -169.46 2.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.834 -0.621 . . . . 3.46 110.17 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.69 23.35 76.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.506 -0.854 . . . . 1.76 111.423 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -94.85 115.91 28.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.212 0.529 . . . . 2.13 111.763 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 p -102.1 121.52 53.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.478 -0.934 . . . . 1.8 108.478 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -98.39 155.58 17.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.699 -0.682 . . . . 1.36 109.594 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.499 ' HG3' HD12 ' A' ' 27' ' ' LEU . 29.2 ptt-85 -128.82 143.91 51.03 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.104 0.478 . . . . 2.73 110.085 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.16 -171.88 21.57 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.356 -1.098 . . . . 0.5 110.356 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.32 140.34 48.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.271 0.557 . . . . 0.75 111.055 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.579 HG22 ' SD ' ' A' ' 17' ' ' MET . 45.7 mm -65.24 122.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.142 -0.935 . . . . 1.14 111.838 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.24 -18.0 10.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 1.31 111.321 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -135.54 123.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.395 0.141 . . . . 2.16 111.051 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.579 ' SD ' HG22 ' A' ' 14' ' ' ILE . 85.7 mmm -118.1 111.23 18.61 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.131 0.419 . . . . 1.92 112.131 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.732 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -112.4 172.23 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.514 -0.921 . . . . 2.53 108.514 165.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -82.89 -25.52 32.4 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.49 -0.484 . . . . 3.24 110.958 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -92.19 -50.23 5.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.724 0.297 . . . . 2.03 111.7 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.732 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.4 p90 -153.15 151.25 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.994 0.426 . . . . 1.47 111.292 -174.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.91 -178.8 15.71 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.891 -0.671 . . . . 0.76 111.817 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -131.88 141.83 49.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.345 -0.613 . . . . 1.22 109.345 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.61 119.78 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.081 0.467 . . . . 1.15 111.581 -170.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -70.83 128.59 36.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 2.3 108.934 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 p -81.2 153.12 27.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.192 -0.458 . . . . 1.36 111.161 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 83' ' ' ILE . 7.2 tp -50.14 -47.73 54.04 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.55 -0.75 . . . . 2.15 111.622 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -104.77 20.88 17.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 2.51 111.023 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 p80 41.48 47.56 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.88 0.872 . . . . 4.08 111.781 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.77 -40.49 22.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.451 -0.795 . . . . 2.89 110.068 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -159.99 179.98 8.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.418 -0.81 . . . . 1.8 109.78 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -114.74 133.3 56.01 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.429 -0.952 . . . . 3.37 108.429 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 t -114.22 112.17 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.461 0.648 . . . . 1.43 111.993 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -72.06 119.97 17.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.222 -0.899 . . . . 1.12 110.491 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -124.77 136.06 53.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.197 -0.456 . . . . 2.46 110.621 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -98.97 118.08 34.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.617 -0.883 . . . . 1.4 108.617 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.07 -17.38 39.14 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.26 0.467 . . . . 0.82 112.26 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 t -56.49 -24.98 49.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.191 -0.459 . . . . 2.03 111.114 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -107.14 24.24 13.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 2.09 111.021 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CZ ' HD13 ' A' ' 47' ' ' LEU . 70.9 t80 -87.41 152.05 22.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 1.39 111.297 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.6 ttm -116.47 110.88 19.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 2.04 109.89 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.05 -139.34 10.81 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.568 -0.825 . . . . 1.05 112.278 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -122.72 99.75 41.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.535 0.207 . . . . 2.51 110.468 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.53 -20.75 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.272 1.981 . . . . 1.14 112.372 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -74.88 -11.83 60.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 2.29 111.168 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -109.46 14.71 23.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 2.45 110.653 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.414 HD13 ' CZ ' ' A' ' 40' ' ' TYR . 38.1 mt -93.83 158.66 15.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 1.29 111.048 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -162.06 175.13 12.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.597 -0.729 . . . . 2.35 109.571 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 mt -72.99 122.22 21.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.849 0.357 . . . . 2.01 111.039 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.08 -4.53 16.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.676 -0.773 . . . . 0.82 112.899 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -86.83 132.96 33.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.048 0.424 . . . . 1.16 111.237 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 3.4 mp0 -82.14 143.52 31.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.86 -0.609 . . . . 2.51 111.138 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.0 m -141.48 153.58 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.704 -0.68 . . . . 1.12 110.193 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -113.64 137.62 51.34 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.235 -0.654 . . . . 1.49 109.235 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.487 ' CB ' HG21 ' A' ' 75' ' ' VAL . 1.3 p90 -164.45 163.03 22.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.398 0.618 . . . . 0.79 112.372 -175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -113.3 147.72 37.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 1.49 110.025 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.2 135.73 46.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.647 -0.421 . . . . 1.55 110.327 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.76 -56.07 7.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 2.04 111.002 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 12.7 tpp180 63.68 13.33 7.29 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.135 -0.938 . . . . 5.95 110.055 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -62.06 141.07 58.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.565 -0.743 . . . . 6.03 109.47 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.97 -37.22 3.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.79 -0.924 . . . . 4.94 110.79 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' O ' HG23 ' A' ' 63' ' ' THR . 15.7 m120 63.11 12.57 6.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.299 0.64 . . . . 6.83 112.121 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -167.91 127.17 1.28 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.967 -0.56 . . . . 6.81 110.176 -175.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 m -72.89 25.15 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.685 -0.689 . . . . 5.34 112.079 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' H ' ' C ' ' A' ' 63' ' ' THR . 20.6 m -78.46 -20.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 7.41 110.99 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -101.9 8.28 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 6.29 110.216 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.89 135.11 2.06 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.072 -0.811 . . . . 4.4 111.072 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -52.08 -54.31 31.85 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.064 0.394 . . . . 4.58 112.064 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 p -98.8 151.02 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.418 -0.356 . . . . 2.58 110.909 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' CD1' ' HA ' ' A' ' 59' ' ' ARG . 63.2 mt -105.24 152.41 39.79 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 2.92 110.333 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.33 174.98 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.586 2.19 . . . . 1.58 112.134 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.72 159.52 22.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.596 -0.275 . . . . 1.33 110.84 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -130.1 145.39 51.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.709 0.29 . . . . 2.3 111.566 -176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 55.17 85.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.047 -0.979 . . . . 2.67 111.823 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.487 HG21 ' CB ' ' A' ' 55' ' ' TYR . 43.5 t -115.86 119.38 61.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.056 -0.52 . . . . 1.46 110.623 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -120.22 164.74 15.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.636 -0.505 . . . . 4.04 109.636 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.4 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.9 mtt -81.12 144.27 31.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.815 0.34 . . . . 1.5 110.653 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 26.2 tp -121.68 129.43 25.19 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 2.27 110.183 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 28.2 Cg_exo -63.83 154.37 70.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.624 2.216 . . . . 2.54 112.476 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.585 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -64.07 168.82 4.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.915 -0.584 . . . . 4.95 111.248 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.9 t30 76.58 2.84 3.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.628 0.771 . . . . 3.42 110.735 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.7 p -86.99 -11.12 51.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.815 0.816 . . . . 2.12 109.191 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 27' ' ' LEU . 8.4 mm -100.52 132.51 22.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 114.463 -1.244 . . . . 1.37 108.565 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.05 142.04 66.42 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.159 1.906 . . . . 1.17 111.495 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.03 143.28 47.29 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.695 -0.402 . . . . 3.13 110.485 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 33.1 Cg_endo -63.84 141.46 78.32 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.117 2.545 . . . . 1.39 112.917 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.07 93.39 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.992 -0.549 . . . . 1.69 110.03 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.07 137.01 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.728 -0.842 . . . . 1.49 108.728 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -82.65 -61.06 1.98 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.911 -0.316 . . . . 3.44 111.73 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 91' ' ' THR . 39.1 mt-10 -91.45 -55.52 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.453 -0.499 . . . . 2.84 111.082 -175.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 166.43 161.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.716 -0.846 . . . . 2.07 108.716 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -105.5 -50.41 3.22 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.511 -0.476 . . . . 1.45 110.788 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.82 145.64 31.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.943 0.402 . . . . 1.73 111.04 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.64 ' O ' HD21 ' A' ' 118' ' ' LEU . 3.9 p-10 -113.41 148.1 36.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.774 -1.195 . . . . 1.86 107.774 171.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -163.43 -163.75 16.91 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 118.973 -1.584 . . . . 0.54 113.225 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 21.1 t -133.94 146.88 30.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.7 -0.482 . . . . 2.06 109.7 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.95 117.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.077 -0.342 . . . . 1.31 110.077 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.88 -57.0 3.14 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.159 0.429 . . . . 1.31 112.159 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 -138.96 109.46 7.71 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 4.44 111.48 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.36 169.74 20.67 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.154 2.569 . . . . 2.49 111.914 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 111' ' ' TYR . 7.6 mp -88.17 88.4 7.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.229 -0.441 . . . . 3.85 110.95 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -98.02 -64.86 1.0 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.361 -0.536 . . . . 6.1 109.836 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 33.7 t -96.49 7.62 46.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.701 . . . . 4.3 111.117 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.02 -46.05 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.826 0.306 . . . . 3.76 111.826 -170.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 91.5 m-20 60.17 170.05 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 5.3 111.858 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 105' ' ' ASN . 45.4 Cg_endo -71.16 0.8 6.13 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.35 2.033 . . . . 4.95 111.522 166.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.94 -35.02 57.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.459 -0.791 . . . . 3.94 110.994 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.48 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 4.7 tp60 -105.85 151.65 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 6.23 111.058 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 111' ' ' TYR . 8.3 tt0 -69.3 -14.05 62.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.796 -0.638 . . . . 5.86 112.217 -175.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 43.3 mt-10 -75.36 14.51 0.58 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.191 -0.318 . . . . 4.95 111.518 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.525 ' O ' HD23 ' A' ' 101' ' ' LEU . 55.7 t80 -58.76 -33.49 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 3.34 112.111 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.25 -23.56 65.71 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.178 -0.209 . . . . 1.67 111.532 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.19 153.23 22.06 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.773 -0.727 . . . . 1.08 112.302 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 130' ' ' GLU . 89.3 mt -138.65 142.01 39.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.622 0.725 . . . . 1.5 112.419 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.48 143.88 18.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.521 -1.218 . . . . 1.06 109.964 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 96' ' ' VAL . 11.1 pt-20 -84.63 125.8 32.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.345 0.593 . . . . 1.4 109.586 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.56 HG13 ' CD2' ' A' ' 129' ' ' HIS . 14.6 mm -104.59 128.15 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.463 -0.789 . . . . 1.26 109.386 -173.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.64 HD21 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.18 156.93 20.79 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.299 0.374 . . . . 1.72 110.597 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.548 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m-20 -56.75 154.54 8.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.66 -0.496 . . . . 2.29 109.66 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.91 -22.42 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.06 0.457 . . . . 2.78 110.603 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.65 -3.82 45.5 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.145 -0.479 . . . . 2.13 110.221 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HG3' HD12 ' A' ' 118' ' ' LEU . 26.2 ttm180 64.23 89.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.272 -0.876 . . . . 4.81 111.004 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.9 m -133.34 -64.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 2.38 110.283 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -168.92 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.472 -0.785 . . . . 2.22 110.398 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 p -92.3 135.31 27.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.718 -0.475 . . . . 1.84 109.718 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -78.45 -70.87 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.566 -0.454 . . . . 1.45 110.767 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.6 m -139.89 -83.96 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.64 0.733 . . . . 1.86 111.43 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -175.36 138.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.575 -1.193 . . . . 2.39 109.695 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.56 ' CD2' HG13 ' A' ' 117' ' ' ILE . 35.6 m170 -118.76 140.48 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.252 -0.579 . . . . 0.7 109.703 168.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.536 ' HA ' HD21 ' A' ' 114' ' ' LEU . 19.8 tt0 -94.45 145.07 25.04 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.067 -0.97 . . . . 1.19 109.633 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.76 170.61 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.732 -0.387 . . . . 0.82 110.938 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.03 152.05 20.93 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.72 -0.552 . . . . 0.59 111.72 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.87 -29.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.966 0.412 . . . . 1.25 111.426 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.1 p -74.64 -37.36 62.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 1.68 111.271 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.565 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 47.3 p -86.46 -11.55 51.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.363 -0.38 . . . . 1.46 110.7 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.0 mt -73.93 59.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 2.06 111.107 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.68 -45.81 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.251 0.548 . . . . 1.4 110.839 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.528 HD22 HD23 ' A' ' 143' ' ' LEU . 2.9 p-10 -85.57 31.68 0.59 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 2.83 111.95 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -60.63 -20.01 59.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.023 0.439 . . . . 1.92 111.351 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -76.94 -21.43 54.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 2.83 111.591 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -89.8 175.6 7.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.148 -0.478 . . . . 1.89 110.677 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.0 mp -100.87 101.51 12.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.864 -0.607 . . . . 3.33 109.6 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.528 HD23 HD22 ' A' ' 138' ' ' ASN . 11.8 tp -115.48 114.43 25.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 1.26 110.094 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -124.98 -173.8 2.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.512 -0.313 . . . . 2.0 110.183 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -66.03 136.75 56.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.758 -0.377 . . . . 1.9 110.073 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.41 -9.48 57.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.675 -0.774 . . . . 1.17 111.722 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -89.49 147.57 23.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.099 0.952 . . . . 1.94 110.997 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.04 127.54 44.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.291 -1.777 . . . . 2.45 109.692 -168.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.1 152.57 37.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 1.77 111.768 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 p -118.98 135.71 54.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.214 -0.662 . . . . 1.86 109.214 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -153.94 161.98 41.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.74 110.948 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 123.96 30.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.781 0.8 . . . . 2.72 111.803 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tt -99.3 129.25 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.201 -1.363 . . . . 1.84 110.409 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 15.5 t70 -160.74 -88.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.976 -0.102 . . . . 1.92 110.913 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 4.6 mm-40 -81.66 -19.61 41.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 2.76 111.25 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.7 p -81.7 -17.57 47.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.238 -0.437 . . . . 2.5 110.496 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.73 18.18 16.48 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.808 -0.633 . . . . 1.27 112.842 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 62.8 mtm180 -147.46 -173.82 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.886 -1.153 . . . . 4.13 107.886 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.61 108.35 17.31 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.461 -0.496 . . . . 1.09 109.836 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -115.76 159.95 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 1.2 110.653 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.4 t 59.01 42.26 19.53 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.781 0.675 . . . . 2.15 109.766 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.77 108.81 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.348 -0.842 . . . . 1.93 110.442 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.75 111.33 20.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.387 -0.824 . . . . 2.63 110.143 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.68 120.26 9.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.869 -0.605 . . . . 1.23 110.675 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.84 110.26 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.855 -0.611 . . . . 2.08 110.614 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.67 115.62 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.439 -0.578 . . . . 3.44 109.439 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -91.27 130.71 37.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.485 0.66 . . . . 4.38 110.195 -177.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.946 -1.025 . . . . 4.41 111.329 -178.444 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 112.168 -0.373 . . . . 11.95 112.168 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.82 132.03 26.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.684 0.278 . . . . 10.65 110.654 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.83 81.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.368 -0.693 . . . . 8.95 111.368 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -149.37 116.9 6.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.738 -0.467 . . . . 7.44 109.738 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.86 109.9 17.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 5.59 109.816 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.12 132.48 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.993 0.425 . . . . 3.46 111.066 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.7 23.42 76.77 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.799 -0.715 . . . . 1.76 112.208 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.91 117.41 30.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.341 0.591 . . . . 2.13 111.018 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.12 121.94 37.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.317 -0.856 . . . . 1.8 109.747 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.37 140.3 32.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.771 -0.65 . . . . 1.36 110.342 -173.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 37.5 ttm180 -101.77 152.85 20.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.776 -0.647 . . . . 2.73 110.002 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.97 -169.09 35.11 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.17 -0.772 . . . . 0.5 111.17 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.9 145.13 29.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.757 0.313 . . . . 0.75 110.581 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 112.16 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 1.14 110.589 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.82 -25.18 15.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.468 -0.333 . . . . 1.31 111.395 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.462 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 2.6 p -156.26 134.02 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.354 -0.384 . . . . 2.16 111.237 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.5 mtp -118.85 115.83 25.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.415 -0.587 . . . . 1.92 109.415 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HZ3' HG21 ' A' ' 16' ' ' VAL . 27.2 mmtm -96.25 -161.65 0.89 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.684 -0.487 . . . . 2.53 109.684 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.31 -46.53 27.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.899 -0.591 . . . . 3.24 111.134 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -111.49 -24.61 10.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 2.03 111.626 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 51.5 p90 -143.98 -173.72 4.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.938 0.399 . . . . 1.47 111.109 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.13 -178.36 35.03 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.001 -0.84 . . . . 0.76 111.001 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 67.7 m-85 -125.03 130.54 52.51 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.979 0.419 . . . . 1.22 109.958 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mt -100.03 126.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.976 -0.556 . . . . 1.15 109.542 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.78 127.46 32.45 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.959 -0.756 . . . . 2.3 108.959 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.1 p -63.62 139.72 58.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.34 -0.846 . . . . 1.36 110.729 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 2.3 tm? -57.2 -36.62 71.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.677 0.751 . . . . 2.15 109.468 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -82.72 6.92 16.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.718 -1.128 . . . . 2.51 112.253 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p80 42.71 53.02 4.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.73 0.812 . . . . 4.08 111.733 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.8 -42.66 3.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 2.89 111.444 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.14 174.5 14.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 1.8 111.303 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.24 126.16 50.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 3.37 109.43 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 90.7 t -105.28 121.41 57.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.282 -0.417 . . . . 1.43 111.86 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -82.15 114.57 20.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 1.12 109.691 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -118.15 137.45 52.96 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.179 -0.609 . . . . 2.46 109.424 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -100.79 127.64 47.14 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.174 -0.676 . . . . 1.4 109.174 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -56.99 -22.87 41.75 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.259 0.466 . . . . 0.82 112.259 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -70.55 -8.99 55.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.606 -0.27 . . . . 2.03 111.672 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -116.41 20.15 14.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 2.09 109.948 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -102.67 139.24 38.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 1.39 110.243 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -109.37 136.53 48.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.181 0.515 . . . . 2.04 110.717 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.6 -138.75 13.95 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.019 -0.833 . . . . 1.05 111.019 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -128.67 105.89 18.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.794 -0.447 . . . . 2.51 109.794 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.98 -30.7 38.87 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.843 2.362 . . . . 1.14 112.42 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.38 -18.1 65.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.66 -0.7 . . . . 2.29 111.528 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -98.36 10.65 40.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.079 0.466 . . . . 2.45 110.63 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.0 148.99 24.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.718 -0.673 . . . . 1.29 110.794 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 166.12 22.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 2.35 109.887 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.83 115.18 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 2.01 110.195 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -7.16 21.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.253 -0.499 . . . . 0.82 112.002 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.418 HE21 ' N ' ' A' ' 52' ' ' GLU . 24.8 tp60 -71.54 120.24 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 1.16 111.008 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG2' HG12 ' A' ' 83' ' ' ILE . 9.0 mp0 -65.13 134.09 53.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.294 -0.866 . . . . 2.51 111.371 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 77' ' ' MET . 18.6 m -145.2 166.42 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.751 -0.659 . . . . 1.12 110.108 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.62 150.02 48.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.03 -0.359 . . . . 1.49 110.03 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 12.1 p90 -164.09 -179.9 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.392 . . . . 0.79 111.649 -172.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -127.29 150.22 49.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 1.49 110.617 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.07 142.71 27.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 1.55 110.939 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 77.74 9.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.969 -0.56 . . . . 2.04 110.562 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.34 10.15 39.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.186 -0.672 . . . . 5.95 109.186 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.86 119.45 19.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.233 -0.894 . . . . 6.03 111.113 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.41 -132.21 10.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.697 -0.683 . . . . 4.94 112.682 175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.76 27.02 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 6.83 109.68 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 m -74.27 79.48 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 6.81 111.804 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 t 66.21 17.75 10.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.019 -0.991 . . . . 5.34 111.055 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.68 -27.15 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 7.41 110.761 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 t -107.76 21.24 17.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.052 -0.522 . . . . 6.29 110.262 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.56 -132.84 7.72 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.698 -0.763 . . . . 4.4 112.069 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -111.57 -64.06 1.33 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.217 0.532 . . . . 4.58 110.26 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 p -129.29 143.74 50.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.555 -0.748 . . . . 2.58 110.587 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.78 147.88 60.28 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.692 -0.685 . . . . 2.92 109.676 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.91 167.17 25.41 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.632 2.221 . . . . 1.58 112.91 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.19 146.59 31.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.377 -0.829 . . . . 1.33 110.747 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.09 154.55 27.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 2.3 111.027 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 61.87 41.22 11.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.627 -0.715 . . . . 2.67 111.515 170.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.9 t -71.01 118.59 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 1.46 110.092 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -118.44 154.99 31.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.57 . . . . 4.04 110.237 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.481 ' HA ' HG11 ' A' ' 53' ' ' VAL . 41.4 mtt -78.4 148.47 33.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.963 0.411 . . . . 1.5 110.485 173.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.46 HD13 ' HD2' ' A' ' 79' ' ' PRO . 20.0 tp -126.1 141.77 40.6 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.946 -0.57 . . . . 2.27 109.583 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HD2' HD13 ' A' ' 78' ' ' LEU . 15.0 Cg_endo -58.58 137.81 82.32 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.1 1.867 . . . . 2.54 111.279 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -66.85 164.48 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.694 -0.685 . . . . 4.95 111.861 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 70.44 21.7 5.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.91 -1.041 . . . . 3.42 110.41 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.4 t -89.76 5.14 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.606 0.717 . . . . 2.12 109.744 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 52' ' ' GLU . 28.9 mm -101.98 131.47 22.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 1.37 109.832 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.58 145.35 57.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.214 1.943 . . . . 1.17 111.735 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -120.71 149.8 51.24 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 120.866 -0.334 . . . . 3.13 110.851 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 43.0 Cg_endo -68.52 146.56 68.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.67 2.247 . . . . 1.39 112.195 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.57 95.27 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.332 -0.395 . . . . 1.69 110.338 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.08 136.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 1.49 109.021 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.7 -63.64 1.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.121 -0.631 . . . . 3.44 112.206 -171.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -94.22 -54.63 3.48 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.421 -0.512 . . . . 2.84 111.215 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 t 177.45 163.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.937 -0.764 . . . . 2.07 108.937 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -106.04 -52.72 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.087 0.47 . . . . 1.45 110.61 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.55 151.69 46.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 1.73 110.434 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.59 ' O ' HD22 ' A' ' 118' ' ' LEU . 4.4 p-10 -130.75 128.08 40.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.98 -0.748 . . . . 1.86 108.98 173.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.37 -146.32 4.31 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.859 -1.162 . . . . 0.54 112.723 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.453 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.0 p -142.14 148.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.802 -0.444 . . . . 2.06 109.802 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 ' HG ' ' A' ' 143' ' ' LEU . 86.2 t -59.95 126.76 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.495 0.188 . . . . 1.31 110.774 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -70.12 -52.46 23.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.377 -0.374 . . . . 1.31 110.765 -174.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -169.84 137.6 1.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 4.44 110.399 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 145' ' ' LYS . 66.9 Cg_endo -76.17 130.94 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.268 1.979 . . . . 2.49 110.989 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.611 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -72.39 90.5 1.29 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.073 0.94 . . . . 3.85 111.797 -176.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -97.56 -65.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.608 -0.724 . . . . 6.1 111.368 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.86 11.11 25.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 4.3 111.639 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 38.7 mm -73.88 -9.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.378 -0.374 . . . . 3.76 111.127 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 8.6 t30 74.38 128.77 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 5.3 111.059 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.11 -5.33 14.4 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.014 2.476 . . . . 4.95 115.816 -168.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.85 30.41 7.18 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.659 0.742 . . . . 3.94 110.715 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -116.56 148.32 41.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.417 -0.811 . . . . 6.23 109.416 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -58.6 -18.32 29.13 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.843 0.683 . . . . 5.86 112.843 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -84.11 8.33 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.241 0.543 . . . . 4.95 110.842 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 33.8 t80 -66.92 -27.74 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 3.34 112.136 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.95 -25.93 65.7 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.749 -0.38 . . . . 1.67 111.501 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 157.74 33.46 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.569 -0.824 . . . . 1.08 111.834 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 128' ' ' GLN . 36.0 mt -141.81 148.06 38.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.467 0.651 . . . . 1.5 112.133 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.91 140.73 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.063 -0.971 . . . . 1.06 109.311 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 11.8 pt-20 -87.87 129.21 35.29 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.383 -0.599 . . . . 1.4 109.383 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 12.8 mm -104.43 140.67 21.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.827 -0.624 . . . . 1.26 110.614 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.7 pt? -84.08 146.48 27.89 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.987 -0.375 . . . . 1.72 109.987 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.9 165.47 17.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.71 -0.848 . . . . 2.29 108.71 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.74 -18.72 65.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.866 0.365 . . . . 2.78 111.0 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.95 6.47 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 2.13 110.18 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 55.87 77.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.526 -0.761 . . . . 4.81 111.208 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.9 p -117.73 -79.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 2.38 110.89 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.0 p -137.17 -174.5 3.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 2.22 110.793 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 4.7 p -65.17 129.87 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 1.84 110.721 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.1 -70.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.921 0.391 . . . . 1.45 110.791 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 p -135.97 -85.51 0.36 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.068 -0.514 . . . . 1.86 111.065 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.453 ' HB2' HD23 ' A' ' 114' ' ' LEU . 13.6 pt20 -176.51 137.4 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.573 -0.739 . . . . 2.39 109.763 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.529 ' CD2' HG13 ' A' ' 117' ' ' ILE . 32.1 m170 -121.62 125.83 47.62 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.809 -0.356 . . . . 0.7 110.086 171.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.44 149.42 24.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.639 -0.71 . . . . 1.19 109.9 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.465 ' CD1' HD23 ' A' ' 136' ' ' LEU . 20.9 p90 -117.74 146.86 43.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 0.82 111.294 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.8 150.43 18.33 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.59 112.494 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 134' ' ' THR . 9.2 tp -54.91 -43.02 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.236 0.458 . . . . 1.25 112.236 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.401 ' N ' HG23 ' A' ' 133' ' ' ILE . 3.1 t -77.58 -22.66 50.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.225 0.536 . . . . 1.68 110.203 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 15.2 m -80.66 -18.83 46.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.563 -0.744 . . . . 1.46 110.166 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.465 HD23 ' CD1' ' A' ' 131' ' ' PHE . 50.1 mt -76.53 60.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 2.06 111.419 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.2 t -41.09 -42.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.291 -0.413 . . . . 1.4 111.592 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -92.05 27.79 2.05 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.159 -0.473 . . . . 2.83 111.994 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -60.34 -18.19 48.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.07 0.396 . . . . 1.92 112.07 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -81.43 -19.24 42.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.309 -0.405 . . . . 2.83 111.478 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.48 175.41 9.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.941 -0.572 . . . . 1.89 110.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 pp -104.43 130.32 52.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.754 -0.832 . . . . 3.33 108.754 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.494 ' HG ' HG21 ' A' ' 97' ' ' VAL . 12.3 tp -139.97 109.7 6.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 1.26 109.372 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -122.73 -171.97 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 2.0 110.956 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 62.5 tttm -64.59 116.9 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.637 . . . . 1.9 110.44 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.71 33.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.603 -0.808 . . . . 1.17 112.877 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -91.49 127.64 37.01 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.106 0.453 . . . . 1.94 110.35 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.453 HD23 ' HB ' ' A' ' 96' ' ' VAL . 82.0 mt -73.73 144.24 45.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.34 0.591 . . . . 2.45 110.889 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.28 145.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.346 -0.843 . . . . 1.77 111.114 -173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.4 m -118.45 148.83 42.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.78 -0.645 . . . . 1.86 109.672 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -163.68 162.93 24.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.53 . . . . 0.74 109.808 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.7 122.05 35.21 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.779 0.799 . . . . 2.72 110.965 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.89 141.23 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.841 -1.072 . . . . 1.84 110.076 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 24.8 t70 -171.64 -93.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.625 -0.139 . . . . 1.92 110.625 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 41.9 mm-40 -74.01 -33.19 63.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 2.76 111.48 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -76.19 -15.51 60.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 2.5 110.753 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.65 20.6 39.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.968 -0.634 . . . . 1.27 112.948 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -140.49 -175.05 4.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.841 . . . . 4.13 108.728 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.47 108.38 18.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.216 -0.661 . . . . 1.09 109.216 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.26 158.77 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 1.2 111.218 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 36.8 t 59.34 39.59 22.11 Favored 'General case' 0 C--N 1.334 -0.071 0 N-CA-C 109.273 -0.64 . . . . 2.15 109.273 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -62.25 123.32 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.145 -0.934 . . . . 1.93 110.728 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -132.42 111.69 11.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.28 -0.418 . . . . 2.63 110.187 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.82 109.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 1.23 110.368 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 77.1 t -89.67 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 2.08 111.364 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 123.06 32.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.125 -0.695 . . . . 3.44 109.125 172.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.44 140.66 46.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.736 0.779 . . . . 4.38 110.993 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 114.52 -1.218 . . . . 4.41 110.332 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.854 0.359 . . . . 2.0 111.036 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.28 124.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.122 -0.695 . . . . 1.27 109.122 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.25 138.89 32.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.368 0.604 . . . . 1.14 110.417 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.627 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -104.62 140.44 38.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.461 -0.791 . . . . 2.31 109.88 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.83 -172.39 30.25 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.13 -0.788 . . . . 0.5 111.13 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 143.05 37.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.04 0.448 . . . . 0.68 111.307 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.519 HG21 ' SD ' ' A' ' 17' ' ' MET . 33.1 mm -65.83 125.79 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.56 110.869 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.86 -35.74 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.76 111.384 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.5 123.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 1.55 110.698 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 14' ' ' ILE . 80.5 mmm -116.03 107.39 14.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 1.42 110.954 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.4 mmtt -103.26 179.2 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.437 -1.32 . . . . 2.03 107.437 167.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.68 -18.56 29.28 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.892 -0.723 . . . . 3.24 110.695 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -101.67 -48.51 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.028 0.442 . . . . 2.03 111.592 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 39.9 p90 -142.67 -177.56 5.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.274 -0.421 . . . . 1.25 110.084 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.62 -178.36 34.54 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.748 -0.739 . . . . 0.71 111.795 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.88 130.97 53.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 1.08 110.224 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 mt -101.66 129.27 53.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.622 -0.717 . . . . 0.61 109.674 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.63 131.98 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.751 -0.833 . . . . 2.3 108.751 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.5 p -64.3 151.99 42.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.494 -0.776 . . . . 0.87 111.705 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 83' ' ' ILE . 7.2 tp -62.7 -40.65 97.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.673 -0.694 . . . . 1.58 110.924 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 8.1 m -100.36 24.78 8.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.04 111.277 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' ' NH1' ' A' ' 158' ' ' ARG . 23.1 p80 44.3 51.01 7.71 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.763 0.792 . . . . 3.29 111.709 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 15.8 m-20 -82.02 -51.29 8.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.196 -0.911 . . . . 2.89 109.438 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -175.93 -175.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.089 -0.96 . . . . 1.8 109.678 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.39 136.3 43.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.047 0.451 . . . . 3.37 110.238 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.44 126.93 57.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.697 -0.683 . . . . 0.87 110.963 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -68.8 119.38 13.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.19 0.519 . . . . 1.06 110.124 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -129.58 136.51 49.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.654 -0.703 . . . . 1.96 109.935 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.21 139.27 40.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.346 -0.613 . . . . 1.18 109.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.496 ' HZ ' ' SD ' ' A' ' 17' ' ' MET . 60.0 m-85 -69.79 -16.31 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.032 0.444 . . . . 0.75 111.201 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 t -63.39 -23.22 67.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.76 -0.655 . . . . 1.63 111.77 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.41 24.62 12.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 2.07 110.488 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 91.8 t80 -91.69 146.29 23.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.865 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.77 117.32 31.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.73 110.12 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.95 -157.04 20.97 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.748 -0.739 . . . . 1.05 112.042 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.22 107.36 57.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.932 -0.396 . . . . 2.14 109.932 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 -17.28 38.22 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.772 2.315 . . . . 1.01 113.095 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.99 -21.94 66.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.439 . . . . 2.08 110.8 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -103.53 12.77 34.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.033 -0.53 . . . . 2.18 111.268 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 14.5 mt -88.11 146.94 25.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.14 -0.482 . . . . 0.92 111.572 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -143.49 169.22 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.288 -0.869 . . . . 2.35 110.273 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.2 mt -76.77 116.65 17.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.924 -0.58 . . . . 1.4 110.757 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 2.35 27.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.922 -0.656 . . . . 0.75 112.506 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -78.34 127.37 32.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.792 0.329 . . . . 1.06 111.035 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.627 ' OE1' ' HD2' ' A' ' 11' ' ' ARG . 19.1 tt0 -70.81 130.92 42.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.745 -0.661 . . . . 2.51 110.28 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.59 154.52 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.839 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.83 141.63 47.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.003 -0.739 . . . . 1.49 109.003 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.34 161.73 27.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.401 0.62 . . . . 0.66 111.936 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 p -110.18 163.73 13.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.414 -0.812 . . . . 0.94 109.906 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.32 142.03 33.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.665 0.269 . . . . 1.19 110.571 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 2.04 111.079 -178.186 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.797 -0.075 . . . . 2.3 110.797 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.75 172.45 16.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.705 2.27 . . . . 1.43 113.293 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.65 171.62 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.149 -0.932 . . . . 0.82 109.993 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.15 155.23 40.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.469 0.176 . . . . 2.3 110.622 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.26 55.27 9.41 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.828 0.705 . . . . 2.01 112.099 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 35' ' ' PHE . 40.5 t -86.41 116.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 0.8 110.186 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -122.15 159.63 26.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.739 -0.467 . . . . 3.51 109.739 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.4 mtt -79.53 152.37 30.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.85 0.357 . . . . 1.12 111.163 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -119.16 162.61 30.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 1.67 110.539 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 134.68 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.337 2.025 . . . . 2.15 111.95 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 38.8 ttmt -70.01 155.27 40.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.807 -0.633 . . . . 4.61 110.925 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 17.3 m120 74.76 15.9 3.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.219 0.608 . . . . 2.84 111.402 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 44.8 m -92.23 -19.87 21.75 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.929 -0.309 . . . . 1.7 111.023 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 27' ' ' LEU . 45.3 mm -70.44 126.52 92.31 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.315 -0.624 . . . . 0.92 109.315 171.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.24 154.83 61.49 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.576 2.184 . . . . 1.03 112.331 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -113.64 152.76 45.74 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.059 -0.519 . . . . 2.76 110.171 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.439 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 23.5 Cg_endo -60.63 143.5 99.43 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 1.08 112.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.16 91.72 8.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.302 0.572 . . . . 1.1 110.007 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -142.04 128.67 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.607 -0.886 . . . . 1.23 108.607 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.26 -63.64 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.555 -0.458 . . . . 2.87 112.056 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.58 -53.82 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.982 0.42 . . . . 2.84 111.887 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.2 t 174.74 159.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.108 -0.701 . . . . 1.42 109.108 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -106.22 -58.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 1.3 111.059 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -140.52 158.09 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.064 0.459 . . . . 1.29 110.725 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -122.94 175.9 6.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.467 -0.788 . . . . 1.36 109.045 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.64 -163.13 34.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.264 -0.97 . . . . 0.53 112.198 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.36 148.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.13 -0.693 . . . . 1.37 109.13 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 144' ' ' GLN . 49.1 t -63.91 116.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.601 -0.518 . . . . 0.69 109.601 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 99' ' ' ARG . . . -82.65 -68.84 0.67 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.178 -0.464 . . . . 0.89 111.697 -173.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 4.8 mtm180 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.573 -0.285 . . . . 3.92 111.18 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 112.088 0.403 . . . . 1.24 112.088 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.74 179.88 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.05 -0.523 . . . . 0.94 113.871 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.9 mt -144.48 138.23 27.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.93 111.17 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.6 mt -103.7 139.47 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.233 -0.894 . . . . 0.49 109.237 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.44 116.02 27.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.56 0.695 . . . . 1.4 110.184 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.811 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 15.8 mm -91.52 140.57 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.229 -0.896 . . . . 0.63 109.946 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.66 143.34 29.28 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.953 -0.299 . . . . 1.21 110.238 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.64 -179.49 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 2.29 111.064 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.638 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.6 pm0 -66.64 -25.17 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.262 . . . . 2.78 111.442 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.638 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -90.3 -1.47 57.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.353 -0.61 . . . . 1.77 109.353 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 60.1 43.6 14.07 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.166 -0.924 . . . . 4.14 111.534 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.2 m -114.83 -50.0 2.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.028 0.381 . . . . 1.87 112.028 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.8 p -130.65 -179.5 5.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.964 0.411 . . . . 1.54 111.858 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -81.83 136.64 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.755 -0.657 . . . . 1.29 110.277 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.1 mt -75.09 -69.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 1.03 110.56 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -137.58 -83.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 1.56 111.813 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -174.98 134.37 0.34 Allowed 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 115.458 -0.792 . . . . 2.08 109.757 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -120.38 130.66 54.48 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.608 -0.437 . . . . 0.68 110.692 173.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -91.5 143.98 26.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.419 -0.81 . . . . 1.19 109.395 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.5 p90 -116.98 140.72 49.13 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.059 -0.657 . . . . 0.74 111.056 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.39 152.38 18.37 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.42 -0.809 . . . . 0.51 112.539 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 tp -49.89 -33.38 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.248 0.462 . . . . 0.67 112.248 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.6 p -72.93 -33.75 66.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.438 0.637 . . . . 1.35 110.813 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 16.3 m -74.55 -26.58 60.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.172 -0.922 . . . . 1.1 110.433 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 131' ' ' PHE . 32.1 mt -75.58 60.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.44 -0.8 . . . . 1.46 112.151 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -45.56 -42.5 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.497 0.665 . . . . 0.82 110.481 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -92.11 35.13 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.204 -0.907 . . . . 2.17 111.302 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -58.22 -17.78 21.51 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.477 0.547 . . . . 1.39 112.477 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.39 -22.91 62.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.064 0.459 . . . . 2.46 110.696 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 161.64 27.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 1.89 111.98 -171.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -89.75 30.66 1.02 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.202 -0.908 . . . . 2.88 109.295 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.95 107.83 0.1 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.492 -1.231 . . . . 0.97 110.548 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 13.8 pt20 -129.51 -175.6 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.531 . . . . 1.77 111.55 -170.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 77.8 tttt -59.65 118.19 5.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.587 -0.733 . . . . 1.43 109.929 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.43 -5.25 29.82 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.467 -0.873 . . . . 1.07 112.635 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.39 136.39 33.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.067 0.46 . . . . 1.94 111.079 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.4 mm? -86.0 136.38 33.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.38 -0.827 . . . . 1.79 110.359 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.27 150.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.245 0.545 . . . . 1.16 112.04 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.7 m -125.82 134.98 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 1.44 108.926 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.811 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 44.5 p90 -146.72 -176.61 5.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.079 -0.51 . . . . 0.61 109.7 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 122.31 17.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.277 0.56 . . . . 2.2 110.722 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.6 tt -100.62 130.49 49.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.178 -0.919 . . . . 1.24 110.296 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 13.5 t70 -159.17 -92.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.465 -0.198 . . . . 1.92 110.465 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -83.09 -19.69 36.3 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.08 -0.388 . . . . 2.76 111.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 m -77.92 -16.47 58.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 1.98 110.58 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 53.25 30.89 40.88 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.705 -0.68 . . . . 1.27 113.745 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 29' ' ' HIS . 11.6 ptm180 -161.63 -167.61 1.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.454 -0.943 . . . . 3.61 108.454 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.92 107.66 17.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.294 -0.632 . . . . 0.48 109.294 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -122.18 153.22 39.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.49 110.437 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 t 60.72 45.3 10.26 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.367 -0.605 . . . . 1.55 109.367 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.62 109.33 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.496 -0.774 . . . . 1.26 110.798 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -111.59 120.96 43.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.384 -0.826 . . . . 2.05 110.222 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.6 103.79 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.75 110.034 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.73 136.05 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.706 -0.679 . . . . 1.56 110.533 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.7 mpt_? . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 116.304 -0.407 . . . . 2.94 110.046 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.843 0.354 . . . . 2.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.7 121.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.253 -0.647 . . . . 1.27 109.253 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -93.23 138.0 32.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.122 0.487 . . . . 1.14 109.992 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -108.54 137.8 45.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 2.31 109.786 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.77 -178.39 30.81 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.396 -0.682 . . . . 0.5 111.396 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -132.22 143.44 49.93 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.124 0.488 . . . . 0.68 110.867 -177.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.599 HG21 ' SD ' ' A' ' 17' ' ' MET . 46.5 mm -65.91 129.03 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.56 111.145 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.95 -45.07 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.76 111.264 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 72.9 t -114.78 122.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 1.55 111.068 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 14' ' ' ILE . 87.2 mmm -112.4 105.33 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 1.42 110.805 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 54.6 mttt -113.06 167.47 10.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.554 -0.906 . . . . 2.03 108.554 171.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -75.33 -18.98 59.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.796 -0.361 . . . . 3.24 111.849 -171.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -108.53 -47.05 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.46 . . . . 2.03 111.707 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 6.7 p90 -141.24 172.08 13.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.586 -0.279 . . . . 1.25 110.448 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.33 32.83 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.805 -0.712 . . . . 0.71 111.907 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.7 m-85 -120.8 135.05 55.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.71 -0.478 . . . . 1.08 109.71 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -103.5 133.9 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.02 -0.536 . . . . 0.61 110.536 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -79.26 121.15 24.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.041 -1.096 . . . . 2.3 108.041 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.8 144.16 52.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.134 -0.484 . . . . 0.87 110.727 -175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 HD12 ' A' ' 83' ' ' ILE . 3.1 tp -51.68 -43.35 62.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.58 111.026 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -107.42 27.16 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 2.04 110.731 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 45.48 36.78 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.13 0.972 . . . . 3.29 111.28 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.877 -1.056 . . . . 2.89 111.464 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.23 -174.58 1.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.856 -0.611 . . . . 1.8 110.785 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -103.09 120.74 41.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 3.37 109.438 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.4 t -104.44 125.26 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.779 0.323 . . . . 0.87 111.287 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.56 119.04 21.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.578 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.54 144.08 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.431 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 22.1 t-80 -119.31 135.66 54.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.708 -0.479 . . . . 1.18 109.708 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 76.8 m-85 -74.61 -19.12 60.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.458 0.54 . . . . 0.75 112.458 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 t -68.81 -33.47 73.91 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.826 -0.35 . . . . 1.63 110.954 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 1.2 p-10 -103.9 33.76 3.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.693 0.759 . . . . 2.07 109.633 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 50.7 t80 -102.51 139.21 38.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.696 -1.138 . . . . 0.91 110.437 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.1 ttm -101.11 104.96 16.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 1.73 110.369 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.8 -154.32 25.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 1.05 111.541 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 99.14 41.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.849 -0.426 . . . . 2.14 109.849 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.3 -21.9 66.72 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.739 2.293 . . . . 1.01 113.494 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -87.85 -1.24 57.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.972 0.415 . . . . 2.08 111.043 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -112.7 15.68 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 2.18 110.389 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.92 146.4 23.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.585 -0.734 . . . . 0.92 111.161 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -128.88 172.39 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.602 -0.726 . . . . 2.35 110.241 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.99 123.27 29.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.165 -0.471 . . . . 1.4 110.52 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.25 59.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.674 -0.774 . . . . 0.75 111.976 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -69.94 129.44 39.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.692 0.282 . . . . 1.06 111.051 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.572 ' OE1' ' HB2' ' A' ' 82' ' ' SER . 10.4 tt0 -73.11 127.51 32.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.654 -0.703 . . . . 2.51 110.501 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 77' ' ' MET . 31.4 m -139.93 153.86 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.166 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 78' ' ' LEU . 10.3 pt-20 -114.15 147.18 39.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.101 -0.703 . . . . 1.49 109.101 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.2 p90 -166.72 166.18 16.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.396 0.617 . . . . 0.66 112.357 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.37 166.59 13.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.259 -0.882 . . . . 0.94 110.188 176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -101.96 143.2 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.303 -0.408 . . . . 1.19 110.644 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' O ' HD22 ' A' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.04 110.592 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 58' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.425 0.155 . . . . 2.3 111.021 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.2 150.1 88.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.069 2.513 . . . . 1.43 113.277 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -86.68 141.17 29.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.387 -0.824 . . . . 0.82 110.481 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 165.24 25.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.644 0.259 . . . . 2.3 111.268 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 61.93 27.26 16.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.758 -0.656 . . . . 2.01 111.339 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 t -71.56 120.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.8 111.076 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -129.42 161.7 29.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 3.51 110.222 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.491 ' HA ' HG12 ' A' ' 53' ' ' VAL . 60.2 mtt -80.84 143.93 32.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.12 111.473 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 54' ' ' GLU . 36.3 mt -112.61 162.53 21.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.828 -0.623 . . . . 1.67 110.196 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.37 149.49 80.72 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.685 2.256 . . . . 2.15 111.78 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 38.7 ttmt -79.41 152.17 30.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.247 -0.433 . . . . 4.61 110.734 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 4.9 m-20 70.66 35.19 1.91 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.934 0.494 . . . . 2.84 111.453 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.572 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 49.2 m -107.16 -9.87 16.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.807 0.337 . . . . 1.7 110.813 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD11 ' A' ' 27' ' ' LEU . 49.1 mm -76.36 136.16 68.67 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.52 -0.309 . . . . 0.92 110.366 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.74 157.54 61.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.652 2.235 . . . . 1.03 112.182 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -131.55 157.27 78.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.191 -0.459 . . . . 2.76 110.61 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 20.0 Cg_exo -62.56 138.68 71.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.157 . . . . 1.08 112.094 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 93.17 9.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.221 0.534 . . . . 1.1 110.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t -141.8 133.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.337 -0.986 . . . . 1.23 108.337 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.4 -62.52 1.67 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 2.87 112.621 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -94.09 -54.3 3.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 2.84 111.692 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t 173.77 161.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.643 -0.873 . . . . 1.42 108.643 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.6 m -106.0 -59.01 1.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.724 -0.39 . . . . 1.3 110.91 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -145.07 155.6 43.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.29 110.213 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -115.37 173.2 6.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.969 -0.752 . . . . 1.36 108.969 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.57 -166.08 35.15 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.125 -1.036 . . . . 0.53 111.88 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.72 147.89 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.106 -0.702 . . . . 1.37 109.106 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.82 112.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.784 -0.45 . . . . 0.69 109.784 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 -63.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.89 111.887 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.559 -0.291 . . . . 3.92 111.0 -173.48 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.175 0.435 . . . . 1.24 112.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.04 173.39 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 114.584 0.594 . . . . 0.94 114.584 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 130' ' ' GLU . 74.2 mt -143.87 136.33 26.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.93 111.257 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.3 mt -103.35 138.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.935 -1.03 . . . . 0.49 109.5 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.4 pt-20 -86.78 125.23 33.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.396 0.617 . . . . 1.4 109.611 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.748 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 11.6 mm -102.07 126.33 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.498 -0.774 . . . . 0.63 109.048 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.8 pt? -87.07 152.52 22.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 1.21 110.745 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.67 173.75 9.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.614 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -66.91 -23.26 65.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 2.78 111.09 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -86.8 -3.23 59.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.736 -0.468 . . . . 1.77 109.736 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 66.43 35.98 5.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.322 -0.854 . . . . 4.14 111.051 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m -81.24 -68.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.746 -0.661 . . . . 1.87 111.567 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p -155.28 -174.36 4.94 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.995 0.368 . . . . 1.54 111.995 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 4.6 p -67.12 133.2 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.688 -0.687 . . . . 1.29 111.211 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.21 -69.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.476 -0.329 . . . . 1.03 110.653 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 m -136.51 -84.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.81 -0.356 . . . . 1.56 111.758 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.448 ' HB2' HD22 ' A' ' 114' ' ' LEU . 11.4 pt20 -174.67 138.24 0.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.842 -0.617 . . . . 2.08 110.144 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.519 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -122.6 123.18 40.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.792 0.329 . . . . 0.68 110.359 170.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.0 tt0 -84.22 145.68 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.552 -0.749 . . . . 1.19 109.24 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.515 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.4 p90 -117.66 139.96 50.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 0.74 111.824 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.88 154.37 20.87 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 114.999 -1.0 . . . . 0.51 112.383 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.22 -32.56 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 0.67 111.564 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -74.68 -35.8 62.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.2 0.524 . . . . 1.35 110.705 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 36.9 m -62.82 -32.7 73.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.236 -0.893 . . . . 1.1 110.532 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 131' ' ' PHE . 72.7 mt -75.42 58.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 1.46 112.031 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.0 t -46.3 -43.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.357 0.599 . . . . 0.82 110.318 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 46.2 m-80 -95.87 34.66 1.49 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.3 -0.863 . . . . 2.17 111.508 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -56.65 -21.21 25.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.145 0.498 . . . . 1.39 111.615 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -70.91 -23.1 62.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 2.46 111.414 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.27 164.03 14.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.681 0.623 . . . . 1.89 112.681 -166.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.563 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -79.51 34.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.014 -0.994 . . . . 2.88 111.2 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.7 tp -56.16 105.43 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.021 -175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -121.66 -178.03 3.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.755 -0.657 . . . . 1.77 110.811 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -62.99 136.48 57.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.323 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.3 70.72 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.545 -0.836 . . . . 1.07 112.926 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -92.11 142.28 27.68 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.215 0.508 . . . . 1.94 109.859 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.2 mm? -83.95 138.51 33.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.194 0.521 . . . . 1.79 111.146 -172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.77 153.35 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.366 0.603 . . . . 1.16 111.912 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.2 m -129.57 138.01 51.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.221 -0.9 . . . . 1.44 109.332 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.748 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 38.8 p90 -149.0 174.15 12.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.645 -0.502 . . . . 0.61 109.645 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -130.38 120.46 24.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.397 0.618 . . . . 2.2 110.205 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.55 130.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.823 -0.626 . . . . 1.24 110.354 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 18.8 t70 -155.87 -100.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.954 -0.298 . . . . 1.92 110.718 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.468 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 42.2 mt-10 -83.9 -7.59 59.39 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.08 0.4 . . . . 2.76 112.08 -175.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -12.08 49.24 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.749 -0.464 . . . . 1.98 109.749 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.09 24.21 49.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.127 -0.942 . . . . 1.27 114.308 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -158.08 -177.94 6.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.829 -0.804 . . . . 3.61 108.829 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.14 108.65 16.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.367 -0.533 . . . . 0.48 110.698 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -119.12 159.49 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.49 110.442 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 39.7 t 63.07 38.08 11.09 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.673 0.608 . . . . 1.55 110.091 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.99 111.54 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.476 -0.784 . . . . 1.26 110.657 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.476 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 8.3 t30 -120.52 128.91 53.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.315 -0.402 . . . . 2.05 110.394 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -68.96 117.13 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 0.75 110.282 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.69 130.55 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.844 -0.617 . . . . 1.56 111.66 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 2.94 110.127 176.117 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 121.426 0.632 . . . . 2.0 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.55 116.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.956 -1.02 . . . . 1.27 109.073 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -87.63 138.61 31.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.931 -0.577 . . . . 1.14 110.004 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 22.7 ttm180 -113.55 141.04 47.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.71 -0.677 . . . . 2.31 110.04 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.08 -171.12 36.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.006 -0.838 . . . . 0.5 111.006 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.61 141.95 33.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.184 0.516 . . . . 0.68 111.141 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.34 119.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.296 -0.865 . . . . 0.56 110.823 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.38 -41.73 6.91 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.967 -0.293 . . . . 0.76 111.172 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -121.97 150.76 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.536 -0.542 . . . . 1.55 109.536 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.9 ttm -137.17 106.7 6.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 1.42 110.391 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.7 mmtt -100.71 172.37 7.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.865 -0.791 . . . . 2.03 108.865 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.62 -22.1 61.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.692 0.282 . . . . 3.24 111.668 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -111.14 -41.93 4.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.72 0.295 . . . . 2.03 111.701 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -145.12 176.71 9.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.617 -0.265 . . . . 1.25 110.487 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 -179.97 25.82 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.497 -0.859 . . . . 0.71 112.059 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 16' ' ' VAL . 54.3 m-85 -127.11 151.74 48.24 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.525 -0.546 . . . . 1.08 109.525 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -125.57 115.34 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.17 -0.468 . . . . 0.61 111.058 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.34 126.47 29.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.288 -1.004 . . . . 2.3 108.288 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 164.57 25.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.229 0.537 . . . . 0.87 111.401 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD2' HD12 ' A' ' 83' ' ' ILE . 1.8 tm? -60.58 -48.43 81.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.532 -0.758 . . . . 1.58 111.724 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -98.69 13.65 31.4 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.087 -0.338 . . . . 2.04 110.087 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 55.85 50.27 14.4 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.429 -0.952 . . . . 3.29 108.429 -168.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.14 -48.55 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.993 -1.458 . . . . 2.89 110.275 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -173.26 179.38 2.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 1.8 110.704 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CD ' ' HB3' ' A' ' 23' ' ' PHE . 10.0 tp10 -103.2 139.53 38.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.781 -0.452 . . . . 3.37 109.781 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.53 132.24 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.051 0.453 . . . . 0.87 111.224 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -87.19 118.39 26.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.426 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -120.01 151.3 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.96 108.918 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -115.84 133.0 56.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.476 -0.564 . . . . 1.18 109.476 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -62.47 -22.62 66.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.058 0.762 . . . . 0.75 113.058 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -61.29 -35.84 78.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.779 0.323 . . . . 1.63 111.076 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -96.09 22.54 7.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.259 0.552 . . . . 2.07 110.842 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' OH ' ' HG2' ' A' ' 77' ' ' MET . 39.6 t80 -91.51 136.6 33.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.212 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.33 97.74 7.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 1.73 110.142 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.19 -139.63 7.46 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.143 -0.783 . . . . 1.05 111.143 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 46' ' ' TRP . 1.5 p30 -124.73 91.46 49.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 121.515 0.674 . . . . 2.14 110.703 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.93 -21.04 33.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.003 2.468 . . . . 1.01 113.841 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -81.41 -11.66 59.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.371 0.605 . . . . 2.08 110.154 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 84.3 m95 -106.45 20.31 19.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 2.18 110.248 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 29.3 mt -85.14 -179.6 7.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.794 -0.639 . . . . 0.92 111.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -151.22 161.17 43.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.386 -0.825 . . . . 2.35 110.126 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.51 113.99 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 1.4 108.98 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.25 5.05 35.13 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.872 -0.604 . . . . 0.75 112.019 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.34 131.13 40.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.91 0.386 . . . . 1.06 111.315 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' CD ' HG12 ' A' ' 83' ' ' ILE . 40.2 mt-10 -78.27 128.26 33.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.227 -0.897 . . . . 2.51 111.279 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.89 161.33 18.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.444 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 78' ' ' LEU . 7.1 pt-20 -125.42 148.28 48.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.795 -0.446 . . . . 1.49 109.795 176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 11.9 p90 -163.99 175.17 10.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.66 112.142 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 p -130.14 170.72 13.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.44 -0.8 . . . . 0.94 110.112 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.86 138.75 45.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.78 0.324 . . . . 1.19 111.145 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.863 -0.608 . . . . 2.04 110.124 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.022 -0.733 . . . . 2.3 109.022 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.74 150.35 88.29 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.312 2.008 . . . . 1.43 112.223 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -88.63 137.01 32.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.67 -0.696 . . . . 0.82 111.035 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -112.41 165.74 11.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.845 -0.616 . . . . 2.3 110.334 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 63.18 29.67 16.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.818 -0.628 . . . . 2.01 111.477 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 9.6 t -74.19 108.25 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.8 110.237 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -112.31 167.82 10.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.87 0.367 . . . . 3.51 110.339 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.574 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 84.8 mtp -98.58 136.04 39.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.944 -0.571 . . . . 1.12 111.195 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 54' ' ' GLU . 46.0 mt -107.9 154.89 40.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 1.67 110.556 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.08 140.93 35.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.263 1.975 . . . . 2.15 110.372 169.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.32 164.68 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 4.61 111.034 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.3 t30 76.09 25.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.172 -0.922 . . . . 2.84 109.999 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -95.59 -14.86 23.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.398 -0.819 . . . . 1.7 109.122 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.623 HD12 ' CD2' ' A' ' 27' ' ' LEU . 8.7 mm -92.01 128.99 43.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.441 -0.8 . . . . 0.92 109.783 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.07 154.48 47.33 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.348 2.032 . . . . 1.03 112.14 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 152.15 74.35 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.556 -0.293 . . . . 2.76 110.465 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 18.0 Cg_endo -61.23 125.94 18.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 1.08 112.202 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.14 92.97 7.06 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.999 0.428 . . . . 1.1 111.17 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 26.0 t -142.43 107.33 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 1.23 109.713 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.85 -25.92 27.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.735 -0.386 . . . . 2.87 111.737 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' THR . 69.8 tt0 -73.42 -18.19 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.609 -0.269 . . . . 2.84 110.953 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 41.5 m 81.04 122.72 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.634 -0.712 . . . . 1.42 110.54 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -80.86 -57.64 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.3 112.337 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -141.35 174.73 10.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.232 0.539 . . . . 1.29 111.36 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -141.81 176.83 8.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.132 -0.94 . . . . 1.36 109.273 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.09 179.45 39.57 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 110.464 -1.055 . . . . 0.53 110.464 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.3 m -103.89 159.5 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 117.852 0.826 . . . . 1.37 110.161 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.37 121.57 19.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.196 -0.668 . . . . 0.69 109.196 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -66.86 -53.47 32.08 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.3 0.375 . . . . 0.89 110.731 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 3.92 110.551 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 120.59 0.233 . . . . 1.24 111.247 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.78 166.66 25.23 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.439 -0.665 . . . . 0.94 111.439 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 130' ' ' GLU . 66.8 mt -142.71 138.13 30.34 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.93 111.842 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.89 138.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.654 -1.157 . . . . 0.49 108.746 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.77 124.26 31.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.936 -0.765 . . . . 1.4 108.936 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.736 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.6 mm -101.36 120.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.494 -0.928 . . . . 0.63 108.494 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.0 pt? -83.33 144.25 29.81 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.294 -0.562 . . . . 1.21 110.157 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.07 151.49 12.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 2.29 109.583 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.72 -21.66 64.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 2.78 111.912 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.03 10.26 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.692 0.282 . . . . 1.77 110.374 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 67.52 30.39 6.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.613 -0.721 . . . . 4.14 111.512 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -70.32 -80.37 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.463 -0.335 . . . . 1.87 111.167 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -149.23 -176.45 5.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.687 -0.233 . . . . 1.54 110.643 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -65.25 134.51 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 123.542 0.526 . . . . 1.29 110.234 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -72.71 -67.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.442 -0.344 . . . . 1.03 110.432 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.9 m -137.6 -84.3 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.159 0.504 . . . . 1.56 110.645 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -176.6 139.84 0.33 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.249 -0.887 . . . . 2.08 108.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.3 m-70 -117.48 131.59 56.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.125 -0.63 . . . . 0.68 110.089 172.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.8 tt0 -89.57 139.49 30.49 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.763 -1.108 . . . . 1.19 109.402 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 46.1 p90 -118.67 134.87 54.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 0.74 110.961 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.11 153.94 24.01 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.326 -0.852 . . . . 0.51 112.57 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.2 -27.72 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.01 0.433 . . . . 0.67 110.807 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.8 p -74.86 -36.48 62.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.317 0.58 . . . . 1.35 110.443 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 162' ' ' VAL . 23.9 m -65.66 -30.2 70.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.84 . . . . 1.1 110.87 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.4 mt -71.49 58.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.812 0.695 . . . . 1.46 112.67 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -45.59 -42.28 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.408 0.623 . . . . 0.82 111.045 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.48 34.01 2.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 2.17 111.014 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 16.3 ptpt -54.53 -21.08 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.01 0.524 . . . . 1.39 112.357 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -86.39 -11.95 50.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 2.46 112.12 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.56 166.66 23.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 1.89 110.687 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -86.96 24.49 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.458 -0.337 . . . . 2.88 110.492 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 164' ' ' ALA . 15.8 tp -44.92 117.39 1.32 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.22 -0.9 . . . . 0.97 111.536 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -118.86 -172.97 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 1.77 111.238 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 72.4 tttt -67.53 140.22 57.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.908 -0.587 . . . . 1.43 110.139 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.06 86.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.423 -0.894 . . . . 1.07 112.439 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 7.9 m-20 -82.73 132.37 35.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.559 0.219 . . . . 1.94 110.741 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.54 135.11 42.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.993 -0.549 . . . . 1.79 110.828 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.36 151.45 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 1.16 111.187 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 44.0 p -109.03 136.01 49.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.811 -0.811 . . . . 1.44 108.811 172.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.689 ' HB3' HG12 ' A' ' 162' ' ' VAL . 36.1 p90 -154.24 169.3 23.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.852 0.358 . . . . 0.61 110.327 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 3.7 mpt_? -131.77 123.2 27.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.4 -0.52 . . . . 2.2 110.63 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.503 HG21 ' CD2' ' A' ' 129' ' ' HIS . 8.5 pt -100.14 146.77 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.736 -0.839 . . . . 1.24 108.736 166.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 23.7 t70 -175.1 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.366 -0.134 . . . . 1.92 110.969 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.25 -41.5 73.42 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 2.76 111.503 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 158' ' ' ARG . 42.3 t -84.9 -17.98 36.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.174 -0.466 . . . . 1.98 111.099 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.63 -25.36 1.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.797 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 156' ' ' SER . 67.2 mtt85 -93.02 175.68 6.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.317 0.247 . . . . 3.61 110.388 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.34 110.39 19.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.033 0.444 . . . . 0.48 110.219 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -123.25 160.2 27.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.722 -0.672 . . . . 0.49 110.84 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.6 m 59.93 42.84 15.61 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.944 0.778 . . . . 1.55 110.692 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.7 m -70.96 138.35 21.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.565 0.698 . . . . 1.26 110.892 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -136.04 123.71 22.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.328 -0.851 . . . . 2.05 109.74 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -59.25 125.73 24.82 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 123.372 0.42 . . . . 0.75 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.66 122.7 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.868 -0.606 . . . . 1.56 110.651 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 147' ' ' ASP . 1.6 mpt_? . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 109.188 -0.671 . . . . 2.94 109.188 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.932 0.396 . . . . 2.0 111.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.19 119.9 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.19 0.519 . . . . 1.14 109.798 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -112.39 138.71 48.73 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.482 -0.781 . . . . 2.31 110.187 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.42 -163.29 13.5 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.443 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -152.06 156.86 40.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.062 0.458 . . . . 0.68 110.69 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.32 119.26 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.711 -0.677 . . . . 0.56 111.218 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.88 -38.16 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.49 -0.323 . . . . 0.76 111.34 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.1 p -134.75 131.71 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.85 0.357 . . . . 1.55 110.739 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.2 mtp -123.06 129.91 52.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 1.42 110.449 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -173.46 2.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.131 -1.063 . . . . 2.03 108.131 171.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -87.54 -15.75 36.58 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.346 -0.542 . . . . 3.24 110.645 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.52 -47.13 3.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.429 0.529 . . . . 2.03 112.429 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -142.33 -175.42 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.127 0.489 . . . . 1.25 111.445 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.04 36.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.324 -0.71 . . . . 0.71 111.324 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.546 ' H ' HG13 ' A' ' 16' ' ' VAL . 79.4 m-85 -124.16 138.62 54.4 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.578 -0.527 . . . . 1.08 109.578 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -99.79 123.2 52.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.163 -0.471 . . . . 0.61 110.72 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.443 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 31.0 tt0 -76.15 118.92 19.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.056 -1.09 . . . . 2.3 108.056 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.18 160.27 31.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.501 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.497 ' CD1' HD12 ' A' ' 83' ' ' ILE . 9.1 tp -56.02 -48.57 75.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 1.58 111.616 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -118.56 40.68 3.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 2.04 109.789 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.8 p80 45.73 33.88 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.076 0.86 . . . . 3.29 111.032 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -52.63 -47.3 67.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.744 -1.116 . . . . 2.89 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -169.26 173.53 6.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.8 110.185 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.81 121.03 42.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 3.37 109.166 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -113.39 130.7 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.095 0.474 . . . . 0.87 111.69 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -89.02 120.23 30.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.404 -0.816 . . . . 1.06 110.14 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -121.08 147.33 45.68 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.122 -0.696 . . . . 1.96 109.122 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -109.03 133.16 53.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.572 -0.899 . . . . 1.18 108.572 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -57.67 -23.38 51.13 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.443 0.535 . . . . 0.75 112.443 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -68.97 -15.66 63.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.869 0.366 . . . . 1.63 111.929 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -104.44 8.15 35.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.479 0.657 . . . . 2.07 109.788 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 75.7 t80 -93.02 126.7 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.355 -0.839 . . . . 0.91 110.064 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.4 ttm -96.68 101.87 13.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.357 -0.383 . . . . 1.73 110.294 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.02 -150.95 23.23 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.102 -0.57 . . . . 1.05 111.697 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -105.73 105.34 52.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.778 -0.453 . . . . 2.14 109.778 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.04 -25.88 3.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.805 2.337 . . . . 1.01 113.702 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -69.77 -24.74 63.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.623 0.725 . . . . 2.08 109.523 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.71 20.68 12.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.358 -0.837 . . . . 2.18 111.132 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.51 149.29 25.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.92 110.515 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.55 158.11 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 2.35 109.761 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.67 120.07 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.947 0.403 . . . . 1.4 110.274 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.07 -11.87 26.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.98 -0.629 . . . . 0.75 112.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.33 120.6 13.08 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.961 0.41 . . . . 1.06 111.409 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 5.0 mp0 -64.62 129.05 38.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 2.51 111.146 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 77' ' ' MET . 26.8 m -140.85 149.97 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.654 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -124.33 150.27 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.926 -0.398 . . . . 1.49 109.926 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 3.2 p90 -163.91 179.67 6.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.927 0.394 . . . . 0.66 111.308 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 p -128.45 166.93 17.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.091 -0.504 . . . . 0.94 110.742 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.06 147.4 30.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.359 -0.382 . . . . 1.19 110.97 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.397 0.618 . . . . 2.04 110.681 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.438 -0.578 . . . . 2.3 109.438 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.08 146.6 87.51 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.039 1.826 . . . . 1.43 112.274 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 144.64 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.792 -0.64 . . . . 0.82 110.179 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.02 163.73 18.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.721 0.296 . . . . 2.3 110.837 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.8 57.38 2.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.601 -0.727 . . . . 2.01 110.551 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 21.8 t -93.01 122.59 44.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.8 109.877 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -124.39 147.74 48.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.404 . . . . 3.51 110.106 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.446 ' HA ' HG12 ' A' ' 53' ' ' VAL . 48.9 mtt -70.92 154.12 42.09 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.866 0.365 . . . . 1.12 110.4 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 79' ' ' PRO . 17.3 tp -125.61 144.13 47.1 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.009 -0.541 . . . . 1.67 110.023 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 78' ' ' LEU . 25.3 Cg_endo -61.65 142.9 95.94 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.265 1.977 . . . . 2.15 111.961 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 4.2 ttmp? -62.94 156.67 23.77 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.825 -0.625 . . . . 4.61 111.856 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m120 73.74 24.02 2.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.45 -0.796 . . . . 2.84 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -96.96 8.5 44.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.04 -0.527 . . . . 1.7 110.181 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 27' ' ' LEU . 18.4 mm -108.75 133.06 20.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.636 -0.505 . . . . 0.92 109.636 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.89 149.84 66.59 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.593 2.195 . . . . 1.03 112.621 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.99 145.99 54.83 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.073 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 76.3 Cg_exo -52.31 132.53 44.63 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.592 2.861 . . . . 1.08 113.49 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.03 94.66 8.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.1 110.863 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.29 150.63 27.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.739 -0.838 . . . . 1.23 108.739 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.94 -64.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.076 -0.65 . . . . 2.87 111.37 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' THR . 30.8 tt0 -95.06 -58.63 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.302 -0.559 . . . . 2.84 111.027 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER 175.62 173.96 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.169 -0.923 . . . . 1.42 109.254 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -105.46 -58.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.3 110.73 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.31 178.45 6.87 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.023 -0.535 . . . . 1.29 110.815 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.96 -177.91 4.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.038 -0.528 . . . . 1.36 110.476 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.44 -163.32 29.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.085 -0.579 . . . . 0.53 111.867 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.47 146.36 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.667 -0.494 . . . . 1.37 109.667 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.28 121.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.69 110.301 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HE3' ' A' ' 145' ' ' LYS . . . -73.04 -60.18 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.572 0.582 . . . . 0.89 112.572 -172.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 . . . . . 0 C--N 1.33 -0.245 0 C-N-CA 120.495 -0.482 . . . . 3.92 111.647 -176.214 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.134 0 N-CA-C 112.178 0.436 . . . . 1.24 112.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.83 162.87 30.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.515 -0.85 . . . . 0.94 111.66 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 130' ' ' GLU . 82.6 mt -144.45 147.08 32.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.54 0.686 . . . . 0.93 112.287 -172.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.6 mt -112.48 137.8 43.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.514 -1.221 . . . . 0.49 109.513 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -89.89 120.72 31.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.458 0.647 . . . . 1.4 110.116 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.575 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 34.9 mm -97.8 129.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 0.63 109.582 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -87.35 156.71 19.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.535 -0.302 . . . . 1.21 110.311 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.05 167.57 9.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.392 -0.596 . . . . 2.29 109.392 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.3 pm0 -69.71 -17.07 63.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.042 0.449 . . . . 2.78 110.563 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -99.6 -2.42 35.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 1.77 109.821 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 54.22 80.66 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.505 -0.77 . . . . 4.14 110.731 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.61 -47.37 1.84 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.323 -0.398 . . . . 1.87 111.142 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 -177.75 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 1.54 111.021 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.31 130.68 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.543 -0.91 . . . . 1.29 108.543 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.61 -69.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.6 -0.44 . . . . 1.03 110.869 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -138.75 -85.23 0.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.498 0.666 . . . . 1.56 111.034 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -175.96 137.64 0.33 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.777 -1.101 . . . . 2.08 108.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CG ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -113.19 132.75 55.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.163 -0.615 . . . . 0.68 110.664 173.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.502 ' HA ' HD23 ' A' ' 114' ' ' LEU . 5.7 tt0 -92.54 140.46 29.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.626 -1.17 . . . . 1.19 109.42 -175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.464 ' CD1' HD21 ' A' ' 136' ' ' LEU . 40.7 p90 -118.51 141.41 48.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.74 111.021 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.09 152.93 20.18 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.468 -0.787 . . . . 0.51 112.209 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.73 -30.15 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.212 0.506 . . . . 0.67 111.001 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -78.07 -23.61 47.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.485 0.659 . . . . 1.35 110.542 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.516 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 62.9 m -78.74 -27.6 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.101 -0.954 . . . . 1.1 110.464 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 131' ' ' PHE . 69.4 mt -75.33 60.11 1.1 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.349 -0.841 . . . . 1.46 112.017 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.24 -45.59 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.931 0.396 . . . . 0.82 111.522 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.538 HD21 HD22 ' A' ' 143' ' ' LEU . 2.9 p-10 -92.27 33.9 1.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.753 0.311 . . . . 2.17 111.231 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -53.0 -22.56 5.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.467 0.707 . . . . 1.39 112.674 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.71 -19.04 49.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.364 -0.38 . . . . 2.46 111.26 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 162.86 27.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.625 0.726 . . . . 1.89 112.465 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -81.86 35.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.788 -1.096 . . . . 2.88 110.47 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 138' ' ' ASN . 24.4 tp -63.72 127.09 29.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.97 110.692 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.61 -173.55 3.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 1.77 110.95 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 98' ' ' ALA . 83.8 tttt -66.18 138.53 57.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 1.43 109.9 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.19 66.99 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.738 -0.744 . . . . 1.07 112.626 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -90.62 140.36 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 1.94 110.728 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.03 140.91 33.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.709 -0.678 . . . . 1.79 110.742 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.15 143.91 38.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.508 . . . . 1.16 112.009 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -115.84 125.87 53.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 1.44 109.389 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 51.6 p90 -145.12 168.57 20.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.619 0.247 . . . . 0.61 110.404 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 121.35 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.34 -0.944 . . . . 2.2 110.469 172.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.5 130.46 52.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 1.24 110.324 174.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 22.7 t70 -149.0 -89.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.536 . . . . 1.92 111.862 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -33.52 40.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.379 0.511 . . . . 2.76 112.379 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.2 p -84.12 -17.15 41.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.477 -0.329 . . . . 1.98 111.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.67 23.15 70.46 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.728 -0.749 . . . . 1.27 113.065 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -126.43 173.53 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.679 -0.489 . . . . 3.61 109.679 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.86 18.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.269 -0.641 . . . . 0.48 109.269 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.44 158.18 38.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.196 -0.457 . . . . 0.49 110.438 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 45.6 m 55.4 30.72 15.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.512 0.673 . . . . 1.55 109.304 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.4 126.73 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.135 -0.939 . . . . 1.26 110.932 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.495 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 5.8 t30 -125.34 132.27 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.231 -0.895 . . . . 2.05 110.296 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.42 126.76 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.75 110.389 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.05 119.63 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.068 0.461 . . . . 1.56 111.617 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 2.94 110.691 177.835 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 88.5 mm-40 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.111 0.481 . . . . 2.0 111.455 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.28 115.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.586 -0.734 . . . . 1.27 109.501 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 8' ' ' GLN . 49.5 m-85 -98.69 150.64 21.58 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.255 -0.884 . . . . 1.14 109.662 -176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' C ' HD23 ' A' ' 27' ' ' LEU . 35.2 ttm-85 -108.26 149.41 28.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.813 -0.63 . . . . 2.31 109.994 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.93 170.95 42.25 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.143 -0.783 . . . . 0.5 111.143 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.973 0.416 . . . . 0.68 111.312 -174.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.38 118.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.754 -0.657 . . . . 0.56 110.721 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.58 -43.13 3.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.938 0.399 . . . . 0.76 110.779 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.03 123.59 70.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 1.55 111.039 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.1 mtp -119.19 110.09 16.63 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.566 . . . . 1.42 109.473 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 69.6 mmtt -97.66 -167.92 1.6 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.447 -0.575 . . . . 2.03 109.447 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.93 -26.98 30.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.486 -0.324 . . . . 3.24 111.108 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.65 -44.4 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 2.03 111.227 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -137.95 -170.44 2.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.088 -0.505 . . . . 1.25 110.657 -174.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.66 174.96 34.36 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 0.71 112.234 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -122.82 139.36 54.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.881 -0.415 . . . . 1.08 109.881 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.78 131.71 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.781 -0.645 . . . . 0.61 110.438 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.86 107.15 8.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.126 -1.065 . . . . 2.3 108.126 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -62.57 149.56 42.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.533 -0.303 . . . . 0.87 110.657 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -51.45 -48.25 62.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 1.58 111.303 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -84.4 3.76 34.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 2.04 111.713 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.1 p80 39.96 39.97 0.67 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.124 0.97 . . . . 3.29 111.881 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -88.39 -39.52 14.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.364 -0.835 . . . . 2.89 110.073 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.15 162.8 34.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 1.8 110.107 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -104.31 127.82 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.611 -0.515 . . . . 3.37 109.611 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 55' ' ' TYR . 58.9 t -104.49 128.6 57.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.302 0.572 . . . . 0.87 110.836 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -81.83 114.21 20.3 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.846 -1.07 . . . . 1.06 109.733 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -116.7 145.55 43.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.172 -0.677 . . . . 1.96 109.172 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -109.8 131.62 54.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.392 -0.596 . . . . 1.18 109.392 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.95 -20.27 56.59 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.972 0.415 . . . . 0.75 111.636 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -68.45 -23.28 64.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 1.63 111.118 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -106.76 14.1 27.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.057 0.456 . . . . 2.07 110.723 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -88.45 132.77 34.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.044 -0.526 . . . . 0.91 110.728 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.9 ttm -94.96 109.36 21.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.189 -0.46 . . . . 1.73 110.39 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.39 -141.97 12.89 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.738 -0.744 . . . . 1.05 111.84 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -116.65 103.35 52.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.004 -0.369 . . . . 2.14 110.004 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.17 -23.44 39.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.256 . . . . 1.01 112.949 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -86.16 -4.85 59.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.438 0.637 . . . . 2.08 110.51 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -112.15 19.44 17.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.723 -0.671 . . . . 2.18 110.568 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 47' ' ' LEU . 16.8 mt -87.97 157.33 18.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.643 -0.708 . . . . 0.92 111.091 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -131.2 157.37 43.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.783 -0.644 . . . . 2.35 111.166 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.45 121.87 22.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.117 0.484 . . . . 1.4 110.168 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.09 56.08 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.063 -0.589 . . . . 0.75 112.126 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -73.29 120.47 18.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 1.06 111.233 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.25 129.0 39.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.96 -1.018 . . . . 2.51 111.535 174.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.77 142.44 30.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.44 110.315 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.71 135.42 53.96 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.082 -0.71 . . . . 1.49 109.082 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 33' ' ' VAL . 11.4 p90 -156.8 159.64 38.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.063 -0.517 . . . . 0.66 111.134 -169.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.2 p -112.61 146.79 37.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.461 -0.336 . . . . 0.94 110.814 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.72 140.18 32.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.973 0.416 . . . . 1.19 110.861 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.887 -0.597 . . . . 2.04 110.693 178.45 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 110.032 -0.358 . . . . 2.3 110.032 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.07 147.81 94.38 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.779 2.32 . . . . 1.43 113.367 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.24 137.99 45.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.125 -0.943 . . . . 0.82 110.289 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -118.47 152.85 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.197 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.6 72.91 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.637 . . . . 2.01 110.356 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.9 t -105.18 111.09 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.8 110.204 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -121.82 141.56 51.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 3.51 110.927 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.6 mtm -74.94 144.74 43.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 1.12 110.912 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.5 pt? -128.04 162.87 47.34 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.961 -0.755 . . . . 1.67 108.961 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 21.8 Cg_endo -62.19 163.59 19.62 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.138 1.892 . . . . 2.15 113.127 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HG2' ' H ' ' A' ' 81' ' ' ASN . 26.9 ttpp -79.93 -179.48 7.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.551 -0.749 . . . . 4.61 110.39 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 54.0 m-20 78.07 9.17 2.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.764 0.826 . . . . 2.84 111.218 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -79.61 -34.17 40.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.97 -0.559 . . . . 1.7 110.018 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.57 ' CD1' HD21 ' A' ' 27' ' ' LEU . 10.7 mm -82.76 127.39 70.22 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.603 -0.726 . . . . 0.92 109.771 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.59 144.67 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.486 2.124 . . . . 1.03 112.644 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -103.55 131.42 22.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.779 . . . . 2.76 108.895 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.43 125.11 5.72 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.953 2.436 . . . . 1.08 113.018 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.1 92.4 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.74 . . . . 1.1 111.456 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -141.78 129.84 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.587 -1.264 . . . . 1.23 107.587 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.43 -63.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.568 0.581 . . . . 2.87 112.568 -169.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.5 tp10 -95.41 -55.11 3.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.111 0.481 . . . . 2.84 111.017 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.7 t 169.96 161.47 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.646 -0.706 . . . . 1.42 109.756 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m -105.79 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 1.3 112.256 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -138.91 172.34 13.0 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.494 0.664 . . . . 1.29 112.268 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.89 163.05 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.878 -1.056 . . . . 1.36 109.399 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.54 177.49 45.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.817 -0.706 . . . . 0.53 111.387 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 m -107.79 161.6 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.046 0.45 . . . . 1.37 110.28 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.13 126.9 26.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.133 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.74 -44.35 56.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.89 111.484 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.74 0.274 . . . . 3.92 111.74 177.268 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.204 0 N-CA-C 111.81 0.3 . . . . 1.24 111.81 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 65.21 -176.65 12.42 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.265 -0.493 . . . . 0.94 113.311 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 130' ' ' GLU . 48.4 mt -151.01 139.8 20.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.217 0.532 . . . . 0.93 110.917 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.4 135.22 41.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 0.49 109.308 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 10.6 pt-20 -86.03 112.43 21.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.858 0.837 . . . . 1.4 109.246 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 129' ' ' HIS . 16.9 mm -85.27 141.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.895 -1.048 . . . . 0.63 110.285 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 122' ' ' ARG . 34.9 tp -85.44 136.95 33.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 116.251 -0.431 . . . . 1.21 110.015 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.47 152.82 10.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.059 -0.973 . . . . 2.29 110.441 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.9 pm0 -58.4 -26.72 63.55 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.043 0.386 . . . . 2.78 112.043 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.485 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.93 15.43 22.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.029 -0.268 . . . . 1.77 110.444 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.495 ' HG2' HD21 ' A' ' 118' ' ' LEU . 1.4 tmm_? 64.25 31.8 12.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.818 0.818 . . . . 4.14 109.484 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 m -77.18 -83.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.751 -0.659 . . . . 1.87 111.435 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 p -140.39 -169.76 2.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.737 -0.211 . . . . 1.54 110.779 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -67.97 137.62 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.903 -0.406 . . . . 1.29 109.903 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.9 mt -83.68 -70.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.282 -0.567 . . . . 1.03 110.739 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.8 p -135.88 -85.64 0.36 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.169 0.509 . . . . 1.56 111.714 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -176.48 137.43 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.247 -0.888 . . . . 2.08 109.489 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.781 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.1 m-70 -124.49 132.97 53.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.68 110.254 171.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 114' ' ' LEU . 15.0 tt0 -86.41 150.3 24.4 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.644 -0.707 . . . . 1.19 110.158 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -123.33 140.81 52.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.289 0.566 . . . . 0.74 111.671 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.49 154.74 20.77 Favored Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 115.426 -0.806 . . . . 0.51 111.987 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.35 -23.75 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 117.154 0.477 . . . . 0.67 111.493 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.7 p -81.78 -26.06 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.341 0.591 . . . . 1.35 110.669 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 19.8 m -73.81 -30.0 62.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.41 -0.814 . . . . 1.1 110.001 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 73.1 mt -76.01 60.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.242 -0.89 . . . . 1.46 111.828 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.46 -48.2 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.825 0.345 . . . . 0.82 111.595 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.74 35.84 1.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 2.17 111.167 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 14.8 ptpt -48.23 -25.08 1.37 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.194 1.183 . . . . 1.39 114.194 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -82.24 -11.44 58.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.903 0.383 . . . . 2.46 110.915 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.94 147.34 48.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 1.89 109.904 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.99 87.28 6.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.701 0.762 . . . . 2.88 110.051 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 143' ' ' LEU . 12.2 tp -103.34 109.22 20.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.659 -1.155 . . . . 0.97 110.223 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -104.8 -177.49 3.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.918 -0.583 . . . . 1.77 110.916 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -66.62 141.46 57.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.43 110.104 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.99 -4.23 81.36 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.63 -0.795 . . . . 1.07 113.151 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.1 141.56 28.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.757 -0.777 . . . . 1.94 109.64 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mt -86.82 132.14 33.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.423 0.63 . . . . 1.79 111.746 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.42 152.74 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 1.16 110.875 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.0 p -112.1 140.33 46.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 1.44 109.389 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 42.5 p90 -163.88 168.09 19.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.809 -0.441 . . . . 0.61 109.809 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 124.12 25.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.695 -0.802 . . . . 2.2 111.438 173.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tt -99.44 140.31 19.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.785 -1.098 . . . . 1.24 110.435 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -166.57 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.765 -0.198 . . . . 1.92 110.759 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.36 -36.73 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 2.76 111.573 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.9 t -74.36 -17.44 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.876 0.37 . . . . 1.98 111.015 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.51 19.89 54.7 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.516 -0.849 . . . . 1.27 112.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -139.31 178.23 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.968 -0.753 . . . . 3.61 108.968 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.36 108.64 19.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.251 -0.277 . . . . 0.48 110.251 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -121.3 161.98 21.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.43 . . . . 0.49 110.964 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.5 m 63.84 37.07 9.93 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.712 0.633 . . . . 1.55 109.921 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.8 t -69.15 114.93 6.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.237 -0.892 . . . . 1.26 111.202 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -125.13 118.81 26.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.834 -0.621 . . . . 2.05 109.945 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.94 116.19 3.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.75 110.543 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.05 118.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.506 0.669 . . . . 1.56 111.585 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.702 -0.681 . . . . 2.94 109.923 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.181 0.515 . . . . 2.0 111.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.11 122.52 44.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 1.27 108.896 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.09 137.59 32.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.204 -0.453 . . . . 1.14 110.304 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -106.62 142.24 36.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.096 -0.502 . . . . 2.31 109.676 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.24 -174.01 34.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.183 -0.767 . . . . 0.5 111.183 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -140.81 144.17 35.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.884 0.373 . . . . 0.68 110.8 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.01 115.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.56 111.021 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.42 -44.36 4.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 0.76 110.507 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 23' ' ' PHE . 86.9 t -117.35 123.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.036 -0.529 . . . . 1.55 110.801 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.8 ttm -124.12 110.96 15.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.579 . . . . 1.42 109.968 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.3 mmtt -100.68 -174.3 2.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.754 -0.462 . . . . 2.03 109.754 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.06 -20.3 38.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.931 -0.577 . . . . 3.24 110.485 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -111.78 -49.02 3.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.089 0.471 . . . . 2.03 111.457 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 12.4 p90 -141.23 -174.12 3.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 1.25 109.747 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.74 177.48 33.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.591 -0.814 . . . . 0.71 112.254 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' CZ ' ' HE1' ' A' ' 21' ' ' PHE . 63.5 m-85 -128.78 139.09 52.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.021 0.439 . . . . 1.08 109.954 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -112.47 125.9 69.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.844 -0.617 . . . . 0.61 110.914 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.8 132.01 43.04 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.776 -0.824 . . . . 2.3 108.776 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 p -84.0 150.13 25.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.87 110.199 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 6.9 tp -49.07 -46.85 45.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.788 -0.642 . . . . 1.58 111.828 -174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 m -109.14 30.14 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.028 -0.533 . . . . 2.04 110.74 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 p80 39.4 57.37 2.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.618 1.199 . . . . 3.29 111.389 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.16 -35.97 23.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.73 -1.577 . . . . 2.89 109.918 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -173.72 175.22 2.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.14 -0.936 . . . . 1.8 110.108 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.6 128.57 50.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.196 -1.039 . . . . 3.37 108.196 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 124.37 58.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.648 -0.421 . . . . 0.87 111.043 -174.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.2 112.47 4.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.811 -0.631 . . . . 1.06 109.572 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 75' ' ' VAL . 4.6 t80 -121.64 121.61 37.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.624 0.726 . . . . 1.96 110.796 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.94 128.18 44.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.135 -0.939 . . . . 1.18 108.717 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -62.17 -18.56 61.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.981 0.363 . . . . 0.75 111.981 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -60.05 -34.04 72.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.38 . . . . 1.63 111.03 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -95.65 20.79 9.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.934 0.397 . . . . 2.07 111.215 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 93.1 t80 -94.07 139.62 30.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.91 110.871 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.33 106.16 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.054 -0.521 . . . . 1.73 110.444 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.56 -150.51 17.82 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.862 -0.685 . . . . 1.05 112.173 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -108.37 104.05 52.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.456 0.17 . . . . 2.14 110.729 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.22 -19.95 28.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 1.01 112.819 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -70.44 -22.71 62.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.437 0.637 . . . . 2.08 110.164 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -96.28 19.38 12.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.348 -0.842 . . . . 2.18 110.343 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.402 HD23 ' HG2' ' A' ' 51' ' ' GLN . 55.4 mt -95.84 153.55 17.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 0.92 110.181 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 51' ' ' GLN . 6.0 pt-20 -126.24 162.25 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.969 -0.56 . . . . 2.35 109.935 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 114.58 10.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.017 -0.735 . . . . 1.4 109.017 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.37 4.54 40.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.506 -0.854 . . . . 0.75 112.183 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 57.9 tp60 -73.49 133.1 43.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.897 0.38 . . . . 1.06 110.612 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -86.27 128.24 34.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 2.51 110.799 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 77' ' ' MET . 35.7 m -139.51 160.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.088 -0.505 . . . . 0.44 110.921 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 78' ' ' LEU . 25.4 pt-20 -120.88 140.02 52.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.234 -0.654 . . . . 1.49 109.234 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 75' ' ' VAL . 1.4 p90 -161.78 172.62 15.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.088 0.47 . . . . 0.66 112.075 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 p -131.96 157.86 42.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.684 -0.689 . . . . 0.94 110.77 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.44 149.29 22.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 1.19 111.155 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.972 -0.558 . . . . 2.04 111.125 -179.826 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 70' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 120.709 0.29 . . . . 2.3 111.696 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.09 155.21 66.11 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.854 2.369 . . . . 1.43 112.378 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.03 30.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.82 110.668 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.79 169.32 17.23 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.507 -0.553 . . . . 2.3 109.507 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 t30 60.03 45.54 11.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.636 0.732 . . . . 2.01 109.871 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 35' ' ' PHE . 20.1 t -93.32 114.05 29.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.73 . . . . 0.8 110.359 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 163.28 24.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 3.51 110.239 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.7 mtt -79.63 153.02 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.145 0.498 . . . . 1.12 111.369 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 54' ' ' GLU . 18.8 mt -119.88 158.54 49.69 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.252 -0.885 . . . . 1.67 109.687 172.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.21 153.83 71.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.125 1.883 . . . . 2.15 111.93 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 51' ' ' GLN . 10.8 tptp -78.94 148.68 32.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.077 -0.511 . . . . 4.61 110.839 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 72.01 30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 2.84 110.853 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.3 p -87.63 -11.71 47.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.39 0.614 . . . . 1.7 109.923 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 13.6 mm -84.98 131.56 48.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.315 -0.857 . . . . 0.92 109.627 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.18 150.58 65.85 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.483 2.122 . . . . 1.03 112.412 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -126.92 148.54 65.9 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.403 -0.362 . . . . 2.76 110.206 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.98 127.8 14.09 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.024 2.483 . . . . 1.08 113.625 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.94 94.49 4.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.659 -0.701 . . . . 1.1 110.895 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.86 120.94 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 1.23 109.087 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.05 -62.77 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.544 0.201 . . . . 2.87 111.544 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 6.0 mm-40 -92.98 -55.33 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 2.84 111.733 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 12.5 t 168.91 158.67 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.695 -0.854 . . . . 1.42 108.695 -176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.08 -58.92 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.454 -0.498 . . . . 1.3 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.44 163.61 34.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 1.29 110.803 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -120.87 174.09 6.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.457 -0.942 . . . . 1.36 108.457 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.35 -174.3 46.87 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.027 -1.083 . . . . 0.53 111.606 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.408 HG12 HD13 ' A' ' 148' ' ' LEU . 35.6 m -119.15 162.42 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.008 0.432 . . . . 1.37 110.028 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.39 122.43 17.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.94 -0.573 . . . . 0.69 109.869 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.65 -45.65 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.352 . . . . 0.89 111.61 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 3.92 110.835 179.469 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB3' ' HG2' ' A' ' 130' ' ' GLU . . . . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 112.301 0.482 . . . . 1.24 112.301 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.23 150.7 8.72 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.635 -0.793 . . . . 0.94 112.284 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.443 HD23 ' CA ' ' A' ' 130' ' ' GLU . 67.3 mt -127.28 147.26 50.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.498 0.666 . . . . 0.93 112.597 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 82.3 mt -111.11 141.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.908 -1.042 . . . . 0.49 109.313 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 125' ' ' VAL . 32.7 tt0 -93.11 109.24 20.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.148 0.499 . . . . 1.4 109.981 -176.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.6 mm -91.74 132.52 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.713 . . . . 0.63 110.154 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -91.83 153.91 19.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.131 0.491 . . . . 1.21 111.008 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.534 ' HB3' ' H ' ' A' ' 123' ' ' THR . 2.8 t70 -55.12 146.88 17.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.32 -0.855 . . . . 2.29 109.063 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.744 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.9 pm0 -62.75 -20.01 64.53 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.464 0.542 . . . . 2.78 112.464 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -102.25 13.46 34.6 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.936 -0.394 . . . . 1.77 109.936 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 58.1 80.89 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.652 -0.704 . . . . 4.14 110.378 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.534 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 32.5 m -116.33 -71.99 0.71 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.451 -0.795 . . . . 1.87 109.663 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -146.43 -176.58 5.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.82 -0.627 . . . . 1.54 110.189 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 116' ' ' GLU . 3.6 p -72.38 137.86 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.281 -0.418 . . . . 1.29 110.105 175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.37 -70.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.431 -0.507 . . . . 1.03 110.086 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.2 p -138.48 -87.82 0.24 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.417 0.627 . . . . 1.56 111.193 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.98 139.1 0.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.647 -1.16 . . . . 2.08 108.224 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -117.32 121.06 40.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.455 -0.498 . . . . 0.68 110.448 173.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.443 ' CA ' HD23 ' A' ' 114' ' ' LEU . 9.3 tt0 -78.71 149.31 32.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.736 -0.665 . . . . 1.19 109.849 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -117.77 175.44 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.943 0.402 . . . . 0.74 111.007 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.46 153.09 21.44 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.797 -0.638 . . . . 0.51 111.616 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -51.03 -30.54 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.019 0.409 . . . . 0.67 111.516 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.4 p -74.44 -36.91 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 1.35 110.946 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 16.9 m -69.94 -23.15 63.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 1.1 110.145 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.88 59.78 1.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 1.46 111.846 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.2 t -48.28 -41.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.228 0.537 . . . . 0.82 110.563 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -95.95 33.88 1.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.652 -0.703 . . . . 2.17 110.722 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -52.93 -25.09 10.77 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.799 1.037 . . . . 1.39 113.799 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -84.07 -16.92 42.01 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.586 -0.446 . . . . 2.46 111.363 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -76.01 150.05 37.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 1.89 110.617 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 142' ' ' LEU . 2.1 mm? -84.96 71.37 10.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.935 -0.575 . . . . 2.88 109.745 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.6 tp -75.72 122.88 24.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.97 110.028 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -108.32 172.12 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.024 0.44 . . . . 1.77 111.758 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 146' ' ' GLY . 13.5 tmtt? -70.93 132.82 45.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 1.43 110.366 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.418 ' N ' ' HD3' ' A' ' 145' ' ' LYS . . . 87.56 4.07 80.38 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.47 -0.871 . . . . 1.07 113.05 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.89 152.01 22.4 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.136 -0.626 . . . . 1.94 110.045 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 96' ' ' VAL . 3.3 mm? -77.32 123.47 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.529 0.681 . . . . 1.79 111.513 -172.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.169 -0.923 . . . . 1.16 110.339 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 73.4 m -121.57 152.8 38.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.057 -0.52 . . . . 1.44 110.558 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 162' ' ' VAL . 6.4 p90 -165.49 168.27 16.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.803 -0.635 . . . . 0.61 109.817 -173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.48 122.55 29.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.459 0.647 . . . . 2.2 110.805 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -100.7 137.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.886 . . . . 1.24 110.551 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.548 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 31.6 t70 -169.64 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.19 -0.3 . . . . 1.92 110.19 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.548 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 39.1 mt-10 -76.73 -18.61 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.618 . . . . 2.76 110.035 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.5 p -80.03 -18.68 49.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.542 -0.754 . . . . 1.98 110.643 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.77 2.73 2.69 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.61 -0.723 . . . . 1.27 114.082 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -154.89 -161.16 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.262 -0.644 . . . . 3.61 109.262 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.71 115.58 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.337 0.589 . . . . 0.48 110.842 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -128.79 148.81 50.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.497 -0.774 . . . . 0.49 109.861 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.0 m 55.27 55.17 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.038 0.836 . . . . 1.55 110.916 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 151' ' ' PHE . 4.1 m -77.25 141.62 15.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.287 0.565 . . . . 1.26 110.277 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -138.56 119.95 14.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 2.05 110.286 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.16 103.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.115 -0.493 . . . . 0.75 110.958 174.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.97 118.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.381 0.61 . . . . 1.56 110.698 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 2.94 110.791 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 120.998 0.428 . . . . 2.0 110.977 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 56' ' ' THR . 2.4 p -104.23 129.71 56.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.612 -0.722 . . . . 1.27 109.774 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -113.17 148.72 34.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.279 -0.873 . . . . 1.14 109.881 -174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -110.45 136.42 49.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.147 -0.479 . . . . 2.31 109.907 -177.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.44 -168.2 17.52 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.372 -0.691 . . . . 0.5 111.372 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 149.14 34.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.121 0.486 . . . . 0.68 111.178 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.77 118.99 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.442 -0.799 . . . . 0.56 110.497 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.21 -49.67 3.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.76 111.001 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 23' ' ' PHE . 6.3 p -123.51 139.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.032 -0.531 . . . . 1.55 110.272 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.7 ttm -131.76 122.05 25.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.42 . . . . 1.42 110.993 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -107.43 -170.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.653 -0.869 . . . . 2.03 108.653 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.96 -20.36 25.99 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.438 -0.801 . . . . 3.24 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.83 -48.44 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.063 0.459 . . . . 2.03 111.34 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.3 p90 -143.65 175.78 9.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.36 . . . . 1.25 110.947 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.27 173.23 33.51 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.435 -0.666 . . . . 0.71 111.435 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.648 ' H ' HG13 ' A' ' 16' ' ' VAL . 40.7 m-85 -114.16 126.17 54.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.661 -0.866 . . . . 1.08 108.661 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.69 125.66 46.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.243 -0.435 . . . . 0.61 110.527 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.74 119.7 15.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.172 -0.677 . . . . 2.3 109.172 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.45 160.55 24.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.87 110.315 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 13.9 tp -56.27 -46.4 79.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.341 -0.39 . . . . 1.58 111.929 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.8 t -99.58 13.02 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.59 -0.522 . . . . 2.04 109.59 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.555 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 84.5 m-70 61.22 35.56 18.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.42 -0.809 . . . . 3.29 109.599 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.94 -58.52 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.094 -1.412 . . . . 2.89 111.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.07 178.85 9.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 1.8 109.765 -173.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 131.4 50.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 3.37 110.62 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.98 129.9 64.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.888 -0.597 . . . . 0.87 110.464 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -80.91 113.21 18.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.464 0.65 . . . . 1.06 110.446 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 75' ' ' VAL . 26.3 t80 -121.95 132.49 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 1.96 110.13 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -102.26 124.32 47.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.159 -0.682 . . . . 1.18 109.159 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.97 -18.74 63.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.476 0.547 . . . . 0.75 112.476 -172.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -59.26 -23.28 62.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.007 0.432 . . . . 1.63 110.618 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.18 20.72 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.081 0.467 . . . . 2.07 110.458 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -85.99 140.95 29.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.91 110.336 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 76' ' ' ARG . 48.7 ttm -111.47 89.32 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 1.73 110.425 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.27 -168.97 33.19 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.812 -0.631 . . . . 1.05 111.949 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -98.37 102.75 15.21 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.344 0.593 . . . . 2.14 110.791 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.89 -17.99 13.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 1.01 113.513 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -64.32 -25.72 68.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 2.08 110.107 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.51 23.51 14.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.823 -0.626 . . . . 2.18 111.419 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -89.7 152.02 21.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.717 -0.674 . . . . 0.92 109.719 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.13 157.81 44.77 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.4 mm? -68.67 118.15 11.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.41 -0.359 . . . . 1.4 110.061 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.77 -5.47 16.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.75 112.296 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.31 122.96 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.669 0.271 . . . . 1.06 110.955 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 21.5 mt-10 -64.16 137.41 57.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.693 -0.685 . . . . 2.51 110.656 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 77' ' ' MET . 22.5 m -143.09 148.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.508 -0.553 . . . . 0.44 109.508 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.33 144.48 43.19 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.931 -0.766 . . . . 1.49 108.931 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -162.61 163.89 26.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.038 0.447 . . . . 0.66 111.939 -174.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 9' ' ' VAL . 56.9 p -120.94 153.51 37.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 0.94 109.742 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.67 156.74 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.745 0.307 . . . . 1.19 110.827 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 108.867 -0.79 . . . . 2.04 108.867 176.439 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.424 0.154 . . . . 2.3 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.17 153.16 67.29 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.532 2.155 . . . . 1.43 111.106 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -106.27 147.54 29.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.453 -0.34 . . . . 0.82 111.245 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -126.85 174.22 8.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.495 -0.321 . . . . 2.3 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 58.8 34.2 23.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.869 -0.605 . . . . 2.01 112.232 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 55' ' ' TYR . 40.8 t -78.19 119.74 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.977 0.418 . . . . 0.8 110.899 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 41' ' ' MET . 11.1 mmm180 -124.39 148.72 47.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.675 -0.693 . . . . 3.51 110.35 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.537 ' HA ' HG12 ' A' ' 53' ' ' VAL . 66.7 mtt -69.04 140.95 54.94 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.017 -0.364 . . . . 1.12 110.017 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 31.1 tp -130.61 82.69 64.16 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.389 -0.369 . . . . 1.67 111.502 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.06 116.58 3.97 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.524 1.483 . . . . 2.15 110.305 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -166.22 -21.45 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.904 0.383 . . . . 4.61 111.006 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t30 59.35 41.19 20.1 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.452 -0.944 . . . . 2.84 108.452 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 t -88.44 -5.97 57.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.626 -1.17 . . . . 1.7 110.924 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.4 HD12 HD12 ' A' ' 27' ' ' LEU . 18.3 mm -63.23 119.65 54.65 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.92 109.236 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.68 158.98 53.27 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 122.44 2.094 . . . . 1.03 112.125 -172.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -98.2 139.72 21.4 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.942 -0.572 . . . . 2.76 110.413 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 76.6 Cg_exo -51.02 134.83 43.59 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.113 2.542 . . . . 1.08 112.261 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.76 91.83 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 1.1 110.226 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 152' ' ' ARG . 22.0 t -142.82 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 1.23 109.531 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.92 -59.81 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.02 0.378 . . . . 2.87 112.02 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 91' ' ' THR . 16.7 mm-40 -90.76 -56.29 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.31 0.576 . . . . 2.84 111.145 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 13.1 t 151.01 164.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.431 -1.692 . . . . 1.42 106.431 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.512 HG21 HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -106.48 -58.21 1.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.28 -0.968 . . . . 1.3 111.536 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -140.87 158.37 44.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.028 0.442 . . . . 1.29 110.761 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -140.15 126.04 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.72 -0.673 . . . . 1.36 109.398 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.47 -140.45 3.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.986 -1.102 . . . . 0.53 112.379 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.92 152.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.611 0.243 . . . . 1.37 110.475 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 143' ' ' LEU . 64.8 t -61.89 132.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.69 110.419 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.15 -49.11 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.238 0.458 . . . . 0.89 112.238 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 99' ' ' ARG . 5.4 ttt85 . . . . . 0 C--N 1.327 -0.378 0 C-N-CA 120.257 -0.577 . . . . 3.92 111.823 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 111.761 0.282 . . . . 1.24 111.761 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.53 170.01 46.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.529 -0.843 . . . . 0.94 111.969 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 130' ' ' GLU . 72.6 mt -145.31 144.21 30.61 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.309 0.576 . . . . 0.93 111.613 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.39 138.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.011 -0.995 . . . . 0.49 109.211 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.67 114.75 26.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.643 0.735 . . . . 1.4 110.312 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 14.8 mm -91.34 132.15 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.045 -0.98 . . . . 0.63 109.845 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.9 pt? -85.65 152.74 22.87 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.181 0.301 . . . . 1.21 110.438 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.448 ' OD1' ' HB ' ' A' ' 123' ' ' THR . 18.2 m-20 -56.75 151.67 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.669 -0.493 . . . . 2.29 109.669 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -62.59 -25.95 68.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.735 0.302 . . . . 2.78 110.699 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.49 5.78 43.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.77 109.987 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 60.94 78.92 0.27 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.547 -0.751 . . . . 4.14 110.643 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.448 ' HB ' ' OD1' ' A' ' 119' ' ' ASP . 22.0 m -121.13 -74.18 0.62 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 1.87 110.606 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.5 p -144.03 -174.71 4.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.75 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.1 p -70.92 134.54 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.676 -0.491 . . . . 1.29 109.676 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.68 -69.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 1.03 110.623 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -136.66 -84.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.261 0.553 . . . . 1.56 111.197 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -175.33 142.38 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.035 -0.984 . . . . 2.08 108.899 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.447 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -124.1 124.39 42.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.999 0.428 . . . . 0.68 110.678 172.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.0 tt0 -85.26 143.74 28.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.247 -0.888 . . . . 1.19 108.758 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -117.13 134.31 54.93 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.181 -0.608 . . . . 0.74 111.348 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.555 ' HA3' ' CE1' ' A' ' 29' ' ' HIS . . . -77.95 153.58 40.16 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 114.945 -1.025 . . . . 0.51 113.11 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.37 -37.52 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.545 0.338 . . . . 0.67 111.905 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.6 p -80.0 -32.89 39.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.322 0.582 . . . . 1.35 110.731 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 45.5 m -64.67 -32.81 74.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.263 -0.88 . . . . 1.1 109.934 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.9 tp -78.36 58.38 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.452 -0.795 . . . . 1.46 110.846 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' VAL . 39.0 t -44.91 -40.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.64 0.733 . . . . 0.82 110.675 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.58 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 12.1 m120 -87.87 33.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 2.17 111.283 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -61.9 -16.1 48.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.112 0.482 . . . . 1.39 111.064 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -92.15 -9.13 43.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.795 -0.639 . . . . 2.46 111.285 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.31 166.46 15.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 1.89 110.323 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -98.31 52.57 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.428 0.632 . . . . 2.88 109.753 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 97' ' ' VAL . 13.0 tp -60.02 125.48 23.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.828 -1.078 . . . . 0.97 111.591 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -129.95 171.8 12.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 1.77 110.544 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 97' ' ' VAL . 86.5 tttt -70.57 136.02 48.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.268 -0.573 . . . . 1.43 109.564 176.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.29 -9.12 57.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.486 -0.864 . . . . 1.07 111.398 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -91.81 123.34 35.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.334 -0.987 . . . . 1.94 108.334 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.94 146.87 47.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.049 0.452 . . . . 1.79 110.201 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.17 146.54 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.285 0.564 . . . . 1.16 111.504 -172.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 p -111.52 145.42 39.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.268 -0.878 . . . . 1.44 109.663 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -165.38 158.0 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.914 0.388 . . . . 0.61 110.175 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.43 ' HB3' HG21 ' A' ' 88' ' ' VAL . 24.1 mtt180 -125.65 125.26 42.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.399 -0.593 . . . . 2.2 109.399 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 92' ' ' THR . 9.2 tt -99.64 121.85 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 1.24 109.876 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 7.4 p-10 -145.71 -100.7 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.533 -0.303 . . . . 1.92 111.155 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.549 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 1.4 mt-10 -78.86 -29.0 44.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.026 0.441 . . . . 2.76 110.373 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.0 t -74.02 -17.51 60.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.915 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.72 21.99 58.97 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.719 -0.753 . . . . 1.27 112.37 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 158' ' ' ARG . 52.7 mtt180 -140.79 -171.4 3.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.997 -0.742 . . . . 3.61 108.997 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.86 107.74 18.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.606 -0.438 . . . . 0.48 109.862 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -110.33 161.48 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.49 110.109 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.71 36.93 19.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.24 0.543 . . . . 1.55 110.235 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.35 112.16 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.523 0.678 . . . . 1.26 111.12 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.58 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 3.8 t-20 -131.14 114.52 15.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 2.05 110.476 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.41 131.18 49.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.75 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.54 107.28 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.959 -0.564 . . . . 1.56 110.501 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.362 -0.607 . . . . 2.94 109.362 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.952 0.406 . . . . 2.0 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -90.77 115.29 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.643 -0.873 . . . . 1.27 108.643 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CD2' ' HG ' ' A' ' 57' ' ' LEU . 22.8 m-85 -87.79 139.17 30.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.404 0.621 . . . . 1.14 110.786 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 27.8 ttm180 -100.83 130.12 46.8 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.01 -0.995 . . . . 2.31 110.189 -176.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.63 -177.31 26.99 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.378 -0.689 . . . . 0.5 111.378 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.546 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -149.21 151.05 33.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.964 0.412 . . . . 0.68 111.064 -177.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.7 123.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.857 -0.61 . . . . 0.56 111.477 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 25' ' ' GLU . . . -106.26 -37.08 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.76 111.584 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 23' ' ' PHE . 6.4 p -144.82 149.65 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.074 -0.512 . . . . 1.55 109.953 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.6 mtp -130.71 107.5 9.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.77 -0.456 . . . . 1.42 109.77 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.22 -168.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.03 109.746 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.72 -44.2 43.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.159 0.504 . . . . 3.24 110.885 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -102.91 -27.93 12.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.545 . . . . 2.03 111.655 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.12 -177.91 6.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.895 0.379 . . . . 1.25 111.756 -172.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.95 160.82 28.54 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.931 -0.577 . . . . 0.71 111.719 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.573 ' HB2' HG12 ' A' ' 16' ' ' VAL . 25.9 m-85 -108.38 135.46 49.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.763 -0.458 . . . . 1.08 109.763 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -102.53 125.12 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.61 110.304 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 32.6 tt0 -72.34 117.79 14.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.968 -1.123 . . . . 2.3 107.968 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 31' ' ' GLU . 5.5 p -66.07 157.44 31.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.036 -0.357 . . . . 0.87 110.036 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 17.2 tp -53.23 -36.05 60.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 1.58 111.785 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -110.7 12.61 22.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 2.04 110.054 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.2 p80 40.34 39.81 0.74 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.531 1.132 . . . . 3.29 113.086 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -95.37 -0.87 52.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 2.89 110.472 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HG21 ' A' ' 26' ' ' THR . 28.4 tt0 -156.98 148.08 21.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 1.8 111.248 -170.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.42 121.45 44.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.422 -0.584 . . . . 3.37 109.422 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.4 t -109.47 130.62 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.87 111.44 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 71' ' ' PRO . 14.0 t80 -84.56 120.56 26.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.814 -0.63 . . . . 1.06 110.385 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -124.23 144.96 49.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.367 177.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -116.84 126.92 53.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.716 -0.675 . . . . 1.18 110.101 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -63.93 -20.88 66.19 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.196 0.443 . . . . 0.75 112.196 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.7 t -67.02 -27.23 67.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.62 -0.263 . . . . 1.63 111.517 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -101.93 6.85 41.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.07 111.476 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 79.5 t80 -73.3 129.72 38.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.129 -0.487 . . . . 0.91 110.832 -175.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.5 ttp -98.9 93.09 5.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 1.73 110.389 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.27 -134.77 4.22 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.607 -0.724 . . . . 1.05 111.466 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -132.72 106.02 12.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.721 -0.474 . . . . 2.14 109.721 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.26 -17.85 16.55 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.36 2.04 . . . . 1.01 112.887 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -74.52 -17.01 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.338 0.59 . . . . 2.08 110.357 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -101.03 -2.13 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 2.18 110.844 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 13.1 mt -77.38 146.63 36.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.92 111.736 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.23 173.31 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 2.35 109.66 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.21 130.04 37.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.237 -0.438 . . . . 1.4 110.449 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.97 4.91 58.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.75 112.918 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.4 126.94 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.862 0.331 . . . . 1.06 111.042 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 43.3 mt-10 -72.57 129.97 39.53 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.577 -0.738 . . . . 2.51 110.551 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 77' ' ' MET . 28.5 m -137.92 156.54 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.932 0.396 . . . . 0.44 110.816 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 78' ' ' LEU . 12.9 pt-20 -114.3 138.64 50.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.086 -0.709 . . . . 1.49 109.086 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.425 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.8 p90 -165.3 176.76 8.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.958 0.409 . . . . 0.66 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 p -125.67 145.45 50.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.1 -0.5 . . . . 0.94 110.973 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 10' ' ' TYR . 90.8 mt -73.02 135.39 44.91 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.621 -0.432 . . . . 1.19 110.371 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.065 0 CA-C-N 115.531 -0.759 . . . . 2.04 109.724 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 1.7 mp . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 108.934 -0.765 . . . . 2.3 108.934 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 35.3 Cg_endo -66.01 140.66 61.06 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.019 1.813 . . . . 1.43 111.661 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -58.25 121.22 10.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.493 -0.776 . . . . 0.82 110.593 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.3 148.44 28.99 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.361 0.413 . . . . 2.3 110.842 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.4 t30 59.12 82.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.23 -0.896 . . . . 2.01 110.708 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.49 121.95 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.8 110.253 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -125.97 156.47 39.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.837 -0.431 . . . . 3.51 109.837 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.41 ' HA ' HG12 ' A' ' 53' ' ' VAL . 67.3 mtt -76.91 138.99 40.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.12 110.613 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 54' ' ' GLU . 22.0 tp -113.88 146.0 34.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 1.67 109.255 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.07 155.84 17.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 113.152 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 84.4 tttt -73.35 154.2 40.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.389 -0.823 . . . . 4.61 111.308 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 93.7 m-20 77.36 23.56 0.87 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.622 0.769 . . . . 2.84 110.841 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 m -86.26 -13.08 47.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.863 -0.608 . . . . 1.7 109.512 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 3.5 mm -93.71 130.91 33.46 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.898 -0.778 . . . . 0.92 108.898 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.07 145.91 80.53 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.673 2.248 . . . . 1.03 112.56 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -124.0 137.54 29.1 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 2.76 110.835 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 82.6 Cg_exo -50.23 141.07 32.24 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.692 2.928 . . . . 1.08 113.352 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.58 95.29 5.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 1.1 111.393 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.464 HG11 ' OG1' ' A' ' 92' ' ' THR . 16.7 m -121.54 171.31 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.499 -0.556 . . . . 1.23 109.499 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.47 -63.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.308 -0.557 . . . . 2.87 111.124 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.03 -54.18 3.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.393 0.616 . . . . 2.84 111.269 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t 172.5 163.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.379 -0.971 . . . . 1.42 108.379 -174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.464 ' OG1' HG11 ' A' ' 88' ' ' VAL . 2.1 m -107.18 -59.06 1.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 1.3 111.84 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -148.34 178.04 8.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.573 0.701 . . . . 1.29 111.504 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.42 166.62 23.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.588 -1.264 . . . . 1.36 107.588 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.49 -165.79 30.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.707 -1.235 . . . . 0.53 112.695 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 148' ' ' LEU . 42.0 t -135.7 141.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.547 0.339 . . . . 1.37 110.165 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 66.3 t -59.15 118.99 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.06 -0.348 . . . . 0.69 110.06 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.27 -64.15 1.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 0.89 111.917 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.336 . . . . 3.92 111.862 -174.339 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB1' ' HG2' ' A' ' 130' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.985 0.421 . . . . 1.24 111.76 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 63.57 174.66 3.08 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.97 -0.559 . . . . 0.94 113.035 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 130' ' ' GLU . 55.8 mt -145.49 138.61 26.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.544 0.688 . . . . 0.93 111.715 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.48 138.02 37.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.686 -1.143 . . . . 0.49 109.767 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.62 121.39 29.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.628 . . . . 1.4 109.408 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 129' ' ' HIS . 4.2 mm -103.36 120.45 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.45 -0.795 . . . . 0.63 109.238 -175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -85.18 139.41 31.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 1.21 110.29 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.73 160.9 3.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.147 -0.933 . . . . 2.29 110.218 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.1 -27.0 68.8 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.19 -0.319 . . . . 2.78 111.53 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.05 12.54 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.709 -0.478 . . . . 1.77 109.709 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 48.59 35.91 6.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.794 1.238 . . . . 4.14 111.854 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 20.3 p -75.47 -67.39 0.67 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.608 -0.723 . . . . 1.87 111.118 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.7 p -139.01 172.81 12.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.09 -0.505 . . . . 1.54 111.28 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.6 t -72.92 136.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 1.29 109.474 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -70.98 -69.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.43 -0.508 . . . . 1.03 111.1 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 61.2 m -140.4 -85.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.45 0.643 . . . . 1.56 111.341 172.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -176.5 123.9 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.646 -1.161 . . . . 2.08 108.653 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -111.91 126.93 55.64 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.631 -0.827 . . . . 0.68 110.618 177.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 114' ' ' LEU . 13.3 tt0 -88.1 149.06 24.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.462 -1.244 . . . . 1.19 109.629 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 38.3 p90 -123.7 175.71 6.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.74 110.837 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.443 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -137.44 153.58 22.06 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.625 -0.716 . . . . 0.51 111.564 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 tp -54.24 -23.26 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 117.154 0.477 . . . . 0.67 111.193 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -80.99 -34.4 33.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.323 0.582 . . . . 1.35 110.674 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 36.6 t -76.02 -26.0 56.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.231 -0.895 . . . . 1.1 110.377 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 80.1 mt -75.26 60.22 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.642 . . . . 1.46 112.27 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.5 t -41.41 -49.07 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.827 0.346 . . . . 0.82 111.863 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.56 HD21 HD22 ' A' ' 143' ' ' LEU . 2.7 p-10 -97.47 36.38 1.5 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.721 0.296 . . . . 2.17 111.53 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 13.9 ptpt -51.55 -22.54 3.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.244 0.831 . . . . 1.39 113.244 -177.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -81.66 -20.84 38.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.081 0.467 . . . . 2.46 111.005 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.24 163.36 18.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.641 -0.708 . . . . 1.89 111.431 -173.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.91 100.19 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.804 -0.635 . . . . 2.88 110.276 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 138' ' ' ASN . 7.1 tp -128.11 95.35 4.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.23 -0.655 . . . . 0.97 109.23 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.4 pt20 -130.35 -171.92 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.985 -0.552 . . . . 1.77 110.914 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.9 tttt -60.58 112.99 2.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.039 0.447 . . . . 1.43 110.833 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.02 -2.8 22.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.602 -0.809 . . . . 1.07 112.789 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.58 135.86 33.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.159 0.504 . . . . 1.94 111.095 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.439 HD13 ' CG2' ' A' ' 96' ' ' VAL . 3.1 mm? -81.07 135.96 35.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.043 -0.98 . . . . 1.79 110.147 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.61 151.09 27.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.11 0.481 . . . . 1.16 110.983 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.519 ' OG ' HG11 ' A' ' 165' ' ' VAL . 75.2 m -117.1 143.6 45.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.852 -0.613 . . . . 1.44 109.702 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 30.5 p90 -158.68 173.93 15.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.959 -0.564 . . . . 0.61 109.929 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 124.97 22.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.2 111.261 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 129' ' ' HIS . 12.6 pt -97.2 151.66 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.348 -0.842 . . . . 1.24 109.621 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 35.3 t70 -173.26 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.055 0.222 . . . . 1.92 110.579 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -73.11 -36.5 66.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.957 0.408 . . . . 2.76 111.395 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -82.36 -16.67 48.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 1.98 111.187 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.36 2.08 13.24 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.021 -0.609 . . . . 1.27 112.814 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 153' ' ' ILE . 27.3 mtt85 -130.18 -178.94 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.793 -0.447 . . . . 3.61 109.793 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.43 108.86 18.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.48 111.56 -169.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.558 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.4 156.39 27.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.714 -0.675 . . . . 0.49 109.873 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 64.64 41.1 5.51 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.691 0.619 . . . . 1.55 110.318 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.35 114.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.695 -0.684 . . . . 1.26 110.762 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -123.24 125.51 45.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.377 -0.374 . . . . 2.05 110.44 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.56 120.14 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.75 110.616 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.519 HG11 ' OG ' ' A' ' 150' ' ' SER . 13.6 p -136.37 139.94 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 1.56 111.139 -174.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.375 -0.375 . . . . 2.94 110.096 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.148 0.499 . . . . 2.0 111.732 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 123.47 41.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.319 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.62 151.06 22.79 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.649 -0.871 . . . . 1.14 108.649 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -132.54 153.25 51.15 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.726 -0.79 . . . . 2.31 110.828 177.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.44 -153.84 6.7 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.607 -1.397 . . . . 0.5 109.607 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.55 140.84 30.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.942 0.401 . . . . 0.68 111.1 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -64.76 108.42 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.487 -0.779 . . . . 0.56 110.501 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.49 9.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.079 0.466 . . . . 0.76 110.812 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.38 122.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 1.55 110.375 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 45.6 ttm -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.87 -0.419 . . . . 1.42 109.87 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 71.5 mmtt -101.66 -167.08 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.212 -0.449 . . . . 2.03 109.992 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -83.34 -35.14 25.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 3.24 110.781 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.94 -36.91 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.244 0.461 . . . . 2.03 112.244 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 22.0 p90 -138.82 -170.36 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.791 0.329 . . . . 1.25 111.413 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.1 -169.45 31.6 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.399 -0.68 . . . . 0.71 111.399 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -136.46 142.7 43.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.766 -0.457 . . . . 1.08 109.766 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -114.15 120.58 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.61 110.237 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -70.65 119.58 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.976 -0.75 . . . . 2.3 108.976 171.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 31' ' ' GLU . 7.5 p -62.16 155.67 23.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.247 -0.433 . . . . 0.87 110.274 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 17.5 tp -55.01 -34.37 63.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.154 -0.475 . . . . 1.58 111.539 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 p -99.04 6.71 46.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 2.04 111.46 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 p80 40.18 42.28 1.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.147 0.979 . . . . 3.29 112.112 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -116.62 -16.13 10.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 2.89 110.137 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG21 ' A' ' 26' ' ' THR . 9.2 tp10 -132.18 148.51 52.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8 110.021 -175.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -109.37 128.66 55.29 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.731 -0.47 . . . . 3.37 109.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 55' ' ' TYR . 21.8 t -123.61 116.55 48.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 120.847 0.356 . . . . 0.87 111.052 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -73.73 122.49 22.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.697 . . . . 1.06 110.184 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.69 124.11 40.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.732 -0.667 . . . . 1.96 110.675 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 21' ' ' PHE . 5.3 t60 -101.56 142.35 33.05 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.668 -0.864 . . . . 1.18 108.668 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.42 -21.02 62.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.621 -0.432 . . . . 0.75 112.143 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 22.1 t -61.52 -29.63 70.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 1.63 111.246 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -99.95 17.01 22.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.024 0.44 . . . . 2.07 110.482 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -92.51 129.53 38.42 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.187 -0.46 . . . . 0.91 110.257 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.9 ttp -108.8 91.96 3.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 1.73 110.376 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.05 -130.13 1.83 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.332 -0.849 . . . . 1.05 111.073 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' HD1' ' A' ' 46' ' ' TRP . 36.4 t30 -150.12 111.07 3.28 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.328 . . . . 2.14 110.574 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.34 -16.31 27.89 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.859 2.373 . . . . 1.01 113.385 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.96 -16.47 63.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.686 0.279 . . . . 2.08 111.269 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' HD1' ' ND2' ' A' ' 43' ' ' ASN . 69.6 m95 -115.04 17.52 16.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.539 . . . . 2.18 111.09 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.35 165.5 12.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.92 110.129 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -155.0 166.78 32.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.742 -0.663 . . . . 2.35 109.328 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.6 mm? -69.09 126.28 29.3 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.82 -0.34 62.71 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.749 -0.738 . . . . 0.75 112.438 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -67.43 120.42 13.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.007 0.432 . . . . 1.06 110.72 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 21.9 mt-10 -64.34 122.8 17.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.237 -0.892 . . . . 2.51 110.794 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.9 m -141.53 144.73 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.212 -0.449 . . . . 0.44 109.976 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 19.0 pt-20 -116.17 148.13 40.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.758 -0.377 . . . . 1.49 110.274 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -162.92 177.35 9.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.66 112.003 -171.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.69 166.55 16.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.94 111.021 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.15 137.68 35.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.194 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 2.04 111.064 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 110.6 -0.148 . . . . 2.3 110.6 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.8 155.8 52.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.929 2.42 . . . . 1.43 111.901 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.71 169.5 9.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.989 -0.551 . . . . 0.82 110.262 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.73 172.2 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.768 -0.196 . . . . 2.3 110.607 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.9 m120 60.51 26.6 16.24 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.674 0.609 . . . . 2.01 110.915 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.5 t -70.37 117.66 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.883 -0.599 . . . . 0.8 110.955 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -126.39 157.06 39.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 3.51 110.678 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.505 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.2 mtt -72.4 146.73 46.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.118 -0.492 . . . . 1.12 110.532 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.401 HD12 ' HD2' ' A' ' 79' ' ' PRO . 26.6 tp -119.97 131.23 24.49 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.876 -0.787 . . . . 1.67 108.876 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HD2' HD12 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.42 146.13 64.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.001 1.801 . . . . 2.15 111.849 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 19.5 ptpt -59.47 162.83 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 4.61 110.625 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 8.8 t30 77.5 2.95 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.447 0.641 . . . . 2.84 110.919 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -81.05 -27.65 35.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 1.7 109.655 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.13 116.63 66.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.733 -0.84 . . . . 0.92 108.733 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.58 155.09 40.25 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.552 2.168 . . . . 1.03 112.377 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -113.97 155.03 45.89 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.527 -0.545 . . . . 2.76 109.527 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.493 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 17.0 Cg_exo -65.67 143.12 73.4 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.27 1.98 . . . . 1.08 111.215 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.62 94.56 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 1.1 111.214 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 t -140.96 130.62 25.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.571 -0.74 . . . . 1.23 109.254 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.87 -60.51 1.84 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.131 0.419 . . . . 2.87 112.131 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' O ' ' HB ' ' A' ' 91' ' ' THR . 14.7 pt-20 -90.51 -52.43 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.92 -0.312 . . . . 2.84 111.569 -174.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.8 t 166.1 159.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.613 -0.884 . . . . 1.42 108.613 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.54 -52.02 2.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.196 0.522 . . . . 1.3 110.158 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.99 168.14 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.306 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -125.98 151.55 46.89 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.417 -1.327 . . . . 1.36 107.417 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.18 -173.31 25.45 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.385 -1.388 . . . . 0.53 112.506 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.44 143.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.465 -0.568 . . . . 1.37 109.465 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.24 123.51 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.604 0.24 . . . . 0.69 110.435 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.17 17.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.89 112.033 -173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 . . . . . 0 C--N 1.33 -0.281 0 C-N-CA 120.606 -0.437 . . . . 3.92 111.869 -176.532 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 112.407 0.521 . . . . 1.24 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.3 -178.72 9.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.345 -0.455 . . . . 0.94 113.193 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 130' ' ' GLU . 38.1 mt -152.24 141.01 20.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.292 0.567 . . . . 0.93 111.641 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.3 134.24 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.878 -1.055 . . . . 0.49 109.134 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -86.34 111.04 20.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.67 0.748 . . . . 1.4 109.413 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -90.78 121.34 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.168 -0.924 . . . . 0.63 109.041 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -90.32 150.81 21.75 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.569 -0.453 . . . . 1.21 109.966 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.75 165.1 3.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.144 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.625 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.0 pm0 -65.12 -20.35 66.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 2.78 110.174 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.625 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.38 14.28 24.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 1.77 110.277 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 51.02 29.82 4.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.434 1.093 . . . . 4.14 112.118 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -67.53 0.66 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.392 -0.367 . . . . 1.87 111.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 7.3 p -138.24 -171.6 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.578 -0.283 . . . . 1.54 111.175 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 p -92.52 129.88 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.364 -0.606 . . . . 1.29 109.364 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.56 -69.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 1.03 110.629 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.4 m -139.01 -85.97 0.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.147 0.498 . . . . 1.56 110.46 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.5 143.49 0.48 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.873 -1.058 . . . . 2.08 108.596 173.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.646 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.2 m-70 -116.34 124.46 50.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.68 110.335 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -81.94 140.59 33.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.996 . . . . 1.19 109.469 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' A' ' 136' ' ' LEU . 31.6 p90 -115.97 161.01 19.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.195 0.521 . . . . 0.74 111.27 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.43 152.24 17.25 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.813 -0.63 . . . . 0.51 111.663 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.9 tp -55.16 -29.42 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.96 0.409 . . . . 0.67 111.241 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -71.77 -33.7 68.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.451 0.643 . . . . 1.35 110.403 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 161' ' ' CYS . 2.2 m -66.77 -33.11 74.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.287 -0.87 . . . . 1.1 109.983 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 10.9 mp -75.94 57.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.769 -0.65 . . . . 1.46 111.923 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.3 t -46.58 -48.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.239 0.543 . . . . 0.82 110.545 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -93.4 35.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.465 -0.789 . . . . 2.17 110.962 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 9.9 ptpp? -54.36 -23.69 16.53 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.754 1.02 . . . . 1.39 113.754 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -81.44 -6.26 58.76 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.202 -0.311 . . . . 2.46 111.33 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.45 174.93 4.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 1.89 110.471 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -88.94 17.2 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 2.88 110.507 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -46.2 117.73 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.921 -1.036 . . . . 0.97 111.756 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -135.59 -179.94 5.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 1.77 110.675 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.52 129.32 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 1.43 110.026 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.92 64.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.358 -0.925 . . . . 1.07 112.562 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.93 146.12 24.0 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.94 109.575 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.88 134.77 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.181 0.515 . . . . 1.79 111.513 -170.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 m -129.72 148.12 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.836 -0.62 . . . . 1.16 111.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 64.1 m -113.77 140.52 48.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.534 -0.757 . . . . 1.44 109.096 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.688 ' HB3' HG12 ' A' ' 162' ' ' VAL . 25.7 p90 -151.06 165.75 32.86 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.144 -0.48 . . . . 0.61 109.794 -175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 -126.91 119.65 27.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.063 -0.655 . . . . 2.2 110.423 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 158' ' ' ARG . 12.6 pt -102.46 149.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 109.184 -0.673 . . . . 1.24 109.184 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 6.4 t70 -160.69 -93.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.995 -0.282 . . . . 1.92 110.564 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.59 -34.82 27.54 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.767 -0.373 . . . . 2.76 111.519 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.2 t -77.63 -17.7 57.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.672 0.272 . . . . 1.98 110.699 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.61 -14.66 3.25 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.994 -0.622 . . . . 1.27 113.968 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' ILE . 11.0 ptm180 -103.41 175.48 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.296 0.548 . . . . 3.61 110.054 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.27 109.84 18.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.142 0.496 . . . . 0.48 110.423 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.67 154.8 33.49 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.464 -0.789 . . . . 0.49 110.354 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.422 ' H ' ' HA ' ' A' ' 135' ' ' SER . 37.6 m 57.82 47.22 15.71 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.932 0.77 . . . . 1.55 111.325 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.3 m -70.89 128.3 33.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.642 0.734 . . . . 1.26 110.281 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -128.45 125.62 38.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.668 -0.696 . . . . 2.05 109.739 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.43 128.12 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.613 -0.721 . . . . 0.75 110.819 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.22 110.94 29.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.124 0.488 . . . . 1.56 111.468 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.542 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 2.8 mpt_? . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 108.747 -0.834 . . . . 2.94 108.747 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.338 0.59 . . . . 2.0 111.218 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.31 126.56 44.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.857 -1.065 . . . . 1.27 109.229 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -98.55 137.94 36.47 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.38 -0.6 . . . . 1.14 109.38 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 35.0 ttm180 -112.42 143.25 43.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.863 -0.421 . . . . 2.31 109.863 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.27 -170.24 22.74 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.67 -0.776 . . . . 0.5 111.591 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 139.74 42.29 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.662 0.268 . . . . 0.68 110.369 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.94 118.08 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.56 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.08 -56.65 2.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.614 0.245 . . . . 0.76 111.002 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.93 160.87 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.154 -0.313 . . . . 1.55 110.154 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.1 ttm -141.61 112.29 7.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.268 -0.424 . . . . 1.42 111.035 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 175.95 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.499 -0.556 . . . . 2.03 109.499 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.75 -34.76 76.4 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.581 0.551 . . . . 3.24 111.539 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -111.13 -47.45 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.205 0.446 . . . . 2.03 112.205 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -130.15 169.39 15.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.162 0.506 . . . . 1.25 111.627 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.72 -174.09 23.56 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.71 111.489 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' HB3' ' OE1' ' A' ' 32' ' ' GLU . 48.4 m-85 -129.04 154.4 46.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.119 -0.326 . . . . 1.08 110.119 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mt -133.79 122.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.61 110.316 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -69.0 119.5 13.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.817 -0.438 . . . . 2.3 109.817 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 p -57.6 141.47 48.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 0.87 109.911 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -50.0 -46.25 52.54 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.536 . . . . 1.58 110.708 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -85.81 18.05 3.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.656 . . . . 2.04 111.65 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 p80 43.13 36.2 0.93 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.128 0.971 . . . . 3.29 111.907 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -70.05 -50.99 35.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.274 -0.875 . . . . 2.89 110.382 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.43 -174.59 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 1.8 110.53 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 23' ' ' PHE . 1.1 mm-40 -102.75 145.23 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.974 -0.557 . . . . 3.37 109.976 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG11 ' HE2' ' A' ' 55' ' ' TYR . 20.8 t -122.44 120.54 61.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.21 0.528 . . . . 0.87 111.21 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -74.2 116.91 15.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.364 -0.834 . . . . 1.06 110.392 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -121.99 151.18 41.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.281 -0.637 . . . . 1.96 109.281 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -110.31 128.86 55.75 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.349 -0.611 . . . . 1.18 109.349 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.06 -20.15 65.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 0.75 110.871 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -59.96 -34.83 73.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.555 . . . . 1.63 111.699 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -102.96 -0.54 30.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.028 0.442 . . . . 2.07 110.615 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 54.6 t80 -72.01 128.66 36.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.91 110.213 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.4 ttp -102.21 111.55 23.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.042 0.448 . . . . 1.73 110.239 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 44' ' ' PRO . . . 147.14 -171.87 27.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.687 -0.688 . . . . 1.05 111.429 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.69 105.25 19.66 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.22 -0.289 . . . . 2.14 110.22 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 42' ' ' GLY . 10.0 Cg_exo -66.99 -30.34 39.31 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.469 2.113 . . . . 1.01 112.354 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -70.43 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 2.08 111.19 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.95 7.32 44.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.114 0.483 . . . . 2.18 110.58 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.41 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 20.6 mt -88.16 141.61 28.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.183 0.516 . . . . 0.92 111.306 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -120.92 158.41 27.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.821 . . . . 2.35 109.274 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.78 114.76 12.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.184 -0.672 . . . . 1.4 109.184 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.72 32.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.027 -0.606 . . . . 0.75 112.226 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -65.8 137.39 57.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 1.06 110.67 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.523 ' HG3' HD13 ' A' ' 83' ' ' ILE . 12.9 tt0 -78.63 125.73 29.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.361 -0.836 . . . . 2.51 110.274 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -141.8 155.45 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.176 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.1 148.14 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.968 0.413 . . . . 1.49 110.308 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -159.34 173.66 15.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.975 -0.557 . . . . 0.66 110.81 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 p -127.96 142.81 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.488 -0.324 . . . . 0.94 110.961 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.53 121.92 20.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 120.881 0.372 . . . . 1.19 110.263 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.529 -0.759 . . . . 2.04 111.485 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.599 0.238 . . . . 2.3 110.865 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.76 150.14 78.9 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.779 2.319 . . . . 1.43 113.357 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.94 147.72 25.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.114 -0.948 . . . . 0.82 109.292 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 10.5 pt-20 -125.98 176.43 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.108 -0.237 . . . . 2.3 110.508 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.41 28.08 15.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.627 0.727 . . . . 2.01 109.756 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 17.4 t -66.99 119.0 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.808 . . . . 0.8 109.841 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -133.2 140.3 47.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.998 -0.547 . . . . 3.51 111.644 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.466 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.3 mtt -71.6 149.46 45.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.12 110.485 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -145.9 163.31 31.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 1.67 109.445 170.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 24.7 Cg_exo -64.73 161.88 34.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.1 1.866 . . . . 2.15 112.216 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.45 -169.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 4.61 111.514 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t30 78.74 19.74 0.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.202 -0.908 . . . . 2.84 112.444 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -93.99 -39.27 10.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.199 -0.667 . . . . 1.7 109.199 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.523 HD13 ' HG3' ' A' ' 52' ' ' GLU . 2.3 mp -84.07 119.54 73.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.639 -0.71 . . . . 0.92 110.399 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.09 161.16 32.83 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.462 2.775 . . . . 1.03 112.565 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -93.12 153.97 41.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.414 -0.515 . . . . 2.76 110.188 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.16 164.1 23.7 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.649 2.233 . . . . 1.08 111.265 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.43 91.32 3.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.33 0.586 . . . . 1.1 111.627 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.47 153.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.953 -1.128 . . . . 1.23 107.953 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 -61.42 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.424 -0.511 . . . . 2.87 111.408 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 91' ' ' THR . 9.4 tp10 -92.17 -56.22 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 2.84 111.242 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t 167.17 165.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.283 -1.006 . . . . 1.42 108.283 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 m -106.79 -54.8 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.578 -0.449 . . . . 1.3 111.111 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -146.7 157.1 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 1.29 110.591 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.89 -179.53 3.72 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.558 -0.904 . . . . 1.36 108.558 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.99 -167.6 40.14 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.731 -1.223 . . . . 0.53 112.237 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.74 142.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.925 -0.768 . . . . 1.37 108.925 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 122.52 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.693 0.283 . . . . 0.69 110.712 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -72.94 -54.22 9.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.89 109.872 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 73.3 ttt180 . . . . . 0 CA--C 1.531 0.236 0 O-C-N 123.558 0.536 . . . . 3.92 111.8 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 112.663 0.616 . . . . 1.24 112.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.12 149.03 7.6 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.501 -0.857 . . . . 0.94 111.698 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.2 mt -131.54 154.4 48.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.384 0.612 . . . . 0.93 111.743 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.84 136.6 53.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.981 -1.009 . . . . 0.49 108.82 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.04 110.72 19.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.574 0.702 . . . . 1.4 109.7 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.0 mm -85.43 130.42 36.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.829 -1.078 . . . . 0.63 109.996 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.12 146.34 26.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.81 0.338 . . . . 1.21 110.333 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.19 165.06 9.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.29 110.429 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.533 ' HG3' HD22 ' A' ' 121' ' ' LEU . 11.3 pt-20 -60.25 -25.56 65.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.787 0.292 . . . . 2.78 111.787 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.533 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.67 13.92 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.906 -0.318 . . . . 1.77 110.604 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 39.71 76.67 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.399 1.08 . . . . 4.14 112.318 -175.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.2 p -124.91 -68.55 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.144 -0.934 . . . . 1.87 111.237 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 m -124.17 166.64 15.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 1.54 110.477 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.7 p -73.39 133.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.156 -0.313 . . . . 1.29 110.156 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.48 -69.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.601 -0.272 . . . . 1.03 111.045 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -138.06 -85.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 1.56 110.918 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -175.75 137.09 0.34 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.328 -0.851 . . . . 2.08 108.865 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.777 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.3 m-70 -121.32 133.89 55.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.58 -0.526 . . . . 0.68 109.58 172.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -90.37 152.87 20.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.589 -0.732 . . . . 1.19 109.884 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -117.97 135.48 54.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.291 0.567 . . . . 0.74 110.838 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.29 151.34 21.42 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.396 -0.82 . . . . 0.51 111.734 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.45 -33.64 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.67 110.718 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.7 t -76.29 -30.22 57.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.481 -0.781 . . . . 1.35 110.203 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' VAL . 24.8 m -76.14 -24.18 54.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.753 -0.658 . . . . 1.1 110.159 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.5 mt -71.2 58.26 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.443 -0.798 . . . . 1.46 111.459 176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.3 t -47.24 -47.13 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.436 0.636 . . . . 0.82 110.403 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 15.6 m120 -92.38 34.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.563 -0.744 . . . . 2.17 111.622 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 8.9 ptpp? -61.21 -21.3 63.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.675 0.274 . . . . 1.39 111.726 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -89.06 -2.4 58.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 2.46 111.248 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.83 148.76 24.52 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.428 -0.953 . . . . 1.89 108.428 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.95 92.42 3.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.66 0.743 . . . . 2.88 110.077 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.3 tp -113.31 105.71 13.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.675 -1.148 . . . . 0.97 110.064 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -128.45 -171.35 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.889 -0.324 . . . . 1.77 111.65 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 56.8 tttm -64.01 110.42 2.13 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.31 -0.405 . . . . 1.43 111.138 -175.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.47 -6.69 20.75 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.486 -0.864 . . . . 1.07 112.386 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.56 142.19 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 1.94 110.898 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.31 140.03 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 1.79 111.221 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.65 153.34 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.16 111.772 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -118.29 144.8 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.763 . . . . 1.44 108.983 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.574 ' HB3' HG12 ' A' ' 162' ' ' VAL . 33.8 p90 -158.47 176.86 11.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.016 0.436 . . . . 0.61 110.767 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -135.21 123.8 23.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 2.2 111.286 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.92 122.7 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.261 -0.881 . . . . 1.24 109.332 167.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 4.9 p-10 -152.9 -94.72 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.109 -0.237 . . . . 1.92 110.835 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.493 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 39.3 mm-40 -82.53 -17.32 45.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 2.76 109.233 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 -19.06 35.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.99 -1.004 . . . . 1.98 111.2 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.1 6.5 10.18 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.954 -0.566 . . . . 1.27 113.99 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.12 -167.51 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.852 -0.795 . . . . 3.61 108.852 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.6 18.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.415 -0.587 . . . . 0.48 109.415 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.43 155.21 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.188 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 70.4 m 58.7 37.89 25.06 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.833 0.708 . . . . 1.55 110.837 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 151' ' ' PHE . 33.1 m -65.02 117.76 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.766 0.793 . . . . 1.26 110.329 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.465 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.8 p30 -118.1 123.4 45.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.686 -0.688 . . . . 2.05 110.275 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.435 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -66.16 103.42 0.97 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.335 -0.848 . . . . 0.75 110.831 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.74 110.24 20.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.691 0.758 . . . . 1.56 110.86 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 7.5 mpt_? . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.776 -0.824 . . . . 2.94 108.776 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 120.98 0.419 . . . . 2.0 111.392 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.39 122.52 39.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.805 . . . . 1.27 109.163 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.23 137.52 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.12 -0.491 . . . . 1.14 110.005 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.522 HH11 ' CD2' ' A' ' 78' ' ' LEU . 21.6 ttm-85 -106.44 129.54 54.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.384 -0.825 . . . . 2.31 109.963 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.71 -171.33 22.75 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.795 -0.717 . . . . 0.5 111.765 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.7 148.51 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 0.68 111.075 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.41 118.68 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.513 -0.767 . . . . 0.56 110.791 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.85 -37.94 6.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.76 111.091 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.5 p -130.99 122.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.274 0.559 . . . . 1.55 110.861 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.99 106.24 18.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.429 -0.952 . . . . 1.42 108.429 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 14.7 tppt? -98.4 170.8 8.6 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.067 -0.716 . . . . 2.03 109.067 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 62.5 mt-10 -65.98 -38.64 89.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.169 0.433 . . . . 3.24 112.169 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -112.1 -41.32 3.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.088 0.47 . . . . 2.03 111.524 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.612 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 42.7 p90 -131.0 -161.53 1.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.052 -0.522 . . . . 1.25 110.195 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.91 -177.57 40.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.97 . . . . 0.71 112.245 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.634 ' H ' HG13 ' A' ' 16' ' ' VAL . 75.2 m-85 -125.26 130.3 51.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.598 -0.519 . . . . 1.08 109.598 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -102.9 134.08 44.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.267 -0.642 . . . . 0.61 109.267 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.71 143.33 30.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.933 -1.136 . . . . 2.3 107.933 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 p -67.66 -173.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.035 0.445 . . . . 0.87 110.523 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -81.96 -47.05 13.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.099 0.475 . . . . 1.58 110.658 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -102.68 22.54 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.445 0.535 . . . . 2.04 112.445 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 56.06 58.19 4.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.228 0.537 . . . . 3.29 109.785 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 -44.09 5.85 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.48 -0.782 . . . . 2.89 110.714 -172.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.91 167.34 20.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.04 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -103.6 127.81 50.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.062 0.458 . . . . 3.37 110.551 -175.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.546 HG11 ' HE2' ' A' ' 55' ' ' TYR . 12.1 t -110.27 131.5 61.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.87 111.245 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -89.9 123.81 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.566 -0.743 . . . . 1.06 110.081 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -124.06 153.8 40.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.214 -0.662 . . . . 1.96 109.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -116.11 131.96 56.79 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.939 -0.763 . . . . 1.18 108.939 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 25.8 m-85 -58.7 -27.82 65.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.5 m -65.63 -36.5 83.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.541 0.21 . . . . 1.63 111.449 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -83.85 3.76 32.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.939 0.399 . . . . 2.07 110.981 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 64.9 t80 -83.59 140.44 32.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.891 -0.595 . . . . 0.91 110.091 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.5 ttp -116.52 116.43 27.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.122 0.487 . . . . 1.73 110.334 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.05 -151.49 22.9 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.655 . . . . 1.05 111.678 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -105.19 103.55 42.69 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.633 0.254 . . . . 2.14 110.855 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.03 -27.12 25.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.46 2.107 . . . . 1.01 113.119 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.82 1.0 45.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.975 0.416 . . . . 2.08 111.295 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -110.51 14.55 22.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.475 0.655 . . . . 2.18 109.674 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.5 mt -97.61 152.95 18.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.039 -0.982 . . . . 0.92 110.825 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.0 -178.32 6.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.754 -0.657 . . . . 2.35 109.238 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.7 mt -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.783 0.325 . . . . 1.4 111.414 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.0 -1.59 24.23 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.922 -0.656 . . . . 0.75 113.182 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.69 122.5 23.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.866 0.333 . . . . 1.06 110.98 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.0 mt-10 -61.59 132.86 54.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.609 -0.723 . . . . 2.51 110.373 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 77' ' ' MET . 25.9 m -140.83 148.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.44 110.207 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -114.63 142.71 46.1 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.268 -0.642 . . . . 1.49 109.268 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HE2' HG11 ' A' ' 33' ' ' VAL . 5.8 p90 -162.13 170.82 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.103 0.478 . . . . 0.66 111.559 -175.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 p -125.52 167.7 14.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.94 111.182 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.13 153.02 28.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 1.19 109.994 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 121.358 0.599 . . . . 2.04 110.969 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--O 1.232 0.149 0 N-CA-C 110.244 -0.28 . . . . 2.3 110.244 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.68 149.16 37.89 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.445 2.097 . . . . 1.43 111.823 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.48 36.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 0.82 111.116 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 79.8 mm-40 -119.59 143.78 47.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 2.3 110.436 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.5 t30 59.87 80.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 2.01 110.846 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.3 t -109.4 122.68 64.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.075 -0.512 . . . . 0.8 110.075 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.32 147.24 51.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.576 -0.283 . . . . 3.51 110.747 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.459 ' HA ' HG12 ' A' ' 53' ' ' VAL . 64.1 mtt -66.88 150.37 49.28 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.21 0.528 . . . . 1.12 111.467 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.522 ' CD2' HH11 ' A' ' 11' ' ' ARG . 19.1 tp -147.6 75.96 11.0 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.114 -0.948 . . . . 1.67 110.771 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -90.24 117.99 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.791 1.661 . . . . 2.15 112.716 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -174.05 6.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.117 0.414 . . . . 4.61 112.117 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 t30 57.7 50.56 10.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.027 0.917 . . . . 2.84 108.866 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.0 t -73.64 -10.44 59.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.554 -1.203 . . . . 1.7 109.937 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.638 HD12 ' CD2' ' A' ' 27' ' ' LEU . 6.2 mm -78.22 128.25 78.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.695 . . . . 0.92 109.469 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.1 159.66 48.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.083 2.522 . . . . 1.03 112.904 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -117.55 149.3 44.65 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.73 -0.668 . . . . 2.76 110.382 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.7 149.27 43.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 1.08 111.906 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.04 94.05 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.54 . . . . 1.1 110.603 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 152' ' ' ARG . 21.6 t -139.24 144.37 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.715 -0.846 . . . . 1.23 108.715 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.2 mt -88.22 -64.12 1.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.476 -0.49 . . . . 2.87 111.872 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 91' ' ' THR . 33.5 mt-10 -95.25 -53.82 3.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.357 0.599 . . . . 2.84 110.676 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.2 t 172.0 166.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.769 -1.105 . . . . 1.42 108.114 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -105.66 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.295 -0.562 . . . . 1.3 111.424 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -141.71 171.76 13.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.281 0.562 . . . . 1.29 111.36 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.72 158.09 45.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.018 -1.105 . . . . 1.36 108.018 172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.43 -166.97 28.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.725 -1.226 . . . . 0.53 112.293 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.11 145.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.579 -0.526 . . . . 1.37 109.579 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 84.8 t -60.92 126.73 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.627 -0.26 . . . . 0.69 110.846 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.9 -48.59 17.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.89 110.344 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.018 0.437 . . . . 3.92 111.962 175.528 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.759 0.314 . . . . 1.24 111.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 161.08 36.03 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.499 -0.858 . . . . 0.94 111.508 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 130' ' ' GLU . 36.7 mt -143.44 141.47 30.84 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.628 0.727 . . . . 0.93 112.405 -174.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.9 mt -114.16 139.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.494 -1.23 . . . . 0.49 108.817 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.46 136.35 33.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.173 -0.611 . . . . 1.4 110.206 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 129' ' ' HIS . 22.0 mm -105.75 131.81 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.803 -0.635 . . . . 0.63 109.541 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 118' ' ' LEU . 1.7 pt? -85.55 150.13 24.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.559 -0.291 . . . . 1.21 110.559 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.42 166.85 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.468 . . . . 2.29 110.109 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.49 -26.89 63.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.78 110.648 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 1.1 mm? -91.3 11.87 22.21 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.163 -0.471 . . . . 1.77 110.632 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 4.2 ptp180 47.05 32.89 2.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.982 0.913 . . . . 4.14 112.537 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 p -95.59 -73.0 0.6 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 1.87 112.018 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -179.68 3.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.585 0.231 . . . . 1.54 111.488 -176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -91.36 139.45 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.048 -0.523 . . . . 1.29 109.961 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mt -76.1 -69.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.579 -0.448 . . . . 1.03 110.675 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -138.02 -87.22 0.26 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.076 0.465 . . . . 1.56 110.426 168.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.74 146.85 0.46 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.084 -0.962 . . . . 2.08 109.109 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.473 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -118.8 136.79 53.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.317 0.58 . . . . 0.68 111.119 176.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 20.6 tt0 -86.66 143.53 27.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.707 -1.133 . . . . 1.19 109.897 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -120.41 140.44 51.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.221 0.534 . . . . 0.74 110.713 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.29 154.04 22.1 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.616 -0.72 . . . . 0.51 112.187 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -55.38 -22.0 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.469 0.652 . . . . 0.67 111.013 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -79.19 -37.19 38.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.749 -0.659 . . . . 1.35 110.212 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 162' ' ' VAL . 14.5 m -68.61 -33.47 74.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.322 -0.854 . . . . 1.1 110.517 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.62 58.52 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.46 111.544 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -48.86 -39.11 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.178 0.514 . . . . 0.82 110.88 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.513 HD21 HD22 ' A' ' 143' ' ' LEU . 3.1 p-10 -84.99 33.16 0.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 2.17 111.283 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -61.95 -18.79 61.55 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.123 0.487 . . . . 1.39 111.418 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -76.58 -22.29 54.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 2.46 110.885 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.45 155.15 17.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.829 -0.623 . . . . 1.89 111.933 -169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.403 -0.817 . . . . 2.88 109.505 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.517 HD21 ' CG1' ' A' ' 149' ' ' VAL . 10.6 tp -145.46 119.52 9.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.644 -0.502 . . . . 0.97 109.644 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.425 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.6 pt20 -133.36 -173.23 3.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.839 0.352 . . . . 1.77 111.355 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 54.5 tttm -61.78 114.51 3.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.43 110.499 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.98 -10.34 15.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.856 -0.687 . . . . 1.07 112.256 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.4 133.12 33.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 1.94 110.508 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.9 142.02 28.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.963 -0.562 . . . . 1.79 111.186 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.517 ' CG1' HD21 ' A' ' 143' ' ' LEU . 30.7 m -139.02 158.52 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.315 0.579 . . . . 1.16 111.748 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 8.4 t -115.12 148.01 39.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.339 -0.986 . . . . 1.44 108.339 171.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.64 ' HB3' HG12 ' A' ' 162' ' ' VAL . 18.8 p90 -159.99 163.03 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.61 111.035 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -124.36 121.5 35.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.267 0.556 . . . . 2.2 110.71 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 92' ' ' THR . 3.7 tt -101.66 133.08 46.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.28 -0.873 . . . . 1.24 110.224 171.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.561 ' OD2' ' HG2' ' A' ' 155' ' ' GLU . 21.9 t70 -168.08 -88.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.366 -0.134 . . . . 1.92 111.25 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG2' ' OD2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -68.63 -32.27 72.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.866 0.365 . . . . 2.76 111.323 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 p -83.83 -16.38 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.011 -0.54 . . . . 1.98 111.147 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.3 15.05 60.57 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.988 -0.625 . . . . 1.27 112.752 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.421 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 48.4 mtm180 -151.14 -165.0 2.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.462 . . . . 3.61 109.754 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.29 116.27 24.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.48 111.204 -173.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.576 -0.738 . . . . 0.49 109.632 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 55.02 56.31 6.72 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.744 0.653 . . . . 1.55 111.128 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 151' ' ' PHE . 10.3 m -80.92 146.1 7.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.984 -0.376 . . . . 1.26 109.984 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -148.1 141.6 25.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.907 0.384 . . . . 2.05 110.411 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.24 24.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.75 111.095 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.53 127.92 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.413 -0.358 . . . . 1.56 110.518 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 109.181 -0.674 . . . . 2.94 109.181 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.278 0.561 . . . . 2.0 112.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.92 118.02 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.178 -1.045 . . . . 1.27 108.178 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -87.43 138.28 31.61 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.948 -0.569 . . . . 1.14 110.162 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -106.56 131.62 53.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.533 -0.758 . . . . 2.31 109.286 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.09 -170.8 20.43 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.874 -0.891 . . . . 0.5 110.874 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.96 148.52 32.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.68 111.724 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.9 115.39 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.355 -0.838 . . . . 0.56 110.642 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.01 -26.92 12.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.873 -0.331 . . . . 0.76 110.891 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.29 140.15 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.687 -0.486 . . . . 1.55 109.687 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.9 tpp -125.43 106.09 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 1.42 110.32 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 63.3 mttt -112.08 172.45 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.284 -0.416 . . . . 2.03 110.99 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.14 -45.58 79.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.903 0.705 . . . . 3.24 112.903 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -110.02 -43.04 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.343 0.497 . . . . 2.03 112.343 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 43.5 p90 -132.44 168.2 18.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.789 0.328 . . . . 1.25 111.003 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.19 159.93 28.06 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.374 -0.69 . . . . 0.71 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.93 126.87 52.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.574 -0.528 . . . . 1.08 109.574 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.37 124.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.323 -0.621 . . . . 0.61 109.323 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 9.9 tp10 -82.3 133.3 35.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.968 -0.753 . . . . 2.3 108.968 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -62.82 154.69 29.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.358 -0.837 . . . . 0.87 110.648 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 83' ' ' ILE . 13.2 tp -47.66 -42.68 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 1.58 112.568 -175.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -111.8 18.29 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.274 -0.421 . . . . 2.04 111.811 -174.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.553 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 15.6 m-70 57.46 58.78 3.62 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 3.29 110.415 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -96.87 -47.24 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.283 -0.871 . . . . 2.89 110.869 -174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -158.22 -174.39 4.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 1.8 111.009 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -102.29 123.68 46.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 3.37 110.753 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 ' HE2' ' A' ' 55' ' ' TYR . 17.9 t -111.82 107.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.933 0.397 . . . . 0.87 110.821 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.24 123.41 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.186 0.517 . . . . 1.06 109.759 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -128.13 134.38 49.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.96 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 125.02 47.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.888 -0.782 . . . . 1.18 108.888 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -60.24 -16.75 36.53 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.292 0.478 . . . . 0.75 112.292 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -59.71 -15.48 20.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.25 -0.432 . . . . 1.63 111.715 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -109.43 12.7 24.47 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.665 0.269 . . . . 2.07 111.401 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -82.11 133.42 35.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.722 0.296 . . . . 0.91 110.223 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 ttm -91.97 100.64 13.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.952 0.406 . . . . 1.73 110.613 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.32 -146.02 16.81 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.003 -0.618 . . . . 1.05 112.11 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -112.71 104.74 56.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.689 0.28 . . . . 2.14 110.602 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.82 -5.18 16.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.836 2.358 . . . . 1.01 112.292 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.21 -6.25 46.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.763 -0.653 . . . . 2.08 111.173 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.58 14.0 17.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.18 110.924 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.77 148.78 23.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.005 -0.543 . . . . 0.92 110.579 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -145.0 177.22 8.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.928 -0.578 . . . . 2.35 110.107 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.9 mm? -72.25 123.29 22.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.533 . . . . 1.4 110.944 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.1 1.59 48.31 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.955 -0.566 . . . . 0.75 112.551 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.13 123.74 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.812 0.339 . . . . 1.06 110.657 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.31 140.87 45.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.808 -0.633 . . . . 2.51 111.186 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.82 154.27 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.44 110.684 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.87 134.29 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.648 -0.871 . . . . 1.49 108.648 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.559 ' CB ' HG22 ' A' ' 75' ' ' VAL . 3.5 p90 -164.9 175.89 9.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.527 0.566 . . . . 0.66 112.527 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 p -126.32 173.6 9.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.518 -0.764 . . . . 0.94 111.113 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -108.62 144.72 35.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 1.19 111.019 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 2.04 111.439 -178.128 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.48 0.181 . . . . 2.3 110.932 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.4 148.84 84.7 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.571 2.181 . . . . 1.43 111.762 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.04 156.68 20.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.82 110.566 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.17 166.53 24.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.696 -0.229 . . . . 2.3 110.807 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 55.55 76.53 0.27 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.892 0.745 . . . . 2.01 110.611 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.0 t -115.84 120.3 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.72 -0.673 . . . . 0.8 110.664 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -117.26 151.41 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.416 -0.587 . . . . 3.51 109.416 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtm -87.26 143.4 27.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.966 -0.294 . . . . 1.12 110.641 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -130.16 120.04 18.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.345 -0.983 . . . . 1.67 108.345 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.4 116.53 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.431 2.087 . . . . 2.15 116.002 -163.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? 54.59 127.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.319 1.97 . . . . 4.61 116.319 162.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 t30 75.74 30.47 0.77 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.585 -1.189 . . . . 2.84 110.918 167.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 m -94.83 4.5 53.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 1.7 110.886 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 27' ' ' LEU . 10.3 mm -108.21 136.16 19.85 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.299 -0.63 . . . . 0.92 109.299 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.49 156.2 67.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.527 2.151 . . . . 1.03 112.003 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.28 146.0 43.6 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.714 -0.221 . . . . 2.76 110.943 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 160' ' ' ALA . 36.5 Cg_endo -67.37 150.33 80.91 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.998 2.466 . . . . 1.08 112.139 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.34 94.14 6.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.052 0.453 . . . . 1.1 110.61 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.6 t -138.11 134.58 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 mt -74.83 -65.09 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.582 -0.447 . . . . 2.87 111.928 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 91' ' ' THR . 34.3 mt-10 -96.49 -56.12 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.19 0.519 . . . . 2.84 111.302 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 175.9 160.59 0.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.264 -1.334 . . . . 1.42 107.465 -174.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -101.53 -54.6 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.352 -0.539 . . . . 1.3 110.18 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -138.91 158.52 44.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.791 -0.448 . . . . 1.29 109.791 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -112.92 155.39 24.82 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.901 -1.148 . . . . 1.36 107.901 170.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.72 177.65 38.74 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 119.674 -1.251 . . . . 0.53 112.012 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.46 149.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.605 -0.517 . . . . 1.37 109.605 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.54 123.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.737 0.303 . . . . 0.69 111.276 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.97 4.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.89 111.722 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.522 -0.308 . . . . 3.92 111.01 -176.727 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.647 0.26 . . . . 1.24 111.648 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 87.04 157.61 31.18 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.473 -0.87 . . . . 0.94 112.176 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 130' ' ' GLU . 59.7 mt -144.03 135.33 25.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.93 111.395 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 mt -106.22 138.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.793 -1.094 . . . . 0.49 109.726 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.59 117.15 28.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.593 0.711 . . . . 1.4 110.401 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.2 mm -96.48 132.31 41.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.008 -0.996 . . . . 0.63 109.502 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -86.45 152.79 22.39 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.91 -0.316 . . . . 1.21 110.56 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -59.83 161.39 6.46 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.124 -0.489 . . . . 2.29 111.265 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.41 -23.68 64.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.487 -0.779 . . . . 2.78 111.282 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.38 3.11 54.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.672 -0.24 . . . . 1.77 110.764 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 59.45 88.72 0.07 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.494 0.664 . . . . 4.14 109.759 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -144.5 -77.92 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 1.87 111.378 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 17.0 p -123.83 -166.45 1.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.682 0.277 . . . . 1.54 110.649 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.5 p -95.25 126.2 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.912 -0.585 . . . . 1.29 109.729 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.6 mt -65.31 -69.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 120.719 -0.392 . . . . 1.03 110.883 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -137.91 -85.93 0.28 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 1.56 110.485 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -176.43 139.71 0.35 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.649 -1.16 . . . . 2.08 108.151 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.546 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -117.88 130.19 56.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.69 -0.804 . . . . 0.68 111.277 176.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 16.4 tt0 -85.55 142.67 28.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.476 -1.238 . . . . 1.19 109.435 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 43.1 p90 -117.91 136.09 53.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.31 0.576 . . . . 0.74 110.363 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.55 150.96 22.89 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.508 -0.769 . . . . 0.51 112.312 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.51 -27.95 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.226 0.536 . . . . 0.67 110.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.9 p -76.22 -39.81 53.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.661 -0.7 . . . . 1.35 111.034 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 15.1 p -82.51 -14.96 54.08 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.803 -0.635 . . . . 1.1 110.943 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -79.5 58.28 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 1.46 110.5 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 137' ' ' VAL . 6.8 t -51.45 -35.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.591 . . . . 0.82 110.81 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.504 ' OD1' HD22 ' A' ' 143' ' ' LEU . 6.2 p30 -88.26 21.17 2.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.459 -0.791 . . . . 2.17 111.228 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -54.06 -23.61 14.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.833 0.679 . . . . 1.39 112.833 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -93.04 -1.57 56.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 2.46 111.819 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.17 175.75 9.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.204 -0.453 . . . . 1.89 110.202 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 mt -91.41 29.1 1.53 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.228 0.537 . . . . 2.88 109.828 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 164' ' ' ALA . 18.9 tp -51.44 115.15 1.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.409 -1.269 . . . . 0.97 112.073 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -122.37 -176.31 3.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 1.77 110.544 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.69 130.96 43.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 1.43 109.612 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.67 43.65 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.662 -0.78 . . . . 1.07 112.196 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.99 134.88 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.678 -0.409 . . . . 1.94 110.218 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 165' ' ' VAL . 92.5 mt -80.19 141.28 35.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 1.79 110.258 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.85 142.81 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.124 -0.489 . . . . 1.16 110.738 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.6 p -100.83 121.81 42.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.784 -0.644 . . . . 1.44 109.455 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.0 p90 -144.06 163.61 33.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.117 -0.492 . . . . 0.61 110.103 -176.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.532 ' NE ' ' HB2' ' A' ' 161' ' ' CYS . 0.9 OUTLIER -137.31 124.2 21.35 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.683 0.754 . . . . 2.2 111.247 176.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.401 HG23 HG21 ' A' ' 92' ' ' THR . 1.4 tt -99.35 134.63 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.627 -1.17 . . . . 1.24 110.353 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 10.4 t70 -153.32 -97.34 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.515 0.191 . . . . 1.92 111.515 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.0 41.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.373 . . . . 2.76 111.683 -174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -80.58 -16.84 53.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 1.98 110.182 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.43 17.67 62.3 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.007 -0.542 . . . . 1.27 113.255 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 41.5 mtm180 -145.02 -170.65 3.47 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.14 124.23 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.402 0.62 . . . . 0.48 111.437 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 86' ' ' PRO . . . -135.64 157.91 45.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.443 -0.799 . . . . 0.49 110.091 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.532 ' HB2' ' NE ' ' A' ' 152' ' ' ARG . 59.4 m 49.27 61.91 2.89 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.772 0.67 . . . . 1.55 109.954 -171.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 151' ' ' PHE . 53.6 t -90.89 121.83 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 1.26 110.33 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -136.21 132.75 36.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.964 -0.384 . . . . 2.05 109.964 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.33 120.43 9.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.75 111.472 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' LEU . 7.1 p -127.02 126.46 68.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.747 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.9 mpt_? . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 109.967 -0.383 . . . . 2.94 109.967 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.088 0.471 . . . . 2.0 111.524 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.88 123.38 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 1.27 109.32 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.83 139.76 37.98 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.917 -0.583 . . . . 1.14 109.798 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.443 HH11 ' CD1' ' A' ' 78' ' ' LEU . 37.8 ttm-85 -110.82 148.38 32.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.157 -0.683 . . . . 2.31 109.157 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.39 178.35 46.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.52 -0.847 . . . . 0.5 112.173 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 145.62 48.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.96 0.409 . . . . 0.68 111.17 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -65.96 117.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.419 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' HD22 ' A' ' 49' ' ' LEU . . . -97.9 -42.17 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.078 -0.249 . . . . 0.76 110.914 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 23' ' ' PHE . 2.4 m -124.84 148.63 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 109.949 -0.389 . . . . 1.55 109.949 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.4 mtp -133.79 110.07 9.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.973 -0.38 . . . . 1.42 109.973 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -92.69 170.69 9.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.272 -1.01 . . . . 2.03 108.272 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.66 -16.6 60.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.073 0.463 . . . . 3.24 110.034 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -104.31 -49.27 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.03 111.651 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -147.74 -179.84 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.796 -0.184 . . . . 1.25 110.621 -175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.69 165.28 28.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.275 -0.964 . . . . 0.71 112.389 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HD2' HG21 ' A' ' 16' ' ' VAL . 49.9 m-85 -118.79 128.71 54.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.894 0.378 . . . . 1.08 110.016 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.8 mt -97.77 125.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.956 -0.566 . . . . 0.61 109.493 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 139.16 36.35 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.806 -0.813 . . . . 2.3 108.806 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -66.34 156.87 33.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.176 0.512 . . . . 0.87 111.447 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.539 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -63.4 -42.46 98.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.786 -0.643 . . . . 1.58 111.143 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 p -97.2 12.27 33.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.868 0.692 . . . . 2.04 112.868 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 59.68 58.26 2.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.888 0.375 . . . . 3.29 111.332 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.54 -28.14 5.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.243 0.46 . . . . 2.89 112.243 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -169.55 170.61 8.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.953 0.342 . . . . 1.8 110.614 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.16 140.41 37.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.862 0.363 . . . . 3.37 110.349 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 127.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.043 0.449 . . . . 0.87 110.621 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -84.1 121.51 27.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.898 -0.592 . . . . 1.06 110.776 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -128.05 146.97 50.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.732 -0.84 . . . . 1.96 108.732 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.297 -0.631 . . . . 1.18 109.297 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -64.89 -19.58 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.027 0.441 . . . . 0.75 111.043 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.9 t -62.97 -36.58 83.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.599 -0.728 . . . . 1.63 111.08 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.91 16.85 23.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.865 0.364 . . . . 2.07 110.599 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.553 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 74.9 t80 -75.98 135.9 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.517 -0.549 . . . . 0.91 109.517 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.429 ' H ' HG23 ' A' ' 75' ' ' VAL . 60.4 mtp -98.09 105.93 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.264 0.554 . . . . 1.73 110.961 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.32 -134.59 7.77 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.025 -0.989 . . . . 1.05 111.999 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -118.1 100.83 51.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.339 . . . . 2.14 110.273 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.26 -12.6 21.02 Favored 'Trans proline' 0 N--CA 1.471 0.185 0 C-N-CA 122.976 2.45 . . . . 1.01 113.133 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.17 -13.44 59.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 2.08 110.37 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -102.84 14.63 31.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 2.18 111.359 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -88.67 141.73 28.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.219 -0.446 . . . . 0.92 110.211 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -136.06 170.56 15.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.673 -0.694 . . . . 2.35 109.934 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 15' ' ' ALA . 54.2 mt -74.68 114.59 13.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.01 -0.541 . . . . 1.4 110.488 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.7 26.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.898 -0.668 . . . . 0.75 112.764 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -81.16 116.41 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.048 0.451 . . . . 1.06 111.45 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.53 134.37 54.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.836 -1.075 . . . . 2.51 111.328 176.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.4 m -148.21 141.73 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.674 -0.491 . . . . 0.44 109.674 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 78' ' ' LEU . 11.5 pt-20 -114.82 145.17 42.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.506 -0.478 . . . . 1.49 109.922 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 5.7 p90 -166.64 179.71 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.66 111.651 -168.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 p -131.93 170.54 14.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.94 110.835 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.79 142.62 35.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.672 0.272 . . . . 1.19 111.157 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 121.317 0.579 . . . . 2.04 110.547 177.919 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 110.011 -0.366 . . . . 2.3 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.18 146.55 95.96 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.536 2.158 . . . . 1.43 112.457 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -93.83 146.5 23.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.696 -0.684 . . . . 0.82 111.043 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.58 176.48 5.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 2.3 110.937 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.5 32.41 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.635 0.731 . . . . 2.01 110.797 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 4.2 m -73.74 116.62 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.79 . . . . 0.8 111.693 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -123.27 144.66 49.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 3.51 110.302 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.595 ' HA ' HG12 ' A' ' 53' ' ' VAL . 50.8 mtt -74.07 147.06 43.16 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.097 0.475 . . . . 1.12 111.395 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 54' ' ' GLU . 75.7 mt -119.43 157.2 52.14 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.518 -0.765 . . . . 1.67 110.951 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.5 169.95 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.627 2.218 . . . . 2.15 111.847 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -78.08 175.16 10.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.0 -0.545 . . . . 4.61 111.297 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.03 3.04 4.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.307 -0.861 . . . . 2.84 112.234 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.0 m -71.92 -25.73 62.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.476 -0.329 . . . . 1.7 110.62 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.539 ' CD1' HD21 ' A' ' 27' ' ' LEU . 11.0 mm -105.99 120.99 47.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.92 109.954 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.19 158.99 17.74 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.007 2.471 . . . . 1.03 113.523 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -125.87 165.19 28.59 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.608 -0.724 . . . . 2.76 109.899 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 7.4 Cg_exo -69.47 156.16 64.86 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.668 2.246 . . . . 1.08 111.92 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.51 93.6 4.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.917 0.389 . . . . 1.1 111.373 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 91' ' ' THR . 7.7 t -141.88 92.29 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.771 -0.455 . . . . 1.23 109.771 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.82 -37.85 76.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.788 0.328 . . . . 2.87 110.718 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.14 -26.06 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 2.84 110.8 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.462 ' H ' HG12 ' A' ' 88' ' ' VAL . 66.7 m 70.45 113.05 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.831 . . . . 1.42 111.23 -175.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 t -93.66 -24.11 18.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.025 0.75 . . . . 1.3 113.025 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -138.84 160.87 38.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.909 0.862 . . . . 1.29 112.748 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -140.15 155.49 46.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.952 -1.476 . . . . 1.36 107.186 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.3 -165.69 23.03 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.33 -1.414 . . . . 0.53 112.762 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.85 146.7 24.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.807 -0.442 . . . . 1.37 109.807 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.11 122.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.382 -0.372 . . . . 0.69 110.8 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.3 -67.99 0.75 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.893 -0.594 . . . . 0.89 111.667 -175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 3.92 111.818 -177.665 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 130' ' ' GLU . . . . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.152 0.427 . . . . 1.24 112.152 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.39 158.16 16.28 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.078 -0.809 . . . . 0.94 111.078 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.35 147.41 34.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.028 0.914 . . . . 0.93 113.258 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.45 142.65 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.473 -1.239 . . . . 0.49 110.152 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.12 117.41 25.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 129' ' ' HIS . 8.6 mm -103.72 124.08 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 0.63 110.391 -174.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -97.91 153.47 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.229 -0.656 . . . . 1.21 109.229 175.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.07 177.43 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.274 0.559 . . . . 2.29 111.454 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG3' HD22 ' A' ' 121' ' ' LEU . 10.2 pt-20 -65.85 -25.71 67.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.417 -0.81 . . . . 2.78 111.851 -175.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -94.23 -2.15 52.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.39 -0.596 . . . . 1.77 109.39 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.47 29.14 18.78 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.115 -0.948 . . . . 4.14 110.646 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.8 p -86.1 -38.17 18.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.903 0.334 . . . . 1.87 111.903 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -143.14 166.35 24.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.261 0.553 . . . . 1.54 112.042 -174.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.17 132.37 33.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.186 -0.915 . . . . 1.29 108.68 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -75.82 -71.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.017 -0.673 . . . . 1.03 111.242 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -142.56 -87.29 0.15 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.651 0.738 . . . . 1.56 110.427 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -178.11 133.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.03 -1.441 . . . . 2.08 107.984 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.582 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.5 m-70 -109.21 132.77 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.264 -0.574 . . . . 0.68 110.792 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 112' ' ' ALA . 23.9 tt0 -83.8 147.65 27.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.512 -0.767 . . . . 1.19 110.643 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -119.27 151.21 38.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 0.74 110.709 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.13 150.38 16.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.51 112.194 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -57.09 -26.96 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.217 0.532 . . . . 0.67 111.21 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.7 p -73.85 -32.49 63.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.751 -0.659 . . . . 1.35 110.469 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 14.7 m -87.64 -13.9 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 1.1 110.635 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -73.1 59.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.587 -0.733 . . . . 1.46 111.644 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.9 t -48.94 -42.46 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.247 0.546 . . . . 0.82 110.618 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 20.4 m120 -88.36 33.88 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.615 . . . . 2.17 111.727 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -62.32 -19.2 63.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.205 0.526 . . . . 1.39 110.9 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -81.66 -21.45 38.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 2.46 111.896 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.26 169.05 18.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.665 0.745 . . . . 1.89 112.788 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.652 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -85.66 27.94 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.631 -1.168 . . . . 2.88 110.509 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.9 tp -56.16 113.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.492 -0.777 . . . . 0.97 111.146 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -128.83 -175.08 3.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.786 . . . . 1.77 110.207 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.27 136.22 49.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.075 -0.343 . . . . 1.43 110.075 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.69 -6.62 74.07 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.839 -0.696 . . . . 1.07 112.679 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.44 141.52 28.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.022 -0.671 . . . . 1.94 109.933 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.8 144.09 32.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.779 -0.646 . . . . 1.79 110.981 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 147.59 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.562 -0.745 . . . . 1.16 111.159 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 33.2 t -110.46 146.04 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 1.44 109.898 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 162' ' ' VAL . 15.9 p90 -165.96 174.76 9.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.61 110.018 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 127.45 11.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.04 0.448 . . . . 2.2 111.217 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.542 HG21 ' CD2' ' A' ' 129' ' ' HIS . 8.7 pt -95.84 144.72 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.675 -0.693 . . . . 1.24 109.282 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 5.2 t70 -166.51 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.065 0.228 . . . . 1.92 111.103 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -82.41 -29.24 30.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.448 -0.501 . . . . 2.76 111.843 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.565 ' OG ' ' HG3' ' A' ' 86' ' ' PRO . 59.3 p -84.78 -17.01 39.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.742 0.306 . . . . 1.98 111.529 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.1 25.75 60.24 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.036 -0.602 . . . . 1.27 112.294 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -152.61 178.04 10.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.719 -0.474 . . . . 3.61 109.719 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.27 110.42 19.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.48 111.115 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.28 164.33 21.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.585 -0.734 . . . . 0.49 110.647 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.3 m 60.98 32.12 19.93 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.82 0.7 . . . . 1.55 111.336 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 150' ' ' SER . 10.0 m -64.35 122.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.529 0.68 . . . . 1.26 111.283 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.606 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 6.7 p30 -131.32 125.08 31.83 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.269 -0.878 . . . . 2.05 109.413 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -61.96 133.06 54.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.75 111.189 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 83.6 t -118.23 121.16 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.97 -0.559 . . . . 1.56 111.724 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 108.963 -0.755 . . . . 2.94 108.963 170.27 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.032 0.444 . . . . 2.0 110.772 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.89 120.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.454 -0.794 . . . . 1.27 109.432 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -90.65 158.67 16.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.34 -0.615 . . . . 1.14 109.34 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 30.8 ttm180 -129.1 143.02 50.72 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.307 -0.406 . . . . 2.31 110.485 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.32 -164.88 24.78 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.117 -0.793 . . . . 0.5 111.117 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.87 154.85 39.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.509 . . . . 0.68 111.276 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.6 mm -73.41 110.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.56 111.284 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 133' ' ' ILE . . . -97.52 -49.98 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.101 0.477 . . . . 0.76 110.823 176.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.15 123.56 69.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.475 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.0 ttm -119.03 109.11 15.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.835 -0.62 . . . . 1.42 109.574 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 5.9 tppt? -98.23 -163.44 1.04 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.234 -1.024 . . . . 2.03 108.234 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 9.0 pt-20 -79.43 -39.13 33.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.13 0.419 . . . . 3.24 112.13 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -111.92 -35.06 5.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.008 0.432 . . . . 2.03 112.109 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -134.01 178.04 7.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.509 -0.314 . . . . 1.25 110.951 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.39 171.67 36.65 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.045 -0.598 . . . . 0.71 111.703 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -115.93 127.45 54.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.95 0.405 . . . . 1.08 110.085 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -98.28 127.33 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 0.61 110.976 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.5 117.81 22.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.653 -0.869 . . . . 2.3 108.653 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.7 p -68.94 156.41 38.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 0.87 111.818 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.7 OUTLIER -56.48 -47.25 79.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.533 -0.758 . . . . 1.58 110.976 -178.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.77 9.51 27.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.18 -0.463 . . . . 2.04 111.755 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p80 39.28 37.71 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.449 1.1 . . . . 3.29 112.599 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -98.91 -17.6 18.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 2.89 110.105 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.84 155.39 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.139 -0.937 . . . . 1.8 110.591 -166.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.188 -0.671 . . . . 3.37 109.188 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -108.95 108.56 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.784 -0.366 . . . . 0.87 110.1 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 8.1 t80 -68.58 121.22 15.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 1.06 109.723 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -121.28 128.35 52.27 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.066 -0.515 . . . . 1.96 110.827 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 122.99 41.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.521 -0.918 . . . . 1.18 108.521 174.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -62.18 -16.48 53.29 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.097 0.406 . . . . 0.75 112.097 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -57.14 -29.49 63.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.996 -0.547 . . . . 1.63 111.628 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -103.29 24.04 11.54 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.849 0.357 . . . . 2.07 111.638 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 77.6 t80 -86.22 139.06 31.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.91 110.768 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.4 ttm -96.77 97.09 9.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.098 0.475 . . . . 1.73 110.333 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.95 -136.25 8.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.768 -0.729 . . . . 1.05 112.066 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.5 104.94 33.7 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.25 -0.278 . . . . 2.14 110.25 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -17.36 27.0 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.215 . . . . 1.01 112.226 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -74.35 -8.1 55.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.923 -0.58 . . . . 2.08 110.459 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -107.06 10.5 30.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.728 -0.669 . . . . 2.18 110.597 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.9 142.29 27.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.92 110.306 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -116.1 161.95 18.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.464 -0.789 . . . . 2.35 109.969 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.78 120.22 19.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.59 -0.522 . . . . 1.4 109.59 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 133' ' ' ILE . . . 96.34 3.9 59.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.964 -0.636 . . . . 0.75 112.01 -176.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.09 129.09 38.91 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.956 0.408 . . . . 1.06 110.823 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 30.4 mt-10 -71.41 126.5 29.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.386 -0.825 . . . . 2.51 110.637 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.51 157.74 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.242 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -128.81 150.8 50.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.367 -0.605 . . . . 1.49 109.367 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CB ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -164.0 175.68 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.947 0.721 . . . . 0.66 112.947 -166.254 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -136.85 166.51 23.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.16 -0.927 . . . . 0.94 109.732 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.5 mt -94.71 147.51 23.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.003 0.43 . . . . 1.19 111.342 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.04 110.798 179.091 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.242 -0.281 . . . . 2.3 110.242 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 58.0 Cg_endo -71.76 158.7 52.61 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.47 2.113 . . . . 1.43 113.057 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.55 155.5 19.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.618 -0.719 . . . . 0.82 110.378 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -134.84 164.26 27.97 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.513 -0.312 . . . . 2.3 111.03 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 62.12 29.27 17.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.488 -0.778 . . . . 2.01 111.095 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 55' ' ' TYR . 39.3 t -73.9 122.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.945 -0.571 . . . . 0.8 110.843 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -126.46 156.91 39.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 3.51 110.442 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.467 ' HA ' HG12 ' A' ' 53' ' ' VAL . 61.9 mtt -72.3 143.24 48.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.12 110.814 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.86 143.33 27.36 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.0 -1.0 . . . . 1.67 109.178 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 135.33 69.86 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.768 1.645 . . . . 2.15 111.788 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 6.4 ttpm? -60.58 149.61 34.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.689 -0.687 . . . . 4.61 111.378 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.1 t30 77.88 26.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.34 -0.845 . . . . 2.84 110.55 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.8 m -88.37 -30.66 19.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.24 -1.022 . . . . 1.7 108.24 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.25 123.54 73.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.318 -1.31 . . . . 0.92 108.868 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.48 158.17 48.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.816 2.344 . . . . 1.03 113.649 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.63 155.95 46.77 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.709 -0.678 . . . . 2.76 110.575 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 57.0 Cg_endo -69.16 133.94 27.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.729 2.286 . . . . 1.08 112.87 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.05 94.64 8.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 1.1 110.334 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 3.0 t -137.22 156.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.928 -1.138 . . . . 1.23 107.928 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.18 -64.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.131 -0.627 . . . . 2.87 111.195 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 91' ' ' THR . 78.7 mm-40 -95.06 -57.18 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.576 -0.45 . . . . 2.84 112.062 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -179.98 156.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 1.42 109.902 -171.442 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.502 HG21 ' O ' ' A' ' 153' ' ' ILE . 2.9 m -106.12 -54.24 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.968 0.413 . . . . 1.3 110.219 173.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -143.94 177.56 8.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.357 0.599 . . . . 1.29 110.931 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -145.25 168.37 20.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.323 -1.362 . . . . 1.36 107.323 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.8 -170.38 43.31 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.636 -1.269 . . . . 0.53 112.647 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.427 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.9 p -121.62 146.65 26.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.6 -0.519 . . . . 1.37 109.6 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.72 120.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.036 -0.357 . . . . 0.69 110.036 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -74.17 -65.54 0.83 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.055 -0.521 . . . . 0.89 111.391 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 3.92 110.349 -178.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 N-CA-C 112.856 0.688 . . . . 1.24 112.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.65 162.26 13.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.382 -0.913 . . . . 0.94 111.695 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 128' ' ' GLN . 18.3 mt -143.41 147.24 34.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.93 112.015 -171.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -107.3 141.14 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.089 -0.96 . . . . 0.49 109.289 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 98' ' ' ALA . 8.0 pt-20 -88.86 113.18 24.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.542 0.686 . . . . 1.4 110.109 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 129' ' ' HIS . 6.7 mm -94.3 127.98 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.033 -0.985 . . . . 0.63 109.703 -174.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.3 pt? -85.84 159.61 19.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.162 -0.31 . . . . 1.21 110.162 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.84 164.04 8.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.623 . . . . 2.29 110.345 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -68.31 -17.71 64.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.471 . . . . 2.78 109.744 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.577 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -96.07 -17.19 21.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.612 -0.722 . . . . 1.77 110.462 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 20.9 ttm180 71.2 99.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.836 0.71 . . . . 4.14 111.653 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.0 t -154.75 -41.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.992 -0.283 . . . . 1.87 111.111 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 6.6 p -147.44 -171.95 3.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.742 0.306 . . . . 1.54 111.419 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.46 136.4 24.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.039 -0.528 . . . . 1.29 109.756 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.15 -69.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.67 -0.412 . . . . 1.03 110.925 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -138.61 -84.8 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.466 0.65 . . . . 1.56 110.841 171.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.454 ' HG3' HD13 ' A' ' 114' ' ' LEU . 1.6 pm0 -175.33 141.25 0.53 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.877 -1.056 . . . . 2.08 108.726 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.601 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.1 m-70 -116.46 133.57 55.86 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.67 -0.412 . . . . 0.68 110.161 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.2 tt0 -86.61 146.29 26.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.682 -0.69 . . . . 1.19 109.656 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -117.02 146.63 42.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.889 0.376 . . . . 0.74 110.155 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -108.83 150.05 17.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.757 -0.735 . . . . 0.51 111.744 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.441 HG23 ' HA2' ' A' ' 50' ' ' GLY . 10.4 tp -58.73 -22.49 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.029 0.442 . . . . 0.67 111.369 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.2 p -73.23 -37.19 66.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.439 . . . . 1.35 110.682 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 11.2 p -90.65 -8.84 48.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.116 -0.493 . . . . 1.1 111.733 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 132' ' ' GLY . 54.1 mt -73.45 59.97 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 1.46 111.225 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t -42.34 -47.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.287 0.477 . . . . 0.82 112.287 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.51 HD21 HD22 ' A' ' 143' ' ' LEU . 4.5 p-10 -93.15 34.36 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.737 0.273 . . . . 2.17 111.737 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -59.65 -14.81 15.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.274 0.472 . . . . 1.39 112.274 -176.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -79.86 -16.41 55.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 2.46 110.727 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.81 151.0 20.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.607 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.68 93.11 3.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.416 0.627 . . . . 2.88 110.076 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 138' ' ' ASN . 11.7 tp -100.24 116.98 33.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.159 -0.928 . . . . 0.97 109.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.36 -176.35 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.335 0.588 . . . . 1.77 111.782 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 58.0 tttm -65.47 126.14 27.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.981 -1.009 . . . . 1.43 110.117 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 103.71 -1.57 45.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.448 -0.882 . . . . 1.07 113.133 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -91.69 141.35 28.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.094 0.447 . . . . 1.94 111.04 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HB ' ' A' ' 96' ' ' VAL . 94.5 mt -82.51 139.4 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 1.79 111.278 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.07 153.51 29.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.211 0.529 . . . . 1.16 111.073 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 22.9 t -112.72 142.34 45.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.468 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 27.1 p90 -158.45 158.21 33.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.61 110.354 -175.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 63.2 mtt180 -125.33 120.82 32.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.04 -0.355 . . . . 2.2 110.04 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.502 ' O ' HG21 ' A' ' 92' ' ' THR . 5.3 tt -102.29 120.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.072 -0.513 . . . . 1.24 110.794 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -159.75 -87.54 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.708 0.289 . . . . 1.92 110.478 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 6.0 mm-40 -75.07 -20.84 59.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.661 . . . . 2.76 109.822 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.8 p -83.79 -18.24 38.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.232 -0.895 . . . . 1.98 111.249 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.91 5.46 7.47 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.943 -0.571 . . . . 1.27 113.526 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -153.42 -164.12 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 3.61 108.426 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.1 109.14 17.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.407 0.622 . . . . 0.48 111.119 -172.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -120.18 165.16 15.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.26 -0.882 . . . . 0.49 109.944 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 73.7 m 59.02 36.37 24.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.995 0.426 . . . . 1.55 110.613 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' SER . 42.2 t -73.38 110.67 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 1.26 110.648 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.38 129.39 44.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.875 -0.602 . . . . 2.05 110.25 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 102.66 0.97 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.75 110.896 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.93 137.6 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.177 -0.465 . . . . 1.56 110.394 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.452 -0.34 . . . . 2.94 110.386 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.322 0.582 . . . . 2.0 111.316 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.29 114.5 30.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.11 -0.95 . . . . 1.27 108.868 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.93 138.22 31.71 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.057 -0.72 . . . . 1.14 109.057 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 11.5 ptp180 -129.04 151.52 49.64 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.439 -0.504 . . . . 2.31 110.385 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.25 -158.95 9.39 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.509 -1.036 . . . . 0.5 110.509 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 139.08 44.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.833 0.349 . . . . 0.68 110.629 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.6 mm -64.3 114.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.948 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -40.05 3.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.463 -0.335 . . . . 0.76 111.249 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 54.5 t -116.92 123.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.615 0.245 . . . . 1.55 110.713 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.5 mtp -123.21 108.14 12.48 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.05 -0.722 . . . . 1.42 109.05 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -106.76 -165.31 1.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.625 -0.509 . . . . 2.03 109.625 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 34.3 tt0 -76.24 -46.98 25.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 3.24 111.337 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -101.35 -32.67 10.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.466 . . . . 2.03 111.379 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -148.93 -169.82 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.4 -0.364 . . . . 1.25 111.18 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.37 -176.79 30.82 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.012 -0.613 . . . . 0.71 111.984 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.456 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 84.1 m-85 -131.54 140.31 49.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 1.08 110.442 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.0 131.03 67.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.504 -0.771 . . . . 0.61 109.989 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' OE1' HG22 ' A' ' 133' ' ' ILE . 46.4 mt-10 -70.77 130.39 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.073 -0.714 . . . . 2.3 109.073 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.59 139.53 58.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.761 -0.459 . . . . 0.87 109.761 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.7 tp -52.22 -36.84 53.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 1.58 111.476 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.4 t -108.35 22.75 15.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 2.04 110.93 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 43.47 51.63 6.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.822 0.849 . . . . 3.29 111.856 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.95 -50.27 6.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.666 -1.152 . . . . 2.89 110.397 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.81 -173.04 3.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 1.8 110.576 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -101.53 129.65 47.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.895 0.379 . . . . 3.37 110.9 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.36 122.66 58.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.87 110.923 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.07 120.12 33.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 1.06 110.089 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.32 152.71 38.63 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.381 -0.599 . . . . 1.96 109.381 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -111.61 134.17 53.37 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.493 -0.558 . . . . 1.18 109.493 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 24.7 m-85 -63.91 -27.16 68.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.333 0.494 . . . . 0.75 112.333 -175.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -68.24 -36.42 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.783 0.325 . . . . 1.63 110.766 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -87.52 7.46 29.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.225 0.536 . . . . 2.07 110.894 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 18.0 t80 -84.64 137.31 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.668 -0.697 . . . . 0.91 110.381 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttm -104.52 110.72 23.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.73 110.969 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.5 -138.01 6.58 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.842 -0.617 . . . . 1.05 111.787 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.34 101.96 14.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.955 -0.387 . . . . 2.14 109.955 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 -14.43 30.68 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.509 2.14 . . . . 1.01 112.294 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.74 -18.61 63.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.751 -0.659 . . . . 2.08 110.274 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -109.5 9.09 25.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 2.18 110.952 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.3 145.55 29.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.92 111.473 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -141.04 160.81 39.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.489 -0.778 . . . . 2.35 109.507 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.59 115.01 4.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.879 -0.6 . . . . 1.4 110.882 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.66 0.05 15.58 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.75 113.21 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -75.64 120.22 20.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.922 0.391 . . . . 1.06 110.638 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.83 128.44 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.474 -0.784 . . . . 2.51 109.858 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 77' ' ' MET . 15.0 m -139.79 144.4 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.707 -0.224 . . . . 0.44 110.904 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 16.6 pt-20 -118.19 149.18 41.51 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 1.49 109.809 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.65 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 20.6 p90 -168.57 179.67 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.051 0.453 . . . . 0.66 111.554 -173.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -133.95 141.9 47.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.575 . . . . 0.94 110.695 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.4 mt -72.52 156.39 39.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.357 -0.383 . . . . 1.19 111.14 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 2.04 110.559 177.318 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.819 -0.067 . . . . 2.3 110.819 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.85 152.38 80.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.858 2.372 . . . . 1.43 113.689 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -106.75 124.05 49.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.916 -1.038 . . . . 0.82 109.742 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.36 173.15 6.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.3 111.113 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 60.94 34.44 19.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.942 -0.572 . . . . 2.01 111.394 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 29.6 t -69.18 115.09 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.8 111.181 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -119.36 146.55 45.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.199 -0.91 . . . . 3.51 111.151 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.406 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.0 mtt -78.91 139.09 38.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.566 -0.901 . . . . 1.12 108.566 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.1 pt? -131.87 161.98 59.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 10.8 Cg_endo -53.89 132.45 49.73 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 112.721 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -69.94 163.96 24.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.93 -1.032 . . . . 4.61 111.306 -174.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 78.16 34.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.294 -0.866 . . . . 2.84 111.472 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -94.59 -16.9 22.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 1.7 109.057 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 27' ' ' LEU . 6.5 mm -73.07 135.66 79.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.92 109.854 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.81 159.65 50.05 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.496 2.131 . . . . 1.03 112.548 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -124.95 150.12 65.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.291 -0.413 . . . . 2.76 110.048 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.42 130.01 37.79 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.555 2.17 . . . . 1.08 111.578 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.95 90.99 5.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.472 0.653 . . . . 1.1 110.624 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.47 136.6 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.494 -0.928 . . . . 1.23 108.494 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.84 -60.95 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.552 -0.459 . . . . 2.87 112.009 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.0 tp10 -90.95 -54.47 3.95 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.875 -0.33 . . . . 2.84 110.81 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 169.16 155.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.187 -0.671 . . . . 1.42 109.187 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.42 HG21 HG23 ' A' ' 153' ' ' ILE . 0.6 OUTLIER -105.75 -58.44 1.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 1.3 110.997 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -139.03 147.87 42.66 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.512 -0.313 . . . . 1.29 110.569 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.7 p30 -108.05 125.51 51.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.41 -0.959 . . . . 1.36 108.41 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -133.1 -175.52 14.0 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.056 -1.069 . . . . 0.53 112.321 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.1 t -135.39 146.05 30.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.777 -0.453 . . . . 1.37 109.777 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 143' ' ' LEU . 97.6 t -62.01 121.03 9.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.69 110.828 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.29 -53.22 17.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.89 111.871 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 . . . . . 0 N--CA 1.463 0.205 0 CA-C-N 116.677 -0.238 . . . . 3.92 111.089 -179.719 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.995 0.426 . . . . 1.24 110.807 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.09 145.96 11.43 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.459 -1.057 . . . . 0.94 110.459 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.12 138.83 50.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.69 0.757 . . . . 0.93 111.983 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.53 135.05 47.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.512 -1.222 . . . . 0.49 109.272 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.41 125.97 35.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4 110.263 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.1 mm -101.69 138.09 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.571 -0.741 . . . . 0.63 110.35 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 122' ' ' ARG . 1.3 pt? -85.77 154.14 21.8 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.401 0.438 . . . . 1.21 110.016 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.94 -175.88 5.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.873 0.368 . . . . 2.29 110.365 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.9 pt-20 -68.59 -18.36 64.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.652 0.612 . . . . 2.78 112.652 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -109.19 -0.12 19.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.984 -0.286 . . . . 1.77 110.854 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HB2' HD12 ' A' ' 118' ' ' LEU . 31.2 ttm-85 56.57 70.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 4.14 109.777 -172.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -118.69 -48.29 2.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.876 -0.602 . . . . 1.87 109.962 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -142.35 169.74 17.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.553 -0.749 . . . . 1.54 111.131 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.5 p -81.14 135.06 25.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.375 -0.602 . . . . 1.29 109.375 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.5 mt -71.12 -70.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.554 -0.458 . . . . 1.03 110.824 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -138.59 -85.45 0.26 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.04 0.447 . . . . 1.56 110.971 170.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -177.16 143.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.329 -0.85 . . . . 2.08 109.065 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.401 ' CE1' HG13 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -119.58 132.83 55.81 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.68 111.233 176.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -95.69 144.01 26.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.033 -0.985 . . . . 1.19 109.454 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -117.92 136.69 53.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.74 111.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.29 152.63 22.85 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.605 -0.725 . . . . 0.51 112.292 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.51 HG22 ' OE1' ' A' ' 25' ' ' GLU . 10.6 tp -55.71 -34.66 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.482 0.549 . . . . 0.67 112.482 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -78.32 -22.48 48.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.382 0.61 . . . . 1.35 110.545 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 3.5 m -89.21 -19.73 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.66 -0.7 . . . . 1.1 110.21 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -79.05 60.07 2.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.327 -0.851 . . . . 1.46 111.268 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.0 t -43.73 -41.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.241 0.544 . . . . 0.82 111.347 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.4 m120 -87.91 32.58 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.948 -0.569 . . . . 2.17 111.38 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -59.99 -26.97 66.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.355 0.598 . . . . 1.39 110.524 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -88.84 -13.8 38.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.193 -0.912 . . . . 2.46 111.392 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.97 175.1 8.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.077 -0.965 . . . . 1.89 111.294 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.73 16.51 17.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.991 -0.744 . . . . 2.88 108.991 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.483 ' HG ' HG21 ' A' ' 97' ' ' VAL . 25.4 tp -43.6 107.53 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.188 -1.369 . . . . 0.97 111.448 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.59 -178.51 3.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.841 -0.618 . . . . 1.77 110.733 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -63.85 135.3 56.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 1.43 110.291 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.85 -7.31 67.59 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.365 -0.921 . . . . 1.07 112.931 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.19 146.42 23.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.205 -0.598 . . . . 1.94 109.585 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.56 140.77 29.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.684 -0.689 . . . . 1.79 110.768 -172.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.42 144.87 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 115.139 -0.937 . . . . 1.16 110.731 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.9 m -111.58 143.6 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.146 -0.479 . . . . 1.44 109.878 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.625 ' HB3' HG12 ' A' ' 162' ' ' VAL . 7.0 p90 -157.14 166.6 32.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.146 -0.479 . . . . 0.61 110.116 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -119.22 119.61 34.61 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.003 -0.679 . . . . 2.2 109.517 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 92' ' ' THR . 3.7 tt -103.78 138.41 28.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.419 -0.586 . . . . 1.24 109.419 167.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.82 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.799 -0.36 . . . . 1.92 111.153 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -38.39 22.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.853 0.686 . . . . 2.76 112.853 -173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.9 t -81.45 -16.82 50.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.842 0.312 . . . . 1.98 111.842 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.15 71.76 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.428 -0.892 . . . . 1.27 112.519 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -133.27 -178.23 4.88 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.083 -0.339 . . . . 3.61 110.083 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.99 108.43 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.48 110.377 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -125.33 161.79 26.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.128 -0.487 . . . . 0.49 110.177 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.35 39.86 11.8 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 123.59 0.556 . . . . 1.55 110.045 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 151' ' ' PHE . 15.5 m -69.58 125.08 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 1.26 111.059 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 46.2 t30 -125.74 117.52 23.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.603 -0.726 . . . . 2.05 109.483 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -69.08 102.67 1.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.75 110.43 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.58 130.12 49.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.86 -0.609 . . . . 1.56 110.794 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.854 -0.612 . . . . 2.94 110.458 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 121.167 0.508 . . . . 2.0 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.25 116.01 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.436 -0.802 . . . . 1.27 109.13 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -89.09 138.17 31.66 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.822 -0.626 . . . . 1.14 109.564 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 39.9 ttm180 -116.19 132.37 56.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.616 -0.72 . . . . 2.31 109.462 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.73 -157.23 7.81 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.879 -0.677 . . . . 0.5 111.415 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.494 ' CE2' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -146.04 152.92 40.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.989 0.423 . . . . 0.68 110.949 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.0 mm -71.68 114.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.691 -0.686 . . . . 0.56 110.287 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.83 -42.0 4.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.676 0.274 . . . . 0.76 111.45 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.19 123.12 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.453 . . . . 1.55 111.139 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.5 mtt -113.44 116.07 29.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.5 -0.773 . . . . 1.42 109.931 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 -177.8 3.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 2.03 108.444 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.19 -45.62 72.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.882 0.327 . . . . 3.24 111.882 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -110.92 -18.21 13.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.964 0.357 . . . . 2.03 111.964 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -153.73 -173.34 4.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.251 -0.278 . . . . 1.25 110.251 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.81 -169.99 30.14 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.718 -0.753 . . . . 0.71 111.496 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -130.18 130.54 44.84 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.959 -0.386 . . . . 1.08 109.959 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 35' ' ' PHE . 63.9 mt -90.22 124.03 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.471 -0.566 . . . . 0.61 109.471 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.14 125.17 28.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 2.3 109.482 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.3 p -65.37 144.11 57.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.87 109.942 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.649 HD21 HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -52.93 -46.31 68.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.057 0.456 . . . . 1.58 110.946 -174.589 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 t -92.94 6.57 47.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.105 -0.498 . . . . 2.04 111.542 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 54.46 56.95 6.25 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.013 0.911 . . . . 3.29 109.6 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.39 -33.4 7.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.683 -1.144 . . . . 2.89 110.759 -172.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -142.77 166.49 24.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.283 -0.417 . . . . 1.8 110.911 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.49 126.91 50.92 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.625 -0.879 . . . . 3.37 108.625 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.49 115.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.87 111.492 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -81.21 120.27 24.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.343 -0.844 . . . . 1.06 110.473 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 24' ' ' ILE . 3.9 p90 -123.21 151.23 42.45 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.914 -0.773 . . . . 1.96 108.914 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -120.36 131.76 54.98 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.083 -0.71 . . . . 1.18 109.083 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -60.33 -24.73 65.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -71.32 -12.2 61.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.668 0.27 . . . . 1.63 111.136 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -109.8 0.48 18.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.07 110.512 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.47 127.05 34.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.91 109.998 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.0 ttp -101.02 97.77 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.186 0.517 . . . . 1.73 110.597 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.46 -160.34 30.14 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.619 -0.719 . . . . 1.05 111.331 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -102.98 102.94 30.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.805 0.302 . . . . 2.14 110.193 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.44 -24.05 9.47 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.45 2.1 . . . . 1.01 113.633 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.33 -4.28 50.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.531 0.205 . . . . 2.08 111.5 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -113.23 19.64 16.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.386 0.612 . . . . 2.18 110.704 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.448 HD21 ' HE2' ' A' ' 77' ' ' MET . 56.0 mt -95.04 159.92 14.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.92 108.976 172.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.13 164.88 28.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.821 -0.437 . . . . 2.35 109.821 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.32 113.28 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.28 0.562 . . . . 1.4 110.017 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.28 27.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.862 -0.685 . . . . 0.75 112.643 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -77.3 124.75 28.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.328 . . . . 1.06 110.41 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HG2' HG12 ' A' ' 83' ' ' ILE . 16.4 mp0 -67.97 126.8 30.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.312 -0.858 . . . . 2.51 111.257 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -142.9 149.86 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.44 109.925 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.02 156.28 42.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.24 -0.288 . . . . 1.49 110.401 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 2.4 p90 -170.16 179.42 3.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.877 0.37 . . . . 0.66 111.292 -169.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.4 p -120.8 172.3 7.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.94 110.683 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.67 146.12 49.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.19 111.528 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 2.04 110.091 174.539 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' N ' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 110.238 -0.282 . . . . 2.3 110.238 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.29 150.98 42.71 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.57 2.18 . . . . 1.43 112.236 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.36 129.47 34.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.101 -0.499 . . . . 0.82 109.806 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -116.12 143.33 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.915 0.388 . . . . 2.3 111.123 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.1 70.92 0.58 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.362 -0.836 . . . . 2.01 111.21 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 25.3 t -96.14 125.17 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.8 109.821 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -127.89 149.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 3.51 111.13 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.448 ' HE2' HD21 ' A' ' 47' ' ' LEU . 66.8 mtt -79.23 154.17 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.12 109.935 175.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.3 147.96 32.99 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 1.67 109.658 169.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.93 162.83 27.41 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.54 2.16 . . . . 2.15 112.975 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.27 173.04 5.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 4.61 111.214 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 m120 73.72 3.18 4.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.496 -0.775 . . . . 2.84 110.989 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 m -89.46 -2.39 58.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.351 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.649 HD12 HD21 ' A' ' 27' ' ' LEU . 30.7 mm -110.72 123.39 35.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.203 -0.666 . . . . 0.92 109.203 176.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.49 139.27 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.048 1.832 . . . . 1.03 111.266 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.83 148.51 43.4 Favored Pre-proline 0 C--N 1.314 -0.941 0 C-N-CA 120.821 -0.352 . . . . 2.76 110.427 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.39 130.73 41.43 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.276 2.651 . . . . 1.08 111.932 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.09 93.0 9.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.188 0.518 . . . . 1.1 110.826 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.39 126.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.535 -0.913 . . . . 1.23 108.535 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -59.96 2.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.547 0.203 . . . . 2.87 111.547 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 57.5 mm-40 -91.21 -55.04 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.714 -0.394 . . . . 2.84 111.281 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 13.1 t 171.02 159.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.42 109.9 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 HG23 ' A' ' 153' ' ' ILE . 1.0 OUTLIER -102.44 -54.93 2.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 1.3 109.788 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.577 ' CE1' ' HE2' ' A' ' 151' ' ' PHE . 23.7 p80 -162.93 168.23 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.29 109.623 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.38 -177.52 3.15 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.137 -0.32 . . . . 1.36 110.137 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.65 179.1 47.82 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.838 -0.696 . . . . 0.53 111.698 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.59 145.27 32.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.833 -0.432 . . . . 1.37 109.833 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.6 t -58.79 123.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.365 -0.235 . . . . 0.69 110.365 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.28 -65.96 0.82 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.388 -0.369 . . . . 0.89 111.888 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 110.331 -0.248 . . . . 3.92 110.331 179.081 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.639 0.257 . . . . 1.24 110.96 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 95.96 144.42 16.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.334 -0.46 . . . . 0.94 112.272 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.5 mt -128.99 145.03 51.35 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.699 0.761 . . . . 0.93 112.148 -174.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.13 137.37 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.413 -1.267 . . . . 0.49 108.532 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.0 pt-20 -90.48 125.07 35.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.489 0.661 . . . . 1.4 110.505 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 93' ' ' HIS . 44.0 mm -94.97 136.84 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.894 -1.048 . . . . 0.63 110.43 -174.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -100.73 144.39 29.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.63 167.29 9.27 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.104 0.252 . . . . 2.29 111.023 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' HG3' HD22 ' A' ' 121' ' ' LEU . 13.0 pt-20 -60.2 -29.44 68.71 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.575 0.35 . . . . 2.78 111.528 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.502 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -89.5 6.15 42.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.77 110.527 178.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 69.72 87.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 4.14 111.793 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.6 p -115.8 -159.07 0.7 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.928 -1.033 . . . . 1.87 109.639 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 p -85.84 -161.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.338 -0.392 . . . . 1.54 109.975 170.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.5 p -64.44 120.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 1.29 111.34 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.8 mt -69.1 -67.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 1.03 110.343 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 p -133.28 -86.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.75 -0.38 . . . . 1.56 111.335 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -178.1 129.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.685 . . . . 2.08 109.654 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.462 ' CG ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -116.19 129.72 56.44 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.68 110.246 176.016 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 158' ' ' ARG . 10.4 tt0 -96.77 149.69 21.55 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.071 -0.968 . . . . 1.19 109.958 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 31.0 p90 -117.87 177.11 4.9 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.67 -0.412 . . . . 0.74 110.709 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -134.93 152.98 20.92 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.912 -0.585 . . . . 0.51 111.848 -176.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -52.86 -28.76 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.887 0.375 . . . . 0.67 111.897 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.0 p -77.53 -33.19 54.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.409 0.623 . . . . 1.35 110.436 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 132' ' ' GLY . 47.9 t -72.03 -27.38 62.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.107 -0.951 . . . . 1.1 110.311 177.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.08 59.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.393 -0.821 . . . . 1.46 112.506 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -48.61 -41.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.234 0.54 . . . . 0.82 110.257 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.3 m120 -87.86 32.65 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.759 -0.655 . . . . 2.17 111.414 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -60.59 -21.66 62.88 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.156 0.503 . . . . 1.39 111.264 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -93.14 -6.28 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 2.46 111.371 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -88.51 158.06 18.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.76 -0.654 . . . . 1.89 111.188 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.4 mm? -81.36 49.06 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 2.88 110.43 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 164' ' ' ALA . 21.8 tp -76.4 122.84 25.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.603 -0.726 . . . . 0.97 109.937 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 11.7 pt20 -123.94 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.657 . . . . 1.77 111.732 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.39 121.79 15.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.907 -1.042 . . . . 1.43 109.905 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.33 1.81 44.31 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.322 -0.942 . . . . 1.07 112.53 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.463 ' OD1' ' HG2' ' A' ' 144' ' ' GLN . 13.3 m-20 -91.07 140.13 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.743 0.272 . . . . 1.94 110.393 173.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.78 138.99 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.918 0.39 . . . . 1.79 110.862 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 164' ' ' ALA . 15.6 m -135.97 146.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 1.16 110.823 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.3 p -104.67 133.38 49.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.505 -0.554 . . . . 1.44 109.505 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' HE2' ' CE1' ' A' ' 93' ' ' HIS . 5.5 p90 -146.42 163.57 35.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.116 0.26 . . . . 0.61 110.7 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 1.4 mpp_? -118.54 121.7 40.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.147 0.499 . . . . 2.2 110.194 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 92' ' ' THR . 12.9 tt -100.41 136.95 29.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.696 . . . . 1.24 109.788 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -169.61 -93.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.568 -0.16 . . . . 1.92 110.568 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.52 -19.97 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.826 0.346 . . . . 2.76 111.254 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.3 t -81.66 -17.01 49.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.927 -0.397 . . . . 1.98 109.927 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.32 23.22 57.54 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.791 -0.64 . . . . 1.27 113.51 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 11.4 ptp180 -156.93 -168.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.451 -0.574 . . . . 3.61 109.451 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.6 108.3 17.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.897 0.379 . . . . 0.48 110.319 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.12 144.85 44.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.154 -0.475 . . . . 0.49 111.368 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.9 m 66.17 43.6 2.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.633 -0.712 . . . . 1.55 110.352 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.9 m -65.07 118.7 7.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.622 0.725 . . . . 1.26 110.786 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.431 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.1 t-20 -120.86 124.4 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.48 -0.782 . . . . 2.05 109.882 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.07 112.96 3.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.75 111.041 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.86 129.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.944 -0.571 . . . . 1.56 111.021 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 2.94 110.061 174.934 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.96 0.409 . . . . 2.0 110.788 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.45 114.65 25.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.631 . . . . 1.27 109.459 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.34 159.31 15.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.501 -0.772 . . . . 1.14 109.267 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.518 ' HG3' HD13 ' A' ' 27' ' ' LEU . 6.8 ptp180 -141.05 147.42 38.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.757 -0.46 . . . . 2.31 109.757 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.09 -169.77 22.06 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.172 -0.771 . . . . 0.5 111.172 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.19 140.26 52.69 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.785 0.326 . . . . 0.68 110.468 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.21 116.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.642 -0.708 . . . . 0.56 110.613 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.28 -48.55 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.76 111.355 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 96.2 t -114.45 124.03 70.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.676 0.274 . . . . 1.55 110.649 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.5 ttm -126.94 105.55 8.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.272 -0.422 . . . . 1.42 110.197 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 17.9 mmtp -97.94 -161.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.715 -0.476 . . . . 2.03 109.715 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -50.63 38.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 3.24 111.912 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.417 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 50.8 m-80 -112.24 -34.47 5.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 2.03 111.571 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 p90 -124.82 173.74 8.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.15 -0.477 . . . . 1.25 110.709 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.32 165.74 35.56 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 111.076 -0.81 . . . . 0.71 111.076 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.505 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.6 m-85 -110.44 126.64 54.53 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.183 0.516 . . . . 1.08 109.791 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -95.7 130.23 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.696 -0.853 . . . . 0.61 108.696 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -80.16 128.75 33.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.534 -0.913 . . . . 2.3 108.534 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.6 p -63.34 149.73 45.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.745 -0.661 . . . . 0.87 110.829 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 83' ' ' ILE . 11.4 tp -54.93 -34.12 62.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.305 0.574 . . . . 1.58 111.828 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -110.36 22.46 15.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 2.04 111.431 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.454 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 31.4 p80 43.63 45.73 5.9 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.016 0.912 . . . . 3.29 111.369 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.71 -44.72 9.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.919 -1.037 . . . . 2.89 111.337 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.82 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 1.8 112.07 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.21 121.75 46.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.53 -0.759 . . . . 3.37 110.367 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.19 127.32 64.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.87 111.536 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -91.83 120.62 32.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.95 -0.568 . . . . 1.06 110.053 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -128.45 138.08 52.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.275 -0.42 . . . . 1.96 110.089 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' A' ' 20' ' ' ASN . 3.3 t60 -107.6 124.29 49.73 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -63.18 -18.04 63.06 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.626 0.602 . . . . 0.75 112.626 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 -31.5 68.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.679 0.276 . . . . 1.63 110.841 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.05 5.95 46.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.982 0.42 . . . . 2.07 111.4 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 47.4 t80 -75.34 132.09 40.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.313 -0.403 . . . . 0.91 110.047 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.3 ttp -114.63 91.06 3.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.959 0.409 . . . . 1.73 110.08 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.68 -136.65 4.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.987 -0.845 . . . . 1.05 110.987 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -121.25 96.6 48.04 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 117.023 0.411 . . . . 2.14 110.681 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.39 -22.94 12.03 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.791 2.328 . . . . 1.01 113.013 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -81.66 -5.91 58.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.295 0.569 . . . . 2.08 110.476 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -112.47 18.04 18.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.88 -0.6 . . . . 2.18 110.414 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 49.2 mt -92.32 143.72 26.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.841 -0.618 . . . . 0.92 110.716 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.0 157.96 42.73 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.993 -0.743 . . . . 2.35 108.993 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.7 mm? -60.84 134.43 57.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.966 0.412 . . . . 1.4 110.511 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.29 -15.55 50.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.716 -0.754 . . . . 0.75 113.032 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -66.0 133.32 50.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.997 0.427 . . . . 1.06 111.434 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 1.8 mp0 -81.36 137.39 35.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.889 . . . . 2.51 110.763 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 77' ' ' MET . 23.6 m -144.3 151.54 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.44 109.843 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HB3' HD21 ' A' ' 78' ' ' LEU . 23.9 pt-20 -112.0 144.69 40.93 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.978 -0.378 . . . . 1.49 109.978 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.416 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.6 p90 -161.49 170.71 19.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.66 111.856 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -120.45 143.79 48.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.94 111.049 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.42 143.28 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 1.19 110.875 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.512 . . . . 2.04 110.018 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.886 -0.412 . . . . 2.3 109.886 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.53 165.72 31.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.331 2.021 . . . . 1.43 111.808 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.12 141.06 40.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.508 -0.315 . . . . 0.82 110.419 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 71.3 mm-40 -124.22 152.22 43.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 2.3 110.186 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.29 84.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.729 0.643 . . . . 2.01 111.511 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.6 t -110.94 124.62 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.146 -0.479 . . . . 0.8 110.003 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -118.25 153.42 33.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.802 -0.635 . . . . 3.51 109.792 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.448 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.1 mtp -97.86 119.46 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.7 -0.227 . . . . 1.12 110.783 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -122.56 104.09 37.26 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-O 121.804 0.812 . . . . 1.67 111.401 176.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -88.95 129.49 2.04 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.27 1.98 . . . . 2.15 112.868 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.5 tttp 79.05 133.13 0.06 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.073 1.138 . . . . 4.61 114.073 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.3 t30 68.96 3.23 3.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.444 -1.253 . . . . 2.84 112.891 167.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -78.14 -25.93 47.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.2 -0.6 . . . . 1.7 109.439 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 27' ' ' LEU . 1.8 mm -108.33 128.21 26.09 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.392 -0.966 . . . . 0.92 108.392 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.16 152.08 50.16 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.297 1.998 . . . . 1.03 112.461 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -103.66 142.49 24.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 2.76 109.597 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.73 128.13 21.39 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.297 1.998 . . . . 1.08 111.977 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.26 95.0 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 1.1 111.502 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -137.54 135.01 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.113 -0.699 . . . . 1.23 109.113 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -85.18 -62.0 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.659 -0.416 . . . . 2.87 111.265 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -93.0 -56.93 2.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.534 0.568 . . . . 2.84 112.534 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m 169.12 140.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.866 -1.161 . . . . 1.42 107.866 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -93.21 -55.34 3.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.174 -0.61 . . . . 1.3 110.638 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -145.96 148.29 32.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 1.29 110.987 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -110.7 161.54 15.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.706 -1.22 . . . . 1.36 107.706 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.28 -176.88 41.38 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.429 -1.367 . . . . 0.53 112.838 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.56 146.69 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.828 -0.434 . . . . 1.37 109.828 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.5 t -58.79 119.47 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.316 -0.402 . . . . 0.69 110.575 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -74.4 -37.49 63.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.89 111.192 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 3.92 110.563 172.558 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 N-CA-C 112.049 0.389 . . . . 1.24 112.049 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.3 163.33 30.63 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.94 111.984 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.4 mt -143.45 150.71 39.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.93 111.876 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.5 mt -116.3 136.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.981 -1.009 . . . . 0.49 109.748 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.57 114.67 24.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.678 0.751 . . . . 1.4 110.009 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -91.0 132.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.994 -1.003 . . . . 0.63 109.076 -176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.02 146.01 27.4 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.779 -0.368 . . . . 1.21 110.438 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.81 -178.6 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 2.29 110.401 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.4 pm0 -68.11 -25.14 65.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.895 0.331 . . . . 2.78 111.895 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -93.35 0.71 57.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.904 -0.318 . . . . 1.77 110.476 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 62.95 39.57 10.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.043 -0.526 . . . . 4.14 110.789 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 m -104.38 -50.69 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.87 111.553 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 125' ' ' VAL . 5.2 m -143.36 166.46 24.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.769 0.319 . . . . 1.54 110.794 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -68.72 137.27 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.356 -0.384 . . . . 1.29 110.995 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.16 -68.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 1.03 110.552 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -137.06 -86.41 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.017 0.436 . . . . 1.56 111.046 171.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -177.24 136.43 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.365 -0.834 . . . . 2.08 109.224 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.688 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -118.83 132.89 56.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.66 -0.416 . . . . 0.68 110.48 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.442 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.1 tt0 -91.25 146.82 23.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.424 -0.807 . . . . 1.19 109.507 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -118.75 142.4 47.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.74 110.967 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.25 150.14 24.49 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.825 -0.625 . . . . 0.51 112.522 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.2 tp -54.39 -43.86 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.126 0.488 . . . . 0.67 111.624 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -71.99 -29.56 64.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.213 0.53 . . . . 1.35 110.124 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 6.0 m -73.07 -24.11 60.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.629 . . . . 1.1 110.495 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -77.17 60.05 1.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.947 -0.57 . . . . 1.46 110.486 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 137' ' ' VAL . 21.8 t -39.96 -46.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.782 -0.644 . . . . 0.82 111.503 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.19 33.68 1.35 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 2.17 111.537 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.54 -20.04 52.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.723 0.409 . . . . 1.39 111.765 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 141' ' ' ASP . 3.4 ptt180 -75.74 -22.92 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 2.46 110.976 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 2.9 m-20 -93.29 140.49 29.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.893 -172.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 102.41 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.648 . . . . 2.88 110.788 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.04 118.44 32.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.97 109.93 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -120.24 -179.03 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.707 0.289 . . . . 1.77 111.117 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.55 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 75.2 tttt -65.17 126.94 29.68 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.699 -0.482 . . . . 1.43 109.699 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.74 -17.05 13.62 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.533 -0.758 . . . . 1.07 111.352 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -85.5 129.94 34.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 1.94 110.266 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -81.72 143.75 31.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.79 110.609 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.11 144.9 35.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.814 -0.63 . . . . 1.16 110.308 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.0 m -106.61 128.36 54.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.515 -0.55 . . . . 1.44 109.515 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.588 ' HB3' HG12 ' A' ' 162' ' ' VAL . 30.2 p90 -145.26 -178.61 6.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.481 . . . . 0.61 110.165 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -148.63 124.03 10.3 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.311 -0.556 . . . . 2.2 111.019 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.48 HG21 ' CD2' ' A' ' 129' ' ' HIS . 7.5 pt -99.56 153.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.996 -0.547 . . . . 1.24 109.853 172.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.554 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 33.0 t70 -177.15 -88.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.277 0.361 . . . . 1.92 110.293 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 45.6 mt-10 -74.22 -28.6 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 2.76 110.535 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 158' ' ' ARG . 13.3 p -78.85 -17.34 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 1.98 110.602 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.93 -28.21 0.64 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.135 -0.484 . . . . 1.27 113.111 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 156' ' ' SER . 90.4 mtt180 -120.39 -169.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.62 22.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.341 0.591 . . . . 0.48 111.791 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -126.42 155.79 41.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.185 -0.916 . . . . 0.49 110.061 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.6 m 57.55 51.4 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 1.55 111.087 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.0 m -79.05 145.13 9.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.854 -0.612 . . . . 1.26 110.437 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -149.04 128.8 13.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.359 -0.608 . . . . 2.05 109.359 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.04 124.22 19.56 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.385 0.428 . . . . 0.75 111.094 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 99.9 t -132.54 142.11 43.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 1.56 110.342 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 2.94 110.258 177.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.144 0.497 . . . . 2.0 110.696 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.97 114.7 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.529 -0.915 . . . . 1.27 108.529 172.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -87.18 141.71 28.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.253 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 25.5 mmt85 -100.76 146.0 27.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.575 -0.738 . . . . 2.31 110.285 -177.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.69 -173.26 33.14 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.224 -1.15 . . . . 0.5 110.224 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.44 145.35 36.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.199 0.5 . . . . 0.68 111.196 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.54 101.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.561 -0.745 . . . . 0.56 110.61 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.41 -43.82 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.015 0.436 . . . . 0.76 110.733 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.74 122.6 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.208 -0.451 . . . . 1.55 110.665 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.0 ttm -117.58 107.33 14.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.42 109.788 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.21 170.36 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.159 -0.682 . . . . 2.03 109.159 176.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.728 0.299 . . . . 3.24 111.746 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -102.38 -34.85 9.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.147 0.425 . . . . 2.03 112.147 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.89 -172.79 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.61 0.243 . . . . 1.25 111.186 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.09 173.44 32.68 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.833 -0.699 . . . . 0.71 111.899 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.73 138.71 52.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.832 0.348 . . . . 1.08 110.262 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.09 129.91 58.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.61 109.807 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.48 130.98 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.013 -1.106 . . . . 2.3 108.013 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -65.86 145.22 56.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.89 -0.595 . . . . 0.87 111.382 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 83' ' ' ILE . 2.3 tm? -52.36 -45.33 65.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 1.58 111.202 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -110.83 31.9 5.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.187 -0.46 . . . . 2.04 111.376 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 p80 43.89 45.38 6.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.785 0.834 . . . . 3.29 111.574 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.32 -48.21 62.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.8 -1.091 . . . . 2.89 110.608 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -172.46 -172.34 0.91 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 1.8 110.858 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.09 122.0 42.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 3.37 110.747 -168.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.58 136.29 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 121.116 0.484 . . . . 0.87 111.908 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.12 130.65 55.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 1.06 109.97 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -125.18 156.88 37.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.025 -0.732 . . . . 1.96 109.025 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -118.68 133.06 56.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.757 -0.46 . . . . 1.18 109.757 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.25 -24.04 66.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.867 0.691 . . . . 0.75 112.867 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -66.3 -33.37 75.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.762 0.315 . . . . 1.63 110.779 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.84 19.58 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.264 0.554 . . . . 2.07 110.564 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.458 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 75.0 t80 -92.98 139.69 30.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.654 -0.703 . . . . 0.91 110.304 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 38.0 ttm -119.5 100.42 7.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 1.73 110.108 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.88 -143.05 10.12 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.486 -0.646 . . . . 1.05 111.486 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -115.53 99.38 52.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.789 0.294 . . . . 2.14 110.732 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -81.9 -25.22 3.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.388 2.059 . . . . 1.01 111.918 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.34 -14.29 60.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 2.08 110.315 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -114.39 19.42 16.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.18 111.067 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.458 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 17.1 mt -82.29 169.31 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 0.92 112.202 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -130.77 164.76 24.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.014 -0.993 . . . . 2.35 110.337 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.18 114.87 22.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.6 -0.518 . . . . 1.4 109.6 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.67 3.05 46.67 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.742 -0.663 . . . . 0.75 112.192 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -68.3 122.46 18.41 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 1.06 111.574 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' OE2' ' HG2' ' A' ' 80' ' ' LYS . 26.0 mp0 -61.49 127.12 29.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.412 -0.813 . . . . 2.51 111.14 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.1 149.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.761 -0.654 . . . . 0.44 109.913 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 11' ' ' ARG . 21.6 pt-20 -121.22 137.32 54.73 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.344 -0.613 . . . . 1.49 109.344 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 4.3 p90 -155.39 178.05 10.67 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.684 -0.406 . . . . 0.66 111.411 -172.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -124.3 141.55 51.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.361 -0.381 . . . . 0.94 111.096 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.76 119.82 18.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.19 109.579 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 114.883 -1.053 . . . . 2.04 111.615 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 109.777 -0.453 . . . . 2.3 109.777 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.91 147.76 50.27 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.92 1.747 . . . . 1.43 112.233 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.4 142.07 27.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.82 110.421 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 53.8 mm-40 -113.02 156.66 22.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.061 -0.718 . . . . 2.3 109.061 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 58.07 50.68 9.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.576 0.703 . . . . 2.01 110.282 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 20.3 t -80.85 110.7 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.846 -0.616 . . . . 0.8 110.064 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 76' ' ' ARG . 9.3 mmt180 -107.98 173.69 6.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.578 0.704 . . . . 3.51 111.821 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.442 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 48.1 mtp -117.46 144.05 45.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.859 -1.064 . . . . 1.12 109.301 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.4 pt? -131.56 160.27 68.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 C-N-CA 120.694 -0.403 . . . . 1.67 110.072 175.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 60.7 Cg_endo -73.55 160.97 43.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.833 1.689 . . . . 2.15 112.155 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HG2' ' OE2' ' A' ' 52' ' ' GLU . 41.6 mtmt -74.1 173.92 9.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.788 -0.642 . . . . 4.61 112.125 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.52 30.66 2.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.43 -1.259 . . . . 2.84 110.55 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 t -124.39 11.09 8.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.798 0.809 . . . . 1.7 109.324 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 27' ' ' LEU . 40.9 mm -113.12 125.25 30.04 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 0.92 109.157 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.78 158.33 57.73 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.875 2.383 . . . . 1.03 113.268 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -137.35 152.73 73.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 2.76 109.779 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 10.8 Cg_exo -69.93 150.19 66.82 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.542 2.161 . . . . 1.08 112.545 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.95 92.52 6.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.387 0.613 . . . . 1.1 111.38 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 154' ' ' ASP . 92.2 t -142.79 119.3 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.009 -1.108 . . . . 1.23 108.009 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.82 -63.45 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.197 0.814 . . . . 2.87 113.197 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.19 -59.95 1.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.728 -0.789 . . . . 2.84 112.529 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -179.52 137.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.533 0.733 . . . . 1.42 109.525 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -106.3 -42.52 5.03 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.072 -0.251 . . . . 1.3 110.924 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -141.02 140.11 34.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.682 0.277 . . . . 1.29 110.422 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -116.97 110.14 17.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.239 -0.652 . . . . 1.36 109.239 173.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -114.53 -171.45 17.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.313 -0.946 . . . . 0.53 112.863 -172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -133.96 143.27 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.327 -0.249 . . . . 1.37 110.327 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.41 124.21 13.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.507 -0.315 . . . . 0.69 110.891 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.33 -59.11 2.65 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.226 -0.443 . . . . 0.89 111.172 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 120.859 0.361 . . . . 3.92 110.802 179.379 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 112.022 0.379 . . . . 1.24 112.022 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.77 164.46 38.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.485 -0.864 . . . . 0.94 111.284 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.435 HD13 ' NE2' ' A' ' 128' ' ' GLN . 26.1 mt -146.47 141.66 27.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.809 0.814 . . . . 0.93 112.214 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.13 132.94 55.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.181 -1.372 . . . . 0.49 108.988 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.93 112.42 21.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.883 0.849 . . . . 1.4 109.593 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.3 mm -87.56 134.85 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.694 -1.139 . . . . 0.63 110.249 -170.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.59 148.04 26.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.41 0.624 . . . . 1.21 110.731 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.64 150.89 14.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.994 -1.003 . . . . 2.29 109.116 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.8 -16.94 64.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.752 -0.379 . . . . 2.78 111.682 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.79 10.82 39.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.677 -0.49 . . . . 1.77 109.677 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 63.4 29.93 15.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.264 -0.88 . . . . 4.14 111.096 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 m -73.09 -76.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 1.87 110.988 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -143.94 -166.11 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.499 -0.126 . . . . 1.54 110.742 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 40.0 t -80.55 138.83 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 122.925 0.141 . . . . 1.29 110.689 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.7 mt -77.34 -70.68 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.908 -0.405 . . . . 1.03 109.908 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.4 m -138.52 -86.2 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.346 0.593 . . . . 1.56 110.457 167.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.435 ' NE2' HD13 ' A' ' 114' ' ' LEU . 10.9 pt20 -178.44 144.55 0.3 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.067 -0.97 . . . . 2.08 108.645 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.722 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.9 m-70 -115.46 142.24 46.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.531 0.681 . . . . 0.68 111.282 176.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -89.87 140.76 29.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.263 -1.335 . . . . 1.19 109.176 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CD1' HD21 ' A' ' 136' ' ' LEU . 30.9 p90 -118.07 154.97 31.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.82 0.343 . . . . 0.74 111.171 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.48 151.48 18.41 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.51 112.517 -173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.26 -32.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.008 0.432 . . . . 0.67 112.062 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 p -77.44 -38.02 50.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.438 -0.346 . . . . 1.35 111.106 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 42.2 p -80.49 -11.2 59.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.643 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 131' ' ' PHE . 29.4 mt -74.91 59.29 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 1.46 111.739 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -45.22 -41.38 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.537 . . . . 0.82 111.128 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.5 m120 -91.88 34.25 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.778 -0.646 . . . . 2.17 111.78 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 3.0 ptmt -64.39 -11.47 33.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.422 0.63 . . . . 1.39 110.832 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -87.52 -22.17 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.527 -0.761 . . . . 2.46 110.834 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 9.8 m-20 -92.86 162.54 14.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 1.89 111.726 -167.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.29 95.89 10.15 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.763 -0.653 . . . . 2.88 109.288 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.9 tp -114.78 107.45 15.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.901 -1.045 . . . . 0.97 109.04 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.92 -177.35 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 1.77 111.456 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -59.59 119.59 7.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 1.43 110.708 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.02 -3.55 31.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.564 -0.827 . . . . 1.07 112.904 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -89.7 137.07 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 1.94 110.655 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 148' ' ' LEU . 2.4 mm? -85.13 139.37 31.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 1.79 110.846 -174.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 141.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 1.16 111.461 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.0 p -105.72 123.37 47.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.5 p90 -139.94 164.36 30.2 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.585 -0.524 . . . . 0.61 109.585 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 6.8 mpt_? -123.65 119.25 29.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.018 -0.673 . . . . 2.2 110.136 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 tt -101.66 137.45 29.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.51 -0.768 . . . . 1.24 109.544 170.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 21.6 t70 -162.13 -99.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.915 -0.314 . . . . 1.92 110.731 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 8.8 pt-20 -83.0 -7.08 59.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.2 0.524 . . . . 2.76 111.071 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.4 t -93.26 -17.19 23.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.043 -0.526 . . . . 1.98 109.769 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.17 15.51 58.76 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 116.052 -0.522 . . . . 1.27 113.955 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -139.67 -177.32 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.44 . . . . 3.61 109.813 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.94 108.22 18.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.252 0.548 . . . . 0.48 110.107 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.504 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -118.03 155.74 29.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.49 110.557 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 t 56.37 49.3 15.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 1.55 109.699 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.23 110.74 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.038 -0.983 . . . . 1.26 110.608 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.11 124.4 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 2.05 110.126 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 121.21 14.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.208 -0.293 . . . . 0.75 110.208 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 96.3 t -128.31 140.88 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 1.56 111.091 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 2.94 109.922 176.651 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.212 0.529 . . . . 2.0 111.763 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' HA ' HG22 ' A' ' 56' ' ' THR . 1.1 p -102.1 121.52 53.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.478 -0.934 . . . . 1.27 108.478 170.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -98.39 155.58 17.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.699 -0.682 . . . . 1.14 109.594 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 27' ' ' LEU . 29.2 ptt-85 -128.82 143.91 51.03 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.104 0.478 . . . . 2.31 110.085 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.16 -171.88 21.57 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.356 -1.098 . . . . 0.5 110.356 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.32 140.34 48.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.271 0.557 . . . . 0.68 111.055 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.575 HG21 ' SD ' ' A' ' 17' ' ' MET . 45.7 mm -65.24 122.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.142 -0.935 . . . . 0.56 111.838 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.24 -18.0 10.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.76 111.321 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.41 HG11 ' HD2' ' A' ' 23' ' ' PHE . 96.7 t -135.54 123.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.395 0.141 . . . . 1.55 111.051 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.575 ' SD ' HG21 ' A' ' 14' ' ' ILE . 85.7 mmm -118.1 111.23 18.61 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.131 0.419 . . . . 1.42 112.131 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.749 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -112.4 172.23 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.514 -0.921 . . . . 2.03 108.514 165.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -82.89 -25.52 32.4 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.49 -0.484 . . . . 3.24 110.958 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -92.19 -50.23 5.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.724 0.297 . . . . 2.03 111.7 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.4 p90 -153.15 151.25 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.994 0.426 . . . . 1.25 111.292 -174.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.91 -178.8 15.71 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.891 -0.671 . . . . 0.71 111.817 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HD2' HG11 ' A' ' 16' ' ' VAL . 94.2 m-85 -131.88 141.83 49.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.345 -0.613 . . . . 1.08 109.345 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.61 119.78 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.081 0.467 . . . . 0.61 111.581 -170.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -70.83 128.59 36.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 2.3 108.934 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 p -81.2 153.12 27.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.192 -0.458 . . . . 0.87 111.161 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.2 tp -50.14 -47.73 54.04 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.55 -0.75 . . . . 1.58 111.622 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -104.77 20.88 17.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 2.04 111.023 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 p80 41.48 47.56 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.88 0.872 . . . . 3.29 111.781 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.77 -40.49 22.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.451 -0.795 . . . . 2.89 110.068 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -159.99 179.98 8.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.418 -0.81 . . . . 1.8 109.78 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -114.74 133.3 56.01 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.429 -0.952 . . . . 3.37 108.429 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG11 ' HE2' ' A' ' 55' ' ' TYR . 24.2 t -114.22 112.17 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.461 0.648 . . . . 0.87 111.993 -170.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 5.6 t80 -72.06 119.97 17.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.222 -0.899 . . . . 1.06 110.491 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -124.77 136.06 53.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.197 -0.456 . . . . 1.96 110.621 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -98.97 118.08 34.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.617 -0.883 . . . . 1.18 108.617 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.07 -17.38 39.14 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.26 0.467 . . . . 0.75 112.26 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 t -56.49 -24.98 49.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.191 -0.459 . . . . 1.63 111.114 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -107.14 24.24 13.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 2.07 111.021 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.416 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 70.9 t80 -87.41 152.05 22.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.91 111.297 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.6 ttm -116.47 110.88 19.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 1.73 109.89 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.05 -139.34 10.81 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.568 -0.825 . . . . 1.05 112.278 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -122.72 99.75 41.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.535 0.207 . . . . 2.14 110.468 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.53 -20.75 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.272 1.981 . . . . 1.01 112.372 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -74.88 -11.83 60.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 2.08 111.168 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -109.46 14.71 23.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 2.18 110.653 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 38.1 mt -93.83 158.66 15.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.92 111.048 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -162.06 175.13 12.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.597 -0.729 . . . . 2.35 109.571 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 mt -72.99 122.22 21.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.849 0.357 . . . . 1.4 111.039 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.08 -4.53 16.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.676 -0.773 . . . . 0.75 112.899 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -86.83 132.96 33.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.048 0.424 . . . . 1.06 111.237 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 3.4 mp0 -82.14 143.52 31.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.86 -0.609 . . . . 2.51 111.138 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.0 m -141.48 153.58 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.704 -0.68 . . . . 0.44 110.193 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -113.64 137.62 51.34 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.235 -0.654 . . . . 1.49 109.235 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.518 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.3 p90 -164.45 163.03 22.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.398 0.618 . . . . 0.66 112.372 -175.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 9' ' ' VAL . 68.6 p -113.3 147.72 37.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.94 110.025 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.2 135.73 46.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.647 -0.421 . . . . 1.19 110.327 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 2.04 111.002 -178.543 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.2 mt . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 110.333 -0.247 . . . . 2.3 110.333 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 47.1 Cg_endo -69.33 174.98 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.586 2.19 . . . . 1.43 112.134 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.72 159.52 22.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.596 -0.275 . . . . 0.82 110.84 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -130.1 145.39 51.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.709 0.29 . . . . 2.3 111.566 -176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 55.17 85.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.047 -0.979 . . . . 2.01 111.823 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 55' ' ' TYR . 43.5 t -115.86 119.38 61.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.056 -0.52 . . . . 0.8 110.623 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -120.22 164.74 15.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.636 -0.505 . . . . 3.51 109.636 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.452 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.9 mtt -81.12 144.27 31.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.815 0.34 . . . . 1.12 110.653 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 26.2 tp -121.68 129.43 25.19 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.67 110.183 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 28.2 Cg_exo -63.83 154.37 70.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.624 2.216 . . . . 2.15 112.476 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.685 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -64.07 168.82 4.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.915 -0.584 . . . . 4.61 111.248 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.9 t30 76.58 2.84 3.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.628 0.771 . . . . 2.84 110.735 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.7 p -86.99 -11.12 51.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.815 0.816 . . . . 1.7 109.191 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.584 HD12 ' CD1' ' A' ' 27' ' ' LEU . 8.4 mm -100.52 132.51 22.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 114.463 -1.244 . . . . 0.92 108.565 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.05 142.04 66.42 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.159 1.906 . . . . 1.03 111.495 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -128.03 143.28 47.29 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.695 -0.402 . . . . 2.76 110.485 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.489 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 33.1 Cg_endo -63.84 141.46 78.32 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.117 2.545 . . . . 1.08 112.917 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.07 93.39 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.992 -0.549 . . . . 1.1 110.03 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.07 137.01 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.728 -0.842 . . . . 1.23 108.728 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -82.65 -61.06 1.98 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.911 -0.316 . . . . 2.87 111.73 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 91' ' ' THR . 39.1 mt-10 -91.45 -55.52 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.453 -0.499 . . . . 2.84 111.082 -175.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 166.43 161.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.716 -0.846 . . . . 1.42 108.716 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -105.5 -50.41 3.22 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.511 -0.476 . . . . 1.3 110.788 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -144.82 145.64 31.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.943 0.402 . . . . 1.29 111.04 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.646 ' O ' HD22 ' A' ' 118' ' ' LEU . 3.9 p-10 -113.41 148.1 36.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.774 -1.195 . . . . 1.36 107.774 171.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -163.43 -163.75 16.91 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 118.973 -1.584 . . . . 0.53 113.225 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 21.1 t -133.94 146.88 30.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.7 -0.482 . . . . 1.37 109.7 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.95 117.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.077 -0.342 . . . . 0.69 110.077 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.88 -57.0 3.14 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.159 0.429 . . . . 0.89 112.159 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 3.92 111.48 -176.766 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 111.532 0.197 . . . . 1.24 111.532 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.19 153.23 22.06 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.773 -0.727 . . . . 0.94 112.302 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 130' ' ' GLU . 89.3 mt -138.65 142.01 39.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.622 0.725 . . . . 0.93 112.419 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.48 143.88 18.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.521 -1.218 . . . . 0.49 109.964 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 96' ' ' VAL . 11.1 pt-20 -84.63 125.8 32.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.345 0.593 . . . . 1.4 109.586 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 129' ' ' HIS . 14.6 mm -104.59 128.15 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.63 109.386 -173.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.18 156.93 20.79 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.299 0.374 . . . . 1.21 110.597 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m-20 -56.75 154.54 8.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.66 -0.496 . . . . 2.29 109.66 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.478 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.8 pt-20 -62.91 -22.42 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.06 0.457 . . . . 2.78 110.603 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -95.65 -3.82 45.5 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.145 -0.479 . . . . 1.77 110.221 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 118' ' ' LEU . 26.2 ttm180 64.23 89.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.272 -0.876 . . . . 4.14 111.004 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.9 m -133.34 -64.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 1.87 110.283 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -168.92 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.472 -0.785 . . . . 1.54 110.398 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 p -92.3 135.31 27.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.718 -0.475 . . . . 1.29 109.718 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -78.45 -70.87 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.566 -0.454 . . . . 1.03 110.767 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.6 m -139.89 -83.96 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.64 0.733 . . . . 1.56 111.43 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -175.36 138.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.575 -1.193 . . . . 2.08 109.695 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.6 m-70 -118.76 140.48 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.252 -0.579 . . . . 0.68 109.703 168.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 158' ' ' ARG . 19.8 tt0 -94.45 145.07 25.04 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.067 -0.97 . . . . 1.19 109.633 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 136' ' ' LEU . 33.5 p90 -117.76 170.61 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.732 -0.387 . . . . 0.74 110.938 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.03 152.05 20.93 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.72 -0.552 . . . . 0.51 111.72 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.87 -29.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.966 0.412 . . . . 0.67 111.426 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.1 p -74.64 -37.36 62.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 1.35 111.271 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 47.3 p -86.46 -11.55 51.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.363 -0.38 . . . . 1.1 110.7 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' CD1' ' A' ' 131' ' ' PHE . 62.0 mt -73.93 59.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 1.46 111.107 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.68 -45.81 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.251 0.548 . . . . 0.82 110.839 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -85.57 31.68 0.59 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 2.17 111.95 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -60.63 -20.01 59.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.023 0.439 . . . . 1.39 111.351 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -76.94 -21.43 54.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 2.46 111.591 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -89.8 175.6 7.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.148 -0.478 . . . . 1.89 110.677 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.87 101.51 12.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.864 -0.607 . . . . 2.88 109.6 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.457 HD21 ' CG1' ' A' ' 149' ' ' VAL . 11.8 tp -115.48 114.43 25.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.97 110.094 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -124.98 -173.8 2.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.512 -0.313 . . . . 1.77 110.183 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -66.03 136.75 56.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.758 -0.377 . . . . 1.43 110.073 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.41 -9.48 57.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.675 -0.774 . . . . 1.07 111.722 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 38.4 m-20 -89.49 147.57 23.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.099 0.952 . . . . 1.94 110.997 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 165' ' ' VAL . 1.0 OUTLIER -98.04 127.54 44.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.291 -1.777 . . . . 1.79 109.692 -168.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.457 ' CG1' HD21 ' A' ' 143' ' ' LEU . 29.1 m -129.1 152.57 37.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 1.16 111.768 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 p -118.98 135.71 54.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.214 -0.662 . . . . 1.44 109.214 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -153.94 161.98 41.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.61 110.948 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 123.96 30.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.781 0.8 . . . . 2.2 111.803 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tt -99.3 129.25 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.201 -1.363 . . . . 1.24 110.409 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 15.5 t70 -160.74 -88.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.976 -0.102 . . . . 1.92 110.913 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 4.6 mm-40 -81.66 -19.61 41.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 2.76 111.25 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.7 p -81.7 -17.57 47.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.238 -0.437 . . . . 1.98 110.496 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.73 18.18 16.48 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.808 -0.633 . . . . 1.27 112.842 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 62.8 mtm180 -147.46 -173.82 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.886 -1.153 . . . . 3.61 107.886 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.61 108.35 17.31 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.461 -0.496 . . . . 0.48 109.836 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -115.76 159.95 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.49 110.653 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.4 t 59.01 42.26 19.53 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.781 0.675 . . . . 1.55 109.766 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.77 108.81 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.348 -0.842 . . . . 1.26 110.442 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.75 111.33 20.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.387 -0.824 . . . . 2.05 110.143 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.68 120.26 9.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.869 -0.605 . . . . 0.75 110.675 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 148' ' ' LEU . 59.8 t -102.84 110.26 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.855 -0.611 . . . . 1.56 110.614 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.439 -0.578 . . . . 2.94 109.439 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.341 0.591 . . . . 2.0 111.018 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.12 121.94 37.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.317 -0.856 . . . . 1.27 109.747 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.37 140.3 32.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.771 -0.65 . . . . 1.14 110.342 -173.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 37.5 ttm180 -101.77 152.85 20.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.776 -0.647 . . . . 2.31 110.002 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.97 -169.09 35.11 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.17 -0.772 . . . . 0.5 111.17 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.9 145.13 29.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.757 0.313 . . . . 0.68 110.581 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 112.16 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.56 110.589 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.82 -25.18 15.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.468 -0.333 . . . . 0.76 111.395 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.614 HG11 ' HD2' ' A' ' 23' ' ' PHE . 2.6 p -156.26 134.02 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.354 -0.384 . . . . 1.55 111.237 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.5 mtp -118.85 115.83 25.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.415 -0.587 . . . . 1.42 109.415 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 27.2 mmtm -96.25 -161.65 0.89 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.684 -0.487 . . . . 2.03 109.684 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.31 -46.53 27.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.899 -0.591 . . . . 3.24 111.134 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -111.49 -24.61 10.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 2.03 111.626 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 51.5 p90 -143.98 -173.72 4.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.938 0.399 . . . . 1.25 111.109 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.13 -178.36 35.03 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.001 -0.84 . . . . 0.71 111.001 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.614 ' HD2' HG11 ' A' ' 16' ' ' VAL . 67.7 m-85 -125.03 130.54 52.51 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.979 0.419 . . . . 1.08 109.958 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mt -100.03 126.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.976 -0.556 . . . . 0.61 109.542 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.78 127.46 32.45 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.959 -0.756 . . . . 2.3 108.959 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.1 p -63.62 139.72 58.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.34 -0.846 . . . . 0.87 110.729 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -57.2 -36.62 71.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.677 0.751 . . . . 1.58 109.468 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -82.72 6.92 16.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.718 -1.128 . . . . 2.04 112.253 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p80 42.71 53.02 4.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.73 0.812 . . . . 3.29 111.733 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.8 -42.66 3.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 2.89 111.444 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.14 174.5 14.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 1.8 111.303 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.24 126.16 50.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 3.37 109.43 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 90.7 t -105.28 121.41 57.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.282 -0.417 . . . . 0.87 111.86 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -82.15 114.57 20.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 1.06 109.691 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -118.15 137.45 52.96 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.179 -0.609 . . . . 1.96 109.424 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -100.79 127.64 47.14 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -56.99 -22.87 41.75 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.259 0.466 . . . . 0.75 112.259 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -70.55 -8.99 55.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.606 -0.27 . . . . 1.63 111.672 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -116.41 20.15 14.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 2.07 109.948 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -102.67 139.24 38.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.91 110.243 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -109.37 136.53 48.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.181 0.515 . . . . 1.73 110.717 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.6 -138.75 13.95 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.019 -0.833 . . . . 1.05 111.019 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -128.67 105.89 18.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.794 -0.447 . . . . 2.14 109.794 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.98 -30.7 38.87 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.843 2.362 . . . . 1.01 112.42 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.38 -18.1 65.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.66 -0.7 . . . . 2.08 111.528 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -98.36 10.65 40.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.079 0.466 . . . . 2.18 110.63 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.0 148.99 24.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.718 -0.673 . . . . 0.92 110.794 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 166.12 22.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 2.35 109.887 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.83 115.18 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 1.4 110.195 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -7.16 21.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.253 -0.499 . . . . 0.75 112.002 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.54 120.24 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 1.06 111.008 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 83' ' ' ILE . 9.0 mp0 -65.13 134.09 53.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.294 -0.866 . . . . 2.51 111.371 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.6 m -145.2 166.42 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.751 -0.659 . . . . 0.44 110.108 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.62 150.02 48.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.03 -0.359 . . . . 1.49 110.03 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 12.1 p90 -164.09 -179.9 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.392 . . . . 0.66 111.649 -172.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -127.29 150.22 49.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.94 110.617 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.07 142.71 27.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 1.19 110.939 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.969 -0.56 . . . . 2.04 110.562 178.271 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.676 -0.49 . . . . 2.3 109.676 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.91 167.17 25.41 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.632 2.221 . . . . 1.43 112.91 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -107.19 146.59 31.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.377 -0.829 . . . . 0.82 110.747 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.09 154.55 27.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 2.3 111.027 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 61.87 41.22 11.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.627 -0.715 . . . . 2.01 111.515 170.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.9 t -71.01 118.59 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.8 110.092 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -118.44 154.99 31.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.57 . . . . 3.51 110.237 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.51 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.4 mtt -78.4 148.47 33.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.963 0.411 . . . . 1.12 110.485 173.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 79' ' ' PRO . 20.0 tp -126.1 141.77 40.6 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.946 -0.57 . . . . 1.67 109.583 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 78' ' ' LEU . 15.0 Cg_endo -58.58 137.81 82.32 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.1 1.867 . . . . 2.15 111.279 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -66.85 164.48 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.694 -0.685 . . . . 4.61 111.861 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 70.44 21.7 5.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.91 -1.041 . . . . 2.84 110.41 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.4 t -89.76 5.14 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.606 0.717 . . . . 1.7 109.744 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.602 HD12 HD23 ' A' ' 27' ' ' LEU . 28.9 mm -101.98 131.47 22.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.832 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.58 145.35 57.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.214 1.943 . . . . 1.03 111.735 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -120.71 149.8 51.24 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 120.866 -0.334 . . . . 2.76 110.851 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 43.0 Cg_endo -68.52 146.56 68.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.67 2.247 . . . . 1.08 112.195 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.57 95.27 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.332 -0.395 . . . . 1.1 110.338 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.08 136.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.7 -63.64 1.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.121 -0.631 . . . . 2.87 112.206 -171.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -94.22 -54.63 3.48 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.421 -0.512 . . . . 2.84 111.215 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 t 177.45 163.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.937 -0.764 . . . . 1.42 108.937 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -106.04 -52.72 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.087 0.47 . . . . 1.3 110.61 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.55 151.69 46.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.434 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.596 ' O ' HD22 ' A' ' 118' ' ' LEU . 4.4 p-10 -130.75 128.08 40.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.98 -0.748 . . . . 1.36 108.98 173.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.37 -146.32 4.31 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.859 -1.162 . . . . 0.53 112.723 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.0 p -142.14 148.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.802 -0.444 . . . . 1.37 109.802 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 143' ' ' LEU . 86.2 t -59.95 126.76 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.495 0.188 . . . . 0.69 110.774 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -70.12 -52.46 23.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.377 -0.374 . . . . 0.89 110.765 -174.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 3.92 110.399 178.032 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.662 0.268 . . . . 1.24 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 157.74 33.46 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.569 -0.824 . . . . 0.94 111.834 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 128' ' ' GLN . 36.0 mt -141.81 148.06 38.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.467 0.651 . . . . 0.93 112.133 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.91 140.73 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.063 -0.971 . . . . 0.49 109.311 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 11.8 pt-20 -87.87 129.21 35.29 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.383 -0.599 . . . . 1.4 109.383 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.8 mm -104.43 140.67 21.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.827 -0.624 . . . . 0.63 110.614 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.7 pt? -84.08 146.48 27.89 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.987 -0.375 . . . . 1.21 109.987 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.9 165.47 17.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.71 -0.848 . . . . 2.29 108.71 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.74 -18.72 65.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.866 0.365 . . . . 2.78 111.0 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.95 6.47 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.18 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 55.87 77.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.526 -0.761 . . . . 4.14 111.208 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.9 p -117.73 -79.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.87 110.89 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.0 p -137.17 -174.5 3.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 1.54 110.793 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 4.7 p -65.17 129.87 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 1.29 110.721 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.1 -70.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.921 0.391 . . . . 1.03 110.791 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 p -135.97 -85.51 0.36 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.068 -0.514 . . . . 1.56 111.065 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.462 ' HB2' HD22 ' A' ' 114' ' ' LEU . 13.6 pt20 -176.51 137.4 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.573 -0.739 . . . . 2.08 109.763 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.1 m-70 -121.62 125.83 47.62 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.809 -0.356 . . . . 0.68 110.086 171.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.44 149.42 24.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.639 -0.71 . . . . 1.19 109.9 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 136' ' ' LEU . 20.9 p90 -117.74 146.86 43.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 0.74 111.294 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -101.8 150.43 18.33 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.51 112.494 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.91 -43.02 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.236 0.458 . . . . 0.67 112.236 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -77.58 -22.66 50.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.225 0.536 . . . . 1.35 110.203 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 15.2 m -80.66 -18.83 46.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.563 -0.744 . . . . 1.1 110.166 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 131' ' ' PHE . 50.1 mt -76.53 60.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 1.46 111.419 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.2 t -41.09 -42.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.291 -0.413 . . . . 0.82 111.592 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -92.05 27.79 2.05 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.159 -0.473 . . . . 2.17 111.994 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -60.34 -18.19 48.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.07 0.396 . . . . 1.39 112.07 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -81.43 -19.24 42.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.309 -0.405 . . . . 2.46 111.478 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.48 175.41 9.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.941 -0.572 . . . . 1.89 110.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 pp -104.43 130.32 52.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.754 -0.832 . . . . 2.88 108.754 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 97' ' ' VAL . 12.3 tp -139.97 109.7 6.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.97 109.372 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -122.73 -171.97 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 1.77 110.956 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 62.5 tttm -64.59 116.9 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.637 . . . . 1.43 110.44 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.71 33.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.603 -0.808 . . . . 1.07 112.877 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -91.49 127.64 37.01 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.106 0.453 . . . . 1.94 110.35 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 96' ' ' VAL . 82.0 mt -73.73 144.24 45.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.34 0.591 . . . . 1.79 110.889 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.28 145.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.346 -0.843 . . . . 1.16 111.114 -173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.4 m -118.45 148.83 42.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.672 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -163.68 162.93 24.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.53 . . . . 0.61 109.808 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.7 122.05 35.21 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.779 0.799 . . . . 2.2 110.965 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.89 141.23 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.841 -1.072 . . . . 1.24 110.076 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 24.8 t70 -171.64 -93.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.625 -0.139 . . . . 1.92 110.625 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 41.9 mm-40 -74.01 -33.19 63.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 2.76 111.48 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -76.19 -15.51 60.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 1.98 110.753 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.65 20.6 39.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.968 -0.634 . . . . 1.27 112.948 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -140.49 -175.05 4.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.841 . . . . 3.61 108.728 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.47 108.38 18.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.216 -0.661 . . . . 0.48 109.216 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.26 158.77 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.49 111.218 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 36.8 t 59.34 39.59 22.11 Favored 'General case' 0 C--N 1.334 -0.071 0 N-CA-C 109.273 -0.64 . . . . 1.55 109.273 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -62.25 123.32 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.145 -0.934 . . . . 1.26 110.728 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -132.42 111.69 11.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.28 -0.418 . . . . 2.05 110.187 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.82 109.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.75 110.368 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 77.1 t -89.67 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 1.56 111.364 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.701 0 N-CA-C 109.125 -0.695 . . . . 2.94 109.125 172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.636 -0.586 . . . . 11.74 111.636 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.62 -31.14 2.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.876 0.369 . . . . 10.54 111.19 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.25 -13.73 30.95 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.058 -0.817 . . . . 8.95 111.058 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -105.1 15.46 27.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.92 0.867 . . . . 7.09 108.784 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.21 -168.27 1.44 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.8 -1.091 . . . . 5.59 110.747 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.04 161.1 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 2.99 110.702 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.0 24.47 5.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.49 -0.862 . . . . 1.61 112.052 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -112.93 122.09 46.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 2.0 111.036 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.28 124.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.122 -0.695 . . . . 1.27 109.122 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.25 138.89 32.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.368 0.604 . . . . 1.14 110.417 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.627 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -104.62 140.44 38.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.461 -0.791 . . . . 2.31 109.88 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.83 -172.39 30.25 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.13 -0.788 . . . . 0.5 111.13 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 143.05 37.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.04 0.448 . . . . 0.68 111.307 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.519 HG21 ' SD ' ' A' ' 17' ' ' MET . 33.1 mm -65.83 125.79 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.56 110.869 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.86 -35.74 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.76 111.384 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.5 123.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 1.55 110.698 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 14' ' ' ILE . 80.5 mmm -116.03 107.39 14.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 1.42 110.954 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.4 mmtt -103.26 179.2 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.437 -1.32 . . . . 2.03 107.437 167.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.68 -18.56 29.28 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.892 -0.723 . . . . 3.24 110.695 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -101.67 -48.51 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.028 0.442 . . . . 2.03 111.592 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 39.9 p90 -142.67 -177.56 5.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.274 -0.421 . . . . 1.25 110.084 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.62 -178.36 34.54 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.748 -0.739 . . . . 0.71 111.795 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.88 130.97 53.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 1.08 110.224 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 mt -101.66 129.27 53.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.622 -0.717 . . . . 0.61 109.674 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.63 131.98 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.751 -0.833 . . . . 2.3 108.751 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.5 p -64.3 151.99 42.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.494 -0.776 . . . . 0.87 111.705 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 83' ' ' ILE . 7.2 tp -62.7 -40.65 97.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.673 -0.694 . . . . 1.58 110.924 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 8.1 m -100.36 24.78 8.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.04 111.277 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' ' NH1' ' A' ' 158' ' ' ARG . 23.1 p80 44.3 51.01 7.71 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.763 0.792 . . . . 3.29 111.709 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 15.8 m-20 -82.02 -51.29 8.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.196 -0.911 . . . . 2.89 109.438 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -175.93 -175.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.089 -0.96 . . . . 1.8 109.678 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.39 136.3 43.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.047 0.451 . . . . 3.37 110.238 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.44 126.93 57.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.697 -0.683 . . . . 0.87 110.963 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -68.8 119.38 13.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.19 0.519 . . . . 1.06 110.124 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -129.58 136.51 49.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.654 -0.703 . . . . 1.96 109.935 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.21 139.27 40.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.346 -0.613 . . . . 1.18 109.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.496 ' HZ ' ' SD ' ' A' ' 17' ' ' MET . 60.0 m-85 -69.79 -16.31 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.032 0.444 . . . . 0.75 111.201 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 t -63.39 -23.22 67.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.76 -0.655 . . . . 1.63 111.77 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.41 24.62 12.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 2.07 110.488 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 91.8 t80 -91.69 146.29 23.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.865 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.77 117.32 31.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.73 110.12 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.95 -157.04 20.97 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.748 -0.739 . . . . 1.05 112.042 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.22 107.36 57.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.932 -0.396 . . . . 2.14 109.932 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 -17.28 38.22 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.772 2.315 . . . . 1.01 113.095 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.99 -21.94 66.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.439 . . . . 2.08 110.8 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -103.53 12.77 34.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.033 -0.53 . . . . 2.18 111.268 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 14.5 mt -88.11 146.94 25.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.14 -0.482 . . . . 0.92 111.572 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -143.49 169.22 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.288 -0.869 . . . . 2.35 110.273 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.2 mt -76.77 116.65 17.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.924 -0.58 . . . . 1.4 110.757 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 2.35 27.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.922 -0.656 . . . . 0.75 112.506 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -78.34 127.37 32.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.792 0.329 . . . . 1.06 111.035 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' OE1' ' HD2' ' A' ' 11' ' ' ARG . 19.1 tt0 -70.81 130.92 42.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.745 -0.661 . . . . 2.51 110.28 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.59 154.52 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.839 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.83 141.63 47.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.003 -0.739 . . . . 1.49 109.003 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.34 161.73 27.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.401 0.62 . . . . 0.66 111.936 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 p -110.18 163.73 13.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.414 -0.812 . . . . 0.94 109.906 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.32 142.03 33.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.665 0.269 . . . . 1.19 110.571 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.69 80.89 8.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 2.04 111.079 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.585 ' HD3' HD21 ' A' ' 70' ' ' LEU . 17.5 mmt85 -96.3 7.6 46.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.628 -0.715 . . . . 5.33 110.34 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -92.59 114.08 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 5.42 110.867 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.61 -77.33 0.4 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.964 -0.636 . . . . 4.76 112.154 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -149.2 128.7 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.605 -0.517 . . . . 6.38 109.605 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -72.18 -22.55 61.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.104 0.478 . . . . 6.4 111.929 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -122.02 67.99 0.93 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.382 -0.599 . . . . 5.23 109.382 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.3 t -53.7 -71.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.98 -1.009 . . . . 6.95 110.885 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.4 p -121.31 -28.26 4.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 6.02 111.131 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.51 42.76 0.24 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.691 -0.766 . . . . 4.09 112.158 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.72 -46.61 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.003 0.921 . . . . 4.22 112.506 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 p -69.35 111.53 5.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.498 0.666 . . . . 2.09 110.643 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.585 HD21 ' HD3' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -111.29 164.23 15.49 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.774 -1.103 . . . . 2.3 110.797 -175.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.75 172.45 16.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.705 2.27 . . . . 1.43 113.293 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.65 171.62 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.149 -0.932 . . . . 0.82 109.993 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.15 155.23 40.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.469 0.176 . . . . 2.3 110.622 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.26 55.27 9.41 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.828 0.705 . . . . 2.01 112.099 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 35' ' ' PHE . 40.5 t -86.41 116.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 0.8 110.186 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -122.15 159.63 26.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.739 -0.467 . . . . 3.51 109.739 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.4 mtt -79.53 152.37 30.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.85 0.357 . . . . 1.12 111.163 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -119.16 162.61 30.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 1.67 110.539 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 134.68 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.337 2.025 . . . . 2.15 111.95 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 38.8 ttmt -70.01 155.27 40.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.807 -0.633 . . . . 4.61 110.925 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 17.3 m120 74.76 15.9 3.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.219 0.608 . . . . 2.84 111.402 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 44.8 m -92.23 -19.87 21.75 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.929 -0.309 . . . . 1.7 111.023 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 27' ' ' LEU . 45.3 mm -70.44 126.52 92.31 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.315 -0.624 . . . . 0.92 109.315 171.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.24 154.83 61.49 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.576 2.184 . . . . 1.03 112.331 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -113.64 152.76 45.74 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.059 -0.519 . . . . 2.76 110.171 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.439 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 23.5 Cg_endo -60.63 143.5 99.43 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 1.08 112.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.16 91.72 8.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.302 0.572 . . . . 1.1 110.007 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -142.04 128.67 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.607 -0.886 . . . . 1.23 108.607 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.26 -63.64 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.555 -0.458 . . . . 2.87 112.056 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.58 -53.82 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.982 0.42 . . . . 2.84 111.887 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.2 t 174.74 159.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.108 -0.701 . . . . 1.42 109.108 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -106.22 -58.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 1.3 111.059 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -140.52 158.09 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.064 0.459 . . . . 1.29 110.725 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -122.94 175.9 6.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.467 -0.788 . . . . 1.36 109.045 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.64 -163.13 34.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.264 -0.97 . . . . 0.53 112.198 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.36 148.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.13 -0.693 . . . . 1.37 109.13 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 144' ' ' GLN . 49.1 t -63.91 116.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.601 -0.518 . . . . 0.69 109.601 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 99' ' ' ARG . . . -82.65 -68.84 0.67 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.178 -0.464 . . . . 0.89 111.697 -173.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 4.8 mtm180 -162.85 139.48 5.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.573 -0.285 . . . . 3.92 111.18 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.562 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -70.87 130.65 18.29 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.428 2.085 . . . . 2.22 110.684 171.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.73 89.76 2.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.699 0.762 . . . . 3.32 111.413 -177.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.29 -59.01 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.252 -0.885 . . . . 5.56 110.421 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 6.2 p -85.56 -5.58 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 4.14 111.491 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.7 mp -71.62 -28.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 3.46 110.008 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.715 ' ND2' ' HG3' ' A' ' 109' ' ' GLN . 60.6 t30 -116.34 125.78 28.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 4.99 109.739 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.08 -26.12 80.49 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.281 1.987 . . . . 4.27 111.981 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.69 8.49 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 3.94 111.801 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 64.72 81.11 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.141 0.793 . . . . 5.6 113.141 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.715 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 30.4 mt-30 -89.11 8.55 29.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.494 -0.775 . . . . 5.3 112.341 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.654 ' HA ' HD12 ' A' ' 101' ' ' LEU . 10.7 pt-20 -43.6 -19.34 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.2 1.555 . . . . 4.95 115.2 -166.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -39.02 16.37 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.403 0.281 . . . . 3.19 111.581 172.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.63 ' HB3' HD11 ' A' ' 101' ' ' LEU . . . -76.17 -43.05 44.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.088 0.403 . . . . 1.24 112.088 -169.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 100' ' ' PRO . . . 58.74 179.88 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.05 -0.523 . . . . 0.94 113.871 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.9 mt -144.48 138.23 27.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.93 111.17 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.6 mt -103.7 139.47 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.233 -0.894 . . . . 0.49 109.237 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.44 116.02 27.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.56 0.695 . . . . 1.4 110.184 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.811 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 15.8 mm -91.52 140.57 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.229 -0.896 . . . . 0.63 109.946 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.66 143.34 29.28 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.953 -0.299 . . . . 1.21 110.238 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.64 -179.49 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 2.29 111.064 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.638 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.6 pm0 -66.64 -25.17 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.262 . . . . 2.78 111.442 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.638 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -90.3 -1.47 57.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.353 -0.61 . . . . 1.77 109.353 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 60.1 43.6 14.07 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.166 -0.924 . . . . 4.14 111.534 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.2 m -114.83 -50.0 2.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.028 0.381 . . . . 1.87 112.028 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.8 p -130.65 -179.5 5.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.964 0.411 . . . . 1.54 111.858 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -81.83 136.64 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.755 -0.657 . . . . 1.29 110.277 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.1 mt -75.09 -69.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 1.03 110.56 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -137.58 -83.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 1.56 111.813 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -174.98 134.37 0.34 Allowed 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 115.458 -0.792 . . . . 2.08 109.757 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -120.38 130.66 54.48 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.608 -0.437 . . . . 0.68 110.692 173.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -91.5 143.98 26.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.419 -0.81 . . . . 1.19 109.395 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.5 p90 -116.98 140.72 49.13 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.059 -0.657 . . . . 0.74 111.056 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.39 152.38 18.37 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.42 -0.809 . . . . 0.51 112.539 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 tp -49.89 -33.38 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.248 0.462 . . . . 0.67 112.248 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.6 p -72.93 -33.75 66.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.438 0.637 . . . . 1.35 110.813 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 16.3 m -74.55 -26.58 60.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.172 -0.922 . . . . 1.1 110.433 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 131' ' ' PHE . 32.1 mt -75.58 60.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.44 -0.8 . . . . 1.46 112.151 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -45.56 -42.5 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.497 0.665 . . . . 0.82 110.481 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -92.11 35.13 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.204 -0.907 . . . . 2.17 111.302 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -58.22 -17.78 21.51 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.477 0.547 . . . . 1.39 112.477 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.39 -22.91 62.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.064 0.459 . . . . 2.46 110.696 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 161.64 27.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 1.89 111.98 -171.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -89.75 30.66 1.02 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.202 -0.908 . . . . 2.88 109.295 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.95 107.83 0.1 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.492 -1.231 . . . . 0.97 110.548 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 13.8 pt20 -129.51 -175.6 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.531 . . . . 1.77 111.55 -170.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 77.8 tttt -59.65 118.19 5.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.587 -0.733 . . . . 1.43 109.929 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.43 -5.25 29.82 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.467 -0.873 . . . . 1.07 112.635 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.39 136.39 33.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.067 0.46 . . . . 1.94 111.079 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.4 mm? -86.0 136.38 33.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.38 -0.827 . . . . 1.79 110.359 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.27 150.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.245 0.545 . . . . 1.16 112.04 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.7 m -125.82 134.98 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 1.44 108.926 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.811 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 44.5 p90 -146.72 -176.61 5.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.079 -0.51 . . . . 0.61 109.7 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 122.31 17.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.277 0.56 . . . . 2.2 110.722 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.6 tt -100.62 130.49 49.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.178 -0.919 . . . . 1.24 110.296 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 13.5 t70 -159.17 -92.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.465 -0.198 . . . . 1.92 110.465 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -83.09 -19.69 36.3 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.08 -0.388 . . . . 2.76 111.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 m -77.92 -16.47 58.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 1.98 110.58 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 53.25 30.89 40.88 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.705 -0.68 . . . . 1.27 113.745 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 29' ' ' HIS . 11.6 ptm180 -161.63 -167.61 1.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.454 -0.943 . . . . 3.61 108.454 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.92 107.66 17.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.294 -0.632 . . . . 0.48 109.294 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -122.18 153.22 39.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.49 110.437 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 t 60.72 45.3 10.26 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.367 -0.605 . . . . 1.55 109.367 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.62 109.33 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.496 -0.774 . . . . 1.26 110.798 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -111.59 120.96 43.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.384 -0.826 . . . . 2.05 110.222 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.6 103.79 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.75 110.034 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.73 136.05 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.706 -0.679 . . . . 1.56 110.533 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.7 mpt_? -108.63 120.62 42.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.304 -0.407 . . . . 2.94 110.046 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -88.17 141.84 28.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 3.88 110.281 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 115.768 -0.651 . . . . 4.04 110.912 176.814 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 111.688 -0.565 . . . . 11.74 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 -29.06 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.524 0.202 . . . . 10.54 111.467 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.26 -27.28 2.89 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.856 -0.687 . . . . 8.95 111.842 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 p -104.5 28.01 7.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.395 0.616 . . . . 7.09 109.894 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.45 156.54 28.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.298 -0.865 . . . . 5.59 110.367 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.45 174.26 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.167 -0.469 . . . . 2.99 110.928 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.07 -2.1 27.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.786 -0.721 . . . . 1.61 111.671 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -85.01 121.3 27.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 2.0 110.872 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.7 121.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.253 -0.647 . . . . 1.27 109.253 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -93.23 138.0 32.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.122 0.487 . . . . 1.14 109.992 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -108.54 137.8 45.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 2.31 109.786 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.77 -178.39 30.81 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.396 -0.682 . . . . 0.5 111.396 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -132.22 143.44 49.93 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.124 0.488 . . . . 0.68 110.867 -177.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.599 HG21 ' SD ' ' A' ' 17' ' ' MET . 46.5 mm -65.91 129.03 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.56 111.145 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.95 -45.07 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.76 111.264 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 72.9 t -114.78 122.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 1.55 111.068 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 14' ' ' ILE . 87.2 mmm -112.4 105.33 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 1.42 110.805 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 54.6 mttt -113.06 167.47 10.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.554 -0.906 . . . . 2.03 108.554 171.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -75.33 -18.98 59.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.796 -0.361 . . . . 3.24 111.849 -171.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -108.53 -47.05 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.46 . . . . 2.03 111.707 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 6.7 p90 -141.24 172.08 13.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.586 -0.279 . . . . 1.25 110.448 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.33 32.83 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.805 -0.712 . . . . 0.71 111.907 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.7 m-85 -120.8 135.05 55.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.71 -0.478 . . . . 1.08 109.71 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -103.5 133.9 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.02 -0.536 . . . . 0.61 110.536 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -79.26 121.15 24.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.041 -1.096 . . . . 2.3 108.041 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.8 144.16 52.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.134 -0.484 . . . . 0.87 110.727 -175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 HD12 ' A' ' 83' ' ' ILE . 3.1 tp -51.68 -43.35 62.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.58 111.026 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -107.42 27.16 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 2.04 110.731 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 45.48 36.78 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.13 0.972 . . . . 3.29 111.28 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.877 -1.056 . . . . 2.89 111.464 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.23 -174.58 1.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.856 -0.611 . . . . 1.8 110.785 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -103.09 120.74 41.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 3.37 109.438 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.4 t -104.44 125.26 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.779 0.323 . . . . 0.87 111.287 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.56 119.04 21.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.578 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.54 144.08 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.431 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 22.1 t-80 -119.31 135.66 54.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.708 -0.479 . . . . 1.18 109.708 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 76.8 m-85 -74.61 -19.12 60.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.458 0.54 . . . . 0.75 112.458 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 t -68.81 -33.47 73.91 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.826 -0.35 . . . . 1.63 110.954 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 1.2 p-10 -103.9 33.76 3.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.693 0.759 . . . . 2.07 109.633 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 50.7 t80 -102.51 139.21 38.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.696 -1.138 . . . . 0.91 110.437 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.1 ttm -101.11 104.96 16.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 1.73 110.369 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.8 -154.32 25.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 1.05 111.541 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 99.14 41.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.849 -0.426 . . . . 2.14 109.849 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.3 -21.9 66.72 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.739 2.293 . . . . 1.01 113.494 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -87.85 -1.24 57.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.972 0.415 . . . . 2.08 111.043 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -112.7 15.68 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 2.18 110.389 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.92 146.4 23.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.585 -0.734 . . . . 0.92 111.161 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -128.88 172.39 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.602 -0.726 . . . . 2.35 110.241 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.99 123.27 29.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.165 -0.471 . . . . 1.4 110.52 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.25 59.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.674 -0.774 . . . . 0.75 111.976 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -69.94 129.44 39.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.692 0.282 . . . . 1.06 111.051 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.572 ' OE1' ' HB2' ' A' ' 82' ' ' SER . 10.4 tt0 -73.11 127.51 32.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.654 -0.703 . . . . 2.51 110.501 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 77' ' ' MET . 31.4 m -139.93 153.86 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.166 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 78' ' ' LEU . 10.3 pt-20 -114.15 147.18 39.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.101 -0.703 . . . . 1.49 109.101 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.2 p90 -166.72 166.18 16.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.396 0.617 . . . . 0.66 112.357 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.37 166.59 13.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.259 -0.882 . . . . 0.94 110.188 176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -101.96 143.2 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.303 -0.408 . . . . 1.19 110.644 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' O ' HD22 ' A' ' 70' ' ' LEU . . . -79.76 84.3 5.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.04 110.592 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HD3' HD21 ' A' ' 70' ' ' LEU . 38.6 mmt180 -93.88 5.95 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.085 -0.507 . . . . 5.33 110.625 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -84.38 127.57 34.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 5.42 110.815 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.19 0.68 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.544 -0.836 . . . . 4.76 112.913 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -151.35 137.83 18.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 6.38 110.489 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.1 p -88.62 -26.94 21.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.173 0.511 . . . . 6.4 111.186 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.0 t -92.31 52.65 1.97 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.34 0.59 . . . . 5.23 110.396 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.28 -66.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 6.95 110.191 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 m -87.48 -7.77 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 6.02 110.797 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.95 58.31 0.36 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.759 -0.655 . . . . 4.09 112.045 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 m120 71.14 -30.23 0.2 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.725 0.81 . . . . 4.22 112.373 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.7 p -82.37 128.08 33.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.665 -0.494 . . . . 2.09 109.665 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD21 ' HD3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -126.37 152.18 73.59 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 2.3 111.021 -177.2 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.2 150.1 88.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.069 2.513 . . . . 1.43 113.277 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -86.68 141.17 29.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.387 -0.824 . . . . 0.82 110.481 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 165.24 25.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.644 0.259 . . . . 2.3 111.268 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 61.93 27.26 16.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.758 -0.656 . . . . 2.01 111.339 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 t -71.56 120.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.8 111.076 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -129.42 161.7 29.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 3.51 110.222 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.491 ' HA ' HG12 ' A' ' 53' ' ' VAL . 60.2 mtt -80.84 143.93 32.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.12 111.473 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 54' ' ' GLU . 36.3 mt -112.61 162.53 21.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.828 -0.623 . . . . 1.67 110.196 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.37 149.49 80.72 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.685 2.256 . . . . 2.15 111.78 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 38.7 ttmt -79.41 152.17 30.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.247 -0.433 . . . . 4.61 110.734 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 4.9 m-20 70.66 35.19 1.91 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.934 0.494 . . . . 2.84 111.453 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.572 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 49.2 m -107.16 -9.87 16.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.807 0.337 . . . . 1.7 110.813 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD11 ' A' ' 27' ' ' LEU . 49.1 mm -76.36 136.16 68.67 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.52 -0.309 . . . . 0.92 110.366 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.74 157.54 61.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.652 2.235 . . . . 1.03 112.182 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -131.55 157.27 78.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.191 -0.459 . . . . 2.76 110.61 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 20.0 Cg_exo -62.56 138.68 71.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.157 . . . . 1.08 112.094 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 93.17 9.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.221 0.534 . . . . 1.1 110.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t -141.8 133.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.337 -0.986 . . . . 1.23 108.337 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.4 -62.52 1.67 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 2.87 112.621 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -94.09 -54.3 3.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 2.84 111.692 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t 173.77 161.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.643 -0.873 . . . . 1.42 108.643 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.6 m -106.0 -59.01 1.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.724 -0.39 . . . . 1.3 110.91 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -145.07 155.6 43.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.29 110.213 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -115.37 173.2 6.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.969 -0.752 . . . . 1.36 108.969 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.57 -166.08 35.15 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.125 -1.036 . . . . 0.53 111.88 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.72 147.89 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.106 -0.702 . . . . 1.37 109.106 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.82 112.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.784 -0.45 . . . . 0.69 109.784 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 -63.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.89 111.887 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -169.8 146.63 2.77 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.559 -0.291 . . . . 3.92 111.0 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.571 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 64.0 Cg_endo -75.62 129.75 12.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.146 1.898 . . . . 2.22 111.225 172.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -72.81 86.86 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.716 . . . . 3.32 110.817 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -96.91 -61.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.733 -0.667 . . . . 5.56 111.02 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 6.0 p -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 4.14 111.958 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.98 -22.61 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.145 0.498 . . . . 3.46 110.932 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.51 ' HB3' ' H ' ' A' ' 109' ' ' GLN . 62.5 t30 -118.72 120.98 31.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.408 -0.59 . . . . 4.99 109.408 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 -10.51 25.67 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.318 2.012 . . . . 4.27 111.885 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.09 5.27 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 3.94 110.458 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 66.75 82.56 0.18 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.595 0.712 . . . . 5.6 112.33 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.51 ' H ' ' HB3' ' A' ' 105' ' ' ASN . 6.9 tt0 -88.4 6.11 39.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.48 -0.782 . . . . 5.3 111.354 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.663 ' HA ' HD12 ' A' ' 101' ' ' LEU . 9.9 pt-20 -43.63 -24.91 0.14 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.333 1.605 . . . . 4.95 115.333 -164.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -38.41 7.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.853 0.461 . . . . 3.19 112.026 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.535 ' HB3' HD11 ' A' ' 101' ' ' LEU . . . -78.57 -27.93 45.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.175 0.435 . . . . 1.24 112.175 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 100' ' ' PRO . . . 58.04 173.39 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 114.584 0.594 . . . . 0.94 114.584 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 130' ' ' GLU . 74.2 mt -143.87 136.33 26.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.93 111.257 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.3 mt -103.35 138.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.935 -1.03 . . . . 0.49 109.5 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.4 pt-20 -86.78 125.23 33.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.396 0.617 . . . . 1.4 109.611 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.748 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 11.6 mm -102.07 126.33 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.498 -0.774 . . . . 0.63 109.048 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.8 pt? -87.07 152.52 22.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 1.21 110.745 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.67 173.75 9.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.614 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -66.91 -23.26 65.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 2.78 111.09 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -86.8 -3.23 59.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.736 -0.468 . . . . 1.77 109.736 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 66.43 35.98 5.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.322 -0.854 . . . . 4.14 111.051 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m -81.24 -68.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.746 -0.661 . . . . 1.87 111.567 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p -155.28 -174.36 4.94 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.995 0.368 . . . . 1.54 111.995 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 4.6 p -67.12 133.2 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.688 -0.687 . . . . 1.29 111.211 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.21 -69.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.476 -0.329 . . . . 1.03 110.653 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 m -136.51 -84.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.81 -0.356 . . . . 1.56 111.758 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.448 ' HB2' HD22 ' A' ' 114' ' ' LEU . 11.4 pt20 -174.67 138.24 0.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.842 -0.617 . . . . 2.08 110.144 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.519 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -122.6 123.18 40.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.792 0.329 . . . . 0.68 110.359 170.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.0 tt0 -84.22 145.68 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.552 -0.749 . . . . 1.19 109.24 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.515 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.4 p90 -117.66 139.96 50.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 0.74 111.824 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.88 154.37 20.87 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 114.999 -1.0 . . . . 0.51 112.383 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.22 -32.56 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 0.67 111.564 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -74.68 -35.8 62.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.2 0.524 . . . . 1.35 110.705 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 36.9 m -62.82 -32.7 73.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.236 -0.893 . . . . 1.1 110.532 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 131' ' ' PHE . 72.7 mt -75.42 58.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 1.46 112.031 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.0 t -46.3 -43.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.357 0.599 . . . . 0.82 110.318 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 46.2 m-80 -95.87 34.66 1.49 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.3 -0.863 . . . . 2.17 111.508 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -56.65 -21.21 25.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.145 0.498 . . . . 1.39 111.615 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -70.91 -23.1 62.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 2.46 111.414 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.27 164.03 14.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.681 0.623 . . . . 1.89 112.681 -166.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -79.51 34.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.014 -0.994 . . . . 2.88 111.2 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.7 tp -56.16 105.43 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.021 -175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -121.66 -178.03 3.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.755 -0.657 . . . . 1.77 110.811 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -62.99 136.48 57.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.323 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.3 70.72 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.545 -0.836 . . . . 1.07 112.926 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -92.11 142.28 27.68 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.215 0.508 . . . . 1.94 109.859 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.2 mm? -83.95 138.51 33.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.194 0.521 . . . . 1.79 111.146 -172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.77 153.35 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.366 0.603 . . . . 1.16 111.912 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.2 m -129.57 138.01 51.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.221 -0.9 . . . . 1.44 109.332 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.748 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 38.8 p90 -149.0 174.15 12.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.645 -0.502 . . . . 0.61 109.645 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -130.38 120.46 24.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.397 0.618 . . . . 2.2 110.205 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.55 130.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.823 -0.626 . . . . 1.24 110.354 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 18.8 t70 -155.87 -100.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.954 -0.298 . . . . 1.92 110.718 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.468 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 42.2 mt-10 -83.9 -7.59 59.39 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.08 0.4 . . . . 2.76 112.08 -175.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -12.08 49.24 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.749 -0.464 . . . . 1.98 109.749 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.09 24.21 49.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.127 -0.942 . . . . 1.27 114.308 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -158.08 -177.94 6.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.829 -0.804 . . . . 3.61 108.829 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.14 108.65 16.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.367 -0.533 . . . . 0.48 110.698 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -119.12 159.49 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.49 110.442 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 39.7 t 63.07 38.08 11.09 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.673 0.608 . . . . 1.55 110.091 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.99 111.54 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.476 -0.784 . . . . 1.26 110.657 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.476 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 8.3 t30 -120.52 128.91 53.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.315 -0.402 . . . . 2.05 110.394 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -68.96 117.13 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 0.75 110.282 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.69 130.55 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.844 -0.617 . . . . 1.56 111.66 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.17 133.55 51.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 2.94 110.127 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -105.47 131.02 53.41 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.965 -0.561 . . . . 3.88 110.592 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 116.093 -0.503 . . . . 4.04 110.295 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 111.995 -0.442 . . . . 11.74 111.995 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.7 -27.71 69.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 10.54 111.356 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.22 26.09 10.06 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.835 -0.621 . . . . 8.95 111.602 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -109.31 15.77 22.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 7.09 110.468 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.8 129.04 34.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.868 0.366 . . . . 5.59 110.361 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.08 9.08 30.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.007 -0.542 . . . . 2.99 110.949 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.03 -29.03 4.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 1.61 112.537 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -105.57 113.35 26.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.426 0.632 . . . . 2.0 111.374 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.55 116.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.956 -1.02 . . . . 1.27 109.073 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -87.63 138.61 31.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.931 -0.577 . . . . 1.14 110.004 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 22.7 ttm180 -113.55 141.04 47.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.71 -0.677 . . . . 2.31 110.04 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.08 -171.12 36.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.006 -0.838 . . . . 0.5 111.006 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.61 141.95 33.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.184 0.516 . . . . 0.68 111.141 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.34 119.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.296 -0.865 . . . . 0.56 110.823 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.38 -41.73 6.91 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.967 -0.293 . . . . 0.76 111.172 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -121.97 150.76 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.536 -0.542 . . . . 1.55 109.536 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.9 ttm -137.17 106.7 6.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 1.42 110.391 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.7 mmtt -100.71 172.37 7.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.865 -0.791 . . . . 2.03 108.865 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.62 -22.1 61.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.692 0.282 . . . . 3.24 111.668 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -111.14 -41.93 4.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.72 0.295 . . . . 2.03 111.701 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -145.12 176.71 9.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.617 -0.265 . . . . 1.25 110.487 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 -179.97 25.82 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.497 -0.859 . . . . 0.71 112.059 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 16' ' ' VAL . 54.3 m-85 -127.11 151.74 48.24 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.525 -0.546 . . . . 1.08 109.525 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -125.57 115.34 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.17 -0.468 . . . . 0.61 111.058 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.34 126.47 29.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.288 -1.004 . . . . 2.3 108.288 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 164.57 25.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.229 0.537 . . . . 0.87 111.401 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD2' HD12 ' A' ' 83' ' ' ILE . 1.8 tm? -60.58 -48.43 81.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.532 -0.758 . . . . 1.58 111.724 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -98.69 13.65 31.4 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.087 -0.338 . . . . 2.04 110.087 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 55.85 50.27 14.4 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.429 -0.952 . . . . 3.29 108.429 -168.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.14 -48.55 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.993 -1.458 . . . . 2.89 110.275 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -173.26 179.38 2.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 1.8 110.704 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CD ' ' HB3' ' A' ' 23' ' ' PHE . 10.0 tp10 -103.2 139.53 38.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.781 -0.452 . . . . 3.37 109.781 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.53 132.24 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.051 0.453 . . . . 0.87 111.224 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -87.19 118.39 26.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.426 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -120.01 151.3 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.96 108.918 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -115.84 133.0 56.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.476 -0.564 . . . . 1.18 109.476 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -62.47 -22.62 66.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.058 0.762 . . . . 0.75 113.058 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -61.29 -35.84 78.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.779 0.323 . . . . 1.63 111.076 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -96.09 22.54 7.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.259 0.552 . . . . 2.07 110.842 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' OH ' ' HG2' ' A' ' 77' ' ' MET . 39.6 t80 -91.51 136.6 33.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.212 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.33 97.74 7.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 1.73 110.142 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.19 -139.63 7.46 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.143 -0.783 . . . . 1.05 111.143 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 46' ' ' TRP . 1.5 p30 -124.73 91.46 49.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 121.515 0.674 . . . . 2.14 110.703 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.93 -21.04 33.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.003 2.468 . . . . 1.01 113.841 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -81.41 -11.66 59.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.371 0.605 . . . . 2.08 110.154 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 84.3 m95 -106.45 20.31 19.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 2.18 110.248 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 29.3 mt -85.14 -179.6 7.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.794 -0.639 . . . . 0.92 111.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -151.22 161.17 43.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.386 -0.825 . . . . 2.35 110.126 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.51 113.99 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 1.4 108.98 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.25 5.05 35.13 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.872 -0.604 . . . . 0.75 112.019 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.34 131.13 40.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.91 0.386 . . . . 1.06 111.315 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' CD ' HG12 ' A' ' 83' ' ' ILE . 40.2 mt-10 -78.27 128.26 33.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.227 -0.897 . . . . 2.51 111.279 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.89 161.33 18.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.444 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 78' ' ' LEU . 7.1 pt-20 -125.42 148.28 48.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.795 -0.446 . . . . 1.49 109.795 176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 11.9 p90 -163.99 175.17 10.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.66 112.142 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 p -130.14 170.72 13.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.44 -0.8 . . . . 0.94 110.112 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.86 138.75 45.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.78 0.324 . . . . 1.19 111.145 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 70' ' ' LEU . . . -89.08 85.19 6.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.863 -0.608 . . . . 2.04 110.124 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.54 HH11 HD11 ' A' ' 70' ' ' LEU . 9.8 tpt180 -126.63 6.82 6.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.393 0.616 . . . . 5.33 109.638 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -77.01 114.45 15.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.687 -0.688 . . . . 5.42 110.415 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.74 170.06 13.49 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.842 -0.617 . . . . 4.76 111.679 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -99.58 26.75 5.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.684 0.754 . . . . 6.38 109.744 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -80.1 -14.84 58.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 6.4 110.704 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -81.31 42.84 0.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.91 -0.586 . . . . 5.23 111.265 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.15 -64.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.022 0.439 . . . . 6.95 110.183 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -100.52 2.41 41.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 6.02 109.361 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.74 72.59 2.8 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.269 -0.878 . . . . 4.09 111.945 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -60.12 -49.73 76.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.254 0.549 . . . . 4.22 109.543 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.8 m -117.9 131.1 56.57 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.53 -0.759 . . . . 2.09 109.267 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 HH11 ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.61 153.73 59.65 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.022 -0.733 . . . . 2.3 109.022 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.74 150.35 88.29 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.312 2.008 . . . . 1.43 112.223 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -88.63 137.01 32.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.67 -0.696 . . . . 0.82 111.035 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -112.41 165.74 11.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.845 -0.616 . . . . 2.3 110.334 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 63.18 29.67 16.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.818 -0.628 . . . . 2.01 111.477 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 9.6 t -74.19 108.25 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.8 110.237 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -112.31 167.82 10.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.87 0.367 . . . . 3.51 110.339 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.574 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 84.8 mtp -98.58 136.04 39.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.944 -0.571 . . . . 1.12 111.195 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 54' ' ' GLU . 46.0 mt -107.9 154.89 40.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 1.67 110.556 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.08 140.93 35.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.263 1.975 . . . . 2.15 110.372 169.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.32 164.68 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 4.61 111.034 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.3 t30 76.09 25.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.172 -0.922 . . . . 2.84 109.999 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -95.59 -14.86 23.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.398 -0.819 . . . . 1.7 109.122 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.623 HD12 ' CD2' ' A' ' 27' ' ' LEU . 8.7 mm -92.01 128.99 43.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.441 -0.8 . . . . 0.92 109.783 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.07 154.48 47.33 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.348 2.032 . . . . 1.03 112.14 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 152.15 74.35 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.556 -0.293 . . . . 2.76 110.465 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 18.0 Cg_endo -61.23 125.94 18.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 1.08 112.202 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.14 92.97 7.06 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.999 0.428 . . . . 1.1 111.17 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 26.0 t -142.43 107.33 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 1.23 109.713 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.85 -25.92 27.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.735 -0.386 . . . . 2.87 111.737 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' THR . 69.8 tt0 -73.42 -18.19 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.609 -0.269 . . . . 2.84 110.953 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 41.5 m 81.04 122.72 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.634 -0.712 . . . . 1.42 110.54 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -80.86 -57.64 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.3 112.337 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -141.35 174.73 10.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.232 0.539 . . . . 1.29 111.36 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -141.81 176.83 8.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.132 -0.94 . . . . 1.36 109.273 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.09 179.45 39.57 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 110.464 -1.055 . . . . 0.53 110.464 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.3 m -103.89 159.5 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 117.852 0.826 . . . . 1.37 110.161 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.37 121.57 19.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.196 -0.668 . . . . 0.69 109.196 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -66.86 -53.47 32.08 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.3 0.375 . . . . 0.89 110.731 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.71 146.89 0.88 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 3.92 110.551 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.42 121.46 6.05 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.426 1.418 . . . . 2.22 110.146 167.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.692 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -82.81 97.86 8.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.096 0.95 . . . . 3.32 110.724 -177.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.68 -66.46 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.7 -0.682 . . . . 5.56 111.251 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 9.2 p -95.2 -10.19 31.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.519 0.563 . . . . 4.14 112.519 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 104' ' ' ILE . 4.9 mp -77.36 -45.47 29.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.797 0.666 . . . . 3.46 112.797 -166.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -164.08 91.94 1.06 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 121.072 0.463 . . . . 4.99 111.636 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.46 -40.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.792 2.328 . . . . 4.27 113.411 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.4 28.89 2.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 3.94 112.171 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.517 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 44.2 tp60 -122.91 150.65 42.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.459 -0.571 . . . . 5.6 109.459 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 111' ' ' TYR . 28.8 tp60 -51.41 -30.73 20.29 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.012 0.525 . . . . 5.3 112.077 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.517 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 50.7 mt-10 -73.38 14.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.914 0.388 . . . . 4.95 111.2 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HA ' HD21 ' A' ' 101' ' ' LEU . 15.1 t80 -66.03 -25.69 67.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.283 0.563 . . . . 3.19 110.82 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -65.1 -21.89 66.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.965 -0.561 . . . . 1.24 111.247 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.78 166.66 25.23 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.439 -0.665 . . . . 0.94 111.439 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 130' ' ' GLU . 66.8 mt -142.71 138.13 30.34 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.93 111.842 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.89 138.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.654 -1.157 . . . . 0.49 108.746 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.77 124.26 31.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.936 -0.765 . . . . 1.4 108.936 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.736 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.6 mm -101.36 120.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.494 -0.928 . . . . 0.63 108.494 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.0 pt? -83.33 144.25 29.81 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.294 -0.562 . . . . 1.21 110.157 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.07 151.49 12.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 2.29 109.583 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.72 -21.66 64.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 2.78 111.912 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.03 10.26 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.692 0.282 . . . . 1.77 110.374 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 67.52 30.39 6.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.613 -0.721 . . . . 4.14 111.512 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -70.32 -80.37 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.463 -0.335 . . . . 1.87 111.167 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -149.23 -176.45 5.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.687 -0.233 . . . . 1.54 110.643 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -65.25 134.51 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 123.542 0.526 . . . . 1.29 110.234 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -72.71 -67.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.442 -0.344 . . . . 1.03 110.432 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.9 m -137.6 -84.3 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.159 0.504 . . . . 1.56 110.645 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -176.6 139.84 0.33 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.249 -0.887 . . . . 2.08 108.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.3 m-70 -117.48 131.59 56.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.125 -0.63 . . . . 0.68 110.089 172.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.8 tt0 -89.57 139.49 30.49 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.763 -1.108 . . . . 1.19 109.402 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 46.1 p90 -118.67 134.87 54.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 0.74 110.961 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.11 153.94 24.01 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.326 -0.852 . . . . 0.51 112.57 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.2 -27.72 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.01 0.433 . . . . 0.67 110.807 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.8 p -74.86 -36.48 62.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.317 0.58 . . . . 1.35 110.443 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 162' ' ' VAL . 23.9 m -65.66 -30.2 70.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.84 . . . . 1.1 110.87 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.4 mt -71.49 58.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.812 0.695 . . . . 1.46 112.67 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -45.59 -42.28 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.408 0.623 . . . . 0.82 111.045 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.48 34.01 2.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 2.17 111.014 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 16.3 ptpt -54.53 -21.08 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.01 0.524 . . . . 1.39 112.357 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -86.39 -11.95 50.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 2.46 112.12 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.56 166.66 23.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 1.89 110.687 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -86.96 24.49 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.458 -0.337 . . . . 2.88 110.492 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 164' ' ' ALA . 15.8 tp -44.92 117.39 1.32 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.22 -0.9 . . . . 0.97 111.536 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -118.86 -172.97 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 1.77 111.238 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 72.4 tttt -67.53 140.22 57.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.908 -0.587 . . . . 1.43 110.139 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.06 86.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.423 -0.894 . . . . 1.07 112.439 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 7.9 m-20 -82.73 132.37 35.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.559 0.219 . . . . 1.94 110.741 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.54 135.11 42.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.993 -0.549 . . . . 1.79 110.828 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.36 151.45 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 1.16 111.187 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 44.0 p -109.03 136.01 49.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.811 -0.811 . . . . 1.44 108.811 172.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.689 ' HB3' HG12 ' A' ' 162' ' ' VAL . 36.1 p90 -154.24 169.3 23.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.852 0.358 . . . . 0.61 110.327 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 3.7 mpt_? -131.77 123.2 27.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.4 -0.52 . . . . 2.2 110.63 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.503 HG21 ' CD2' ' A' ' 129' ' ' HIS . 8.5 pt -100.14 146.77 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.736 -0.839 . . . . 1.24 108.736 166.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 23.7 t70 -175.1 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.366 -0.134 . . . . 1.92 110.969 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.25 -41.5 73.42 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 2.76 111.503 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 158' ' ' ARG . 42.3 t -84.9 -17.98 36.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.174 -0.466 . . . . 1.98 111.099 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.63 -25.36 1.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.797 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 156' ' ' SER . 67.2 mtt85 -93.02 175.68 6.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.317 0.247 . . . . 3.61 110.388 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.34 110.39 19.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.033 0.444 . . . . 0.48 110.219 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -123.25 160.2 27.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.722 -0.672 . . . . 0.49 110.84 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.6 m 59.93 42.84 15.61 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.944 0.778 . . . . 1.55 110.692 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.7 m -70.96 138.35 21.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.565 0.698 . . . . 1.26 110.892 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -136.04 123.71 22.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.328 -0.851 . . . . 2.05 109.74 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -59.25 125.73 24.82 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 123.372 0.42 . . . . 0.75 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.66 122.7 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.868 -0.606 . . . . 1.56 110.651 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 147' ' ' ASP . 1.6 mpt_? -110.6 118.49 36.36 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.188 -0.671 . . . . 2.94 109.188 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -102.06 160.68 14.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.486 0.66 . . . . 3.88 111.106 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 114.922 -1.035 . . . . 4.04 110.355 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 112.237 -0.345 . . . . 11.74 112.237 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.39 107.39 19.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.602 0.239 . . . . 10.54 110.828 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.01 46.95 0.94 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.604 -0.808 . . . . 8.95 112.666 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p -79.03 95.24 5.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.064 0.459 . . . . 7.09 111.005 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.64 123.87 42.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.446 . . . . 5.59 110.358 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.38 -29.44 47.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.898 -0.592 . . . . 2.99 111.142 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.56 -29.71 3.23 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.905 -0.588 . . . . 1.61 112.548 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -124.99 123.44 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.932 0.396 . . . . 2.0 111.039 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.19 119.9 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.19 0.519 . . . . 1.14 109.798 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -112.39 138.71 48.73 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.482 -0.781 . . . . 2.31 110.187 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.42 -163.29 13.5 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.443 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -152.06 156.86 40.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.062 0.458 . . . . 0.68 110.69 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.32 119.26 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.711 -0.677 . . . . 0.56 111.218 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.88 -38.16 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.49 -0.323 . . . . 0.76 111.34 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.1 p -134.75 131.71 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.85 0.357 . . . . 1.55 110.739 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.2 mtp -123.06 129.91 52.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 1.42 110.449 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -173.46 2.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.131 -1.063 . . . . 2.03 108.131 171.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -87.54 -15.75 36.58 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.346 -0.542 . . . . 3.24 110.645 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.52 -47.13 3.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.429 0.529 . . . . 2.03 112.429 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -142.33 -175.42 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.127 0.489 . . . . 1.25 111.445 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.04 36.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.324 -0.71 . . . . 0.71 111.324 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' H ' HG13 ' A' ' 16' ' ' VAL . 79.4 m-85 -124.16 138.62 54.4 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.578 -0.527 . . . . 1.08 109.578 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -99.79 123.2 52.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.163 -0.471 . . . . 0.61 110.72 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.443 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 31.0 tt0 -76.15 118.92 19.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.056 -1.09 . . . . 2.3 108.056 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.18 160.27 31.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.501 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.497 ' CD1' HD12 ' A' ' 83' ' ' ILE . 9.1 tp -56.02 -48.57 75.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 1.58 111.616 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -118.56 40.68 3.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 2.04 109.789 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.8 p80 45.73 33.88 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.076 0.86 . . . . 3.29 111.032 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -52.63 -47.3 67.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.744 -1.116 . . . . 2.89 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -169.26 173.53 6.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.8 110.185 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.81 121.03 42.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 3.37 109.166 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -113.39 130.7 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.095 0.474 . . . . 0.87 111.69 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -89.02 120.23 30.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.404 -0.816 . . . . 1.06 110.14 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -121.08 147.33 45.68 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.122 -0.696 . . . . 1.96 109.122 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -109.03 133.16 53.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.572 -0.899 . . . . 1.18 108.572 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -57.67 -23.38 51.13 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.443 0.535 . . . . 0.75 112.443 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -68.97 -15.66 63.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.869 0.366 . . . . 1.63 111.929 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -104.44 8.15 35.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.479 0.657 . . . . 2.07 109.788 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 75.7 t80 -93.02 126.7 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.355 -0.839 . . . . 0.91 110.064 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.4 ttm -96.68 101.87 13.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.357 -0.383 . . . . 1.73 110.294 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.02 -150.95 23.23 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.102 -0.57 . . . . 1.05 111.697 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -105.73 105.34 52.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.778 -0.453 . . . . 2.14 109.778 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.04 -25.88 3.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.805 2.337 . . . . 1.01 113.702 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -69.77 -24.74 63.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.623 0.725 . . . . 2.08 109.523 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.71 20.68 12.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.358 -0.837 . . . . 2.18 111.132 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.51 149.29 25.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.92 110.515 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.55 158.11 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 2.35 109.761 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.67 120.07 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.947 0.403 . . . . 1.4 110.274 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.07 -11.87 26.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.98 -0.629 . . . . 0.75 112.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.33 120.6 13.08 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.961 0.41 . . . . 1.06 111.409 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 5.0 mp0 -64.62 129.05 38.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 2.51 111.146 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 77' ' ' MET . 26.8 m -140.85 149.97 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.654 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -124.33 150.27 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.926 -0.398 . . . . 1.49 109.926 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 3.2 p90 -163.91 179.67 6.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.927 0.394 . . . . 0.66 111.308 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 p -128.45 166.93 17.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.091 -0.504 . . . . 0.94 110.742 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.06 147.4 30.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.359 -0.382 . . . . 1.19 110.97 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 31.13 0.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.397 0.618 . . . . 2.04 110.681 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.61 36.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.712 -0.676 . . . . 5.33 110.823 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.36 99.37 12.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.357 0.503 . . . . 5.42 112.357 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.8 37.27 92.22 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.887 -0.597 . . . . 4.76 113.241 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -110.45 153.7 24.65 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.664 -0.495 . . . . 6.38 109.664 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -66.79 -23.2 66.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.103 0.478 . . . . 6.4 111.298 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 m -81.08 50.47 1.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.22 0.533 . . . . 5.23 109.965 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.01 -35.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 6.95 111.033 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.4 m -73.09 -29.83 63.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 6.02 110.467 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.52 -137.18 2.26 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.921 -0.872 . . . . 4.09 110.921 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.61 79.88 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 0.689 . . . . 4.22 110.826 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.9 p -45.55 132.15 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 2.09 112.103 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -122.91 154.43 64.22 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.418 -0.81 . . . . 2.3 109.438 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.08 146.6 87.51 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.039 1.826 . . . . 1.43 112.274 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 144.64 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.792 -0.64 . . . . 0.82 110.179 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.02 163.73 18.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.721 0.296 . . . . 2.3 110.837 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.8 57.38 2.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.601 -0.727 . . . . 2.01 110.551 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 21.8 t -93.01 122.59 44.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.8 109.877 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -124.39 147.74 48.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.404 . . . . 3.51 110.106 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.446 ' HA ' HG12 ' A' ' 53' ' ' VAL . 48.9 mtt -70.92 154.12 42.09 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.866 0.365 . . . . 1.12 110.4 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 79' ' ' PRO . 17.3 tp -125.61 144.13 47.1 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.009 -0.541 . . . . 1.67 110.023 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 78' ' ' LEU . 25.3 Cg_endo -61.65 142.9 95.94 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.265 1.977 . . . . 2.15 111.961 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 4.2 ttmp? -62.94 156.67 23.77 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.825 -0.625 . . . . 4.61 111.856 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m120 73.74 24.02 2.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.45 -0.796 . . . . 2.84 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -96.96 8.5 44.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.04 -0.527 . . . . 1.7 110.181 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 27' ' ' LEU . 18.4 mm -108.75 133.06 20.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.636 -0.505 . . . . 0.92 109.636 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.89 149.84 66.59 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.593 2.195 . . . . 1.03 112.621 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.99 145.99 54.83 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.073 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 76.3 Cg_exo -52.31 132.53 44.63 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.592 2.861 . . . . 1.08 113.49 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.03 94.66 8.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.1 110.863 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.29 150.63 27.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.739 -0.838 . . . . 1.23 108.739 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.94 -64.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.076 -0.65 . . . . 2.87 111.37 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' THR . 30.8 tt0 -95.06 -58.63 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.302 -0.559 . . . . 2.84 111.027 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER 175.62 173.96 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.169 -0.923 . . . . 1.42 109.254 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -105.46 -58.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.3 110.73 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.31 178.45 6.87 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.023 -0.535 . . . . 1.29 110.815 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.96 -177.91 4.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.038 -0.528 . . . . 1.36 110.476 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.44 -163.32 29.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.085 -0.579 . . . . 0.53 111.867 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.47 146.36 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.667 -0.494 . . . . 1.37 109.667 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.28 121.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.69 110.301 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HE3' ' A' ' 145' ' ' LYS . . . -73.04 -60.18 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.572 0.582 . . . . 0.89 112.572 -172.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -164.56 158.15 15.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.495 -0.482 . . . . 3.92 111.647 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.36 170.42 10.6 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.701 2.268 . . . . 2.22 112.028 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 101' ' ' LEU . 1.5 mm? -90.7 89.8 7.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.599 -0.273 . . . . 3.32 110.495 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -98.41 -65.23 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 5.56 111.434 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 4.4 p -92.89 3.35 55.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.678 -0.692 . . . . 4.14 111.277 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.78 HG23 ' HG3' ' A' ' 110' ' ' GLU . 1.4 mp -67.0 -34.12 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 3.46 111.788 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 28.0 t-20 72.87 115.63 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.781 0.676 . . . . 4.99 110.707 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.53 1.99 3.8 Favored 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.458 2.772 . . . . 4.27 113.806 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -105.57 28.69 7.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.511 0.672 . . . . 3.94 109.388 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -144.24 142.33 30.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 5.6 109.859 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.09 -26.02 10.1 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.582 0.956 . . . . 5.3 113.582 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.78 ' HG3' HG23 ' A' ' 104' ' ' ILE . 12.9 pt-20 -74.44 2.97 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 4.95 110.801 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.476 ' OH ' ' HB ' ' A' ' 16' ' ' VAL . 8.7 t80 -61.39 -24.39 66.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.546 -0.752 . . . . 3.19 111.838 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -27.7 69.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.178 0.436 . . . . 1.24 112.178 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.83 162.87 30.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.515 -0.85 . . . . 0.94 111.66 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 130' ' ' GLU . 82.6 mt -144.45 147.08 32.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.54 0.686 . . . . 0.93 112.287 -172.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.6 mt -112.48 137.8 43.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.514 -1.221 . . . . 0.49 109.513 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -89.89 120.72 31.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.458 0.647 . . . . 1.4 110.116 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.575 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 34.9 mm -97.8 129.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 0.63 109.582 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -87.35 156.71 19.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.535 -0.302 . . . . 1.21 110.311 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.05 167.57 9.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.392 -0.596 . . . . 2.29 109.392 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.3 pm0 -69.71 -17.07 63.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.042 0.449 . . . . 2.78 110.563 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -99.6 -2.42 35.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 1.77 109.821 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 54.22 80.66 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.505 -0.77 . . . . 4.14 110.731 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.61 -47.37 1.84 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.323 -0.398 . . . . 1.87 111.142 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 -177.75 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 1.54 111.021 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.31 130.68 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.543 -0.91 . . . . 1.29 108.543 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.61 -69.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.6 -0.44 . . . . 1.03 110.869 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -138.75 -85.23 0.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.498 0.666 . . . . 1.56 111.034 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -175.96 137.64 0.33 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.777 -1.101 . . . . 2.08 108.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CG ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -113.19 132.75 55.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.163 -0.615 . . . . 0.68 110.664 173.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.502 ' HA ' HD23 ' A' ' 114' ' ' LEU . 5.7 tt0 -92.54 140.46 29.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.626 -1.17 . . . . 1.19 109.42 -175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.464 ' CD1' HD21 ' A' ' 136' ' ' LEU . 40.7 p90 -118.51 141.41 48.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.74 111.021 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.09 152.93 20.18 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.468 -0.787 . . . . 0.51 112.209 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.73 -30.15 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.212 0.506 . . . . 0.67 111.001 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -78.07 -23.61 47.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.485 0.659 . . . . 1.35 110.542 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.516 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 62.9 m -78.74 -27.6 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.101 -0.954 . . . . 1.1 110.464 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 131' ' ' PHE . 69.4 mt -75.33 60.11 1.1 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.349 -0.841 . . . . 1.46 112.017 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.24 -45.59 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.931 0.396 . . . . 0.82 111.522 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.538 HD21 HD22 ' A' ' 143' ' ' LEU . 2.9 p-10 -92.27 33.9 1.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.753 0.311 . . . . 2.17 111.231 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -53.0 -22.56 5.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.467 0.707 . . . . 1.39 112.674 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.71 -19.04 49.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.364 -0.38 . . . . 2.46 111.26 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 162.86 27.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.625 0.726 . . . . 1.89 112.465 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -81.86 35.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.788 -1.096 . . . . 2.88 110.47 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 138' ' ' ASN . 24.4 tp -63.72 127.09 29.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.97 110.692 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.61 -173.55 3.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 1.77 110.95 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 98' ' ' ALA . 83.8 tttt -66.18 138.53 57.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 1.43 109.9 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.19 66.99 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.738 -0.744 . . . . 1.07 112.626 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -90.62 140.36 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 1.94 110.728 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.03 140.91 33.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.709 -0.678 . . . . 1.79 110.742 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.15 143.91 38.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.508 . . . . 1.16 112.009 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -115.84 125.87 53.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 1.44 109.389 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 51.6 p90 -145.12 168.57 20.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.619 0.247 . . . . 0.61 110.404 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 121.35 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.34 -0.944 . . . . 2.2 110.469 172.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.5 130.46 52.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 1.24 110.324 174.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 22.7 t70 -149.0 -89.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.536 . . . . 1.92 111.862 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -33.52 40.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.379 0.511 . . . . 2.76 112.379 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.2 p -84.12 -17.15 41.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.477 -0.329 . . . . 1.98 111.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.67 23.15 70.46 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.728 -0.749 . . . . 1.27 113.065 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -126.43 173.53 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.679 -0.489 . . . . 3.61 109.679 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.86 18.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.269 -0.641 . . . . 0.48 109.269 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.44 158.18 38.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.196 -0.457 . . . . 0.49 110.438 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 45.6 m 55.4 30.72 15.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.512 0.673 . . . . 1.55 109.304 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.4 126.73 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.135 -0.939 . . . . 1.26 110.932 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.495 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 5.8 t30 -125.34 132.27 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.231 -0.895 . . . . 2.05 110.296 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.42 126.76 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.75 110.389 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.05 119.63 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.068 0.461 . . . . 1.56 111.617 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -90.82 156.6 17.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 2.94 110.691 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -80.88 134.05 35.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.051 -0.522 . . . . 3.88 110.176 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.503 -0.771 . . . . 4.04 110.919 -179.49 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.15 -0.38 . . . . 11.74 112.15 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.38 131.66 54.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 10.54 110.687 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.15 90.83 2.07 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.617 -0.801 . . . . 8.95 111.764 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.9 m -148.82 117.55 6.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.972 0.415 . . . . 7.09 111.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -113.94 18.35 17.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.872 0.844 . . . . 5.59 109.242 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.55 -178.19 4.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.348 -1.297 . . . . 2.99 109.606 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.71 23.48 53.02 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.33 -0.938 . . . . 1.61 111.033 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 88.5 mm-40 -61.25 119.74 9.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.063 -0.568 . . . . 2.0 111.455 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.28 115.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.586 -0.734 . . . . 1.27 109.501 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 8' ' ' GLN . 49.5 m-85 -98.69 150.64 21.58 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.255 -0.884 . . . . 1.14 109.662 -176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' C ' HD23 ' A' ' 27' ' ' LEU . 35.2 ttm-85 -108.26 149.41 28.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.813 -0.63 . . . . 2.31 109.994 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.93 170.95 42.25 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.143 -0.783 . . . . 0.5 111.143 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.973 0.416 . . . . 0.68 111.312 -174.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.38 118.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.754 -0.657 . . . . 0.56 110.721 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.58 -43.13 3.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.938 0.399 . . . . 0.76 110.779 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.03 123.59 70.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 1.55 111.039 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.1 mtp -119.19 110.09 16.63 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.566 . . . . 1.42 109.473 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 69.6 mmtt -97.66 -167.92 1.6 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.447 -0.575 . . . . 2.03 109.447 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.93 -26.98 30.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.486 -0.324 . . . . 3.24 111.108 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.65 -44.4 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 2.03 111.227 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -137.95 -170.44 2.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.088 -0.505 . . . . 1.25 110.657 -174.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.66 174.96 34.36 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 0.71 112.234 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -122.82 139.36 54.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.881 -0.415 . . . . 1.08 109.881 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.78 131.71 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.781 -0.645 . . . . 0.61 110.438 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.86 107.15 8.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.126 -1.065 . . . . 2.3 108.126 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -62.57 149.56 42.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.533 -0.303 . . . . 0.87 110.657 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -51.45 -48.25 62.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 1.58 111.303 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -84.4 3.76 34.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 2.04 111.713 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.1 p80 39.96 39.97 0.67 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.124 0.97 . . . . 3.29 111.881 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -88.39 -39.52 14.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.364 -0.835 . . . . 2.89 110.073 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.15 162.8 34.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 1.8 110.107 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.479 ' OE2' ' HG2' ' A' ' 109' ' ' GLN . 19.9 pt-20 -104.31 127.82 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.611 -0.515 . . . . 3.37 109.611 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 55' ' ' TYR . 58.9 t -104.49 128.6 57.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.302 0.572 . . . . 0.87 110.836 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -81.83 114.21 20.3 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.846 -1.07 . . . . 1.06 109.733 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -116.7 145.55 43.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.172 -0.677 . . . . 1.96 109.172 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -109.8 131.62 54.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.392 -0.596 . . . . 1.18 109.392 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.95 -20.27 56.59 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.972 0.415 . . . . 0.75 111.636 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -68.45 -23.28 64.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 1.63 111.118 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -106.76 14.1 27.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.057 0.456 . . . . 2.07 110.723 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -88.45 132.77 34.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.044 -0.526 . . . . 0.91 110.728 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.9 ttm -94.96 109.36 21.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.189 -0.46 . . . . 1.73 110.39 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.39 -141.97 12.89 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.738 -0.744 . . . . 1.05 111.84 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -116.65 103.35 52.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.004 -0.369 . . . . 2.14 110.004 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.17 -23.44 39.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.256 . . . . 1.01 112.949 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -86.16 -4.85 59.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.438 0.637 . . . . 2.08 110.51 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -112.15 19.44 17.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.723 -0.671 . . . . 2.18 110.568 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 47' ' ' LEU . 16.8 mt -87.97 157.33 18.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.643 -0.708 . . . . 0.92 111.091 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -131.2 157.37 43.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.783 -0.644 . . . . 2.35 111.166 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.45 121.87 22.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.117 0.484 . . . . 1.4 110.168 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.09 56.08 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.063 -0.589 . . . . 0.75 112.126 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -73.29 120.47 18.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 1.06 111.233 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.25 129.0 39.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.96 -1.018 . . . . 2.51 111.535 174.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.77 142.44 30.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.44 110.315 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.71 135.42 53.96 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.082 -0.71 . . . . 1.49 109.082 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 33' ' ' VAL . 11.4 p90 -156.8 159.64 38.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.063 -0.517 . . . . 0.66 111.134 -169.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.2 p -112.61 146.79 37.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.461 -0.336 . . . . 0.94 110.814 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.72 140.18 32.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.973 0.416 . . . . 1.19 110.861 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 -79.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.887 -0.597 . . . . 2.04 110.693 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HD2' HD13 ' A' ' 70' ' ' LEU . 15.4 ptm180 32.11 63.94 0.25 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.311 1.007 . . . . 5.33 112.34 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -112.94 -69.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 5.42 111.196 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.23 127.28 4.85 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.292 -0.956 . . . . 4.76 113.073 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 55.11 25.95 7.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.583 0.753 . . . . 6.38 112.507 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.34 21.11 8.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.974 0.416 . . . . 6.4 111.707 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.2 m -90.73 24.84 2.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 5.23 111.232 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.22 -25.9 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.097 0.406 . . . . 6.95 112.097 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.8 t -108.99 14.44 24.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.322 0.582 . . . . 6.02 110.111 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.42 -84.83 1.06 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.594 -0.73 . . . . 4.09 112.551 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.94 -26.2 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.766 0.317 . . . . 4.22 110.742 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.1 m -72.8 114.47 10.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.065 -0.717 . . . . 2.09 109.065 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD13 ' HD2' ' A' ' 59' ' ' ARG . 58.8 mt -107.82 124.83 33.67 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 2.3 110.032 -174.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.07 147.81 94.38 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.779 2.32 . . . . 1.43 113.367 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.24 137.99 45.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.125 -0.943 . . . . 0.82 110.289 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -118.47 152.85 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.197 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.6 72.91 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.637 . . . . 2.01 110.356 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.9 t -105.18 111.09 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.8 110.204 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -121.82 141.56 51.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 3.51 110.927 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.6 mtm -74.94 144.74 43.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 1.12 110.912 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.5 pt? -128.04 162.87 47.34 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.961 -0.755 . . . . 1.67 108.961 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 21.8 Cg_endo -62.19 163.59 19.62 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.138 1.892 . . . . 2.15 113.127 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HG2' ' H ' ' A' ' 81' ' ' ASN . 26.9 ttpp -79.93 -179.48 7.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.551 -0.749 . . . . 4.61 110.39 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 54.0 m-20 78.07 9.17 2.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.764 0.826 . . . . 2.84 111.218 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -79.61 -34.17 40.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.97 -0.559 . . . . 1.7 110.018 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.57 ' CD1' HD21 ' A' ' 27' ' ' LEU . 10.7 mm -82.76 127.39 70.22 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.603 -0.726 . . . . 0.92 109.771 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.59 144.67 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.486 2.124 . . . . 1.03 112.644 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -103.55 131.42 22.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.779 . . . . 2.76 108.895 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.43 125.11 5.72 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.953 2.436 . . . . 1.08 113.018 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.1 92.4 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.74 . . . . 1.1 111.456 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -141.78 129.84 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.587 -1.264 . . . . 1.23 107.587 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.43 -63.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.568 0.581 . . . . 2.87 112.568 -169.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.5 tp10 -95.41 -55.11 3.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.111 0.481 . . . . 2.84 111.017 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.7 t 169.96 161.47 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.646 -0.706 . . . . 1.42 109.756 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m -105.79 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 1.3 112.256 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -138.91 172.34 13.0 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.494 0.664 . . . . 1.29 112.268 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.89 163.05 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.878 -1.056 . . . . 1.36 109.399 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.54 177.49 45.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.817 -0.706 . . . . 0.53 111.387 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 m -107.79 161.6 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.046 0.45 . . . . 1.37 110.28 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.13 126.9 26.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.133 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.74 -44.35 56.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.89 111.484 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -171.7 143.96 1.51 Allowed Pre-proline 0 N--CA 1.463 0.18 0 N-CA-C 111.74 0.274 . . . . 3.92 111.74 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.81 159.73 41.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.596 2.197 . . . . 2.22 110.71 170.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HA ' HD13 ' A' ' 104' ' ' ILE . 5.0 mp -114.06 91.49 3.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.246 0.546 . . . . 3.32 112.169 -173.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -96.36 -58.99 1.92 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.727 -0.669 . . . . 5.56 110.406 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 58.3 m -92.75 8.94 37.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.234 -0.439 . . . . 4.14 111.713 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.557 HD13 ' HA ' ' A' ' 101' ' ' LEU . 4.1 mp -107.03 32.27 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.424 0.631 . . . . 3.46 110.784 -174.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.85 97.84 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.929 0.714 . . . . 4.99 112.929 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.65 -6.28 13.43 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.4 2.066 . . . . 4.27 112.606 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -113.3 27.73 9.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 3.94 111.365 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 6.9 tp-100 -135.78 160.67 37.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.986 -0.746 . . . . 5.6 108.986 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.479 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 14.1 mm100 -54.77 -24.1 21.01 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.251 0.463 . . . . 5.3 112.251 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.32 -18.42 65.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.553 -0.294 . . . . 4.95 110.878 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 108' ' ' GLN . 4.0 t80 -57.33 -21.34 34.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.532 0.733 . . . . 3.19 112.305 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.11 44.83 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.81 0.3 . . . . 1.24 111.81 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 65.21 -176.65 12.42 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.265 -0.493 . . . . 0.94 113.311 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 130' ' ' GLU . 48.4 mt -151.01 139.8 20.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.217 0.532 . . . . 0.93 110.917 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.4 135.22 41.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 0.49 109.308 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 10.6 pt-20 -86.03 112.43 21.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.858 0.837 . . . . 1.4 109.246 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 129' ' ' HIS . 16.9 mm -85.27 141.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.895 -1.048 . . . . 0.63 110.285 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 122' ' ' ARG . 34.9 tp -85.44 136.95 33.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 116.251 -0.431 . . . . 1.21 110.015 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.47 152.82 10.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.059 -0.973 . . . . 2.29 110.441 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.9 pm0 -58.4 -26.72 63.55 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.043 0.386 . . . . 2.78 112.043 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.485 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.93 15.43 22.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.029 -0.268 . . . . 1.77 110.444 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.495 ' HG2' HD21 ' A' ' 118' ' ' LEU . 1.4 tmm_? 64.25 31.8 12.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.818 0.818 . . . . 4.14 109.484 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 m -77.18 -83.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.751 -0.659 . . . . 1.87 111.435 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 p -140.39 -169.76 2.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.737 -0.211 . . . . 1.54 110.779 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -67.97 137.62 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.903 -0.406 . . . . 1.29 109.903 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.9 mt -83.68 -70.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.282 -0.567 . . . . 1.03 110.739 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.8 p -135.88 -85.64 0.36 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.169 0.509 . . . . 1.56 111.714 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -176.48 137.43 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.247 -0.888 . . . . 2.08 109.489 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.781 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.1 m-70 -124.49 132.97 53.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.68 110.254 171.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 114' ' ' LEU . 15.0 tt0 -86.41 150.3 24.4 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.644 -0.707 . . . . 1.19 110.158 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -123.33 140.81 52.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.289 0.566 . . . . 0.74 111.671 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.49 154.74 20.77 Favored Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 115.426 -0.806 . . . . 0.51 111.987 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.35 -23.75 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 117.154 0.477 . . . . 0.67 111.493 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.7 p -81.78 -26.06 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.341 0.591 . . . . 1.35 110.669 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 19.8 m -73.81 -30.0 62.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.41 -0.814 . . . . 1.1 110.001 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 73.1 mt -76.01 60.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.242 -0.89 . . . . 1.46 111.828 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.46 -48.2 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.825 0.345 . . . . 0.82 111.595 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.74 35.84 1.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 2.17 111.167 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 14.8 ptpt -48.23 -25.08 1.37 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.194 1.183 . . . . 1.39 114.194 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -82.24 -11.44 58.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.903 0.383 . . . . 2.46 110.915 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.94 147.34 48.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 1.89 109.904 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.99 87.28 6.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.701 0.762 . . . . 2.88 110.051 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 143' ' ' LEU . 12.2 tp -103.34 109.22 20.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.659 -1.155 . . . . 0.97 110.223 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -104.8 -177.49 3.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.918 -0.583 . . . . 1.77 110.916 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -66.62 141.46 57.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.43 110.104 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.99 -4.23 81.36 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.63 -0.795 . . . . 1.07 113.151 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.1 141.56 28.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.757 -0.777 . . . . 1.94 109.64 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.602 HD13 ' OE1' ' A' ' 167' ' ' GLN . 3.6 mt -86.82 132.14 33.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.423 0.63 . . . . 1.79 111.746 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.42 152.74 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 1.16 110.875 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.0 p -112.1 140.33 46.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 1.44 109.389 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 42.5 p90 -163.88 168.09 19.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.809 -0.441 . . . . 0.61 109.809 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 124.12 25.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.695 -0.802 . . . . 2.2 111.438 173.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tt -99.44 140.31 19.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.785 -1.098 . . . . 1.24 110.435 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -166.57 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.765 -0.198 . . . . 1.92 110.759 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.36 -36.73 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 2.76 111.573 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.9 t -74.36 -17.44 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.876 0.37 . . . . 1.98 111.015 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.51 19.89 54.7 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.516 -0.849 . . . . 1.27 112.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -139.31 178.23 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.968 -0.753 . . . . 3.61 108.968 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.36 108.64 19.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.251 -0.277 . . . . 0.48 110.251 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -121.3 161.98 21.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.43 . . . . 0.49 110.964 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.5 m 63.84 37.07 9.93 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.712 0.633 . . . . 1.55 109.921 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.8 t -69.15 114.93 6.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.237 -0.892 . . . . 1.26 111.202 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -125.13 118.81 26.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.834 -0.621 . . . . 2.05 109.945 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.94 116.19 3.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.75 110.543 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.05 118.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.506 0.669 . . . . 1.56 111.585 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.93 138.9 36.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.702 -0.681 . . . . 2.94 109.923 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.602 ' OE1' HD13 ' A' ' 148' ' ' LEU . 24.4 mp0 -99.88 150.98 21.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.603 0.716 . . . . 3.88 111.118 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 114.819 -1.082 . . . . 4.04 110.05 175.199 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 111.917 -0.473 . . . . 11.74 111.917 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.05 110.54 22.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.739 0.304 . . . . 10.54 110.898 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.04 -174.65 30.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.288 -0.958 . . . . 8.95 112.47 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 p -85.38 -43.93 13.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.957 0.408 . . . . 7.09 110.821 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -152.47 -178.12 6.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.875 -0.602 . . . . 5.59 110.654 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.72 -21.86 40.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 2.99 111.83 -175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.93 23.26 72.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.884 -0.674 . . . . 1.61 112.324 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 18.9 mm-40 -117.54 122.42 43.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 2.0 111.563 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.11 122.52 44.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 1.27 108.896 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.09 137.59 32.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.204 -0.453 . . . . 1.14 110.304 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -106.62 142.24 36.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.096 -0.502 . . . . 2.31 109.676 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.24 -174.01 34.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.183 -0.767 . . . . 0.5 111.183 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -140.81 144.17 35.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.884 0.373 . . . . 0.68 110.8 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.01 115.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.56 111.021 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.42 -44.36 4.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 0.76 110.507 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 23' ' ' PHE . 86.9 t -117.35 123.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.036 -0.529 . . . . 1.55 110.801 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.8 ttm -124.12 110.96 15.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.579 . . . . 1.42 109.968 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.3 mmtt -100.68 -174.3 2.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.754 -0.462 . . . . 2.03 109.754 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.06 -20.3 38.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.931 -0.577 . . . . 3.24 110.485 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -111.78 -49.02 3.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.089 0.471 . . . . 2.03 111.457 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 12.4 p90 -141.23 -174.12 3.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 1.25 109.747 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.74 177.48 33.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.591 -0.814 . . . . 0.71 112.254 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' CZ ' ' HE1' ' A' ' 21' ' ' PHE . 63.5 m-85 -128.78 139.09 52.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.021 0.439 . . . . 1.08 109.954 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -112.47 125.9 69.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.844 -0.617 . . . . 0.61 110.914 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.8 132.01 43.04 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.776 -0.824 . . . . 2.3 108.776 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 p -84.0 150.13 25.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.87 110.199 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 6.9 tp -49.07 -46.85 45.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.788 -0.642 . . . . 1.58 111.828 -174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 m -109.14 30.14 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.028 -0.533 . . . . 2.04 110.74 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 p80 39.4 57.37 2.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.618 1.199 . . . . 3.29 111.389 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.16 -35.97 23.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.73 -1.577 . . . . 2.89 109.918 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -173.72 175.22 2.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.14 -0.936 . . . . 1.8 110.108 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 106' ' ' PRO . 35.1 tt0 -103.6 128.57 50.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.196 -1.039 . . . . 3.37 108.196 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 124.37 58.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.648 -0.421 . . . . 0.87 111.043 -174.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.2 112.47 4.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.811 -0.631 . . . . 1.06 109.572 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 75' ' ' VAL . 4.6 t80 -121.64 121.61 37.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.624 0.726 . . . . 1.96 110.796 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.94 128.18 44.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.135 -0.939 . . . . 1.18 108.717 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -62.17 -18.56 61.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.981 0.363 . . . . 0.75 111.981 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -60.05 -34.04 72.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.38 . . . . 1.63 111.03 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -95.65 20.79 9.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.934 0.397 . . . . 2.07 111.215 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 93.1 t80 -94.07 139.62 30.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.91 110.871 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.33 106.16 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.054 -0.521 . . . . 1.73 110.444 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.56 -150.51 17.82 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.862 -0.685 . . . . 1.05 112.173 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -108.37 104.05 52.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.456 0.17 . . . . 2.14 110.729 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.22 -19.95 28.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 1.01 112.819 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -70.44 -22.71 62.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.437 0.637 . . . . 2.08 110.164 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -96.28 19.38 12.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.348 -0.842 . . . . 2.18 110.343 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD23 ' HG2' ' A' ' 51' ' ' GLN . 55.4 mt -95.84 153.55 17.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 0.92 110.181 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 51' ' ' GLN . 6.0 pt-20 -126.24 162.25 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.969 -0.56 . . . . 2.35 109.935 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 114.58 10.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.017 -0.735 . . . . 1.4 109.017 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.37 4.54 40.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.506 -0.854 . . . . 0.75 112.183 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 57.9 tp60 -73.49 133.1 43.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.897 0.38 . . . . 1.06 110.612 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -86.27 128.24 34.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 2.51 110.799 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 77' ' ' MET . 35.7 m -139.51 160.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.088 -0.505 . . . . 0.44 110.921 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 78' ' ' LEU . 25.4 pt-20 -120.88 140.02 52.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.234 -0.654 . . . . 1.49 109.234 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 75' ' ' VAL . 1.4 p90 -161.78 172.62 15.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.088 0.47 . . . . 0.66 112.075 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 p -131.96 157.86 42.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.684 -0.689 . . . . 0.94 110.77 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.44 149.29 22.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 1.19 111.155 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.72 99.61 7.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.972 -0.558 . . . . 2.04 111.125 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -130.42 76.94 1.76 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.047 -0.723 . . . . 5.33 109.047 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.97 -14.91 57.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 5.42 111.254 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.7 172.08 29.7 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.929 -0.653 . . . . 4.76 111.722 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.45 50.81 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.179 0.514 . . . . 6.38 110.63 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -77.73 43.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.804 -0.635 . . . . 6.4 110.957 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -81.09 6.41 13.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.813 -0.631 . . . . 5.23 111.021 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.03 -37.77 10.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.176 -0.466 . . . . 6.95 110.926 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 p -105.07 20.12 19.4 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.913 0.338 . . . . 6.02 111.913 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.12 134.61 1.93 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.733 -0.746 . . . . 4.09 111.868 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.31 -46.41 27.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.002 0.43 . . . . 4.22 110.455 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -110.05 127.42 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 2.09 110.712 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.576 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.4 mm? -67.6 155.27 91.63 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.705 -0.68 . . . . 2.3 111.696 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.09 155.21 66.11 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.854 2.369 . . . . 1.43 112.378 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.03 30.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.82 110.668 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.79 169.32 17.23 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.507 -0.553 . . . . 2.3 109.507 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 t30 60.03 45.54 11.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.636 0.732 . . . . 2.01 109.871 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 35' ' ' PHE . 20.1 t -93.32 114.05 29.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.73 . . . . 0.8 110.359 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 163.28 24.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 3.51 110.239 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.7 mtt -79.63 153.02 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.145 0.498 . . . . 1.12 111.369 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 54' ' ' GLU . 18.8 mt -119.88 158.54 49.69 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.252 -0.885 . . . . 1.67 109.687 172.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.21 153.83 71.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.125 1.883 . . . . 2.15 111.93 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 51' ' ' GLN . 10.8 tptp -78.94 148.68 32.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.077 -0.511 . . . . 4.61 110.839 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 72.01 30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 2.84 110.853 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.3 p -87.63 -11.71 47.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.39 0.614 . . . . 1.7 109.923 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 13.6 mm -84.98 131.56 48.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.315 -0.857 . . . . 0.92 109.627 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.18 150.58 65.85 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.483 2.122 . . . . 1.03 112.412 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -126.92 148.54 65.9 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.403 -0.362 . . . . 2.76 110.206 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.98 127.8 14.09 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.024 2.483 . . . . 1.08 113.625 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.94 94.49 4.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.659 -0.701 . . . . 1.1 110.895 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.86 120.94 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 1.23 109.087 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.05 -62.77 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.544 0.201 . . . . 2.87 111.544 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 6.0 mm-40 -92.98 -55.33 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 2.84 111.733 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 12.5 t 168.91 158.67 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.695 -0.854 . . . . 1.42 108.695 -176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.08 -58.92 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.454 -0.498 . . . . 1.3 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.44 163.61 34.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 1.29 110.803 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -120.87 174.09 6.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.457 -0.942 . . . . 1.36 108.457 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.35 -174.3 46.87 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.027 -1.083 . . . . 0.53 111.606 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.408 HG12 HD13 ' A' ' 148' ' ' LEU . 35.6 m -119.15 162.42 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.008 0.432 . . . . 1.37 110.028 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.39 122.43 17.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.94 -0.573 . . . . 0.69 109.869 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.65 -45.65 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.352 . . . . 0.89 111.61 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -172.98 124.98 0.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 3.92 110.835 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.12 147.03 16.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.548 2.165 . . . . 2.22 111.671 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.745 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.1 pt? -78.94 90.79 4.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 3.32 111.595 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -97.55 -65.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.14 -0.482 . . . . 5.56 110.588 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.04 1.49 56.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.998 -0.546 . . . . 4.14 110.794 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.9 mp -71.19 -42.55 75.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.723 -0.671 . . . . 3.46 111.161 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 72.42 147.04 0.12 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.638 0.775 . . . . 4.99 111.381 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . 54.8 Cg_endo -68.56 -19.87 41.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.845 2.363 . . . . 4.27 111.962 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.88 -14.3 61.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.373 -0.83 . . . . 3.94 110.325 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -96.92 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.949 -0.569 . . . . 5.6 110.332 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.3 -22.63 66.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.846 0.684 . . . . 5.3 112.846 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -85.61 15.85 4.33 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.779 0.323 . . . . 4.95 111.268 -175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' O ' HD13 ' A' ' 101' ' ' LEU . 14.0 t80 -50.11 -42.9 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.169 0.803 . . . . 3.19 113.169 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB3' ' HG2' ' A' ' 130' ' ' GLU . . . -76.57 -11.31 59.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.301 0.482 . . . . 1.24 112.301 -169.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.23 150.7 8.72 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.635 -0.793 . . . . 0.94 112.284 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD23 ' CA ' ' A' ' 130' ' ' GLU . 67.3 mt -127.28 147.26 50.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.498 0.666 . . . . 0.93 112.597 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 82.3 mt -111.11 141.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.908 -1.042 . . . . 0.49 109.313 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 125' ' ' VAL . 32.7 tt0 -93.11 109.24 20.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.148 0.499 . . . . 1.4 109.981 -176.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.6 mm -91.74 132.52 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.713 . . . . 0.63 110.154 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -91.83 153.91 19.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.131 0.491 . . . . 1.21 111.008 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.534 ' HB3' ' H ' ' A' ' 123' ' ' THR . 2.8 t70 -55.12 146.88 17.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.32 -0.855 . . . . 2.29 109.063 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.744 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.9 pm0 -62.75 -20.01 64.53 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.464 0.542 . . . . 2.78 112.464 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -102.25 13.46 34.6 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.936 -0.394 . . . . 1.77 109.936 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 58.1 80.89 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.652 -0.704 . . . . 4.14 110.378 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.534 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 32.5 m -116.33 -71.99 0.71 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.451 -0.795 . . . . 1.87 109.663 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -146.43 -176.58 5.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.82 -0.627 . . . . 1.54 110.189 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 116' ' ' GLU . 3.6 p -72.38 137.86 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.281 -0.418 . . . . 1.29 110.105 175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.37 -70.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.431 -0.507 . . . . 1.03 110.086 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.2 p -138.48 -87.82 0.24 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.417 0.627 . . . . 1.56 111.193 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.98 139.1 0.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.647 -1.16 . . . . 2.08 108.224 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -117.32 121.06 40.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.455 -0.498 . . . . 0.68 110.448 173.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' CA ' HD23 ' A' ' 114' ' ' LEU . 9.3 tt0 -78.71 149.31 32.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.736 -0.665 . . . . 1.19 109.849 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -117.77 175.44 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.943 0.402 . . . . 0.74 111.007 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.46 153.09 21.44 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.797 -0.638 . . . . 0.51 111.616 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -51.03 -30.54 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.019 0.409 . . . . 0.67 111.516 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.4 p -74.44 -36.91 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 1.35 110.946 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 16.9 m -69.94 -23.15 63.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 1.1 110.145 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.88 59.78 1.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 1.46 111.846 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.2 t -48.28 -41.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.228 0.537 . . . . 0.82 110.563 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -95.95 33.88 1.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.652 -0.703 . . . . 2.17 110.722 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -52.93 -25.09 10.77 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.799 1.037 . . . . 1.39 113.799 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -84.07 -16.92 42.01 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.586 -0.446 . . . . 2.46 111.363 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -76.01 150.05 37.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 1.89 110.617 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 142' ' ' LEU . 2.1 mm? -84.96 71.37 10.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.935 -0.575 . . . . 2.88 109.745 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.6 tp -75.72 122.88 24.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.97 110.028 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -108.32 172.12 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.024 0.44 . . . . 1.77 111.758 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 146' ' ' GLY . 13.5 tmtt? -70.93 132.82 45.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 1.43 110.366 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.418 ' N ' ' HD3' ' A' ' 145' ' ' LYS . . . 87.56 4.07 80.38 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.47 -0.871 . . . . 1.07 113.05 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.89 152.01 22.4 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.136 -0.626 . . . . 1.94 110.045 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 96' ' ' VAL . 3.3 mm? -77.32 123.47 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.529 0.681 . . . . 1.79 111.513 -172.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.169 -0.923 . . . . 1.16 110.339 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 73.4 m -121.57 152.8 38.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.057 -0.52 . . . . 1.44 110.558 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 162' ' ' VAL . 6.4 p90 -165.49 168.27 16.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.803 -0.635 . . . . 0.61 109.817 -173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.48 122.55 29.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.459 0.647 . . . . 2.2 110.805 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -100.7 137.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.886 . . . . 1.24 110.551 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.548 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 31.6 t70 -169.64 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.19 -0.3 . . . . 1.92 110.19 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.548 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 39.1 mt-10 -76.73 -18.61 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.618 . . . . 2.76 110.035 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.5 p -80.03 -18.68 49.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.542 -0.754 . . . . 1.98 110.643 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.77 2.73 2.69 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.61 -0.723 . . . . 1.27 114.082 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -154.89 -161.16 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.262 -0.644 . . . . 3.61 109.262 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.71 115.58 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.337 0.589 . . . . 0.48 110.842 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -128.79 148.81 50.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.497 -0.774 . . . . 0.49 109.861 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.0 m 55.27 55.17 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.038 0.836 . . . . 1.55 110.916 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 151' ' ' PHE . 4.1 m -77.25 141.62 15.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.287 0.565 . . . . 1.26 110.277 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -138.56 119.95 14.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 2.05 110.286 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.16 103.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.115 -0.493 . . . . 0.75 110.958 174.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.97 118.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.381 0.61 . . . . 1.56 110.698 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 119.6 36.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 2.94 110.791 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.16 164.23 15.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.261 -0.644 . . . . 3.88 109.261 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 4.04 110.71 -177.557 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.336 -0.306 . . . . 11.74 112.336 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.8 -75.23 0.48 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.583 0.23 . . . . 10.54 111.07 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.46 -18.67 56.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.783 -0.722 . . . . 8.95 112.258 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 p -96.15 39.45 1.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.024 0.44 . . . . 7.09 110.602 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.66 97.67 0.22 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.781 -0.645 . . . . 5.59 111.728 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.9 -83.24 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.183 -0.917 . . . . 2.99 113.068 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.26 -4.17 58.47 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.495 -0.642 . . . . 1.61 111.495 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.54 133.52 35.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 2.0 110.977 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 56' ' ' THR . 2.4 p -104.23 129.71 56.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.612 -0.722 . . . . 1.27 109.774 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -113.17 148.72 34.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.279 -0.873 . . . . 1.14 109.881 -174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -110.45 136.42 49.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.147 -0.479 . . . . 2.31 109.907 -177.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.44 -168.2 17.52 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.372 -0.691 . . . . 0.5 111.372 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 149.14 34.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.121 0.486 . . . . 0.68 111.178 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.77 118.99 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.442 -0.799 . . . . 0.56 110.497 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.21 -49.67 3.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.76 111.001 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 23' ' ' PHE . 6.3 p -123.51 139.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.032 -0.531 . . . . 1.55 110.272 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.7 ttm -131.76 122.05 25.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.42 . . . . 1.42 110.993 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -107.43 -170.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.653 -0.869 . . . . 2.03 108.653 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.96 -20.36 25.99 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.438 -0.801 . . . . 3.24 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.83 -48.44 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.063 0.459 . . . . 2.03 111.34 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.3 p90 -143.65 175.78 9.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.36 . . . . 1.25 110.947 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.27 173.23 33.51 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.435 -0.666 . . . . 0.71 111.435 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.648 ' H ' HG13 ' A' ' 16' ' ' VAL . 40.7 m-85 -114.16 126.17 54.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.661 -0.866 . . . . 1.08 108.661 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.69 125.66 46.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.243 -0.435 . . . . 0.61 110.527 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.74 119.7 15.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.172 -0.677 . . . . 2.3 109.172 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.45 160.55 24.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.87 110.315 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 13.9 tp -56.27 -46.4 79.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.341 -0.39 . . . . 1.58 111.929 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.8 t -99.58 13.02 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.59 -0.522 . . . . 2.04 109.59 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.555 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 84.5 m-70 61.22 35.56 18.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.42 -0.809 . . . . 3.29 109.599 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.94 -58.52 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.094 -1.412 . . . . 2.89 111.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.07 178.85 9.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 1.8 109.765 -173.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 131.4 50.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 3.37 110.62 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.98 129.9 64.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.888 -0.597 . . . . 0.87 110.464 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -80.91 113.21 18.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.464 0.65 . . . . 1.06 110.446 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 75' ' ' VAL . 26.3 t80 -121.95 132.49 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 1.96 110.13 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -102.26 124.32 47.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.159 -0.682 . . . . 1.18 109.159 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.97 -18.74 63.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.476 0.547 . . . . 0.75 112.476 -172.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -59.26 -23.28 62.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.007 0.432 . . . . 1.63 110.618 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.18 20.72 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.081 0.467 . . . . 2.07 110.458 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -85.99 140.95 29.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.91 110.336 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 76' ' ' ARG . 48.7 ttm -111.47 89.32 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 1.73 110.425 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.27 -168.97 33.19 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.812 -0.631 . . . . 1.05 111.949 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -98.37 102.75 15.21 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.344 0.593 . . . . 2.14 110.791 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.89 -17.99 13.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 1.01 113.513 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -64.32 -25.72 68.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 2.08 110.107 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -106.51 23.51 14.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.823 -0.626 . . . . 2.18 111.419 -176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -89.7 152.02 21.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.717 -0.674 . . . . 0.92 109.719 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.13 157.81 44.77 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.4 mm? -68.67 118.15 11.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.41 -0.359 . . . . 1.4 110.061 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.77 -5.47 16.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.75 112.296 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.31 122.96 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.669 0.271 . . . . 1.06 110.955 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 21.5 mt-10 -64.16 137.41 57.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.693 -0.685 . . . . 2.51 110.656 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 77' ' ' MET . 22.5 m -143.09 148.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.508 -0.553 . . . . 0.44 109.508 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.33 144.48 43.19 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.931 -0.766 . . . . 1.49 108.931 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -162.61 163.89 26.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.038 0.447 . . . . 0.66 111.939 -174.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 9' ' ' VAL . 56.9 p -120.94 153.51 37.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 0.94 109.742 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.67 156.74 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.745 0.307 . . . . 1.19 110.827 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.89 -174.38 3.3 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.867 -0.79 . . . . 2.04 108.867 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HD3' ' CD2' ' A' ' 70' ' ' LEU . 72.5 ttt180 61.01 41.11 14.41 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.997 0.811 . . . . 5.33 110.218 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -97.81 174.36 6.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.663 -0.699 . . . . 5.42 110.707 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.2 -152.13 17.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.905 -0.664 . . . . 4.76 112.306 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.75 20.3 3.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 6.38 110.422 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -99.76 12.51 36.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.599 -0.728 . . . . 6.4 110.898 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.36 6.3 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 5.23 112.332 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 m -92.27 -28.01 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.024 -0.534 . . . . 6.95 109.979 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 m -107.06 -28.4 10.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.911 -0.586 . . . . 6.02 110.246 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -94.32 78.21 0.96 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.354 -0.698 . . . . 4.09 111.354 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -72.62 -41.02 66.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.013 0.435 . . . . 4.22 110.553 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 m -122.37 128.46 51.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.584 -0.895 . . . . 2.09 108.584 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' CD2' ' HD3' ' A' ' 59' ' ' ARG . 31.7 mt -109.85 138.44 20.71 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 121.202 -0.199 . . . . 2.3 110.92 -173.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.17 153.16 67.29 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.532 2.155 . . . . 1.43 111.106 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -106.27 147.54 29.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.453 -0.34 . . . . 0.82 111.245 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -126.85 174.22 8.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.495 -0.321 . . . . 2.3 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 58.8 34.2 23.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.869 -0.605 . . . . 2.01 112.232 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 55' ' ' TYR . 40.8 t -78.19 119.74 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.977 0.418 . . . . 0.8 110.899 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 41' ' ' MET . 11.1 mmm180 -124.39 148.72 47.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.675 -0.693 . . . . 3.51 110.35 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.537 ' HA ' HG12 ' A' ' 53' ' ' VAL . 66.7 mtt -69.04 140.95 54.94 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.017 -0.364 . . . . 1.12 110.017 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 31.1 tp -130.61 82.69 64.16 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.389 -0.369 . . . . 1.67 111.502 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.06 116.58 3.97 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.524 1.483 . . . . 2.15 110.305 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -166.22 -21.45 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.904 0.383 . . . . 4.61 111.006 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t30 59.35 41.19 20.1 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.452 -0.944 . . . . 2.84 108.452 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 t -88.44 -5.97 57.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.626 -1.17 . . . . 1.7 110.924 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.4 HD12 HD12 ' A' ' 27' ' ' LEU . 18.3 mm -63.23 119.65 54.65 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.92 109.236 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.68 158.98 53.27 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 122.44 2.094 . . . . 1.03 112.125 -172.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -98.2 139.72 21.4 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.942 -0.572 . . . . 2.76 110.413 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 76.6 Cg_exo -51.02 134.83 43.59 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.113 2.542 . . . . 1.08 112.261 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.76 91.83 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 1.1 110.226 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 152' ' ' ARG . 22.0 t -142.82 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 1.23 109.531 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.92 -59.81 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.02 0.378 . . . . 2.87 112.02 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 91' ' ' THR . 16.7 mm-40 -90.76 -56.29 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.31 0.576 . . . . 2.84 111.145 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 13.1 t 151.01 164.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.431 -1.692 . . . . 1.42 106.431 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.512 HG21 HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -106.48 -58.21 1.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.28 -0.968 . . . . 1.3 111.536 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -140.87 158.37 44.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.028 0.442 . . . . 1.29 110.761 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -140.15 126.04 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.72 -0.673 . . . . 1.36 109.398 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.47 -140.45 3.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.986 -1.102 . . . . 0.53 112.379 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.92 152.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.611 0.243 . . . . 1.37 110.475 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 143' ' ' LEU . 64.8 t -61.89 132.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.69 110.419 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.15 -49.11 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.238 0.458 . . . . 0.89 112.238 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 99' ' ' ARG . 5.4 ttt85 -157.76 126.19 2.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.257 -0.577 . . . . 3.92 111.823 -172.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.15 145.87 24.86 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.802 2.335 . . . . 2.22 111.717 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -93.65 89.97 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.325 0.583 . . . . 3.32 112.162 -176.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -98.44 -62.62 1.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.328 0.585 . . . . 5.56 110.468 170.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.51 7.35 26.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.425 -0.807 . . . . 4.14 111.081 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -77.34 -42.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.047 -0.524 . . . . 3.46 110.675 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 73.13 146.9 0.12 Allowed Pre-proline 0 N--CA 1.472 0.653 0 O-C-N 123.682 0.614 . . . . 4.99 110.735 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.435 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 55.4 Cg_endo -71.19 0.25 6.98 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.736 2.29 . . . . 4.27 112.412 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.94 -14.52 23.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.039 0.447 . . . . 3.94 110.298 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.427 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 52.0 tp60 -89.45 148.12 23.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 5.6 110.129 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -63.47 -28.75 70.17 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.862 0.69 . . . . 5.3 112.862 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 108' ' ' GLN . 1.3 pt-20 -88.41 16.12 6.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.026 0.441 . . . . 4.95 111.17 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 6.8 t80 -49.58 -33.17 14.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.383 -0.826 . . . . 3.19 111.633 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.56 -16.63 63.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.207 -0.451 . . . . 1.24 111.761 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.53 170.01 46.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.529 -0.843 . . . . 0.94 111.969 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 130' ' ' GLU . 72.6 mt -145.31 144.21 30.61 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.309 0.576 . . . . 0.93 111.613 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.39 138.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.011 -0.995 . . . . 0.49 109.211 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.67 114.75 26.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.643 0.735 . . . . 1.4 110.312 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 14.8 mm -91.34 132.15 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.045 -0.98 . . . . 0.63 109.845 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.9 pt? -85.65 152.74 22.87 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.181 0.301 . . . . 1.21 110.438 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.448 ' OD1' ' HB ' ' A' ' 123' ' ' THR . 18.2 m-20 -56.75 151.67 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.669 -0.493 . . . . 2.29 109.669 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -62.59 -25.95 68.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.735 0.302 . . . . 2.78 110.699 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.49 5.78 43.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.77 109.987 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 60.94 78.92 0.27 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.547 -0.751 . . . . 4.14 110.643 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.448 ' HB ' ' OD1' ' A' ' 119' ' ' ASP . 22.0 m -121.13 -74.18 0.62 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 1.87 110.606 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.5 p -144.03 -174.71 4.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.75 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.1 p -70.92 134.54 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.676 -0.491 . . . . 1.29 109.676 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.68 -69.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 1.03 110.623 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -136.66 -84.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.261 0.553 . . . . 1.56 111.197 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -175.33 142.38 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.035 -0.984 . . . . 2.08 108.899 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.447 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -124.1 124.39 42.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.999 0.428 . . . . 0.68 110.678 172.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.0 tt0 -85.26 143.74 28.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.247 -0.888 . . . . 1.19 108.758 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -117.13 134.31 54.93 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.181 -0.608 . . . . 0.74 111.348 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.555 ' HA3' ' CE1' ' A' ' 29' ' ' HIS . . . -77.95 153.58 40.16 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 114.945 -1.025 . . . . 0.51 113.11 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.37 -37.52 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.545 0.338 . . . . 0.67 111.905 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.6 p -80.0 -32.89 39.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.322 0.582 . . . . 1.35 110.731 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 45.5 m -64.67 -32.81 74.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.263 -0.88 . . . . 1.1 109.934 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.9 tp -78.36 58.38 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.452 -0.795 . . . . 1.46 110.846 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' VAL . 39.0 t -44.91 -40.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.64 0.733 . . . . 0.82 110.675 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.58 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 12.1 m120 -87.87 33.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 2.17 111.283 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -61.9 -16.1 48.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.112 0.482 . . . . 1.39 111.064 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -92.15 -9.13 43.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.795 -0.639 . . . . 2.46 111.285 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.31 166.46 15.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 1.89 110.323 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -98.31 52.57 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.428 0.632 . . . . 2.88 109.753 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 97' ' ' VAL . 13.0 tp -60.02 125.48 23.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.828 -1.078 . . . . 0.97 111.591 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -129.95 171.8 12.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 1.77 110.544 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 97' ' ' VAL . 86.5 tttt -70.57 136.02 48.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.268 -0.573 . . . . 1.43 109.564 176.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.29 -9.12 57.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.486 -0.864 . . . . 1.07 111.398 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -91.81 123.34 35.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.334 -0.987 . . . . 1.94 108.334 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.94 146.87 47.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.049 0.452 . . . . 1.79 110.201 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.17 146.54 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.285 0.564 . . . . 1.16 111.504 -172.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 p -111.52 145.42 39.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.268 -0.878 . . . . 1.44 109.663 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -165.38 158.0 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.914 0.388 . . . . 0.61 110.175 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.43 ' HB3' HG21 ' A' ' 88' ' ' VAL . 24.1 mtt180 -125.65 125.26 42.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.399 -0.593 . . . . 2.2 109.399 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 92' ' ' THR . 9.2 tt -99.64 121.85 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 1.24 109.876 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 7.4 p-10 -145.71 -100.7 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.533 -0.303 . . . . 1.92 111.155 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.549 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 1.4 mt-10 -78.86 -29.0 44.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.026 0.441 . . . . 2.76 110.373 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.0 t -74.02 -17.51 60.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.915 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.72 21.99 58.97 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.719 -0.753 . . . . 1.27 112.37 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 158' ' ' ARG . 52.7 mtt180 -140.79 -171.4 3.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.997 -0.742 . . . . 3.61 108.997 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.86 107.74 18.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.606 -0.438 . . . . 0.48 109.862 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -110.33 161.48 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.49 110.109 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.71 36.93 19.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.24 0.543 . . . . 1.55 110.235 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.35 112.16 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.523 0.678 . . . . 1.26 111.12 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.58 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 3.8 t-20 -131.14 114.52 15.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 2.05 110.476 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.41 131.18 49.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.75 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.54 107.28 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.959 -0.564 . . . . 1.56 110.501 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? -87.08 115.05 24.21 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.362 -0.607 . . . . 2.94 109.362 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.873 -0.603 . . . . 3.88 111.553 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.908 -1.042 . . . . 4.04 111.271 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 N-CA-C 112.04 -0.424 . . . . 11.74 112.04 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.48 80.45 8.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.057 0.456 . . . . 10.54 110.314 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.99 111.98 0.66 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.85 -0.614 . . . . 8.95 111.591 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 m -130.31 6.07 4.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.44 0.162 . . . . 7.09 110.979 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -115.79 162.21 17.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.836 0.351 . . . . 5.59 110.569 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.75 -18.34 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.99 110.586 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.04 22.04 70.26 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.148 -0.549 . . . . 1.61 112.693 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -106.53 124.17 49.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 2.0 111.451 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -90.77 115.29 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.643 -0.873 . . . . 1.27 108.643 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CD2' ' HG ' ' A' ' 57' ' ' LEU . 22.8 m-85 -87.79 139.17 30.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.404 0.621 . . . . 1.14 110.786 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 27.8 ttm180 -100.83 130.12 46.8 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.01 -0.995 . . . . 2.31 110.189 -176.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.63 -177.31 26.99 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.378 -0.689 . . . . 0.5 111.378 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -149.21 151.05 33.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.964 0.412 . . . . 0.68 111.064 -177.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.7 123.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.857 -0.61 . . . . 0.56 111.477 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 25' ' ' GLU . . . -106.26 -37.08 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.76 111.584 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 23' ' ' PHE . 6.4 p -144.82 149.65 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.074 -0.512 . . . . 1.55 109.953 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.6 mtp -130.71 107.5 9.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.77 -0.456 . . . . 1.42 109.77 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.22 -168.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.03 109.746 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.72 -44.2 43.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.159 0.504 . . . . 3.24 110.885 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -102.91 -27.93 12.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.545 . . . . 2.03 111.655 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.12 -177.91 6.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.895 0.379 . . . . 1.25 111.756 -172.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.95 160.82 28.54 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.931 -0.577 . . . . 0.71 111.719 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' HB2' HG12 ' A' ' 16' ' ' VAL . 25.9 m-85 -108.38 135.46 49.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.763 -0.458 . . . . 1.08 109.763 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -102.53 125.12 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.61 110.304 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 32.6 tt0 -72.34 117.79 14.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.968 -1.123 . . . . 2.3 107.968 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 31' ' ' GLU . 5.5 p -66.07 157.44 31.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.036 -0.357 . . . . 0.87 110.036 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 17.2 tp -53.23 -36.05 60.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 1.58 111.785 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -110.7 12.61 22.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 2.04 110.054 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.2 p80 40.34 39.81 0.74 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.531 1.132 . . . . 3.29 113.086 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -95.37 -0.87 52.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 2.89 110.472 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HG21 ' A' ' 26' ' ' THR . 28.4 tt0 -156.98 148.08 21.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 1.8 111.248 -170.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.42 121.45 44.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.422 -0.584 . . . . 3.37 109.422 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.4 t -109.47 130.62 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.87 111.44 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 71' ' ' PRO . 14.0 t80 -84.56 120.56 26.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.814 -0.63 . . . . 1.06 110.385 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -124.23 144.96 49.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.367 177.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -116.84 126.92 53.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.716 -0.675 . . . . 1.18 110.101 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -63.93 -20.88 66.19 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.196 0.443 . . . . 0.75 112.196 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.7 t -67.02 -27.23 67.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.62 -0.263 . . . . 1.63 111.517 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -101.93 6.85 41.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.07 111.476 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 79.5 t80 -73.3 129.72 38.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.129 -0.487 . . . . 0.91 110.832 -175.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.5 ttp -98.9 93.09 5.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 1.73 110.389 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.27 -134.77 4.22 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.607 -0.724 . . . . 1.05 111.466 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -132.72 106.02 12.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.721 -0.474 . . . . 2.14 109.721 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.26 -17.85 16.55 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.36 2.04 . . . . 1.01 112.887 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -74.52 -17.01 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.338 0.59 . . . . 2.08 110.357 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -101.03 -2.13 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 2.18 110.844 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 13.1 mt -77.38 146.63 36.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.92 111.736 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.23 173.31 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 2.35 109.66 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.21 130.04 37.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.237 -0.438 . . . . 1.4 110.449 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.97 4.91 58.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.75 112.918 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.4 126.94 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.862 0.331 . . . . 1.06 111.042 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 43.3 mt-10 -72.57 129.97 39.53 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.577 -0.738 . . . . 2.51 110.551 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 77' ' ' MET . 28.5 m -137.92 156.54 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.932 0.396 . . . . 0.44 110.816 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 78' ' ' LEU . 12.9 pt-20 -114.3 138.64 50.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.086 -0.709 . . . . 1.49 109.086 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.425 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.8 p90 -165.3 176.76 8.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.958 0.409 . . . . 0.66 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 p -125.67 145.45 50.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.1 -0.5 . . . . 0.94 110.973 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 10' ' ' TYR . 90.8 mt -73.02 135.39 44.91 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.621 -0.432 . . . . 1.19 110.371 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . . . -80.76 98.52 7.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.531 -0.759 . . . . 2.04 109.724 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD2' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER 37.16 41.44 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.866 1.266 . . . . 5.33 114.318 171.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.78 91.23 4.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.243 0.544 . . . . 5.42 111.012 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.41 30.11 4.12 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.604 -0.726 . . . . 4.76 111.927 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.03 -175.43 3.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 6.38 109.935 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -79.92 -35.85 37.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.642 0.258 . . . . 6.4 111.439 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.1 m 64.69 8.58 4.57 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.049 0.539 . . . . 5.23 112.032 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.11 -23.7 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 6.95 111.488 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.532 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 7.2 m -93.42 2.76 56.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 6.02 110.439 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.53 9.18 57.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 4.09 112.35 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' OD1' ' HB2' ' A' ' 66' ' ' SER . 17.5 m120 -80.88 54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.347 0.594 . . . . 4.22 111.269 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 p -103.5 143.74 32.33 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.448 -0.796 . . . . 2.09 110.279 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 70' ' ' LEU . 1.7 mp -94.01 136.65 23.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.934 -0.765 . . . . 2.3 108.934 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 35.3 Cg_endo -66.01 140.66 61.06 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.019 1.813 . . . . 1.43 111.661 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -58.25 121.22 10.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.493 -0.776 . . . . 0.82 110.593 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.3 148.44 28.99 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.361 0.413 . . . . 2.3 110.842 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.4 t30 59.12 82.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.23 -0.896 . . . . 2.01 110.708 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.49 121.95 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.8 110.253 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -125.97 156.47 39.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.837 -0.431 . . . . 3.51 109.837 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.41 ' HA ' HG12 ' A' ' 53' ' ' VAL . 67.3 mtt -76.91 138.99 40.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.12 110.613 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 54' ' ' GLU . 22.0 tp -113.88 146.0 34.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 1.67 109.255 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.07 155.84 17.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 113.152 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 84.4 tttt -73.35 154.2 40.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.389 -0.823 . . . . 4.61 111.308 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 93.7 m-20 77.36 23.56 0.87 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.622 0.769 . . . . 2.84 110.841 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 m -86.26 -13.08 47.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.863 -0.608 . . . . 1.7 109.512 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 3.5 mm -93.71 130.91 33.46 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.898 -0.778 . . . . 0.92 108.898 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.07 145.91 80.53 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.673 2.248 . . . . 1.03 112.56 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -124.0 137.54 29.1 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 2.76 110.835 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 82.6 Cg_exo -50.23 141.07 32.24 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.692 2.928 . . . . 1.08 113.352 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.58 95.29 5.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 1.1 111.393 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.464 HG11 ' OG1' ' A' ' 92' ' ' THR . 16.7 m -121.54 171.31 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.499 -0.556 . . . . 1.23 109.499 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.47 -63.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.308 -0.557 . . . . 2.87 111.124 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.03 -54.18 3.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.393 0.616 . . . . 2.84 111.269 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t 172.5 163.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.379 -0.971 . . . . 1.42 108.379 -174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.464 ' OG1' HG11 ' A' ' 88' ' ' VAL . 2.1 m -107.18 -59.06 1.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 1.3 111.84 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -148.34 178.04 8.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.573 0.701 . . . . 1.29 111.504 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.42 166.62 23.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.588 -1.264 . . . . 1.36 107.588 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.49 -165.79 30.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.707 -1.235 . . . . 0.53 112.695 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 148' ' ' LEU . 42.0 t -135.7 141.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.547 0.339 . . . . 1.37 110.165 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 66.3 t -59.15 118.99 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.06 -0.348 . . . . 0.69 110.06 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.27 -64.15 1.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 0.89 111.917 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -160.51 158.1 24.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.336 . . . . 3.92 111.862 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.64 177.24 7.09 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.966 2.444 . . . . 2.22 111.038 169.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -126.78 90.65 3.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.444 0.64 . . . . 3.32 112.029 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -80.01 -20.5 45.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 5.56 109.724 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 56.6 m -72.63 -21.27 61.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 4.14 111.084 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.09 -43.78 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.69 0.281 . . . . 3.46 110.352 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.04 114.94 34.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.404 . . . . 4.99 110.329 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.17 -41.25 0.66 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.509 2.139 . . . . 4.27 114.133 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.36 -37.8 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.774 -0.37 . . . . 3.94 110.94 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -124.7 87.98 2.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.138 0.494 . . . . 5.6 110.091 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -65.78 -12.8 57.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.453 0.644 . . . . 5.3 110.947 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.89 5.82 50.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.444 -0.798 . . . . 4.95 111.052 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' OH ' ' HA ' ' A' ' 25' ' ' GLU . 71.9 t80 -54.98 -52.15 63.98 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.789 0.681 . . . . 3.19 110.548 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.602 ' HB3' HD21 ' A' ' 101' ' ' LEU . . . -114.53 -46.05 2.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.38 -0.827 . . . . 1.24 111.76 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 63.57 174.66 3.08 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.97 -0.559 . . . . 0.94 113.035 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 130' ' ' GLU . 55.8 mt -145.49 138.61 26.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.544 0.688 . . . . 0.93 111.715 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.48 138.02 37.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.686 -1.143 . . . . 0.49 109.767 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.62 121.39 29.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.628 . . . . 1.4 109.408 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 129' ' ' HIS . 4.2 mm -103.36 120.45 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.45 -0.795 . . . . 0.63 109.238 -175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -85.18 139.41 31.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 1.21 110.29 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.73 160.9 3.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.147 -0.933 . . . . 2.29 110.218 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.1 -27.0 68.8 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.19 -0.319 . . . . 2.78 111.53 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.05 12.54 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.709 -0.478 . . . . 1.77 109.709 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 48.59 35.91 6.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.794 1.238 . . . . 4.14 111.854 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 20.3 p -75.47 -67.39 0.67 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.608 -0.723 . . . . 1.87 111.118 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.7 p -139.01 172.81 12.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.09 -0.505 . . . . 1.54 111.28 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.6 t -72.92 136.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 1.29 109.474 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -70.98 -69.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.43 -0.508 . . . . 1.03 111.1 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 61.2 m -140.4 -85.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.45 0.643 . . . . 1.56 111.341 172.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -176.5 123.9 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.646 -1.161 . . . . 2.08 108.653 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -111.91 126.93 55.64 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.631 -0.827 . . . . 0.68 110.618 177.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 114' ' ' LEU . 13.3 tt0 -88.1 149.06 24.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.462 -1.244 . . . . 1.19 109.629 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 38.3 p90 -123.7 175.71 6.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.74 110.837 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.443 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -137.44 153.58 22.06 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.625 -0.716 . . . . 0.51 111.564 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 tp -54.24 -23.26 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 117.154 0.477 . . . . 0.67 111.193 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -80.99 -34.4 33.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.323 0.582 . . . . 1.35 110.674 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 36.6 t -76.02 -26.0 56.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.231 -0.895 . . . . 1.1 110.377 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 80.1 mt -75.26 60.22 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.642 . . . . 1.46 112.27 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.5 t -41.41 -49.07 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.827 0.346 . . . . 0.82 111.863 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.56 HD21 HD22 ' A' ' 143' ' ' LEU . 2.7 p-10 -97.47 36.38 1.5 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.721 0.296 . . . . 2.17 111.53 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 13.9 ptpt -51.55 -22.54 3.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.244 0.831 . . . . 1.39 113.244 -177.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -81.66 -20.84 38.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.081 0.467 . . . . 2.46 111.005 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.24 163.36 18.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.641 -0.708 . . . . 1.89 111.431 -173.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.91 100.19 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.804 -0.635 . . . . 2.88 110.276 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 138' ' ' ASN . 7.1 tp -128.11 95.35 4.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.23 -0.655 . . . . 0.97 109.23 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.4 pt20 -130.35 -171.92 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.985 -0.552 . . . . 1.77 110.914 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.9 tttt -60.58 112.99 2.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.039 0.447 . . . . 1.43 110.833 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.02 -2.8 22.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.602 -0.809 . . . . 1.07 112.789 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.58 135.86 33.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.159 0.504 . . . . 1.94 111.095 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.439 HD13 ' CG2' ' A' ' 96' ' ' VAL . 3.1 mm? -81.07 135.96 35.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.043 -0.98 . . . . 1.79 110.147 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.61 151.09 27.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.11 0.481 . . . . 1.16 110.983 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.519 ' OG ' HG11 ' A' ' 165' ' ' VAL . 75.2 m -117.1 143.6 45.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.852 -0.613 . . . . 1.44 109.702 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 30.5 p90 -158.68 173.93 15.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.959 -0.564 . . . . 0.61 109.929 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 124.97 22.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.2 111.261 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 129' ' ' HIS . 12.6 pt -97.2 151.66 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.348 -0.842 . . . . 1.24 109.621 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 35.3 t70 -173.26 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.055 0.222 . . . . 1.92 110.579 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -73.11 -36.5 66.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.957 0.408 . . . . 2.76 111.395 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -82.36 -16.67 48.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 1.98 111.187 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.36 2.08 13.24 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.021 -0.609 . . . . 1.27 112.814 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 153' ' ' ILE . 27.3 mtt85 -130.18 -178.94 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.793 -0.447 . . . . 3.61 109.793 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.43 108.86 18.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.48 111.56 -169.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.558 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.4 156.39 27.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.714 -0.675 . . . . 0.49 109.873 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 64.64 41.1 5.51 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.691 0.619 . . . . 1.55 110.318 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.35 114.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.695 -0.684 . . . . 1.26 110.762 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -123.24 125.51 45.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.377 -0.374 . . . . 2.05 110.44 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.56 120.14 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.75 110.616 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.519 HG11 ' OG ' ' A' ' 150' ' ' SER . 13.6 p -136.37 139.94 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 1.56 111.139 -174.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 139.56 50.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.375 -0.375 . . . . 2.94 110.096 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -136.27 167.27 21.61 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 3.88 109.548 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 116.273 -0.421 . . . . 4.04 110.352 178.395 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 112.227 -0.349 . . . . 11.74 112.227 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.35 115.33 12.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 10.54 110.839 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.42 119.65 0.67 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.752 -0.737 . . . . 8.95 112.128 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -109.99 112.11 23.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.144 -0.317 . . . . 7.09 110.144 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.43 159.02 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.034 -0.53 . . . . 5.59 110.8 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.89 91.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.527 -0.76 . . . . 2.99 110.246 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.52 23.56 72.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.582 -0.735 . . . . 1.61 113.206 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.25 122.58 37.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.148 0.499 . . . . 2.0 111.732 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 123.47 41.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.319 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.62 151.06 22.79 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.649 -0.871 . . . . 1.14 108.649 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -132.54 153.25 51.15 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.726 -0.79 . . . . 2.31 110.828 177.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.44 -153.84 6.7 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.607 -1.397 . . . . 0.5 109.607 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.55 140.84 30.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.942 0.401 . . . . 0.68 111.1 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -64.76 108.42 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.487 -0.779 . . . . 0.56 110.501 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.49 9.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.079 0.466 . . . . 0.76 110.812 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.38 122.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 1.55 110.375 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 45.6 ttm -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.87 -0.419 . . . . 1.42 109.87 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 71.5 mmtt -101.66 -167.08 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.212 -0.449 . . . . 2.03 109.992 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -83.34 -35.14 25.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 3.24 110.781 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.94 -36.91 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.244 0.461 . . . . 2.03 112.244 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 22.0 p90 -138.82 -170.36 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.791 0.329 . . . . 1.25 111.413 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.1 -169.45 31.6 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.399 -0.68 . . . . 0.71 111.399 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -136.46 142.7 43.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.766 -0.457 . . . . 1.08 109.766 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -114.15 120.58 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.61 110.237 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -70.65 119.58 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.976 -0.75 . . . . 2.3 108.976 171.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 31' ' ' GLU . 7.5 p -62.16 155.67 23.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.247 -0.433 . . . . 0.87 110.274 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 17.5 tp -55.01 -34.37 63.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.154 -0.475 . . . . 1.58 111.539 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 p -99.04 6.71 46.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 2.04 111.46 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 p80 40.18 42.28 1.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.147 0.979 . . . . 3.29 112.112 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -116.62 -16.13 10.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 2.89 110.137 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG21 ' A' ' 26' ' ' THR . 9.2 tp10 -132.18 148.51 52.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8 110.021 -175.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -109.37 128.66 55.29 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.731 -0.47 . . . . 3.37 109.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 55' ' ' TYR . 21.8 t -123.61 116.55 48.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 120.847 0.356 . . . . 0.87 111.052 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -73.73 122.49 22.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.697 . . . . 1.06 110.184 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.69 124.11 40.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.732 -0.667 . . . . 1.96 110.675 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 21' ' ' PHE . 5.3 t60 -101.56 142.35 33.05 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.668 -0.864 . . . . 1.18 108.668 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.42 -21.02 62.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.621 -0.432 . . . . 0.75 112.143 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 22.1 t -61.52 -29.63 70.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 1.63 111.246 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -99.95 17.01 22.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.024 0.44 . . . . 2.07 110.482 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -92.51 129.53 38.42 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.187 -0.46 . . . . 0.91 110.257 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.9 ttp -108.8 91.96 3.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 1.73 110.376 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.05 -130.13 1.83 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.332 -0.849 . . . . 1.05 111.073 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' HD1' ' A' ' 46' ' ' TRP . 36.4 t30 -150.12 111.07 3.28 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.328 . . . . 2.14 110.574 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.34 -16.31 27.89 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.859 2.373 . . . . 1.01 113.385 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.96 -16.47 63.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.686 0.279 . . . . 2.08 111.269 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.471 ' HD1' ' ND2' ' A' ' 43' ' ' ASN . 69.6 m95 -115.04 17.52 16.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.539 . . . . 2.18 111.09 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.35 165.5 12.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.92 110.129 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -155.0 166.78 32.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.742 -0.663 . . . . 2.35 109.328 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.6 mm? -69.09 126.28 29.3 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.82 -0.34 62.71 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.749 -0.738 . . . . 0.75 112.438 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -67.43 120.42 13.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.007 0.432 . . . . 1.06 110.72 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 21.9 mt-10 -64.34 122.8 17.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.237 -0.892 . . . . 2.51 110.794 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.9 m -141.53 144.73 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.212 -0.449 . . . . 0.44 109.976 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 19.0 pt-20 -116.17 148.13 40.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.758 -0.377 . . . . 1.49 110.274 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -162.92 177.35 9.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.66 112.003 -171.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.69 166.55 16.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.94 111.021 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.15 137.68 35.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.194 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.62 34.65 0.59 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 2.04 111.064 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -88.85 61.18 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.797 0.808 . . . . 5.33 110.073 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -141.69 168.2 20.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.606 -1.179 . . . . 5.42 108.217 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.74 -68.37 3.55 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.881 -0.676 . . . . 4.76 112.608 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -78.93 168.69 19.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.694 0.283 . . . . 6.38 110.576 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 p -67.67 -31.21 71.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.148 -0.478 . . . . 6.4 111.171 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t 68.15 8.18 6.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.327 -0.851 . . . . 5.23 111.606 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.21 -33.01 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 6.95 110.264 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 p -96.55 5.9 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 6.02 110.464 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.32 90.59 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.965 -0.636 . . . . 4.09 111.713 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -60.79 -47.15 87.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.868 0.366 . . . . 4.22 110.62 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.99 139.49 52.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.591 . . . . 2.09 109.556 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.66 153.49 70.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.358 -0.383 . . . . 2.3 110.6 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.8 155.8 52.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.929 2.42 . . . . 1.43 111.901 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.71 169.5 9.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.989 -0.551 . . . . 0.82 110.262 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.73 172.2 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.768 -0.196 . . . . 2.3 110.607 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.9 m120 60.51 26.6 16.24 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.674 0.609 . . . . 2.01 110.915 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.5 t -70.37 117.66 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.883 -0.599 . . . . 0.8 110.955 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -126.39 157.06 39.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 3.51 110.678 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.505 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.2 mtt -72.4 146.73 46.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.118 -0.492 . . . . 1.12 110.532 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.401 HD12 ' HD2' ' A' ' 79' ' ' PRO . 26.6 tp -119.97 131.23 24.49 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.876 -0.787 . . . . 1.67 108.876 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HD2' HD12 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.42 146.13 64.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.001 1.801 . . . . 2.15 111.849 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 19.5 ptpt -59.47 162.83 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 4.61 110.625 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 8.8 t30 77.5 2.95 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.447 0.641 . . . . 2.84 110.919 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -81.05 -27.65 35.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 1.7 109.655 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.13 116.63 66.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.733 -0.84 . . . . 0.92 108.733 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.58 155.09 40.25 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.552 2.168 . . . . 1.03 112.377 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -113.97 155.03 45.89 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.527 -0.545 . . . . 2.76 109.527 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.493 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 17.0 Cg_exo -65.67 143.12 73.4 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.27 1.98 . . . . 1.08 111.215 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.62 94.56 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 1.1 111.214 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 t -140.96 130.62 25.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.571 -0.74 . . . . 1.23 109.254 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.87 -60.51 1.84 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.131 0.419 . . . . 2.87 112.131 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' O ' ' HB ' ' A' ' 91' ' ' THR . 14.7 pt-20 -90.51 -52.43 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.92 -0.312 . . . . 2.84 111.569 -174.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.8 t 166.1 159.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.613 -0.884 . . . . 1.42 108.613 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.54 -52.02 2.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.196 0.522 . . . . 1.3 110.158 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.99 168.14 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.306 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -125.98 151.55 46.89 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.417 -1.327 . . . . 1.36 107.417 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.18 -173.31 25.45 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.385 -1.388 . . . . 0.53 112.506 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.44 143.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.465 -0.568 . . . . 1.37 109.465 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.24 123.51 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.604 0.24 . . . . 0.69 110.435 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.17 17.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.89 112.033 -173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 12.1 ptm180 -154.23 139.8 12.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.606 -0.437 . . . . 3.92 111.869 -176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 4.8 Cg_exo -80.42 167.76 18.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.956 2.437 . . . . 2.22 111.133 170.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mt -118.82 86.68 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.935 -0.306 . . . . 3.32 111.307 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -102.7 -63.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 5.56 111.994 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 23.1 p -71.88 -26.97 62.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.468 -0.787 . . . . 4.14 112.913 -165.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' A' ' 110' ' ' GLU . 49.6 mt -67.67 -33.59 62.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.404 -0.362 . . . . 3.46 111.738 -173.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 9.2 t30 70.45 134.37 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 123.866 0.728 . . . . 4.99 110.73 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 105' ' ' ASN . 38.2 Cg_endo -64.9 0.78 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.727 2.952 . . . . 4.27 115.517 -171.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.91 -2.25 58.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 3.94 110.92 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.581 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 6.5 tp-100 -107.82 142.82 37.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.586 -0.524 . . . . 5.6 109.586 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -58.63 -23.08 58.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.256 0.551 . . . . 5.3 111.271 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 30.6 tp10 -61.26 -11.98 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.222 -0.899 . . . . 4.95 110.855 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.83 -20.99 25.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.812 0.845 . . . . 3.19 112.122 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.47 -14.53 61.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.407 0.521 . . . . 1.24 112.407 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.3 -178.72 9.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.345 -0.455 . . . . 0.94 113.193 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 130' ' ' GLU . 38.1 mt -152.24 141.01 20.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.292 0.567 . . . . 0.93 111.641 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.3 134.24 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.878 -1.055 . . . . 0.49 109.134 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -86.34 111.04 20.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.67 0.748 . . . . 1.4 109.413 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -90.78 121.34 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.168 -0.924 . . . . 0.63 109.041 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -90.32 150.81 21.75 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.569 -0.453 . . . . 1.21 109.966 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.75 165.1 3.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.144 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.0 pm0 -65.12 -20.35 66.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 2.78 110.174 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.625 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.38 14.28 24.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 1.77 110.277 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 51.02 29.82 4.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.434 1.093 . . . . 4.14 112.118 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -67.53 0.66 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.392 -0.367 . . . . 1.87 111.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 7.3 p -138.24 -171.6 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.578 -0.283 . . . . 1.54 111.175 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 p -92.52 129.88 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.364 -0.606 . . . . 1.29 109.364 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.56 -69.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 1.03 110.629 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.4 m -139.01 -85.97 0.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.147 0.498 . . . . 1.56 110.46 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.5 143.49 0.48 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.873 -1.058 . . . . 2.08 108.596 173.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.646 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.2 m-70 -116.34 124.46 50.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.68 110.335 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -81.94 140.59 33.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.996 . . . . 1.19 109.469 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' A' ' 136' ' ' LEU . 31.6 p90 -115.97 161.01 19.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.195 0.521 . . . . 0.74 111.27 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.43 152.24 17.25 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.813 -0.63 . . . . 0.51 111.663 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.9 tp -55.16 -29.42 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.96 0.409 . . . . 0.67 111.241 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -71.77 -33.7 68.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.451 0.643 . . . . 1.35 110.403 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 161' ' ' CYS . 2.2 m -66.77 -33.11 74.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.287 -0.87 . . . . 1.1 109.983 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 10.9 mp -75.94 57.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.769 -0.65 . . . . 1.46 111.923 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.3 t -46.58 -48.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.239 0.543 . . . . 0.82 110.545 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -93.4 35.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.465 -0.789 . . . . 2.17 110.962 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 9.9 ptpp? -54.36 -23.69 16.53 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.754 1.02 . . . . 1.39 113.754 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -81.44 -6.26 58.76 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.202 -0.311 . . . . 2.46 111.33 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.45 174.93 4.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 1.89 110.471 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -88.94 17.2 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 2.88 110.507 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -46.2 117.73 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.921 -1.036 . . . . 0.97 111.756 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -135.59 -179.94 5.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 1.77 110.675 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.52 129.32 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 1.43 110.026 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.92 64.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.358 -0.925 . . . . 1.07 112.562 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.93 146.12 24.0 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.94 109.575 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.88 134.77 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.181 0.515 . . . . 1.79 111.513 -170.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 m -129.72 148.12 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.836 -0.62 . . . . 1.16 111.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 64.1 m -113.77 140.52 48.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.534 -0.757 . . . . 1.44 109.096 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.688 ' HB3' HG12 ' A' ' 162' ' ' VAL . 25.7 p90 -151.06 165.75 32.86 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.144 -0.48 . . . . 0.61 109.794 -175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 -126.91 119.65 27.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.063 -0.655 . . . . 2.2 110.423 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 158' ' ' ARG . 12.6 pt -102.46 149.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 109.184 -0.673 . . . . 1.24 109.184 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 6.4 t70 -160.69 -93.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.995 -0.282 . . . . 1.92 110.564 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.59 -34.82 27.54 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.767 -0.373 . . . . 2.76 111.519 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.2 t -77.63 -17.7 57.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.672 0.272 . . . . 1.98 110.699 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.61 -14.66 3.25 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.994 -0.622 . . . . 1.27 113.968 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' ILE . 11.0 ptm180 -103.41 175.48 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.296 0.548 . . . . 3.61 110.054 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.27 109.84 18.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.142 0.496 . . . . 0.48 110.423 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.67 154.8 33.49 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.464 -0.789 . . . . 0.49 110.354 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.422 ' H ' ' HA ' ' A' ' 135' ' ' SER . 37.6 m 57.82 47.22 15.71 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.932 0.77 . . . . 1.55 111.325 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.3 m -70.89 128.3 33.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.642 0.734 . . . . 1.26 110.281 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -128.45 125.62 38.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.668 -0.696 . . . . 2.05 109.739 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.43 128.12 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.613 -0.721 . . . . 0.75 110.819 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.22 110.94 29.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.124 0.488 . . . . 1.56 111.468 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.542 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 2.8 mpt_? -94.07 126.49 39.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.747 -0.834 . . . . 2.94 108.747 174.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.72 167.59 20.56 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.0 -0.545 . . . . 3.88 110.924 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 4.04 112.475 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.142 -0.383 . . . . 11.74 112.142 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.57 116.26 9.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.096 0.474 . . . . 10.54 111.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.13 105.3 1.55 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.534 -0.757 . . . . 8.95 111.474 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.0 p -113.07 112.42 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.859 0.361 . . . . 7.09 110.704 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -86.93 169.94 12.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.947 -0.569 . . . . 5.59 110.067 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.91 -21.15 40.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.984 -0.553 . . . . 2.99 110.021 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.84 -29.72 4.49 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.761 -0.654 . . . . 1.61 112.458 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -100.27 118.85 37.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.338 0.59 . . . . 2.0 111.218 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.31 126.56 44.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.857 -1.065 . . . . 1.27 109.229 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -98.55 137.94 36.47 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.38 -0.6 . . . . 1.14 109.38 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 35.0 ttm180 -112.42 143.25 43.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.863 -0.421 . . . . 2.31 109.863 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.27 -170.24 22.74 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.67 -0.776 . . . . 0.5 111.591 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 139.74 42.29 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.662 0.268 . . . . 0.68 110.369 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.94 118.08 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.56 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.08 -56.65 2.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.614 0.245 . . . . 0.76 111.002 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.93 160.87 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.154 -0.313 . . . . 1.55 110.154 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.1 ttm -141.61 112.29 7.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.268 -0.424 . . . . 1.42 111.035 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 175.95 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.499 -0.556 . . . . 2.03 109.499 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.75 -34.76 76.4 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.581 0.551 . . . . 3.24 111.539 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -111.13 -47.45 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.205 0.446 . . . . 2.03 112.205 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -130.15 169.39 15.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.162 0.506 . . . . 1.25 111.627 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.72 -174.09 23.56 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.71 111.489 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' HB3' ' OE1' ' A' ' 32' ' ' GLU . 48.4 m-85 -129.04 154.4 46.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.119 -0.326 . . . . 1.08 110.119 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mt -133.79 122.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.61 110.316 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -69.0 119.5 13.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.817 -0.438 . . . . 2.3 109.817 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 p -57.6 141.47 48.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 0.87 109.911 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -50.0 -46.25 52.54 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.536 . . . . 1.58 110.708 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -85.81 18.05 3.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.656 . . . . 2.04 111.65 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 p80 43.13 36.2 0.93 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.128 0.971 . . . . 3.29 111.907 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -70.05 -50.99 35.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.274 -0.875 . . . . 2.89 110.382 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.43 -174.59 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 1.8 110.53 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 23' ' ' PHE . 1.1 mm-40 -102.75 145.23 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.974 -0.557 . . . . 3.37 109.976 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG11 ' HE2' ' A' ' 55' ' ' TYR . 20.8 t -122.44 120.54 61.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.21 0.528 . . . . 0.87 111.21 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -74.2 116.91 15.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.364 -0.834 . . . . 1.06 110.392 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -121.99 151.18 41.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.281 -0.637 . . . . 1.96 109.281 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -110.31 128.86 55.75 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.349 -0.611 . . . . 1.18 109.349 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.06 -20.15 65.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 0.75 110.871 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -59.96 -34.83 73.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.555 . . . . 1.63 111.699 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -102.96 -0.54 30.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.028 0.442 . . . . 2.07 110.615 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 54.6 t80 -72.01 128.66 36.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.91 110.213 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.4 ttp -102.21 111.55 23.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.042 0.448 . . . . 1.73 110.239 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 44' ' ' PRO . . . 147.14 -171.87 27.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.687 -0.688 . . . . 1.05 111.429 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.69 105.25 19.66 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.22 -0.289 . . . . 2.14 110.22 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 42' ' ' GLY . 10.0 Cg_exo -66.99 -30.34 39.31 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.469 2.113 . . . . 1.01 112.354 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -70.43 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 2.08 111.19 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.95 7.32 44.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.114 0.483 . . . . 2.18 110.58 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.41 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 20.6 mt -88.16 141.61 28.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.183 0.516 . . . . 0.92 111.306 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -120.92 158.41 27.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.821 . . . . 2.35 109.274 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.78 114.76 12.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.184 -0.672 . . . . 1.4 109.184 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.72 32.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.027 -0.606 . . . . 0.75 112.226 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -65.8 137.39 57.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 1.06 110.67 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.523 ' HG3' HD13 ' A' ' 83' ' ' ILE . 12.9 tt0 -78.63 125.73 29.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.361 -0.836 . . . . 2.51 110.274 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -141.8 155.45 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.176 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.1 148.14 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.968 0.413 . . . . 1.49 110.308 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -159.34 173.66 15.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.975 -0.557 . . . . 0.66 110.81 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 p -127.96 142.81 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.488 -0.324 . . . . 0.94 110.961 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.53 121.92 20.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 120.881 0.372 . . . . 1.19 110.263 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -77.21 -30.34 54.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.529 -0.759 . . . . 2.04 111.485 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD3' HD21 ' A' ' 70' ' ' LEU . 7.5 tpp180 58.44 34.67 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.851 0.834 . . . . 5.33 109.552 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.7 97.1 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.211 -0.904 . . . . 5.42 109.921 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.52 -169.06 32.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.954 -0.641 . . . . 4.76 112.777 -176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 65.13 19.8 11.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 6.38 111.113 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -112.74 -0.75 14.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.408 -0.814 . . . . 6.4 109.871 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 14.1 m -70.24 1.04 5.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.649 -0.705 . . . . 5.23 112.246 -174.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.07 -23.6 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.48 . . . . 6.95 110.824 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 m -120.91 9.66 10.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 6.02 110.853 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' SER . . . 176.09 133.5 1.79 Allowed Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.512 -0.635 . . . . 4.09 111.512 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -61.39 -45.26 95.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.127 0.489 . . . . 4.22 110.659 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.4 m -97.64 144.11 27.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.829 -0.623 . . . . 2.09 110.301 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 ' HD3' ' A' ' 59' ' ' ARG . 1.1 pp -88.28 151.93 49.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 2.3 110.865 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.76 150.14 78.9 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.779 2.319 . . . . 1.43 113.357 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.94 147.72 25.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.114 -0.948 . . . . 0.82 109.292 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 10.5 pt-20 -125.98 176.43 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.108 -0.237 . . . . 2.3 110.508 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.41 28.08 15.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.627 0.727 . . . . 2.01 109.756 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 17.4 t -66.99 119.0 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.808 . . . . 0.8 109.841 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -133.2 140.3 47.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.998 -0.547 . . . . 3.51 111.644 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.466 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.3 mtt -71.6 149.46 45.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.12 110.485 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -145.9 163.31 31.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 1.67 109.445 170.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 24.7 Cg_exo -64.73 161.88 34.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.1 1.866 . . . . 2.15 112.216 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.45 -169.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 4.61 111.514 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t30 78.74 19.74 0.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.202 -0.908 . . . . 2.84 112.444 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -93.99 -39.27 10.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.199 -0.667 . . . . 1.7 109.199 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.523 HD13 ' HG3' ' A' ' 52' ' ' GLU . 2.3 mp -84.07 119.54 73.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.639 -0.71 . . . . 0.92 110.399 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.09 161.16 32.83 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.462 2.775 . . . . 1.03 112.565 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -93.12 153.97 41.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.414 -0.515 . . . . 2.76 110.188 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.16 164.1 23.7 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.649 2.233 . . . . 1.08 111.265 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.43 91.32 3.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.33 0.586 . . . . 1.1 111.627 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.47 153.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.953 -1.128 . . . . 1.23 107.953 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 -61.42 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.424 -0.511 . . . . 2.87 111.408 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 91' ' ' THR . 9.4 tp10 -92.17 -56.22 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 2.84 111.242 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t 167.17 165.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.283 -1.006 . . . . 1.42 108.283 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 m -106.79 -54.8 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.578 -0.449 . . . . 1.3 111.111 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -146.7 157.1 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 1.29 110.591 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.89 -179.53 3.72 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.558 -0.904 . . . . 1.36 108.558 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.99 -167.6 40.14 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.731 -1.223 . . . . 0.53 112.237 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.74 142.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.925 -0.768 . . . . 1.37 108.925 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 122.52 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.693 0.283 . . . . 0.69 110.712 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -72.94 -54.22 9.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.89 109.872 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 73.3 ttt180 177.74 130.03 0.2 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.558 0.536 . . . . 3.92 111.8 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 1.1 Cg_endo -85.67 130.51 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.149 2.566 . . . . 2.22 110.392 166.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' CD2' ' HA2' ' A' ' 113' ' ' GLY . 0.4 OUTLIER -128.55 102.48 6.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 112.491 0.552 . . . . 3.32 112.491 -172.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -97.55 -36.42 10.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.095 0.474 . . . . 5.56 111.116 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.3 p -92.66 -46.45 7.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.445 0.906 . . . . 4.14 113.445 -169.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.454 ' H ' HG12 ' A' ' 104' ' ' ILE . 9.3 pt -68.9 -44.82 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 114.576 1.325 . . . . 3.46 114.576 -164.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -138.75 89.55 13.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.401 -0.52 . . . . 4.99 111.907 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 95.9 Cg_endo -88.85 -8.16 5.11 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.909 2.406 . . . . 4.27 112.437 175.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.01 7.19 43.6 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.128 -0.487 . . . . 3.94 110.879 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -114.76 142.36 46.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.297 -0.41 . . . . 5.6 110.812 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -47.35 -38.9 13.85 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.762 0.825 . . . . 5.3 112.508 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 1.5 pt-20 -85.09 16.0 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 4.95 112.295 -173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.479 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 49.1 t80 -47.93 -30.78 4.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.161 0.8 . . . . 3.19 113.161 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.44 -35.53 63.36 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.663 0.616 . . . . 1.24 112.663 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 101' ' ' LEU . . . 124.12 149.03 7.6 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.501 -0.857 . . . . 0.94 111.698 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.2 mt -131.54 154.4 48.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.384 0.612 . . . . 0.93 111.743 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.84 136.6 53.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.981 -1.009 . . . . 0.49 108.82 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.04 110.72 19.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.574 0.702 . . . . 1.4 109.7 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.0 mm -85.43 130.42 36.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.829 -1.078 . . . . 0.63 109.996 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.12 146.34 26.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.81 0.338 . . . . 1.21 110.333 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.19 165.06 9.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.29 110.429 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.533 ' HG3' HD22 ' A' ' 121' ' ' LEU . 11.3 pt-20 -60.25 -25.56 65.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.787 0.292 . . . . 2.78 111.787 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.533 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.67 13.92 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.906 -0.318 . . . . 1.77 110.604 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 39.71 76.67 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.399 1.08 . . . . 4.14 112.318 -175.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.2 p -124.91 -68.55 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.144 -0.934 . . . . 1.87 111.237 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 m -124.17 166.64 15.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 1.54 110.477 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.7 p -73.39 133.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.156 -0.313 . . . . 1.29 110.156 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.48 -69.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.601 -0.272 . . . . 1.03 111.045 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -138.06 -85.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 1.56 110.918 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -175.75 137.09 0.34 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.328 -0.851 . . . . 2.08 108.865 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.777 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.3 m-70 -121.32 133.89 55.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.58 -0.526 . . . . 0.68 109.58 172.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -90.37 152.87 20.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.589 -0.732 . . . . 1.19 109.884 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -117.97 135.48 54.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.291 0.567 . . . . 0.74 110.838 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.29 151.34 21.42 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.396 -0.82 . . . . 0.51 111.734 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.45 -33.64 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.67 110.718 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.7 t -76.29 -30.22 57.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.481 -0.781 . . . . 1.35 110.203 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' VAL . 24.8 m -76.14 -24.18 54.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.753 -0.658 . . . . 1.1 110.159 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.5 mt -71.2 58.26 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.443 -0.798 . . . . 1.46 111.459 176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.3 t -47.24 -47.13 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.436 0.636 . . . . 0.82 110.403 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 15.6 m120 -92.38 34.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.563 -0.744 . . . . 2.17 111.622 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 8.9 ptpp? -61.21 -21.3 63.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.675 0.274 . . . . 1.39 111.726 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -89.06 -2.4 58.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 2.46 111.248 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.83 148.76 24.52 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.428 -0.953 . . . . 1.89 108.428 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.95 92.42 3.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.66 0.743 . . . . 2.88 110.077 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.3 tp -113.31 105.71 13.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.675 -1.148 . . . . 0.97 110.064 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -128.45 -171.35 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.889 -0.324 . . . . 1.77 111.65 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 56.8 tttm -64.01 110.42 2.13 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.31 -0.405 . . . . 1.43 111.138 -175.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.47 -6.69 20.75 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.486 -0.864 . . . . 1.07 112.386 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.56 142.19 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 1.94 110.898 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.31 140.03 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 1.79 111.221 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.65 153.34 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.16 111.772 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -118.29 144.8 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.763 . . . . 1.44 108.983 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.574 ' HB3' HG12 ' A' ' 162' ' ' VAL . 33.8 p90 -158.47 176.86 11.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.016 0.436 . . . . 0.61 110.767 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -135.21 123.8 23.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 2.2 111.286 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.92 122.7 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.261 -0.881 . . . . 1.24 109.332 167.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 4.9 p-10 -152.9 -94.72 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.109 -0.237 . . . . 1.92 110.835 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.493 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 39.3 mm-40 -82.53 -17.32 45.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 2.76 109.233 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 -19.06 35.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.99 -1.004 . . . . 1.98 111.2 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.1 6.5 10.18 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.954 -0.566 . . . . 1.27 113.99 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.12 -167.51 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.852 -0.795 . . . . 3.61 108.852 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.6 18.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.415 -0.587 . . . . 0.48 109.415 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.43 155.21 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.188 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 70.4 m 58.7 37.89 25.06 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.833 0.708 . . . . 1.55 110.837 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 151' ' ' PHE . 33.1 m -65.02 117.76 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.766 0.793 . . . . 1.26 110.329 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.465 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.8 p30 -118.1 123.4 45.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.686 -0.688 . . . . 2.05 110.275 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.435 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -66.16 103.42 0.97 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.335 -0.848 . . . . 0.75 110.831 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.74 110.24 20.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.691 0.758 . . . . 1.56 110.86 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 7.5 mpt_? -83.13 114.39 21.29 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.776 -0.824 . . . . 2.94 108.776 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -106.84 167.7 9.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 3.88 110.981 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.884 -1.053 . . . . 4.04 110.376 176.701 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.12 -0.392 . . . . 11.74 112.12 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.92 178.26 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.466 -0.198 . . . . 10.54 110.466 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.63 138.78 27.83 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 8.95 112.415 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 m -140.6 137.28 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.787 -0.449 . . . . 7.09 109.787 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -70.41 118.09 12.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.3 0.572 . . . . 5.59 110.302 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.16 46.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.804 -0.635 . . . . 2.99 111.231 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.89 23.52 71.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 1.61 112.491 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -92.83 119.58 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 2.0 111.392 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.39 122.52 39.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.805 . . . . 1.27 109.163 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.23 137.52 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.12 -0.491 . . . . 1.14 110.005 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.522 HH11 ' CD2' ' A' ' 78' ' ' LEU . 21.6 ttm-85 -106.44 129.54 54.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.384 -0.825 . . . . 2.31 109.963 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.71 -171.33 22.75 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.795 -0.717 . . . . 0.5 111.765 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.7 148.51 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 0.68 111.075 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.41 118.68 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.513 -0.767 . . . . 0.56 110.791 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.85 -37.94 6.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.76 111.091 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.5 p -130.99 122.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.274 0.559 . . . . 1.55 110.861 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.99 106.24 18.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.429 -0.952 . . . . 1.42 108.429 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 14.7 tppt? -98.4 170.8 8.6 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.067 -0.716 . . . . 2.03 109.067 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 62.5 mt-10 -65.98 -38.64 89.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.169 0.433 . . . . 3.24 112.169 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -112.1 -41.32 3.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.088 0.47 . . . . 2.03 111.524 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.612 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 42.7 p90 -131.0 -161.53 1.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.052 -0.522 . . . . 1.25 110.195 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.91 -177.57 40.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.97 . . . . 0.71 112.245 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.634 ' H ' HG13 ' A' ' 16' ' ' VAL . 75.2 m-85 -125.26 130.3 51.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.598 -0.519 . . . . 1.08 109.598 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -102.9 134.08 44.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.267 -0.642 . . . . 0.61 109.267 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.71 143.33 30.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.933 -1.136 . . . . 2.3 107.933 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 p -67.66 -173.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.035 0.445 . . . . 0.87 110.523 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -81.96 -47.05 13.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.099 0.475 . . . . 1.58 110.658 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -102.68 22.54 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.445 0.535 . . . . 2.04 112.445 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 56.06 58.19 4.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.228 0.537 . . . . 3.29 109.785 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 -44.09 5.85 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.48 -0.782 . . . . 2.89 110.714 -172.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.91 167.34 20.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.04 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -103.6 127.81 50.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.062 0.458 . . . . 3.37 110.551 -175.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.546 HG11 ' HE2' ' A' ' 55' ' ' TYR . 12.1 t -110.27 131.5 61.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.87 111.245 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -89.9 123.81 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.566 -0.743 . . . . 1.06 110.081 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -124.06 153.8 40.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.214 -0.662 . . . . 1.96 109.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -116.11 131.96 56.79 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.939 -0.763 . . . . 1.18 108.939 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 25.8 m-85 -58.7 -27.82 65.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.5 m -65.63 -36.5 83.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.541 0.21 . . . . 1.63 111.449 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -83.85 3.76 32.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.939 0.399 . . . . 2.07 110.981 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 64.9 t80 -83.59 140.44 32.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.891 -0.595 . . . . 0.91 110.091 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.5 ttp -116.52 116.43 27.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.122 0.487 . . . . 1.73 110.334 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.05 -151.49 22.9 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.655 . . . . 1.05 111.678 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -105.19 103.55 42.69 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.633 0.254 . . . . 2.14 110.855 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.03 -27.12 25.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.46 2.107 . . . . 1.01 113.119 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.82 1.0 45.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.975 0.416 . . . . 2.08 111.295 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -110.51 14.55 22.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.475 0.655 . . . . 2.18 109.674 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.5 mt -97.61 152.95 18.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.039 -0.982 . . . . 0.92 110.825 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.0 -178.32 6.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.754 -0.657 . . . . 2.35 109.238 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.7 mt -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.783 0.325 . . . . 1.4 111.414 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.0 -1.59 24.23 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.922 -0.656 . . . . 0.75 113.182 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.69 122.5 23.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.866 0.333 . . . . 1.06 110.98 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.0 mt-10 -61.59 132.86 54.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.609 -0.723 . . . . 2.51 110.373 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 77' ' ' MET . 25.9 m -140.83 148.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.44 110.207 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -114.63 142.71 46.1 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.268 -0.642 . . . . 1.49 109.268 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HE2' HG11 ' A' ' 33' ' ' VAL . 5.8 p90 -162.13 170.82 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.103 0.478 . . . . 0.66 111.559 -175.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 p -125.52 167.7 14.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.94 111.182 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.13 153.02 28.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 1.19 109.994 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -96.2 -33.54 11.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.358 0.599 . . . . 2.04 110.969 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.481 ' CB ' HD22 ' A' ' 70' ' ' LEU . 99.4 mtt180 -91.57 56.34 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.324 -0.853 . . . . 5.33 110.498 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.06 131.36 48.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 5.42 110.215 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.43 154.91 6.45 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.883 -0.887 . . . . 4.76 110.883 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -79.41 74.76 6.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.405 0.621 . . . . 6.38 110.823 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -121.12 -0.04 10.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.33 -0.85 . . . . 6.4 110.277 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 34.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.626 0.727 . . . . 5.23 110.036 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.44 -24.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.527 -0.76 . . . . 6.95 110.332 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -85.81 -15.53 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 6.02 111.214 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.77 51.73 1.62 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.584 -0.817 . . . . 4.09 111.821 -175.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -131.81 86.62 2.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.189 -0.671 . . . . 4.22 109.189 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.93 144.83 17.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.411 -0.813 . . . . 2.09 111.578 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD22 ' CB ' ' A' ' 59' ' ' ARG . 17.9 mt -122.0 138.48 28.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.734 -0.666 . . . . 2.3 110.244 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.68 149.16 37.89 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.445 2.097 . . . . 1.43 111.823 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.48 36.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 0.82 111.116 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 79.8 mm-40 -119.59 143.78 47.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 2.3 110.436 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.5 t30 59.87 80.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 2.01 110.846 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.3 t -109.4 122.68 64.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.075 -0.512 . . . . 0.8 110.075 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.32 147.24 51.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.576 -0.283 . . . . 3.51 110.747 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.459 ' HA ' HG12 ' A' ' 53' ' ' VAL . 64.1 mtt -66.88 150.37 49.28 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.21 0.528 . . . . 1.12 111.467 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.522 ' CD2' HH11 ' A' ' 11' ' ' ARG . 19.1 tp -147.6 75.96 11.0 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.114 -0.948 . . . . 1.67 110.771 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -90.24 117.99 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.791 1.661 . . . . 2.15 112.716 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -174.05 6.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.117 0.414 . . . . 4.61 112.117 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 t30 57.7 50.56 10.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.027 0.917 . . . . 2.84 108.866 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.0 t -73.64 -10.44 59.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.554 -1.203 . . . . 1.7 109.937 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.638 HD12 ' CD2' ' A' ' 27' ' ' LEU . 6.2 mm -78.22 128.25 78.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.695 . . . . 0.92 109.469 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.1 159.66 48.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.083 2.522 . . . . 1.03 112.904 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -117.55 149.3 44.65 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.73 -0.668 . . . . 2.76 110.382 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.7 149.27 43.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 1.08 111.906 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.04 94.05 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.54 . . . . 1.1 110.603 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 152' ' ' ARG . 21.6 t -139.24 144.37 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.715 -0.846 . . . . 1.23 108.715 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.2 mt -88.22 -64.12 1.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.476 -0.49 . . . . 2.87 111.872 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 91' ' ' THR . 33.5 mt-10 -95.25 -53.82 3.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.357 0.599 . . . . 2.84 110.676 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.2 t 172.0 166.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.769 -1.105 . . . . 1.42 108.114 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -105.66 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.295 -0.562 . . . . 1.3 111.424 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -141.71 171.76 13.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.281 0.562 . . . . 1.29 111.36 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.72 158.09 45.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.018 -1.105 . . . . 1.36 108.018 172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.43 -166.97 28.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.725 -1.226 . . . . 0.53 112.293 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.11 145.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.579 -0.526 . . . . 1.37 109.579 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 84.8 t -60.92 126.73 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.627 -0.26 . . . . 0.69 110.846 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.9 -48.59 17.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.89 110.344 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -174.61 143.82 0.86 Allowed Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 121.018 0.437 . . . . 3.92 111.962 175.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.22 177.4 7.21 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.17 2.58 . . . . 2.22 110.659 167.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.8 OUTLIER -118.94 90.14 3.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.291 0.478 . . . . 3.32 112.291 -173.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -98.34 -62.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.362 0.601 . . . . 5.56 110.069 166.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 3.8 p -91.83 10.49 28.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 4.14 111.889 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 47.8 mm -79.38 -22.13 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 3.46 110.48 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 8.8 t-20 73.07 127.65 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 O-C-N 123.817 0.698 . . . . 4.99 111.229 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 -14.74 30.02 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.999 2.466 . . . . 4.27 113.224 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -80.46 -12.3 59.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.382 0.611 . . . . 3.94 109.699 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 6.6 tp-100 -83.06 141.36 32.09 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.609 -0.723 . . . . 5.6 109.385 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.77 1.74 14.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.352 . . . . 5.3 111.532 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.52 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 46.3 mt-10 -85.82 12.87 8.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.801 -0.444 . . . . 4.95 109.801 173.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.548 ' OH ' ' HB ' ' A' ' 16' ' ' VAL . 53.5 t80 -55.52 -34.14 64.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 3.19 112.894 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.79 -25.57 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.759 0.314 . . . . 1.24 111.844 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 161.08 36.03 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.499 -0.858 . . . . 0.94 111.508 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 130' ' ' GLU . 36.7 mt -143.44 141.47 30.84 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.628 0.727 . . . . 0.93 112.405 -174.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.9 mt -114.16 139.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.494 -1.23 . . . . 0.49 108.817 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.46 136.35 33.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.173 -0.611 . . . . 1.4 110.206 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 129' ' ' HIS . 22.0 mm -105.75 131.81 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.803 -0.635 . . . . 0.63 109.541 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 118' ' ' LEU . 1.7 pt? -85.55 150.13 24.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.559 -0.291 . . . . 1.21 110.559 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.42 166.85 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.468 . . . . 2.29 110.109 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.49 -26.89 63.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.78 110.648 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 1.1 mm? -91.3 11.87 22.21 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.163 -0.471 . . . . 1.77 110.632 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 4.2 ptp180 47.05 32.89 2.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.982 0.913 . . . . 4.14 112.537 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 p -95.59 -73.0 0.6 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 1.87 112.018 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -179.68 3.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.585 0.231 . . . . 1.54 111.488 -176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -91.36 139.45 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.048 -0.523 . . . . 1.29 109.961 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mt -76.1 -69.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.579 -0.448 . . . . 1.03 110.675 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -138.02 -87.22 0.26 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.076 0.465 . . . . 1.56 110.426 168.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.74 146.85 0.46 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.084 -0.962 . . . . 2.08 109.109 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.473 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -118.8 136.79 53.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.317 0.58 . . . . 0.68 111.119 176.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 20.6 tt0 -86.66 143.53 27.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.707 -1.133 . . . . 1.19 109.897 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -120.41 140.44 51.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.221 0.534 . . . . 0.74 110.713 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.29 154.04 22.1 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.616 -0.72 . . . . 0.51 112.187 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -55.38 -22.0 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.469 0.652 . . . . 0.67 111.013 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -79.19 -37.19 38.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.749 -0.659 . . . . 1.35 110.212 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 162' ' ' VAL . 14.5 m -68.61 -33.47 74.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.322 -0.854 . . . . 1.1 110.517 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.62 58.52 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.46 111.544 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -48.86 -39.11 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.178 0.514 . . . . 0.82 110.88 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.513 HD21 HD22 ' A' ' 143' ' ' LEU . 3.1 p-10 -84.99 33.16 0.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 2.17 111.283 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -61.95 -18.79 61.55 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.123 0.487 . . . . 1.39 111.418 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -76.58 -22.29 54.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 2.46 110.885 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.45 155.15 17.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.829 -0.623 . . . . 1.89 111.933 -169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.403 -0.817 . . . . 2.88 109.505 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.517 HD21 ' CG1' ' A' ' 149' ' ' VAL . 10.6 tp -145.46 119.52 9.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.644 -0.502 . . . . 0.97 109.644 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.6 pt20 -133.36 -173.23 3.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.839 0.352 . . . . 1.77 111.355 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 54.5 tttm -61.78 114.51 3.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.43 110.499 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.98 -10.34 15.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.856 -0.687 . . . . 1.07 112.256 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.4 133.12 33.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 1.94 110.508 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.9 142.02 28.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.963 -0.562 . . . . 1.79 111.186 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.517 ' CG1' HD21 ' A' ' 143' ' ' LEU . 30.7 m -139.02 158.52 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.315 0.579 . . . . 1.16 111.748 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 8.4 t -115.12 148.01 39.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.339 -0.986 . . . . 1.44 108.339 171.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.64 ' HB3' HG12 ' A' ' 162' ' ' VAL . 18.8 p90 -159.99 163.03 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.61 111.035 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -124.36 121.5 35.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.267 0.556 . . . . 2.2 110.71 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 92' ' ' THR . 3.7 tt -101.66 133.08 46.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.28 -0.873 . . . . 1.24 110.224 171.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.561 ' OD2' ' HG2' ' A' ' 155' ' ' GLU . 21.9 t70 -168.08 -88.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.366 -0.134 . . . . 1.92 111.25 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG2' ' OD2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -68.63 -32.27 72.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.866 0.365 . . . . 2.76 111.323 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 p -83.83 -16.38 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.011 -0.54 . . . . 1.98 111.147 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.3 15.05 60.57 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.988 -0.625 . . . . 1.27 112.752 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.421 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 48.4 mtm180 -151.14 -165.0 2.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.462 . . . . 3.61 109.754 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.29 116.27 24.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.48 111.204 -173.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.576 -0.738 . . . . 0.49 109.632 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 55.02 56.31 6.72 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.744 0.653 . . . . 1.55 111.128 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 151' ' ' PHE . 10.3 m -80.92 146.1 7.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.984 -0.376 . . . . 1.26 109.984 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -148.1 141.6 25.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.907 0.384 . . . . 2.05 110.411 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.24 24.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.75 111.095 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.53 127.92 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.413 -0.358 . . . . 1.56 110.518 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? -95.65 114.99 26.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.181 -0.674 . . . . 2.94 109.181 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -98.21 114.5 26.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.084 -0.507 . . . . 3.88 110.715 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.45 -0.796 . . . . 4.04 110.423 -178.292 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 N-CA-C 112.027 -0.429 . . . . 11.74 112.027 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.87 106.28 3.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 10.54 110.673 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.57 14.24 62.12 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.152 -0.547 . . . . 8.95 112.475 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 t -84.48 99.7 10.87 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.319 -0.623 . . . . 7.09 109.319 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.1 122.13 37.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.004 -0.544 . . . . 5.59 111.239 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.92 -23.93 52.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.106 -0.701 . . . . 2.99 109.106 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.86 -29.24 8.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.167 -0.924 . . . . 1.61 113.116 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -108.85 119.8 40.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.278 0.561 . . . . 2.0 112.138 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.92 118.02 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.178 -1.045 . . . . 1.27 108.178 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -87.43 138.28 31.61 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.948 -0.569 . . . . 1.14 110.162 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -106.56 131.62 53.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.533 -0.758 . . . . 2.31 109.286 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.09 -170.8 20.43 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.874 -0.891 . . . . 0.5 110.874 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.96 148.52 32.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.68 111.724 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.9 115.39 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.355 -0.838 . . . . 0.56 110.642 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.01 -26.92 12.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.873 -0.331 . . . . 0.76 110.891 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.29 140.15 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.687 -0.486 . . . . 1.55 109.687 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.9 tpp -125.43 106.09 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 1.42 110.32 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 63.3 mttt -112.08 172.45 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.284 -0.416 . . . . 2.03 110.99 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.14 -45.58 79.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.903 0.705 . . . . 3.24 112.903 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -110.02 -43.04 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.343 0.497 . . . . 2.03 112.343 -174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 43.5 p90 -132.44 168.2 18.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.789 0.328 . . . . 1.25 111.003 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.19 159.93 28.06 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.374 -0.69 . . . . 0.71 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.93 126.87 52.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.574 -0.528 . . . . 1.08 109.574 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.37 124.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.323 -0.621 . . . . 0.61 109.323 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 9.9 tp10 -82.3 133.3 35.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.968 -0.753 . . . . 2.3 108.968 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -62.82 154.69 29.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.358 -0.837 . . . . 0.87 110.648 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 83' ' ' ILE . 13.2 tp -47.66 -42.68 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 1.58 112.568 -175.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -111.8 18.29 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.274 -0.421 . . . . 2.04 111.811 -174.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.553 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 15.6 m-70 57.46 58.78 3.62 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 3.29 110.415 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -96.87 -47.24 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.283 -0.871 . . . . 2.89 110.869 -174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -158.22 -174.39 4.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 1.8 111.009 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -102.29 123.68 46.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 3.37 110.753 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 ' HE2' ' A' ' 55' ' ' TYR . 17.9 t -111.82 107.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.933 0.397 . . . . 0.87 110.821 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.24 123.41 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.186 0.517 . . . . 1.06 109.759 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -128.13 134.38 49.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.96 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 125.02 47.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.888 -0.782 . . . . 1.18 108.888 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -60.24 -16.75 36.53 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.292 0.478 . . . . 0.75 112.292 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -59.71 -15.48 20.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.25 -0.432 . . . . 1.63 111.715 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -109.43 12.7 24.47 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.665 0.269 . . . . 2.07 111.401 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -82.11 133.42 35.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.722 0.296 . . . . 0.91 110.223 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 ttm -91.97 100.64 13.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.952 0.406 . . . . 1.73 110.613 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.32 -146.02 16.81 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.003 -0.618 . . . . 1.05 112.11 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -112.71 104.74 56.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.689 0.28 . . . . 2.14 110.602 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.82 -5.18 16.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.836 2.358 . . . . 1.01 112.292 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.21 -6.25 46.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.763 -0.653 . . . . 2.08 111.173 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.58 14.0 17.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.18 110.924 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.77 148.78 23.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.005 -0.543 . . . . 0.92 110.579 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -145.0 177.22 8.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.928 -0.578 . . . . 2.35 110.107 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.9 mm? -72.25 123.29 22.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.533 . . . . 1.4 110.944 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.1 1.59 48.31 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.955 -0.566 . . . . 0.75 112.551 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.13 123.74 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.812 0.339 . . . . 1.06 110.657 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.31 140.87 45.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.808 -0.633 . . . . 2.51 111.186 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.82 154.27 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.44 110.684 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.87 134.29 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.648 -0.871 . . . . 1.49 108.648 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.559 ' CB ' HG22 ' A' ' 75' ' ' VAL . 3.5 p90 -164.9 175.89 9.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.527 0.566 . . . . 0.66 112.527 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 p -126.32 173.6 9.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.518 -0.764 . . . . 0.94 111.113 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -108.62 144.72 35.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 1.19 111.019 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.86 37.34 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 2.04 111.439 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -90.39 61.23 4.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.322 -0.622 . . . . 5.33 109.322 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -74.14 -74.14 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.764 . . . . 5.42 110.929 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.52 146.89 9.46 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.876 -0.678 . . . . 4.76 111.42 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 179.92 173.62 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.338 -0.986 . . . . 6.38 108.338 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.9 p -70.29 -27.62 64.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.262 -0.644 . . . . 6.4 109.262 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t 68.45 7.1 5.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 114.714 -1.13 . . . . 5.23 111.216 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.2 m -75.46 -23.64 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.22 0.533 . . . . 6.95 110.079 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 p -104.28 5.2 34.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.564 -0.744 . . . . 6.02 110.902 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.62 101.73 0.2 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.694 -0.765 . . . . 4.09 112.577 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -87.86 -48.82 7.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.056 -0.72 . . . . 4.22 109.056 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.5 133.65 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.36 -0.836 . . . . 2.09 108.775 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.04 150.25 43.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.671 -0.241 . . . . 2.3 110.932 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.4 148.84 84.7 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.571 2.181 . . . . 1.43 111.762 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.04 156.68 20.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.82 110.566 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.17 166.53 24.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.696 -0.229 . . . . 2.3 110.807 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 55.55 76.53 0.27 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.892 0.745 . . . . 2.01 110.611 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.0 t -115.84 120.3 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.72 -0.673 . . . . 0.8 110.664 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -117.26 151.41 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.416 -0.587 . . . . 3.51 109.416 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtm -87.26 143.4 27.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.966 -0.294 . . . . 1.12 110.641 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -130.16 120.04 18.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.345 -0.983 . . . . 1.67 108.345 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.4 116.53 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.431 2.087 . . . . 2.15 116.002 -163.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? 54.59 127.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.319 1.97 . . . . 4.61 116.319 162.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 t30 75.74 30.47 0.77 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.585 -1.189 . . . . 2.84 110.918 167.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 m -94.83 4.5 53.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 1.7 110.886 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 27' ' ' LEU . 10.3 mm -108.21 136.16 19.85 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.299 -0.63 . . . . 0.92 109.299 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.49 156.2 67.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.527 2.151 . . . . 1.03 112.003 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.28 146.0 43.6 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.714 -0.221 . . . . 2.76 110.943 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 160' ' ' ALA . 36.5 Cg_endo -67.37 150.33 80.91 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.998 2.466 . . . . 1.08 112.139 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.34 94.14 6.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.052 0.453 . . . . 1.1 110.61 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.6 t -138.11 134.58 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 mt -74.83 -65.09 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.582 -0.447 . . . . 2.87 111.928 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 91' ' ' THR . 34.3 mt-10 -96.49 -56.12 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.19 0.519 . . . . 2.84 111.302 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 175.9 160.59 0.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.264 -1.334 . . . . 1.42 107.465 -174.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -101.53 -54.6 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.352 -0.539 . . . . 1.3 110.18 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -138.91 158.52 44.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.791 -0.448 . . . . 1.29 109.791 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -112.92 155.39 24.82 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.901 -1.148 . . . . 1.36 107.901 170.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.72 177.65 38.74 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 119.674 -1.251 . . . . 0.53 112.012 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.46 149.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.605 -0.517 . . . . 1.37 109.605 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.54 123.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.737 0.303 . . . . 0.69 111.276 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.97 4.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.89 111.722 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -151.69 120.79 3.44 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.522 -0.308 . . . . 3.92 111.01 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.08 151.44 67.26 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.059 2.506 . . . . 2.22 111.362 172.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 111' ' ' TYR . 1.7 mm? -86.12 89.17 7.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.266 . . . . 3.32 111.203 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -98.79 -63.98 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.355 -0.538 . . . . 5.56 110.814 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.3 p -92.65 10.66 29.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 4.14 111.807 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 105' ' ' ASN . 48.2 mm -83.63 -41.82 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.318 -0.401 . . . . 3.46 111.422 -173.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' TYR . 93.3 m-20 75.05 142.66 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.672 0 O-C-N 123.685 0.616 . . . . 4.99 111.903 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.657 ' HA ' ' CG ' ' A' ' 111' ' ' TYR . 38.4 Cg_endo -67.04 -16.65 49.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.274 2.649 . . . . 4.27 113.464 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -87.44 -5.43 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 3.94 110.786 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.54 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 5.9 tp-100 -87.39 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 5.6 109.656 172.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.05 0.04 22.84 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.786 0.662 . . . . 5.3 112.786 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 108' ' ' GLN . 4.2 pt-20 -114.23 15.33 18.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.818 0.818 . . . . 4.95 110.166 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.657 ' CG ' ' HA ' ' A' ' 106' ' ' PRO . 7.7 t80 -66.05 -20.99 66.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.491 -1.231 . . . . 3.19 111.791 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.55 -10.79 55.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.023 -0.271 . . . . 1.24 111.648 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 87.04 157.61 31.18 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.473 -0.87 . . . . 0.94 112.176 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 130' ' ' GLU . 59.7 mt -144.03 135.33 25.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.93 111.395 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 mt -106.22 138.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.793 -1.094 . . . . 0.49 109.726 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.59 117.15 28.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.593 0.711 . . . . 1.4 110.401 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.2 mm -96.48 132.31 41.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.008 -0.996 . . . . 0.63 109.502 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -86.45 152.79 22.39 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.91 -0.316 . . . . 1.21 110.56 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -59.83 161.39 6.46 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.124 -0.489 . . . . 2.29 111.265 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.41 -23.68 64.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.487 -0.779 . . . . 2.78 111.282 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.38 3.11 54.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.672 -0.24 . . . . 1.77 110.764 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 59.45 88.72 0.07 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.494 0.664 . . . . 4.14 109.759 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -144.5 -77.92 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 1.87 111.378 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 17.0 p -123.83 -166.45 1.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.682 0.277 . . . . 1.54 110.649 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.5 p -95.25 126.2 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.912 -0.585 . . . . 1.29 109.729 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.6 mt -65.31 -69.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 120.719 -0.392 . . . . 1.03 110.883 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -137.91 -85.93 0.28 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 1.56 110.485 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -176.43 139.71 0.35 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.649 -1.16 . . . . 2.08 108.151 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.546 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -117.88 130.19 56.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.69 -0.804 . . . . 0.68 111.277 176.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 16.4 tt0 -85.55 142.67 28.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.476 -1.238 . . . . 1.19 109.435 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 43.1 p90 -117.91 136.09 53.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.31 0.576 . . . . 0.74 110.363 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.55 150.96 22.89 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.508 -0.769 . . . . 0.51 112.312 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.51 -27.95 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.226 0.536 . . . . 0.67 110.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.9 p -76.22 -39.81 53.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.661 -0.7 . . . . 1.35 111.034 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 15.1 p -82.51 -14.96 54.08 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.803 -0.635 . . . . 1.1 110.943 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -79.5 58.28 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 1.46 110.5 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 137' ' ' VAL . 6.8 t -51.45 -35.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.591 . . . . 0.82 110.81 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.504 ' OD1' HD22 ' A' ' 143' ' ' LEU . 6.2 p30 -88.26 21.17 2.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.459 -0.791 . . . . 2.17 111.228 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -54.06 -23.61 14.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.833 0.679 . . . . 1.39 112.833 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -93.04 -1.57 56.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 2.46 111.819 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.17 175.75 9.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.204 -0.453 . . . . 1.89 110.202 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 mt -91.41 29.1 1.53 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.228 0.537 . . . . 2.88 109.828 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 164' ' ' ALA . 18.9 tp -51.44 115.15 1.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.409 -1.269 . . . . 0.97 112.073 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -122.37 -176.31 3.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 1.77 110.544 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.69 130.96 43.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 1.43 109.612 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.67 43.65 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.662 -0.78 . . . . 1.07 112.196 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.99 134.88 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.678 -0.409 . . . . 1.94 110.218 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 165' ' ' VAL . 92.5 mt -80.19 141.28 35.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 1.79 110.258 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.85 142.81 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.124 -0.489 . . . . 1.16 110.738 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.6 p -100.83 121.81 42.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.784 -0.644 . . . . 1.44 109.455 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.0 p90 -144.06 163.61 33.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.117 -0.492 . . . . 0.61 110.103 -176.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.532 ' NE ' ' HB2' ' A' ' 161' ' ' CYS . 0.9 OUTLIER -137.31 124.2 21.35 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.683 0.754 . . . . 2.2 111.247 176.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.401 HG23 HG21 ' A' ' 92' ' ' THR . 1.4 tt -99.35 134.63 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.627 -1.17 . . . . 1.24 110.353 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 10.4 t70 -153.32 -97.34 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.515 0.191 . . . . 1.92 111.515 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.0 41.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.373 . . . . 2.76 111.683 -174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -80.58 -16.84 53.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 1.98 110.182 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.43 17.67 62.3 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.007 -0.542 . . . . 1.27 113.255 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 41.5 mtm180 -145.02 -170.65 3.47 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.14 124.23 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.402 0.62 . . . . 0.48 111.437 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 86' ' ' PRO . . . -135.64 157.91 45.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.443 -0.799 . . . . 0.49 110.091 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.532 ' HB2' ' NE ' ' A' ' 152' ' ' ARG . 59.4 m 49.27 61.91 2.89 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.772 0.67 . . . . 1.55 109.954 -171.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 151' ' ' PHE . 53.6 t -90.89 121.83 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 1.26 110.33 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -136.21 132.75 36.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.964 -0.384 . . . . 2.05 109.964 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.33 120.43 9.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.75 111.472 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' LEU . 7.1 p -127.02 126.46 68.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.747 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.9 mpt_? -99.91 123.91 44.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.967 -0.383 . . . . 2.94 109.967 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -126.47 166.29 17.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.758 -0.655 . . . . 3.88 109.918 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.763 -0.653 . . . . 4.04 110.38 178.212 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 N-CA-C 112.307 -0.317 . . . . 11.74 112.307 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.92 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.603 0.24 . . . . 10.54 110.993 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.32 55.83 0.42 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.847 -0.692 . . . . 8.95 112.439 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 t -146.64 161.72 39.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.264 -0.643 . . . . 7.09 109.264 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.08 -166.28 0.89 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.829 -0.623 . . . . 5.59 109.384 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.48 -29.18 67.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.8 0.333 . . . . 2.99 111.212 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.36 -20.8 8.04 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.089 -0.577 . . . . 1.61 112.767 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -123.78 130.46 52.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.088 0.471 . . . . 2.0 111.524 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.88 123.38 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 1.27 109.32 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.83 139.76 37.98 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.917 -0.583 . . . . 1.14 109.798 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.443 HH11 ' CD1' ' A' ' 78' ' ' LEU . 37.8 ttm-85 -110.82 148.38 32.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.157 -0.683 . . . . 2.31 109.157 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.39 178.35 46.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.52 -0.847 . . . . 0.5 112.173 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 145.62 48.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.96 0.409 . . . . 0.68 111.17 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -65.96 117.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.419 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' HD22 ' A' ' 49' ' ' LEU . . . -97.9 -42.17 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.078 -0.249 . . . . 0.76 110.914 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 23' ' ' PHE . 2.4 m -124.84 148.63 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 109.949 -0.389 . . . . 1.55 109.949 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.4 mtp -133.79 110.07 9.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.973 -0.38 . . . . 1.42 109.973 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -92.69 170.69 9.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.272 -1.01 . . . . 2.03 108.272 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.66 -16.6 60.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.073 0.463 . . . . 3.24 110.034 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -104.31 -49.27 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.03 111.651 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -147.74 -179.84 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.796 -0.184 . . . . 1.25 110.621 -175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.69 165.28 28.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.275 -0.964 . . . . 0.71 112.389 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HD2' HG21 ' A' ' 16' ' ' VAL . 49.9 m-85 -118.79 128.71 54.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.894 0.378 . . . . 1.08 110.016 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.8 mt -97.77 125.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.956 -0.566 . . . . 0.61 109.493 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 139.16 36.35 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.806 -0.813 . . . . 2.3 108.806 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -66.34 156.87 33.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.176 0.512 . . . . 0.87 111.447 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.539 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -63.4 -42.46 98.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.786 -0.643 . . . . 1.58 111.143 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 p -97.2 12.27 33.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.868 0.692 . . . . 2.04 112.868 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 59.68 58.26 2.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.888 0.375 . . . . 3.29 111.332 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.54 -28.14 5.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.243 0.46 . . . . 2.89 112.243 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -169.55 170.61 8.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.953 0.342 . . . . 1.8 110.614 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.16 140.41 37.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.862 0.363 . . . . 3.37 110.349 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 127.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.043 0.449 . . . . 0.87 110.621 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -84.1 121.51 27.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.898 -0.592 . . . . 1.06 110.776 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -128.05 146.97 50.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.732 -0.84 . . . . 1.96 108.732 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.297 -0.631 . . . . 1.18 109.297 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -64.89 -19.58 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.027 0.441 . . . . 0.75 111.043 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.9 t -62.97 -36.58 83.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.599 -0.728 . . . . 1.63 111.08 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.91 16.85 23.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.865 0.364 . . . . 2.07 110.599 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.553 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 74.9 t80 -75.98 135.9 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.517 -0.549 . . . . 0.91 109.517 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.429 ' H ' HG23 ' A' ' 75' ' ' VAL . 60.4 mtp -98.09 105.93 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.264 0.554 . . . . 1.73 110.961 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.32 -134.59 7.77 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.025 -0.989 . . . . 1.05 111.999 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -118.1 100.83 51.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.339 . . . . 2.14 110.273 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.26 -12.6 21.02 Favored 'Trans proline' 0 N--CA 1.471 0.185 0 C-N-CA 122.976 2.45 . . . . 1.01 113.133 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.17 -13.44 59.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 2.08 110.37 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -102.84 14.63 31.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 2.18 111.359 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -88.67 141.73 28.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.219 -0.446 . . . . 0.92 110.211 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -136.06 170.56 15.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.673 -0.694 . . . . 2.35 109.934 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 15' ' ' ALA . 54.2 mt -74.68 114.59 13.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.01 -0.541 . . . . 1.4 110.488 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.7 26.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.898 -0.668 . . . . 0.75 112.764 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -81.16 116.41 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.048 0.451 . . . . 1.06 111.45 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.53 134.37 54.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.836 -1.075 . . . . 2.51 111.328 176.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.4 m -148.21 141.73 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.674 -0.491 . . . . 0.44 109.674 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 78' ' ' LEU . 11.5 pt-20 -114.82 145.17 42.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.506 -0.478 . . . . 1.49 109.922 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 5.7 p90 -166.64 179.71 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.66 111.651 -168.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 p -131.93 170.54 14.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.94 110.835 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.79 142.62 35.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.672 0.272 . . . . 1.19 111.157 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.64 70.92 10.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.317 0.579 . . . . 2.04 110.547 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD2' HD21 ' A' ' 70' ' ' LEU . 2.2 tpm_? -88.56 16.82 6.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.917 0.865 . . . . 5.33 110.02 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -95.09 131.44 41.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.623 -0.717 . . . . 5.42 110.049 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 166.66 12.3 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.547 -0.835 . . . . 4.76 112.87 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -104.9 27.28 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.474 0.654 . . . . 6.38 110.451 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -87.37 12.61 11.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 6.4 111.474 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t -89.26 47.77 1.53 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 5.23 110.49 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.94 -38.18 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 6.95 110.541 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 t -114.99 -30.37 6.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.148 -0.686 . . . . 6.02 109.148 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.78 45.73 48.71 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.573 -0.739 . . . . 4.09 114.546 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -80.94 -62.41 1.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.486 0.643 . . . . 4.22 109.953 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.16 117.6 6.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 2.09 110.784 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.43 HD21 ' HD2' ' A' ' 59' ' ' ARG . 1.5 pp -99.75 154.45 37.25 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.479 -0.782 . . . . 2.3 110.011 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.18 146.55 95.96 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.536 2.158 . . . . 1.43 112.457 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -93.83 146.5 23.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.696 -0.684 . . . . 0.82 111.043 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.58 176.48 5.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 2.3 110.937 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.5 32.41 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.635 0.731 . . . . 2.01 110.797 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 4.2 m -73.74 116.62 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.79 . . . . 0.8 111.693 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -123.27 144.66 49.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 3.51 110.302 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.595 ' HA ' HG12 ' A' ' 53' ' ' VAL . 50.8 mtt -74.07 147.06 43.16 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.097 0.475 . . . . 1.12 111.395 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 54' ' ' GLU . 75.7 mt -119.43 157.2 52.14 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.518 -0.765 . . . . 1.67 110.951 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.5 169.95 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.627 2.218 . . . . 2.15 111.847 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -78.08 175.16 10.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.0 -0.545 . . . . 4.61 111.297 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.03 3.04 4.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.307 -0.861 . . . . 2.84 112.234 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.0 m -71.92 -25.73 62.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.476 -0.329 . . . . 1.7 110.62 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.539 ' CD1' HD21 ' A' ' 27' ' ' LEU . 11.0 mm -105.99 120.99 47.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.92 109.954 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.19 158.99 17.74 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.007 2.471 . . . . 1.03 113.523 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -125.87 165.19 28.59 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.608 -0.724 . . . . 2.76 109.899 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 7.4 Cg_exo -69.47 156.16 64.86 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.668 2.246 . . . . 1.08 111.92 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.51 93.6 4.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.917 0.389 . . . . 1.1 111.373 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 91' ' ' THR . 7.7 t -141.88 92.29 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.771 -0.455 . . . . 1.23 109.771 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.82 -37.85 76.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.788 0.328 . . . . 2.87 110.718 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.14 -26.06 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 2.84 110.8 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.462 ' H ' HG12 ' A' ' 88' ' ' VAL . 66.7 m 70.45 113.05 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.831 . . . . 1.42 111.23 -175.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 t -93.66 -24.11 18.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.025 0.75 . . . . 1.3 113.025 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -138.84 160.87 38.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.909 0.862 . . . . 1.29 112.748 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -140.15 155.49 46.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.952 -1.476 . . . . 1.36 107.186 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.3 -165.69 23.03 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.33 -1.414 . . . . 0.53 112.762 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.85 146.7 24.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.807 -0.442 . . . . 1.37 109.807 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.11 122.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.382 -0.372 . . . . 0.69 110.8 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.3 -67.99 0.75 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.893 -0.594 . . . . 0.89 111.667 -175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -157.34 124.53 2.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 3.92 111.818 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.34 158.64 44.49 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.72 2.28 . . . . 2.22 110.699 169.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.0 pt? -79.53 88.12 5.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.988 0.899 . . . . 3.32 111.758 -174.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -98.31 -63.33 1.14 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.538 -0.755 . . . . 5.56 109.82 169.023 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.2 p -92.07 -7.79 47.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.688 -0.687 . . . . 4.14 111.454 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 101' ' ' LEU . 91.8 mt -67.76 -42.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 3.46 111.603 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 71.8 151.5 0.14 Allowed Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.294 0.637 . . . . 4.99 111.25 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -13.1 33.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 4.27 111.891 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.79 -20.54 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.621 -0.718 . . . . 3.94 110.266 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -85.34 152.83 22.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.745 -0.661 . . . . 5.6 109.581 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -70.2 -11.15 60.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.124 0.488 . . . . 5.3 111.19 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.58 16.92 5.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.319 0.581 . . . . 4.95 110.836 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.532 ' O ' HD13 ' A' ' 101' ' ' LEU . 22.8 t80 -50.35 -36.2 31.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 3.19 113.77 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 130' ' ' GLU . . . -72.82 -29.04 62.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.152 0.427 . . . . 1.24 112.152 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.39 158.16 16.28 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.078 -0.809 . . . . 0.94 111.078 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.35 147.41 34.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.028 0.914 . . . . 0.93 113.258 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.45 142.65 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.473 -1.239 . . . . 0.49 110.152 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.12 117.41 25.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 129' ' ' HIS . 8.6 mm -103.72 124.08 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 0.63 110.391 -174.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -97.91 153.47 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.229 -0.656 . . . . 1.21 109.229 175.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.07 177.43 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.274 0.559 . . . . 2.29 111.454 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG3' HD22 ' A' ' 121' ' ' LEU . 10.2 pt-20 -65.85 -25.71 67.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.417 -0.81 . . . . 2.78 111.851 -175.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -94.23 -2.15 52.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.39 -0.596 . . . . 1.77 109.39 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.47 29.14 18.78 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.115 -0.948 . . . . 4.14 110.646 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.8 p -86.1 -38.17 18.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.903 0.334 . . . . 1.87 111.903 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -143.14 166.35 24.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.261 0.553 . . . . 1.54 112.042 -174.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.17 132.37 33.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.186 -0.915 . . . . 1.29 108.68 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -75.82 -71.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.017 -0.673 . . . . 1.03 111.242 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -142.56 -87.29 0.15 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.651 0.738 . . . . 1.56 110.427 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -178.11 133.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.03 -1.441 . . . . 2.08 107.984 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.582 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.5 m-70 -109.21 132.77 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.264 -0.574 . . . . 0.68 110.792 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 112' ' ' ALA . 23.9 tt0 -83.8 147.65 27.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.512 -0.767 . . . . 1.19 110.643 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -119.27 151.21 38.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 0.74 110.709 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.13 150.38 16.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.51 112.194 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -57.09 -26.96 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.217 0.532 . . . . 0.67 111.21 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.7 p -73.85 -32.49 63.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.751 -0.659 . . . . 1.35 110.469 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 14.7 m -87.64 -13.9 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 1.1 110.635 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -73.1 59.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.587 -0.733 . . . . 1.46 111.644 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.9 t -48.94 -42.46 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.247 0.546 . . . . 0.82 110.618 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 20.4 m120 -88.36 33.88 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.615 . . . . 2.17 111.727 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -62.32 -19.2 63.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.205 0.526 . . . . 1.39 110.9 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -81.66 -21.45 38.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 2.46 111.896 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.26 169.05 18.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.665 0.745 . . . . 1.89 112.788 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.652 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -85.66 27.94 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.631 -1.168 . . . . 2.88 110.509 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.9 tp -56.16 113.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.492 -0.777 . . . . 0.97 111.146 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -128.83 -175.08 3.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.786 . . . . 1.77 110.207 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.27 136.22 49.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.075 -0.343 . . . . 1.43 110.075 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.69 -6.62 74.07 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.839 -0.696 . . . . 1.07 112.679 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.44 141.52 28.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.022 -0.671 . . . . 1.94 109.933 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.8 144.09 32.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.779 -0.646 . . . . 1.79 110.981 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 147.59 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.562 -0.745 . . . . 1.16 111.159 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 33.2 t -110.46 146.04 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 1.44 109.898 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 162' ' ' VAL . 15.9 p90 -165.96 174.76 9.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.61 110.018 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 127.45 11.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.04 0.448 . . . . 2.2 111.217 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.542 HG21 ' CD2' ' A' ' 129' ' ' HIS . 8.7 pt -95.84 144.72 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.675 -0.693 . . . . 1.24 109.282 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 5.2 t70 -166.51 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.065 0.228 . . . . 1.92 111.103 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -82.41 -29.24 30.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.448 -0.501 . . . . 2.76 111.843 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.565 ' OG ' ' HG3' ' A' ' 86' ' ' PRO . 59.3 p -84.78 -17.01 39.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.742 0.306 . . . . 1.98 111.529 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.1 25.75 60.24 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.036 -0.602 . . . . 1.27 112.294 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -152.61 178.04 10.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.719 -0.474 . . . . 3.61 109.719 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.27 110.42 19.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.48 111.115 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.28 164.33 21.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.585 -0.734 . . . . 0.49 110.647 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.3 m 60.98 32.12 19.93 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.82 0.7 . . . . 1.55 111.336 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 150' ' ' SER . 10.0 m -64.35 122.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.529 0.68 . . . . 1.26 111.283 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.606 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 6.7 p30 -131.32 125.08 31.83 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.269 -0.878 . . . . 2.05 109.413 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -61.96 133.06 54.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.75 111.189 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 83.6 t -118.23 121.16 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.97 -0.559 . . . . 1.56 111.724 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -91.38 138.9 31.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.963 -0.755 . . . . 2.94 108.963 170.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -120.43 149.38 42.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.358 0.599 . . . . 3.88 111.221 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 115.447 -0.797 . . . . 4.04 109.928 172.697 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.161 -0.376 . . . . 11.74 112.161 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.21 127.33 37.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.558 0.218 . . . . 10.54 110.684 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.35 -78.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.684 -0.566 . . . . 8.95 111.684 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 137.27 7.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.895 -0.409 . . . . 7.09 109.895 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -85.29 172.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.849 0.357 . . . . 5.59 110.242 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.57 -17.88 46.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.886 -0.597 . . . . 2.99 111.596 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.99 -29.42 1.59 Allowed Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.288 -0.415 . . . . 1.61 112.787 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.21 126.26 42.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.032 0.444 . . . . 2.0 110.772 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.89 120.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.454 -0.794 . . . . 1.27 109.432 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -90.65 158.67 16.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.34 -0.615 . . . . 1.14 109.34 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 30.8 ttm180 -129.1 143.02 50.72 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.307 -0.406 . . . . 2.31 110.485 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.32 -164.88 24.78 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.117 -0.793 . . . . 0.5 111.117 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.87 154.85 39.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.509 . . . . 0.68 111.276 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.6 mm -73.41 110.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.56 111.284 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 133' ' ' ILE . . . -97.52 -49.98 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.101 0.477 . . . . 0.76 110.823 176.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.15 123.56 69.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.475 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.0 ttm -119.03 109.11 15.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.835 -0.62 . . . . 1.42 109.574 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 5.9 tppt? -98.23 -163.44 1.04 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.234 -1.024 . . . . 2.03 108.234 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 9.0 pt-20 -79.43 -39.13 33.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.13 0.419 . . . . 3.24 112.13 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -111.92 -35.06 5.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.008 0.432 . . . . 2.03 112.109 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -134.01 178.04 7.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.509 -0.314 . . . . 1.25 110.951 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.39 171.67 36.65 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.045 -0.598 . . . . 0.71 111.703 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -115.93 127.45 54.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.95 0.405 . . . . 1.08 110.085 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -98.28 127.33 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 0.61 110.976 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.5 117.81 22.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.653 -0.869 . . . . 2.3 108.653 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.7 p -68.94 156.41 38.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 0.87 111.818 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.7 OUTLIER -56.48 -47.25 79.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.533 -0.758 . . . . 1.58 110.976 -178.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.77 9.51 27.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.18 -0.463 . . . . 2.04 111.755 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p80 39.28 37.71 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.449 1.1 . . . . 3.29 112.599 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HA ' ' NE2' ' A' ' 109' ' ' GLN . 5.7 t70 -98.91 -17.6 18.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 2.89 110.105 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.84 155.39 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.139 -0.937 . . . . 1.8 110.591 -166.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.188 -0.671 . . . . 3.37 109.188 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -108.95 108.56 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.784 -0.366 . . . . 0.87 110.1 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 8.1 t80 -68.58 121.22 15.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 1.06 109.723 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -121.28 128.35 52.27 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.066 -0.515 . . . . 1.96 110.827 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 122.99 41.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.521 -0.918 . . . . 1.18 108.521 174.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -62.18 -16.48 53.29 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.097 0.406 . . . . 0.75 112.097 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -57.14 -29.49 63.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.996 -0.547 . . . . 1.63 111.628 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -103.29 24.04 11.54 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.849 0.357 . . . . 2.07 111.638 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 77.6 t80 -86.22 139.06 31.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.91 110.768 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.4 ttm -96.77 97.09 9.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.098 0.475 . . . . 1.73 110.333 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.95 -136.25 8.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.768 -0.729 . . . . 1.05 112.066 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.5 104.94 33.7 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.25 -0.278 . . . . 2.14 110.25 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -17.36 27.0 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.215 . . . . 1.01 112.226 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -74.35 -8.1 55.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.923 -0.58 . . . . 2.08 110.459 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -107.06 10.5 30.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.728 -0.669 . . . . 2.18 110.597 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.9 142.29 27.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.92 110.306 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -116.1 161.95 18.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.464 -0.789 . . . . 2.35 109.969 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.78 120.22 19.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.59 -0.522 . . . . 1.4 109.59 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 133' ' ' ILE . . . 96.34 3.9 59.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.964 -0.636 . . . . 0.75 112.01 -176.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.09 129.09 38.91 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.956 0.408 . . . . 1.06 110.823 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 30.4 mt-10 -71.41 126.5 29.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.386 -0.825 . . . . 2.51 110.637 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.51 157.74 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.242 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -128.81 150.8 50.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.367 -0.605 . . . . 1.49 109.367 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CB ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -164.0 175.68 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.947 0.721 . . . . 0.66 112.947 -166.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -136.85 166.51 23.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.16 -0.927 . . . . 0.94 109.732 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.5 mt -94.71 147.51 23.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.003 0.43 . . . . 1.19 111.342 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.86 26.62 1.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.04 110.798 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -88.0 61.25 6.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.622 0.725 . . . . 5.33 110.056 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.005 -0.998 . . . . 5.42 110.074 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.41 -171.99 31.33 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.559 -0.617 . . . . 4.76 111.559 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -72.0 113.43 9.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.824 0.345 . . . . 6.38 110.281 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.4 m -141.78 -82.96 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 6.4 110.778 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 15.5 t -91.45 12.83 19.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.438 0.637 . . . . 5.23 110.317 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.59 -20.45 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.57 . . . . 6.95 111.018 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -81.71 -8.7 59.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.966 -0.561 . . . . 6.02 110.731 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.14 -66.67 0.92 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.887 -0.673 . . . . 4.09 111.714 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -166.72 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 4.22 110.274 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.96 171.95 17.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 2.09 110.191 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 1.1 pp -125.97 154.4 73.81 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.242 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 58.0 Cg_endo -71.76 158.7 52.61 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.47 2.113 . . . . 1.43 113.057 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.55 155.5 19.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.618 -0.719 . . . . 0.82 110.378 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -134.84 164.26 27.97 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.513 -0.312 . . . . 2.3 111.03 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 62.12 29.27 17.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.488 -0.778 . . . . 2.01 111.095 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 55' ' ' TYR . 39.3 t -73.9 122.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.945 -0.571 . . . . 0.8 110.843 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -126.46 156.91 39.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 3.51 110.442 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.467 ' HA ' HG12 ' A' ' 53' ' ' VAL . 61.9 mtt -72.3 143.24 48.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.12 110.814 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.86 143.33 27.36 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.0 -1.0 . . . . 1.67 109.178 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 135.33 69.86 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.768 1.645 . . . . 2.15 111.788 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 6.4 ttpm? -60.58 149.61 34.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.689 -0.687 . . . . 4.61 111.378 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.1 t30 77.88 26.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.34 -0.845 . . . . 2.84 110.55 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.8 m -88.37 -30.66 19.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.24 -1.022 . . . . 1.7 108.24 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.25 123.54 73.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.318 -1.31 . . . . 0.92 108.868 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.48 158.17 48.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.816 2.344 . . . . 1.03 113.649 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.63 155.95 46.77 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.709 -0.678 . . . . 2.76 110.575 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 57.0 Cg_endo -69.16 133.94 27.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.729 2.286 . . . . 1.08 112.87 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.05 94.64 8.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 1.1 110.334 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 3.0 t -137.22 156.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.928 -1.138 . . . . 1.23 107.928 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.18 -64.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.131 -0.627 . . . . 2.87 111.195 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 91' ' ' THR . 78.7 mm-40 -95.06 -57.18 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.576 -0.45 . . . . 2.84 112.062 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -179.98 156.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 1.42 109.902 -171.442 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.502 HG21 ' O ' ' A' ' 153' ' ' ILE . 2.9 m -106.12 -54.24 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.968 0.413 . . . . 1.3 110.219 173.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -143.94 177.56 8.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.357 0.599 . . . . 1.29 110.931 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -145.25 168.37 20.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.323 -1.362 . . . . 1.36 107.323 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.8 -170.38 43.31 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.636 -1.269 . . . . 0.53 112.647 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.427 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.9 p -121.62 146.65 26.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.6 -0.519 . . . . 1.37 109.6 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.72 120.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.036 -0.357 . . . . 0.69 110.036 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -74.17 -65.54 0.83 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.055 -0.521 . . . . 0.89 111.391 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -169.51 109.39 0.48 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 3.92 110.349 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.56 122.58 7.02 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.687 2.258 . . . . 2.22 110.874 173.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.851 ' H ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -102.39 115.73 31.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 3.32 111.091 -176.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -98.51 -64.71 1.01 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 5.56 110.666 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.84 -7.35 40.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.727 -0.669 . . . . 4.14 112.397 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.36 -42.52 90.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.472 0.545 . . . . 3.46 112.472 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -170.73 103.53 0.41 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.473 -0.195 . . . . 4.99 110.473 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.45 -7.37 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.195 2.596 . . . . 4.27 112.801 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.74 23.98 9.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 3.94 110.554 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -128.04 163.85 23.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.797 -0.445 . . . . 5.6 109.797 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 30' ' ' ASP . 39.6 tt0 -74.52 -28.71 61.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.623 0.249 . . . . 5.3 111.523 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.81 15.27 0.68 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.282 -0.417 . . . . 4.95 111.939 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.571 ' HA ' HD21 ' A' ' 101' ' ' LEU . 63.0 t80 -48.9 -32.2 8.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.252 -0.886 . . . . 3.19 113.137 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.65 63.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.856 0.688 . . . . 1.24 112.856 -170.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.65 162.26 13.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.382 -0.913 . . . . 0.94 111.695 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 128' ' ' GLN . 18.3 mt -143.41 147.24 34.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.93 112.015 -171.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -107.3 141.14 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.089 -0.96 . . . . 0.49 109.289 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 98' ' ' ALA . 8.0 pt-20 -88.86 113.18 24.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.542 0.686 . . . . 1.4 110.109 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 129' ' ' HIS . 6.7 mm -94.3 127.98 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.033 -0.985 . . . . 0.63 109.703 -174.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.3 pt? -85.84 159.61 19.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.162 -0.31 . . . . 1.21 110.162 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.84 164.04 8.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.623 . . . . 2.29 110.345 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -68.31 -17.71 64.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.471 . . . . 2.78 109.744 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.577 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -96.07 -17.19 21.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.612 -0.722 . . . . 1.77 110.462 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 20.9 ttm180 71.2 99.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.836 0.71 . . . . 4.14 111.653 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.0 t -154.75 -41.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.992 -0.283 . . . . 1.87 111.111 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 6.6 p -147.44 -171.95 3.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.742 0.306 . . . . 1.54 111.419 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.46 136.4 24.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.039 -0.528 . . . . 1.29 109.756 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.15 -69.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.67 -0.412 . . . . 1.03 110.925 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -138.61 -84.8 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.466 0.65 . . . . 1.56 110.841 171.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.454 ' HG3' HD13 ' A' ' 114' ' ' LEU . 1.6 pm0 -175.33 141.25 0.53 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.877 -1.056 . . . . 2.08 108.726 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.601 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.1 m-70 -116.46 133.57 55.86 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.67 -0.412 . . . . 0.68 110.161 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.2 tt0 -86.61 146.29 26.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.682 -0.69 . . . . 1.19 109.656 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -117.02 146.63 42.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.889 0.376 . . . . 0.74 110.155 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -108.83 150.05 17.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.757 -0.735 . . . . 0.51 111.744 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.441 HG23 ' HA2' ' A' ' 50' ' ' GLY . 10.4 tp -58.73 -22.49 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.029 0.442 . . . . 0.67 111.369 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.2 p -73.23 -37.19 66.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.439 . . . . 1.35 110.682 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 11.2 p -90.65 -8.84 48.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.116 -0.493 . . . . 1.1 111.733 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 132' ' ' GLY . 54.1 mt -73.45 59.97 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 1.46 111.225 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t -42.34 -47.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.287 0.477 . . . . 0.82 112.287 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.51 HD21 HD22 ' A' ' 143' ' ' LEU . 4.5 p-10 -93.15 34.36 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.737 0.273 . . . . 2.17 111.737 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -59.65 -14.81 15.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.274 0.472 . . . . 1.39 112.274 -176.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -79.86 -16.41 55.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 2.46 110.727 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.81 151.0 20.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.607 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.68 93.11 3.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.416 0.627 . . . . 2.88 110.076 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 138' ' ' ASN . 11.7 tp -100.24 116.98 33.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.159 -0.928 . . . . 0.97 109.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.36 -176.35 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.335 0.588 . . . . 1.77 111.782 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 58.0 tttm -65.47 126.14 27.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.981 -1.009 . . . . 1.43 110.117 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 103.71 -1.57 45.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.448 -0.882 . . . . 1.07 113.133 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -91.69 141.35 28.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.094 0.447 . . . . 1.94 111.04 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HB ' ' A' ' 96' ' ' VAL . 94.5 mt -82.51 139.4 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 1.79 111.278 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.07 153.51 29.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.211 0.529 . . . . 1.16 111.073 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 22.9 t -112.72 142.34 45.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.468 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 27.1 p90 -158.45 158.21 33.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.61 110.354 -175.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 63.2 mtt180 -125.33 120.82 32.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.04 -0.355 . . . . 2.2 110.04 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.502 ' O ' HG21 ' A' ' 92' ' ' THR . 5.3 tt -102.29 120.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.072 -0.513 . . . . 1.24 110.794 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -159.75 -87.54 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.708 0.289 . . . . 1.92 110.478 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 6.0 mm-40 -75.07 -20.84 59.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.661 . . . . 2.76 109.822 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.8 p -83.79 -18.24 38.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.232 -0.895 . . . . 1.98 111.249 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.91 5.46 7.47 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.943 -0.571 . . . . 1.27 113.526 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -153.42 -164.12 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 3.61 108.426 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.1 109.14 17.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.407 0.622 . . . . 0.48 111.119 -172.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -120.18 165.16 15.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.26 -0.882 . . . . 0.49 109.944 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 73.7 m 59.02 36.37 24.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.995 0.426 . . . . 1.55 110.613 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' SER . 42.2 t -73.38 110.67 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 1.26 110.648 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.38 129.39 44.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.875 -0.602 . . . . 2.05 110.25 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 102.66 0.97 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.75 110.896 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.93 137.6 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.177 -0.465 . . . . 1.56 110.394 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 140.29 45.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.452 -0.34 . . . . 2.94 110.386 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 101.36 2.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.062 -0.718 . . . . 3.88 109.062 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.434 0 CA-C-N 116.061 -0.518 . . . . 4.04 111.046 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.162 -0.375 . . . . 11.74 112.162 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.64 41.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.409 -0.219 . . . . 10.54 110.409 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.23 -88.06 1.58 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.064 -0.589 . . . . 8.95 112.344 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -155.96 107.12 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.146 -0.316 . . . . 7.09 110.146 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -104.23 172.32 6.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.621 -0.511 . . . . 5.59 109.621 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.05 -17.31 47.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 2.99 111.312 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.42 18.11 67.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.047 -0.597 . . . . 1.61 112.148 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 11.4 mm-40 -130.52 119.8 23.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.322 0.582 . . . . 2.0 111.316 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.29 114.5 30.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.11 -0.95 . . . . 1.27 108.868 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.93 138.22 31.71 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.057 -0.72 . . . . 1.14 109.057 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 11.5 ptp180 -129.04 151.52 49.64 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.439 -0.504 . . . . 2.31 110.385 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.25 -158.95 9.39 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.509 -1.036 . . . . 0.5 110.509 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 139.08 44.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.833 0.349 . . . . 0.68 110.629 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.6 mm -64.3 114.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.948 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -40.05 3.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.463 -0.335 . . . . 0.76 111.249 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 54.5 t -116.92 123.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.615 0.245 . . . . 1.55 110.713 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.5 mtp -123.21 108.14 12.48 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.05 -0.722 . . . . 1.42 109.05 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -106.76 -165.31 1.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.625 -0.509 . . . . 2.03 109.625 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 34.3 tt0 -76.24 -46.98 25.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 3.24 111.337 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -101.35 -32.67 10.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.466 . . . . 2.03 111.379 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -148.93 -169.82 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.4 -0.364 . . . . 1.25 111.18 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.37 -176.79 30.82 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.012 -0.613 . . . . 0.71 111.984 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.456 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 84.1 m-85 -131.54 140.31 49.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 1.08 110.442 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.0 131.03 67.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.504 -0.771 . . . . 0.61 109.989 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' OE1' HG22 ' A' ' 133' ' ' ILE . 46.4 mt-10 -70.77 130.39 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.073 -0.714 . . . . 2.3 109.073 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.59 139.53 58.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.761 -0.459 . . . . 0.87 109.761 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.7 tp -52.22 -36.84 53.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 1.58 111.476 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.4 t -108.35 22.75 15.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 2.04 110.93 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 43.47 51.63 6.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.822 0.849 . . . . 3.29 111.856 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.95 -50.27 6.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.666 -1.152 . . . . 2.89 110.397 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.81 -173.04 3.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 1.8 110.576 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -101.53 129.65 47.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.895 0.379 . . . . 3.37 110.9 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.36 122.66 58.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.87 110.923 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.07 120.12 33.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 1.06 110.089 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.32 152.71 38.63 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.381 -0.599 . . . . 1.96 109.381 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -111.61 134.17 53.37 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.493 -0.558 . . . . 1.18 109.493 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 24.7 m-85 -63.91 -27.16 68.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.333 0.494 . . . . 0.75 112.333 -175.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -68.24 -36.42 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.783 0.325 . . . . 1.63 110.766 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -87.52 7.46 29.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.225 0.536 . . . . 2.07 110.894 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 18.0 t80 -84.64 137.31 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.668 -0.697 . . . . 0.91 110.381 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttm -104.52 110.72 23.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.73 110.969 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.5 -138.01 6.58 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.842 -0.617 . . . . 1.05 111.787 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.34 101.96 14.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.955 -0.387 . . . . 2.14 109.955 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 -14.43 30.68 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.509 2.14 . . . . 1.01 112.294 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.74 -18.61 63.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.751 -0.659 . . . . 2.08 110.274 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -109.5 9.09 25.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 2.18 110.952 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.3 145.55 29.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.92 111.473 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -141.04 160.81 39.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.489 -0.778 . . . . 2.35 109.507 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.59 115.01 4.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.879 -0.6 . . . . 1.4 110.882 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.66 0.05 15.58 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.75 113.21 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -75.64 120.22 20.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.922 0.391 . . . . 1.06 110.638 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.83 128.44 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.474 -0.784 . . . . 2.51 109.858 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 77' ' ' MET . 15.0 m -139.79 144.4 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.707 -0.224 . . . . 0.44 110.904 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 16.6 pt-20 -118.19 149.18 41.51 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 1.49 109.809 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.65 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 20.6 p90 -168.57 179.67 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.051 0.453 . . . . 0.66 111.554 -173.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -133.95 141.9 47.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.575 . . . . 0.94 110.695 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.4 mt -72.52 156.39 39.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.357 -0.383 . . . . 1.19 111.14 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.99 -92.93 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 2.04 110.559 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 55.35 60.2 3.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.548 -0.751 . . . . 5.33 110.608 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -79.86 99.58 7.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.178 -0.919 . . . . 5.42 110.321 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.35 -170.11 15.35 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.6 -0.727 . . . . 4.76 112.199 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -93.58 35.45 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.544 0.688 . . . . 6.38 110.069 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.7 p -80.67 10.26 5.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.246 -0.888 . . . . 6.4 111.913 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 m -71.77 -2.32 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 5.23 111.723 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.91 -24.16 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.82 -0.627 . . . . 6.95 110.937 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -116.87 -9.54 11.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 6.02 110.713 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.34 86.3 0.41 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.746 -0.74 . . . . 4.09 111.91 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.92 -45.32 93.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 4.22 110.061 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -127.69 125.45 40.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.794 -0.639 . . . . 2.09 109.573 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.6 162.81 42.61 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.293 -0.412 . . . . 2.3 110.819 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.85 152.38 80.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.858 2.372 . . . . 1.43 113.689 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -106.75 124.05 49.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.916 -1.038 . . . . 0.82 109.742 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.36 173.15 6.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.3 111.113 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 60.94 34.44 19.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.942 -0.572 . . . . 2.01 111.394 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 29.6 t -69.18 115.09 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.8 111.181 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -119.36 146.55 45.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.199 -0.91 . . . . 3.51 111.151 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.406 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.0 mtt -78.91 139.09 38.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.566 -0.901 . . . . 1.12 108.566 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.1 pt? -131.87 161.98 59.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 10.8 Cg_endo -53.89 132.45 49.73 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 112.721 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -69.94 163.96 24.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.93 -1.032 . . . . 4.61 111.306 -174.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 78.16 34.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.294 -0.866 . . . . 2.84 111.472 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -94.59 -16.9 22.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 1.7 109.057 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 27' ' ' LEU . 6.5 mm -73.07 135.66 79.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.92 109.854 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.81 159.65 50.05 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.496 2.131 . . . . 1.03 112.548 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -124.95 150.12 65.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.291 -0.413 . . . . 2.76 110.048 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.42 130.01 37.79 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.555 2.17 . . . . 1.08 111.578 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.95 90.99 5.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.472 0.653 . . . . 1.1 110.624 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.47 136.6 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.494 -0.928 . . . . 1.23 108.494 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.84 -60.95 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.552 -0.459 . . . . 2.87 112.009 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.0 tp10 -90.95 -54.47 3.95 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.875 -0.33 . . . . 2.84 110.81 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 169.16 155.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.187 -0.671 . . . . 1.42 109.187 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.42 HG21 HG23 ' A' ' 153' ' ' ILE . 0.6 OUTLIER -105.75 -58.44 1.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 1.3 110.997 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -139.03 147.87 42.66 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.512 -0.313 . . . . 1.29 110.569 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.7 p30 -108.05 125.51 51.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.41 -0.959 . . . . 1.36 108.41 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -133.1 -175.52 14.0 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.056 -1.069 . . . . 0.53 112.321 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.1 t -135.39 146.05 30.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.777 -0.453 . . . . 1.37 109.777 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 143' ' ' LEU . 97.6 t -62.01 121.03 9.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.69 110.828 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.29 -53.22 17.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.89 111.871 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -172.85 154.51 2.84 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.677 -0.238 . . . . 3.92 111.089 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.69 172.24 16.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.062 2.508 . . . . 2.22 112.39 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -106.99 88.31 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.25 0.548 . . . . 3.32 111.767 -177.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -100.21 -63.32 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.111 0.482 . . . . 5.56 112.028 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.02 9.41 33.36 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.965 -0.561 . . . . 4.14 111.208 -173.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.9 mp -81.63 -27.88 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.426 . . . . 3.46 111.762 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 111' ' ' TYR . 78.1 m-20 75.52 156.18 0.16 Allowed Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 123.228 0.611 . . . . 4.99 110.213 -173.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.468 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 72.3 Cg_endo -91.23 -0.2 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.32 2.014 . . . . 4.27 113.673 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.28 -5.74 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 3.94 111.389 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 67.4 mt-30 -93.67 165.36 12.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 5.6 110.813 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.47 -30.58 61.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.511 -0.551 . . . . 5.3 109.511 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.55 ' OE2' ' HB3' ' A' ' 108' ' ' GLN . 2.4 pm0 -68.2 -4.42 13.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.554 -0.748 . . . . 4.95 111.54 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.576 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.57 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.988 -0.551 . . . . 3.19 111.022 176.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.36 73.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 1.24 110.807 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.09 145.96 11.43 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.459 -1.057 . . . . 0.94 110.459 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.12 138.83 50.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.69 0.757 . . . . 0.93 111.983 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.53 135.05 47.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.512 -1.222 . . . . 0.49 109.272 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.41 125.97 35.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4 110.263 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.1 mm -101.69 138.09 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.571 -0.741 . . . . 0.63 110.35 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 122' ' ' ARG . 1.3 pt? -85.77 154.14 21.8 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.401 0.438 . . . . 1.21 110.016 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.94 -175.88 5.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.873 0.368 . . . . 2.29 110.365 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.9 pt-20 -68.59 -18.36 64.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.652 0.612 . . . . 2.78 112.652 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -109.19 -0.12 19.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.984 -0.286 . . . . 1.77 110.854 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HB2' HD12 ' A' ' 118' ' ' LEU . 31.2 ttm-85 56.57 70.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 4.14 109.777 -172.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -118.69 -48.29 2.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.876 -0.602 . . . . 1.87 109.962 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -142.35 169.74 17.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.553 -0.749 . . . . 1.54 111.131 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.5 p -81.14 135.06 25.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.375 -0.602 . . . . 1.29 109.375 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.5 mt -71.12 -70.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.554 -0.458 . . . . 1.03 110.824 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -138.59 -85.45 0.26 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.04 0.447 . . . . 1.56 110.971 170.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -177.16 143.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.329 -0.85 . . . . 2.08 109.065 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.401 ' CE1' HG13 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -119.58 132.83 55.81 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.68 111.233 176.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -95.69 144.01 26.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.033 -0.985 . . . . 1.19 109.454 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -117.92 136.69 53.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.74 111.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.29 152.63 22.85 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.605 -0.725 . . . . 0.51 112.292 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.51 HG22 ' OE1' ' A' ' 25' ' ' GLU . 10.6 tp -55.71 -34.66 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.482 0.549 . . . . 0.67 112.482 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -78.32 -22.48 48.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.382 0.61 . . . . 1.35 110.545 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 3.5 m -89.21 -19.73 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.66 -0.7 . . . . 1.1 110.21 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -79.05 60.07 2.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.327 -0.851 . . . . 1.46 111.268 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.0 t -43.73 -41.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.241 0.544 . . . . 0.82 111.347 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.4 m120 -87.91 32.58 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.948 -0.569 . . . . 2.17 111.38 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -59.99 -26.97 66.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.355 0.598 . . . . 1.39 110.524 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -88.84 -13.8 38.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.193 -0.912 . . . . 2.46 111.392 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.97 175.1 8.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.077 -0.965 . . . . 1.89 111.294 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.73 16.51 17.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.991 -0.744 . . . . 2.88 108.991 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.483 ' HG ' HG21 ' A' ' 97' ' ' VAL . 25.4 tp -43.6 107.53 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.188 -1.369 . . . . 0.97 111.448 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.59 -178.51 3.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.841 -0.618 . . . . 1.77 110.733 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -63.85 135.3 56.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 1.43 110.291 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.85 -7.31 67.59 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.365 -0.921 . . . . 1.07 112.931 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.19 146.42 23.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.205 -0.598 . . . . 1.94 109.585 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.56 140.77 29.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.684 -0.689 . . . . 1.79 110.768 -172.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.42 144.87 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 115.139 -0.937 . . . . 1.16 110.731 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.9 m -111.58 143.6 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.146 -0.479 . . . . 1.44 109.878 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.625 ' HB3' HG12 ' A' ' 162' ' ' VAL . 7.0 p90 -157.14 166.6 32.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.146 -0.479 . . . . 0.61 110.116 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -119.22 119.61 34.61 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.003 -0.679 . . . . 2.2 109.517 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 92' ' ' THR . 3.7 tt -103.78 138.41 28.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.419 -0.586 . . . . 1.24 109.419 167.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.82 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.799 -0.36 . . . . 1.92 111.153 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -38.39 22.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.853 0.686 . . . . 2.76 112.853 -173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.9 t -81.45 -16.82 50.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.842 0.312 . . . . 1.98 111.842 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.15 71.76 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.428 -0.892 . . . . 1.27 112.519 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -133.27 -178.23 4.88 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.083 -0.339 . . . . 3.61 110.083 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.99 108.43 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.48 110.377 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -125.33 161.79 26.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.128 -0.487 . . . . 0.49 110.177 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.35 39.86 11.8 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 123.59 0.556 . . . . 1.55 110.045 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 151' ' ' PHE . 15.5 m -69.58 125.08 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 1.26 111.059 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 46.2 t30 -125.74 117.52 23.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.603 -0.726 . . . . 2.05 109.483 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -69.08 102.67 1.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.75 110.43 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.58 130.12 49.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.86 -0.609 . . . . 1.56 110.794 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.56 115.33 27.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.854 -0.612 . . . . 2.94 110.458 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -136.78 167.91 20.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.568 -0.742 . . . . 3.88 109.215 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 120.934 0.397 . . . . 4.04 110.93 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.945 -0.462 . . . . 11.74 111.945 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.55 99.16 6.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 10.54 110.489 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 74.18 1.89 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.781 -0.723 . . . . 8.95 112.649 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -112.37 99.26 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.599 0.238 . . . . 7.09 110.642 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -124.99 124.1 41.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.598 -0.519 . . . . 5.59 109.598 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.17 -39.8 22.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.341 -0.39 . . . . 2.99 110.981 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.14 -29.72 1.88 Allowed Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 116.142 -0.481 . . . . 1.61 112.759 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -119.87 116.86 26.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 2.0 111.171 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.25 116.01 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.436 -0.802 . . . . 1.27 109.13 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -89.09 138.17 31.66 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.822 -0.626 . . . . 1.14 109.564 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 39.9 ttm180 -116.19 132.37 56.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.616 -0.72 . . . . 2.31 109.462 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.73 -157.23 7.81 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.879 -0.677 . . . . 0.5 111.415 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.494 ' CE2' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -146.04 152.92 40.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.989 0.423 . . . . 0.68 110.949 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.0 mm -71.68 114.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.691 -0.686 . . . . 0.56 110.287 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.83 -42.0 4.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.676 0.274 . . . . 0.76 111.45 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.19 123.12 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.453 . . . . 1.55 111.139 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.5 mtt -113.44 116.07 29.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.5 -0.773 . . . . 1.42 109.931 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 -177.8 3.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 2.03 108.444 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.19 -45.62 72.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.882 0.327 . . . . 3.24 111.882 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -110.92 -18.21 13.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.964 0.357 . . . . 2.03 111.964 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -153.73 -173.34 4.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.251 -0.278 . . . . 1.25 110.251 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.81 -169.99 30.14 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.718 -0.753 . . . . 0.71 111.496 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -130.18 130.54 44.84 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.959 -0.386 . . . . 1.08 109.959 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 35' ' ' PHE . 63.9 mt -90.22 124.03 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.471 -0.566 . . . . 0.61 109.471 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.14 125.17 28.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 2.3 109.482 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.3 p -65.37 144.11 57.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.87 109.942 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.649 HD21 HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -52.93 -46.31 68.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.057 0.456 . . . . 1.58 110.946 -174.589 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 t -92.94 6.57 47.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.105 -0.498 . . . . 2.04 111.542 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 54.46 56.95 6.25 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.013 0.911 . . . . 3.29 109.6 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.39 -33.4 7.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.683 -1.144 . . . . 2.89 110.759 -172.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -142.77 166.49 24.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.283 -0.417 . . . . 1.8 110.911 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.49 126.91 50.92 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.625 -0.879 . . . . 3.37 108.625 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.49 115.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.87 111.492 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -81.21 120.27 24.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.343 -0.844 . . . . 1.06 110.473 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 24' ' ' ILE . 3.9 p90 -123.21 151.23 42.45 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.914 -0.773 . . . . 1.96 108.914 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -120.36 131.76 54.98 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.083 -0.71 . . . . 1.18 109.083 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -60.33 -24.73 65.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -71.32 -12.2 61.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.668 0.27 . . . . 1.63 111.136 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -109.8 0.48 18.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.07 110.512 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.47 127.05 34.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.91 109.998 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.0 ttp -101.02 97.77 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.186 0.517 . . . . 1.73 110.597 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.46 -160.34 30.14 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.619 -0.719 . . . . 1.05 111.331 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -102.98 102.94 30.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.805 0.302 . . . . 2.14 110.193 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.44 -24.05 9.47 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.45 2.1 . . . . 1.01 113.633 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.33 -4.28 50.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.531 0.205 . . . . 2.08 111.5 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -113.23 19.64 16.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.386 0.612 . . . . 2.18 110.704 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD21 ' HE2' ' A' ' 77' ' ' MET . 56.0 mt -95.04 159.92 14.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.92 108.976 172.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.13 164.88 28.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.821 -0.437 . . . . 2.35 109.821 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.32 113.28 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.28 0.562 . . . . 1.4 110.017 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.28 27.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.862 -0.685 . . . . 0.75 112.643 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -77.3 124.75 28.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.328 . . . . 1.06 110.41 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HG2' HG12 ' A' ' 83' ' ' ILE . 16.4 mp0 -67.97 126.8 30.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.312 -0.858 . . . . 2.51 111.257 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -142.9 149.86 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.44 109.925 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.02 156.28 42.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.24 -0.288 . . . . 1.49 110.401 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 2.4 p90 -170.16 179.42 3.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.877 0.37 . . . . 0.66 111.292 -169.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.4 p -120.8 172.3 7.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.94 110.683 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.67 146.12 49.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.19 111.528 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.0 80.85 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 2.04 110.091 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -130.85 19.44 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 5.33 110.68 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.35 -45.69 7.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.657 -0.702 . . . . 5.42 111.664 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.15 20.73 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.478 -0.868 . . . . 4.76 111.788 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -74.41 80.93 1.9 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 6.38 110.491 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -127.58 -5.0 5.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.403 -0.817 . . . . 6.4 109.495 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.5 m -83.76 28.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.481 -0.781 . . . . 5.23 111.372 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.66 -29.66 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.23 0.538 . . . . 6.95 110.206 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -121.2 -7.37 9.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.482 -0.781 . . . . 6.02 110.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.69 95.74 1.23 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.659 -0.701 . . . . 4.09 111.726 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -49.76 -65.23 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 122.972 0.509 . . . . 4.22 111.604 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 34.4 m -114.66 120.51 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.219 -0.446 . . . . 2.09 110.461 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.631 HD13 ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -84.78 149.61 54.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.802 -0.635 . . . . 2.3 110.238 177.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.29 150.98 42.71 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.57 2.18 . . . . 1.43 112.236 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.36 129.47 34.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.101 -0.499 . . . . 0.82 109.806 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -116.12 143.33 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.915 0.388 . . . . 2.3 111.123 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.1 70.92 0.58 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.362 -0.836 . . . . 2.01 111.21 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 25.3 t -96.14 125.17 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.8 109.821 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -127.89 149.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 3.51 111.13 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.448 ' HE2' HD21 ' A' ' 47' ' ' LEU . 66.8 mtt -79.23 154.17 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.12 109.935 175.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.3 147.96 32.99 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 1.67 109.658 169.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.93 162.83 27.41 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.54 2.16 . . . . 2.15 112.975 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.27 173.04 5.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 4.61 111.214 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 m120 73.72 3.18 4.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.496 -0.775 . . . . 2.84 110.989 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 m -89.46 -2.39 58.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.351 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.649 HD12 HD21 ' A' ' 27' ' ' LEU . 30.7 mm -110.72 123.39 35.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.203 -0.666 . . . . 0.92 109.203 176.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.49 139.27 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.048 1.832 . . . . 1.03 111.266 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.83 148.51 43.4 Favored Pre-proline 0 C--N 1.314 -0.941 0 C-N-CA 120.821 -0.352 . . . . 2.76 110.427 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.39 130.73 41.43 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.276 2.651 . . . . 1.08 111.932 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.09 93.0 9.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.188 0.518 . . . . 1.1 110.826 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.39 126.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.535 -0.913 . . . . 1.23 108.535 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -59.96 2.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.547 0.203 . . . . 2.87 111.547 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 57.5 mm-40 -91.21 -55.04 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.714 -0.394 . . . . 2.84 111.281 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 13.1 t 171.02 159.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.42 109.9 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 HG23 ' A' ' 153' ' ' ILE . 1.0 OUTLIER -102.44 -54.93 2.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 1.3 109.788 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.577 ' CE1' ' HE2' ' A' ' 151' ' ' PHE . 23.7 p80 -162.93 168.23 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.29 109.623 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.38 -177.52 3.15 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.137 -0.32 . . . . 1.36 110.137 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.65 179.1 47.82 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.838 -0.696 . . . . 0.53 111.698 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.59 145.27 32.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.833 -0.432 . . . . 1.37 109.833 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.6 t -58.79 123.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.365 -0.235 . . . . 0.69 110.365 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.28 -65.96 0.82 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.388 -0.369 . . . . 0.89 111.888 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 110' ' ' GLU . 35.6 ptt180 -157.48 147.55 15.64 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.331 -0.248 . . . . 3.92 110.331 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 7.4 Cg_exo -74.97 154.59 42.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.003 2.469 . . . . 2.22 111.911 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.703 ' H ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -107.1 102.66 11.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.924 0.868 . . . . 3.32 111.628 -176.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -97.91 -64.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.735 -0.666 . . . . 5.56 111.068 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.7 m -93.86 9.84 35.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.154 -0.475 . . . . 4.14 111.803 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 108' ' ' GLN . 1.7 mp -68.78 -44.14 82.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.036 0.384 . . . . 3.46 112.036 -172.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.466 ' ND2' ' HD2' ' A' ' 106' ' ' PRO . 26.3 t-20 65.75 138.36 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 122.673 0.389 . . . . 4.99 111.328 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HD2' ' ND2' ' A' ' 105' ' ' ASN . 14.7 Cg_endo -55.97 -12.24 6.84 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 123.911 3.074 . . . . 4.27 114.984 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -69.23 -29.77 67.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.594 0.712 . . . . 3.94 109.634 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.482 ' HG3' ' HB3' ' A' ' 110' ' ' GLU . 51.5 tp60 -93.01 119.46 32.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.661 -1.237 . . . . 5.6 107.661 168.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.596 ' HG2' ' OE1' ' A' ' 130' ' ' GLU . 1.4 pm0 -63.45 -14.46 50.92 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.213 0.53 . . . . 5.3 111.431 -171.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 108' ' ' GLN . 47.1 tt0 -62.42 -11.69 17.33 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.698 -0.683 . . . . 4.95 110.549 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -27.44 55.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.642 -0.708 . . . . 3.19 110.835 174.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.71 62.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.034 -0.53 . . . . 1.24 110.96 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 95.96 144.42 16.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.334 -0.46 . . . . 0.94 112.272 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.5 mt -128.99 145.03 51.35 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.699 0.761 . . . . 0.93 112.148 -174.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.13 137.37 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.413 -1.267 . . . . 0.49 108.532 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.0 pt-20 -90.48 125.07 35.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.489 0.661 . . . . 1.4 110.505 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 93' ' ' HIS . 44.0 mm -94.97 136.84 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.894 -1.048 . . . . 0.63 110.43 -174.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -100.73 144.39 29.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.63 167.29 9.27 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.104 0.252 . . . . 2.29 111.023 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' HG3' HD22 ' A' ' 121' ' ' LEU . 13.0 pt-20 -60.2 -29.44 68.71 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.575 0.35 . . . . 2.78 111.528 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.502 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -89.5 6.15 42.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.77 110.527 178.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 69.72 87.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 4.14 111.793 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.6 p -115.8 -159.07 0.7 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.928 -1.033 . . . . 1.87 109.639 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 p -85.84 -161.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.338 -0.392 . . . . 1.54 109.975 170.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.5 p -64.44 120.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 1.29 111.34 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.8 mt -69.1 -67.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 1.03 110.343 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 p -133.28 -86.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.75 -0.38 . . . . 1.56 111.335 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -178.1 129.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.685 . . . . 2.08 109.654 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.462 ' CG ' HG13 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -116.19 129.72 56.44 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.68 110.246 176.016 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.596 ' OE1' ' HG2' ' A' ' 109' ' ' GLN . 10.4 tt0 -96.77 149.69 21.55 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.071 -0.968 . . . . 1.19 109.958 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 31.0 p90 -117.87 177.11 4.9 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.67 -0.412 . . . . 0.74 110.709 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -134.93 152.98 20.92 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.912 -0.585 . . . . 0.51 111.848 -176.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -52.86 -28.76 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.887 0.375 . . . . 0.67 111.897 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.0 p -77.53 -33.19 54.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.409 0.623 . . . . 1.35 110.436 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 132' ' ' GLY . 47.9 t -72.03 -27.38 62.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.107 -0.951 . . . . 1.1 110.311 177.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.08 59.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.393 -0.821 . . . . 1.46 112.506 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -48.61 -41.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.234 0.54 . . . . 0.82 110.257 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.3 m120 -87.86 32.65 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.759 -0.655 . . . . 2.17 111.414 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -60.59 -21.66 62.88 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.156 0.503 . . . . 1.39 111.264 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -93.14 -6.28 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 2.46 111.371 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -88.51 158.06 18.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.76 -0.654 . . . . 1.89 111.188 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.4 mm? -81.36 49.06 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 2.88 110.43 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 164' ' ' ALA . 21.8 tp -76.4 122.84 25.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.603 -0.726 . . . . 0.97 109.937 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 11.7 pt20 -123.94 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.657 . . . . 1.77 111.732 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.39 121.79 15.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.907 -1.042 . . . . 1.43 109.905 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.33 1.81 44.31 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.322 -0.942 . . . . 1.07 112.53 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.463 ' OD1' ' HG2' ' A' ' 144' ' ' GLN . 13.3 m-20 -91.07 140.13 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.743 0.272 . . . . 1.94 110.393 173.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.78 138.99 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.918 0.39 . . . . 1.79 110.862 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 164' ' ' ALA . 15.6 m -135.97 146.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 1.16 110.823 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.3 p -104.67 133.38 49.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.505 -0.554 . . . . 1.44 109.505 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' HE2' ' CE1' ' A' ' 93' ' ' HIS . 5.5 p90 -146.42 163.57 35.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.116 0.26 . . . . 0.61 110.7 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 1.4 mpp_? -118.54 121.7 40.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.147 0.499 . . . . 2.2 110.194 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 92' ' ' THR . 12.9 tt -100.41 136.95 29.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.696 . . . . 1.24 109.788 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -169.61 -93.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.568 -0.16 . . . . 1.92 110.568 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.52 -19.97 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.826 0.346 . . . . 2.76 111.254 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.3 t -81.66 -17.01 49.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.927 -0.397 . . . . 1.98 109.927 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.32 23.22 57.54 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.791 -0.64 . . . . 1.27 113.51 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 11.4 ptp180 -156.93 -168.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.451 -0.574 . . . . 3.61 109.451 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.6 108.3 17.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.897 0.379 . . . . 0.48 110.319 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.12 144.85 44.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.154 -0.475 . . . . 0.49 111.368 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.9 m 66.17 43.6 2.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.633 -0.712 . . . . 1.55 110.352 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.9 m -65.07 118.7 7.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.622 0.725 . . . . 1.26 110.786 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.431 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.1 t-20 -120.86 124.4 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.48 -0.782 . . . . 2.05 109.882 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.07 112.96 3.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.75 111.041 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.86 129.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.944 -0.571 . . . . 1.56 111.021 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -98.47 116.78 31.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 2.94 110.061 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.01 148.59 51.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.184 0.516 . . . . 3.88 110.437 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 51.0 tttp . . . . . 0 N--CA 1.435 -1.196 0 CA-C-N 115.387 -0.824 . . . . 4.04 111.229 -178.148 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.96 -0.456 . . . . 11.74 111.96 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.21 -178.46 5.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.891 -0.411 . . . . 10.54 109.891 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.62 30.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.601 -0.809 . . . . 8.95 111.8 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -82.74 54.69 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.536 0.684 . . . . 7.09 110.657 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.78 78.98 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.464 -0.789 . . . . 5.59 110.964 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.93 -14.95 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.927 -0.579 . . . . 2.99 110.524 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -29.77 3.77 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.932 -0.576 . . . . 1.61 112.445 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -129.54 128.41 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.96 0.409 . . . . 2.0 110.788 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.45 114.65 25.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.631 . . . . 1.27 109.459 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.34 159.31 15.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.501 -0.772 . . . . 1.14 109.267 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.518 ' HG3' HD13 ' A' ' 27' ' ' LEU . 6.8 ptp180 -141.05 147.42 38.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.757 -0.46 . . . . 2.31 109.757 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.09 -169.77 22.06 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.172 -0.771 . . . . 0.5 111.172 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.19 140.26 52.69 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.785 0.326 . . . . 0.68 110.468 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.21 116.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.642 -0.708 . . . . 0.56 110.613 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.28 -48.55 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.76 111.355 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 96.2 t -114.45 124.03 70.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.676 0.274 . . . . 1.55 110.649 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.5 ttm -126.94 105.55 8.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.272 -0.422 . . . . 1.42 110.197 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 17.9 mmtp -97.94 -161.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.715 -0.476 . . . . 2.03 109.715 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -50.63 38.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 3.24 111.912 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 50.8 m-80 -112.24 -34.47 5.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 2.03 111.571 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 p90 -124.82 173.74 8.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.15 -0.477 . . . . 1.25 110.709 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.32 165.74 35.56 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 111.076 -0.81 . . . . 0.71 111.076 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.6 m-85 -110.44 126.64 54.53 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.183 0.516 . . . . 1.08 109.791 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -95.7 130.23 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.696 -0.853 . . . . 0.61 108.696 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -80.16 128.75 33.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.534 -0.913 . . . . 2.3 108.534 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.6 p -63.34 149.73 45.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.745 -0.661 . . . . 0.87 110.829 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 83' ' ' ILE . 11.4 tp -54.93 -34.12 62.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.305 0.574 . . . . 1.58 111.828 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -110.36 22.46 15.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 2.04 111.431 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.454 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 31.4 p80 43.63 45.73 5.9 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.016 0.912 . . . . 3.29 111.369 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.71 -44.72 9.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.919 -1.037 . . . . 2.89 111.337 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.82 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 1.8 112.07 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.21 121.75 46.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.53 -0.759 . . . . 3.37 110.367 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.19 127.32 64.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.87 111.536 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -91.83 120.62 32.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.95 -0.568 . . . . 1.06 110.053 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -128.45 138.08 52.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.275 -0.42 . . . . 1.96 110.089 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' A' ' 20' ' ' ASN . 3.3 t60 -107.6 124.29 49.73 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -63.18 -18.04 63.06 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.626 0.602 . . . . 0.75 112.626 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 -31.5 68.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.679 0.276 . . . . 1.63 110.841 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.05 5.95 46.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.982 0.42 . . . . 2.07 111.4 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 47.4 t80 -75.34 132.09 40.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.313 -0.403 . . . . 0.91 110.047 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.3 ttp -114.63 91.06 3.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.959 0.409 . . . . 1.73 110.08 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.68 -136.65 4.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.987 -0.845 . . . . 1.05 110.987 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -121.25 96.6 48.04 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 117.023 0.411 . . . . 2.14 110.681 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.39 -22.94 12.03 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.791 2.328 . . . . 1.01 113.013 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -81.66 -5.91 58.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.295 0.569 . . . . 2.08 110.476 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -112.47 18.04 18.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.88 -0.6 . . . . 2.18 110.414 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 49.2 mt -92.32 143.72 26.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.841 -0.618 . . . . 0.92 110.716 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.0 157.96 42.73 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.993 -0.743 . . . . 2.35 108.993 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.7 mm? -60.84 134.43 57.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.966 0.412 . . . . 1.4 110.511 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.29 -15.55 50.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.716 -0.754 . . . . 0.75 113.032 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -66.0 133.32 50.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.997 0.427 . . . . 1.06 111.434 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 1.8 mp0 -81.36 137.39 35.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.889 . . . . 2.51 110.763 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 77' ' ' MET . 23.6 m -144.3 151.54 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.44 109.843 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HB3' HD21 ' A' ' 78' ' ' LEU . 23.9 pt-20 -112.0 144.69 40.93 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.978 -0.378 . . . . 1.49 109.978 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.416 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.6 p90 -161.49 170.71 19.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.66 111.856 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -120.45 143.79 48.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.94 111.049 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.42 143.28 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 1.19 110.875 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -87.37 76.93 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.512 . . . . 2.04 110.018 176.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD3' HD12 ' A' ' 70' ' ' LEU . 20.9 tpp180 -91.12 57.68 3.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 5.33 109.614 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -64.35 133.38 52.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 5.42 110.279 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.89 76.77 1.56 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.956 -0.566 . . . . 4.76 113.425 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -90.28 -163.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 6.38 109.361 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 65' ' ' VAL . 9.9 t -68.13 -22.13 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.09 -0.244 . . . . 6.4 110.749 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.4 m 64.96 16.36 10.5 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.101 0.778 . . . . 5.23 113.101 169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 63' ' ' THR . 19.9 m -99.25 -26.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 6.95 111.373 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -107.72 -4.32 18.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.008 0.433 . . . . 6.02 110.386 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.41 79.52 1.77 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.865 -0.683 . . . . 4.09 112.432 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -66.36 -44.09 84.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.865 0.364 . . . . 4.22 110.888 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -135.85 136.39 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 2.09 110.321 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD12 ' HD3' ' A' ' 59' ' ' ARG . 78.4 mt -110.3 146.09 33.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.978 -0.555 . . . . 2.3 109.886 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.53 165.72 31.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.331 2.021 . . . . 1.43 111.808 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.12 141.06 40.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.508 -0.315 . . . . 0.82 110.419 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 71.3 mm-40 -124.22 152.22 43.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 2.3 110.186 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.29 84.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.729 0.643 . . . . 2.01 111.511 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.6 t -110.94 124.62 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.146 -0.479 . . . . 0.8 110.003 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -118.25 153.42 33.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.802 -0.635 . . . . 3.51 109.792 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.448 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.1 mtp -97.86 119.46 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.7 -0.227 . . . . 1.12 110.783 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -122.56 104.09 37.26 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-O 121.804 0.812 . . . . 1.67 111.401 176.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -88.95 129.49 2.04 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.27 1.98 . . . . 2.15 112.868 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.5 tttp 79.05 133.13 0.06 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.073 1.138 . . . . 4.61 114.073 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.3 t30 68.96 3.23 3.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.444 -1.253 . . . . 2.84 112.891 167.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -78.14 -25.93 47.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.2 -0.6 . . . . 1.7 109.439 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 27' ' ' LEU . 1.8 mm -108.33 128.21 26.09 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.392 -0.966 . . . . 0.92 108.392 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.16 152.08 50.16 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.297 1.998 . . . . 1.03 112.461 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -103.66 142.49 24.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 2.76 109.597 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.73 128.13 21.39 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.297 1.998 . . . . 1.08 111.977 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.26 95.0 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 1.1 111.502 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -137.54 135.01 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.113 -0.699 . . . . 1.23 109.113 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -85.18 -62.0 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.659 -0.416 . . . . 2.87 111.265 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -93.0 -56.93 2.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.534 0.568 . . . . 2.84 112.534 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m 169.12 140.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.866 -1.161 . . . . 1.42 107.866 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -93.21 -55.34 3.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.174 -0.61 . . . . 1.3 110.638 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -145.96 148.29 32.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 1.29 110.987 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -110.7 161.54 15.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.706 -1.22 . . . . 1.36 107.706 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.28 -176.88 41.38 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.429 -1.367 . . . . 0.53 112.838 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.56 146.69 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.828 -0.434 . . . . 1.37 109.828 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.5 t -58.79 119.47 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.316 -0.402 . . . . 0.69 110.575 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -74.4 -37.49 63.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.89 111.192 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -177.66 131.46 0.33 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 3.92 110.563 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 144' ' ' GLN . 17.0 Cg_exo -70.96 169.29 20.79 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.437 2.091 . . . . 2.22 111.501 169.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -106.76 90.24 3.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.262 0.554 . . . . 3.32 111.629 -175.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -98.17 -62.99 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 5.56 110.212 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 m -91.71 5.21 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 4.14 111.19 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.26 -44.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.413 -0.358 . . . . 3.46 110.443 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.505 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 6.2 t30 67.89 153.23 0.13 Allowed Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.7 0.625 . . . . 4.99 111.515 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 105' ' ' ASN . 32.8 Cg_endo -65.36 -12.27 34.1 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.551 2.167 . . . . 4.27 112.764 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.75 1.72 25.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 3.94 111.329 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -117.46 149.56 40.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.79 0.328 . . . . 5.6 110.422 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -71.28 -0.25 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 5.3 111.773 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -103.8 13.09 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.271 0.558 . . . . 4.95 110.096 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.475 ' O ' HD13 ' A' ' 101' ' ' LEU . 10.4 t80 -57.3 -35.1 69.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.041 -0.981 . . . . 3.19 112.428 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.54 -22.96 64.47 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.049 0.389 . . . . 1.24 112.049 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.3 163.33 30.63 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.94 111.984 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.4 mt -143.45 150.71 39.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.93 111.876 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.5 mt -116.3 136.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.981 -1.009 . . . . 0.49 109.748 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.57 114.67 24.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.678 0.751 . . . . 1.4 110.009 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -91.0 132.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.994 -1.003 . . . . 0.63 109.076 -176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.02 146.01 27.4 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.779 -0.368 . . . . 1.21 110.438 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.81 -178.6 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 2.29 110.401 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.4 pm0 -68.11 -25.14 65.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.895 0.331 . . . . 2.78 111.895 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -93.35 0.71 57.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.904 -0.318 . . . . 1.77 110.476 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 62.95 39.57 10.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.043 -0.526 . . . . 4.14 110.789 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 m -104.38 -50.69 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.87 111.553 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 125' ' ' VAL . 5.2 m -143.36 166.46 24.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.769 0.319 . . . . 1.54 110.794 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -68.72 137.27 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.356 -0.384 . . . . 1.29 110.995 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.16 -68.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 1.03 110.552 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -137.06 -86.41 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.017 0.436 . . . . 1.56 111.046 171.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -177.24 136.43 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.365 -0.834 . . . . 2.08 109.224 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.688 ' HB2' HD11 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -118.83 132.89 56.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.66 -0.416 . . . . 0.68 110.48 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.442 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.1 tt0 -91.25 146.82 23.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.424 -0.807 . . . . 1.19 109.507 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -118.75 142.4 47.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.74 110.967 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.25 150.14 24.49 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.825 -0.625 . . . . 0.51 112.522 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.2 tp -54.39 -43.86 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.126 0.488 . . . . 0.67 111.624 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -71.99 -29.56 64.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.213 0.53 . . . . 1.35 110.124 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 6.0 m -73.07 -24.11 60.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.629 . . . . 1.1 110.495 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -77.17 60.05 1.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.947 -0.57 . . . . 1.46 110.486 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 137' ' ' VAL . 21.8 t -39.96 -46.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.782 -0.644 . . . . 0.82 111.503 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -94.19 33.68 1.35 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 2.17 111.537 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.54 -20.04 52.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.723 0.409 . . . . 1.39 111.765 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 141' ' ' ASP . 3.4 ptt180 -75.74 -22.92 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 2.46 110.976 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 2.9 m-20 -93.29 140.49 29.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.893 -172.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 102.41 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.648 . . . . 2.88 110.788 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.04 118.44 32.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.97 109.93 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 23.3 pt20 -120.24 -179.03 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.707 0.289 . . . . 1.77 111.117 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.55 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 75.2 tttt -65.17 126.94 29.68 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.699 -0.482 . . . . 1.43 109.699 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.74 -17.05 13.62 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.533 -0.758 . . . . 1.07 111.352 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -85.5 129.94 34.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 1.94 110.266 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -81.72 143.75 31.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.79 110.609 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.11 144.9 35.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.814 -0.63 . . . . 1.16 110.308 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.0 m -106.61 128.36 54.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.515 -0.55 . . . . 1.44 109.515 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.588 ' HB3' HG12 ' A' ' 162' ' ' VAL . 30.2 p90 -145.26 -178.61 6.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.481 . . . . 0.61 110.165 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -148.63 124.03 10.3 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.311 -0.556 . . . . 2.2 111.019 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.48 HG21 ' CD2' ' A' ' 129' ' ' HIS . 7.5 pt -99.56 153.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.996 -0.547 . . . . 1.24 109.853 172.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.554 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 33.0 t70 -177.15 -88.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.277 0.361 . . . . 1.92 110.293 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 45.6 mt-10 -74.22 -28.6 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 2.76 110.535 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 158' ' ' ARG . 13.3 p -78.85 -17.34 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 1.98 110.602 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.93 -28.21 0.64 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.135 -0.484 . . . . 1.27 113.111 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 156' ' ' SER . 90.4 mtt180 -120.39 -169.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.62 22.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.341 0.591 . . . . 0.48 111.791 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -126.42 155.79 41.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.185 -0.916 . . . . 0.49 110.061 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.6 m 57.55 51.4 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 1.55 111.087 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.0 m -79.05 145.13 9.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.854 -0.612 . . . . 1.26 110.437 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -149.04 128.8 13.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.359 -0.608 . . . . 2.05 109.359 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.04 124.22 19.56 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.385 0.428 . . . . 0.75 111.094 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 99.9 t -132.54 142.11 43.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 1.56 110.342 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -101.31 145.26 29.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 2.94 110.258 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -96.22 120.64 36.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.159 -0.473 . . . . 3.88 110.495 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.139 -0.482 . . . . 4.04 110.934 177.261 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.663 -0.175 . . . . 11.74 112.663 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.36 173.89 9.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.264 -0.273 . . . . 10.54 110.264 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.37 83.11 0.55 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 121.022 -0.609 . . . . 8.95 112.375 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 p -134.51 110.63 9.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 7.09 111.361 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.27 48.05 20.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.601 -0.727 . . . . 5.59 111.973 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.41 67.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 2.99 110.786 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.61 -29.73 8.73 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.884 -0.598 . . . . 1.61 112.469 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -137.07 132.19 33.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.144 0.497 . . . . 2.0 110.696 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.97 114.7 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.529 -0.915 . . . . 1.27 108.529 172.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -87.18 141.71 28.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.253 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 25.5 mmt85 -100.76 146.0 27.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.575 -0.738 . . . . 2.31 110.285 -177.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.69 -173.26 33.14 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.224 -1.15 . . . . 0.5 110.224 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.44 145.35 36.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.199 0.5 . . . . 0.68 111.196 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.54 101.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.561 -0.745 . . . . 0.56 110.61 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.41 -43.82 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.015 0.436 . . . . 0.76 110.733 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.74 122.6 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.208 -0.451 . . . . 1.55 110.665 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.0 ttm -117.58 107.33 14.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.42 109.788 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.21 170.36 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.159 -0.682 . . . . 2.03 109.159 176.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.728 0.299 . . . . 3.24 111.746 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -102.38 -34.85 9.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.147 0.425 . . . . 2.03 112.147 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.89 -172.79 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.61 0.243 . . . . 1.25 111.186 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.09 173.44 32.68 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.833 -0.699 . . . . 0.71 111.899 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.73 138.71 52.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.832 0.348 . . . . 1.08 110.262 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.09 129.91 58.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.61 109.807 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.48 130.98 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.013 -1.106 . . . . 2.3 108.013 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -65.86 145.22 56.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.89 -0.595 . . . . 0.87 111.382 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 83' ' ' ILE . 2.3 tm? -52.36 -45.33 65.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 1.58 111.202 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -110.83 31.9 5.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.187 -0.46 . . . . 2.04 111.376 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 p80 43.89 45.38 6.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.785 0.834 . . . . 3.29 111.574 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.32 -48.21 62.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.8 -1.091 . . . . 2.89 110.608 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -172.46 -172.34 0.91 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 1.8 110.858 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.09 122.0 42.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 3.37 110.747 -168.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.58 136.29 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 121.116 0.484 . . . . 0.87 111.908 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.12 130.65 55.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 1.06 109.97 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -125.18 156.88 37.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.025 -0.732 . . . . 1.96 109.025 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -118.68 133.06 56.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.757 -0.46 . . . . 1.18 109.757 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.25 -24.04 66.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.867 0.691 . . . . 0.75 112.867 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -66.3 -33.37 75.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.762 0.315 . . . . 1.63 110.779 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.84 19.58 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.264 0.554 . . . . 2.07 110.564 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.458 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 75.0 t80 -92.98 139.69 30.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.654 -0.703 . . . . 0.91 110.304 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 38.0 ttm -119.5 100.42 7.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 1.73 110.108 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.88 -143.05 10.12 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.486 -0.646 . . . . 1.05 111.486 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -115.53 99.38 52.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.789 0.294 . . . . 2.14 110.732 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -81.9 -25.22 3.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.388 2.059 . . . . 1.01 111.918 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.34 -14.29 60.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 2.08 110.315 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -114.39 19.42 16.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.18 111.067 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.458 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 17.1 mt -82.29 169.31 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 0.92 112.202 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -130.77 164.76 24.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.014 -0.993 . . . . 2.35 110.337 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.18 114.87 22.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.6 -0.518 . . . . 1.4 109.6 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.67 3.05 46.67 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.742 -0.663 . . . . 0.75 112.192 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -68.3 122.46 18.41 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 1.06 111.574 -177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' OE2' ' HG2' ' A' ' 80' ' ' LYS . 26.0 mp0 -61.49 127.12 29.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.412 -0.813 . . . . 2.51 111.14 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.1 149.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.761 -0.654 . . . . 0.44 109.913 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 11' ' ' ARG . 21.6 pt-20 -121.22 137.32 54.73 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.344 -0.613 . . . . 1.49 109.344 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 4.3 p90 -155.39 178.05 10.67 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.684 -0.406 . . . . 0.66 111.411 -172.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -124.3 141.55 51.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.361 -0.381 . . . . 0.94 111.096 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.76 119.82 18.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.19 109.579 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -77.64 -39.17 46.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.883 -1.053 . . . . 2.04 111.615 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HB2' HD22 ' A' ' 70' ' ' LEU . 7.1 mpt_? -100.27 37.59 1.64 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.224 -0.898 . . . . 5.33 109.526 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.57 -24.26 67.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.417 -0.811 . . . . 5.42 111.067 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.91 17.01 35.93 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.716 -0.754 . . . . 4.76 112.642 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 15.2 m120 -115.74 121.44 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.787 -0.449 . . . . 6.38 109.787 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 p -88.34 87.16 7.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.409 0.623 . . . . 6.4 112.165 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 p 53.95 31.8 14.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.576 -1.193 . . . . 5.23 112.397 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.93 -30.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.142 0.496 . . . . 6.95 110.478 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 p -80.43 1.24 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.068 -0.514 . . . . 6.02 111.292 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.71 -91.52 1.49 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.934 -0.651 . . . . 4.09 112.072 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -105.98 -53.99 2.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.833 0.349 . . . . 4.22 110.939 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.2 m -134.07 152.35 51.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.136 -0.484 . . . . 2.09 110.676 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 59' ' ' ARG . 3.0 pp -126.89 148.41 65.3 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.789 -0.641 . . . . 2.3 109.777 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HG2' ' NH1' ' A' ' 59' ' ' ARG . 40.5 Cg_endo -71.91 147.76 50.27 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.92 1.747 . . . . 1.43 112.233 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.4 142.07 27.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.82 110.421 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 53.8 mm-40 -113.02 156.66 22.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.061 -0.718 . . . . 2.3 109.061 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 58.07 50.68 9.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.576 0.703 . . . . 2.01 110.282 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 20.3 t -80.85 110.7 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.846 -0.616 . . . . 0.8 110.064 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 76' ' ' ARG . 9.3 mmt180 -107.98 173.69 6.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.578 0.704 . . . . 3.51 111.821 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.442 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 48.1 mtp -117.46 144.05 45.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.859 -1.064 . . . . 1.12 109.301 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.4 pt? -131.56 160.27 68.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 C-N-CA 120.694 -0.403 . . . . 1.67 110.072 175.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 60.7 Cg_endo -73.55 160.97 43.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.833 1.689 . . . . 2.15 112.155 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HG2' ' OE2' ' A' ' 52' ' ' GLU . 41.6 mtmt -74.1 173.92 9.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.788 -0.642 . . . . 4.61 112.125 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.52 30.66 2.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.43 -1.259 . . . . 2.84 110.55 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 t -124.39 11.09 8.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.798 0.809 . . . . 1.7 109.324 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 27' ' ' LEU . 40.9 mm -113.12 125.25 30.04 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 0.92 109.157 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.78 158.33 57.73 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.875 2.383 . . . . 1.03 113.268 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -137.35 152.73 73.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 2.76 109.779 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 10.8 Cg_exo -69.93 150.19 66.82 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.542 2.161 . . . . 1.08 112.545 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.95 92.52 6.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.387 0.613 . . . . 1.1 111.38 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 154' ' ' ASP . 92.2 t -142.79 119.3 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.009 -1.108 . . . . 1.23 108.009 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.82 -63.45 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.197 0.814 . . . . 2.87 113.197 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.19 -59.95 1.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.728 -0.789 . . . . 2.84 112.529 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -179.52 137.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.533 0.733 . . . . 1.42 109.525 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -106.3 -42.52 5.03 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.072 -0.251 . . . . 1.3 110.924 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -141.02 140.11 34.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.682 0.277 . . . . 1.29 110.422 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -116.97 110.14 17.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.239 -0.652 . . . . 1.36 109.239 173.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -114.53 -171.45 17.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.313 -0.946 . . . . 0.53 112.863 -172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -133.96 143.27 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.327 -0.249 . . . . 1.37 110.327 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.41 124.21 13.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.507 -0.315 . . . . 0.69 110.891 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.33 -59.11 2.65 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.226 -0.443 . . . . 0.89 111.172 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -151.07 129.05 5.84 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.859 0.361 . . . . 3.92 110.802 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.18 141.4 18.41 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.675 2.25 . . . . 2.22 111.429 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 98.14 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.239 0.543 . . . . 3.32 112.075 -175.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -95.86 -63.99 1.1 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 5.56 110.828 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 35.0 t -94.2 10.43 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 4.14 111.714 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 47.8 mm -66.88 -39.43 83.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.703 0.26 . . . . 3.46 111.703 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 41.1 t30 71.35 123.73 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.764 0.665 . . . . 4.99 111.212 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 111' ' ' TYR . 32.6 Cg_endo -64.54 0.93 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.37 2.713 . . . . 4.27 114.335 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -88.27 3.34 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.572 0.701 . . . . 3.94 110.045 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -127.79 142.95 51.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.815 -0.63 . . . . 5.6 109.633 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -69.65 2.46 3.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.63 0.974 . . . . 5.3 113.63 -170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.87 6.01 30.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 4.95 109.767 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 106' ' ' PRO . 12.0 t80 -56.31 -31.77 64.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.147 -0.933 . . . . 3.19 112.313 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.49 -28.83 69.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.022 0.379 . . . . 1.24 112.022 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.77 164.46 38.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.485 -0.864 . . . . 0.94 111.284 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD13 ' NE2' ' A' ' 128' ' ' GLN . 26.1 mt -146.47 141.66 27.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.809 0.814 . . . . 0.93 112.214 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.13 132.94 55.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.181 -1.372 . . . . 0.49 108.988 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.93 112.42 21.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.883 0.849 . . . . 1.4 109.593 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.3 mm -87.56 134.85 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.694 -1.139 . . . . 0.63 110.249 -170.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.59 148.04 26.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.41 0.624 . . . . 1.21 110.731 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.64 150.89 14.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.994 -1.003 . . . . 2.29 109.116 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.8 -16.94 64.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.752 -0.379 . . . . 2.78 111.682 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.79 10.82 39.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.677 -0.49 . . . . 1.77 109.677 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 63.4 29.93 15.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.264 -0.88 . . . . 4.14 111.096 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 m -73.09 -76.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 1.87 110.988 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -143.94 -166.11 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.499 -0.126 . . . . 1.54 110.742 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 40.0 t -80.55 138.83 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 122.925 0.141 . . . . 1.29 110.689 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.7 mt -77.34 -70.68 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.908 -0.405 . . . . 1.03 109.908 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.4 m -138.52 -86.2 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.346 0.593 . . . . 1.56 110.457 167.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.435 ' NE2' HD13 ' A' ' 114' ' ' LEU . 10.9 pt20 -178.44 144.55 0.3 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.067 -0.97 . . . . 2.08 108.645 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.722 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.9 m-70 -115.46 142.24 46.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.531 0.681 . . . . 0.68 111.282 176.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -89.87 140.76 29.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.263 -1.335 . . . . 1.19 109.176 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CD1' HD21 ' A' ' 136' ' ' LEU . 30.9 p90 -118.07 154.97 31.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.82 0.343 . . . . 0.74 111.171 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.48 151.48 18.41 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.51 112.517 -173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.26 -32.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.008 0.432 . . . . 0.67 112.062 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 p -77.44 -38.02 50.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.438 -0.346 . . . . 1.35 111.106 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 42.2 p -80.49 -11.2 59.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.643 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 131' ' ' PHE . 29.4 mt -74.91 59.29 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 1.46 111.739 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -45.22 -41.38 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.537 . . . . 0.82 111.128 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.5 m120 -91.88 34.25 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.778 -0.646 . . . . 2.17 111.78 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 3.0 ptmt -64.39 -11.47 33.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.422 0.63 . . . . 1.39 110.832 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -87.52 -22.17 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.527 -0.761 . . . . 2.46 110.834 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 9.8 m-20 -92.86 162.54 14.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 1.89 111.726 -167.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.29 95.89 10.15 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.763 -0.653 . . . . 2.88 109.288 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.9 tp -114.78 107.45 15.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.901 -1.045 . . . . 0.97 109.04 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.92 -177.35 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 1.77 111.456 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -59.59 119.59 7.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 1.43 110.708 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.02 -3.55 31.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.564 -0.827 . . . . 1.07 112.904 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -89.7 137.07 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 1.94 110.655 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 148' ' ' LEU . 2.4 mm? -85.13 139.37 31.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 1.79 110.846 -174.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 141.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 1.16 111.461 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.0 p -105.72 123.37 47.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.5 p90 -139.94 164.36 30.2 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.585 -0.524 . . . . 0.61 109.585 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 6.8 mpt_? -123.65 119.25 29.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.018 -0.673 . . . . 2.2 110.136 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 tt -101.66 137.45 29.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.51 -0.768 . . . . 1.24 109.544 170.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 21.6 t70 -162.13 -99.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.915 -0.314 . . . . 1.92 110.731 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 8.8 pt-20 -83.0 -7.08 59.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.2 0.524 . . . . 2.76 111.071 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.4 t -93.26 -17.19 23.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.043 -0.526 . . . . 1.98 109.769 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.17 15.51 58.76 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 116.052 -0.522 . . . . 1.27 113.955 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -139.67 -177.32 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.44 . . . . 3.61 109.813 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.94 108.22 18.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.252 0.548 . . . . 0.48 110.107 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.504 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -118.03 155.74 29.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.49 110.557 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 t 56.37 49.3 15.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 1.55 109.699 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.23 110.74 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.038 -0.983 . . . . 1.26 110.608 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.11 124.4 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 2.05 110.126 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 121.21 14.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.208 -0.293 . . . . 0.75 110.208 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 96.3 t -128.31 140.88 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 1.56 111.091 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -109.91 122.26 47.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 2.94 109.922 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -99.95 158.84 15.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.238 -0.653 . . . . 3.88 109.238 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 115.791 -0.64 . . . . 4.04 110.403 -176.99 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.38 -0.288 . . . . 11.74 112.38 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.89 136.93 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.986 -0.376 . . . . 10.54 109.986 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.46 49.6 0.1 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.417 -0.897 . . . . 8.95 111.708 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.4 m -149.12 120.87 8.09 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.765 -0.458 . . . . 7.09 109.765 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -113.51 99.34 7.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.242 -0.435 . . . . 5.59 109.927 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.5 -169.46 2.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.834 -0.621 . . . . 2.99 110.17 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.69 23.35 76.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.506 -0.854 . . . . 1.61 111.423 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -94.85 115.91 28.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.212 0.529 . . . . 2.0 111.763 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' HA ' HG22 ' A' ' 56' ' ' THR . 1.1 p -102.1 121.52 53.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.478 -0.934 . . . . 1.27 108.478 170.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -98.39 155.58 17.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.699 -0.682 . . . . 1.14 109.594 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 27' ' ' LEU . 29.2 ptt-85 -128.82 143.91 51.03 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.104 0.478 . . . . 2.31 110.085 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.16 -171.88 21.57 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.356 -1.098 . . . . 0.5 110.356 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.32 140.34 48.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.271 0.557 . . . . 0.68 111.055 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.575 HG21 ' SD ' ' A' ' 17' ' ' MET . 45.7 mm -65.24 122.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.142 -0.935 . . . . 0.56 111.838 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.24 -18.0 10.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.76 111.321 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.41 HG11 ' HD2' ' A' ' 23' ' ' PHE . 96.7 t -135.54 123.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.395 0.141 . . . . 1.55 111.051 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.575 ' SD ' HG21 ' A' ' 14' ' ' ILE . 85.7 mmm -118.1 111.23 18.61 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.131 0.419 . . . . 1.42 112.131 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.749 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -112.4 172.23 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.514 -0.921 . . . . 2.03 108.514 165.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -82.89 -25.52 32.4 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.49 -0.484 . . . . 3.24 110.958 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -92.19 -50.23 5.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.724 0.297 . . . . 2.03 111.7 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.4 p90 -153.15 151.25 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.994 0.426 . . . . 1.25 111.292 -174.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.91 -178.8 15.71 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.891 -0.671 . . . . 0.71 111.817 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HD2' HG11 ' A' ' 16' ' ' VAL . 94.2 m-85 -131.88 141.83 49.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.345 -0.613 . . . . 1.08 109.345 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.61 119.78 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.081 0.467 . . . . 0.61 111.581 -170.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -70.83 128.59 36.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 2.3 108.934 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 p -81.2 153.12 27.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.192 -0.458 . . . . 0.87 111.161 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.2 tp -50.14 -47.73 54.04 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.55 -0.75 . . . . 1.58 111.622 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -104.77 20.88 17.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 2.04 111.023 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 p80 41.48 47.56 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.88 0.872 . . . . 3.29 111.781 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.77 -40.49 22.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.451 -0.795 . . . . 2.89 110.068 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -159.99 179.98 8.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.418 -0.81 . . . . 1.8 109.78 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -114.74 133.3 56.01 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.429 -0.952 . . . . 3.37 108.429 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG11 ' HE2' ' A' ' 55' ' ' TYR . 24.2 t -114.22 112.17 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.461 0.648 . . . . 0.87 111.993 -170.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 5.6 t80 -72.06 119.97 17.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.222 -0.899 . . . . 1.06 110.491 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -124.77 136.06 53.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.197 -0.456 . . . . 1.96 110.621 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -98.97 118.08 34.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.617 -0.883 . . . . 1.18 108.617 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.07 -17.38 39.14 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.26 0.467 . . . . 0.75 112.26 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 t -56.49 -24.98 49.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.191 -0.459 . . . . 1.63 111.114 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -107.14 24.24 13.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 2.07 111.021 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.416 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 70.9 t80 -87.41 152.05 22.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.91 111.297 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.6 ttm -116.47 110.88 19.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 1.73 109.89 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.05 -139.34 10.81 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.568 -0.825 . . . . 1.05 112.278 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -122.72 99.75 41.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.535 0.207 . . . . 2.14 110.468 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.53 -20.75 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.272 1.981 . . . . 1.01 112.372 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -74.88 -11.83 60.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 2.08 111.168 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -109.46 14.71 23.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 2.18 110.653 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 38.1 mt -93.83 158.66 15.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.92 111.048 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -162.06 175.13 12.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.597 -0.729 . . . . 2.35 109.571 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 mt -72.99 122.22 21.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.849 0.357 . . . . 1.4 111.039 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.08 -4.53 16.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.676 -0.773 . . . . 0.75 112.899 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -86.83 132.96 33.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.048 0.424 . . . . 1.06 111.237 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 3.4 mp0 -82.14 143.52 31.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.86 -0.609 . . . . 2.51 111.138 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.0 m -141.48 153.58 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.704 -0.68 . . . . 0.44 110.193 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -113.64 137.62 51.34 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.235 -0.654 . . . . 1.49 109.235 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.518 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.3 p90 -164.45 163.03 22.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.398 0.618 . . . . 0.66 112.372 -175.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 9' ' ' VAL . 68.6 p -113.3 147.72 37.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.94 110.025 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.2 135.73 46.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.647 -0.421 . . . . 1.19 110.327 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.76 -56.07 7.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 2.04 111.002 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 12.7 tpp180 63.68 13.33 7.29 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.135 -0.938 . . . . 5.33 110.055 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -62.06 141.07 58.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.565 -0.743 . . . . 5.42 109.47 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.97 -37.22 3.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.79 -0.924 . . . . 4.76 110.79 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 63' ' ' THR . 15.7 m120 63.11 12.57 6.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.299 0.64 . . . . 6.38 112.121 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -167.91 127.17 1.28 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.967 -0.56 . . . . 6.4 110.176 -175.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 m -72.89 25.15 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.685 -0.689 . . . . 5.23 112.079 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' H ' ' C ' ' A' ' 63' ' ' THR . 20.6 m -78.46 -20.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 6.95 110.99 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -101.9 8.28 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 6.02 110.216 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.89 135.11 2.06 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.072 -0.811 . . . . 4.09 111.072 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -52.08 -54.31 31.85 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.064 0.394 . . . . 4.22 112.064 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 p -98.8 151.02 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.418 -0.356 . . . . 2.09 110.909 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 59' ' ' ARG . 63.2 mt -105.24 152.41 39.79 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 2.3 110.333 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 47.1 Cg_endo -69.33 174.98 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.586 2.19 . . . . 1.43 112.134 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.72 159.52 22.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.596 -0.275 . . . . 0.82 110.84 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -130.1 145.39 51.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.709 0.29 . . . . 2.3 111.566 -176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 55.17 85.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.047 -0.979 . . . . 2.01 111.823 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 55' ' ' TYR . 43.5 t -115.86 119.38 61.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.056 -0.52 . . . . 0.8 110.623 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -120.22 164.74 15.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.636 -0.505 . . . . 3.51 109.636 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.452 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.9 mtt -81.12 144.27 31.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.815 0.34 . . . . 1.12 110.653 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 26.2 tp -121.68 129.43 25.19 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.67 110.183 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 28.2 Cg_exo -63.83 154.37 70.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.624 2.216 . . . . 2.15 112.476 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.685 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -64.07 168.82 4.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.915 -0.584 . . . . 4.61 111.248 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.9 t30 76.58 2.84 3.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.628 0.771 . . . . 2.84 110.735 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.7 p -86.99 -11.12 51.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.815 0.816 . . . . 1.7 109.191 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.584 HD12 ' CD1' ' A' ' 27' ' ' LEU . 8.4 mm -100.52 132.51 22.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 114.463 -1.244 . . . . 0.92 108.565 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.05 142.04 66.42 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.159 1.906 . . . . 1.03 111.495 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -128.03 143.28 47.29 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.695 -0.402 . . . . 2.76 110.485 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.489 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 33.1 Cg_endo -63.84 141.46 78.32 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.117 2.545 . . . . 1.08 112.917 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.07 93.39 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.992 -0.549 . . . . 1.1 110.03 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.07 137.01 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.728 -0.842 . . . . 1.23 108.728 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -82.65 -61.06 1.98 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.911 -0.316 . . . . 2.87 111.73 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 91' ' ' THR . 39.1 mt-10 -91.45 -55.52 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.453 -0.499 . . . . 2.84 111.082 -175.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 166.43 161.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.716 -0.846 . . . . 1.42 108.716 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -105.5 -50.41 3.22 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.511 -0.476 . . . . 1.3 110.788 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -144.82 145.64 31.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.943 0.402 . . . . 1.29 111.04 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.646 ' O ' HD22 ' A' ' 118' ' ' LEU . 3.9 p-10 -113.41 148.1 36.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.774 -1.195 . . . . 1.36 107.774 171.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -163.43 -163.75 16.91 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 118.973 -1.584 . . . . 0.53 113.225 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 21.1 t -133.94 146.88 30.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.7 -0.482 . . . . 1.37 109.7 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.95 117.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.077 -0.342 . . . . 0.69 110.077 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.88 -57.0 3.14 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.159 0.429 . . . . 0.89 112.159 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 5.7 ptm85 -138.96 109.46 7.71 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 3.92 111.48 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 3.5 Cg_exo -77.36 169.74 20.67 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.154 2.569 . . . . 2.22 111.914 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 111' ' ' TYR . 7.6 mp -88.17 88.4 7.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.229 -0.441 . . . . 3.32 110.95 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -98.02 -64.86 1.0 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.361 -0.536 . . . . 5.56 109.836 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 33.7 t -96.49 7.62 46.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.701 . . . . 4.14 111.117 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.02 -46.05 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.826 0.306 . . . . 3.46 111.826 -170.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 91.5 m-20 60.17 170.05 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 4.99 111.858 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 105' ' ' ASN . 45.4 Cg_endo -71.16 0.8 6.13 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.35 2.033 . . . . 4.27 111.522 166.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.94 -35.02 57.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.459 -0.791 . . . . 3.94 110.994 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 4.7 tp60 -105.85 151.65 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 5.6 111.058 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.3 -14.05 62.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.796 -0.638 . . . . 5.3 112.217 -175.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 43.3 mt-10 -75.36 14.51 0.58 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.191 -0.318 . . . . 4.95 111.518 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.51 ' O ' HD21 ' A' ' 101' ' ' LEU . 55.7 t80 -58.76 -33.49 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 3.19 112.111 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.25 -23.56 65.71 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.178 -0.209 . . . . 1.24 111.532 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.19 153.23 22.06 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.773 -0.727 . . . . 0.94 112.302 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 130' ' ' GLU . 89.3 mt -138.65 142.01 39.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.622 0.725 . . . . 0.93 112.419 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.48 143.88 18.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.521 -1.218 . . . . 0.49 109.964 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 96' ' ' VAL . 11.1 pt-20 -84.63 125.8 32.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.345 0.593 . . . . 1.4 109.586 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 129' ' ' HIS . 14.6 mm -104.59 128.15 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.63 109.386 -173.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.18 156.93 20.79 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.299 0.374 . . . . 1.21 110.597 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m-20 -56.75 154.54 8.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.66 -0.496 . . . . 2.29 109.66 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.478 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.8 pt-20 -62.91 -22.42 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.06 0.457 . . . . 2.78 110.603 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -95.65 -3.82 45.5 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.145 -0.479 . . . . 1.77 110.221 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 118' ' ' LEU . 26.2 ttm180 64.23 89.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.272 -0.876 . . . . 4.14 111.004 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.9 m -133.34 -64.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 1.87 110.283 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -168.92 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.472 -0.785 . . . . 1.54 110.398 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 p -92.3 135.31 27.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.718 -0.475 . . . . 1.29 109.718 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -78.45 -70.87 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.566 -0.454 . . . . 1.03 110.767 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.6 m -139.89 -83.96 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.64 0.733 . . . . 1.56 111.43 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -175.36 138.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.575 -1.193 . . . . 2.08 109.695 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.6 m-70 -118.76 140.48 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.252 -0.579 . . . . 0.68 109.703 168.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 158' ' ' ARG . 19.8 tt0 -94.45 145.07 25.04 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.067 -0.97 . . . . 1.19 109.633 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 136' ' ' LEU . 33.5 p90 -117.76 170.61 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.732 -0.387 . . . . 0.74 110.938 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.03 152.05 20.93 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.72 -0.552 . . . . 0.51 111.72 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.87 -29.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.966 0.412 . . . . 0.67 111.426 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.1 p -74.64 -37.36 62.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 1.35 111.271 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 47.3 p -86.46 -11.55 51.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.363 -0.38 . . . . 1.1 110.7 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' CD1' ' A' ' 131' ' ' PHE . 62.0 mt -73.93 59.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 1.46 111.107 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.68 -45.81 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.251 0.548 . . . . 0.82 110.839 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -85.57 31.68 0.59 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 2.17 111.95 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -60.63 -20.01 59.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.023 0.439 . . . . 1.39 111.351 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -76.94 -21.43 54.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 2.46 111.591 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -89.8 175.6 7.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.148 -0.478 . . . . 1.89 110.677 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.87 101.51 12.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.864 -0.607 . . . . 2.88 109.6 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.457 HD21 ' CG1' ' A' ' 149' ' ' VAL . 11.8 tp -115.48 114.43 25.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.97 110.094 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -124.98 -173.8 2.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.512 -0.313 . . . . 1.77 110.183 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -66.03 136.75 56.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.758 -0.377 . . . . 1.43 110.073 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.41 -9.48 57.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.675 -0.774 . . . . 1.07 111.722 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 38.4 m-20 -89.49 147.57 23.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.099 0.952 . . . . 1.94 110.997 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 165' ' ' VAL . 1.0 OUTLIER -98.04 127.54 44.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.291 -1.777 . . . . 1.79 109.692 -168.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.457 ' CG1' HD21 ' A' ' 143' ' ' LEU . 29.1 m -129.1 152.57 37.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 1.16 111.768 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 p -118.98 135.71 54.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.214 -0.662 . . . . 1.44 109.214 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -153.94 161.98 41.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.61 110.948 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 123.96 30.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.781 0.8 . . . . 2.2 111.803 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tt -99.3 129.25 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.201 -1.363 . . . . 1.24 110.409 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 15.5 t70 -160.74 -88.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.976 -0.102 . . . . 1.92 110.913 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 4.6 mm-40 -81.66 -19.61 41.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 2.76 111.25 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.7 p -81.7 -17.57 47.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.238 -0.437 . . . . 1.98 110.496 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.73 18.18 16.48 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.808 -0.633 . . . . 1.27 112.842 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 62.8 mtm180 -147.46 -173.82 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.886 -1.153 . . . . 3.61 107.886 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.61 108.35 17.31 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.461 -0.496 . . . . 0.48 109.836 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -115.76 159.95 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.49 110.653 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.4 t 59.01 42.26 19.53 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.781 0.675 . . . . 1.55 109.766 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.77 108.81 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.348 -0.842 . . . . 1.26 110.442 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.75 111.33 20.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.387 -0.824 . . . . 2.05 110.143 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.68 120.26 9.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.869 -0.605 . . . . 0.75 110.675 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 148' ' ' LEU . 59.8 t -102.84 110.26 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.855 -0.611 . . . . 1.56 110.614 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.67 115.62 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.439 -0.578 . . . . 2.94 109.439 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -91.27 130.71 37.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.485 0.66 . . . . 3.88 110.195 -177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.946 -1.025 . . . . 4.04 111.329 -178.444 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 112.168 -0.373 . . . . 11.74 112.168 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.82 132.03 26.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.684 0.278 . . . . 10.54 110.654 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.83 81.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.368 -0.693 . . . . 8.95 111.368 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -149.37 116.9 6.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.738 -0.467 . . . . 7.09 109.738 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.86 109.9 17.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 5.59 109.816 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.12 132.48 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.993 0.425 . . . . 2.99 111.066 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.7 23.42 76.77 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.799 -0.715 . . . . 1.61 112.208 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -92.91 117.41 30.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.341 0.591 . . . . 2.0 111.018 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.12 121.94 37.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.317 -0.856 . . . . 1.27 109.747 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.37 140.3 32.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.771 -0.65 . . . . 1.14 110.342 -173.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 37.5 ttm180 -101.77 152.85 20.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.776 -0.647 . . . . 2.31 110.002 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.97 -169.09 35.11 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.17 -0.772 . . . . 0.5 111.17 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.9 145.13 29.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.757 0.313 . . . . 0.68 110.581 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 112.16 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.56 110.589 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.82 -25.18 15.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.468 -0.333 . . . . 0.76 111.395 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.614 HG11 ' HD2' ' A' ' 23' ' ' PHE . 2.6 p -156.26 134.02 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.354 -0.384 . . . . 1.55 111.237 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.5 mtp -118.85 115.83 25.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.415 -0.587 . . . . 1.42 109.415 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 27.2 mmtm -96.25 -161.65 0.89 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.684 -0.487 . . . . 2.03 109.684 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.31 -46.53 27.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.899 -0.591 . . . . 3.24 111.134 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -111.49 -24.61 10.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 2.03 111.626 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 51.5 p90 -143.98 -173.72 4.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.938 0.399 . . . . 1.25 111.109 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.13 -178.36 35.03 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.001 -0.84 . . . . 0.71 111.001 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.614 ' HD2' HG11 ' A' ' 16' ' ' VAL . 67.7 m-85 -125.03 130.54 52.51 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.979 0.419 . . . . 1.08 109.958 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mt -100.03 126.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.976 -0.556 . . . . 0.61 109.542 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.78 127.46 32.45 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.959 -0.756 . . . . 2.3 108.959 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.1 p -63.62 139.72 58.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.34 -0.846 . . . . 0.87 110.729 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -57.2 -36.62 71.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.677 0.751 . . . . 1.58 109.468 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -82.72 6.92 16.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.718 -1.128 . . . . 2.04 112.253 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p80 42.71 53.02 4.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.73 0.812 . . . . 3.29 111.733 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.8 -42.66 3.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 2.89 111.444 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.14 174.5 14.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 1.8 111.303 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.24 126.16 50.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 3.37 109.43 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 90.7 t -105.28 121.41 57.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.282 -0.417 . . . . 0.87 111.86 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -82.15 114.57 20.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 1.06 109.691 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -118.15 137.45 52.96 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.179 -0.609 . . . . 1.96 109.424 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -100.79 127.64 47.14 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -56.99 -22.87 41.75 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.259 0.466 . . . . 0.75 112.259 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -70.55 -8.99 55.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.606 -0.27 . . . . 1.63 111.672 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -116.41 20.15 14.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 2.07 109.948 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -102.67 139.24 38.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.91 110.243 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -109.37 136.53 48.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.181 0.515 . . . . 1.73 110.717 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.6 -138.75 13.95 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.019 -0.833 . . . . 1.05 111.019 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -128.67 105.89 18.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.794 -0.447 . . . . 2.14 109.794 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.98 -30.7 38.87 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.843 2.362 . . . . 1.01 112.42 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.38 -18.1 65.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.66 -0.7 . . . . 2.08 111.528 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -98.36 10.65 40.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.079 0.466 . . . . 2.18 110.63 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.0 148.99 24.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.718 -0.673 . . . . 0.92 110.794 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 166.12 22.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 2.35 109.887 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.83 115.18 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 1.4 110.195 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -7.16 21.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.253 -0.499 . . . . 0.75 112.002 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.54 120.24 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 1.06 111.008 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 83' ' ' ILE . 9.0 mp0 -65.13 134.09 53.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.294 -0.866 . . . . 2.51 111.371 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.6 m -145.2 166.42 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.751 -0.659 . . . . 0.44 110.108 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.62 150.02 48.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.03 -0.359 . . . . 1.49 110.03 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 12.1 p90 -164.09 -179.9 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.392 . . . . 0.66 111.649 -172.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -127.29 150.22 49.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.94 110.617 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.07 142.71 27.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 1.19 110.939 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 77.74 9.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.969 -0.56 . . . . 2.04 110.562 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.34 10.15 39.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.186 -0.672 . . . . 5.33 109.186 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.86 119.45 19.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.233 -0.894 . . . . 5.42 111.113 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.41 -132.21 10.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.697 -0.683 . . . . 4.76 112.682 175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.76 27.02 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 6.38 109.68 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 m -74.27 79.48 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 6.4 111.804 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 t 66.21 17.75 10.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.019 -0.991 . . . . 5.23 111.055 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.68 -27.15 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 6.95 110.761 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 t -107.76 21.24 17.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.052 -0.522 . . . . 6.02 110.262 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.56 -132.84 7.72 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.698 -0.763 . . . . 4.09 112.069 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -111.57 -64.06 1.33 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.217 0.532 . . . . 4.22 110.26 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 p -129.29 143.74 50.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.555 -0.748 . . . . 2.09 110.587 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.78 147.88 60.28 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.692 -0.685 . . . . 2.3 109.676 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.91 167.17 25.41 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.632 2.221 . . . . 1.43 112.91 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -107.19 146.59 31.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.377 -0.829 . . . . 0.82 110.747 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.09 154.55 27.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 2.3 111.027 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 61.87 41.22 11.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.627 -0.715 . . . . 2.01 111.515 170.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.9 t -71.01 118.59 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.8 110.092 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -118.44 154.99 31.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.57 . . . . 3.51 110.237 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.51 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.4 mtt -78.4 148.47 33.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.963 0.411 . . . . 1.12 110.485 173.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 79' ' ' PRO . 20.0 tp -126.1 141.77 40.6 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.946 -0.57 . . . . 1.67 109.583 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 78' ' ' LEU . 15.0 Cg_endo -58.58 137.81 82.32 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.1 1.867 . . . . 2.15 111.279 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -66.85 164.48 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.694 -0.685 . . . . 4.61 111.861 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 70.44 21.7 5.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.91 -1.041 . . . . 2.84 110.41 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.4 t -89.76 5.14 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.606 0.717 . . . . 1.7 109.744 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.602 HD12 HD23 ' A' ' 27' ' ' LEU . 28.9 mm -101.98 131.47 22.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.832 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.58 145.35 57.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.214 1.943 . . . . 1.03 111.735 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -120.71 149.8 51.24 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 120.866 -0.334 . . . . 2.76 110.851 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 43.0 Cg_endo -68.52 146.56 68.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.67 2.247 . . . . 1.08 112.195 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.57 95.27 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.332 -0.395 . . . . 1.1 110.338 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.08 136.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.7 -63.64 1.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.121 -0.631 . . . . 2.87 112.206 -171.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -94.22 -54.63 3.48 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.421 -0.512 . . . . 2.84 111.215 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 t 177.45 163.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.937 -0.764 . . . . 1.42 108.937 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -106.04 -52.72 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.087 0.47 . . . . 1.3 110.61 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.55 151.69 46.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.434 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.596 ' O ' HD22 ' A' ' 118' ' ' LEU . 4.4 p-10 -130.75 128.08 40.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.98 -0.748 . . . . 1.36 108.98 173.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.37 -146.32 4.31 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.859 -1.162 . . . . 0.53 112.723 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.0 p -142.14 148.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.802 -0.444 . . . . 1.37 109.802 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 143' ' ' LEU . 86.2 t -59.95 126.76 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.495 0.188 . . . . 0.69 110.774 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -70.12 -52.46 23.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.377 -0.374 . . . . 0.89 110.765 -174.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -169.84 137.6 1.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 3.92 110.399 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 145' ' ' LYS . 66.9 Cg_endo -76.17 130.94 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.268 1.979 . . . . 2.22 110.989 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.616 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -72.39 90.5 1.29 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.073 0.94 . . . . 3.32 111.797 -176.262 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -97.56 -65.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.608 -0.724 . . . . 5.56 111.368 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.86 11.11 25.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 4.14 111.639 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 38.7 mm -73.88 -9.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.378 -0.374 . . . . 3.46 111.127 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 8.6 t30 74.38 128.77 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 4.99 111.059 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.11 -5.33 14.4 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.014 2.476 . . . . 4.27 115.816 -168.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.85 30.41 7.18 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.659 0.742 . . . . 3.94 110.715 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -116.56 148.32 41.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.417 -0.811 . . . . 5.6 109.416 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -58.6 -18.32 29.13 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.843 0.683 . . . . 5.3 112.843 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -84.11 8.33 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.241 0.543 . . . . 4.95 110.842 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.465 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 33.8 t80 -66.92 -27.74 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 3.19 112.136 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.95 -25.93 65.7 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.749 -0.38 . . . . 1.24 111.501 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 157.74 33.46 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.569 -0.824 . . . . 0.94 111.834 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 128' ' ' GLN . 36.0 mt -141.81 148.06 38.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.467 0.651 . . . . 0.93 112.133 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.91 140.73 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.063 -0.971 . . . . 0.49 109.311 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 11.8 pt-20 -87.87 129.21 35.29 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.383 -0.599 . . . . 1.4 109.383 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.8 mm -104.43 140.67 21.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.827 -0.624 . . . . 0.63 110.614 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.7 pt? -84.08 146.48 27.89 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.987 -0.375 . . . . 1.21 109.987 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.9 165.47 17.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.71 -0.848 . . . . 2.29 108.71 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.74 -18.72 65.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.866 0.365 . . . . 2.78 111.0 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.95 6.47 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.18 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 55.87 77.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.526 -0.761 . . . . 4.14 111.208 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.9 p -117.73 -79.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.87 110.89 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.0 p -137.17 -174.5 3.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 1.54 110.793 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 4.7 p -65.17 129.87 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 1.29 110.721 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.1 -70.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.921 0.391 . . . . 1.03 110.791 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 p -135.97 -85.51 0.36 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.068 -0.514 . . . . 1.56 111.065 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.462 ' HB2' HD22 ' A' ' 114' ' ' LEU . 13.6 pt20 -176.51 137.4 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.573 -0.739 . . . . 2.08 109.763 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 117' ' ' ILE . 1.1 m-70 -121.62 125.83 47.62 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.809 -0.356 . . . . 0.68 110.086 171.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.44 149.42 24.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.639 -0.71 . . . . 1.19 109.9 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 136' ' ' LEU . 20.9 p90 -117.74 146.86 43.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 0.74 111.294 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -101.8 150.43 18.33 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.51 112.494 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.91 -43.02 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.236 0.458 . . . . 0.67 112.236 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -77.58 -22.66 50.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.225 0.536 . . . . 1.35 110.203 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 15.2 m -80.66 -18.83 46.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.563 -0.744 . . . . 1.1 110.166 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 131' ' ' PHE . 50.1 mt -76.53 60.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 1.46 111.419 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.2 t -41.09 -42.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.291 -0.413 . . . . 0.82 111.592 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -92.05 27.79 2.05 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.159 -0.473 . . . . 2.17 111.994 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -60.34 -18.19 48.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.07 0.396 . . . . 1.39 112.07 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -81.43 -19.24 42.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.309 -0.405 . . . . 2.46 111.478 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.48 175.41 9.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.941 -0.572 . . . . 1.89 110.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 pp -104.43 130.32 52.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.754 -0.832 . . . . 2.88 108.754 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 97' ' ' VAL . 12.3 tp -139.97 109.7 6.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.97 109.372 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -122.73 -171.97 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 1.77 110.956 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.489 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 62.5 tttm -64.59 116.9 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.637 . . . . 1.43 110.44 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.71 33.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.603 -0.808 . . . . 1.07 112.877 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -91.49 127.64 37.01 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.106 0.453 . . . . 1.94 110.35 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 96' ' ' VAL . 82.0 mt -73.73 144.24 45.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.34 0.591 . . . . 1.79 110.889 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.28 145.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.346 -0.843 . . . . 1.16 111.114 -173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.4 m -118.45 148.83 42.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.672 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -163.68 162.93 24.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.53 . . . . 0.61 109.808 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.7 122.05 35.21 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.779 0.799 . . . . 2.2 110.965 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.89 141.23 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.841 -1.072 . . . . 1.24 110.076 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 24.8 t70 -171.64 -93.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.625 -0.139 . . . . 1.92 110.625 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 41.9 mm-40 -74.01 -33.19 63.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 2.76 111.48 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -76.19 -15.51 60.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 1.98 110.753 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.65 20.6 39.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.968 -0.634 . . . . 1.27 112.948 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -140.49 -175.05 4.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.841 . . . . 3.61 108.728 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.47 108.38 18.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.216 -0.661 . . . . 0.48 109.216 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.26 158.77 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.49 111.218 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 36.8 t 59.34 39.59 22.11 Favored 'General case' 0 C--N 1.334 -0.071 0 N-CA-C 109.273 -0.64 . . . . 1.55 109.273 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -62.25 123.32 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.145 -0.934 . . . . 1.26 110.728 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -132.42 111.69 11.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.28 -0.418 . . . . 2.05 110.187 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.82 109.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.75 110.368 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 77.1 t -89.67 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 1.56 111.364 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 123.06 32.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.125 -0.695 . . . . 2.94 109.125 172.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -73.44 140.66 46.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.736 0.779 . . . . 3.88 110.993 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 114.52 -1.218 . . . . 4.04 110.332 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.854 0.359 . . . . 2.0 111.036 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.28 124.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.122 -0.695 . . . . 1.27 109.122 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.25 138.89 32.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.368 0.604 . . . . 1.14 110.417 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.627 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -104.62 140.44 38.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.461 -0.791 . . . . 2.31 109.88 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.83 -172.39 30.25 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.13 -0.788 . . . . 0.5 111.13 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 143.05 37.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.04 0.448 . . . . 0.68 111.307 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.519 HG21 ' SD ' ' A' ' 17' ' ' MET . 33.1 mm -65.83 125.79 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.56 110.869 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.86 -35.74 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.76 111.384 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.5 123.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 1.55 110.698 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 14' ' ' ILE . 80.5 mmm -116.03 107.39 14.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 1.42 110.954 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.4 mmtt -103.26 179.2 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.437 -1.32 . . . . 2.03 107.437 167.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.68 -18.56 29.28 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.892 -0.723 . . . . 3.24 110.695 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -101.67 -48.51 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.028 0.442 . . . . 2.03 111.592 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 39.9 p90 -142.67 -177.56 5.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.274 -0.421 . . . . 1.25 110.084 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.62 -178.36 34.54 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.748 -0.739 . . . . 0.71 111.795 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.88 130.97 53.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 1.08 110.224 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 mt -101.66 129.27 53.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.622 -0.717 . . . . 0.61 109.674 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.63 131.98 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.751 -0.833 . . . . 2.3 108.751 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.5 p -64.3 151.99 42.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.494 -0.776 . . . . 0.87 111.705 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 83' ' ' ILE . 7.2 tp -62.7 -40.65 97.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.673 -0.694 . . . . 1.58 110.924 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 8.1 m -100.36 24.78 8.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.04 111.277 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' ' NH1' ' A' ' 158' ' ' ARG . 23.1 p80 44.3 51.01 7.71 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.763 0.792 . . . . 3.29 111.709 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 15.8 m-20 -82.02 -51.29 8.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.196 -0.911 . . . . 2.89 109.438 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -175.93 -175.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.089 -0.96 . . . . 1.8 109.678 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.39 136.3 43.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.047 0.451 . . . . 3.37 110.238 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.44 126.93 57.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.697 -0.683 . . . . 0.87 110.963 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -68.8 119.38 13.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.19 0.519 . . . . 1.06 110.124 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -129.58 136.51 49.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.654 -0.703 . . . . 1.96 109.935 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.21 139.27 40.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.346 -0.613 . . . . 1.18 109.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.496 ' HZ ' ' SD ' ' A' ' 17' ' ' MET . 60.0 m-85 -69.79 -16.31 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.032 0.444 . . . . 0.75 111.201 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 t -63.39 -23.22 67.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.76 -0.655 . . . . 1.63 111.77 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.41 24.62 12.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 2.07 110.488 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 91.8 t80 -91.69 146.29 23.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.865 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.77 117.32 31.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.73 110.12 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.95 -157.04 20.97 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.748 -0.739 . . . . 1.05 112.042 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.22 107.36 57.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.932 -0.396 . . . . 2.14 109.932 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 -17.28 38.22 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.772 2.315 . . . . 1.01 113.095 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -64.99 -21.94 66.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.439 . . . . 2.08 110.8 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -103.53 12.77 34.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.033 -0.53 . . . . 2.18 111.268 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 14.5 mt -88.11 146.94 25.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.14 -0.482 . . . . 0.92 111.572 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -143.49 169.22 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.288 -0.869 . . . . 2.35 110.273 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.2 mt -76.77 116.65 17.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.924 -0.58 . . . . 1.4 110.757 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 2.35 27.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.922 -0.656 . . . . 0.75 112.506 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -78.34 127.37 32.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.792 0.329 . . . . 1.06 111.035 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.627 ' OE1' ' HD2' ' A' ' 11' ' ' ARG . 19.1 tt0 -70.81 130.92 42.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.745 -0.661 . . . . 2.51 110.28 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.59 154.52 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.839 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.83 141.63 47.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.003 -0.739 . . . . 1.49 109.003 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.34 161.73 27.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.401 0.62 . . . . 0.66 111.936 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 p -110.18 163.73 13.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.414 -0.812 . . . . 0.94 109.906 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.32 142.03 33.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.665 0.269 . . . . 1.19 110.571 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 2.04 111.079 -178.186 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.797 -0.075 . . . . 2.3 110.797 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.75 172.45 16.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.705 2.27 . . . . 1.43 113.293 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.65 171.62 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.149 -0.932 . . . . 0.82 109.993 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.15 155.23 40.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.469 0.176 . . . . 2.3 110.622 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.26 55.27 9.41 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.828 0.705 . . . . 2.01 112.099 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 35' ' ' PHE . 40.5 t -86.41 116.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 0.8 110.186 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -122.15 159.63 26.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.739 -0.467 . . . . 3.51 109.739 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.4 mtt -79.53 152.37 30.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.85 0.357 . . . . 1.12 111.163 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -119.16 162.61 30.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 1.67 110.539 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 134.68 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.337 2.025 . . . . 2.15 111.95 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 38.8 ttmt -70.01 155.27 40.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.807 -0.633 . . . . 4.61 110.925 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 17.3 m120 74.76 15.9 3.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.219 0.608 . . . . 2.84 111.402 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 44.8 m -92.23 -19.87 21.75 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.929 -0.309 . . . . 1.7 111.023 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 27' ' ' LEU . 45.3 mm -70.44 126.52 92.31 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.315 -0.624 . . . . 0.92 109.315 171.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.24 154.83 61.49 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.576 2.184 . . . . 1.03 112.331 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -113.64 152.76 45.74 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.059 -0.519 . . . . 2.76 110.171 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.439 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 23.5 Cg_endo -60.63 143.5 99.43 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 1.08 112.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.16 91.72 8.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.302 0.572 . . . . 1.1 110.007 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -142.04 128.67 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.607 -0.886 . . . . 1.23 108.607 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.26 -63.64 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.555 -0.458 . . . . 2.87 112.056 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.58 -53.82 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.982 0.42 . . . . 2.84 111.887 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.2 t 174.74 159.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.108 -0.701 . . . . 1.42 109.108 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -106.22 -58.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 1.3 111.059 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -140.52 158.09 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.064 0.459 . . . . 1.29 110.725 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -122.94 175.9 6.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.467 -0.788 . . . . 1.36 109.045 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.64 -163.13 34.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.264 -0.97 . . . . 0.53 112.198 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.36 148.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.13 -0.693 . . . . 1.37 109.13 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 144' ' ' GLN . 49.1 t -63.91 116.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.601 -0.518 . . . . 0.69 109.601 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 99' ' ' ARG . . . -82.65 -68.84 0.67 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.178 -0.464 . . . . 0.89 111.697 -173.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 4.8 mtm180 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.573 -0.285 . . . . 3.92 111.18 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 112.088 0.403 . . . . 1.24 112.088 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.74 179.88 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.05 -0.523 . . . . 0.94 113.871 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.9 mt -144.48 138.23 27.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.93 111.17 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.6 mt -103.7 139.47 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.233 -0.894 . . . . 0.49 109.237 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.44 116.02 27.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.56 0.695 . . . . 1.4 110.184 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.811 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 15.8 mm -91.52 140.57 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.229 -0.896 . . . . 0.63 109.946 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.66 143.34 29.28 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.953 -0.299 . . . . 1.21 110.238 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.64 -179.49 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 2.29 111.064 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.638 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.6 pm0 -66.64 -25.17 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.262 . . . . 2.78 111.442 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.638 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -90.3 -1.47 57.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.353 -0.61 . . . . 1.77 109.353 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 60.1 43.6 14.07 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.166 -0.924 . . . . 4.14 111.534 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.2 m -114.83 -50.0 2.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.028 0.381 . . . . 1.87 112.028 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.8 p -130.65 -179.5 5.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.964 0.411 . . . . 1.54 111.858 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -81.83 136.64 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.755 -0.657 . . . . 1.29 110.277 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.1 mt -75.09 -69.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 1.03 110.56 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -137.58 -83.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 1.56 111.813 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -174.98 134.37 0.34 Allowed 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 115.458 -0.792 . . . . 2.08 109.757 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 117' ' ' ILE . 15.8 m170 -120.38 130.66 54.48 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.608 -0.437 . . . . 0.68 110.692 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -91.5 143.98 26.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.419 -0.81 . . . . 1.19 109.395 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.5 p90 -116.98 140.72 49.13 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.059 -0.657 . . . . 0.74 111.056 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.39 152.38 18.37 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.42 -0.809 . . . . 0.51 112.539 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 tp -49.89 -33.38 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.248 0.462 . . . . 0.67 112.248 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.6 p -72.93 -33.75 66.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.438 0.637 . . . . 1.35 110.813 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 16.3 m -74.55 -26.58 60.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.172 -0.922 . . . . 1.1 110.433 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 131' ' ' PHE . 32.1 mt -75.58 60.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.44 -0.8 . . . . 1.46 112.151 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -45.56 -42.5 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.497 0.665 . . . . 0.82 110.481 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 45.7 m-80 -92.11 35.13 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.204 -0.907 . . . . 2.17 111.302 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -58.22 -17.78 21.51 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.477 0.547 . . . . 1.39 112.477 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.39 -22.91 62.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.064 0.459 . . . . 2.46 110.696 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 161.64 27.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 1.89 111.98 -171.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -89.75 30.66 1.02 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.202 -0.908 . . . . 2.88 109.295 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.95 107.83 0.1 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.492 -1.231 . . . . 0.97 110.548 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 13.8 pt20 -129.51 -175.6 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.531 . . . . 1.77 111.55 -170.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 77.8 tttt -59.65 118.19 5.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.587 -0.733 . . . . 1.43 109.929 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.43 -5.25 29.82 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.467 -0.873 . . . . 1.07 112.635 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.39 136.39 33.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.067 0.46 . . . . 1.94 111.079 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.4 mm? -86.0 136.38 33.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.38 -0.827 . . . . 1.79 110.359 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.27 150.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.245 0.545 . . . . 1.16 112.04 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.7 m -125.82 134.98 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 1.44 108.926 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.811 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 44.5 p90 -146.72 -176.61 5.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.079 -0.51 . . . . 0.61 109.7 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 122.31 17.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.277 0.56 . . . . 2.2 110.722 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.6 tt -100.62 130.49 49.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.178 -0.919 . . . . 1.24 110.296 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 13.5 t70 -159.17 -92.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.465 -0.198 . . . . 1.92 110.465 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -83.09 -19.69 36.3 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.08 -0.388 . . . . 2.76 111.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 m -77.92 -16.47 58.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 1.98 110.58 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 53.25 30.89 40.88 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.705 -0.68 . . . . 1.27 113.745 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 29' ' ' HIS . 11.6 ptm180 -161.63 -167.61 1.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.454 -0.943 . . . . 3.61 108.454 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.92 107.66 17.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.294 -0.632 . . . . 0.48 109.294 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -122.18 153.22 39.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.49 110.437 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 t 60.72 45.3 10.26 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.367 -0.605 . . . . 1.55 109.367 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.62 109.33 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.496 -0.774 . . . . 1.26 110.798 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.505 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 54.2 t30 -111.59 120.96 43.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.384 -0.826 . . . . 2.05 110.222 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.6 103.79 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.75 110.034 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.73 136.05 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.706 -0.679 . . . . 1.56 110.533 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.7 mpt_? . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 116.304 -0.407 . . . . 2.94 110.046 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.843 0.354 . . . . 2.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.7 121.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.253 -0.647 . . . . 1.27 109.253 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -93.23 138.0 32.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.122 0.487 . . . . 1.14 109.992 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -108.54 137.8 45.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 2.31 109.786 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.77 -178.39 30.81 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.396 -0.682 . . . . 0.5 111.396 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -132.22 143.44 49.93 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.124 0.488 . . . . 0.68 110.867 -177.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.599 HG21 ' SD ' ' A' ' 17' ' ' MET . 46.5 mm -65.91 129.03 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.56 111.145 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.95 -45.07 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.76 111.264 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 72.9 t -114.78 122.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 1.55 111.068 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 14' ' ' ILE . 87.2 mmm -112.4 105.33 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 1.42 110.805 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 54.6 mttt -113.06 167.47 10.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.554 -0.906 . . . . 2.03 108.554 171.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -75.33 -18.98 59.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.796 -0.361 . . . . 3.24 111.849 -171.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -108.53 -47.05 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.46 . . . . 2.03 111.707 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 6.7 p90 -141.24 172.08 13.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.586 -0.279 . . . . 1.25 110.448 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.33 32.83 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.805 -0.712 . . . . 0.71 111.907 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.7 m-85 -120.8 135.05 55.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.71 -0.478 . . . . 1.08 109.71 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -103.5 133.9 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.02 -0.536 . . . . 0.61 110.536 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -79.26 121.15 24.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.041 -1.096 . . . . 2.3 108.041 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.8 144.16 52.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.134 -0.484 . . . . 0.87 110.727 -175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 HD12 ' A' ' 83' ' ' ILE . 3.1 tp -51.68 -43.35 62.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.58 111.026 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -107.42 27.16 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 2.04 110.731 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.428 ' CD2' ' HD3' ' A' ' 158' ' ' ARG . 16.8 p80 45.48 36.78 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.13 0.972 . . . . 3.29 111.28 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.877 -1.056 . . . . 2.89 111.464 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.23 -174.58 1.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.856 -0.611 . . . . 1.8 110.785 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -103.09 120.74 41.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 3.37 109.438 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.4 t -104.44 125.26 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.779 0.323 . . . . 0.87 111.287 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.56 119.04 21.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.578 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.54 144.08 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.431 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 7.4 t60 -119.31 135.66 54.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.708 -0.479 . . . . 1.18 109.708 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 76.8 m-85 -74.61 -19.12 60.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.458 0.54 . . . . 0.75 112.458 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 t -68.81 -33.47 73.91 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.826 -0.35 . . . . 1.63 110.954 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 1.2 p-10 -103.9 33.76 3.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.693 0.759 . . . . 2.07 109.633 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 50.7 t80 -102.51 139.21 38.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.696 -1.138 . . . . 0.91 110.437 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.1 ttm -101.11 104.96 16.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 1.73 110.369 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.8 -154.32 25.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 1.05 111.541 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 99.14 41.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.849 -0.426 . . . . 2.14 109.849 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.3 -21.9 66.72 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.739 2.293 . . . . 1.01 113.494 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.85 -1.24 57.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.972 0.415 . . . . 2.08 111.043 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -112.7 15.68 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 2.18 110.389 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.92 146.4 23.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.585 -0.734 . . . . 0.92 111.161 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -128.88 172.39 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.602 -0.726 . . . . 2.35 110.241 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.99 123.27 29.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.165 -0.471 . . . . 1.4 110.52 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.25 59.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.674 -0.774 . . . . 0.75 111.976 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -69.94 129.44 39.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.692 0.282 . . . . 1.06 111.051 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.572 ' OE1' ' HB2' ' A' ' 82' ' ' SER . 10.4 tt0 -73.11 127.51 32.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.654 -0.703 . . . . 2.51 110.501 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 77' ' ' MET . 31.4 m -139.93 153.86 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.166 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 78' ' ' LEU . 10.3 pt-20 -114.15 147.18 39.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.101 -0.703 . . . . 1.49 109.101 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.2 p90 -166.72 166.18 16.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.396 0.617 . . . . 0.66 112.357 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.37 166.59 13.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.259 -0.882 . . . . 0.94 110.188 176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -101.96 143.2 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.303 -0.408 . . . . 1.19 110.644 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' O ' HD22 ' A' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.04 110.592 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 58' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.425 0.155 . . . . 2.3 111.021 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.2 150.1 88.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.069 2.513 . . . . 1.43 113.277 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -86.68 141.17 29.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.387 -0.824 . . . . 0.82 110.481 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 165.24 25.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.644 0.259 . . . . 2.3 111.268 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 61.93 27.26 16.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.758 -0.656 . . . . 2.01 111.339 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 t -71.56 120.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.8 111.076 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -129.42 161.7 29.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 3.51 110.222 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.491 ' HA ' HG12 ' A' ' 53' ' ' VAL . 60.2 mtt -80.84 143.93 32.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.12 111.473 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 54' ' ' GLU . 36.3 mt -112.61 162.53 21.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.828 -0.623 . . . . 1.67 110.196 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.37 149.49 80.72 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.685 2.256 . . . . 2.15 111.78 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 38.7 ttmt -79.41 152.17 30.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.247 -0.433 . . . . 4.61 110.734 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 4.9 m-20 70.66 35.19 1.91 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.934 0.494 . . . . 2.84 111.453 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.572 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 49.2 m -107.16 -9.87 16.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.807 0.337 . . . . 1.7 110.813 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD11 ' A' ' 27' ' ' LEU . 49.1 mm -76.36 136.16 68.67 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.52 -0.309 . . . . 0.92 110.366 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.74 157.54 61.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.652 2.235 . . . . 1.03 112.182 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -131.55 157.27 78.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.191 -0.459 . . . . 2.76 110.61 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 20.0 Cg_exo -62.56 138.68 71.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.157 . . . . 1.08 112.094 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 93.17 9.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.221 0.534 . . . . 1.1 110.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t -141.8 133.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.337 -0.986 . . . . 1.23 108.337 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.4 -62.52 1.67 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 2.87 112.621 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -94.09 -54.3 3.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 2.84 111.692 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t 173.77 161.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.643 -0.873 . . . . 1.42 108.643 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.486 HG22 ' CD2' ' A' ' 93' ' ' HIS . 7.6 m -106.0 -59.01 1.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.724 -0.39 . . . . 1.3 110.91 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.486 ' CD2' HG22 ' A' ' 92' ' ' THR . 98.2 m-70 -145.07 155.6 43.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.29 110.213 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -115.37 173.2 6.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.969 -0.752 . . . . 1.36 108.969 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.57 -166.08 35.15 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.125 -1.036 . . . . 0.53 111.88 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.72 147.89 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.106 -0.702 . . . . 1.37 109.106 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.82 112.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.784 -0.45 . . . . 0.69 109.784 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 -63.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.89 111.887 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.559 -0.291 . . . . 3.92 111.0 -173.48 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.175 0.435 . . . . 1.24 112.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.04 173.39 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 114.584 0.594 . . . . 0.94 114.584 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 130' ' ' GLU . 74.2 mt -143.87 136.33 26.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.93 111.257 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.3 mt -103.35 138.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.935 -1.03 . . . . 0.49 109.5 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.4 pt-20 -86.78 125.23 33.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.396 0.617 . . . . 1.4 109.611 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.748 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 11.6 mm -102.07 126.33 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.498 -0.774 . . . . 0.63 109.048 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.8 pt? -87.07 152.52 22.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 1.21 110.745 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.67 173.75 9.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.614 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -66.91 -23.26 65.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 2.78 111.09 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -86.8 -3.23 59.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.736 -0.468 . . . . 1.77 109.736 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 66.43 35.98 5.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.322 -0.854 . . . . 4.14 111.051 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m -81.24 -68.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.746 -0.661 . . . . 1.87 111.567 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p -155.28 -174.36 4.94 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.995 0.368 . . . . 1.54 111.995 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 4.6 p -67.12 133.2 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.688 -0.687 . . . . 1.29 111.211 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.21 -69.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.476 -0.329 . . . . 1.03 110.653 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 m -136.51 -84.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.81 -0.356 . . . . 1.56 111.758 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.448 ' HB2' HD22 ' A' ' 114' ' ' LEU . 11.4 pt20 -174.67 138.24 0.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.842 -0.617 . . . . 2.08 110.144 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.519 ' HB2' HD11 ' A' ' 117' ' ' ILE . 21.6 m170 -122.6 123.18 40.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.792 0.329 . . . . 0.68 110.359 170.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.0 tt0 -84.22 145.68 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.552 -0.749 . . . . 1.19 109.24 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.515 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.4 p90 -117.66 139.96 50.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 0.74 111.824 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.88 154.37 20.87 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 114.999 -1.0 . . . . 0.51 112.383 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.22 -32.56 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 0.67 111.564 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -74.68 -35.8 62.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.2 0.524 . . . . 1.35 110.705 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 36.9 m -62.82 -32.7 73.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.236 -0.893 . . . . 1.1 110.532 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 131' ' ' PHE . 72.7 mt -75.42 58.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 1.46 112.031 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.0 t -46.3 -43.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.357 0.599 . . . . 0.82 110.318 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 46.2 m-80 -95.87 34.66 1.49 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.3 -0.863 . . . . 2.17 111.508 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -56.65 -21.21 25.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.145 0.498 . . . . 1.39 111.615 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -70.91 -23.1 62.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 2.46 111.414 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.27 164.03 14.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.681 0.623 . . . . 1.89 112.681 -166.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.563 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -79.51 34.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.014 -0.994 . . . . 2.88 111.2 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.7 tp -56.16 105.43 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.021 -175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -121.66 -178.03 3.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.755 -0.657 . . . . 1.77 110.811 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -62.99 136.48 57.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.323 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.3 70.72 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.545 -0.836 . . . . 1.07 112.926 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -92.11 142.28 27.68 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.215 0.508 . . . . 1.94 109.859 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.2 mm? -83.95 138.51 33.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.194 0.521 . . . . 1.79 111.146 -172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.77 153.35 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.366 0.603 . . . . 1.16 111.912 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.2 m -129.57 138.01 51.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.221 -0.9 . . . . 1.44 109.332 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.748 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 38.8 p90 -149.0 174.15 12.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.645 -0.502 . . . . 0.61 109.645 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -130.38 120.46 24.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.397 0.618 . . . . 2.2 110.205 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.55 130.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.823 -0.626 . . . . 1.24 110.354 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 18.8 t70 -155.87 -100.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.954 -0.298 . . . . 1.92 110.718 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.468 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 42.2 mt-10 -83.9 -7.59 59.39 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.08 0.4 . . . . 2.76 112.08 -175.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -12.08 49.24 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.749 -0.464 . . . . 1.98 109.749 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.09 24.21 49.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.127 -0.942 . . . . 1.27 114.308 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.428 ' HD3' ' CD2' ' A' ' 29' ' ' HIS . 15.1 ptt-85 -158.08 -177.94 6.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.829 -0.804 . . . . 3.61 108.829 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.14 108.65 16.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.367 -0.533 . . . . 0.48 110.698 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -119.12 159.49 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.49 110.442 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 39.7 t 63.07 38.08 11.09 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.673 0.608 . . . . 1.55 110.091 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.99 111.54 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.476 -0.784 . . . . 1.26 110.657 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.476 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 8.3 t30 -120.52 128.91 53.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.315 -0.402 . . . . 2.05 110.394 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -68.96 117.13 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 0.75 110.282 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.69 130.55 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.844 -0.617 . . . . 1.56 111.66 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 2.94 110.127 176.117 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 121.426 0.632 . . . . 2.0 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.55 116.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.956 -1.02 . . . . 1.27 109.073 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -87.63 138.61 31.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.931 -0.577 . . . . 1.14 110.004 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 22.7 ttm180 -113.55 141.04 47.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.71 -0.677 . . . . 2.31 110.04 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.08 -171.12 36.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.006 -0.838 . . . . 0.5 111.006 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.61 141.95 33.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.184 0.516 . . . . 0.68 111.141 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.34 119.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.296 -0.865 . . . . 0.56 110.823 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.38 -41.73 6.91 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.967 -0.293 . . . . 0.76 111.172 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -121.97 150.76 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.536 -0.542 . . . . 1.55 109.536 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.9 ttm -137.17 106.7 6.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 1.42 110.391 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.7 mmtt -100.71 172.37 7.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.865 -0.791 . . . . 2.03 108.865 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.62 -22.1 61.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.692 0.282 . . . . 3.24 111.668 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -111.14 -41.93 4.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.72 0.295 . . . . 2.03 111.701 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -145.12 176.71 9.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.617 -0.265 . . . . 1.25 110.487 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 -179.97 25.82 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.497 -0.859 . . . . 0.71 112.059 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 16' ' ' VAL . 54.3 m-85 -127.11 151.74 48.24 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.525 -0.546 . . . . 1.08 109.525 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -125.57 115.34 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.17 -0.468 . . . . 0.61 111.058 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.34 126.47 29.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.288 -1.004 . . . . 2.3 108.288 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 164.57 25.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.229 0.537 . . . . 0.87 111.401 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD2' HD12 ' A' ' 83' ' ' ILE . 1.8 tm? -60.58 -48.43 81.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.532 -0.758 . . . . 1.58 111.724 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -98.69 13.65 31.4 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.087 -0.338 . . . . 2.04 110.087 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 55.85 50.27 14.4 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.429 -0.952 . . . . 3.29 108.429 -168.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.14 -48.55 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.993 -1.458 . . . . 2.89 110.275 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -173.26 179.38 2.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 1.8 110.704 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CD ' ' HB3' ' A' ' 23' ' ' PHE . 10.0 tp10 -103.2 139.53 38.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.781 -0.452 . . . . 3.37 109.781 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.53 132.24 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.051 0.453 . . . . 0.87 111.224 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -87.19 118.39 26.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.426 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -120.01 151.3 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.96 108.918 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -115.84 133.0 56.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.476 -0.564 . . . . 1.18 109.476 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -62.47 -22.62 66.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.058 0.762 . . . . 0.75 113.058 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -61.29 -35.84 78.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.779 0.323 . . . . 1.63 111.076 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -96.09 22.54 7.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.259 0.552 . . . . 2.07 110.842 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' OH ' ' HG2' ' A' ' 77' ' ' MET . 39.6 t80 -91.51 136.6 33.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.212 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.33 97.74 7.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 1.73 110.142 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.19 -139.63 7.46 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.143 -0.783 . . . . 1.05 111.143 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 46' ' ' TRP . 1.5 p30 -124.73 91.46 49.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 121.515 0.674 . . . . 2.14 110.703 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.93 -21.04 33.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.003 2.468 . . . . 1.01 113.841 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.41 -11.66 59.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.371 0.605 . . . . 2.08 110.154 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 84.3 m95 -106.45 20.31 19.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 2.18 110.248 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 29.3 mt -85.14 -179.6 7.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.794 -0.639 . . . . 0.92 111.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -151.22 161.17 43.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.386 -0.825 . . . . 2.35 110.126 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.51 113.99 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 1.4 108.98 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.25 5.05 35.13 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.872 -0.604 . . . . 0.75 112.019 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.34 131.13 40.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.91 0.386 . . . . 1.06 111.315 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' CD ' HG12 ' A' ' 83' ' ' ILE . 40.2 mt-10 -78.27 128.26 33.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.227 -0.897 . . . . 2.51 111.279 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.89 161.33 18.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.444 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 78' ' ' LEU . 7.1 pt-20 -125.42 148.28 48.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.795 -0.446 . . . . 1.49 109.795 176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 11.9 p90 -163.99 175.17 10.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.66 112.142 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 p -130.14 170.72 13.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.44 -0.8 . . . . 0.94 110.112 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.86 138.75 45.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.78 0.324 . . . . 1.19 111.145 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.863 -0.608 . . . . 2.04 110.124 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.022 -0.733 . . . . 2.3 109.022 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.74 150.35 88.29 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.312 2.008 . . . . 1.43 112.223 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -88.63 137.01 32.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.67 -0.696 . . . . 0.82 111.035 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -112.41 165.74 11.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.845 -0.616 . . . . 2.3 110.334 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 63.18 29.67 16.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.818 -0.628 . . . . 2.01 111.477 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 9.6 t -74.19 108.25 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.8 110.237 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -112.31 167.82 10.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.87 0.367 . . . . 3.51 110.339 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.574 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 84.8 mtp -98.58 136.04 39.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.944 -0.571 . . . . 1.12 111.195 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 54' ' ' GLU . 46.0 mt -107.9 154.89 40.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 1.67 110.556 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.08 140.93 35.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.263 1.975 . . . . 2.15 110.372 169.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.32 164.68 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 4.61 111.034 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.09 25.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.172 -0.922 . . . . 2.84 109.999 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -95.59 -14.86 23.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.398 -0.819 . . . . 1.7 109.122 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.623 HD12 ' CD2' ' A' ' 27' ' ' LEU . 8.7 mm -92.01 128.99 43.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.441 -0.8 . . . . 0.92 109.783 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.07 154.48 47.33 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.348 2.032 . . . . 1.03 112.14 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 152.15 74.35 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.556 -0.293 . . . . 2.76 110.465 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 18.0 Cg_endo -61.23 125.94 18.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 1.08 112.202 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.14 92.97 7.06 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.999 0.428 . . . . 1.1 111.17 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 26.0 t -142.43 107.33 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 1.23 109.713 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.85 -25.92 27.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.735 -0.386 . . . . 2.87 111.737 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' THR . 69.8 tt0 -73.42 -18.19 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.609 -0.269 . . . . 2.84 110.953 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 41.5 m 81.04 122.72 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.634 -0.712 . . . . 1.42 110.54 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -80.86 -57.64 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.3 112.337 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -141.35 174.73 10.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.232 0.539 . . . . 1.29 111.36 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -141.81 176.83 8.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.132 -0.94 . . . . 1.36 109.273 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.09 179.45 39.57 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 110.464 -1.055 . . . . 0.53 110.464 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.3 m -103.89 159.5 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 117.852 0.826 . . . . 1.37 110.161 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.37 121.57 19.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.196 -0.668 . . . . 0.69 109.196 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -66.86 -53.47 32.08 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.3 0.375 . . . . 0.89 110.731 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 3.92 110.551 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 120.59 0.233 . . . . 1.24 111.247 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.78 166.66 25.23 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.439 -0.665 . . . . 0.94 111.439 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 130' ' ' GLU . 66.8 mt -142.71 138.13 30.34 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.93 111.842 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.89 138.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.654 -1.157 . . . . 0.49 108.746 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.77 124.26 31.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.936 -0.765 . . . . 1.4 108.936 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.736 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.6 mm -101.36 120.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.494 -0.928 . . . . 0.63 108.494 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.0 pt? -83.33 144.25 29.81 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.294 -0.562 . . . . 1.21 110.157 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.07 151.49 12.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 2.29 109.583 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.72 -21.66 64.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 2.78 111.912 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.03 10.26 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.692 0.282 . . . . 1.77 110.374 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 67.52 30.39 6.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.613 -0.721 . . . . 4.14 111.512 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -70.32 -80.37 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.463 -0.335 . . . . 1.87 111.167 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -149.23 -176.45 5.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.687 -0.233 . . . . 1.54 110.643 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -65.25 134.51 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 123.542 0.526 . . . . 1.29 110.234 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -72.71 -67.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.442 -0.344 . . . . 1.03 110.432 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.9 m -137.6 -84.3 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.159 0.504 . . . . 1.56 110.645 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -176.6 139.84 0.33 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.249 -0.887 . . . . 2.08 108.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' ILE . 33.6 m170 -117.48 131.59 56.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.125 -0.63 . . . . 0.68 110.089 172.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.8 tt0 -89.57 139.49 30.49 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.763 -1.108 . . . . 1.19 109.402 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 46.1 p90 -118.67 134.87 54.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 0.74 110.961 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.11 153.94 24.01 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.326 -0.852 . . . . 0.51 112.57 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.2 -27.72 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.01 0.433 . . . . 0.67 110.807 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.8 p -74.86 -36.48 62.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.317 0.58 . . . . 1.35 110.443 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 162' ' ' VAL . 23.9 m -65.66 -30.2 70.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.84 . . . . 1.1 110.87 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.4 mt -71.49 58.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.812 0.695 . . . . 1.46 112.67 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -45.59 -42.28 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.408 0.623 . . . . 0.82 111.045 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.48 34.01 2.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 2.17 111.014 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 16.3 ptpt -54.53 -21.08 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.01 0.524 . . . . 1.39 112.357 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -86.39 -11.95 50.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 2.46 112.12 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.56 166.66 23.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 1.89 110.687 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -86.96 24.49 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.458 -0.337 . . . . 2.88 110.492 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 164' ' ' ALA . 15.8 tp -44.92 117.39 1.32 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.22 -0.9 . . . . 0.97 111.536 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -118.86 -172.97 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 1.77 111.238 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 72.4 tttt -67.53 140.22 57.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.908 -0.587 . . . . 1.43 110.139 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.06 86.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.423 -0.894 . . . . 1.07 112.439 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 7.9 m-20 -82.73 132.37 35.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.559 0.219 . . . . 1.94 110.741 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.54 135.11 42.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.993 -0.549 . . . . 1.79 110.828 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.36 151.45 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 1.16 111.187 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 44.0 p -109.03 136.01 49.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.811 -0.811 . . . . 1.44 108.811 172.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.689 ' HB3' HG12 ' A' ' 162' ' ' VAL . 36.1 p90 -154.24 169.3 23.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.852 0.358 . . . . 0.61 110.327 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 3.7 mpt_? -131.77 123.2 27.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.4 -0.52 . . . . 2.2 110.63 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.428 HD13 ' CE1' ' A' ' 129' ' ' HIS . 8.5 pt -100.14 146.77 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.736 -0.839 . . . . 1.24 108.736 166.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 23.7 t70 -175.1 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.366 -0.134 . . . . 1.92 110.969 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.25 -41.5 73.42 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 2.76 111.503 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 158' ' ' ARG . 42.3 t -84.9 -17.98 36.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.174 -0.466 . . . . 1.98 111.099 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.63 -25.36 1.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.797 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 156' ' ' SER . 67.2 mtt85 -93.02 175.68 6.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.317 0.247 . . . . 3.61 110.388 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.34 110.39 19.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.033 0.444 . . . . 0.48 110.219 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -123.25 160.2 27.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.722 -0.672 . . . . 0.49 110.84 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.6 m 59.93 42.84 15.61 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.944 0.778 . . . . 1.55 110.692 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.7 m -70.96 138.35 21.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.565 0.698 . . . . 1.26 110.892 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.04 123.71 22.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.328 -0.851 . . . . 2.05 109.74 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -59.25 125.73 24.82 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 123.372 0.42 . . . . 0.75 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.66 122.7 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.868 -0.606 . . . . 1.56 110.651 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 147' ' ' ASP . 1.6 mpt_? . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 109.188 -0.671 . . . . 2.94 109.188 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 120.932 0.396 . . . . 2.0 111.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.19 119.9 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.19 0.519 . . . . 1.14 109.798 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -112.39 138.71 48.73 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.482 -0.781 . . . . 2.31 110.187 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.42 -163.29 13.5 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.443 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -152.06 156.86 40.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.062 0.458 . . . . 0.68 110.69 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.32 119.26 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.711 -0.677 . . . . 0.56 111.218 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.88 -38.16 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.49 -0.323 . . . . 0.76 111.34 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.1 p -134.75 131.71 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.85 0.357 . . . . 1.55 110.739 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.2 mtp -123.06 129.91 52.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 1.42 110.449 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -173.46 2.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.131 -1.063 . . . . 2.03 108.131 171.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -87.54 -15.75 36.58 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.346 -0.542 . . . . 3.24 110.645 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.52 -47.13 3.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.429 0.529 . . . . 2.03 112.429 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -142.33 -175.42 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.127 0.489 . . . . 1.25 111.445 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.04 36.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.324 -0.71 . . . . 0.71 111.324 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.546 ' H ' HG13 ' A' ' 16' ' ' VAL . 79.4 m-85 -124.16 138.62 54.4 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.578 -0.527 . . . . 1.08 109.578 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -99.79 123.2 52.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.163 -0.471 . . . . 0.61 110.72 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.443 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 31.0 tt0 -76.15 118.92 19.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.056 -1.09 . . . . 2.3 108.056 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.18 160.27 31.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.501 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.497 ' CD1' HD12 ' A' ' 83' ' ' ILE . 9.1 tp -56.02 -48.57 75.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 1.58 111.616 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -118.56 40.68 3.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 2.04 109.789 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.8 p80 45.73 33.88 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.076 0.86 . . . . 3.29 111.032 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -52.63 -47.3 67.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.744 -1.116 . . . . 2.89 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -169.26 173.53 6.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.8 110.185 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.81 121.03 42.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 3.37 109.166 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -113.39 130.7 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.095 0.474 . . . . 0.87 111.69 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -89.02 120.23 30.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.404 -0.816 . . . . 1.06 110.14 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -121.08 147.33 45.68 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.122 -0.696 . . . . 1.96 109.122 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.409 ' HB3' HD22 ' A' ' 39' ' ' ASN . 4.3 t60 -109.03 133.16 53.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.572 -0.899 . . . . 1.18 108.572 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -57.67 -23.38 51.13 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.443 0.535 . . . . 0.75 112.443 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -68.97 -15.66 63.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.869 0.366 . . . . 1.63 111.929 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 36' ' ' HIS . 49.0 m-80 -104.44 8.15 35.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.479 0.657 . . . . 2.07 109.788 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 75.7 t80 -93.02 126.7 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.355 -0.839 . . . . 0.91 110.064 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.4 ttm -96.68 101.87 13.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.357 -0.383 . . . . 1.73 110.294 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.02 -150.95 23.23 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.102 -0.57 . . . . 1.05 111.697 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -105.73 105.34 52.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.778 -0.453 . . . . 2.14 109.778 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.04 -25.88 3.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.805 2.337 . . . . 1.01 113.702 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -69.77 -24.74 63.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.623 0.725 . . . . 2.08 109.523 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.71 20.68 12.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.358 -0.837 . . . . 2.18 111.132 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.51 149.29 25.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.92 110.515 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.55 158.11 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 2.35 109.761 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.67 120.07 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.947 0.403 . . . . 1.4 110.274 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.07 -11.87 26.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.98 -0.629 . . . . 0.75 112.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.33 120.6 13.08 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.961 0.41 . . . . 1.06 111.409 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 5.0 mp0 -64.62 129.05 38.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 2.51 111.146 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 77' ' ' MET . 26.8 m -140.85 149.97 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.654 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -124.33 150.27 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.926 -0.398 . . . . 1.49 109.926 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 3.2 p90 -163.91 179.67 6.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.927 0.394 . . . . 0.66 111.308 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 p -128.45 166.93 17.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.091 -0.504 . . . . 0.94 110.742 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.06 147.4 30.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.359 -0.382 . . . . 1.19 110.97 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.397 0.618 . . . . 2.04 110.681 179.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.438 -0.578 . . . . 2.3 109.438 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.08 146.6 87.51 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.039 1.826 . . . . 1.43 112.274 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 144.64 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.792 -0.64 . . . . 0.82 110.179 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.02 163.73 18.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.721 0.296 . . . . 2.3 110.837 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.8 57.38 2.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.601 -0.727 . . . . 2.01 110.551 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 21.8 t -93.01 122.59 44.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.8 109.877 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -124.39 147.74 48.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.404 . . . . 3.51 110.106 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.446 ' HA ' HG12 ' A' ' 53' ' ' VAL . 48.9 mtt -70.92 154.12 42.09 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.866 0.365 . . . . 1.12 110.4 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 79' ' ' PRO . 17.3 tp -125.61 144.13 47.1 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.009 -0.541 . . . . 1.67 110.023 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 78' ' ' LEU . 25.3 Cg_endo -61.65 142.9 95.94 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.265 1.977 . . . . 2.15 111.961 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 4.2 ttmp? -62.94 156.67 23.77 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.825 -0.625 . . . . 4.61 111.856 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m120 73.74 24.02 2.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.45 -0.796 . . . . 2.84 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -96.96 8.5 44.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.04 -0.527 . . . . 1.7 110.181 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 27' ' ' LEU . 18.4 mm -108.75 133.06 20.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.636 -0.505 . . . . 0.92 109.636 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.89 149.84 66.59 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.593 2.195 . . . . 1.03 112.621 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.99 145.99 54.83 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.073 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 76.3 Cg_exo -52.31 132.53 44.63 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.592 2.861 . . . . 1.08 113.49 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.03 94.66 8.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.1 110.863 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.29 150.63 27.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.739 -0.838 . . . . 1.23 108.739 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.94 -64.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.076 -0.65 . . . . 2.87 111.37 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' THR . 30.8 tt0 -95.06 -58.63 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.302 -0.559 . . . . 2.84 111.027 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER 175.62 173.96 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.169 -0.923 . . . . 1.42 109.254 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -105.46 -58.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.3 110.73 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.31 178.45 6.87 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.023 -0.535 . . . . 1.29 110.815 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.96 -177.91 4.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.038 -0.528 . . . . 1.36 110.476 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.44 -163.32 29.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.085 -0.579 . . . . 0.53 111.867 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.47 146.36 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.667 -0.494 . . . . 1.37 109.667 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.28 121.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.69 110.301 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HE3' ' A' ' 145' ' ' LYS . . . -73.04 -60.18 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.572 0.582 . . . . 0.89 112.572 -172.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 . . . . . 0 C--N 1.33 -0.245 0 C-N-CA 120.495 -0.482 . . . . 3.92 111.647 -176.214 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.134 0 N-CA-C 112.178 0.436 . . . . 1.24 112.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.83 162.87 30.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.515 -0.85 . . . . 0.94 111.66 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 130' ' ' GLU . 82.6 mt -144.45 147.08 32.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.54 0.686 . . . . 0.93 112.287 -172.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.6 mt -112.48 137.8 43.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.514 -1.221 . . . . 0.49 109.513 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -89.89 120.72 31.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.458 0.647 . . . . 1.4 110.116 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.575 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 34.9 mm -97.8 129.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 0.63 109.582 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -87.35 156.71 19.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.535 -0.302 . . . . 1.21 110.311 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.05 167.57 9.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.392 -0.596 . . . . 2.29 109.392 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.3 pm0 -69.71 -17.07 63.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.042 0.449 . . . . 2.78 110.563 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -99.6 -2.42 35.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 1.77 109.821 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 54.22 80.66 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.505 -0.77 . . . . 4.14 110.731 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.61 -47.37 1.84 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.323 -0.398 . . . . 1.87 111.142 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 -177.75 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 1.54 111.021 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.31 130.68 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.543 -0.91 . . . . 1.29 108.543 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.61 -69.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.6 -0.44 . . . . 1.03 110.869 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -138.75 -85.23 0.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.498 0.666 . . . . 1.56 111.034 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -175.96 137.64 0.33 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.777 -1.101 . . . . 2.08 108.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.524 ' CD2' HG13 ' A' ' 117' ' ' ILE . 19.1 m170 -113.19 132.75 55.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.163 -0.615 . . . . 0.68 110.664 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.502 ' HA ' HD23 ' A' ' 114' ' ' LEU . 5.7 tt0 -92.54 140.46 29.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.626 -1.17 . . . . 1.19 109.42 -175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.464 ' CD1' HD21 ' A' ' 136' ' ' LEU . 40.7 p90 -118.51 141.41 48.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.74 111.021 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.09 152.93 20.18 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.468 -0.787 . . . . 0.51 112.209 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.73 -30.15 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.212 0.506 . . . . 0.67 111.001 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -78.07 -23.61 47.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.485 0.659 . . . . 1.35 110.542 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.516 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 62.9 m -78.74 -27.6 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.101 -0.954 . . . . 1.1 110.464 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 131' ' ' PHE . 69.4 mt -75.33 60.11 1.1 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.349 -0.841 . . . . 1.46 112.017 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.24 -45.59 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.931 0.396 . . . . 0.82 111.522 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.538 HD21 HD22 ' A' ' 143' ' ' LEU . 2.9 p-10 -92.27 33.9 1.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.753 0.311 . . . . 2.17 111.231 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -53.0 -22.56 5.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.467 0.707 . . . . 1.39 112.674 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.71 -19.04 49.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.364 -0.38 . . . . 2.46 111.26 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 162.86 27.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.625 0.726 . . . . 1.89 112.465 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -81.86 35.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.788 -1.096 . . . . 2.88 110.47 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 138' ' ' ASN . 24.4 tp -63.72 127.09 29.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.97 110.692 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.61 -173.55 3.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 1.77 110.95 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 98' ' ' ALA . 83.8 tttt -66.18 138.53 57.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 1.43 109.9 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.19 66.99 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.738 -0.744 . . . . 1.07 112.626 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -90.62 140.36 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 1.94 110.728 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.03 140.91 33.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.709 -0.678 . . . . 1.79 110.742 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.15 143.91 38.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.508 . . . . 1.16 112.009 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -115.84 125.87 53.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 1.44 109.389 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 51.6 p90 -145.12 168.57 20.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.619 0.247 . . . . 0.61 110.404 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 121.35 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.34 -0.944 . . . . 2.2 110.469 172.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.5 130.46 52.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 1.24 110.324 174.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 22.7 t70 -149.0 -89.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.536 . . . . 1.92 111.862 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -33.52 40.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.379 0.511 . . . . 2.76 112.379 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.2 p -84.12 -17.15 41.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.477 -0.329 . . . . 1.98 111.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.67 23.15 70.46 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.728 -0.749 . . . . 1.27 113.065 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -126.43 173.53 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.679 -0.489 . . . . 3.61 109.679 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.86 18.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.269 -0.641 . . . . 0.48 109.269 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.44 158.18 38.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.196 -0.457 . . . . 0.49 110.438 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 45.6 m 55.4 30.72 15.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.512 0.673 . . . . 1.55 109.304 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.4 126.73 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.135 -0.939 . . . . 1.26 110.932 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.495 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 5.8 t30 -125.34 132.27 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.231 -0.895 . . . . 2.05 110.296 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.42 126.76 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.75 110.389 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.05 119.63 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.068 0.461 . . . . 1.56 111.617 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 2.94 110.691 177.835 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 15.7 mm100 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.111 0.481 . . . . 2.0 111.455 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.28 115.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.586 -0.734 . . . . 1.27 109.501 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 8' ' ' GLN . 49.5 m-85 -98.69 150.64 21.58 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.255 -0.884 . . . . 1.14 109.662 -176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' C ' HD23 ' A' ' 27' ' ' LEU . 35.2 ttm-85 -108.26 149.41 28.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.813 -0.63 . . . . 2.31 109.994 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.93 170.95 42.25 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.143 -0.783 . . . . 0.5 111.143 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.973 0.416 . . . . 0.68 111.312 -174.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.38 118.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.754 -0.657 . . . . 0.56 110.721 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.58 -43.13 3.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.938 0.399 . . . . 0.76 110.779 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.03 123.59 70.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 1.55 111.039 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.1 mtp -119.19 110.09 16.63 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.566 . . . . 1.42 109.473 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 69.6 mmtt -97.66 -167.92 1.6 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.447 -0.575 . . . . 2.03 109.447 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.93 -26.98 30.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.486 -0.324 . . . . 3.24 111.108 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.65 -44.4 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 2.03 111.227 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -137.95 -170.44 2.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.088 -0.505 . . . . 1.25 110.657 -174.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.66 174.96 34.36 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 0.71 112.234 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -122.82 139.36 54.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.881 -0.415 . . . . 1.08 109.881 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.78 131.71 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.781 -0.645 . . . . 0.61 110.438 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.86 107.15 8.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.126 -1.065 . . . . 2.3 108.126 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -62.57 149.56 42.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.533 -0.303 . . . . 0.87 110.657 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -51.45 -48.25 62.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 1.58 111.303 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -84.4 3.76 34.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 2.04 111.713 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.1 p80 39.96 39.97 0.67 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.124 0.97 . . . . 3.29 111.881 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -88.39 -39.52 14.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.364 -0.835 . . . . 2.89 110.073 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.15 162.8 34.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 1.8 110.107 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -104.31 127.82 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.611 -0.515 . . . . 3.37 109.611 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 55' ' ' TYR . 58.9 t -104.49 128.6 57.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.302 0.572 . . . . 0.87 110.836 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -81.83 114.21 20.3 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.846 -1.07 . . . . 1.06 109.733 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -116.7 145.55 43.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.172 -0.677 . . . . 1.96 109.172 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.8 131.62 54.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.392 -0.596 . . . . 1.18 109.392 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.95 -20.27 56.59 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.972 0.415 . . . . 0.75 111.636 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -68.45 -23.28 64.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 1.63 111.118 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -106.76 14.1 27.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.057 0.456 . . . . 2.07 110.723 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -88.45 132.77 34.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.044 -0.526 . . . . 0.91 110.728 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.9 ttm -94.96 109.36 21.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.189 -0.46 . . . . 1.73 110.39 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.39 -141.97 12.89 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.738 -0.744 . . . . 1.05 111.84 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -116.65 103.35 52.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.004 -0.369 . . . . 2.14 110.004 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.17 -23.44 39.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.256 . . . . 1.01 112.949 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -86.16 -4.85 59.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.438 0.637 . . . . 2.08 110.51 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -112.15 19.44 17.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.723 -0.671 . . . . 2.18 110.568 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 47' ' ' LEU . 16.8 mt -87.97 157.33 18.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.643 -0.708 . . . . 0.92 111.091 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -131.2 157.37 43.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.783 -0.644 . . . . 2.35 111.166 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.45 121.87 22.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.117 0.484 . . . . 1.4 110.168 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.09 56.08 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.063 -0.589 . . . . 0.75 112.126 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -73.29 120.47 18.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 1.06 111.233 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.25 129.0 39.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.96 -1.018 . . . . 2.51 111.535 174.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.77 142.44 30.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.44 110.315 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.71 135.42 53.96 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.082 -0.71 . . . . 1.49 109.082 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 33' ' ' VAL . 11.4 p90 -156.8 159.64 38.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.063 -0.517 . . . . 0.66 111.134 -169.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.2 p -112.61 146.79 37.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.461 -0.336 . . . . 0.94 110.814 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.72 140.18 32.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.973 0.416 . . . . 1.19 110.861 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.887 -0.597 . . . . 2.04 110.693 178.45 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 110.032 -0.358 . . . . 2.3 110.032 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.07 147.81 94.38 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.779 2.32 . . . . 1.43 113.367 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.24 137.99 45.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.125 -0.943 . . . . 0.82 110.289 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -118.47 152.85 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.197 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.6 72.91 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.637 . . . . 2.01 110.356 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.9 t -105.18 111.09 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.8 110.204 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -121.82 141.56 51.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 3.51 110.927 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.6 mtm -74.94 144.74 43.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 1.12 110.912 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.5 pt? -128.04 162.87 47.34 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.961 -0.755 . . . . 1.67 108.961 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 21.8 Cg_endo -62.19 163.59 19.62 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.138 1.892 . . . . 2.15 113.127 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HG2' ' H ' ' A' ' 81' ' ' ASN . 26.9 ttpp -79.93 -179.48 7.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.551 -0.749 . . . . 4.61 110.39 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 54.0 m-20 78.07 9.17 2.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.764 0.826 . . . . 2.84 111.218 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -79.61 -34.17 40.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.97 -0.559 . . . . 1.7 110.018 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.57 ' CD1' HD21 ' A' ' 27' ' ' LEU . 10.7 mm -82.76 127.39 70.22 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.603 -0.726 . . . . 0.92 109.771 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.59 144.67 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.486 2.124 . . . . 1.03 112.644 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -103.55 131.42 22.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.779 . . . . 2.76 108.895 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.43 125.11 5.72 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.953 2.436 . . . . 1.08 113.018 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.1 92.4 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.74 . . . . 1.1 111.456 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -141.78 129.84 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.587 -1.264 . . . . 1.23 107.587 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.43 -63.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.568 0.581 . . . . 2.87 112.568 -169.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.5 tp10 -95.41 -55.11 3.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.111 0.481 . . . . 2.84 111.017 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.7 t 169.96 161.47 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.646 -0.706 . . . . 1.42 109.756 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.434 HG22 ' CD2' ' A' ' 93' ' ' HIS . 5.7 m -105.79 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 1.3 112.256 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.434 ' CD2' HG22 ' A' ' 92' ' ' THR . 89.6 m-70 -138.91 172.34 13.0 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.494 0.664 . . . . 1.29 112.268 -171.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.89 163.05 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.878 -1.056 . . . . 1.36 109.399 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.54 177.49 45.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.817 -0.706 . . . . 0.53 111.387 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 m -107.79 161.6 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.046 0.45 . . . . 1.37 110.28 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.13 126.9 26.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.133 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.74 -44.35 56.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.89 111.484 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 111.74 0.274 . . . . 3.92 111.74 177.268 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.204 0 N-CA-C 111.81 0.3 . . . . 1.24 111.81 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 65.21 -176.65 12.42 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.265 -0.493 . . . . 0.94 113.311 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 130' ' ' GLU . 48.4 mt -151.01 139.8 20.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.217 0.532 . . . . 0.93 110.917 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.4 135.22 41.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 0.49 109.308 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 10.6 pt-20 -86.03 112.43 21.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.858 0.837 . . . . 1.4 109.246 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 129' ' ' HIS . 16.9 mm -85.27 141.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.895 -1.048 . . . . 0.63 110.285 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 122' ' ' ARG . 34.9 tp -85.44 136.95 33.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 116.251 -0.431 . . . . 1.21 110.015 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.47 152.82 10.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.059 -0.973 . . . . 2.29 110.441 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.9 pm0 -58.4 -26.72 63.55 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.043 0.386 . . . . 2.78 112.043 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.485 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.93 15.43 22.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.029 -0.268 . . . . 1.77 110.444 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.495 ' HG2' HD21 ' A' ' 118' ' ' LEU . 1.4 tmm_? 64.25 31.8 12.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.818 0.818 . . . . 4.14 109.484 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 m -77.18 -83.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.751 -0.659 . . . . 1.87 111.435 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 p -140.39 -169.76 2.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.737 -0.211 . . . . 1.54 110.779 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -67.97 137.62 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.903 -0.406 . . . . 1.29 109.903 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.9 mt -83.68 -70.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.282 -0.567 . . . . 1.03 110.739 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.8 p -135.88 -85.64 0.36 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.169 0.509 . . . . 1.56 111.714 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.448 ' O ' ' HD2' ' A' ' 129' ' ' HIS . 7.5 pt20 -176.48 137.43 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.247 -0.888 . . . . 2.08 109.489 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.781 ' HB2' HD11 ' A' ' 117' ' ' ILE . 33.8 m170 -124.49 132.97 53.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.68 110.254 171.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 114' ' ' LEU . 15.0 tt0 -86.41 150.3 24.4 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.644 -0.707 . . . . 1.19 110.158 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -123.33 140.81 52.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.289 0.566 . . . . 0.74 111.671 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.49 154.74 20.77 Favored Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 115.426 -0.806 . . . . 0.51 111.987 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.35 -23.75 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 117.154 0.477 . . . . 0.67 111.493 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.7 p -81.78 -26.06 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.341 0.591 . . . . 1.35 110.669 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 19.8 m -73.81 -30.0 62.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.41 -0.814 . . . . 1.1 110.001 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 73.1 mt -76.01 60.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.242 -0.89 . . . . 1.46 111.828 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.46 -48.2 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.825 0.345 . . . . 0.82 111.595 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.74 35.84 1.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 2.17 111.167 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 14.8 ptpt -48.23 -25.08 1.37 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.194 1.183 . . . . 1.39 114.194 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -82.24 -11.44 58.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.903 0.383 . . . . 2.46 110.915 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.94 147.34 48.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 1.89 109.904 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.99 87.28 6.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.701 0.762 . . . . 2.88 110.051 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 143' ' ' LEU . 12.2 tp -103.34 109.22 20.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.659 -1.155 . . . . 0.97 110.223 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -104.8 -177.49 3.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.918 -0.583 . . . . 1.77 110.916 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -66.62 141.46 57.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.43 110.104 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.99 -4.23 81.36 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.63 -0.795 . . . . 1.07 113.151 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.1 141.56 28.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.757 -0.777 . . . . 1.94 109.64 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mt -86.82 132.14 33.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.423 0.63 . . . . 1.79 111.746 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.42 152.74 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 1.16 110.875 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.0 p -112.1 140.33 46.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 1.44 109.389 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 42.5 p90 -163.88 168.09 19.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.809 -0.441 . . . . 0.61 109.809 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 124.12 25.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.695 -0.802 . . . . 2.2 111.438 173.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tt -99.44 140.31 19.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.785 -1.098 . . . . 1.24 110.435 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -166.57 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.765 -0.198 . . . . 1.92 110.759 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.36 -36.73 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 2.76 111.573 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.9 t -74.36 -17.44 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.876 0.37 . . . . 1.98 111.015 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.51 19.89 54.7 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.516 -0.849 . . . . 1.27 112.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -139.31 178.23 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.968 -0.753 . . . . 3.61 108.968 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.36 108.64 19.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.251 -0.277 . . . . 0.48 110.251 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -121.3 161.98 21.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.43 . . . . 0.49 110.964 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.5 m 63.84 37.07 9.93 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.712 0.633 . . . . 1.55 109.921 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.8 t -69.15 114.93 6.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.237 -0.892 . . . . 1.26 111.202 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -125.13 118.81 26.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.834 -0.621 . . . . 2.05 109.945 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.94 116.19 3.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.75 110.543 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.05 118.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.506 0.669 . . . . 1.56 111.585 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.702 -0.681 . . . . 2.94 109.923 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 18.9 mm-40 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.181 0.515 . . . . 2.0 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.11 122.52 44.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 1.27 108.896 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.09 137.59 32.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.204 -0.453 . . . . 1.14 110.304 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -106.62 142.24 36.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.096 -0.502 . . . . 2.31 109.676 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.24 -174.01 34.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.183 -0.767 . . . . 0.5 111.183 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -140.81 144.17 35.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.884 0.373 . . . . 0.68 110.8 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.01 115.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.56 111.021 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.42 -44.36 4.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 0.76 110.507 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 23' ' ' PHE . 86.9 t -117.35 123.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.036 -0.529 . . . . 1.55 110.801 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.8 ttm -124.12 110.96 15.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.579 . . . . 1.42 109.968 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.3 mmtt -100.68 -174.3 2.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.754 -0.462 . . . . 2.03 109.754 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.06 -20.3 38.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.931 -0.577 . . . . 3.24 110.485 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -111.78 -49.02 3.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.089 0.471 . . . . 2.03 111.457 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 12.4 p90 -141.23 -174.12 3.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 1.25 109.747 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.74 177.48 33.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.591 -0.814 . . . . 0.71 112.254 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' CZ ' ' HE1' ' A' ' 21' ' ' PHE . 63.5 m-85 -128.78 139.09 52.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.021 0.439 . . . . 1.08 109.954 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -112.47 125.9 69.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.844 -0.617 . . . . 0.61 110.914 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.8 132.01 43.04 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.776 -0.824 . . . . 2.3 108.776 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 p -84.0 150.13 25.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.87 110.199 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 6.9 tp -49.07 -46.85 45.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.788 -0.642 . . . . 1.58 111.828 -174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 m -109.14 30.14 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.028 -0.533 . . . . 2.04 110.74 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 p80 39.4 57.37 2.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.618 1.199 . . . . 3.29 111.389 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.16 -35.97 23.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.73 -1.577 . . . . 2.89 109.918 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -173.72 175.22 2.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.14 -0.936 . . . . 1.8 110.108 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.6 128.57 50.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.196 -1.039 . . . . 3.37 108.196 170.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 124.37 58.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.648 -0.421 . . . . 0.87 111.043 -174.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.2 112.47 4.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.811 -0.631 . . . . 1.06 109.572 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 75' ' ' VAL . 4.6 t80 -121.64 121.61 37.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.624 0.726 . . . . 1.96 110.796 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.94 128.18 44.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.135 -0.939 . . . . 1.18 108.717 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -62.17 -18.56 61.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.981 0.363 . . . . 0.75 111.981 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -60.05 -34.04 72.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.38 . . . . 1.63 111.03 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -95.65 20.79 9.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.934 0.397 . . . . 2.07 111.215 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 93.1 t80 -94.07 139.62 30.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.91 110.871 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.33 106.16 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.054 -0.521 . . . . 1.73 110.444 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.56 -150.51 17.82 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.862 -0.685 . . . . 1.05 112.173 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -108.37 104.05 52.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.456 0.17 . . . . 2.14 110.729 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.22 -19.95 28.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 1.01 112.819 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -70.44 -22.71 62.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.437 0.637 . . . . 2.08 110.164 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -96.28 19.38 12.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.348 -0.842 . . . . 2.18 110.343 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.402 HD23 ' HG2' ' A' ' 51' ' ' GLN . 55.4 mt -95.84 153.55 17.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 0.92 110.181 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 51' ' ' GLN . 6.0 pt-20 -126.24 162.25 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.969 -0.56 . . . . 2.35 109.935 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 114.58 10.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.017 -0.735 . . . . 1.4 109.017 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.37 4.54 40.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.506 -0.854 . . . . 0.75 112.183 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 57.9 tp60 -73.49 133.1 43.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.897 0.38 . . . . 1.06 110.612 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -86.27 128.24 34.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 2.51 110.799 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 77' ' ' MET . 35.7 m -139.51 160.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.088 -0.505 . . . . 0.44 110.921 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 78' ' ' LEU . 25.4 pt-20 -120.88 140.02 52.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.234 -0.654 . . . . 1.49 109.234 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 75' ' ' VAL . 1.4 p90 -161.78 172.62 15.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.088 0.47 . . . . 0.66 112.075 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 p -131.96 157.86 42.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.684 -0.689 . . . . 0.94 110.77 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.44 149.29 22.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 1.19 111.155 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.972 -0.558 . . . . 2.04 111.125 -179.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 70' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 120.709 0.29 . . . . 2.3 111.696 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.09 155.21 66.11 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.854 2.369 . . . . 1.43 112.378 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.03 30.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.82 110.668 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.79 169.32 17.23 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.507 -0.553 . . . . 2.3 109.507 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 t30 60.03 45.54 11.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.636 0.732 . . . . 2.01 109.871 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 35' ' ' PHE . 20.1 t -93.32 114.05 29.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.73 . . . . 0.8 110.359 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 163.28 24.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 3.51 110.239 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.7 mtt -79.63 153.02 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.145 0.498 . . . . 1.12 111.369 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 54' ' ' GLU . 18.8 mt -119.88 158.54 49.69 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.252 -0.885 . . . . 1.67 109.687 172.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.21 153.83 71.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.125 1.883 . . . . 2.15 111.93 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 51' ' ' GLN . 10.8 tptp -78.94 148.68 32.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.077 -0.511 . . . . 4.61 110.839 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 72.01 30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 2.84 110.853 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.3 p -87.63 -11.71 47.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.39 0.614 . . . . 1.7 109.923 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 13.6 mm -84.98 131.56 48.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.315 -0.857 . . . . 0.92 109.627 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.18 150.58 65.85 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.483 2.122 . . . . 1.03 112.412 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -126.92 148.54 65.9 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.403 -0.362 . . . . 2.76 110.206 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.98 127.8 14.09 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.024 2.483 . . . . 1.08 113.625 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.94 94.49 4.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.659 -0.701 . . . . 1.1 110.895 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.86 120.94 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 1.23 109.087 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.05 -62.77 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.544 0.201 . . . . 2.87 111.544 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 6.0 mm-40 -92.98 -55.33 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 2.84 111.733 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 12.5 t 168.91 158.67 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.695 -0.854 . . . . 1.42 108.695 -176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.08 -58.92 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.454 -0.498 . . . . 1.3 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.44 163.61 34.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 1.29 110.803 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -120.87 174.09 6.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.457 -0.942 . . . . 1.36 108.457 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.35 -174.3 46.87 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.027 -1.083 . . . . 0.53 111.606 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.408 HG12 HD13 ' A' ' 148' ' ' LEU . 35.6 m -119.15 162.42 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.008 0.432 . . . . 1.37 110.028 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.39 122.43 17.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.94 -0.573 . . . . 0.69 109.869 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.65 -45.65 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.352 . . . . 0.89 111.61 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 3.92 110.835 179.469 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB3' ' HG2' ' A' ' 130' ' ' GLU . . . . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 112.301 0.482 . . . . 1.24 112.301 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.23 150.7 8.72 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.635 -0.793 . . . . 0.94 112.284 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.443 HD23 ' CA ' ' A' ' 130' ' ' GLU . 67.3 mt -127.28 147.26 50.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.498 0.666 . . . . 0.93 112.597 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 82.3 mt -111.11 141.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.908 -1.042 . . . . 0.49 109.313 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 125' ' ' VAL . 32.7 tt0 -93.11 109.24 20.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.148 0.499 . . . . 1.4 109.981 -176.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.6 mm -91.74 132.52 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.713 . . . . 0.63 110.154 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -91.83 153.91 19.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.131 0.491 . . . . 1.21 111.008 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.534 ' HB3' ' H ' ' A' ' 123' ' ' THR . 2.8 t70 -55.12 146.88 17.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.32 -0.855 . . . . 2.29 109.063 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.744 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.9 pm0 -62.75 -20.01 64.53 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.464 0.542 . . . . 2.78 112.464 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -102.25 13.46 34.6 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.936 -0.394 . . . . 1.77 109.936 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 58.1 80.89 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.652 -0.704 . . . . 4.14 110.378 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.534 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 32.5 m -116.33 -71.99 0.71 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.451 -0.795 . . . . 1.87 109.663 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -146.43 -176.58 5.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.82 -0.627 . . . . 1.54 110.189 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 116' ' ' GLU . 3.6 p -72.38 137.86 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.281 -0.418 . . . . 1.29 110.105 175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.37 -70.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.431 -0.507 . . . . 1.03 110.086 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.2 p -138.48 -87.82 0.24 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.417 0.627 . . . . 1.56 111.193 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.98 139.1 0.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.647 -1.16 . . . . 2.08 108.224 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 117' ' ' ILE . 25.9 m170 -117.32 121.06 40.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.455 -0.498 . . . . 0.68 110.448 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.443 ' CA ' HD23 ' A' ' 114' ' ' LEU . 9.3 tt0 -78.71 149.31 32.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.736 -0.665 . . . . 1.19 109.849 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -117.77 175.44 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.943 0.402 . . . . 0.74 111.007 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.46 153.09 21.44 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.797 -0.638 . . . . 0.51 111.616 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -51.03 -30.54 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.019 0.409 . . . . 0.67 111.516 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.4 p -74.44 -36.91 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 1.35 110.946 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 16.9 m -69.94 -23.15 63.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 1.1 110.145 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.88 59.78 1.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 1.46 111.846 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.2 t -48.28 -41.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.228 0.537 . . . . 0.82 110.563 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.95 33.88 1.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.652 -0.703 . . . . 2.17 110.722 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -52.93 -25.09 10.77 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.799 1.037 . . . . 1.39 113.799 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -84.07 -16.92 42.01 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.586 -0.446 . . . . 2.46 111.363 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -76.01 150.05 37.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 1.89 110.617 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 142' ' ' LEU . 2.1 mm? -84.96 71.37 10.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.935 -0.575 . . . . 2.88 109.745 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.6 tp -75.72 122.88 24.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.97 110.028 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -108.32 172.12 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.024 0.44 . . . . 1.77 111.758 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 146' ' ' GLY . 13.5 tmtt? -70.93 132.82 45.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 1.43 110.366 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.418 ' N ' ' HD3' ' A' ' 145' ' ' LYS . . . 87.56 4.07 80.38 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.47 -0.871 . . . . 1.07 113.05 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.89 152.01 22.4 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.136 -0.626 . . . . 1.94 110.045 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 96' ' ' VAL . 3.3 mm? -77.32 123.47 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.529 0.681 . . . . 1.79 111.513 -172.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.169 -0.923 . . . . 1.16 110.339 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 73.4 m -121.57 152.8 38.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.057 -0.52 . . . . 1.44 110.558 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 162' ' ' VAL . 6.4 p90 -165.49 168.27 16.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.803 -0.635 . . . . 0.61 109.817 -173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.48 122.55 29.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.459 0.647 . . . . 2.2 110.805 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -100.7 137.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.886 . . . . 1.24 110.551 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.548 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 31.6 t70 -169.64 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.19 -0.3 . . . . 1.92 110.19 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.548 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 39.1 mt-10 -76.73 -18.61 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.618 . . . . 2.76 110.035 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.5 p -80.03 -18.68 49.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.542 -0.754 . . . . 1.98 110.643 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.77 2.73 2.69 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.61 -0.723 . . . . 1.27 114.082 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -154.89 -161.16 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.262 -0.644 . . . . 3.61 109.262 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.71 115.58 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.337 0.589 . . . . 0.48 110.842 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -128.79 148.81 50.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.497 -0.774 . . . . 0.49 109.861 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.0 m 55.27 55.17 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.038 0.836 . . . . 1.55 110.916 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 151' ' ' PHE . 4.1 m -77.25 141.62 15.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.287 0.565 . . . . 1.26 110.277 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -138.56 119.95 14.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 2.05 110.286 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.16 103.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.115 -0.493 . . . . 0.75 110.958 174.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.97 118.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.381 0.61 . . . . 1.56 110.698 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 2.94 110.791 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 120.998 0.428 . . . . 2.0 110.977 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 56' ' ' THR . 2.4 p -104.23 129.71 56.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.612 -0.722 . . . . 1.27 109.774 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -113.17 148.72 34.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.279 -0.873 . . . . 1.14 109.881 -174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -110.45 136.42 49.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.147 -0.479 . . . . 2.31 109.907 -177.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.44 -168.2 17.52 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.372 -0.691 . . . . 0.5 111.372 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 149.14 34.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.121 0.486 . . . . 0.68 111.178 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.77 118.99 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.442 -0.799 . . . . 0.56 110.497 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.21 -49.67 3.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.76 111.001 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 23' ' ' PHE . 6.3 p -123.51 139.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.032 -0.531 . . . . 1.55 110.272 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.7 ttm -131.76 122.05 25.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.42 . . . . 1.42 110.993 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -107.43 -170.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.653 -0.869 . . . . 2.03 108.653 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.96 -20.36 25.99 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.438 -0.801 . . . . 3.24 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.83 -48.44 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.063 0.459 . . . . 2.03 111.34 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.3 p90 -143.65 175.78 9.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.36 . . . . 1.25 110.947 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.27 173.23 33.51 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.435 -0.666 . . . . 0.71 111.435 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.648 ' H ' HG13 ' A' ' 16' ' ' VAL . 40.7 m-85 -114.16 126.17 54.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.661 -0.866 . . . . 1.08 108.661 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.69 125.66 46.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.243 -0.435 . . . . 0.61 110.527 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.74 119.7 15.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.172 -0.677 . . . . 2.3 109.172 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.45 160.55 24.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.87 110.315 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 13.9 tp -56.27 -46.4 79.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.341 -0.39 . . . . 1.58 111.929 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.8 t -99.58 13.02 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.59 -0.522 . . . . 2.04 109.59 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.555 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 84.5 m-70 61.22 35.56 18.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.42 -0.809 . . . . 3.29 109.599 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.94 -58.52 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.094 -1.412 . . . . 2.89 111.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.07 178.85 9.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 1.8 109.765 -173.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 131.4 50.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 3.37 110.62 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.98 129.9 64.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.888 -0.597 . . . . 0.87 110.464 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -80.91 113.21 18.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.464 0.65 . . . . 1.06 110.446 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 75' ' ' VAL . 26.3 t80 -121.95 132.49 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 1.96 110.13 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -102.26 124.32 47.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.159 -0.682 . . . . 1.18 109.159 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.97 -18.74 63.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.476 0.547 . . . . 0.75 112.476 -172.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -59.26 -23.28 62.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.007 0.432 . . . . 1.63 110.618 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.18 20.72 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.081 0.467 . . . . 2.07 110.458 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -85.99 140.95 29.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.91 110.336 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 76' ' ' ARG . 48.7 ttm -111.47 89.32 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 1.73 110.425 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.27 -168.97 33.19 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.812 -0.631 . . . . 1.05 111.949 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.482 HD22 ' HB2' ' A' ' 46' ' ' TRP . 4.3 p-10 -98.37 102.75 15.21 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.344 0.593 . . . . 2.14 110.791 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.89 -17.99 13.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 1.01 113.513 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -64.32 -25.72 68.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 2.08 110.107 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' HB2' HD22 ' A' ' 43' ' ' ASN . 84.1 m95 -106.51 23.51 14.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.823 -0.626 . . . . 2.18 111.419 -176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -89.7 152.02 21.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.717 -0.674 . . . . 0.92 109.719 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.13 157.81 44.77 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.4 mm? -68.67 118.15 11.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.41 -0.359 . . . . 1.4 110.061 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.77 -5.47 16.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.75 112.296 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -76.31 122.96 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.669 0.271 . . . . 1.06 110.955 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 21.5 mt-10 -64.16 137.41 57.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.693 -0.685 . . . . 2.51 110.656 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 77' ' ' MET . 22.5 m -143.09 148.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.508 -0.553 . . . . 0.44 109.508 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.33 144.48 43.19 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.931 -0.766 . . . . 1.49 108.931 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -162.61 163.89 26.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.038 0.447 . . . . 0.66 111.939 -174.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 9' ' ' VAL . 56.9 p -120.94 153.51 37.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 0.94 109.742 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.67 156.74 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.745 0.307 . . . . 1.19 110.827 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 108.867 -0.79 . . . . 2.04 108.867 176.439 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.424 0.154 . . . . 2.3 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.17 153.16 67.29 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.532 2.155 . . . . 1.43 111.106 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -106.27 147.54 29.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.453 -0.34 . . . . 0.82 111.245 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -126.85 174.22 8.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.495 -0.321 . . . . 2.3 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 58.8 34.2 23.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.869 -0.605 . . . . 2.01 112.232 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 55' ' ' TYR . 40.8 t -78.19 119.74 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.977 0.418 . . . . 0.8 110.899 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 41' ' ' MET . 11.1 mmm180 -124.39 148.72 47.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.675 -0.693 . . . . 3.51 110.35 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.537 ' HA ' HG12 ' A' ' 53' ' ' VAL . 66.7 mtt -69.04 140.95 54.94 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.017 -0.364 . . . . 1.12 110.017 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 31.1 tp -130.61 82.69 64.16 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.389 -0.369 . . . . 1.67 111.502 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.06 116.58 3.97 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.524 1.483 . . . . 2.15 110.305 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -166.22 -21.45 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.904 0.383 . . . . 4.61 111.006 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t30 59.35 41.19 20.1 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.452 -0.944 . . . . 2.84 108.452 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 t -88.44 -5.97 57.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.626 -1.17 . . . . 1.7 110.924 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.4 HD12 HD12 ' A' ' 27' ' ' LEU . 18.3 mm -63.23 119.65 54.65 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.92 109.236 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.68 158.98 53.27 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 122.44 2.094 . . . . 1.03 112.125 -172.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -98.2 139.72 21.4 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.942 -0.572 . . . . 2.76 110.413 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 76.6 Cg_exo -51.02 134.83 43.59 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.113 2.542 . . . . 1.08 112.261 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.76 91.83 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 1.1 110.226 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 152' ' ' ARG . 22.0 t -142.82 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 1.23 109.531 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.92 -59.81 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.02 0.378 . . . . 2.87 112.02 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 91' ' ' THR . 16.7 mm-40 -90.76 -56.29 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.31 0.576 . . . . 2.84 111.145 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 13.1 t 151.01 164.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.431 -1.692 . . . . 1.42 106.431 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.512 HG21 HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -106.48 -58.21 1.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.28 -0.968 . . . . 1.3 111.536 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -140.87 158.37 44.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.028 0.442 . . . . 1.29 110.761 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -140.15 126.04 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.72 -0.673 . . . . 1.36 109.398 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.47 -140.45 3.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.986 -1.102 . . . . 0.53 112.379 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.92 152.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.611 0.243 . . . . 1.37 110.475 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 143' ' ' LEU . 64.8 t -61.89 132.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.69 110.419 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.15 -49.11 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.238 0.458 . . . . 0.89 112.238 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 99' ' ' ARG . 5.4 ttt85 . . . . . 0 C--N 1.327 -0.378 0 C-N-CA 120.257 -0.577 . . . . 3.92 111.823 -172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 111.761 0.282 . . . . 1.24 111.761 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.53 170.01 46.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.529 -0.843 . . . . 0.94 111.969 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 130' ' ' GLU . 72.6 mt -145.31 144.21 30.61 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.309 0.576 . . . . 0.93 111.613 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.39 138.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.011 -0.995 . . . . 0.49 109.211 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.67 114.75 26.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.643 0.735 . . . . 1.4 110.312 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 129' ' ' HIS . 14.8 mm -91.34 132.15 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.045 -0.98 . . . . 0.63 109.845 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.9 pt? -85.65 152.74 22.87 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.181 0.301 . . . . 1.21 110.438 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.448 ' OD1' ' HB ' ' A' ' 123' ' ' THR . 18.2 m-20 -56.75 151.67 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.669 -0.493 . . . . 2.29 109.669 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -62.59 -25.95 68.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.735 0.302 . . . . 2.78 110.699 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.49 5.78 43.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.77 109.987 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 60.94 78.92 0.27 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.547 -0.751 . . . . 4.14 110.643 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.448 ' HB ' ' OD1' ' A' ' 119' ' ' ASP . 22.0 m -121.13 -74.18 0.62 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 1.87 110.606 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.5 p -144.03 -174.71 4.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.75 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.1 p -70.92 134.54 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.676 -0.491 . . . . 1.29 109.676 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.68 -69.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 1.03 110.623 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -136.66 -84.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.261 0.553 . . . . 1.56 111.197 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -175.33 142.38 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.035 -0.984 . . . . 2.08 108.899 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.509 ' CD2' HG13 ' A' ' 117' ' ' ILE . 17.5 m170 -124.1 124.39 42.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.999 0.428 . . . . 0.68 110.678 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.0 tt0 -85.26 143.74 28.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.247 -0.888 . . . . 1.19 108.758 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -117.13 134.31 54.93 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.181 -0.608 . . . . 0.74 111.348 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.555 ' HA3' ' CE1' ' A' ' 29' ' ' HIS . . . -77.95 153.58 40.16 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 114.945 -1.025 . . . . 0.51 113.11 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.37 -37.52 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.545 0.338 . . . . 0.67 111.905 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.6 p -80.0 -32.89 39.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.322 0.582 . . . . 1.35 110.731 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 45.5 m -64.67 -32.81 74.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.263 -0.88 . . . . 1.1 109.934 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.9 tp -78.36 58.38 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.452 -0.795 . . . . 1.46 110.846 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' VAL . 39.0 t -44.91 -40.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.64 0.733 . . . . 0.82 110.675 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.73 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 33.7 m-80 -87.87 33.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 2.17 111.283 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -61.9 -16.1 48.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.112 0.482 . . . . 1.39 111.064 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -92.15 -9.13 43.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.795 -0.639 . . . . 2.46 111.285 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.31 166.46 15.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 1.89 110.323 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -98.31 52.57 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.428 0.632 . . . . 2.88 109.753 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 97' ' ' VAL . 13.0 tp -60.02 125.48 23.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.828 -1.078 . . . . 0.97 111.591 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -129.95 171.8 12.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 1.77 110.544 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 97' ' ' VAL . 86.5 tttt -70.57 136.02 48.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.268 -0.573 . . . . 1.43 109.564 176.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.29 -9.12 57.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.486 -0.864 . . . . 1.07 111.398 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -91.81 123.34 35.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.334 -0.987 . . . . 1.94 108.334 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.94 146.87 47.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.049 0.452 . . . . 1.79 110.201 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.17 146.54 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.285 0.564 . . . . 1.16 111.504 -172.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 p -111.52 145.42 39.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.268 -0.878 . . . . 1.44 109.663 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -165.38 158.0 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.914 0.388 . . . . 0.61 110.175 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.43 ' HB3' HG21 ' A' ' 88' ' ' VAL . 24.1 mtt180 -125.65 125.26 42.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.399 -0.593 . . . . 2.2 109.399 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 92' ' ' THR . 9.2 tt -99.64 121.85 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 1.24 109.876 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 7.4 p-10 -145.71 -100.7 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.533 -0.303 . . . . 1.92 111.155 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.549 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 1.4 mt-10 -78.86 -29.0 44.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.026 0.441 . . . . 2.76 110.373 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.0 t -74.02 -17.51 60.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.915 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.72 21.99 58.97 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.719 -0.753 . . . . 1.27 112.37 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 158' ' ' ARG . 52.7 mtt180 -140.79 -171.4 3.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.997 -0.742 . . . . 3.61 108.997 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.86 107.74 18.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.606 -0.438 . . . . 0.48 109.862 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -110.33 161.48 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.49 110.109 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.71 36.93 19.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.24 0.543 . . . . 1.55 110.235 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.35 112.16 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.523 0.678 . . . . 1.26 111.12 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.73 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 53.2 t30 -131.14 114.52 15.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 2.05 110.476 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.41 131.18 49.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.75 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.54 107.28 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.959 -0.564 . . . . 1.56 110.501 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.362 -0.607 . . . . 2.94 109.362 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.952 0.406 . . . . 2.0 111.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -90.77 115.29 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.643 -0.873 . . . . 1.27 108.643 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CD2' ' HG ' ' A' ' 57' ' ' LEU . 22.8 m-85 -87.79 139.17 30.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.404 0.621 . . . . 1.14 110.786 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 27.8 ttm180 -100.83 130.12 46.8 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.01 -0.995 . . . . 2.31 110.189 -176.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.63 -177.31 26.99 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.378 -0.689 . . . . 0.5 111.378 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.546 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -149.21 151.05 33.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.964 0.412 . . . . 0.68 111.064 -177.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.7 123.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.857 -0.61 . . . . 0.56 111.477 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 25' ' ' GLU . . . -106.26 -37.08 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.76 111.584 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 23' ' ' PHE . 6.4 p -144.82 149.65 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.074 -0.512 . . . . 1.55 109.953 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.6 mtp -130.71 107.5 9.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.77 -0.456 . . . . 1.42 109.77 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.22 -168.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.03 109.746 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.72 -44.2 43.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.159 0.504 . . . . 3.24 110.885 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -102.91 -27.93 12.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.545 . . . . 2.03 111.655 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.12 -177.91 6.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.895 0.379 . . . . 1.25 111.756 -172.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.95 160.82 28.54 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.931 -0.577 . . . . 0.71 111.719 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.573 ' HB2' HG12 ' A' ' 16' ' ' VAL . 25.9 m-85 -108.38 135.46 49.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.763 -0.458 . . . . 1.08 109.763 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -102.53 125.12 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.61 110.304 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 32.6 tt0 -72.34 117.79 14.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.968 -1.123 . . . . 2.3 107.968 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 31' ' ' GLU . 5.5 p -66.07 157.44 31.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.036 -0.357 . . . . 0.87 110.036 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 17.2 tp -53.23 -36.05 60.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 1.58 111.785 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -110.7 12.61 22.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 2.04 110.054 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.2 p80 40.34 39.81 0.74 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.531 1.132 . . . . 3.29 113.086 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -95.37 -0.87 52.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 2.89 110.472 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HG21 ' A' ' 26' ' ' THR . 28.4 tt0 -156.98 148.08 21.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 1.8 111.248 -170.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.42 121.45 44.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.422 -0.584 . . . . 3.37 109.422 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.4 t -109.47 130.62 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.87 111.44 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 71' ' ' PRO . 14.0 t80 -84.56 120.56 26.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.814 -0.63 . . . . 1.06 110.385 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -124.23 144.96 49.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.367 177.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -116.84 126.92 53.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.716 -0.675 . . . . 1.18 110.101 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -63.93 -20.88 66.19 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.196 0.443 . . . . 0.75 112.196 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.7 t -67.02 -27.23 67.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.62 -0.263 . . . . 1.63 111.517 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -101.93 6.85 41.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.07 111.476 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 79.5 t80 -73.3 129.72 38.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.129 -0.487 . . . . 0.91 110.832 -175.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.5 ttp -98.9 93.09 5.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 1.73 110.389 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.27 -134.77 4.22 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.607 -0.724 . . . . 1.05 111.466 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -132.72 106.02 12.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.721 -0.474 . . . . 2.14 109.721 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.26 -17.85 16.55 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.36 2.04 . . . . 1.01 112.887 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -74.52 -17.01 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.338 0.59 . . . . 2.08 110.357 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -101.03 -2.13 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 2.18 110.844 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 13.1 mt -77.38 146.63 36.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.92 111.736 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.23 173.31 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 2.35 109.66 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.21 130.04 37.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.237 -0.438 . . . . 1.4 110.449 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.97 4.91 58.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.75 112.918 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.4 126.94 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.862 0.331 . . . . 1.06 111.042 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 43.3 mt-10 -72.57 129.97 39.53 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.577 -0.738 . . . . 2.51 110.551 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 77' ' ' MET . 28.5 m -137.92 156.54 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.932 0.396 . . . . 0.44 110.816 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 78' ' ' LEU . 12.9 pt-20 -114.3 138.64 50.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.086 -0.709 . . . . 1.49 109.086 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.425 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.8 p90 -165.3 176.76 8.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.958 0.409 . . . . 0.66 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 p -125.67 145.45 50.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.1 -0.5 . . . . 0.94 110.973 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 10' ' ' TYR . 90.8 mt -73.02 135.39 44.91 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.621 -0.432 . . . . 1.19 110.371 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.065 0 CA-C-N 115.531 -0.759 . . . . 2.04 109.724 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 58' ' ' ALA . 1.7 mp . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 108.934 -0.765 . . . . 2.3 108.934 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 35.3 Cg_endo -66.01 140.66 61.06 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.019 1.813 . . . . 1.43 111.661 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -58.25 121.22 10.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.493 -0.776 . . . . 0.82 110.593 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.3 148.44 28.99 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.361 0.413 . . . . 2.3 110.842 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.4 t30 59.12 82.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.23 -0.896 . . . . 2.01 110.708 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.49 121.95 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.8 110.253 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -125.97 156.47 39.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.837 -0.431 . . . . 3.51 109.837 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.41 ' HA ' HG12 ' A' ' 53' ' ' VAL . 67.3 mtt -76.91 138.99 40.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.12 110.613 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 54' ' ' GLU . 22.0 tp -113.88 146.0 34.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 1.67 109.255 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.07 155.84 17.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 113.152 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 84.4 tttt -73.35 154.2 40.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.389 -0.823 . . . . 4.61 111.308 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 93.7 m-20 77.36 23.56 0.87 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.622 0.769 . . . . 2.84 110.841 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 m -86.26 -13.08 47.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.863 -0.608 . . . . 1.7 109.512 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 3.5 mm -93.71 130.91 33.46 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.898 -0.778 . . . . 0.92 108.898 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.07 145.91 80.53 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.673 2.248 . . . . 1.03 112.56 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -124.0 137.54 29.1 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 2.76 110.835 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 82.6 Cg_exo -50.23 141.07 32.24 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.692 2.928 . . . . 1.08 113.352 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.58 95.29 5.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 1.1 111.393 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.464 HG11 ' OG1' ' A' ' 92' ' ' THR . 16.7 m -121.54 171.31 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.499 -0.556 . . . . 1.23 109.499 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.47 -63.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.308 -0.557 . . . . 2.87 111.124 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.03 -54.18 3.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.393 0.616 . . . . 2.84 111.269 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t 172.5 163.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.379 -0.971 . . . . 1.42 108.379 -174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.464 ' OG1' HG11 ' A' ' 88' ' ' VAL . 2.1 m -107.18 -59.06 1.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 1.3 111.84 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -148.34 178.04 8.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.573 0.701 . . . . 1.29 111.504 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.42 166.62 23.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.588 -1.264 . . . . 1.36 107.588 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.49 -165.79 30.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.707 -1.235 . . . . 0.53 112.695 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 148' ' ' LEU . 42.0 t -135.7 141.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.547 0.339 . . . . 1.37 110.165 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 66.3 t -59.15 118.99 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.06 -0.348 . . . . 0.69 110.06 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.27 -64.15 1.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 0.89 111.917 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.336 . . . . 3.92 111.862 -174.339 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB1' ' HG2' ' A' ' 130' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.985 0.421 . . . . 1.24 111.76 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 63.57 174.66 3.08 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.97 -0.559 . . . . 0.94 113.035 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 130' ' ' GLU . 55.8 mt -145.49 138.61 26.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.544 0.688 . . . . 0.93 111.715 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.48 138.02 37.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.686 -1.143 . . . . 0.49 109.767 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.62 121.39 29.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.628 . . . . 1.4 109.408 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 129' ' ' HIS . 4.2 mm -103.36 120.45 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.45 -0.795 . . . . 0.63 109.238 -175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -85.18 139.41 31.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 1.21 110.29 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.73 160.9 3.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.147 -0.933 . . . . 2.29 110.218 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.1 -27.0 68.8 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.19 -0.319 . . . . 2.78 111.53 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.05 12.54 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.709 -0.478 . . . . 1.77 109.709 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 48.59 35.91 6.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.794 1.238 . . . . 4.14 111.854 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 20.3 p -75.47 -67.39 0.67 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.608 -0.723 . . . . 1.87 111.118 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.7 p -139.01 172.81 12.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.09 -0.505 . . . . 1.54 111.28 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.6 t -72.92 136.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 1.29 109.474 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -70.98 -69.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.43 -0.508 . . . . 1.03 111.1 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 61.2 m -140.4 -85.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.45 0.643 . . . . 1.56 111.341 172.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -176.5 123.9 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.646 -1.161 . . . . 2.08 108.653 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 117' ' ' ILE . 31.5 m170 -111.91 126.93 55.64 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.631 -0.827 . . . . 0.68 110.618 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 114' ' ' LEU . 13.3 tt0 -88.1 149.06 24.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.462 -1.244 . . . . 1.19 109.629 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 38.3 p90 -123.7 175.71 6.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.74 110.837 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.443 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -137.44 153.58 22.06 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.625 -0.716 . . . . 0.51 111.564 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 tp -54.24 -23.26 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 117.154 0.477 . . . . 0.67 111.193 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -80.99 -34.4 33.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.323 0.582 . . . . 1.35 110.674 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 36.6 t -76.02 -26.0 56.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.231 -0.895 . . . . 1.1 110.377 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 80.1 mt -75.26 60.22 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.642 . . . . 1.46 112.27 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.5 t -41.41 -49.07 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.827 0.346 . . . . 0.82 111.863 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.56 HD21 HD22 ' A' ' 143' ' ' LEU . 2.7 p-10 -97.47 36.38 1.5 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.721 0.296 . . . . 2.17 111.53 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 13.9 ptpt -51.55 -22.54 3.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.244 0.831 . . . . 1.39 113.244 -177.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -81.66 -20.84 38.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.081 0.467 . . . . 2.46 111.005 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.24 163.36 18.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.641 -0.708 . . . . 1.89 111.431 -173.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.91 100.19 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.804 -0.635 . . . . 2.88 110.276 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 138' ' ' ASN . 7.1 tp -128.11 95.35 4.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.23 -0.655 . . . . 0.97 109.23 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.4 pt20 -130.35 -171.92 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.985 -0.552 . . . . 1.77 110.914 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.9 tttt -60.58 112.99 2.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.039 0.447 . . . . 1.43 110.833 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.02 -2.8 22.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.602 -0.809 . . . . 1.07 112.789 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.58 135.86 33.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.159 0.504 . . . . 1.94 111.095 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.439 HD13 ' CG2' ' A' ' 96' ' ' VAL . 3.1 mm? -81.07 135.96 35.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.043 -0.98 . . . . 1.79 110.147 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.61 151.09 27.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.11 0.481 . . . . 1.16 110.983 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.519 ' OG ' HG11 ' A' ' 165' ' ' VAL . 75.2 m -117.1 143.6 45.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.852 -0.613 . . . . 1.44 109.702 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 30.5 p90 -158.68 173.93 15.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.959 -0.564 . . . . 0.61 109.929 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 124.97 22.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.2 111.261 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.471 HD13 ' CE1' ' A' ' 129' ' ' HIS . 12.6 pt -97.2 151.66 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.348 -0.842 . . . . 1.24 109.621 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 35.3 t70 -173.26 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.055 0.222 . . . . 1.92 110.579 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -73.11 -36.5 66.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.957 0.408 . . . . 2.76 111.395 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -82.36 -16.67 48.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 1.98 111.187 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.36 2.08 13.24 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.021 -0.609 . . . . 1.27 112.814 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 153' ' ' ILE . 27.3 mtt85 -130.18 -178.94 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.793 -0.447 . . . . 3.61 109.793 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.43 108.86 18.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.48 111.56 -169.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.558 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.4 156.39 27.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.714 -0.675 . . . . 0.49 109.873 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 64.64 41.1 5.51 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.691 0.619 . . . . 1.55 110.318 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.35 114.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.695 -0.684 . . . . 1.26 110.762 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.24 125.51 45.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.377 -0.374 . . . . 2.05 110.44 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.56 120.14 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.75 110.616 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.519 HG11 ' OG ' ' A' ' 150' ' ' SER . 13.6 p -136.37 139.94 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 1.56 111.139 -174.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.375 -0.375 . . . . 2.94 110.096 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.148 0.499 . . . . 2.0 111.732 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 123.47 41.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.319 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.62 151.06 22.79 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.649 -0.871 . . . . 1.14 108.649 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -132.54 153.25 51.15 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.726 -0.79 . . . . 2.31 110.828 177.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.44 -153.84 6.7 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.607 -1.397 . . . . 0.5 109.607 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.55 140.84 30.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.942 0.401 . . . . 0.68 111.1 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -64.76 108.42 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.487 -0.779 . . . . 0.56 110.501 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.49 9.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.079 0.466 . . . . 0.76 110.812 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.38 122.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 1.55 110.375 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 45.6 ttm -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.87 -0.419 . . . . 1.42 109.87 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 71.5 mmtt -101.66 -167.08 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.212 -0.449 . . . . 2.03 109.992 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -83.34 -35.14 25.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 3.24 110.781 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.94 -36.91 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.244 0.461 . . . . 2.03 112.244 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 22.0 p90 -138.82 -170.36 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.791 0.329 . . . . 1.25 111.413 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.1 -169.45 31.6 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.399 -0.68 . . . . 0.71 111.399 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -136.46 142.7 43.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.766 -0.457 . . . . 1.08 109.766 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -114.15 120.58 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.61 110.237 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -70.65 119.58 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.976 -0.75 . . . . 2.3 108.976 171.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 31' ' ' GLU . 7.5 p -62.16 155.67 23.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.247 -0.433 . . . . 0.87 110.274 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 17.5 tp -55.01 -34.37 63.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.154 -0.475 . . . . 1.58 111.539 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 p -99.04 6.71 46.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 2.04 111.46 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 p80 40.18 42.28 1.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.147 0.979 . . . . 3.29 112.112 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -116.62 -16.13 10.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 2.89 110.137 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG21 ' A' ' 26' ' ' THR . 9.2 tp10 -132.18 148.51 52.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8 110.021 -175.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -109.37 128.66 55.29 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.731 -0.47 . . . . 3.37 109.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 55' ' ' TYR . 21.8 t -123.61 116.55 48.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 120.847 0.356 . . . . 0.87 111.052 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -73.73 122.49 22.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.697 . . . . 1.06 110.184 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.69 124.11 40.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.732 -0.667 . . . . 1.96 110.675 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 21' ' ' PHE . 5.3 t60 -101.56 142.35 33.05 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.668 -0.864 . . . . 1.18 108.668 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.42 -21.02 62.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.621 -0.432 . . . . 0.75 112.143 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 22.1 t -61.52 -29.63 70.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 1.63 111.246 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -99.95 17.01 22.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.024 0.44 . . . . 2.07 110.482 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -92.51 129.53 38.42 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.187 -0.46 . . . . 0.91 110.257 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.9 ttp -108.8 91.96 3.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 1.73 110.376 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.05 -130.13 1.83 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.332 -0.849 . . . . 1.05 111.073 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' HD1' ' A' ' 46' ' ' TRP . 36.4 t30 -150.12 111.07 3.28 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.328 . . . . 2.14 110.574 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.34 -16.31 27.89 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.859 2.373 . . . . 1.01 113.385 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.96 -16.47 63.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.686 0.279 . . . . 2.08 111.269 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.471 ' HD1' ' ND2' ' A' ' 43' ' ' ASN . 69.6 m95 -115.04 17.52 16.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.539 . . . . 2.18 111.09 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.35 165.5 12.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.92 110.129 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -155.0 166.78 32.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.742 -0.663 . . . . 2.35 109.328 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.6 mm? -69.09 126.28 29.3 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.82 -0.34 62.71 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.749 -0.738 . . . . 0.75 112.438 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.43 120.42 13.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.007 0.432 . . . . 1.06 110.72 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 21.9 mt-10 -64.34 122.8 17.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.237 -0.892 . . . . 2.51 110.794 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.9 m -141.53 144.73 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.212 -0.449 . . . . 0.44 109.976 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 19.0 pt-20 -116.17 148.13 40.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.758 -0.377 . . . . 1.49 110.274 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -162.92 177.35 9.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.66 112.003 -171.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.69 166.55 16.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.94 111.021 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.15 137.68 35.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.194 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 2.04 111.064 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 110.6 -0.148 . . . . 2.3 110.6 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.8 155.8 52.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.929 2.42 . . . . 1.43 111.901 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.71 169.5 9.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.989 -0.551 . . . . 0.82 110.262 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG3' HD22 ' A' ' 74' ' ' ASN . 9.9 pt-20 -158.73 172.2 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.768 -0.196 . . . . 2.3 110.607 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.532 HD22 ' HG3' ' A' ' 73' ' ' GLU . 50.2 m-80 60.51 26.6 16.24 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.674 0.609 . . . . 2.01 110.915 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.5 t -70.37 117.66 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.883 -0.599 . . . . 0.8 110.955 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -126.39 157.06 39.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 3.51 110.678 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.505 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.2 mtt -72.4 146.73 46.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.118 -0.492 . . . . 1.12 110.532 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.401 HD12 ' HD2' ' A' ' 79' ' ' PRO . 26.6 tp -119.97 131.23 24.49 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.876 -0.787 . . . . 1.67 108.876 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HD2' HD12 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.42 146.13 64.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.001 1.801 . . . . 2.15 111.849 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 19.5 ptpt -59.47 162.83 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 4.61 110.625 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 8.8 t30 77.5 2.95 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.447 0.641 . . . . 2.84 110.919 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -81.05 -27.65 35.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 1.7 109.655 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.13 116.63 66.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.733 -0.84 . . . . 0.92 108.733 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.58 155.09 40.25 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.552 2.168 . . . . 1.03 112.377 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.97 155.03 45.89 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.527 -0.545 . . . . 2.76 109.527 178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.493 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 17.0 Cg_exo -65.67 143.12 73.4 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.27 1.98 . . . . 1.08 111.215 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.62 94.56 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 1.1 111.214 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 t -140.96 130.62 25.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.571 -0.74 . . . . 1.23 109.254 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.87 -60.51 1.84 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.131 0.419 . . . . 2.87 112.131 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' O ' ' HB ' ' A' ' 91' ' ' THR . 14.7 pt-20 -90.51 -52.43 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.92 -0.312 . . . . 2.84 111.569 -174.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.8 t 166.1 159.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.613 -0.884 . . . . 1.42 108.613 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.54 -52.02 2.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.196 0.522 . . . . 1.3 110.158 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.99 168.14 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.306 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -125.98 151.55 46.89 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.417 -1.327 . . . . 1.36 107.417 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.18 -173.31 25.45 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.385 -1.388 . . . . 0.53 112.506 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.44 143.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.465 -0.568 . . . . 1.37 109.465 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.24 123.51 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.604 0.24 . . . . 0.69 110.435 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.17 17.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.89 112.033 -173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 . . . . . 0 C--N 1.33 -0.281 0 C-N-CA 120.606 -0.437 . . . . 3.92 111.869 -176.532 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 112.407 0.521 . . . . 1.24 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.3 -178.72 9.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.345 -0.455 . . . . 0.94 113.193 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 130' ' ' GLU . 38.1 mt -152.24 141.01 20.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.292 0.567 . . . . 0.93 111.641 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.3 134.24 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.878 -1.055 . . . . 0.49 109.134 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -86.34 111.04 20.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.67 0.748 . . . . 1.4 109.413 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -90.78 121.34 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.168 -0.924 . . . . 0.63 109.041 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -90.32 150.81 21.75 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.569 -0.453 . . . . 1.21 109.966 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.75 165.1 3.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.144 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.625 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.0 pm0 -65.12 -20.35 66.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 2.78 110.174 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.625 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.38 14.28 24.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 1.77 110.277 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 51.02 29.82 4.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.434 1.093 . . . . 4.14 112.118 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -67.53 0.66 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.392 -0.367 . . . . 1.87 111.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 7.3 p -138.24 -171.6 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.578 -0.283 . . . . 1.54 111.175 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 p -92.52 129.88 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.364 -0.606 . . . . 1.29 109.364 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.56 -69.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 1.03 110.629 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.4 m -139.01 -85.97 0.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.147 0.498 . . . . 1.56 110.46 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.5 143.49 0.48 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.873 -1.058 . . . . 2.08 108.596 173.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.646 ' HB2' HD11 ' A' ' 117' ' ' ILE . 33.3 m170 -116.34 124.46 50.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.68 110.335 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -81.94 140.59 33.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.996 . . . . 1.19 109.469 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' A' ' 136' ' ' LEU . 31.6 p90 -115.97 161.01 19.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.195 0.521 . . . . 0.74 111.27 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.43 152.24 17.25 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.813 -0.63 . . . . 0.51 111.663 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.9 tp -55.16 -29.42 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.96 0.409 . . . . 0.67 111.241 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -71.77 -33.7 68.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.451 0.643 . . . . 1.35 110.403 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 161' ' ' CYS . 2.2 m -66.77 -33.11 74.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.287 -0.87 . . . . 1.1 109.983 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 10.9 mp -75.94 57.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.769 -0.65 . . . . 1.46 111.923 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.3 t -46.58 -48.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.239 0.543 . . . . 0.82 110.545 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -93.4 35.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.465 -0.789 . . . . 2.17 110.962 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 9.9 ptpp? -54.36 -23.69 16.53 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.754 1.02 . . . . 1.39 113.754 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -81.44 -6.26 58.76 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.202 -0.311 . . . . 2.46 111.33 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.45 174.93 4.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 1.89 110.471 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -88.94 17.2 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 2.88 110.507 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -46.2 117.73 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.921 -1.036 . . . . 0.97 111.756 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -135.59 -179.94 5.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 1.77 110.675 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.52 129.32 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 1.43 110.026 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.92 64.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.358 -0.925 . . . . 1.07 112.562 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.93 146.12 24.0 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.94 109.575 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.88 134.77 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.181 0.515 . . . . 1.79 111.513 -170.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 m -129.72 148.12 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.836 -0.62 . . . . 1.16 111.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 64.1 m -113.77 140.52 48.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.534 -0.757 . . . . 1.44 109.096 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.688 ' HB3' HG12 ' A' ' 162' ' ' VAL . 25.7 p90 -151.06 165.75 32.86 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.144 -0.48 . . . . 0.61 109.794 -175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 -126.91 119.65 27.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.063 -0.655 . . . . 2.2 110.423 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 129' ' ' HIS . 12.6 pt -102.46 149.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 109.184 -0.673 . . . . 1.24 109.184 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 6.4 t70 -160.69 -93.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.995 -0.282 . . . . 1.92 110.564 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.59 -34.82 27.54 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.767 -0.373 . . . . 2.76 111.519 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.2 t -77.63 -17.7 57.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.672 0.272 . . . . 1.98 110.699 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.61 -14.66 3.25 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.994 -0.622 . . . . 1.27 113.968 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' ILE . 11.0 ptm180 -103.41 175.48 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.296 0.548 . . . . 3.61 110.054 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.27 109.84 18.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.142 0.496 . . . . 0.48 110.423 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.67 154.8 33.49 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.464 -0.789 . . . . 0.49 110.354 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.422 ' H ' ' HA ' ' A' ' 135' ' ' SER . 37.6 m 57.82 47.22 15.71 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.932 0.77 . . . . 1.55 111.325 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.3 m -70.89 128.3 33.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.642 0.734 . . . . 1.26 110.281 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -128.45 125.62 38.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.668 -0.696 . . . . 2.05 109.739 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.43 128.12 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.613 -0.721 . . . . 0.75 110.819 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.22 110.94 29.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.124 0.488 . . . . 1.56 111.468 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.542 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 2.8 mpt_? . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 108.747 -0.834 . . . . 2.94 108.747 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.338 0.59 . . . . 2.0 111.218 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.31 126.56 44.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.857 -1.065 . . . . 1.27 109.229 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -98.55 137.94 36.47 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.38 -0.6 . . . . 1.14 109.38 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 35.0 ttm180 -112.42 143.25 43.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.863 -0.421 . . . . 2.31 109.863 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.27 -170.24 22.74 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.67 -0.776 . . . . 0.5 111.591 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 139.74 42.29 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.662 0.268 . . . . 0.68 110.369 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.94 118.08 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.56 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.08 -56.65 2.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.614 0.245 . . . . 0.76 111.002 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.93 160.87 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.154 -0.313 . . . . 1.55 110.154 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.1 ttm -141.61 112.29 7.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.268 -0.424 . . . . 1.42 111.035 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 175.95 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.499 -0.556 . . . . 2.03 109.499 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.75 -34.76 76.4 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.581 0.551 . . . . 3.24 111.539 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -111.13 -47.45 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.205 0.446 . . . . 2.03 112.205 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -130.15 169.39 15.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.162 0.506 . . . . 1.25 111.627 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.72 -174.09 23.56 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.71 111.489 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' HB3' ' OE1' ' A' ' 32' ' ' GLU . 48.4 m-85 -129.04 154.4 46.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.119 -0.326 . . . . 1.08 110.119 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mt -133.79 122.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.61 110.316 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -69.0 119.5 13.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.817 -0.438 . . . . 2.3 109.817 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 p -57.6 141.47 48.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 0.87 109.911 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -50.0 -46.25 52.54 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.536 . . . . 1.58 110.708 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -85.81 18.05 3.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.656 . . . . 2.04 111.65 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 p80 43.13 36.2 0.93 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.128 0.971 . . . . 3.29 111.907 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -70.05 -50.99 35.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.274 -0.875 . . . . 2.89 110.382 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.43 -174.59 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 1.8 110.53 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 23' ' ' PHE . 1.1 mm-40 -102.75 145.23 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.974 -0.557 . . . . 3.37 109.976 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG11 ' HE2' ' A' ' 55' ' ' TYR . 20.8 t -122.44 120.54 61.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.21 0.528 . . . . 0.87 111.21 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -74.2 116.91 15.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.364 -0.834 . . . . 1.06 110.392 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -121.99 151.18 41.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.281 -0.637 . . . . 1.96 109.281 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.31 128.86 55.75 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.349 -0.611 . . . . 1.18 109.349 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.06 -20.15 65.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 0.75 110.871 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -59.96 -34.83 73.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.555 . . . . 1.63 111.699 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -102.96 -0.54 30.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.028 0.442 . . . . 2.07 110.615 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 54.6 t80 -72.01 128.66 36.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.91 110.213 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.4 ttp -102.21 111.55 23.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.042 0.448 . . . . 1.73 110.239 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 44' ' ' PRO . . . 147.14 -171.87 27.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.687 -0.688 . . . . 1.05 111.429 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.69 105.25 19.66 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.22 -0.289 . . . . 2.14 110.22 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 42' ' ' GLY . 10.0 Cg_exo -66.99 -30.34 39.31 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.469 2.113 . . . . 1.01 112.354 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -70.43 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 2.08 111.19 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.95 7.32 44.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.114 0.483 . . . . 2.18 110.58 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.41 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 20.6 mt -88.16 141.61 28.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.183 0.516 . . . . 0.92 111.306 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -120.92 158.41 27.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.821 . . . . 2.35 109.274 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.78 114.76 12.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.184 -0.672 . . . . 1.4 109.184 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.72 32.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.027 -0.606 . . . . 0.75 112.226 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -65.8 137.39 57.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 1.06 110.67 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.523 ' HG3' HD13 ' A' ' 83' ' ' ILE . 12.9 tt0 -78.63 125.73 29.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.361 -0.836 . . . . 2.51 110.274 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -141.8 155.45 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.176 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.1 148.14 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.968 0.413 . . . . 1.49 110.308 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -159.34 173.66 15.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.975 -0.557 . . . . 0.66 110.81 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 p -127.96 142.81 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.488 -0.324 . . . . 0.94 110.961 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.53 121.92 20.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 120.881 0.372 . . . . 1.19 110.263 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.529 -0.759 . . . . 2.04 111.485 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.599 0.238 . . . . 2.3 110.865 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.76 150.14 78.9 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.779 2.319 . . . . 1.43 113.357 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.94 147.72 25.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.114 -0.948 . . . . 0.82 109.292 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 10.5 pt-20 -125.98 176.43 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.108 -0.237 . . . . 2.3 110.508 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.41 28.08 15.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.627 0.727 . . . . 2.01 109.756 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 17.4 t -66.99 119.0 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.808 . . . . 0.8 109.841 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -133.2 140.3 47.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.998 -0.547 . . . . 3.51 111.644 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.466 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.3 mtt -71.6 149.46 45.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.12 110.485 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -145.9 163.31 31.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 1.67 109.445 170.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 24.7 Cg_exo -64.73 161.88 34.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.1 1.866 . . . . 2.15 112.216 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.45 -169.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 4.61 111.514 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t30 78.74 19.74 0.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.202 -0.908 . . . . 2.84 112.444 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -93.99 -39.27 10.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.199 -0.667 . . . . 1.7 109.199 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.523 HD13 ' HG3' ' A' ' 52' ' ' GLU . 2.3 mp -84.07 119.54 73.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.639 -0.71 . . . . 0.92 110.399 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.09 161.16 32.83 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.462 2.775 . . . . 1.03 112.565 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -93.12 153.97 41.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.414 -0.515 . . . . 2.76 110.188 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.16 164.1 23.7 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.649 2.233 . . . . 1.08 111.265 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.43 91.32 3.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.33 0.586 . . . . 1.1 111.627 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.47 153.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.953 -1.128 . . . . 1.23 107.953 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 -61.42 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.424 -0.511 . . . . 2.87 111.408 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 91' ' ' THR . 9.4 tp10 -92.17 -56.22 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 2.84 111.242 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t 167.17 165.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.283 -1.006 . . . . 1.42 108.283 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 m -106.79 -54.8 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.578 -0.449 . . . . 1.3 111.111 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -146.7 157.1 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 1.29 110.591 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.89 -179.53 3.72 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.558 -0.904 . . . . 1.36 108.558 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.99 -167.6 40.14 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.731 -1.223 . . . . 0.53 112.237 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.74 142.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.925 -0.768 . . . . 1.37 108.925 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 122.52 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.693 0.283 . . . . 0.69 110.712 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -72.94 -54.22 9.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.89 109.872 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 73.3 ttt180 . . . . . 0 CA--C 1.531 0.236 0 O-C-N 123.558 0.536 . . . . 3.92 111.8 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 112.663 0.616 . . . . 1.24 112.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.12 149.03 7.6 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.501 -0.857 . . . . 0.94 111.698 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.2 mt -131.54 154.4 48.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.384 0.612 . . . . 0.93 111.743 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.84 136.6 53.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.981 -1.009 . . . . 0.49 108.82 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.04 110.72 19.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.574 0.702 . . . . 1.4 109.7 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.0 mm -85.43 130.42 36.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.829 -1.078 . . . . 0.63 109.996 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.12 146.34 26.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.81 0.338 . . . . 1.21 110.333 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.19 165.06 9.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.29 110.429 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.533 ' HG3' HD22 ' A' ' 121' ' ' LEU . 11.3 pt-20 -60.25 -25.56 65.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.787 0.292 . . . . 2.78 111.787 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.533 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.67 13.92 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.906 -0.318 . . . . 1.77 110.604 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 39.71 76.67 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.399 1.08 . . . . 4.14 112.318 -175.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.2 p -124.91 -68.55 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.144 -0.934 . . . . 1.87 111.237 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 m -124.17 166.64 15.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 1.54 110.477 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.7 p -73.39 133.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.156 -0.313 . . . . 1.29 110.156 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.48 -69.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.601 -0.272 . . . . 1.03 111.045 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -138.06 -85.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 1.56 110.918 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -175.75 137.09 0.34 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.328 -0.851 . . . . 2.08 108.865 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.777 ' HB2' HD11 ' A' ' 117' ' ' ILE . 35.3 m170 -121.32 133.89 55.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.58 -0.526 . . . . 0.68 109.58 172.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -90.37 152.87 20.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.589 -0.732 . . . . 1.19 109.884 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -117.97 135.48 54.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.291 0.567 . . . . 0.74 110.838 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.29 151.34 21.42 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.396 -0.82 . . . . 0.51 111.734 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.45 -33.64 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.67 110.718 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.7 t -76.29 -30.22 57.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.481 -0.781 . . . . 1.35 110.203 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' VAL . 24.8 m -76.14 -24.18 54.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.753 -0.658 . . . . 1.1 110.159 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.5 mt -71.2 58.26 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.443 -0.798 . . . . 1.46 111.459 176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.3 t -47.24 -47.13 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.436 0.636 . . . . 0.82 110.403 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.615 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 35.6 m-80 -92.38 34.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.563 -0.744 . . . . 2.17 111.622 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 8.9 ptpp? -61.21 -21.3 63.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.675 0.274 . . . . 1.39 111.726 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -89.06 -2.4 58.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 2.46 111.248 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.83 148.76 24.52 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.428 -0.953 . . . . 1.89 108.428 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.95 92.42 3.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.66 0.743 . . . . 2.88 110.077 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.3 tp -113.31 105.71 13.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.675 -1.148 . . . . 0.97 110.064 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -128.45 -171.35 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.889 -0.324 . . . . 1.77 111.65 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 56.8 tttm -64.01 110.42 2.13 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.31 -0.405 . . . . 1.43 111.138 -175.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.47 -6.69 20.75 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.486 -0.864 . . . . 1.07 112.386 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.56 142.19 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 1.94 110.898 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.31 140.03 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 1.79 111.221 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.65 153.34 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.16 111.772 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -118.29 144.8 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.763 . . . . 1.44 108.983 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.574 ' HB3' HG12 ' A' ' 162' ' ' VAL . 33.8 p90 -158.47 176.86 11.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.016 0.436 . . . . 0.61 110.767 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -135.21 123.8 23.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 2.2 111.286 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.92 122.7 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.261 -0.881 . . . . 1.24 109.332 167.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 4.9 p-10 -152.9 -94.72 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.109 -0.237 . . . . 1.92 110.835 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.493 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 39.3 mm-40 -82.53 -17.32 45.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 2.76 109.233 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 -19.06 35.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.99 -1.004 . . . . 1.98 111.2 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.1 6.5 10.18 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.954 -0.566 . . . . 1.27 113.99 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.12 -167.51 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.852 -0.795 . . . . 3.61 108.852 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.6 18.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.415 -0.587 . . . . 0.48 109.415 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.43 155.21 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.188 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 70.4 m 58.7 37.89 25.06 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.833 0.708 . . . . 1.55 110.837 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 151' ' ' PHE . 33.1 m -65.02 117.76 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.766 0.793 . . . . 1.26 110.329 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.615 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 4.8 p30 -118.1 123.4 45.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.686 -0.688 . . . . 2.05 110.275 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.435 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -66.16 103.42 0.97 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.335 -0.848 . . . . 0.75 110.831 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.74 110.24 20.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.691 0.758 . . . . 1.56 110.86 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 7.5 mpt_? . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 108.776 -0.824 . . . . 2.94 108.776 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 120.98 0.419 . . . . 2.0 111.392 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.39 122.52 39.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.805 . . . . 1.27 109.163 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.23 137.52 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.12 -0.491 . . . . 1.14 110.005 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.522 HH11 ' CD2' ' A' ' 78' ' ' LEU . 21.6 ttm-85 -106.44 129.54 54.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.384 -0.825 . . . . 2.31 109.963 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.71 -171.33 22.75 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.795 -0.717 . . . . 0.5 111.765 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.7 148.51 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 0.68 111.075 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.41 118.68 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.513 -0.767 . . . . 0.56 110.791 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.85 -37.94 6.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.76 111.091 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.5 p -130.99 122.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.274 0.559 . . . . 1.55 110.861 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.99 106.24 18.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.429 -0.952 . . . . 1.42 108.429 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 14.7 tppt? -98.4 170.8 8.6 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.067 -0.716 . . . . 2.03 109.067 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 62.5 mt-10 -65.98 -38.64 89.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.169 0.433 . . . . 3.24 112.169 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -112.1 -41.32 3.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.088 0.47 . . . . 2.03 111.524 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.612 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 42.7 p90 -131.0 -161.53 1.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.052 -0.522 . . . . 1.25 110.195 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.91 -177.57 40.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.97 . . . . 0.71 112.245 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.634 ' H ' HG13 ' A' ' 16' ' ' VAL . 75.2 m-85 -125.26 130.3 51.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.598 -0.519 . . . . 1.08 109.598 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -102.9 134.08 44.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.267 -0.642 . . . . 0.61 109.267 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.71 143.33 30.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.933 -1.136 . . . . 2.3 107.933 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 p -67.66 -173.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.035 0.445 . . . . 0.87 110.523 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -81.96 -47.05 13.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.099 0.475 . . . . 1.58 110.658 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -102.68 22.54 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.445 0.535 . . . . 2.04 112.445 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 56.06 58.19 4.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.228 0.537 . . . . 3.29 109.785 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 -44.09 5.85 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.48 -0.782 . . . . 2.89 110.714 -172.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.91 167.34 20.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.04 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -103.6 127.81 50.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.062 0.458 . . . . 3.37 110.551 -175.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.546 HG11 ' HE2' ' A' ' 55' ' ' TYR . 12.1 t -110.27 131.5 61.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.87 111.245 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -89.9 123.81 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.566 -0.743 . . . . 1.06 110.081 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -124.06 153.8 40.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.214 -0.662 . . . . 1.96 109.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.419 ' HD2' ' H ' ' A' ' 38' ' ' SER . 2.3 t60 -116.11 131.96 56.79 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.939 -0.763 . . . . 1.18 108.939 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 25.8 m-85 -58.7 -27.82 65.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.419 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 69.5 m -65.63 -36.5 83.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.541 0.21 . . . . 1.63 111.449 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -83.85 3.76 32.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.939 0.399 . . . . 2.07 110.981 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 64.9 t80 -83.59 140.44 32.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.891 -0.595 . . . . 0.91 110.091 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.5 ttp -116.52 116.43 27.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.122 0.487 . . . . 1.73 110.334 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.05 -151.49 22.9 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.655 . . . . 1.05 111.678 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -105.19 103.55 42.69 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.633 0.254 . . . . 2.14 110.855 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.03 -27.12 25.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.46 2.107 . . . . 1.01 113.119 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.82 1.0 45.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.975 0.416 . . . . 2.08 111.295 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -110.51 14.55 22.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.475 0.655 . . . . 2.18 109.674 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.5 mt -97.61 152.95 18.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.039 -0.982 . . . . 0.92 110.825 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.0 -178.32 6.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.754 -0.657 . . . . 2.35 109.238 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.7 mt -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.783 0.325 . . . . 1.4 111.414 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.0 -1.59 24.23 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.922 -0.656 . . . . 0.75 113.182 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.442 HE21 ' N ' ' A' ' 52' ' ' GLU . 25.9 tp60 -74.69 122.5 23.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.866 0.333 . . . . 1.06 110.98 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.0 mt-10 -61.59 132.86 54.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.609 -0.723 . . . . 2.51 110.373 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 77' ' ' MET . 25.9 m -140.83 148.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.44 110.207 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -114.63 142.71 46.1 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.268 -0.642 . . . . 1.49 109.268 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HE2' HG11 ' A' ' 33' ' ' VAL . 5.8 p90 -162.13 170.82 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.103 0.478 . . . . 0.66 111.559 -175.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 p -125.52 167.7 14.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.94 111.182 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.13 153.02 28.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 1.19 109.994 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 121.358 0.599 . . . . 2.04 110.969 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--O 1.232 0.149 0 N-CA-C 110.244 -0.28 . . . . 2.3 110.244 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.68 149.16 37.89 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.445 2.097 . . . . 1.43 111.823 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.48 36.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 0.82 111.116 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 79.8 mm-40 -119.59 143.78 47.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 2.3 110.436 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.5 t30 59.87 80.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 2.01 110.846 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.3 t -109.4 122.68 64.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.075 -0.512 . . . . 0.8 110.075 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.32 147.24 51.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.576 -0.283 . . . . 3.51 110.747 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.459 ' HA ' HG12 ' A' ' 53' ' ' VAL . 64.1 mtt -66.88 150.37 49.28 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.21 0.528 . . . . 1.12 111.467 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.522 ' CD2' HH11 ' A' ' 11' ' ' ARG . 19.1 tp -147.6 75.96 11.0 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.114 -0.948 . . . . 1.67 110.771 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -90.24 117.99 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.791 1.661 . . . . 2.15 112.716 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -174.05 6.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.117 0.414 . . . . 4.61 112.117 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 t30 57.7 50.56 10.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.027 0.917 . . . . 2.84 108.866 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.0 t -73.64 -10.44 59.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.554 -1.203 . . . . 1.7 109.937 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.638 HD12 ' CD2' ' A' ' 27' ' ' LEU . 6.2 mm -78.22 128.25 78.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.695 . . . . 0.92 109.469 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.1 159.66 48.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.083 2.522 . . . . 1.03 112.904 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -117.55 149.3 44.65 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.73 -0.668 . . . . 2.76 110.382 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.7 149.27 43.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 1.08 111.906 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.04 94.05 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.54 . . . . 1.1 110.603 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 152' ' ' ARG . 21.6 t -139.24 144.37 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.715 -0.846 . . . . 1.23 108.715 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.2 mt -88.22 -64.12 1.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.476 -0.49 . . . . 2.87 111.872 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 91' ' ' THR . 33.5 mt-10 -95.25 -53.82 3.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.357 0.599 . . . . 2.84 110.676 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.2 t 172.0 166.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.769 -1.105 . . . . 1.42 108.114 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -105.66 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.295 -0.562 . . . . 1.3 111.424 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -141.71 171.76 13.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.281 0.562 . . . . 1.29 111.36 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.72 158.09 45.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.018 -1.105 . . . . 1.36 108.018 172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.43 -166.97 28.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.725 -1.226 . . . . 0.53 112.293 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.11 145.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.579 -0.526 . . . . 1.37 109.579 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 84.8 t -60.92 126.73 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.627 -0.26 . . . . 0.69 110.846 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.9 -48.59 17.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.89 110.344 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.018 0.437 . . . . 3.92 111.962 175.528 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.759 0.314 . . . . 1.24 111.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 161.08 36.03 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.499 -0.858 . . . . 0.94 111.508 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 130' ' ' GLU . 36.7 mt -143.44 141.47 30.84 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.628 0.727 . . . . 0.93 112.405 -174.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.9 mt -114.16 139.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.494 -1.23 . . . . 0.49 108.817 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.46 136.35 33.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.173 -0.611 . . . . 1.4 110.206 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 129' ' ' HIS . 22.0 mm -105.75 131.81 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.803 -0.635 . . . . 0.63 109.541 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 118' ' ' LEU . 1.7 pt? -85.55 150.13 24.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.559 -0.291 . . . . 1.21 110.559 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.42 166.85 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.468 . . . . 2.29 110.109 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.49 -26.89 63.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.78 110.648 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 1.1 mm? -91.3 11.87 22.21 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.163 -0.471 . . . . 1.77 110.632 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 4.2 ptp180 47.05 32.89 2.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.982 0.913 . . . . 4.14 112.537 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 p -95.59 -73.0 0.6 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 1.87 112.018 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -179.68 3.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.585 0.231 . . . . 1.54 111.488 -176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -91.36 139.45 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.048 -0.523 . . . . 1.29 109.961 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mt -76.1 -69.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.579 -0.448 . . . . 1.03 110.675 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -138.02 -87.22 0.26 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.076 0.465 . . . . 1.56 110.426 168.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.74 146.85 0.46 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.084 -0.962 . . . . 2.08 109.109 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.473 ' HB2' HD11 ' A' ' 117' ' ' ILE . 27.7 m170 -118.8 136.79 53.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.317 0.58 . . . . 0.68 111.119 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 20.6 tt0 -86.66 143.53 27.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.707 -1.133 . . . . 1.19 109.897 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -120.41 140.44 51.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.221 0.534 . . . . 0.74 110.713 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.29 154.04 22.1 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.616 -0.72 . . . . 0.51 112.187 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -55.38 -22.0 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.469 0.652 . . . . 0.67 111.013 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -79.19 -37.19 38.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.749 -0.659 . . . . 1.35 110.212 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 162' ' ' VAL . 14.5 m -68.61 -33.47 74.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.322 -0.854 . . . . 1.1 110.517 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.62 58.52 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.46 111.544 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -48.86 -39.11 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.178 0.514 . . . . 0.82 110.88 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.513 HD21 HD22 ' A' ' 143' ' ' LEU . 3.1 p-10 -84.99 33.16 0.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 2.17 111.283 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -61.95 -18.79 61.55 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.123 0.487 . . . . 1.39 111.418 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -76.58 -22.29 54.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 2.46 110.885 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.45 155.15 17.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.829 -0.623 . . . . 1.89 111.933 -169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.403 -0.817 . . . . 2.88 109.505 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.517 HD21 ' CG1' ' A' ' 149' ' ' VAL . 10.6 tp -145.46 119.52 9.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.644 -0.502 . . . . 0.97 109.644 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.425 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.6 pt20 -133.36 -173.23 3.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.839 0.352 . . . . 1.77 111.355 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 54.5 tttm -61.78 114.51 3.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.43 110.499 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.98 -10.34 15.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.856 -0.687 . . . . 1.07 112.256 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.4 133.12 33.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 1.94 110.508 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.9 142.02 28.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.963 -0.562 . . . . 1.79 111.186 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.517 ' CG1' HD21 ' A' ' 143' ' ' LEU . 30.7 m -139.02 158.52 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.315 0.579 . . . . 1.16 111.748 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 8.4 t -115.12 148.01 39.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.339 -0.986 . . . . 1.44 108.339 171.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.64 ' HB3' HG12 ' A' ' 162' ' ' VAL . 18.8 p90 -159.99 163.03 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.61 111.035 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -124.36 121.5 35.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.267 0.556 . . . . 2.2 110.71 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 92' ' ' THR . 3.7 tt -101.66 133.08 46.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.28 -0.873 . . . . 1.24 110.224 171.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.561 ' OD2' ' HG2' ' A' ' 155' ' ' GLU . 21.9 t70 -168.08 -88.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.366 -0.134 . . . . 1.92 111.25 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG2' ' OD2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -68.63 -32.27 72.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.866 0.365 . . . . 2.76 111.323 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 p -83.83 -16.38 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.011 -0.54 . . . . 1.98 111.147 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.3 15.05 60.57 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.988 -0.625 . . . . 1.27 112.752 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.421 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 48.4 mtm180 -151.14 -165.0 2.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.462 . . . . 3.61 109.754 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.29 116.27 24.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.48 111.204 -173.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.576 -0.738 . . . . 0.49 109.632 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 55.02 56.31 6.72 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.744 0.653 . . . . 1.55 111.128 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 151' ' ' PHE . 10.3 m -80.92 146.1 7.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.984 -0.376 . . . . 1.26 109.984 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -148.1 141.6 25.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.907 0.384 . . . . 2.05 110.411 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.24 24.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.75 111.095 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.53 127.92 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.413 -0.358 . . . . 1.56 110.518 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 109.181 -0.674 . . . . 2.94 109.181 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.278 0.561 . . . . 2.0 112.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.92 118.02 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.178 -1.045 . . . . 1.27 108.178 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -87.43 138.28 31.61 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.948 -0.569 . . . . 1.14 110.162 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -106.56 131.62 53.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.533 -0.758 . . . . 2.31 109.286 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.09 -170.8 20.43 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.874 -0.891 . . . . 0.5 110.874 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.96 148.52 32.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.68 111.724 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.9 115.39 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.355 -0.838 . . . . 0.56 110.642 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.01 -26.92 12.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.873 -0.331 . . . . 0.76 110.891 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.29 140.15 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.687 -0.486 . . . . 1.55 109.687 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.9 tpp -125.43 106.09 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 1.42 110.32 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 63.3 mttt -112.08 172.45 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.284 -0.416 . . . . 2.03 110.99 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.14 -45.58 79.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.903 0.705 . . . . 3.24 112.903 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.02 -43.04 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.343 0.497 . . . . 2.03 112.343 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 43.5 p90 -132.44 168.2 18.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.789 0.328 . . . . 1.25 111.003 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.19 159.93 28.06 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.374 -0.69 . . . . 0.71 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.93 126.87 52.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.574 -0.528 . . . . 1.08 109.574 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.37 124.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.323 -0.621 . . . . 0.61 109.323 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 9.9 tp10 -82.3 133.3 35.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.968 -0.753 . . . . 2.3 108.968 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -62.82 154.69 29.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.358 -0.837 . . . . 0.87 110.648 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 83' ' ' ILE . 13.2 tp -47.66 -42.68 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 1.58 112.568 -175.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -111.8 18.29 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.274 -0.421 . . . . 2.04 111.811 -174.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.553 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 15.6 m-70 57.46 58.78 3.62 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 3.29 110.415 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -96.87 -47.24 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.283 -0.871 . . . . 2.89 110.869 -174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -158.22 -174.39 4.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 1.8 111.009 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -102.29 123.68 46.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 3.37 110.753 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 ' HE2' ' A' ' 55' ' ' TYR . 17.9 t -111.82 107.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.933 0.397 . . . . 0.87 110.821 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.24 123.41 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.186 0.517 . . . . 1.06 109.759 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -128.13 134.38 49.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.96 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 125.02 47.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.888 -0.782 . . . . 1.18 108.888 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -60.24 -16.75 36.53 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.292 0.478 . . . . 0.75 112.292 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -59.71 -15.48 20.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.25 -0.432 . . . . 1.63 111.715 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -109.43 12.7 24.47 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.665 0.269 . . . . 2.07 111.401 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -82.11 133.42 35.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.722 0.296 . . . . 0.91 110.223 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 ttm -91.97 100.64 13.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.952 0.406 . . . . 1.73 110.613 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.32 -146.02 16.81 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.003 -0.618 . . . . 1.05 112.11 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -112.71 104.74 56.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.689 0.28 . . . . 2.14 110.602 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.82 -5.18 16.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.836 2.358 . . . . 1.01 112.292 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.21 -6.25 46.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.763 -0.653 . . . . 2.08 111.173 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.58 14.0 17.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.18 110.924 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.77 148.78 23.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.005 -0.543 . . . . 0.92 110.579 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -145.0 177.22 8.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.928 -0.578 . . . . 2.35 110.107 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.9 mm? -72.25 123.29 22.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.533 . . . . 1.4 110.944 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.1 1.59 48.31 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.955 -0.566 . . . . 0.75 112.551 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -79.13 123.74 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.812 0.339 . . . . 1.06 110.657 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.31 140.87 45.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.808 -0.633 . . . . 2.51 111.186 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.82 154.27 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.44 110.684 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.87 134.29 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.648 -0.871 . . . . 1.49 108.648 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.559 ' CB ' HG22 ' A' ' 75' ' ' VAL . 3.5 p90 -164.9 175.89 9.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.527 0.566 . . . . 0.66 112.527 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 p -126.32 173.6 9.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.518 -0.764 . . . . 0.94 111.113 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -108.62 144.72 35.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 1.19 111.019 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 2.04 111.439 -178.128 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.48 0.181 . . . . 2.3 110.932 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.4 148.84 84.7 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.571 2.181 . . . . 1.43 111.762 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.04 156.68 20.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.82 110.566 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.17 166.53 24.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.696 -0.229 . . . . 2.3 110.807 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 55.55 76.53 0.27 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.892 0.745 . . . . 2.01 110.611 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.0 t -115.84 120.3 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.72 -0.673 . . . . 0.8 110.664 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -117.26 151.41 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.416 -0.587 . . . . 3.51 109.416 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtm -87.26 143.4 27.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.966 -0.294 . . . . 1.12 110.641 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -130.16 120.04 18.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.345 -0.983 . . . . 1.67 108.345 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.4 116.53 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.431 2.087 . . . . 2.15 116.002 -163.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? 54.59 127.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.319 1.97 . . . . 4.61 116.319 162.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 t30 75.74 30.47 0.77 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.585 -1.189 . . . . 2.84 110.918 167.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 m -94.83 4.5 53.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 1.7 110.886 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 27' ' ' LEU . 10.3 mm -108.21 136.16 19.85 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.299 -0.63 . . . . 0.92 109.299 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.49 156.2 67.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.527 2.151 . . . . 1.03 112.003 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.28 146.0 43.6 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.714 -0.221 . . . . 2.76 110.943 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 160' ' ' ALA . 36.5 Cg_endo -67.37 150.33 80.91 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.998 2.466 . . . . 1.08 112.139 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.34 94.14 6.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.052 0.453 . . . . 1.1 110.61 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.6 t -138.11 134.58 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 mt -74.83 -65.09 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.582 -0.447 . . . . 2.87 111.928 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 91' ' ' THR . 34.3 mt-10 -96.49 -56.12 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.19 0.519 . . . . 2.84 111.302 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 175.9 160.59 0.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.264 -1.334 . . . . 1.42 107.465 -174.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -101.53 -54.6 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.352 -0.539 . . . . 1.3 110.18 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -138.91 158.52 44.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.791 -0.448 . . . . 1.29 109.791 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -112.92 155.39 24.82 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.901 -1.148 . . . . 1.36 107.901 170.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.72 177.65 38.74 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 119.674 -1.251 . . . . 0.53 112.012 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.46 149.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.605 -0.517 . . . . 1.37 109.605 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.54 123.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.737 0.303 . . . . 0.69 111.276 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.97 4.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.89 111.722 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.522 -0.308 . . . . 3.92 111.01 -176.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.647 0.26 . . . . 1.24 111.648 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 87.04 157.61 31.18 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.473 -0.87 . . . . 0.94 112.176 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 130' ' ' GLU . 59.7 mt -144.03 135.33 25.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.93 111.395 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 mt -106.22 138.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.793 -1.094 . . . . 0.49 109.726 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.59 117.15 28.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.593 0.711 . . . . 1.4 110.401 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.2 mm -96.48 132.31 41.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.008 -0.996 . . . . 0.63 109.502 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -86.45 152.79 22.39 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.91 -0.316 . . . . 1.21 110.56 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -59.83 161.39 6.46 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.124 -0.489 . . . . 2.29 111.265 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.41 -23.68 64.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.487 -0.779 . . . . 2.78 111.282 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.38 3.11 54.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.672 -0.24 . . . . 1.77 110.764 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 59.45 88.72 0.07 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.494 0.664 . . . . 4.14 109.759 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -144.5 -77.92 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 1.87 111.378 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 17.0 p -123.83 -166.45 1.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.682 0.277 . . . . 1.54 110.649 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.5 p -95.25 126.2 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.912 -0.585 . . . . 1.29 109.729 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.6 mt -65.31 -69.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 120.719 -0.392 . . . . 1.03 110.883 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -137.91 -85.93 0.28 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 1.56 110.485 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -176.43 139.71 0.35 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.649 -1.16 . . . . 2.08 108.151 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.546 ' HB2' HD11 ' A' ' 117' ' ' ILE . 19.4 m170 -117.88 130.19 56.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.69 -0.804 . . . . 0.68 111.277 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 16.4 tt0 -85.55 142.67 28.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.476 -1.238 . . . . 1.19 109.435 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 43.1 p90 -117.91 136.09 53.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.31 0.576 . . . . 0.74 110.363 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.55 150.96 22.89 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.508 -0.769 . . . . 0.51 112.312 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.51 -27.95 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.226 0.536 . . . . 0.67 110.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.9 p -76.22 -39.81 53.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.661 -0.7 . . . . 1.35 111.034 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 15.1 p -82.51 -14.96 54.08 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.803 -0.635 . . . . 1.1 110.943 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -79.5 58.28 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 1.46 110.5 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 137' ' ' VAL . 6.8 t -51.45 -35.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.591 . . . . 0.82 110.81 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.504 ' OD1' HD22 ' A' ' 143' ' ' LEU . 6.2 p30 -88.26 21.17 2.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.459 -0.791 . . . . 2.17 111.228 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -54.06 -23.61 14.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.833 0.679 . . . . 1.39 112.833 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -93.04 -1.57 56.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 2.46 111.819 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.17 175.75 9.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.204 -0.453 . . . . 1.89 110.202 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 mt -91.41 29.1 1.53 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.228 0.537 . . . . 2.88 109.828 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 164' ' ' ALA . 18.9 tp -51.44 115.15 1.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.409 -1.269 . . . . 0.97 112.073 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -122.37 -176.31 3.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 1.77 110.544 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.69 130.96 43.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 1.43 109.612 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.67 43.65 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.662 -0.78 . . . . 1.07 112.196 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.99 134.88 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.678 -0.409 . . . . 1.94 110.218 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 165' ' ' VAL . 92.5 mt -80.19 141.28 35.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 1.79 110.258 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.85 142.81 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.124 -0.489 . . . . 1.16 110.738 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.6 p -100.83 121.81 42.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.784 -0.644 . . . . 1.44 109.455 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.0 p90 -144.06 163.61 33.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.117 -0.492 . . . . 0.61 110.103 -176.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.532 ' NE ' ' HB2' ' A' ' 161' ' ' CYS . 0.9 OUTLIER -137.31 124.2 21.35 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.683 0.754 . . . . 2.2 111.247 176.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.401 HG23 HG21 ' A' ' 92' ' ' THR . 1.4 tt -99.35 134.63 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.627 -1.17 . . . . 1.24 110.353 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 10.4 t70 -153.32 -97.34 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.515 0.191 . . . . 1.92 111.515 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.0 41.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.373 . . . . 2.76 111.683 -174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -80.58 -16.84 53.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 1.98 110.182 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.43 17.67 62.3 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.007 -0.542 . . . . 1.27 113.255 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 41.5 mtm180 -145.02 -170.65 3.47 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.14 124.23 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.402 0.62 . . . . 0.48 111.437 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 86' ' ' PRO . . . -135.64 157.91 45.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.443 -0.799 . . . . 0.49 110.091 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.532 ' HB2' ' NE ' ' A' ' 152' ' ' ARG . 59.4 m 49.27 61.91 2.89 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.772 0.67 . . . . 1.55 109.954 -171.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 151' ' ' PHE . 53.6 t -90.89 121.83 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 1.26 110.33 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -136.21 132.75 36.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.964 -0.384 . . . . 2.05 109.964 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.33 120.43 9.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.75 111.472 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' LEU . 7.1 p -127.02 126.46 68.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.747 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.9 mpt_? . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 109.967 -0.383 . . . . 2.94 109.967 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.088 0.471 . . . . 2.0 111.524 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.88 123.38 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 1.27 109.32 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.83 139.76 37.98 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.917 -0.583 . . . . 1.14 109.798 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.443 HH11 ' CD1' ' A' ' 78' ' ' LEU . 37.8 ttm-85 -110.82 148.38 32.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.157 -0.683 . . . . 2.31 109.157 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.39 178.35 46.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.52 -0.847 . . . . 0.5 112.173 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 145.62 48.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.96 0.409 . . . . 0.68 111.17 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -65.96 117.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.419 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' HD22 ' A' ' 49' ' ' LEU . . . -97.9 -42.17 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.078 -0.249 . . . . 0.76 110.914 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 23' ' ' PHE . 2.4 m -124.84 148.63 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 109.949 -0.389 . . . . 1.55 109.949 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.4 mtp -133.79 110.07 9.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.973 -0.38 . . . . 1.42 109.973 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -92.69 170.69 9.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.272 -1.01 . . . . 2.03 108.272 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.66 -16.6 60.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.073 0.463 . . . . 3.24 110.034 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -104.31 -49.27 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.03 111.651 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -147.74 -179.84 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.796 -0.184 . . . . 1.25 110.621 -175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.69 165.28 28.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.275 -0.964 . . . . 0.71 112.389 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HD2' HG21 ' A' ' 16' ' ' VAL . 49.9 m-85 -118.79 128.71 54.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.894 0.378 . . . . 1.08 110.016 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.8 mt -97.77 125.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.956 -0.566 . . . . 0.61 109.493 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 139.16 36.35 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.806 -0.813 . . . . 2.3 108.806 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -66.34 156.87 33.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.176 0.512 . . . . 0.87 111.447 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.539 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -63.4 -42.46 98.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.786 -0.643 . . . . 1.58 111.143 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 p -97.2 12.27 33.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.868 0.692 . . . . 2.04 112.868 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 59.68 58.26 2.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.888 0.375 . . . . 3.29 111.332 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.54 -28.14 5.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.243 0.46 . . . . 2.89 112.243 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -169.55 170.61 8.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.953 0.342 . . . . 1.8 110.614 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.16 140.41 37.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.862 0.363 . . . . 3.37 110.349 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 127.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.043 0.449 . . . . 0.87 110.621 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -84.1 121.51 27.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.898 -0.592 . . . . 1.06 110.776 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -128.05 146.97 50.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.732 -0.84 . . . . 1.96 108.732 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HD2' ' H ' ' A' ' 38' ' ' SER . 2.0 t60 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.297 -0.631 . . . . 1.18 109.297 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -64.89 -19.58 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.027 0.441 . . . . 0.75 111.043 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 20.9 t -62.97 -36.58 83.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.599 -0.728 . . . . 1.63 111.08 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.91 16.85 23.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.865 0.364 . . . . 2.07 110.599 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.553 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 74.9 t80 -75.98 135.9 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.517 -0.549 . . . . 0.91 109.517 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.429 ' H ' HG23 ' A' ' 75' ' ' VAL . 60.4 mtp -98.09 105.93 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.264 0.554 . . . . 1.73 110.961 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.32 -134.59 7.77 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.025 -0.989 . . . . 1.05 111.999 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.1 100.83 51.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.339 . . . . 2.14 110.273 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.26 -12.6 21.02 Favored 'Trans proline' 0 N--CA 1.471 0.185 0 C-N-CA 122.976 2.45 . . . . 1.01 113.133 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.17 -13.44 59.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 2.08 110.37 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -102.84 14.63 31.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 2.18 111.359 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -88.67 141.73 28.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.219 -0.446 . . . . 0.92 110.211 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -136.06 170.56 15.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.673 -0.694 . . . . 2.35 109.934 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 15' ' ' ALA . 54.2 mt -74.68 114.59 13.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.01 -0.541 . . . . 1.4 110.488 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.7 26.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.898 -0.668 . . . . 0.75 112.764 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -81.16 116.41 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.048 0.451 . . . . 1.06 111.45 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.53 134.37 54.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.836 -1.075 . . . . 2.51 111.328 176.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.4 m -148.21 141.73 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.674 -0.491 . . . . 0.44 109.674 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 78' ' ' LEU . 11.5 pt-20 -114.82 145.17 42.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.506 -0.478 . . . . 1.49 109.922 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 5.7 p90 -166.64 179.71 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.66 111.651 -168.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 p -131.93 170.54 14.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.94 110.835 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.79 142.62 35.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.672 0.272 . . . . 1.19 111.157 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 121.317 0.579 . . . . 2.04 110.547 177.919 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 110.011 -0.366 . . . . 2.3 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.18 146.55 95.96 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.536 2.158 . . . . 1.43 112.457 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -93.83 146.5 23.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.696 -0.684 . . . . 0.82 111.043 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.58 176.48 5.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 2.3 110.937 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.5 32.41 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.635 0.731 . . . . 2.01 110.797 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 4.2 m -73.74 116.62 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.79 . . . . 0.8 111.693 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -123.27 144.66 49.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 3.51 110.302 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.595 ' HA ' HG12 ' A' ' 53' ' ' VAL . 50.8 mtt -74.07 147.06 43.16 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.097 0.475 . . . . 1.12 111.395 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 54' ' ' GLU . 75.7 mt -119.43 157.2 52.14 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.518 -0.765 . . . . 1.67 110.951 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.5 169.95 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.627 2.218 . . . . 2.15 111.847 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -78.08 175.16 10.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.0 -0.545 . . . . 4.61 111.297 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.03 3.04 4.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.307 -0.861 . . . . 2.84 112.234 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.0 m -71.92 -25.73 62.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.476 -0.329 . . . . 1.7 110.62 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.539 ' CD1' HD21 ' A' ' 27' ' ' LEU . 11.0 mm -105.99 120.99 47.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.92 109.954 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.19 158.99 17.74 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.007 2.471 . . . . 1.03 113.523 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -125.87 165.19 28.59 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.608 -0.724 . . . . 2.76 109.899 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 7.4 Cg_exo -69.47 156.16 64.86 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.668 2.246 . . . . 1.08 111.92 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.51 93.6 4.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.917 0.389 . . . . 1.1 111.373 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 91' ' ' THR . 7.7 t -141.88 92.29 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.771 -0.455 . . . . 1.23 109.771 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.82 -37.85 76.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.788 0.328 . . . . 2.87 110.718 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.14 -26.06 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 2.84 110.8 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.462 ' H ' HG12 ' A' ' 88' ' ' VAL . 66.7 m 70.45 113.05 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.831 . . . . 1.42 111.23 -175.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 t -93.66 -24.11 18.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.025 0.75 . . . . 1.3 113.025 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -138.84 160.87 38.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.909 0.862 . . . . 1.29 112.748 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -140.15 155.49 46.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.952 -1.476 . . . . 1.36 107.186 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.3 -165.69 23.03 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.33 -1.414 . . . . 0.53 112.762 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.85 146.7 24.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.807 -0.442 . . . . 1.37 109.807 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.11 122.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.382 -0.372 . . . . 0.69 110.8 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.3 -67.99 0.75 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.893 -0.594 . . . . 0.89 111.667 -175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 3.92 111.818 -177.665 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 130' ' ' GLU . . . . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.152 0.427 . . . . 1.24 112.152 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.39 158.16 16.28 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.078 -0.809 . . . . 0.94 111.078 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.35 147.41 34.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.028 0.914 . . . . 0.93 113.258 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.45 142.65 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.473 -1.239 . . . . 0.49 110.152 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.12 117.41 25.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 129' ' ' HIS . 8.6 mm -103.72 124.08 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 0.63 110.391 -174.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -97.91 153.47 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.229 -0.656 . . . . 1.21 109.229 175.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.07 177.43 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.274 0.559 . . . . 2.29 111.454 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG3' HD22 ' A' ' 121' ' ' LEU . 10.2 pt-20 -65.85 -25.71 67.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.417 -0.81 . . . . 2.78 111.851 -175.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -94.23 -2.15 52.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.39 -0.596 . . . . 1.77 109.39 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.47 29.14 18.78 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.115 -0.948 . . . . 4.14 110.646 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.8 p -86.1 -38.17 18.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.903 0.334 . . . . 1.87 111.903 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -143.14 166.35 24.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.261 0.553 . . . . 1.54 112.042 -174.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.17 132.37 33.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.186 -0.915 . . . . 1.29 108.68 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -75.82 -71.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.017 -0.673 . . . . 1.03 111.242 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -142.56 -87.29 0.15 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.651 0.738 . . . . 1.56 110.427 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -178.11 133.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.03 -1.441 . . . . 2.08 107.984 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.582 ' HB2' HD11 ' A' ' 117' ' ' ILE . 35.6 m170 -109.21 132.77 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.264 -0.574 . . . . 0.68 110.792 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 112' ' ' ALA . 23.9 tt0 -83.8 147.65 27.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.512 -0.767 . . . . 1.19 110.643 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -119.27 151.21 38.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 0.74 110.709 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.13 150.38 16.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.51 112.194 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -57.09 -26.96 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.217 0.532 . . . . 0.67 111.21 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.7 p -73.85 -32.49 63.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.751 -0.659 . . . . 1.35 110.469 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 14.7 m -87.64 -13.9 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 1.1 110.635 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -73.1 59.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.587 -0.733 . . . . 1.46 111.644 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.9 t -48.94 -42.46 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.247 0.546 . . . . 0.82 110.618 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 20.4 m120 -88.36 33.88 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.615 . . . . 2.17 111.727 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -62.32 -19.2 63.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.205 0.526 . . . . 1.39 110.9 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -81.66 -21.45 38.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 2.46 111.896 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.26 169.05 18.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.665 0.745 . . . . 1.89 112.788 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.652 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -85.66 27.94 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.631 -1.168 . . . . 2.88 110.509 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.9 tp -56.16 113.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.492 -0.777 . . . . 0.97 111.146 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -128.83 -175.08 3.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.786 . . . . 1.77 110.207 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.27 136.22 49.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.075 -0.343 . . . . 1.43 110.075 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.69 -6.62 74.07 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.839 -0.696 . . . . 1.07 112.679 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.44 141.52 28.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.022 -0.671 . . . . 1.94 109.933 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.8 144.09 32.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.779 -0.646 . . . . 1.79 110.981 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 147.59 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.562 -0.745 . . . . 1.16 111.159 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 33.2 t -110.46 146.04 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 1.44 109.898 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 162' ' ' VAL . 15.9 p90 -165.96 174.76 9.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.61 110.018 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 127.45 11.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.04 0.448 . . . . 2.2 111.217 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.464 HD13 ' CE1' ' A' ' 129' ' ' HIS . 8.7 pt -95.84 144.72 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.675 -0.693 . . . . 1.24 109.282 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 5.2 t70 -166.51 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.065 0.228 . . . . 1.92 111.103 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -82.41 -29.24 30.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.448 -0.501 . . . . 2.76 111.843 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.565 ' OG ' ' HG3' ' A' ' 86' ' ' PRO . 59.3 p -84.78 -17.01 39.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.742 0.306 . . . . 1.98 111.529 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.1 25.75 60.24 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.036 -0.602 . . . . 1.27 112.294 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -152.61 178.04 10.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.719 -0.474 . . . . 3.61 109.719 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.27 110.42 19.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.48 111.115 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.28 164.33 21.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.585 -0.734 . . . . 0.49 110.647 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.3 m 60.98 32.12 19.93 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.82 0.7 . . . . 1.55 111.336 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 150' ' ' SER . 10.0 m -64.35 122.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.529 0.68 . . . . 1.26 111.283 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.606 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 6.7 p30 -131.32 125.08 31.83 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.269 -0.878 . . . . 2.05 109.413 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -61.96 133.06 54.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.75 111.189 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 83.6 t -118.23 121.16 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.97 -0.559 . . . . 1.56 111.724 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 108.963 -0.755 . . . . 2.94 108.963 170.27 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.032 0.444 . . . . 2.0 110.772 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.89 120.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.454 -0.794 . . . . 1.27 109.432 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -90.65 158.67 16.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.34 -0.615 . . . . 1.14 109.34 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 30.8 ttm180 -129.1 143.02 50.72 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.307 -0.406 . . . . 2.31 110.485 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.32 -164.88 24.78 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.117 -0.793 . . . . 0.5 111.117 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.87 154.85 39.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.509 . . . . 0.68 111.276 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.6 mm -73.41 110.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.56 111.284 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 133' ' ' ILE . . . -97.52 -49.98 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.101 0.477 . . . . 0.76 110.823 176.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.15 123.56 69.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.475 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.0 ttm -119.03 109.11 15.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.835 -0.62 . . . . 1.42 109.574 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 5.9 tppt? -98.23 -163.44 1.04 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.234 -1.024 . . . . 2.03 108.234 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' HD22 ' A' ' 20' ' ' ASN . 9.0 pt-20 -79.43 -39.13 33.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.13 0.419 . . . . 3.24 112.13 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.425 HD22 ' HG3' ' A' ' 19' ' ' GLU . 48.7 m-80 -111.92 -35.06 5.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.008 0.432 . . . . 2.03 112.109 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -134.01 178.04 7.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.509 -0.314 . . . . 1.25 110.951 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.39 171.67 36.65 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.045 -0.598 . . . . 0.71 111.703 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -115.93 127.45 54.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.95 0.405 . . . . 1.08 110.085 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -98.28 127.33 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 0.61 110.976 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.5 117.81 22.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.653 -0.869 . . . . 2.3 108.653 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.7 p -68.94 156.41 38.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 0.87 111.818 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.7 OUTLIER -56.48 -47.25 79.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.533 -0.758 . . . . 1.58 110.976 -178.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.77 9.51 27.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.18 -0.463 . . . . 2.04 111.755 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p80 39.28 37.71 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.449 1.1 . . . . 3.29 112.599 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -98.91 -17.6 18.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 2.89 110.105 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.84 155.39 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.139 -0.937 . . . . 1.8 110.591 -166.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.188 -0.671 . . . . 3.37 109.188 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -108.95 108.56 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.784 -0.366 . . . . 0.87 110.1 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 8.1 t80 -68.58 121.22 15.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 1.06 109.723 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -121.28 128.35 52.27 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.066 -0.515 . . . . 1.96 110.827 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 122.99 41.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.521 -0.918 . . . . 1.18 108.521 174.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -62.18 -16.48 53.29 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.097 0.406 . . . . 0.75 112.097 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -57.14 -29.49 63.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.996 -0.547 . . . . 1.63 111.628 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -103.29 24.04 11.54 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.849 0.357 . . . . 2.07 111.638 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 77.6 t80 -86.22 139.06 31.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.91 110.768 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.4 ttm -96.77 97.09 9.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.098 0.475 . . . . 1.73 110.333 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.95 -136.25 8.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.768 -0.729 . . . . 1.05 112.066 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.5 104.94 33.7 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.25 -0.278 . . . . 2.14 110.25 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -17.36 27.0 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.215 . . . . 1.01 112.226 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -74.35 -8.1 55.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.923 -0.58 . . . . 2.08 110.459 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -107.06 10.5 30.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.728 -0.669 . . . . 2.18 110.597 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.9 142.29 27.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.92 110.306 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -116.1 161.95 18.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.464 -0.789 . . . . 2.35 109.969 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.78 120.22 19.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.59 -0.522 . . . . 1.4 109.59 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 133' ' ' ILE . . . 96.34 3.9 59.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.964 -0.636 . . . . 0.75 112.01 -176.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.09 129.09 38.91 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.956 0.408 . . . . 1.06 110.823 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 30.4 mt-10 -71.41 126.5 29.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.386 -0.825 . . . . 2.51 110.637 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.51 157.74 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.242 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -128.81 150.8 50.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.367 -0.605 . . . . 1.49 109.367 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CB ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -164.0 175.68 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.947 0.721 . . . . 0.66 112.947 -166.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -136.85 166.51 23.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.16 -0.927 . . . . 0.94 109.732 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.5 mt -94.71 147.51 23.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.003 0.43 . . . . 1.19 111.342 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.04 110.798 179.091 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.242 -0.281 . . . . 2.3 110.242 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 58.0 Cg_endo -71.76 158.7 52.61 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.47 2.113 . . . . 1.43 113.057 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.55 155.5 19.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.618 -0.719 . . . . 0.82 110.378 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -134.84 164.26 27.97 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.513 -0.312 . . . . 2.3 111.03 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 62.12 29.27 17.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.488 -0.778 . . . . 2.01 111.095 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 55' ' ' TYR . 39.3 t -73.9 122.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.945 -0.571 . . . . 0.8 110.843 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -126.46 156.91 39.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 3.51 110.442 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.467 ' HA ' HG12 ' A' ' 53' ' ' VAL . 61.9 mtt -72.3 143.24 48.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.12 110.814 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.86 143.33 27.36 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.0 -1.0 . . . . 1.67 109.178 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 135.33 69.86 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.768 1.645 . . . . 2.15 111.788 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 6.4 ttpm? -60.58 149.61 34.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.689 -0.687 . . . . 4.61 111.378 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 77.88 26.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.34 -0.845 . . . . 2.84 110.55 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.8 m -88.37 -30.66 19.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.24 -1.022 . . . . 1.7 108.24 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.25 123.54 73.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.318 -1.31 . . . . 0.92 108.868 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.48 158.17 48.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.816 2.344 . . . . 1.03 113.649 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.63 155.95 46.77 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.709 -0.678 . . . . 2.76 110.575 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 57.0 Cg_endo -69.16 133.94 27.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.729 2.286 . . . . 1.08 112.87 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.05 94.64 8.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 1.1 110.334 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 3.0 t -137.22 156.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.928 -1.138 . . . . 1.23 107.928 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.18 -64.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.131 -0.627 . . . . 2.87 111.195 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 91' ' ' THR . 78.7 mm-40 -95.06 -57.18 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.576 -0.45 . . . . 2.84 112.062 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -179.98 156.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 1.42 109.902 -171.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.502 HG21 ' O ' ' A' ' 153' ' ' ILE . 2.9 m -106.12 -54.24 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.968 0.413 . . . . 1.3 110.219 173.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -143.94 177.56 8.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.357 0.599 . . . . 1.29 110.931 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -145.25 168.37 20.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.323 -1.362 . . . . 1.36 107.323 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.8 -170.38 43.31 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.636 -1.269 . . . . 0.53 112.647 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.427 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.9 p -121.62 146.65 26.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.6 -0.519 . . . . 1.37 109.6 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.72 120.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.036 -0.357 . . . . 0.69 110.036 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -74.17 -65.54 0.83 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.055 -0.521 . . . . 0.89 111.391 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 3.92 110.349 -178.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 N-CA-C 112.856 0.688 . . . . 1.24 112.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.65 162.26 13.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.382 -0.913 . . . . 0.94 111.695 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 128' ' ' GLN . 18.3 mt -143.41 147.24 34.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.93 112.015 -171.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -107.3 141.14 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.089 -0.96 . . . . 0.49 109.289 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 98' ' ' ALA . 8.0 pt-20 -88.86 113.18 24.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.542 0.686 . . . . 1.4 110.109 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 129' ' ' HIS . 6.7 mm -94.3 127.98 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.033 -0.985 . . . . 0.63 109.703 -174.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.3 pt? -85.84 159.61 19.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.162 -0.31 . . . . 1.21 110.162 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.84 164.04 8.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.623 . . . . 2.29 110.345 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -68.31 -17.71 64.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.471 . . . . 2.78 109.744 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.577 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -96.07 -17.19 21.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.612 -0.722 . . . . 1.77 110.462 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 20.9 ttm180 71.2 99.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.836 0.71 . . . . 4.14 111.653 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.0 t -154.75 -41.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.992 -0.283 . . . . 1.87 111.111 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 6.6 p -147.44 -171.95 3.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.742 0.306 . . . . 1.54 111.419 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.46 136.4 24.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.039 -0.528 . . . . 1.29 109.756 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.15 -69.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.67 -0.412 . . . . 1.03 110.925 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -138.61 -84.8 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.466 0.65 . . . . 1.56 110.841 171.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.454 ' HG3' HD13 ' A' ' 114' ' ' LEU . 1.6 pm0 -175.33 141.25 0.53 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.877 -1.056 . . . . 2.08 108.726 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.601 ' HB2' HD11 ' A' ' 117' ' ' ILE . 32.7 m170 -116.46 133.57 55.86 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.67 -0.412 . . . . 0.68 110.161 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.2 tt0 -86.61 146.29 26.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.682 -0.69 . . . . 1.19 109.656 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -117.02 146.63 42.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.889 0.376 . . . . 0.74 110.155 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -108.83 150.05 17.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.757 -0.735 . . . . 0.51 111.744 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.441 HG23 ' HA2' ' A' ' 50' ' ' GLY . 10.4 tp -58.73 -22.49 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.029 0.442 . . . . 0.67 111.369 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.2 p -73.23 -37.19 66.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.439 . . . . 1.35 110.682 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 11.2 p -90.65 -8.84 48.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.116 -0.493 . . . . 1.1 111.733 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 132' ' ' GLY . 54.1 mt -73.45 59.97 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 1.46 111.225 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t -42.34 -47.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.287 0.477 . . . . 0.82 112.287 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.51 HD21 HD22 ' A' ' 143' ' ' LEU . 4.5 p-10 -93.15 34.36 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.737 0.273 . . . . 2.17 111.737 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -59.65 -14.81 15.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.274 0.472 . . . . 1.39 112.274 -176.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -79.86 -16.41 55.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 2.46 110.727 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.81 151.0 20.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.607 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.68 93.11 3.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.416 0.627 . . . . 2.88 110.076 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 138' ' ' ASN . 11.7 tp -100.24 116.98 33.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.159 -0.928 . . . . 0.97 109.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.36 -176.35 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.335 0.588 . . . . 1.77 111.782 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 58.0 tttm -65.47 126.14 27.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.981 -1.009 . . . . 1.43 110.117 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 103.71 -1.57 45.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.448 -0.882 . . . . 1.07 113.133 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -91.69 141.35 28.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.094 0.447 . . . . 1.94 111.04 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HB ' ' A' ' 96' ' ' VAL . 94.5 mt -82.51 139.4 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 1.79 111.278 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.07 153.51 29.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.211 0.529 . . . . 1.16 111.073 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 22.9 t -112.72 142.34 45.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.468 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 27.1 p90 -158.45 158.21 33.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.61 110.354 -175.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 63.2 mtt180 -125.33 120.82 32.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.04 -0.355 . . . . 2.2 110.04 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.502 ' O ' HG21 ' A' ' 92' ' ' THR . 5.3 tt -102.29 120.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.072 -0.513 . . . . 1.24 110.794 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -159.75 -87.54 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.708 0.289 . . . . 1.92 110.478 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 6.0 mm-40 -75.07 -20.84 59.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.661 . . . . 2.76 109.822 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.8 p -83.79 -18.24 38.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.232 -0.895 . . . . 1.98 111.249 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.91 5.46 7.47 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.943 -0.571 . . . . 1.27 113.526 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -153.42 -164.12 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 3.61 108.426 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.1 109.14 17.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.407 0.622 . . . . 0.48 111.119 -172.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -120.18 165.16 15.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.26 -0.882 . . . . 0.49 109.944 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 73.7 m 59.02 36.37 24.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.995 0.426 . . . . 1.55 110.613 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' SER . 42.2 t -73.38 110.67 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 1.26 110.648 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.38 129.39 44.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.875 -0.602 . . . . 2.05 110.25 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 102.66 0.97 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.75 110.896 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.93 137.6 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.177 -0.465 . . . . 1.56 110.394 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.452 -0.34 . . . . 2.94 110.386 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 11.4 mm-40 . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.322 0.582 . . . . 2.0 111.316 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.29 114.5 30.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.11 -0.95 . . . . 1.27 108.868 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.93 138.22 31.71 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.057 -0.72 . . . . 1.14 109.057 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 11.5 ptp180 -129.04 151.52 49.64 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.439 -0.504 . . . . 2.31 110.385 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.25 -158.95 9.39 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.509 -1.036 . . . . 0.5 110.509 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 139.08 44.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.833 0.349 . . . . 0.68 110.629 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.6 mm -64.3 114.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.948 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -40.05 3.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.463 -0.335 . . . . 0.76 111.249 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 54.5 t -116.92 123.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.615 0.245 . . . . 1.55 110.713 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.5 mtp -123.21 108.14 12.48 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.05 -0.722 . . . . 1.42 109.05 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -106.76 -165.31 1.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.625 -0.509 . . . . 2.03 109.625 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 34.3 tt0 -76.24 -46.98 25.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 3.24 111.337 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -101.35 -32.67 10.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.466 . . . . 2.03 111.379 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -148.93 -169.82 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.4 -0.364 . . . . 1.25 111.18 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.37 -176.79 30.82 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.012 -0.613 . . . . 0.71 111.984 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.456 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 84.1 m-85 -131.54 140.31 49.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 1.08 110.442 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.0 131.03 67.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.504 -0.771 . . . . 0.61 109.989 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' OE1' HG22 ' A' ' 133' ' ' ILE . 46.4 mt-10 -70.77 130.39 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.073 -0.714 . . . . 2.3 109.073 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.59 139.53 58.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.761 -0.459 . . . . 0.87 109.761 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.7 tp -52.22 -36.84 53.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 1.58 111.476 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.4 t -108.35 22.75 15.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 2.04 110.93 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 43.47 51.63 6.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.822 0.849 . . . . 3.29 111.856 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.95 -50.27 6.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.666 -1.152 . . . . 2.89 110.397 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.81 -173.04 3.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 1.8 110.576 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -101.53 129.65 47.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.895 0.379 . . . . 3.37 110.9 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.36 122.66 58.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.87 110.923 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.07 120.12 33.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 1.06 110.089 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.32 152.71 38.63 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.381 -0.599 . . . . 1.96 109.381 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -111.61 134.17 53.37 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.493 -0.558 . . . . 1.18 109.493 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 24.7 m-85 -63.91 -27.16 68.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.333 0.494 . . . . 0.75 112.333 -175.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -68.24 -36.42 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.783 0.325 . . . . 1.63 110.766 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -87.52 7.46 29.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.225 0.536 . . . . 2.07 110.894 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 18.0 t80 -84.64 137.31 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.668 -0.697 . . . . 0.91 110.381 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttm -104.52 110.72 23.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.73 110.969 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.5 -138.01 6.58 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.842 -0.617 . . . . 1.05 111.787 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.34 101.96 14.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.955 -0.387 . . . . 2.14 109.955 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 -14.43 30.68 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.509 2.14 . . . . 1.01 112.294 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.74 -18.61 63.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.751 -0.659 . . . . 2.08 110.274 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -109.5 9.09 25.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 2.18 110.952 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.3 145.55 29.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.92 111.473 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -141.04 160.81 39.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.489 -0.778 . . . . 2.35 109.507 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.59 115.01 4.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.879 -0.6 . . . . 1.4 110.882 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.66 0.05 15.58 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.75 113.21 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -75.64 120.22 20.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.922 0.391 . . . . 1.06 110.638 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.83 128.44 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.474 -0.784 . . . . 2.51 109.858 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 77' ' ' MET . 15.0 m -139.79 144.4 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.707 -0.224 . . . . 0.44 110.904 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 16.6 pt-20 -118.19 149.18 41.51 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 1.49 109.809 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.65 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 20.6 p90 -168.57 179.67 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.051 0.453 . . . . 0.66 111.554 -173.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -133.95 141.9 47.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.575 . . . . 0.94 110.695 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.4 mt -72.52 156.39 39.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.357 -0.383 . . . . 1.19 111.14 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 2.04 110.559 177.318 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.819 -0.067 . . . . 2.3 110.819 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.85 152.38 80.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.858 2.372 . . . . 1.43 113.689 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -106.75 124.05 49.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.916 -1.038 . . . . 0.82 109.742 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.36 173.15 6.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.3 111.113 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 60.94 34.44 19.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.942 -0.572 . . . . 2.01 111.394 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 29.6 t -69.18 115.09 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.8 111.181 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -119.36 146.55 45.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.199 -0.91 . . . . 3.51 111.151 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.406 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.0 mtt -78.91 139.09 38.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.566 -0.901 . . . . 1.12 108.566 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.1 pt? -131.87 161.98 59.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 10.8 Cg_endo -53.89 132.45 49.73 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 112.721 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -69.94 163.96 24.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.93 -1.032 . . . . 4.61 111.306 -174.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 78.16 34.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.294 -0.866 . . . . 2.84 111.472 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -94.59 -16.9 22.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 1.7 109.057 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 27' ' ' LEU . 6.5 mm -73.07 135.66 79.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.92 109.854 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.81 159.65 50.05 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.496 2.131 . . . . 1.03 112.548 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -124.95 150.12 65.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.291 -0.413 . . . . 2.76 110.048 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.42 130.01 37.79 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.555 2.17 . . . . 1.08 111.578 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.95 90.99 5.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.472 0.653 . . . . 1.1 110.624 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.47 136.6 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.494 -0.928 . . . . 1.23 108.494 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.84 -60.95 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.552 -0.459 . . . . 2.87 112.009 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.0 tp10 -90.95 -54.47 3.95 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.875 -0.33 . . . . 2.84 110.81 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 169.16 155.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.187 -0.671 . . . . 1.42 109.187 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.42 HG21 HG23 ' A' ' 153' ' ' ILE . 0.6 OUTLIER -105.75 -58.44 1.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 1.3 110.997 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -139.03 147.87 42.66 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.512 -0.313 . . . . 1.29 110.569 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.7 p30 -108.05 125.51 51.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.41 -0.959 . . . . 1.36 108.41 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -133.1 -175.52 14.0 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.056 -1.069 . . . . 0.53 112.321 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.1 t -135.39 146.05 30.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.777 -0.453 . . . . 1.37 109.777 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 143' ' ' LEU . 97.6 t -62.01 121.03 9.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.69 110.828 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.29 -53.22 17.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.89 111.871 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 . . . . . 0 N--CA 1.463 0.205 0 CA-C-N 116.677 -0.238 . . . . 3.92 111.089 -179.719 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.995 0.426 . . . . 1.24 110.807 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.09 145.96 11.43 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.459 -1.057 . . . . 0.94 110.459 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.12 138.83 50.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.69 0.757 . . . . 0.93 111.983 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.53 135.05 47.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.512 -1.222 . . . . 0.49 109.272 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.41 125.97 35.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4 110.263 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.1 mm -101.69 138.09 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.571 -0.741 . . . . 0.63 110.35 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 122' ' ' ARG . 1.3 pt? -85.77 154.14 21.8 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.401 0.438 . . . . 1.21 110.016 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.94 -175.88 5.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.873 0.368 . . . . 2.29 110.365 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.9 pt-20 -68.59 -18.36 64.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.652 0.612 . . . . 2.78 112.652 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -109.19 -0.12 19.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.984 -0.286 . . . . 1.77 110.854 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HB2' HD12 ' A' ' 118' ' ' LEU . 31.2 ttm-85 56.57 70.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 4.14 109.777 -172.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -118.69 -48.29 2.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.876 -0.602 . . . . 1.87 109.962 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -142.35 169.74 17.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.553 -0.749 . . . . 1.54 111.131 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.5 p -81.14 135.06 25.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.375 -0.602 . . . . 1.29 109.375 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.5 mt -71.12 -70.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.554 -0.458 . . . . 1.03 110.824 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -138.59 -85.45 0.26 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.04 0.447 . . . . 1.56 110.971 170.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -177.16 143.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.329 -0.85 . . . . 2.08 109.065 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.54 ' CE1' HD12 ' A' ' 153' ' ' ILE . 26.8 m170 -119.58 132.83 55.81 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.68 111.233 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -95.69 144.01 26.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.033 -0.985 . . . . 1.19 109.454 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -117.92 136.69 53.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.74 111.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.29 152.63 22.85 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.605 -0.725 . . . . 0.51 112.292 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.51 HG22 ' OE1' ' A' ' 25' ' ' GLU . 10.6 tp -55.71 -34.66 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.482 0.549 . . . . 0.67 112.482 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -78.32 -22.48 48.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.382 0.61 . . . . 1.35 110.545 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 3.5 m -89.21 -19.73 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.66 -0.7 . . . . 1.1 110.21 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -79.05 60.07 2.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.327 -0.851 . . . . 1.46 111.268 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.0 t -43.73 -41.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.241 0.544 . . . . 0.82 111.347 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.4 m120 -87.91 32.58 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.948 -0.569 . . . . 2.17 111.38 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -59.99 -26.97 66.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.355 0.598 . . . . 1.39 110.524 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -88.84 -13.8 38.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.193 -0.912 . . . . 2.46 111.392 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.97 175.1 8.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.077 -0.965 . . . . 1.89 111.294 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.73 16.51 17.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.991 -0.744 . . . . 2.88 108.991 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.483 ' HG ' HG21 ' A' ' 97' ' ' VAL . 25.4 tp -43.6 107.53 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.188 -1.369 . . . . 0.97 111.448 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.59 -178.51 3.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.841 -0.618 . . . . 1.77 110.733 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -63.85 135.3 56.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 1.43 110.291 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.85 -7.31 67.59 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.365 -0.921 . . . . 1.07 112.931 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.19 146.42 23.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.205 -0.598 . . . . 1.94 109.585 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.56 140.77 29.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.684 -0.689 . . . . 1.79 110.768 -172.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.42 144.87 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 115.139 -0.937 . . . . 1.16 110.731 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.9 m -111.58 143.6 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.146 -0.479 . . . . 1.44 109.878 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.625 ' HB3' HG12 ' A' ' 162' ' ' VAL . 7.0 p90 -157.14 166.6 32.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.146 -0.479 . . . . 0.61 110.116 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -119.22 119.61 34.61 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.003 -0.679 . . . . 2.2 109.517 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.54 HD12 ' CE1' ' A' ' 129' ' ' HIS . 3.7 tt -103.78 138.41 28.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.419 -0.586 . . . . 1.24 109.419 167.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.82 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.799 -0.36 . . . . 1.92 111.153 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -38.39 22.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.853 0.686 . . . . 2.76 112.853 -173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.9 t -81.45 -16.82 50.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.842 0.312 . . . . 1.98 111.842 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.15 71.76 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.428 -0.892 . . . . 1.27 112.519 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -133.27 -178.23 4.88 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.083 -0.339 . . . . 3.61 110.083 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.99 108.43 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.48 110.377 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -125.33 161.79 26.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.128 -0.487 . . . . 0.49 110.177 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.35 39.86 11.8 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 123.59 0.556 . . . . 1.55 110.045 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 151' ' ' PHE . 15.5 m -69.58 125.08 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 1.26 111.059 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 46.2 t30 -125.74 117.52 23.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.603 -0.726 . . . . 2.05 109.483 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -69.08 102.67 1.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.75 110.43 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.58 130.12 49.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.86 -0.609 . . . . 1.56 110.794 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.854 -0.612 . . . . 2.94 110.458 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 121.167 0.508 . . . . 2.0 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.25 116.01 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.436 -0.802 . . . . 1.27 109.13 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -89.09 138.17 31.66 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.822 -0.626 . . . . 1.14 109.564 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 39.9 ttm180 -116.19 132.37 56.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.616 -0.72 . . . . 2.31 109.462 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.73 -157.23 7.81 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.879 -0.677 . . . . 0.5 111.415 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.494 ' CE2' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -146.04 152.92 40.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.989 0.423 . . . . 0.68 110.949 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.0 mm -71.68 114.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.691 -0.686 . . . . 0.56 110.287 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.83 -42.0 4.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.676 0.274 . . . . 0.76 111.45 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.19 123.12 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.453 . . . . 1.55 111.139 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.5 mtt -113.44 116.07 29.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.5 -0.773 . . . . 1.42 109.931 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 -177.8 3.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 2.03 108.444 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.19 -45.62 72.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.882 0.327 . . . . 3.24 111.882 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -110.92 -18.21 13.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.964 0.357 . . . . 2.03 111.964 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -153.73 -173.34 4.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.251 -0.278 . . . . 1.25 110.251 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.81 -169.99 30.14 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.718 -0.753 . . . . 0.71 111.496 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -130.18 130.54 44.84 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.959 -0.386 . . . . 1.08 109.959 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 35' ' ' PHE . 63.9 mt -90.22 124.03 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.471 -0.566 . . . . 0.61 109.471 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.14 125.17 28.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 2.3 109.482 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.3 p -65.37 144.11 57.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.87 109.942 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.649 HD21 HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -52.93 -46.31 68.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.057 0.456 . . . . 1.58 110.946 -174.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 t -92.94 6.57 47.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.105 -0.498 . . . . 2.04 111.542 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 54.46 56.95 6.25 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.013 0.911 . . . . 3.29 109.6 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.39 -33.4 7.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.683 -1.144 . . . . 2.89 110.759 -172.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -142.77 166.49 24.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.283 -0.417 . . . . 1.8 110.911 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.49 126.91 50.92 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.625 -0.879 . . . . 3.37 108.625 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.49 115.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.87 111.492 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -81.21 120.27 24.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.343 -0.844 . . . . 1.06 110.473 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 24' ' ' ILE . 3.9 p90 -123.21 151.23 42.45 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.914 -0.773 . . . . 1.96 108.914 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -120.36 131.76 54.98 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.083 -0.71 . . . . 1.18 109.083 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -60.33 -24.73 65.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -71.32 -12.2 61.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.668 0.27 . . . . 1.63 111.136 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -109.8 0.48 18.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.07 110.512 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.47 127.05 34.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.91 109.998 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.0 ttp -101.02 97.77 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.186 0.517 . . . . 1.73 110.597 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.46 -160.34 30.14 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.619 -0.719 . . . . 1.05 111.331 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -102.98 102.94 30.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.805 0.302 . . . . 2.14 110.193 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.44 -24.05 9.47 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.45 2.1 . . . . 1.01 113.633 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.33 -4.28 50.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.531 0.205 . . . . 2.08 111.5 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -113.23 19.64 16.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.386 0.612 . . . . 2.18 110.704 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.448 HD21 ' HE2' ' A' ' 77' ' ' MET . 56.0 mt -95.04 159.92 14.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.92 108.976 172.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.13 164.88 28.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.821 -0.437 . . . . 2.35 109.821 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.32 113.28 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.28 0.562 . . . . 1.4 110.017 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.28 27.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.862 -0.685 . . . . 0.75 112.643 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.468 HE21 ' N ' ' A' ' 52' ' ' GLU . 28.2 tp60 -77.3 124.75 28.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.328 . . . . 1.06 110.41 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' N ' HE21 ' A' ' 51' ' ' GLN . 16.4 mp0 -67.97 126.8 30.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.312 -0.858 . . . . 2.51 111.257 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -142.9 149.86 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.44 109.925 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.02 156.28 42.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.24 -0.288 . . . . 1.49 110.401 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 2.4 p90 -170.16 179.42 3.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.877 0.37 . . . . 0.66 111.292 -169.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.4 p -120.8 172.3 7.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.94 110.683 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.67 146.12 49.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.19 111.528 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 2.04 110.091 174.539 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' N ' HD13 ' A' ' 70' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 110.238 -0.282 . . . . 2.3 110.238 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.29 150.98 42.71 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.57 2.18 . . . . 1.43 112.236 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.36 129.47 34.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.101 -0.499 . . . . 0.82 109.806 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -116.12 143.33 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.915 0.388 . . . . 2.3 111.123 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.1 70.92 0.58 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.362 -0.836 . . . . 2.01 111.21 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 25.3 t -96.14 125.17 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.8 109.821 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -127.89 149.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 3.51 111.13 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.448 ' HE2' HD21 ' A' ' 47' ' ' LEU . 66.8 mtt -79.23 154.17 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.12 109.935 175.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.3 147.96 32.99 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 1.67 109.658 169.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.93 162.83 27.41 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.54 2.16 . . . . 2.15 112.975 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.27 173.04 5.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 4.61 111.214 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 m120 73.72 3.18 4.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.496 -0.775 . . . . 2.84 110.989 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 m -89.46 -2.39 58.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.351 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.649 HD12 HD21 ' A' ' 27' ' ' LEU . 30.7 mm -110.72 123.39 35.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.203 -0.666 . . . . 0.92 109.203 176.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.49 139.27 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.048 1.832 . . . . 1.03 111.266 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.83 148.51 43.4 Favored Pre-proline 0 C--N 1.314 -0.941 0 C-N-CA 120.821 -0.352 . . . . 2.76 110.427 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.39 130.73 41.43 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.276 2.651 . . . . 1.08 111.932 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.09 93.0 9.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.188 0.518 . . . . 1.1 110.826 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.39 126.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.535 -0.913 . . . . 1.23 108.535 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -59.96 2.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.547 0.203 . . . . 2.87 111.547 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 57.5 mm-40 -91.21 -55.04 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.714 -0.394 . . . . 2.84 111.281 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 13.1 t 171.02 159.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.42 109.9 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 HG23 ' A' ' 153' ' ' ILE . 1.0 OUTLIER -102.44 -54.93 2.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 1.3 109.788 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.577 ' CE1' ' HE2' ' A' ' 151' ' ' PHE . 23.7 p80 -162.93 168.23 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.29 109.623 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.38 -177.52 3.15 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.137 -0.32 . . . . 1.36 110.137 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.65 179.1 47.82 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.838 -0.696 . . . . 0.53 111.698 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.59 145.27 32.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.833 -0.432 . . . . 1.37 109.833 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.6 t -58.79 123.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.365 -0.235 . . . . 0.69 110.365 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.28 -65.96 0.82 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.388 -0.369 . . . . 0.89 111.888 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 110.331 -0.248 . . . . 3.92 110.331 179.081 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.639 0.257 . . . . 1.24 110.96 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 95.96 144.42 16.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.334 -0.46 . . . . 0.94 112.272 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.5 mt -128.99 145.03 51.35 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.699 0.761 . . . . 0.93 112.148 -174.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.13 137.37 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.413 -1.267 . . . . 0.49 108.532 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.0 pt-20 -90.48 125.07 35.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.489 0.661 . . . . 1.4 110.505 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 93' ' ' HIS . 44.0 mm -94.97 136.84 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.894 -1.048 . . . . 0.63 110.43 -174.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -100.73 144.39 29.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.63 167.29 9.27 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.104 0.252 . . . . 2.29 111.023 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' HG3' HD22 ' A' ' 121' ' ' LEU . 13.0 pt-20 -60.2 -29.44 68.71 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.575 0.35 . . . . 2.78 111.528 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.502 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -89.5 6.15 42.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.77 110.527 178.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 69.72 87.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 4.14 111.793 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.6 p -115.8 -159.07 0.7 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.928 -1.033 . . . . 1.87 109.639 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 p -85.84 -161.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.338 -0.392 . . . . 1.54 109.975 170.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.5 p -64.44 120.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 1.29 111.34 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.8 mt -69.1 -67.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 1.03 110.343 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 p -133.28 -86.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.75 -0.38 . . . . 1.56 111.335 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -178.1 129.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.685 . . . . 2.08 109.654 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.471 ' CD2' HG13 ' A' ' 117' ' ' ILE . 13.4 m170 -116.19 129.72 56.44 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.68 110.246 176.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 158' ' ' ARG . 10.4 tt0 -96.77 149.69 21.55 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.071 -0.968 . . . . 1.19 109.958 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 31.0 p90 -117.87 177.11 4.9 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.67 -0.412 . . . . 0.74 110.709 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -134.93 152.98 20.92 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.912 -0.585 . . . . 0.51 111.848 -176.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -52.86 -28.76 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.887 0.375 . . . . 0.67 111.897 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.0 p -77.53 -33.19 54.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.409 0.623 . . . . 1.35 110.436 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 132' ' ' GLY . 47.9 t -72.03 -27.38 62.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.107 -0.951 . . . . 1.1 110.311 177.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.08 59.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.393 -0.821 . . . . 1.46 112.506 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -48.61 -41.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.234 0.54 . . . . 0.82 110.257 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.3 m120 -87.86 32.65 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.759 -0.655 . . . . 2.17 111.414 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -60.59 -21.66 62.88 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.156 0.503 . . . . 1.39 111.264 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -93.14 -6.28 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 2.46 111.371 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -88.51 158.06 18.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.76 -0.654 . . . . 1.89 111.188 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.4 mm? -81.36 49.06 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 2.88 110.43 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 164' ' ' ALA . 21.8 tp -76.4 122.84 25.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.603 -0.726 . . . . 0.97 109.937 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 11.7 pt20 -123.94 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.657 . . . . 1.77 111.732 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.39 121.79 15.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.907 -1.042 . . . . 1.43 109.905 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.33 1.81 44.31 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.322 -0.942 . . . . 1.07 112.53 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.463 ' OD1' ' HG2' ' A' ' 144' ' ' GLN . 13.3 m-20 -91.07 140.13 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.743 0.272 . . . . 1.94 110.393 173.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.78 138.99 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.918 0.39 . . . . 1.79 110.862 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 164' ' ' ALA . 15.6 m -135.97 146.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 1.16 110.823 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.3 p -104.67 133.38 49.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.505 -0.554 . . . . 1.44 109.505 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' HE2' ' CE1' ' A' ' 93' ' ' HIS . 5.5 p90 -146.42 163.57 35.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.116 0.26 . . . . 0.61 110.7 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 1.4 mpp_? -118.54 121.7 40.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.147 0.499 . . . . 2.2 110.194 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 92' ' ' THR . 12.9 tt -100.41 136.95 29.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.696 . . . . 1.24 109.788 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -169.61 -93.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.568 -0.16 . . . . 1.92 110.568 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.52 -19.97 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.826 0.346 . . . . 2.76 111.254 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.3 t -81.66 -17.01 49.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.927 -0.397 . . . . 1.98 109.927 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.32 23.22 57.54 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.791 -0.64 . . . . 1.27 113.51 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 11.4 ptp180 -156.93 -168.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.451 -0.574 . . . . 3.61 109.451 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.6 108.3 17.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.897 0.379 . . . . 0.48 110.319 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.12 144.85 44.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.154 -0.475 . . . . 0.49 111.368 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.9 m 66.17 43.6 2.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.633 -0.712 . . . . 1.55 110.352 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.9 m -65.07 118.7 7.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.622 0.725 . . . . 1.26 110.786 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.431 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.1 t-20 -120.86 124.4 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.48 -0.782 . . . . 2.05 109.882 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.07 112.96 3.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.75 111.041 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.86 129.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.944 -0.571 . . . . 1.56 111.021 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 2.94 110.061 174.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.96 0.409 . . . . 2.0 110.788 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.45 114.65 25.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.631 . . . . 1.27 109.459 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.34 159.31 15.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.501 -0.772 . . . . 1.14 109.267 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.518 ' HG3' HD13 ' A' ' 27' ' ' LEU . 6.8 ptp180 -141.05 147.42 38.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.757 -0.46 . . . . 2.31 109.757 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.09 -169.77 22.06 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.172 -0.771 . . . . 0.5 111.172 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.19 140.26 52.69 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.785 0.326 . . . . 0.68 110.468 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.21 116.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.642 -0.708 . . . . 0.56 110.613 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.28 -48.55 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.76 111.355 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 96.2 t -114.45 124.03 70.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.676 0.274 . . . . 1.55 110.649 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.5 ttm -126.94 105.55 8.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.272 -0.422 . . . . 1.42 110.197 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 17.9 mmtp -97.94 -161.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.715 -0.476 . . . . 2.03 109.715 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -50.63 38.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 3.24 111.912 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.417 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 50.8 m-80 -112.24 -34.47 5.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 2.03 111.571 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 p90 -124.82 173.74 8.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.15 -0.477 . . . . 1.25 110.709 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.32 165.74 35.56 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 111.076 -0.81 . . . . 0.71 111.076 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.505 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.6 m-85 -110.44 126.64 54.53 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.183 0.516 . . . . 1.08 109.791 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -95.7 130.23 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.696 -0.853 . . . . 0.61 108.696 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -80.16 128.75 33.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.534 -0.913 . . . . 2.3 108.534 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.6 p -63.34 149.73 45.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.745 -0.661 . . . . 0.87 110.829 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 83' ' ' ILE . 11.4 tp -54.93 -34.12 62.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.305 0.574 . . . . 1.58 111.828 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -110.36 22.46 15.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 2.04 111.431 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.454 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 31.4 p80 43.63 45.73 5.9 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.016 0.912 . . . . 3.29 111.369 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.71 -44.72 9.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.919 -1.037 . . . . 2.89 111.337 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.82 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 1.8 112.07 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.21 121.75 46.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.53 -0.759 . . . . 3.37 110.367 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.19 127.32 64.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.87 111.536 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -91.83 120.62 32.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.95 -0.568 . . . . 1.06 110.053 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -128.45 138.08 52.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.275 -0.42 . . . . 1.96 110.089 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' A' ' 20' ' ' ASN . 3.3 t60 -107.6 124.29 49.73 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -63.18 -18.04 63.06 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.626 0.602 . . . . 0.75 112.626 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 -31.5 68.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.679 0.276 . . . . 1.63 110.841 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.05 5.95 46.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.982 0.42 . . . . 2.07 111.4 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 47.4 t80 -75.34 132.09 40.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.313 -0.403 . . . . 0.91 110.047 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.3 ttp -114.63 91.06 3.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.959 0.409 . . . . 1.73 110.08 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.68 -136.65 4.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.987 -0.845 . . . . 1.05 110.987 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -121.25 96.6 48.04 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 117.023 0.411 . . . . 2.14 110.681 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.39 -22.94 12.03 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.791 2.328 . . . . 1.01 113.013 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -81.66 -5.91 58.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.295 0.569 . . . . 2.08 110.476 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -112.47 18.04 18.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.88 -0.6 . . . . 2.18 110.414 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 49.2 mt -92.32 143.72 26.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.841 -0.618 . . . . 0.92 110.716 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.0 157.96 42.73 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.993 -0.743 . . . . 2.35 108.993 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.7 mm? -60.84 134.43 57.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.966 0.412 . . . . 1.4 110.511 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.29 -15.55 50.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.716 -0.754 . . . . 0.75 113.032 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -66.0 133.32 50.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.997 0.427 . . . . 1.06 111.434 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 1.8 mp0 -81.36 137.39 35.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.889 . . . . 2.51 110.763 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 77' ' ' MET . 23.6 m -144.3 151.54 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.44 109.843 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HB3' HD21 ' A' ' 78' ' ' LEU . 23.9 pt-20 -112.0 144.69 40.93 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.978 -0.378 . . . . 1.49 109.978 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.416 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.6 p90 -161.49 170.71 19.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.66 111.856 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -120.45 143.79 48.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.94 111.049 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.42 143.28 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 1.19 110.875 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.512 . . . . 2.04 110.018 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.886 -0.412 . . . . 2.3 109.886 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.53 165.72 31.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.331 2.021 . . . . 1.43 111.808 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.12 141.06 40.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.508 -0.315 . . . . 0.82 110.419 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 71.3 mm-40 -124.22 152.22 43.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 2.3 110.186 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.29 84.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.729 0.643 . . . . 2.01 111.511 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.6 t -110.94 124.62 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.146 -0.479 . . . . 0.8 110.003 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -118.25 153.42 33.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.802 -0.635 . . . . 3.51 109.792 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.448 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.1 mtp -97.86 119.46 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.7 -0.227 . . . . 1.12 110.783 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -122.56 104.09 37.26 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-O 121.804 0.812 . . . . 1.67 111.401 176.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -88.95 129.49 2.04 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.27 1.98 . . . . 2.15 112.868 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.5 tttp 79.05 133.13 0.06 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.073 1.138 . . . . 4.61 114.073 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.3 t30 68.96 3.23 3.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.444 -1.253 . . . . 2.84 112.891 167.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -78.14 -25.93 47.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.2 -0.6 . . . . 1.7 109.439 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 27' ' ' LEU . 1.8 mm -108.33 128.21 26.09 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.392 -0.966 . . . . 0.92 108.392 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.16 152.08 50.16 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.297 1.998 . . . . 1.03 112.461 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -103.66 142.49 24.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 2.76 109.597 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.73 128.13 21.39 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.297 1.998 . . . . 1.08 111.977 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.26 95.0 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 1.1 111.502 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -137.54 135.01 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.113 -0.699 . . . . 1.23 109.113 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -85.18 -62.0 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.659 -0.416 . . . . 2.87 111.265 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -93.0 -56.93 2.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.534 0.568 . . . . 2.84 112.534 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m 169.12 140.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.866 -1.161 . . . . 1.42 107.866 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -93.21 -55.34 3.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.174 -0.61 . . . . 1.3 110.638 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -145.96 148.29 32.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 1.29 110.987 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -110.7 161.54 15.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.706 -1.22 . . . . 1.36 107.706 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.28 -176.88 41.38 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.429 -1.367 . . . . 0.53 112.838 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.56 146.69 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.828 -0.434 . . . . 1.37 109.828 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.5 t -58.79 119.47 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.316 -0.402 . . . . 0.69 110.575 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -74.4 -37.49 63.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.89 111.192 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 3.92 110.563 172.558 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 N-CA-C 112.049 0.389 . . . . 1.24 112.049 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.3 163.33 30.63 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.94 111.984 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.4 mt -143.45 150.71 39.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.93 111.876 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.5 mt -116.3 136.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.981 -1.009 . . . . 0.49 109.748 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.57 114.67 24.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.678 0.751 . . . . 1.4 110.009 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -91.0 132.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.994 -1.003 . . . . 0.63 109.076 -176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.02 146.01 27.4 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.779 -0.368 . . . . 1.21 110.438 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.81 -178.6 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 2.29 110.401 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.4 pm0 -68.11 -25.14 65.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.895 0.331 . . . . 2.78 111.895 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -93.35 0.71 57.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.904 -0.318 . . . . 1.77 110.476 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 62.95 39.57 10.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.043 -0.526 . . . . 4.14 110.789 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 m -104.38 -50.69 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.87 111.553 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 125' ' ' VAL . 5.2 m -143.36 166.46 24.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.769 0.319 . . . . 1.54 110.794 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -68.72 137.27 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.356 -0.384 . . . . 1.29 110.995 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.16 -68.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 1.03 110.552 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -137.06 -86.41 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.017 0.436 . . . . 1.56 111.046 171.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -177.24 136.43 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.365 -0.834 . . . . 2.08 109.224 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.688 ' HB2' HD11 ' A' ' 117' ' ' ILE . 27.3 m170 -118.83 132.89 56.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.66 -0.416 . . . . 0.68 110.48 174.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.442 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.1 tt0 -91.25 146.82 23.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.424 -0.807 . . . . 1.19 109.507 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -118.75 142.4 47.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.74 110.967 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.25 150.14 24.49 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.825 -0.625 . . . . 0.51 112.522 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.2 tp -54.39 -43.86 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.126 0.488 . . . . 0.67 111.624 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -71.99 -29.56 64.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.213 0.53 . . . . 1.35 110.124 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 6.0 m -73.07 -24.11 60.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.629 . . . . 1.1 110.495 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -77.17 60.05 1.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.947 -0.57 . . . . 1.46 110.486 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 137' ' ' VAL . 21.8 t -39.96 -46.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.782 -0.644 . . . . 0.82 111.503 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 3.3 p30 -94.19 33.68 1.35 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 2.17 111.537 -173.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.54 -20.04 52.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.723 0.409 . . . . 1.39 111.765 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 141' ' ' ASP . 3.4 ptt180 -75.74 -22.92 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 2.46 110.976 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 2.9 m-20 -93.29 140.49 29.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.893 -172.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 102.41 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.648 . . . . 2.88 110.788 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.04 118.44 32.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.97 109.93 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -120.24 -179.03 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.707 0.289 . . . . 1.77 111.117 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.55 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 75.2 tttt -65.17 126.94 29.68 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.699 -0.482 . . . . 1.43 109.699 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.74 -17.05 13.62 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.533 -0.758 . . . . 1.07 111.352 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -85.5 129.94 34.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 1.94 110.266 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -81.72 143.75 31.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.79 110.609 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.11 144.9 35.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.814 -0.63 . . . . 1.16 110.308 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.0 m -106.61 128.36 54.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.515 -0.55 . . . . 1.44 109.515 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.588 ' HB3' HG12 ' A' ' 162' ' ' VAL . 30.2 p90 -145.26 -178.61 6.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.481 . . . . 0.61 110.165 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -148.63 124.03 10.3 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.311 -0.556 . . . . 2.2 111.019 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.482 HD13 ' CE1' ' A' ' 129' ' ' HIS . 7.5 pt -99.56 153.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.996 -0.547 . . . . 1.24 109.853 172.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.554 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 33.0 t70 -177.15 -88.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.277 0.361 . . . . 1.92 110.293 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 45.6 mt-10 -74.22 -28.6 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 2.76 110.535 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 158' ' ' ARG . 13.3 p -78.85 -17.34 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 1.98 110.602 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.93 -28.21 0.64 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.135 -0.484 . . . . 1.27 113.111 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 156' ' ' SER . 90.4 mtt180 -120.39 -169.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.62 22.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.341 0.591 . . . . 0.48 111.791 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -126.42 155.79 41.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.185 -0.916 . . . . 0.49 110.061 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.6 m 57.55 51.4 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 1.55 111.087 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.0 m -79.05 145.13 9.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.854 -0.612 . . . . 1.26 110.437 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -149.04 128.8 13.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.359 -0.608 . . . . 2.05 109.359 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' N ' HD22 ' A' ' 163' ' ' ASN . . . -60.04 124.22 19.56 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.385 0.428 . . . . 0.75 111.094 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 99.9 t -132.54 142.11 43.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 1.56 110.342 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 2.94 110.258 177.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.144 0.497 . . . . 2.0 110.696 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.97 114.7 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.529 -0.915 . . . . 1.27 108.529 172.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -87.18 141.71 28.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.253 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 25.5 mmt85 -100.76 146.0 27.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.575 -0.738 . . . . 2.31 110.285 -177.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.69 -173.26 33.14 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.224 -1.15 . . . . 0.5 110.224 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.44 145.35 36.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.199 0.5 . . . . 0.68 111.196 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.54 101.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.561 -0.745 . . . . 0.56 110.61 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.41 -43.82 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.015 0.436 . . . . 0.76 110.733 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.74 122.6 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.208 -0.451 . . . . 1.55 110.665 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.0 ttm -117.58 107.33 14.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.42 109.788 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.21 170.36 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.159 -0.682 . . . . 2.03 109.159 176.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.728 0.299 . . . . 3.24 111.746 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -102.38 -34.85 9.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.147 0.425 . . . . 2.03 112.147 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.89 -172.79 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.61 0.243 . . . . 1.25 111.186 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.09 173.44 32.68 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.833 -0.699 . . . . 0.71 111.899 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.73 138.71 52.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.832 0.348 . . . . 1.08 110.262 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.09 129.91 58.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.61 109.807 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.48 130.98 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.013 -1.106 . . . . 2.3 108.013 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -65.86 145.22 56.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.89 -0.595 . . . . 0.87 111.382 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 83' ' ' ILE . 2.3 tm? -52.36 -45.33 65.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 1.58 111.202 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -110.83 31.9 5.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.187 -0.46 . . . . 2.04 111.376 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 p80 43.89 45.38 6.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.785 0.834 . . . . 3.29 111.574 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.32 -48.21 62.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.8 -1.091 . . . . 2.89 110.608 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -172.46 -172.34 0.91 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 1.8 110.858 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.09 122.0 42.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 3.37 110.747 -168.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.58 136.29 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 121.116 0.484 . . . . 0.87 111.908 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.12 130.65 55.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 1.06 109.97 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -125.18 156.88 37.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.025 -0.732 . . . . 1.96 109.025 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' HD2' ' H ' ' A' ' 38' ' ' SER . 8.2 t60 -118.68 133.06 56.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.757 -0.46 . . . . 1.18 109.757 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.25 -24.04 66.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.867 0.691 . . . . 0.75 112.867 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 22.9 t -66.3 -33.37 75.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.762 0.315 . . . . 1.63 110.779 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.84 19.58 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.264 0.554 . . . . 2.07 110.564 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.458 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 75.0 t80 -92.98 139.69 30.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.654 -0.703 . . . . 0.91 110.304 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 38.0 ttm -119.5 100.42 7.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 1.73 110.108 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.88 -143.05 10.12 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.486 -0.646 . . . . 1.05 111.486 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -115.53 99.38 52.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.789 0.294 . . . . 2.14 110.732 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -81.9 -25.22 3.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.388 2.059 . . . . 1.01 111.918 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.34 -14.29 60.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 2.08 110.315 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -114.39 19.42 16.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.18 111.067 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.458 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 17.1 mt -82.29 169.31 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 0.92 112.202 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -130.77 164.76 24.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.014 -0.993 . . . . 2.35 110.337 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.18 114.87 22.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.6 -0.518 . . . . 1.4 109.6 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.67 3.05 46.67 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.742 -0.663 . . . . 0.75 112.192 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.446 HE21 ' N ' ' A' ' 52' ' ' GLU . 27.3 tp60 -68.3 122.46 18.41 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 1.06 111.574 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' OE2' ' HG2' ' A' ' 80' ' ' LYS . 26.0 mp0 -61.49 127.12 29.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.412 -0.813 . . . . 2.51 111.14 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.1 149.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.761 -0.654 . . . . 0.44 109.913 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 11' ' ' ARG . 21.6 pt-20 -121.22 137.32 54.73 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.344 -0.613 . . . . 1.49 109.344 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 4.3 p90 -155.39 178.05 10.67 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.684 -0.406 . . . . 0.66 111.411 -172.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -124.3 141.55 51.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.361 -0.381 . . . . 0.94 111.096 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.76 119.82 18.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.19 109.579 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 114.883 -1.053 . . . . 2.04 111.615 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 109.777 -0.453 . . . . 2.3 109.777 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.91 147.76 50.27 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.92 1.747 . . . . 1.43 112.233 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.4 142.07 27.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.82 110.421 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 53.8 mm-40 -113.02 156.66 22.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.061 -0.718 . . . . 2.3 109.061 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 58.07 50.68 9.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.576 0.703 . . . . 2.01 110.282 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 20.3 t -80.85 110.7 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.846 -0.616 . . . . 0.8 110.064 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 76' ' ' ARG . 9.3 mmt180 -107.98 173.69 6.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.578 0.704 . . . . 3.51 111.821 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.442 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 48.1 mtp -117.46 144.05 45.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.859 -1.064 . . . . 1.12 109.301 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.4 pt? -131.56 160.27 68.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 C-N-CA 120.694 -0.403 . . . . 1.67 110.072 175.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 60.7 Cg_endo -73.55 160.97 43.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.833 1.689 . . . . 2.15 112.155 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HG2' ' OE2' ' A' ' 52' ' ' GLU . 41.6 mtmt -74.1 173.92 9.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.788 -0.642 . . . . 4.61 112.125 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.52 30.66 2.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.43 -1.259 . . . . 2.84 110.55 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 t -124.39 11.09 8.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.798 0.809 . . . . 1.7 109.324 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 27' ' ' LEU . 40.9 mm -113.12 125.25 30.04 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 0.92 109.157 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.78 158.33 57.73 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.875 2.383 . . . . 1.03 113.268 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -137.35 152.73 73.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 2.76 109.779 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 10.8 Cg_exo -69.93 150.19 66.82 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.542 2.161 . . . . 1.08 112.545 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.95 92.52 6.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.387 0.613 . . . . 1.1 111.38 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 154' ' ' ASP . 92.2 t -142.79 119.3 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.009 -1.108 . . . . 1.23 108.009 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.82 -63.45 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.197 0.814 . . . . 2.87 113.197 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.19 -59.95 1.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.728 -0.789 . . . . 2.84 112.529 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -179.52 137.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.533 0.733 . . . . 1.42 109.525 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -106.3 -42.52 5.03 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.072 -0.251 . . . . 1.3 110.924 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -141.02 140.11 34.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.682 0.277 . . . . 1.29 110.422 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -116.97 110.14 17.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.239 -0.652 . . . . 1.36 109.239 173.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -114.53 -171.45 17.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.313 -0.946 . . . . 0.53 112.863 -172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -133.96 143.27 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.327 -0.249 . . . . 1.37 110.327 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.41 124.21 13.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.507 -0.315 . . . . 0.69 110.891 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.33 -59.11 2.65 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.226 -0.443 . . . . 0.89 111.172 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 120.859 0.361 . . . . 3.92 110.802 179.379 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 112.022 0.379 . . . . 1.24 112.022 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.77 164.46 38.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.485 -0.864 . . . . 0.94 111.284 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.435 HD13 ' NE2' ' A' ' 128' ' ' GLN . 26.1 mt -146.47 141.66 27.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.809 0.814 . . . . 0.93 112.214 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.13 132.94 55.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.181 -1.372 . . . . 0.49 108.988 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.93 112.42 21.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.883 0.849 . . . . 1.4 109.593 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.3 mm -87.56 134.85 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.694 -1.139 . . . . 0.63 110.249 -170.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.59 148.04 26.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.41 0.624 . . . . 1.21 110.731 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.64 150.89 14.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.994 -1.003 . . . . 2.29 109.116 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.8 -16.94 64.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.752 -0.379 . . . . 2.78 111.682 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.79 10.82 39.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.677 -0.49 . . . . 1.77 109.677 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 63.4 29.93 15.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.264 -0.88 . . . . 4.14 111.096 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 m -73.09 -76.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 1.87 110.988 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -143.94 -166.11 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.499 -0.126 . . . . 1.54 110.742 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 40.0 t -80.55 138.83 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 122.925 0.141 . . . . 1.29 110.689 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.7 mt -77.34 -70.68 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.908 -0.405 . . . . 1.03 109.908 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.4 m -138.52 -86.2 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.346 0.593 . . . . 1.56 110.457 167.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.435 ' NE2' HD13 ' A' ' 114' ' ' LEU . 10.9 pt20 -178.44 144.55 0.3 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.067 -0.97 . . . . 2.08 108.645 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.722 ' HB2' HD11 ' A' ' 117' ' ' ILE . 40.0 m170 -115.46 142.24 46.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.531 0.681 . . . . 0.68 111.282 176.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -89.87 140.76 29.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.263 -1.335 . . . . 1.19 109.176 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CD1' HD21 ' A' ' 136' ' ' LEU . 30.9 p90 -118.07 154.97 31.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.82 0.343 . . . . 0.74 111.171 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.48 151.48 18.41 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.51 112.517 -173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.26 -32.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.008 0.432 . . . . 0.67 112.062 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 p -77.44 -38.02 50.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.438 -0.346 . . . . 1.35 111.106 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 42.2 p -80.49 -11.2 59.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.643 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 131' ' ' PHE . 29.4 mt -74.91 59.29 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 1.46 111.739 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -45.22 -41.38 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.537 . . . . 0.82 111.128 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.5 m120 -91.88 34.25 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.778 -0.646 . . . . 2.17 111.78 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 3.0 ptmt -64.39 -11.47 33.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.422 0.63 . . . . 1.39 110.832 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -87.52 -22.17 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.527 -0.761 . . . . 2.46 110.834 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 9.8 m-20 -92.86 162.54 14.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 1.89 111.726 -167.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.29 95.89 10.15 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.763 -0.653 . . . . 2.88 109.288 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.9 tp -114.78 107.45 15.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.901 -1.045 . . . . 0.97 109.04 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.92 -177.35 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 1.77 111.456 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -59.59 119.59 7.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 1.43 110.708 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.02 -3.55 31.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.564 -0.827 . . . . 1.07 112.904 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -89.7 137.07 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 1.94 110.655 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 148' ' ' LEU . 2.4 mm? -85.13 139.37 31.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 1.79 110.846 -174.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 141.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 1.16 111.461 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.0 p -105.72 123.37 47.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.5 p90 -139.94 164.36 30.2 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.585 -0.524 . . . . 0.61 109.585 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 6.8 mpt_? -123.65 119.25 29.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.018 -0.673 . . . . 2.2 110.136 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 tt -101.66 137.45 29.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.51 -0.768 . . . . 1.24 109.544 170.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 21.6 t70 -162.13 -99.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.915 -0.314 . . . . 1.92 110.731 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 8.8 pt-20 -83.0 -7.08 59.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.2 0.524 . . . . 2.76 111.071 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.4 t -93.26 -17.19 23.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.043 -0.526 . . . . 1.98 109.769 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.17 15.51 58.76 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 116.052 -0.522 . . . . 1.27 113.955 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -139.67 -177.32 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.44 . . . . 3.61 109.813 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.94 108.22 18.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.252 0.548 . . . . 0.48 110.107 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.504 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -118.03 155.74 29.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.49 110.557 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 t 56.37 49.3 15.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 1.55 109.699 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.23 110.74 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.038 -0.983 . . . . 1.26 110.608 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.11 124.4 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 2.05 110.126 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 121.21 14.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.208 -0.293 . . . . 0.75 110.208 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 96.3 t -128.31 140.88 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 1.56 111.091 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 2.94 109.922 176.651 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.212 0.529 . . . . 2.0 111.763 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' HA ' HG22 ' A' ' 56' ' ' THR . 1.1 p -102.1 121.52 53.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.478 -0.934 . . . . 1.27 108.478 170.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -98.39 155.58 17.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.699 -0.682 . . . . 1.14 109.594 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 27' ' ' LEU . 29.2 ptt-85 -128.82 143.91 51.03 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.104 0.478 . . . . 2.31 110.085 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.16 -171.88 21.57 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.356 -1.098 . . . . 0.5 110.356 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.32 140.34 48.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.271 0.557 . . . . 0.68 111.055 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.575 HG21 ' SD ' ' A' ' 17' ' ' MET . 45.7 mm -65.24 122.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.142 -0.935 . . . . 0.56 111.838 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.24 -18.0 10.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.76 111.321 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.41 HG11 ' HD2' ' A' ' 23' ' ' PHE . 96.7 t -135.54 123.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.395 0.141 . . . . 1.55 111.051 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.575 ' SD ' HG21 ' A' ' 14' ' ' ILE . 85.7 mmm -118.1 111.23 18.61 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.131 0.419 . . . . 1.42 112.131 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.749 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -112.4 172.23 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.514 -0.921 . . . . 2.03 108.514 165.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -82.89 -25.52 32.4 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.49 -0.484 . . . . 3.24 110.958 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -92.19 -50.23 5.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.724 0.297 . . . . 2.03 111.7 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.4 p90 -153.15 151.25 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.994 0.426 . . . . 1.25 111.292 -174.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.91 -178.8 15.71 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.891 -0.671 . . . . 0.71 111.817 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HD2' HG11 ' A' ' 16' ' ' VAL . 94.2 m-85 -131.88 141.83 49.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.345 -0.613 . . . . 1.08 109.345 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.61 119.78 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.081 0.467 . . . . 0.61 111.581 -170.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -70.83 128.59 36.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 2.3 108.934 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 p -81.2 153.12 27.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.192 -0.458 . . . . 0.87 111.161 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.2 tp -50.14 -47.73 54.04 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.55 -0.75 . . . . 1.58 111.622 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -104.77 20.88 17.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 2.04 111.023 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 p80 41.48 47.56 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.88 0.872 . . . . 3.29 111.781 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.77 -40.49 22.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.451 -0.795 . . . . 2.89 110.068 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -159.99 179.98 8.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.418 -0.81 . . . . 1.8 109.78 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -114.74 133.3 56.01 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.429 -0.952 . . . . 3.37 108.429 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG11 ' HE2' ' A' ' 55' ' ' TYR . 24.2 t -114.22 112.17 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.461 0.648 . . . . 0.87 111.993 -170.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 5.6 t80 -72.06 119.97 17.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.222 -0.899 . . . . 1.06 110.491 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -124.77 136.06 53.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.197 -0.456 . . . . 1.96 110.621 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -98.97 118.08 34.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.617 -0.883 . . . . 1.18 108.617 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.07 -17.38 39.14 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.26 0.467 . . . . 0.75 112.26 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 t -56.49 -24.98 49.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.191 -0.459 . . . . 1.63 111.114 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -107.14 24.24 13.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 2.07 111.021 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.416 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 70.9 t80 -87.41 152.05 22.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.91 111.297 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.6 ttm -116.47 110.88 19.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 1.73 109.89 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.05 -139.34 10.81 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.568 -0.825 . . . . 1.05 112.278 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -122.72 99.75 41.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.535 0.207 . . . . 2.14 110.468 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.53 -20.75 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.272 1.981 . . . . 1.01 112.372 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -74.88 -11.83 60.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 2.08 111.168 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -109.46 14.71 23.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 2.18 110.653 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 38.1 mt -93.83 158.66 15.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.92 111.048 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -162.06 175.13 12.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.597 -0.729 . . . . 2.35 109.571 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 mt -72.99 122.22 21.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.849 0.357 . . . . 1.4 111.039 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.08 -4.53 16.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.676 -0.773 . . . . 0.75 112.899 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -86.83 132.96 33.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.048 0.424 . . . . 1.06 111.237 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 3.4 mp0 -82.14 143.52 31.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.86 -0.609 . . . . 2.51 111.138 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.0 m -141.48 153.58 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.704 -0.68 . . . . 0.44 110.193 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -113.64 137.62 51.34 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.235 -0.654 . . . . 1.49 109.235 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.518 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.3 p90 -164.45 163.03 22.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.398 0.618 . . . . 0.66 112.372 -175.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 9' ' ' VAL . 68.6 p -113.3 147.72 37.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.94 110.025 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.2 135.73 46.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.647 -0.421 . . . . 1.19 110.327 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 2.04 111.002 -178.543 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.2 mt . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 110.333 -0.247 . . . . 2.3 110.333 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 47.1 Cg_endo -69.33 174.98 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.586 2.19 . . . . 1.43 112.134 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.72 159.52 22.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.596 -0.275 . . . . 0.82 110.84 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -130.1 145.39 51.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.709 0.29 . . . . 2.3 111.566 -176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 55.17 85.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.047 -0.979 . . . . 2.01 111.823 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 55' ' ' TYR . 43.5 t -115.86 119.38 61.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.056 -0.52 . . . . 0.8 110.623 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -120.22 164.74 15.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.636 -0.505 . . . . 3.51 109.636 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.452 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.9 mtt -81.12 144.27 31.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.815 0.34 . . . . 1.12 110.653 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 26.2 tp -121.68 129.43 25.19 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.67 110.183 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 28.2 Cg_exo -63.83 154.37 70.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.624 2.216 . . . . 2.15 112.476 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.685 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -64.07 168.82 4.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.915 -0.584 . . . . 4.61 111.248 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.9 t30 76.58 2.84 3.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.628 0.771 . . . . 2.84 110.735 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.7 p -86.99 -11.12 51.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.815 0.816 . . . . 1.7 109.191 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.584 HD12 ' CD1' ' A' ' 27' ' ' LEU . 8.4 mm -100.52 132.51 22.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 114.463 -1.244 . . . . 0.92 108.565 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.05 142.04 66.42 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.159 1.906 . . . . 1.03 111.495 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.03 143.28 47.29 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.695 -0.402 . . . . 2.76 110.485 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.489 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 33.1 Cg_endo -63.84 141.46 78.32 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.117 2.545 . . . . 1.08 112.917 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.07 93.39 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.992 -0.549 . . . . 1.1 110.03 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.07 137.01 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.728 -0.842 . . . . 1.23 108.728 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -82.65 -61.06 1.98 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.911 -0.316 . . . . 2.87 111.73 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 91' ' ' THR . 39.1 mt-10 -91.45 -55.52 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.453 -0.499 . . . . 2.84 111.082 -175.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 166.43 161.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.716 -0.846 . . . . 1.42 108.716 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -105.5 -50.41 3.22 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.511 -0.476 . . . . 1.3 110.788 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.82 145.64 31.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.943 0.402 . . . . 1.29 111.04 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.646 ' O ' HD22 ' A' ' 118' ' ' LEU . 3.9 p-10 -113.41 148.1 36.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.774 -1.195 . . . . 1.36 107.774 171.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -163.43 -163.75 16.91 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 118.973 -1.584 . . . . 0.53 113.225 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 21.1 t -133.94 146.88 30.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.7 -0.482 . . . . 1.37 109.7 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.95 117.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.077 -0.342 . . . . 0.69 110.077 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.88 -57.0 3.14 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.159 0.429 . . . . 0.89 112.159 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 3.92 111.48 -176.766 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 111.532 0.197 . . . . 1.24 111.532 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.19 153.23 22.06 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.773 -0.727 . . . . 0.94 112.302 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 130' ' ' GLU . 89.3 mt -138.65 142.01 39.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.622 0.725 . . . . 0.93 112.419 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.48 143.88 18.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.521 -1.218 . . . . 0.49 109.964 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 96' ' ' VAL . 11.1 pt-20 -84.63 125.8 32.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.345 0.593 . . . . 1.4 109.586 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 129' ' ' HIS . 14.6 mm -104.59 128.15 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.63 109.386 -173.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.18 156.93 20.79 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.299 0.374 . . . . 1.21 110.597 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m-20 -56.75 154.54 8.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.66 -0.496 . . . . 2.29 109.66 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.478 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.8 pt-20 -62.91 -22.42 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.06 0.457 . . . . 2.78 110.603 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -95.65 -3.82 45.5 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.145 -0.479 . . . . 1.77 110.221 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 118' ' ' LEU . 26.2 ttm180 64.23 89.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.272 -0.876 . . . . 4.14 111.004 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.9 m -133.34 -64.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 1.87 110.283 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -168.92 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.472 -0.785 . . . . 1.54 110.398 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 p -92.3 135.31 27.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.718 -0.475 . . . . 1.29 109.718 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -78.45 -70.87 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.566 -0.454 . . . . 1.03 110.767 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.6 m -139.89 -83.96 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.64 0.733 . . . . 1.56 111.43 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -175.36 138.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.575 -1.193 . . . . 2.08 109.695 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' A' ' 117' ' ' ILE . 35.6 m170 -118.76 140.48 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.252 -0.579 . . . . 0.68 109.703 168.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 158' ' ' ARG . 19.8 tt0 -94.45 145.07 25.04 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.067 -0.97 . . . . 1.19 109.633 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 136' ' ' LEU . 33.5 p90 -117.76 170.61 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.732 -0.387 . . . . 0.74 110.938 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.03 152.05 20.93 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.72 -0.552 . . . . 0.51 111.72 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.87 -29.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.966 0.412 . . . . 0.67 111.426 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.1 p -74.64 -37.36 62.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 1.35 111.271 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 47.3 p -86.46 -11.55 51.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.363 -0.38 . . . . 1.1 110.7 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' CD1' ' A' ' 131' ' ' PHE . 62.0 mt -73.93 59.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 1.46 111.107 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.68 -45.81 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.251 0.548 . . . . 0.82 110.839 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.808 HD21 HD22 ' A' ' 143' ' ' LEU . 2.9 p-10 -85.57 31.68 0.59 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 2.17 111.95 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -60.63 -20.01 59.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.023 0.439 . . . . 1.39 111.351 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -76.94 -21.43 54.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 2.46 111.591 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -89.8 175.6 7.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.148 -0.478 . . . . 1.89 110.677 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.87 101.51 12.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.864 -0.607 . . . . 2.88 109.6 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.808 HD22 HD21 ' A' ' 138' ' ' ASN . 11.8 tp -115.48 114.43 25.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.97 110.094 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -124.98 -173.8 2.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.512 -0.313 . . . . 1.77 110.183 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -66.03 136.75 56.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.758 -0.377 . . . . 1.43 110.073 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.41 -9.48 57.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.675 -0.774 . . . . 1.07 111.722 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 38.4 m-20 -89.49 147.57 23.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.099 0.952 . . . . 1.94 110.997 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 165' ' ' VAL . 1.0 OUTLIER -98.04 127.54 44.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.291 -1.777 . . . . 1.79 109.692 -168.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.457 ' CG1' HD21 ' A' ' 143' ' ' LEU . 29.1 m -129.1 152.57 37.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 1.16 111.768 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 p -118.98 135.71 54.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.214 -0.662 . . . . 1.44 109.214 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -153.94 161.98 41.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.61 110.948 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 123.96 30.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.781 0.8 . . . . 2.2 111.803 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tt -99.3 129.25 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.201 -1.363 . . . . 1.24 110.409 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 15.5 t70 -160.74 -88.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.976 -0.102 . . . . 1.92 110.913 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 4.6 mm-40 -81.66 -19.61 41.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 2.76 111.25 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.7 p -81.7 -17.57 47.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.238 -0.437 . . . . 1.98 110.496 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.73 18.18 16.48 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.808 -0.633 . . . . 1.27 112.842 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 62.8 mtm180 -147.46 -173.82 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.886 -1.153 . . . . 3.61 107.886 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.61 108.35 17.31 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.461 -0.496 . . . . 0.48 109.836 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -115.76 159.95 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.49 110.653 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.4 t 59.01 42.26 19.53 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.781 0.675 . . . . 1.55 109.766 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.77 108.81 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.348 -0.842 . . . . 1.26 110.442 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.75 111.33 20.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.387 -0.824 . . . . 2.05 110.143 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.68 120.26 9.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.869 -0.605 . . . . 0.75 110.675 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 148' ' ' LEU . 59.8 t -102.84 110.26 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.855 -0.611 . . . . 1.56 110.614 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.439 -0.578 . . . . 2.94 109.439 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.341 0.591 . . . . 2.0 111.018 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.12 121.94 37.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.317 -0.856 . . . . 1.27 109.747 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.37 140.3 32.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.771 -0.65 . . . . 1.14 110.342 -173.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 37.5 ttm180 -101.77 152.85 20.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.776 -0.647 . . . . 2.31 110.002 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.97 -169.09 35.11 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.17 -0.772 . . . . 0.5 111.17 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.9 145.13 29.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.757 0.313 . . . . 0.68 110.581 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 112.16 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.56 110.589 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.82 -25.18 15.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.468 -0.333 . . . . 0.76 111.395 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.614 HG11 ' HD2' ' A' ' 23' ' ' PHE . 2.6 p -156.26 134.02 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.354 -0.384 . . . . 1.55 111.237 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.5 mtp -118.85 115.83 25.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.415 -0.587 . . . . 1.42 109.415 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 27.2 mmtm -96.25 -161.65 0.89 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.684 -0.487 . . . . 2.03 109.684 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.31 -46.53 27.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.899 -0.591 . . . . 3.24 111.134 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -111.49 -24.61 10.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 2.03 111.626 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 51.5 p90 -143.98 -173.72 4.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.938 0.399 . . . . 1.25 111.109 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.13 -178.36 35.03 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.001 -0.84 . . . . 0.71 111.001 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.614 ' HD2' HG11 ' A' ' 16' ' ' VAL . 67.7 m-85 -125.03 130.54 52.51 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.979 0.419 . . . . 1.08 109.958 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mt -100.03 126.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.976 -0.556 . . . . 0.61 109.542 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.78 127.46 32.45 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.959 -0.756 . . . . 2.3 108.959 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.1 p -63.62 139.72 58.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.34 -0.846 . . . . 0.87 110.729 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -57.2 -36.62 71.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.677 0.751 . . . . 1.58 109.468 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -82.72 6.92 16.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.718 -1.128 . . . . 2.04 112.253 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p80 42.71 53.02 4.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.73 0.812 . . . . 3.29 111.733 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.8 -42.66 3.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 2.89 111.444 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.14 174.5 14.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 1.8 111.303 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.24 126.16 50.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 3.37 109.43 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 90.7 t -105.28 121.41 57.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.282 -0.417 . . . . 0.87 111.86 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -82.15 114.57 20.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 1.06 109.691 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -118.15 137.45 52.96 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.179 -0.609 . . . . 1.96 109.424 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -100.79 127.64 47.14 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -56.99 -22.87 41.75 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.259 0.466 . . . . 0.75 112.259 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -70.55 -8.99 55.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.606 -0.27 . . . . 1.63 111.672 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -116.41 20.15 14.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 2.07 109.948 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -102.67 139.24 38.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.91 110.243 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -109.37 136.53 48.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.181 0.515 . . . . 1.73 110.717 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.6 -138.75 13.95 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.019 -0.833 . . . . 1.05 111.019 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -128.67 105.89 18.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.794 -0.447 . . . . 2.14 109.794 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.98 -30.7 38.87 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.843 2.362 . . . . 1.01 112.42 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.38 -18.1 65.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.66 -0.7 . . . . 2.08 111.528 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -98.36 10.65 40.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.079 0.466 . . . . 2.18 110.63 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.0 148.99 24.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.718 -0.673 . . . . 0.92 110.794 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 166.12 22.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 2.35 109.887 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.83 115.18 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 1.4 110.195 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -7.16 21.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.253 -0.499 . . . . 0.75 112.002 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.465 HE21 ' N ' ' A' ' 52' ' ' GLU . 24.8 tp60 -71.54 120.24 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 1.06 111.008 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 83' ' ' ILE . 9.0 mp0 -65.13 134.09 53.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.294 -0.866 . . . . 2.51 111.371 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.6 m -145.2 166.42 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.751 -0.659 . . . . 0.44 110.108 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.62 150.02 48.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.03 -0.359 . . . . 1.49 110.03 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 12.1 p90 -164.09 -179.9 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.392 . . . . 0.66 111.649 -172.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -127.29 150.22 49.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.94 110.617 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.07 142.71 27.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 1.19 110.939 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.969 -0.56 . . . . 2.04 110.562 178.271 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.676 -0.49 . . . . 2.3 109.676 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.91 167.17 25.41 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.632 2.221 . . . . 1.43 112.91 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -107.19 146.59 31.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.377 -0.829 . . . . 0.82 110.747 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.09 154.55 27.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 2.3 111.027 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 61.87 41.22 11.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.627 -0.715 . . . . 2.01 111.515 170.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.9 t -71.01 118.59 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.8 110.092 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -118.44 154.99 31.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.57 . . . . 3.51 110.237 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.51 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.4 mtt -78.4 148.47 33.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.963 0.411 . . . . 1.12 110.485 173.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 79' ' ' PRO . 20.0 tp -126.1 141.77 40.6 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.946 -0.57 . . . . 1.67 109.583 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 78' ' ' LEU . 15.0 Cg_endo -58.58 137.81 82.32 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.1 1.867 . . . . 2.15 111.279 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -66.85 164.48 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.694 -0.685 . . . . 4.61 111.861 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 70.44 21.7 5.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.91 -1.041 . . . . 2.84 110.41 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.4 t -89.76 5.14 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.606 0.717 . . . . 1.7 109.744 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.602 HD12 HD23 ' A' ' 27' ' ' LEU . 28.9 mm -101.98 131.47 22.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.832 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.58 145.35 57.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.214 1.943 . . . . 1.03 111.735 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -120.71 149.8 51.24 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 120.866 -0.334 . . . . 2.76 110.851 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 43.0 Cg_endo -68.52 146.56 68.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.67 2.247 . . . . 1.08 112.195 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.57 95.27 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.332 -0.395 . . . . 1.1 110.338 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.08 136.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.7 -63.64 1.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.121 -0.631 . . . . 2.87 112.206 -171.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -94.22 -54.63 3.48 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.421 -0.512 . . . . 2.84 111.215 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 t 177.45 163.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.937 -0.764 . . . . 1.42 108.937 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -106.04 -52.72 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.087 0.47 . . . . 1.3 110.61 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.55 151.69 46.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.434 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.596 ' O ' HD22 ' A' ' 118' ' ' LEU . 4.4 p-10 -130.75 128.08 40.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.98 -0.748 . . . . 1.36 108.98 173.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.37 -146.32 4.31 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.859 -1.162 . . . . 0.53 112.723 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.0 p -142.14 148.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.802 -0.444 . . . . 1.37 109.802 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 143' ' ' LEU . 86.2 t -59.95 126.76 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.495 0.188 . . . . 0.69 110.774 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -70.12 -52.46 23.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.377 -0.374 . . . . 0.89 110.765 -174.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 3.92 110.399 178.032 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.662 0.268 . . . . 1.24 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 157.74 33.46 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.569 -0.824 . . . . 0.94 111.834 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 128' ' ' GLN . 36.0 mt -141.81 148.06 38.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.467 0.651 . . . . 0.93 112.133 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.91 140.73 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.063 -0.971 . . . . 0.49 109.311 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 11.8 pt-20 -87.87 129.21 35.29 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.383 -0.599 . . . . 1.4 109.383 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.8 mm -104.43 140.67 21.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.827 -0.624 . . . . 0.63 110.614 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.7 pt? -84.08 146.48 27.89 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.987 -0.375 . . . . 1.21 109.987 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.9 165.47 17.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.71 -0.848 . . . . 2.29 108.71 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.74 -18.72 65.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.866 0.365 . . . . 2.78 111.0 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.95 6.47 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.18 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 55.87 77.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.526 -0.761 . . . . 4.14 111.208 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.9 p -117.73 -79.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.87 110.89 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.0 p -137.17 -174.5 3.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 1.54 110.793 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 4.7 p -65.17 129.87 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 1.29 110.721 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.1 -70.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.921 0.391 . . . . 1.03 110.791 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 p -135.97 -85.51 0.36 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.068 -0.514 . . . . 1.56 111.065 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.462 ' HB2' HD22 ' A' ' 114' ' ' LEU . 13.6 pt20 -176.51 137.4 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.573 -0.739 . . . . 2.08 109.763 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 117' ' ' ILE . 32.1 m170 -121.62 125.83 47.62 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.809 -0.356 . . . . 0.68 110.086 171.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.44 149.42 24.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.639 -0.71 . . . . 1.19 109.9 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 136' ' ' LEU . 20.9 p90 -117.74 146.86 43.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 0.74 111.294 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -101.8 150.43 18.33 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.51 112.494 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.91 -43.02 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.236 0.458 . . . . 0.67 112.236 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -77.58 -22.66 50.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.225 0.536 . . . . 1.35 110.203 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 15.2 m -80.66 -18.83 46.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.563 -0.744 . . . . 1.1 110.166 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 131' ' ' PHE . 50.1 mt -76.53 60.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 1.46 111.419 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.2 t -41.09 -42.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.291 -0.413 . . . . 0.82 111.592 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -92.05 27.79 2.05 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.159 -0.473 . . . . 2.17 111.994 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -60.34 -18.19 48.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.07 0.396 . . . . 1.39 112.07 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -81.43 -19.24 42.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.309 -0.405 . . . . 2.46 111.478 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.48 175.41 9.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.941 -0.572 . . . . 1.89 110.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 pp -104.43 130.32 52.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.754 -0.832 . . . . 2.88 108.754 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 97' ' ' VAL . 12.3 tp -139.97 109.7 6.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.97 109.372 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -122.73 -171.97 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 1.77 110.956 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 62.5 tttm -64.59 116.9 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.637 . . . . 1.43 110.44 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.71 33.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.603 -0.808 . . . . 1.07 112.877 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -91.49 127.64 37.01 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.106 0.453 . . . . 1.94 110.35 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 96' ' ' VAL . 82.0 mt -73.73 144.24 45.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.34 0.591 . . . . 1.79 110.889 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.28 145.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.346 -0.843 . . . . 1.16 111.114 -173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.4 m -118.45 148.83 42.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.672 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -163.68 162.93 24.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.53 . . . . 0.61 109.808 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.7 122.05 35.21 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.779 0.799 . . . . 2.2 110.965 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.89 141.23 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.841 -1.072 . . . . 1.24 110.076 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 24.8 t70 -171.64 -93.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.625 -0.139 . . . . 1.92 110.625 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 41.9 mm-40 -74.01 -33.19 63.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 2.76 111.48 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -76.19 -15.51 60.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 1.98 110.753 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.65 20.6 39.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.968 -0.634 . . . . 1.27 112.948 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -140.49 -175.05 4.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.841 . . . . 3.61 108.728 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.47 108.38 18.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.216 -0.661 . . . . 0.48 109.216 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.26 158.77 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.49 111.218 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 36.8 t 59.34 39.59 22.11 Favored 'General case' 0 C--N 1.334 -0.071 0 N-CA-C 109.273 -0.64 . . . . 1.55 109.273 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -62.25 123.32 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.145 -0.934 . . . . 1.26 110.728 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -132.42 111.69 11.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.28 -0.418 . . . . 2.05 110.187 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.82 109.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.75 110.368 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 77.1 t -89.67 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 1.56 111.364 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.701 0 N-CA-C 109.125 -0.695 . . . . 2.94 109.125 172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.636 -0.586 . . . . 11.74 111.636 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.62 -31.14 2.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.876 0.369 . . . . 10.54 111.19 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.25 -13.73 30.95 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.058 -0.817 . . . . 8.95 111.058 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 m -105.1 15.46 27.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.92 0.867 . . . . 7.09 108.784 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.21 -168.27 1.44 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.8 -1.091 . . . . 5.59 110.747 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.04 161.1 14.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 2.99 110.702 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.0 24.47 5.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.49 -0.862 . . . . 1.61 112.052 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -112.93 122.09 46.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 2.0 111.036 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.28 124.83 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.122 -0.695 . . . . 1.27 109.122 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.25 138.89 32.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.368 0.604 . . . . 1.14 110.417 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.627 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -104.62 140.44 38.01 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.461 -0.791 . . . . 2.31 109.88 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.83 -172.39 30.25 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.13 -0.788 . . . . 0.5 111.13 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.4 143.05 37.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.04 0.448 . . . . 0.68 111.307 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.519 HG21 ' SD ' ' A' ' 17' ' ' MET . 33.1 mm -65.83 125.79 23.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.455 -0.793 . . . . 0.56 110.869 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.86 -35.74 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.791 0.329 . . . . 0.76 111.384 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.5 123.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 1.55 110.698 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 14' ' ' ILE . 80.5 mmm -116.03 107.39 14.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 1.42 110.954 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.4 mmtt -103.26 179.2 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.437 -1.32 . . . . 2.03 107.437 167.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.68 -18.56 29.28 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.892 -0.723 . . . . 3.24 110.695 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -101.67 -48.51 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.028 0.442 . . . . 2.03 111.592 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 39.9 p90 -142.67 -177.56 5.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.274 -0.421 . . . . 1.25 110.084 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.62 -178.36 34.54 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.748 -0.739 . . . . 0.71 111.795 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.88 130.97 53.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 1.08 110.224 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.9 mt -101.66 129.27 53.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.622 -0.717 . . . . 0.61 109.674 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.63 131.98 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.751 -0.833 . . . . 2.3 108.751 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.5 p -64.3 151.99 42.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.494 -0.776 . . . . 0.87 111.705 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 83' ' ' ILE . 7.2 tp -62.7 -40.65 97.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.673 -0.694 . . . . 1.58 110.924 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 8.1 m -100.36 24.78 8.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.496 -0.775 . . . . 2.04 111.277 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' ' NH1' ' A' ' 158' ' ' ARG . 23.1 p80 44.3 51.01 7.71 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.763 0.792 . . . . 3.29 111.709 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 15.8 m-20 -82.02 -51.29 8.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.196 -0.911 . . . . 2.89 109.438 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -175.93 -175.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.089 -0.96 . . . . 1.8 109.678 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.39 136.3 43.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.047 0.451 . . . . 3.37 110.238 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.44 126.93 57.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.697 -0.683 . . . . 0.87 110.963 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -68.8 119.38 13.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.19 0.519 . . . . 1.06 110.124 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -129.58 136.51 49.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.654 -0.703 . . . . 1.96 109.935 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.21 139.27 40.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.346 -0.613 . . . . 1.18 109.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.496 ' HZ ' ' SD ' ' A' ' 17' ' ' MET . 60.0 m-85 -69.79 -16.31 63.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.032 0.444 . . . . 0.75 111.201 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.6 t -63.39 -23.22 67.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.76 -0.655 . . . . 1.63 111.77 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -111.41 24.62 12.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 2.07 110.488 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 91.8 t80 -91.69 146.29 23.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.865 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.3 ttm -113.77 117.32 31.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 1.73 110.12 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.95 -157.04 20.97 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.748 -0.739 . . . . 1.05 112.042 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -111.22 107.36 57.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.932 -0.396 . . . . 2.14 109.932 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 -17.28 38.22 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.772 2.315 . . . . 1.01 113.095 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -64.99 -21.94 66.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.439 . . . . 2.08 110.8 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -103.53 12.77 34.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.033 -0.53 . . . . 2.18 111.268 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 14.5 mt -88.11 146.94 25.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.14 -0.482 . . . . 0.92 111.572 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -143.49 169.22 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.288 -0.869 . . . . 2.35 110.273 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.2 mt -76.77 116.65 17.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.924 -0.58 . . . . 1.4 110.757 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 2.35 27.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.922 -0.656 . . . . 0.75 112.506 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -78.34 127.37 32.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.792 0.329 . . . . 1.06 111.035 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' OE1' ' HD2' ' A' ' 11' ' ' ARG . 19.1 tt0 -70.81 130.92 42.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.745 -0.661 . . . . 2.51 110.28 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.59 154.52 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.839 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.83 141.63 47.08 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.003 -0.739 . . . . 1.49 109.003 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.34 161.73 27.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.401 0.62 . . . . 0.66 111.936 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 p -110.18 163.73 13.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.414 -0.812 . . . . 0.94 109.906 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -101.32 142.03 33.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.665 0.269 . . . . 1.19 110.571 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.69 80.89 8.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 2.04 111.079 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.585 ' HD3' HD21 ' A' ' 70' ' ' LEU . 17.5 mmt85 -96.3 7.6 46.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.628 -0.715 . . . . 5.33 110.34 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -92.59 114.08 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 5.42 110.867 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.61 -77.33 0.4 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.964 -0.636 . . . . 4.76 112.154 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -149.2 128.7 13.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.605 -0.517 . . . . 6.38 109.605 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -72.18 -22.55 61.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.104 0.478 . . . . 6.4 111.929 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -122.02 67.99 0.93 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.382 -0.599 . . . . 5.23 109.382 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.3 t -53.7 -71.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.98 -1.009 . . . . 6.95 110.885 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.4 p -121.31 -28.26 4.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 6.02 111.131 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.51 42.76 0.24 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.691 -0.766 . . . . 4.09 112.158 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.72 -46.61 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.003 0.921 . . . . 4.22 112.506 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 p -69.35 111.53 5.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.498 0.666 . . . . 2.09 110.643 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.585 HD21 ' HD3' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -111.29 164.23 15.49 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.774 -1.103 . . . . 2.3 110.797 -175.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.75 172.45 16.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.705 2.27 . . . . 1.43 113.293 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.65 171.62 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.149 -0.932 . . . . 0.82 109.993 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -149.15 155.23 40.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.469 0.176 . . . . 2.3 110.622 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.26 55.27 9.41 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.828 0.705 . . . . 2.01 112.099 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 35' ' ' PHE . 40.5 t -86.41 116.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 0.8 110.186 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -122.15 159.63 26.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.739 -0.467 . . . . 3.51 109.739 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.4 mtt -79.53 152.37 30.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.85 0.357 . . . . 1.12 111.163 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -119.16 162.61 30.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 1.67 110.539 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 134.68 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.337 2.025 . . . . 2.15 111.95 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 38.8 ttmt -70.01 155.27 40.84 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.807 -0.633 . . . . 4.61 110.925 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 17.3 m120 74.76 15.9 3.13 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.219 0.608 . . . . 2.84 111.402 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 44.8 m -92.23 -19.87 21.75 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.929 -0.309 . . . . 1.7 111.023 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD11 ' A' ' 27' ' ' LEU . 45.3 mm -70.44 126.52 92.31 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.315 -0.624 . . . . 0.92 109.315 171.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.24 154.83 61.49 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.576 2.184 . . . . 1.03 112.331 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -113.64 152.76 45.74 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.059 -0.519 . . . . 2.76 110.171 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.439 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 23.5 Cg_endo -60.63 143.5 99.43 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 1.08 112.16 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.16 91.72 8.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.302 0.572 . . . . 1.1 110.007 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -142.04 128.67 19.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.607 -0.886 . . . . 1.23 108.607 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.26 -63.64 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.555 -0.458 . . . . 2.87 112.056 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.58 -53.82 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.982 0.42 . . . . 2.84 111.887 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.2 t 174.74 159.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.108 -0.701 . . . . 1.42 109.108 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -106.22 -58.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 1.3 111.059 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -140.52 158.09 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.064 0.459 . . . . 1.29 110.725 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -122.94 175.9 6.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.467 -0.788 . . . . 1.36 109.045 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.64 -163.13 34.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.264 -0.97 . . . . 0.53 112.198 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.36 148.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.13 -0.693 . . . . 1.37 109.13 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 144' ' ' GLN . 49.1 t -63.91 116.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.601 -0.518 . . . . 0.69 109.601 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 99' ' ' ARG . . . -82.65 -68.84 0.67 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.178 -0.464 . . . . 0.89 111.697 -173.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 4.8 mtm180 -162.85 139.48 5.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.573 -0.285 . . . . 3.92 111.18 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.562 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -70.87 130.65 18.29 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.428 2.085 . . . . 2.22 110.684 171.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.73 89.76 2.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.699 0.762 . . . . 3.32 111.413 -177.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.29 -59.01 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.252 -0.885 . . . . 5.56 110.421 -175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 6.2 p -85.56 -5.58 59.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 4.14 111.491 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.7 mp -71.62 -28.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 3.46 110.008 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.715 ' ND2' ' HG3' ' A' ' 109' ' ' GLN . 60.6 t30 -116.34 125.78 28.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 4.99 109.739 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.08 -26.12 80.49 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.281 1.987 . . . . 4.27 111.981 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.69 8.49 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 3.94 111.801 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 64.72 81.11 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.141 0.793 . . . . 5.6 113.141 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.715 ' HG3' ' ND2' ' A' ' 105' ' ' ASN . 30.4 mt-30 -89.11 8.55 29.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.494 -0.775 . . . . 5.3 112.341 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.654 ' HA ' HD12 ' A' ' 101' ' ' LEU . 10.7 pt-20 -43.6 -19.34 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.2 1.555 . . . . 4.95 115.2 -166.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -39.02 16.37 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.403 0.281 . . . . 3.19 111.581 172.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.63 ' HB3' HD11 ' A' ' 101' ' ' LEU . . . -76.17 -43.05 44.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 112.088 0.403 . . . . 1.24 112.088 -169.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 100' ' ' PRO . . . 58.74 179.88 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.05 -0.523 . . . . 0.94 113.871 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.9 mt -144.48 138.23 27.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.93 111.17 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.6 mt -103.7 139.47 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.233 -0.894 . . . . 0.49 109.237 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.44 116.02 27.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.56 0.695 . . . . 1.4 110.184 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.811 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 15.8 mm -91.52 140.57 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.229 -0.896 . . . . 0.63 109.946 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.66 143.34 29.28 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.953 -0.299 . . . . 1.21 110.238 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.64 -179.49 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.496 . . . . 2.29 111.064 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.638 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.6 pm0 -66.64 -25.17 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.262 . . . . 2.78 111.442 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.638 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -90.3 -1.47 57.92 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.353 -0.61 . . . . 1.77 109.353 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 60.1 43.6 14.07 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.166 -0.924 . . . . 4.14 111.534 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.2 m -114.83 -50.0 2.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.028 0.381 . . . . 1.87 112.028 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.8 p -130.65 -179.5 5.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.964 0.411 . . . . 1.54 111.858 -173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -81.83 136.64 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.755 -0.657 . . . . 1.29 110.277 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.1 mt -75.09 -69.22 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 1.03 110.56 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -137.58 -83.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 1.56 111.813 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -174.98 134.37 0.34 Allowed 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 115.458 -0.792 . . . . 2.08 109.757 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 117' ' ' ILE . 15.8 m170 -120.38 130.66 54.48 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.608 -0.437 . . . . 0.68 110.692 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -91.5 143.98 26.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.419 -0.81 . . . . 1.19 109.395 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.5 p90 -116.98 140.72 49.13 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.059 -0.657 . . . . 0.74 111.056 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.39 152.38 18.37 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.42 -0.809 . . . . 0.51 112.539 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.1 tp -49.89 -33.38 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.248 0.462 . . . . 0.67 112.248 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.6 p -72.93 -33.75 66.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.438 0.637 . . . . 1.35 110.813 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 16.3 m -74.55 -26.58 60.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.172 -0.922 . . . . 1.1 110.433 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 131' ' ' PHE . 32.1 mt -75.58 60.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.44 -0.8 . . . . 1.46 112.151 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -45.56 -42.5 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.497 0.665 . . . . 0.82 110.481 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 45.7 m-80 -92.11 35.13 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.204 -0.907 . . . . 2.17 111.302 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -58.22 -17.78 21.51 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.477 0.547 . . . . 1.39 112.477 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.39 -22.91 62.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.064 0.459 . . . . 2.46 110.696 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.47 161.64 27.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 1.89 111.98 -171.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -89.75 30.66 1.02 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.202 -0.908 . . . . 2.88 109.295 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.95 107.83 0.1 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.492 -1.231 . . . . 0.97 110.548 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 13.8 pt20 -129.51 -175.6 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.531 . . . . 1.77 111.55 -170.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 77.8 tttt -59.65 118.19 5.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.587 -0.733 . . . . 1.43 109.929 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.43 -5.25 29.82 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.467 -0.873 . . . . 1.07 112.635 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.39 136.39 33.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.067 0.46 . . . . 1.94 111.079 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.4 mm? -86.0 136.38 33.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.38 -0.827 . . . . 1.79 110.359 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.27 150.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.245 0.545 . . . . 1.16 112.04 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.7 m -125.82 134.98 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 1.44 108.926 170.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.811 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 44.5 p90 -146.72 -176.61 5.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.079 -0.51 . . . . 0.61 109.7 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 122.31 17.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.277 0.56 . . . . 2.2 110.722 174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.6 tt -100.62 130.49 49.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.178 -0.919 . . . . 1.24 110.296 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 13.5 t70 -159.17 -92.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.465 -0.198 . . . . 1.92 110.465 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -83.09 -19.69 36.3 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.08 -0.388 . . . . 2.76 111.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 m -77.92 -16.47 58.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.226 -0.443 . . . . 1.98 110.58 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 53.25 30.89 40.88 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.705 -0.68 . . . . 1.27 113.745 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 29' ' ' HIS . 11.6 ptm180 -161.63 -167.61 1.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.454 -0.943 . . . . 3.61 108.454 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.92 107.66 17.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.294 -0.632 . . . . 0.48 109.294 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -122.18 153.22 39.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.49 110.437 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 t 60.72 45.3 10.26 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.367 -0.605 . . . . 1.55 109.367 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.62 109.33 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.496 -0.774 . . . . 1.26 110.798 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.505 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 54.2 t30 -111.59 120.96 43.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.384 -0.826 . . . . 2.05 110.222 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.6 103.79 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.75 110.034 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.73 136.05 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.706 -0.679 . . . . 1.56 110.533 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.7 mpt_? -108.63 120.62 42.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.304 -0.407 . . . . 2.94 110.046 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -88.17 141.84 28.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.154 -0.476 . . . . 3.88 110.281 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 115.768 -0.651 . . . . 4.04 110.912 176.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 111.688 -0.565 . . . . 11.74 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 -29.06 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.524 0.202 . . . . 10.54 111.467 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.26 -27.28 2.89 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.856 -0.687 . . . . 8.95 111.842 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.3 p -104.5 28.01 7.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.395 0.616 . . . . 7.09 109.894 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.45 156.54 28.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.298 -0.865 . . . . 5.59 110.367 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.45 174.26 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.167 -0.469 . . . . 2.99 110.928 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.07 -2.1 27.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.786 -0.721 . . . . 1.61 111.671 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -85.01 121.3 27.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 2.0 110.872 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.7 121.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.253 -0.647 . . . . 1.27 109.253 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -93.23 138.0 32.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.122 0.487 . . . . 1.14 109.992 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 16.9 ttp180 -108.54 137.8 45.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 2.31 109.786 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.77 -178.39 30.81 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.396 -0.682 . . . . 0.5 111.396 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -132.22 143.44 49.93 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.124 0.488 . . . . 0.68 110.867 -177.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.599 HG21 ' SD ' ' A' ' 17' ' ' MET . 46.5 mm -65.91 129.03 29.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.54 -0.755 . . . . 0.56 111.145 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.95 -45.07 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.366 -0.379 . . . . 0.76 111.264 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 72.9 t -114.78 122.79 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.487 -0.324 . . . . 1.55 111.068 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 14' ' ' ILE . 87.2 mmm -112.4 105.33 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 1.42 110.805 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 54.6 mttt -113.06 167.47 10.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.554 -0.906 . . . . 2.03 108.554 171.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -75.33 -18.98 59.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.796 -0.361 . . . . 3.24 111.849 -171.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -108.53 -47.05 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.46 . . . . 2.03 111.707 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 6.7 p90 -141.24 172.08 13.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.586 -0.279 . . . . 1.25 110.448 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.33 32.83 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.805 -0.712 . . . . 0.71 111.907 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.7 m-85 -120.8 135.05 55.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.71 -0.478 . . . . 1.08 109.71 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.5 mt -103.5 133.9 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.02 -0.536 . . . . 0.61 110.536 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -79.26 121.15 24.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.041 -1.096 . . . . 2.3 108.041 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.8 144.16 52.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.134 -0.484 . . . . 0.87 110.727 -175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 HD12 ' A' ' 83' ' ' ILE . 3.1 tp -51.68 -43.35 62.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 1.58 111.026 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -107.42 27.16 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 2.04 110.731 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.428 ' CD2' ' HD3' ' A' ' 158' ' ' ARG . 16.8 p80 45.48 36.78 2.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.13 0.972 . . . . 3.29 111.28 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.877 -1.056 . . . . 2.89 111.464 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.23 -174.58 1.75 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.856 -0.611 . . . . 1.8 110.785 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -103.09 120.74 41.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 3.37 109.438 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.4 t -104.44 125.26 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.779 0.323 . . . . 0.87 111.287 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -78.56 119.04 21.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.578 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.54 144.08 51.11 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.667 -0.697 . . . . 1.96 109.431 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 7.4 t60 -119.31 135.66 54.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.708 -0.479 . . . . 1.18 109.708 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 76.8 m-85 -74.61 -19.12 60.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.458 0.54 . . . . 0.75 112.458 -173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 t -68.81 -33.47 73.91 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.826 -0.35 . . . . 1.63 110.954 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 1.2 p-10 -103.9 33.76 3.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.693 0.759 . . . . 2.07 109.633 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 50.7 t80 -102.51 139.21 38.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.696 -1.138 . . . . 0.91 110.437 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.1 ttm -101.11 104.96 16.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 1.73 110.369 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.8 -154.32 25.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 1.05 111.541 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 99.14 41.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.849 -0.426 . . . . 2.14 109.849 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.3 -21.9 66.72 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.739 2.293 . . . . 1.01 113.494 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -87.85 -1.24 57.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.972 0.415 . . . . 2.08 111.043 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -112.7 15.68 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.297 0.57 . . . . 2.18 110.389 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.92 146.4 23.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.585 -0.734 . . . . 0.92 111.161 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -128.88 172.39 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.602 -0.726 . . . . 2.35 110.241 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.99 123.27 29.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.165 -0.471 . . . . 1.4 110.52 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.71 4.25 59.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.674 -0.774 . . . . 0.75 111.976 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -69.94 129.44 39.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.692 0.282 . . . . 1.06 111.051 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.572 ' OE1' ' HB2' ' A' ' 82' ' ' SER . 10.4 tt0 -73.11 127.51 32.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.654 -0.703 . . . . 2.51 110.501 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 77' ' ' MET . 31.4 m -139.93 153.86 23.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.166 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 78' ' ' LEU . 10.3 pt-20 -114.15 147.18 39.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.101 -0.703 . . . . 1.49 109.101 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.2 p90 -166.72 166.18 16.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.396 0.617 . . . . 0.66 112.357 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.37 166.59 13.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.259 -0.882 . . . . 0.94 110.188 176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -101.96 143.2 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.303 -0.408 . . . . 1.19 110.644 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' O ' HD22 ' A' ' 70' ' ' LEU . . . -79.76 84.3 5.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.04 110.592 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HD3' HD21 ' A' ' 70' ' ' LEU . 38.6 mmt180 -93.88 5.95 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.085 -0.507 . . . . 5.33 110.625 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -84.38 127.57 34.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 5.42 110.815 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.19 0.68 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.544 -0.836 . . . . 4.76 112.913 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -151.35 137.83 18.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 6.38 110.489 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.1 p -88.62 -26.94 21.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.173 0.511 . . . . 6.4 111.186 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.0 t -92.31 52.65 1.97 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.34 0.59 . . . . 5.23 110.396 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.28 -66.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.812 -0.631 . . . . 6.95 110.191 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 m -87.48 -7.77 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 6.02 110.797 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.95 58.31 0.36 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.759 -0.655 . . . . 4.09 112.045 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 m120 71.14 -30.23 0.2 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.725 0.81 . . . . 4.22 112.373 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.7 p -82.37 128.08 33.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.665 -0.494 . . . . 2.09 109.665 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD21 ' HD3' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -126.37 152.18 73.59 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 2.3 111.021 -177.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.2 150.1 88.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.069 2.513 . . . . 1.43 113.277 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -86.68 141.17 29.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.387 -0.824 . . . . 0.82 110.481 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 165.24 25.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.644 0.259 . . . . 2.3 111.268 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 61.93 27.26 16.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.758 -0.656 . . . . 2.01 111.339 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 t -71.56 120.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.066 -0.516 . . . . 0.8 111.076 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -129.42 161.7 29.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.316 -0.402 . . . . 3.51 110.222 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.491 ' HA ' HG12 ' A' ' 53' ' ' VAL . 60.2 mtt -80.84 143.93 32.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.12 111.473 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 54' ' ' GLU . 36.3 mt -112.61 162.53 21.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.828 -0.623 . . . . 1.67 110.196 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -67.37 149.49 80.72 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.685 2.256 . . . . 2.15 111.78 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 38.7 ttmt -79.41 152.17 30.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.247 -0.433 . . . . 4.61 110.734 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 4.9 m-20 70.66 35.19 1.91 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.934 0.494 . . . . 2.84 111.453 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.572 ' HB2' ' OE1' ' A' ' 52' ' ' GLU . 49.2 m -107.16 -9.87 16.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.807 0.337 . . . . 1.7 110.813 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD11 ' A' ' 27' ' ' LEU . 49.1 mm -76.36 136.16 68.67 Favored Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 116.52 -0.309 . . . . 0.92 110.366 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.74 157.54 61.41 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.652 2.235 . . . . 1.03 112.182 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -131.55 157.27 78.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.191 -0.459 . . . . 2.76 110.61 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 20.0 Cg_exo -62.56 138.68 71.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.535 2.157 . . . . 1.08 112.094 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.43 93.17 9.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.221 0.534 . . . . 1.1 110.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t -141.8 133.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.337 -0.986 . . . . 1.23 108.337 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.4 -62.52 1.67 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 2.87 112.621 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -94.09 -54.3 3.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 2.84 111.692 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 t 173.77 161.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.643 -0.873 . . . . 1.42 108.643 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.486 HG22 ' CD2' ' A' ' 93' ' ' HIS . 7.6 m -106.0 -59.01 1.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.724 -0.39 . . . . 1.3 110.91 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.486 ' CD2' HG22 ' A' ' 92' ' ' THR . 98.2 m-70 -145.07 155.6 43.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 1.29 110.213 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -115.37 173.2 6.64 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.969 -0.752 . . . . 1.36 108.969 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 179.57 -166.08 35.15 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.125 -1.036 . . . . 0.53 111.88 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.72 147.89 33.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.106 -0.702 . . . . 1.37 109.106 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.82 112.83 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.784 -0.45 . . . . 0.69 109.784 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 -63.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.89 111.887 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -169.8 146.63 2.77 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.559 -0.291 . . . . 3.92 111.0 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.571 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 64.0 Cg_endo -75.62 129.75 12.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.146 1.898 . . . . 2.22 111.225 172.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -72.81 86.86 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.716 . . . . 3.32 110.817 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -96.91 -61.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.733 -0.667 . . . . 5.56 111.02 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 6.0 p -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 4.14 111.958 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.98 -22.61 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.145 0.498 . . . . 3.46 110.932 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.51 ' HB3' ' H ' ' A' ' 109' ' ' GLN . 62.5 t30 -118.72 120.98 31.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.408 -0.59 . . . . 4.99 109.408 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.96 -10.51 25.67 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.318 2.012 . . . . 4.27 111.885 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.09 5.27 27.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 3.94 110.458 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 66.75 82.56 0.18 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.595 0.712 . . . . 5.6 112.33 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.51 ' H ' ' HB3' ' A' ' 105' ' ' ASN . 6.9 tt0 -88.4 6.11 39.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.48 -0.782 . . . . 5.3 111.354 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.663 ' HA ' HD12 ' A' ' 101' ' ' LEU . 9.9 pt-20 -43.63 -24.91 0.14 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.333 1.605 . . . . 4.95 115.333 -164.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -38.41 7.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.853 0.461 . . . . 3.19 112.026 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.535 ' HB3' HD11 ' A' ' 101' ' ' LEU . . . -78.57 -27.93 45.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.175 0.435 . . . . 1.24 112.175 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 100' ' ' PRO . . . 58.04 173.39 0.37 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 114.584 0.594 . . . . 0.94 114.584 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 130' ' ' GLU . 74.2 mt -143.87 136.33 26.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.473 0.654 . . . . 0.93 111.257 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.3 mt -103.35 138.86 26.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.935 -1.03 . . . . 0.49 109.5 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.4 pt-20 -86.78 125.23 33.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.396 0.617 . . . . 1.4 109.611 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.748 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 11.6 mm -102.07 126.33 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.498 -0.774 . . . . 0.63 109.048 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.8 pt? -87.07 152.52 22.29 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 1.21 110.745 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.67 173.75 9.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.614 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -66.91 -23.26 65.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 2.78 111.09 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -86.8 -3.23 59.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.736 -0.468 . . . . 1.77 109.736 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 66.43 35.98 5.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.322 -0.854 . . . . 4.14 111.051 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m -81.24 -68.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.746 -0.661 . . . . 1.87 111.567 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 p -155.28 -174.36 4.94 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.995 0.368 . . . . 1.54 111.995 -173.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 4.6 p -67.12 133.2 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.688 -0.687 . . . . 1.29 111.211 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.21 -69.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.476 -0.329 . . . . 1.03 110.653 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 m -136.51 -84.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.81 -0.356 . . . . 1.56 111.758 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.448 ' HB2' HD22 ' A' ' 114' ' ' LEU . 11.4 pt20 -174.67 138.24 0.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.842 -0.617 . . . . 2.08 110.144 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.519 ' HB2' HD11 ' A' ' 117' ' ' ILE . 21.6 m170 -122.6 123.18 40.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.792 0.329 . . . . 0.68 110.359 170.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.0 tt0 -84.22 145.68 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.552 -0.749 . . . . 1.19 109.24 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.515 ' CD1' HD21 ' A' ' 136' ' ' LEU . 32.4 p90 -117.66 139.96 50.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.449 0.642 . . . . 0.74 111.824 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.88 154.37 20.87 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 114.999 -1.0 . . . . 0.51 112.383 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.22 -32.56 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 0.67 111.564 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.4 p -74.68 -35.8 62.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.2 0.524 . . . . 1.35 110.705 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 36.9 m -62.82 -32.7 73.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.236 -0.893 . . . . 1.1 110.532 175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 131' ' ' PHE . 72.7 mt -75.42 58.92 1.03 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 1.46 112.031 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.0 t -46.3 -43.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.357 0.599 . . . . 0.82 110.318 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 46.2 m-80 -95.87 34.66 1.49 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.3 -0.863 . . . . 2.17 111.508 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -56.65 -21.21 25.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.145 0.498 . . . . 1.39 111.615 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -70.91 -23.1 62.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 2.46 111.414 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.27 164.03 14.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.681 0.623 . . . . 1.89 112.681 -166.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -79.51 34.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.014 -0.994 . . . . 2.88 111.2 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.7 tp -56.16 105.43 0.19 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.796 -0.638 . . . . 0.97 111.021 -175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -121.66 -178.03 3.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.755 -0.657 . . . . 1.77 110.811 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -62.99 136.48 57.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.323 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.3 70.72 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.545 -0.836 . . . . 1.07 112.926 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -92.11 142.28 27.68 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.215 0.508 . . . . 1.94 109.859 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 148' ' ' LEU . 3.2 mm? -83.95 138.51 33.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.194 0.521 . . . . 1.79 111.146 -172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.77 153.35 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.366 0.603 . . . . 1.16 111.912 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 73.2 m -129.57 138.01 51.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.221 -0.9 . . . . 1.44 109.332 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.748 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 38.8 p90 -149.0 174.15 12.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.645 -0.502 . . . . 0.61 109.645 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -130.38 120.46 24.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.397 0.618 . . . . 2.2 110.205 173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.55 130.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.823 -0.626 . . . . 1.24 110.354 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 18.8 t70 -155.87 -100.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.954 -0.298 . . . . 1.92 110.718 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.468 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 42.2 mt-10 -83.9 -7.59 59.39 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.08 0.4 . . . . 2.76 112.08 -175.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -12.08 49.24 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.749 -0.464 . . . . 1.98 109.749 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.09 24.21 49.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.127 -0.942 . . . . 1.27 114.308 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.428 ' HD3' ' CD2' ' A' ' 29' ' ' HIS . 15.1 ptt-85 -158.08 -177.94 6.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.829 -0.804 . . . . 3.61 108.829 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.14 108.65 16.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.367 -0.533 . . . . 0.48 110.698 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -119.12 159.49 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.541 -0.754 . . . . 0.49 110.442 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 39.7 t 63.07 38.08 11.09 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.673 0.608 . . . . 1.55 110.091 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.99 111.54 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.476 -0.784 . . . . 1.26 110.657 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.476 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 8.3 t30 -120.52 128.91 53.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.315 -0.402 . . . . 2.05 110.394 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -68.96 117.13 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 0.75 110.282 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.69 130.55 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.844 -0.617 . . . . 1.56 111.66 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -107.17 133.55 51.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 2.94 110.127 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -105.47 131.02 53.41 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.965 -0.561 . . . . 3.88 110.592 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 116.093 -0.503 . . . . 4.04 110.295 174.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 111.995 -0.442 . . . . 11.74 111.995 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.7 -27.71 69.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.431 . . . . 10.54 111.356 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.22 26.09 10.06 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.835 -0.621 . . . . 8.95 111.602 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -109.31 15.77 22.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.803 0.335 . . . . 7.09 110.468 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.8 129.04 34.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.868 0.366 . . . . 5.59 110.361 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.08 9.08 30.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.007 -0.542 . . . . 2.99 110.949 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.03 -29.03 4.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 1.61 112.537 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -105.57 113.35 26.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.426 0.632 . . . . 2.0 111.374 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -92.55 116.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.956 -1.02 . . . . 1.27 109.073 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -87.63 138.61 31.32 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.931 -0.577 . . . . 1.14 110.004 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 22.7 ttm180 -113.55 141.04 47.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.71 -0.677 . . . . 2.31 110.04 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.08 -171.12 36.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.006 -0.838 . . . . 0.5 111.006 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.61 141.95 33.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.184 0.516 . . . . 0.68 111.141 -176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.34 119.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.296 -0.865 . . . . 0.56 110.823 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.38 -41.73 6.91 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.967 -0.293 . . . . 0.76 111.172 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -121.97 150.76 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.536 -0.542 . . . . 1.55 109.536 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.9 ttm -137.17 106.7 6.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.099 0.476 . . . . 1.42 110.391 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.7 mmtt -100.71 172.37 7.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.865 -0.791 . . . . 2.03 108.865 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.62 -22.1 61.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.692 0.282 . . . . 3.24 111.668 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -111.14 -41.93 4.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.72 0.295 . . . . 2.03 111.701 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -145.12 176.71 9.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.617 -0.265 . . . . 1.25 110.487 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 -179.97 25.82 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.497 -0.859 . . . . 0.71 112.059 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' H ' HG22 ' A' ' 16' ' ' VAL . 54.3 m-85 -127.11 151.74 48.24 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.525 -0.546 . . . . 1.08 109.525 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -125.57 115.34 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.17 -0.468 . . . . 0.61 111.058 -171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.34 126.47 29.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.288 -1.004 . . . . 2.3 108.288 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 164.57 25.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.229 0.537 . . . . 0.87 111.401 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD2' HD12 ' A' ' 83' ' ' ILE . 1.8 tm? -60.58 -48.43 81.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.532 -0.758 . . . . 1.58 111.724 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -98.69 13.65 31.4 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.087 -0.338 . . . . 2.04 110.087 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 55.85 50.27 14.4 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.429 -0.952 . . . . 3.29 108.429 -168.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.14 -48.55 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.993 -1.458 . . . . 2.89 110.275 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -173.26 179.38 2.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.805 -0.634 . . . . 1.8 110.704 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' CD ' ' HB3' ' A' ' 23' ' ' PHE . 10.0 tp10 -103.2 139.53 38.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.781 -0.452 . . . . 3.37 109.781 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.53 132.24 64.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.051 0.453 . . . . 0.87 111.224 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -87.19 118.39 26.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.426 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -120.01 151.3 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 1.96 108.918 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -115.84 133.0 56.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.476 -0.564 . . . . 1.18 109.476 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -62.47 -22.62 66.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.058 0.762 . . . . 0.75 113.058 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -61.29 -35.84 78.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.779 0.323 . . . . 1.63 111.076 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -96.09 22.54 7.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.259 0.552 . . . . 2.07 110.842 -176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' OH ' ' HG2' ' A' ' 77' ' ' MET . 39.6 t80 -91.51 136.6 33.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.212 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.33 97.74 7.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.002 0.429 . . . . 1.73 110.142 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.19 -139.63 7.46 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.143 -0.783 . . . . 1.05 111.143 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 46' ' ' TRP . 1.5 p30 -124.73 91.46 49.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 121.515 0.674 . . . . 2.14 110.703 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.93 -21.04 33.26 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.003 2.468 . . . . 1.01 113.841 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.41 -11.66 59.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.371 0.605 . . . . 2.08 110.154 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 84.3 m95 -106.45 20.31 19.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 2.18 110.248 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 29.3 mt -85.14 -179.6 7.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.794 -0.639 . . . . 0.92 111.508 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -151.22 161.17 43.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.386 -0.825 . . . . 2.35 110.126 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.51 113.99 18.08 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.98 -0.748 . . . . 1.4 108.98 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.25 5.05 35.13 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.872 -0.604 . . . . 0.75 112.019 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.34 131.13 40.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.91 0.386 . . . . 1.06 111.315 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' CD ' HG12 ' A' ' 83' ' ' ILE . 40.2 mt-10 -78.27 128.26 33.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.227 -0.897 . . . . 2.51 111.279 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.89 161.33 18.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.444 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 78' ' ' LEU . 7.1 pt-20 -125.42 148.28 48.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.795 -0.446 . . . . 1.49 109.795 176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.548 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 11.9 p90 -163.99 175.17 10.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.66 112.142 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 p -130.14 170.72 13.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.44 -0.8 . . . . 0.94 110.112 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.86 138.75 45.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.78 0.324 . . . . 1.19 111.145 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 70' ' ' LEU . . . -89.08 85.19 6.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.863 -0.608 . . . . 2.04 110.124 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.54 HH11 HD11 ' A' ' 70' ' ' LEU . 9.8 tpt180 -126.63 6.82 6.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.393 0.616 . . . . 5.33 109.638 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -77.01 114.45 15.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.687 -0.688 . . . . 5.42 110.415 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.74 170.06 13.49 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.842 -0.617 . . . . 4.76 111.679 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -99.58 26.75 5.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.684 0.754 . . . . 6.38 109.744 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -80.1 -14.84 58.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 6.4 110.704 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -81.31 42.84 0.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.91 -0.586 . . . . 5.23 111.265 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.15 -64.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.022 0.439 . . . . 6.95 110.183 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -100.52 2.41 41.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 6.02 109.361 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.74 72.59 2.8 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.269 -0.878 . . . . 4.09 111.945 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -60.12 -49.73 76.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.254 0.549 . . . . 4.22 109.543 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.8 m -117.9 131.1 56.57 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.53 -0.759 . . . . 2.09 109.267 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.54 HD11 HH11 ' A' ' 59' ' ' ARG . 0.5 OUTLIER -121.61 153.73 59.65 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.022 -0.733 . . . . 2.3 109.022 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.74 150.35 88.29 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.312 2.008 . . . . 1.43 112.223 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -88.63 137.01 32.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.67 -0.696 . . . . 0.82 111.035 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -112.41 165.74 11.94 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.845 -0.616 . . . . 2.3 110.334 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 63.18 29.67 16.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.818 -0.628 . . . . 2.01 111.477 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 9.6 t -74.19 108.25 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.8 110.237 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -112.31 167.82 10.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.87 0.367 . . . . 3.51 110.339 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.574 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 84.8 mtp -98.58 136.04 39.25 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.944 -0.571 . . . . 1.12 111.195 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 54' ' ' GLU . 46.0 mt -107.9 154.89 40.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 1.67 110.556 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.08 140.93 35.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.263 1.975 . . . . 2.15 110.372 169.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.32 164.68 13.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.734 0.302 . . . . 4.61 111.034 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.09 25.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.172 -0.922 . . . . 2.84 109.999 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -95.59 -14.86 23.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.398 -0.819 . . . . 1.7 109.122 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.623 HD12 ' CD2' ' A' ' 27' ' ' LEU . 8.7 mm -92.01 128.99 43.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.441 -0.8 . . . . 0.92 109.783 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.07 154.48 47.33 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.348 2.032 . . . . 1.03 112.14 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.44 152.15 74.35 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.556 -0.293 . . . . 2.76 110.465 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 18.0 Cg_endo -61.23 125.94 18.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 1.08 112.202 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.14 92.97 7.06 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.999 0.428 . . . . 1.1 111.17 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 26.0 t -142.43 107.33 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 1.23 109.713 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.85 -25.92 27.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.735 -0.386 . . . . 2.87 111.737 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' THR . 69.8 tt0 -73.42 -18.19 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.609 -0.269 . . . . 2.84 110.953 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 41.5 m 81.04 122.72 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.634 -0.712 . . . . 1.42 110.54 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -80.86 -57.64 3.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.3 112.337 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -141.35 174.73 10.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.232 0.539 . . . . 1.29 111.36 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -141.81 176.83 8.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.132 -0.94 . . . . 1.36 109.273 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.09 179.45 39.57 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 110.464 -1.055 . . . . 0.53 110.464 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 147' ' ' ASP . 3.3 m -103.89 159.5 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 117.852 0.826 . . . . 1.37 110.161 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.37 121.57 19.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.196 -0.668 . . . . 0.69 109.196 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -66.86 -53.47 32.08 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 123.3 0.375 . . . . 0.89 110.731 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -175.71 146.89 0.88 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 3.92 110.551 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.42 121.46 6.05 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.426 1.418 . . . . 2.22 110.146 167.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.692 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -82.81 97.86 8.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.096 0.95 . . . . 3.32 110.724 -177.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -97.68 -66.46 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.7 -0.682 . . . . 5.56 111.251 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 9.2 p -95.2 -10.19 31.16 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.519 0.563 . . . . 4.14 112.519 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 104' ' ' ILE . 4.9 mp -77.36 -45.47 29.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.797 0.666 . . . . 3.46 112.797 -166.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -164.08 91.94 1.06 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 121.072 0.463 . . . . 4.99 111.636 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.46 -40.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.792 2.328 . . . . 4.27 113.411 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.4 28.89 2.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 3.94 112.171 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.517 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 44.2 tp60 -122.91 150.65 42.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.459 -0.571 . . . . 5.6 109.459 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 111' ' ' TYR . 28.8 tp60 -51.41 -30.73 20.29 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.012 0.525 . . . . 5.3 112.077 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.517 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 50.7 mt-10 -73.38 14.5 0.33 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.914 0.388 . . . . 4.95 111.2 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HA ' HD21 ' A' ' 101' ' ' LEU . 15.1 t80 -66.03 -25.69 67.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.283 0.563 . . . . 3.19 110.82 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -65.1 -21.89 66.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.965 -0.561 . . . . 1.24 111.247 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.78 166.66 25.23 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.439 -0.665 . . . . 0.94 111.439 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 130' ' ' GLU . 66.8 mt -142.71 138.13 30.34 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.93 111.842 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.89 138.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.654 -1.157 . . . . 0.49 108.746 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.77 124.26 31.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.936 -0.765 . . . . 1.4 108.936 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.736 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.6 mm -101.36 120.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.494 -0.928 . . . . 0.63 108.494 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.0 pt? -83.33 144.25 29.81 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.294 -0.562 . . . . 1.21 110.157 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.07 151.49 12.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 2.29 109.583 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -61.72 -21.66 64.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 2.78 111.912 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.03 10.26 36.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.692 0.282 . . . . 1.77 110.374 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 67.52 30.39 6.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.613 -0.721 . . . . 4.14 111.512 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -70.32 -80.37 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.463 -0.335 . . . . 1.87 111.167 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -149.23 -176.45 5.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.687 -0.233 . . . . 1.54 110.643 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -65.25 134.51 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 123.542 0.526 . . . . 1.29 110.234 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -72.71 -67.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.442 -0.344 . . . . 1.03 110.432 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.9 m -137.6 -84.3 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.159 0.504 . . . . 1.56 110.645 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -176.6 139.84 0.33 Allowed 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.249 -0.887 . . . . 2.08 108.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.736 ' HB2' HD11 ' A' ' 117' ' ' ILE . 33.6 m170 -117.48 131.59 56.7 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.125 -0.63 . . . . 0.68 110.089 172.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.8 tt0 -89.57 139.49 30.49 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.763 -1.108 . . . . 1.19 109.402 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 46.1 p90 -118.67 134.87 54.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 0.74 110.961 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.11 153.94 24.01 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.326 -0.852 . . . . 0.51 112.57 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.2 -27.72 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.01 0.433 . . . . 0.67 110.807 173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 31.8 p -74.86 -36.48 62.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.317 0.58 . . . . 1.35 110.443 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 162' ' ' VAL . 23.9 m -65.66 -30.2 70.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.353 -0.84 . . . . 1.1 110.87 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.4 mt -71.49 58.54 0.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.812 0.695 . . . . 1.46 112.67 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -45.59 -42.28 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.408 0.623 . . . . 0.82 111.045 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.48 34.01 2.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.75 -0.659 . . . . 2.17 111.014 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 16.3 ptpt -54.53 -21.08 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.01 0.524 . . . . 1.39 112.357 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -86.39 -11.95 50.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 2.46 112.12 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -75.56 166.66 23.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 1.89 110.687 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.7 pt? -86.96 24.49 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.458 -0.337 . . . . 2.88 110.492 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 164' ' ' ALA . 15.8 tp -44.92 117.39 1.32 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.22 -0.9 . . . . 0.97 111.536 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -118.86 -172.97 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 1.77 111.238 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 72.4 tttt -67.53 140.22 57.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.908 -0.587 . . . . 1.43 110.139 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.06 86.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.423 -0.894 . . . . 1.07 112.439 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 7.9 m-20 -82.73 132.37 35.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.559 0.219 . . . . 1.94 110.741 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.54 135.11 42.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.993 -0.549 . . . . 1.79 110.828 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.36 151.45 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 1.16 111.187 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 44.0 p -109.03 136.01 49.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.811 -0.811 . . . . 1.44 108.811 172.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.689 ' HB3' HG12 ' A' ' 162' ' ' VAL . 36.1 p90 -154.24 169.3 23.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.852 0.358 . . . . 0.61 110.327 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 3.7 mpt_? -131.77 123.2 27.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.4 -0.52 . . . . 2.2 110.63 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.428 HD13 ' CE1' ' A' ' 129' ' ' HIS . 8.5 pt -100.14 146.77 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.736 -0.839 . . . . 1.24 108.736 166.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 23.7 t70 -175.1 -87.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 121.366 -0.134 . . . . 1.92 110.969 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -70.25 -41.5 73.42 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 2.76 111.503 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 158' ' ' ARG . 42.3 t -84.9 -17.98 36.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.174 -0.466 . . . . 1.98 111.099 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 74.63 -25.36 1.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.79 -0.719 . . . . 1.27 112.797 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 156' ' ' SER . 67.2 mtt85 -93.02 175.68 6.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.317 0.247 . . . . 3.61 110.388 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.34 110.39 19.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.033 0.444 . . . . 0.48 110.219 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -123.25 160.2 27.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.722 -0.672 . . . . 0.49 110.84 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.6 m 59.93 42.84 15.61 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.944 0.778 . . . . 1.55 110.692 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.7 m -70.96 138.35 21.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.565 0.698 . . . . 1.26 110.892 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.04 123.71 22.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.328 -0.851 . . . . 2.05 109.74 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -59.25 125.73 24.82 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 123.372 0.42 . . . . 0.75 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.66 122.7 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.868 -0.606 . . . . 1.56 110.651 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 147' ' ' ASP . 1.6 mpt_? -110.6 118.49 36.36 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.188 -0.671 . . . . 2.94 109.188 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -102.06 160.68 14.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.486 0.66 . . . . 3.88 111.106 -172.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 114.922 -1.035 . . . . 4.04 110.355 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 112.237 -0.345 . . . . 11.74 112.237 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.39 107.39 19.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.602 0.239 . . . . 10.54 110.828 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.01 46.95 0.94 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.604 -0.808 . . . . 8.95 112.666 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 p -79.03 95.24 5.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.064 0.459 . . . . 7.09 111.005 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.64 123.87 42.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.446 . . . . 5.59 110.358 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.38 -29.44 47.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.898 -0.592 . . . . 2.99 111.142 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.56 -29.71 3.23 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.905 -0.588 . . . . 1.61 112.548 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -124.99 123.44 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.932 0.396 . . . . 2.0 111.039 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.19 119.9 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.19 0.519 . . . . 1.14 109.798 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -112.39 138.71 48.73 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.482 -0.781 . . . . 2.31 110.187 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.42 -163.29 13.5 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.443 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -152.06 156.86 40.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.062 0.458 . . . . 0.68 110.69 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.32 119.26 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.711 -0.677 . . . . 0.56 111.218 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.88 -38.16 5.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.49 -0.323 . . . . 0.76 111.34 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.1 p -134.75 131.71 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.85 0.357 . . . . 1.55 110.739 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.2 mtp -123.06 129.91 52.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 1.42 110.449 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 -173.46 2.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.131 -1.063 . . . . 2.03 108.131 171.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -87.54 -15.75 36.58 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.346 -0.542 . . . . 3.24 110.645 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -111.52 -47.13 3.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.429 0.529 . . . . 2.03 112.429 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -142.33 -175.42 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.127 0.489 . . . . 1.25 111.445 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.04 36.98 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.324 -0.71 . . . . 0.71 111.324 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' H ' HG13 ' A' ' 16' ' ' VAL . 79.4 m-85 -124.16 138.62 54.4 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.578 -0.527 . . . . 1.08 109.578 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -99.79 123.2 52.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.163 -0.471 . . . . 0.61 110.72 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.443 ' OE1' ' HE1' ' A' ' 13' ' ' PHE . 31.0 tt0 -76.15 118.92 19.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.056 -1.09 . . . . 2.3 108.056 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.18 160.27 31.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.391 -0.368 . . . . 0.87 111.501 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.497 ' CD1' HD12 ' A' ' 83' ' ' ILE . 9.1 tp -56.02 -48.57 75.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 1.58 111.616 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -118.56 40.68 3.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 2.04 109.789 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.8 p80 45.73 33.88 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.076 0.86 . . . . 3.29 111.032 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -52.63 -47.3 67.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.744 -1.116 . . . . 2.89 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -169.26 173.53 6.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 1.8 110.185 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -104.81 121.03 42.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 3.37 109.166 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -113.39 130.7 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.095 0.474 . . . . 0.87 111.69 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -89.02 120.23 30.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.404 -0.816 . . . . 1.06 110.14 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -121.08 147.33 45.68 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.122 -0.696 . . . . 1.96 109.122 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.409 ' HB3' HD22 ' A' ' 39' ' ' ASN . 4.3 t60 -109.03 133.16 53.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.572 -0.899 . . . . 1.18 108.572 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -57.67 -23.38 51.13 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.443 0.535 . . . . 0.75 112.443 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -68.97 -15.66 63.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.869 0.366 . . . . 1.63 111.929 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 36' ' ' HIS . 49.0 m-80 -104.44 8.15 35.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.479 0.657 . . . . 2.07 109.788 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 75.7 t80 -93.02 126.7 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.355 -0.839 . . . . 0.91 110.064 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.4 ttm -96.68 101.87 13.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.357 -0.383 . . . . 1.73 110.294 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.02 -150.95 23.23 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.102 -0.57 . . . . 1.05 111.697 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -105.73 105.34 52.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.778 -0.453 . . . . 2.14 109.778 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.04 -25.88 3.2 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.805 2.337 . . . . 1.01 113.702 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -69.77 -24.74 63.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.623 0.725 . . . . 2.08 109.523 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -98.71 20.68 12.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.358 -0.837 . . . . 2.18 111.132 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.51 149.29 25.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.92 110.515 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.55 158.11 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 2.35 109.761 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.67 120.07 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.947 0.403 . . . . 1.4 110.274 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.07 -11.87 26.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.98 -0.629 . . . . 0.75 112.422 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -65.33 120.6 13.08 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.961 0.41 . . . . 1.06 111.409 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 5.0 mp0 -64.62 129.05 38.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.259 -0.882 . . . . 2.51 111.146 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 77' ' ' MET . 26.8 m -140.85 149.97 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.654 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -124.33 150.27 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.926 -0.398 . . . . 1.49 109.926 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 3.2 p90 -163.91 179.67 6.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.927 0.394 . . . . 0.66 111.308 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 p -128.45 166.93 17.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.091 -0.504 . . . . 0.94 110.742 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.06 147.4 30.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.359 -0.382 . . . . 1.19 110.97 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.61 31.13 0.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.397 0.618 . . . . 2.04 110.681 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.61 36.15 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.712 -0.676 . . . . 5.33 110.823 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.36 99.37 12.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.357 0.503 . . . . 5.42 112.357 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.8 37.27 92.22 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.887 -0.597 . . . . 4.76 113.241 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -110.45 153.7 24.65 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.664 -0.495 . . . . 6.38 109.664 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -66.79 -23.2 66.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.103 0.478 . . . . 6.4 111.298 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 m -81.08 50.47 1.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.22 0.533 . . . . 5.23 109.965 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.01 -35.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 6.95 111.033 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.4 m -73.09 -29.83 63.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.995 0.426 . . . . 6.02 110.467 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -171.52 -137.18 2.26 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.921 -0.872 . . . . 4.09 110.921 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.61 79.88 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 0.689 . . . . 4.22 110.826 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.9 p -45.55 132.15 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.092 -0.958 . . . . 2.09 112.103 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.4 pp -122.91 154.43 64.22 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.418 -0.81 . . . . 2.3 109.438 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.08 146.6 87.51 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.039 1.826 . . . . 1.43 112.274 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 144.64 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.792 -0.64 . . . . 0.82 110.179 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.02 163.73 18.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.721 0.296 . . . . 2.3 110.837 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.8 57.38 2.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.601 -0.727 . . . . 2.01 110.551 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 21.8 t -93.01 122.59 44.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.8 109.877 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -124.39 147.74 48.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.31 -0.404 . . . . 3.51 110.106 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.446 ' HA ' HG12 ' A' ' 53' ' ' VAL . 48.9 mtt -70.92 154.12 42.09 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.866 0.365 . . . . 1.12 110.4 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 79' ' ' PRO . 17.3 tp -125.61 144.13 47.1 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.009 -0.541 . . . . 1.67 110.023 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 78' ' ' LEU . 25.3 Cg_endo -61.65 142.9 95.94 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.265 1.977 . . . . 2.15 111.961 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 4.2 ttmp? -62.94 156.67 23.77 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.825 -0.625 . . . . 4.61 111.856 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m120 73.74 24.02 2.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.45 -0.796 . . . . 2.84 111.721 174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -96.96 8.5 44.32 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.04 -0.527 . . . . 1.7 110.181 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.497 HD12 ' CD1' ' A' ' 27' ' ' LEU . 18.4 mm -108.75 133.06 20.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.636 -0.505 . . . . 0.92 109.636 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.89 149.84 66.59 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.593 2.195 . . . . 1.03 112.621 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -135.99 145.99 54.83 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.073 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 160' ' ' ALA . 76.3 Cg_exo -52.31 132.53 44.63 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.592 2.861 . . . . 1.08 113.49 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.03 94.66 8.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.1 110.863 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.29 150.63 27.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.739 -0.838 . . . . 1.23 108.739 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.94 -64.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.076 -0.65 . . . . 2.87 111.37 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 91' ' ' THR . 30.8 tt0 -95.06 -58.63 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.302 -0.559 . . . . 2.84 111.027 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER 175.62 173.96 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.169 -0.923 . . . . 1.42 109.254 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -105.46 -58.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.851 0.358 . . . . 1.3 110.73 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.31 178.45 6.87 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.023 -0.535 . . . . 1.29 110.815 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.96 -177.91 4.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.038 -0.528 . . . . 1.36 110.476 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.44 -163.32 29.17 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.085 -0.579 . . . . 0.53 111.867 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -130.47 146.36 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.667 -0.494 . . . . 1.37 109.667 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.28 121.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.69 110.301 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' O ' ' HE3' ' A' ' 145' ' ' LYS . . . -73.04 -60.18 2.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.572 0.582 . . . . 0.89 112.572 -172.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -164.56 158.15 15.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.495 -0.482 . . . . 3.92 111.647 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.36 170.42 10.6 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.701 2.268 . . . . 2.22 112.028 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 101' ' ' LEU . 1.5 mm? -90.7 89.8 7.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.599 -0.273 . . . . 3.32 110.495 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -98.41 -65.23 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 5.56 111.434 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 4.4 p -92.89 3.35 55.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.678 -0.692 . . . . 4.14 111.277 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.78 HG23 ' HG3' ' A' ' 110' ' ' GLU . 1.4 mp -67.0 -34.12 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 3.46 111.788 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.587 HD21 ' HB3' ' A' ' 107' ' ' ASP . 9.8 t30 72.87 115.63 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.781 0.676 . . . . 4.99 110.707 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.53 1.99 3.8 Favored 'Trans proline' 0 N--CA 1.476 0.494 0 C-N-CA 123.458 2.772 . . . . 4.27 113.806 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.587 ' HB3' HD21 ' A' ' 105' ' ' ASN . 1.2 t70 -105.57 28.69 7.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.511 0.672 . . . . 3.94 109.388 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -144.24 142.33 30.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 5.6 109.859 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.09 -26.02 10.1 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.582 0.956 . . . . 5.3 113.582 -172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.78 ' HG3' HG23 ' A' ' 104' ' ' ILE . 12.9 pt-20 -74.44 2.97 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 4.95 110.801 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.476 ' OH ' ' HB ' ' A' ' 16' ' ' VAL . 8.7 t80 -61.39 -24.39 66.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.546 -0.752 . . . . 3.19 111.838 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -27.7 69.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.178 0.436 . . . . 1.24 112.178 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.83 162.87 30.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.515 -0.85 . . . . 0.94 111.66 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 130' ' ' GLU . 82.6 mt -144.45 147.08 32.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.54 0.686 . . . . 0.93 112.287 -172.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.6 mt -112.48 137.8 43.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.514 -1.221 . . . . 0.49 109.513 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -89.89 120.72 31.37 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.458 0.647 . . . . 1.4 110.116 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.575 HD12 ' HZ ' ' A' ' 151' ' ' PHE . 34.9 mm -97.8 129.53 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.41 -0.814 . . . . 0.63 109.582 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -87.35 156.71 19.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.535 -0.302 . . . . 1.21 110.311 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.05 167.57 9.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.392 -0.596 . . . . 2.29 109.392 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.3 pm0 -69.71 -17.07 63.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.042 0.449 . . . . 2.78 110.563 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -99.6 -2.42 35.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 1.77 109.821 177.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 54.22 80.66 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.505 -0.77 . . . . 4.14 110.731 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.61 -47.37 1.84 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.323 -0.398 . . . . 1.87 111.142 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 -177.75 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 1.54 111.021 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.31 130.68 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.543 -0.91 . . . . 1.29 108.543 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.8 mt -68.61 -69.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.6 -0.44 . . . . 1.03 110.869 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -138.75 -85.23 0.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.498 0.666 . . . . 1.56 111.034 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -175.96 137.64 0.33 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.777 -1.101 . . . . 2.08 108.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.524 ' CD2' HG13 ' A' ' 117' ' ' ILE . 19.1 m170 -113.19 132.75 55.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.163 -0.615 . . . . 0.68 110.664 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.502 ' HA ' HD23 ' A' ' 114' ' ' LEU . 5.7 tt0 -92.54 140.46 29.53 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.626 -1.17 . . . . 1.19 109.42 -175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.464 ' CD1' HD21 ' A' ' 136' ' ' LEU . 40.7 p90 -118.51 141.41 48.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.74 111.021 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.09 152.93 20.18 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.468 -0.787 . . . . 0.51 112.209 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.73 -30.15 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.212 0.506 . . . . 0.67 111.001 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -78.07 -23.61 47.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.485 0.659 . . . . 1.35 110.542 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.516 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 62.9 m -78.74 -27.6 44.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.101 -0.954 . . . . 1.1 110.464 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 131' ' ' PHE . 69.4 mt -75.33 60.11 1.1 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.349 -0.841 . . . . 1.46 112.017 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.5 t -44.24 -45.59 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.931 0.396 . . . . 0.82 111.522 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.538 HD21 HD22 ' A' ' 143' ' ' LEU . 2.9 p-10 -92.27 33.9 1.06 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.753 0.311 . . . . 2.17 111.231 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -53.0 -22.56 5.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.467 0.707 . . . . 1.39 112.674 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -79.71 -19.04 49.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.364 -0.38 . . . . 2.46 111.26 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 162.86 27.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.625 0.726 . . . . 1.89 112.465 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -81.86 35.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.788 -1.096 . . . . 2.88 110.47 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 138' ' ' ASN . 24.4 tp -63.72 127.09 29.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.97 110.692 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.61 -173.55 3.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 1.77 110.95 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 98' ' ' ALA . 83.8 tttt -66.18 138.53 57.76 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 1.43 109.9 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.19 66.99 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.738 -0.744 . . . . 1.07 112.626 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -90.62 140.36 29.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 1.94 110.728 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.03 140.91 33.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.709 -0.678 . . . . 1.79 110.742 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.15 143.91 38.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.508 . . . . 1.16 112.009 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.0 p -115.84 125.87 53.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 1.44 109.389 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HZ ' HD12 ' A' ' 117' ' ' ILE . 51.6 p90 -145.12 168.57 20.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.619 0.247 . . . . 0.61 110.404 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 121.35 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.34 -0.944 . . . . 2.2 110.469 172.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.5 130.46 52.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 1.24 110.324 174.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 22.7 t70 -149.0 -89.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.536 . . . . 1.92 111.862 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -33.52 40.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.379 0.511 . . . . 2.76 112.379 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.2 p -84.12 -17.15 41.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.477 -0.329 . . . . 1.98 111.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.67 23.15 70.46 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.728 -0.749 . . . . 1.27 113.065 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -126.43 173.53 9.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.679 -0.489 . . . . 3.61 109.679 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.86 18.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.269 -0.641 . . . . 0.48 109.269 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.44 158.18 38.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.196 -0.457 . . . . 0.49 110.438 -175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 45.6 m 55.4 30.72 15.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.512 0.673 . . . . 1.55 109.304 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.4 126.73 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.135 -0.939 . . . . 1.26 110.932 -173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.495 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 5.8 t30 -125.34 132.27 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.231 -0.895 . . . . 2.05 110.296 -176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.42 126.76 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.75 110.389 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.05 119.63 24.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.068 0.461 . . . . 1.56 111.617 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -90.82 156.6 17.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 2.94 110.691 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -80.88 134.05 35.68 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.051 -0.522 . . . . 3.88 110.176 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.503 -0.771 . . . . 4.04 110.919 -179.49 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.15 -0.38 . . . . 11.74 112.15 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.38 131.66 54.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.983 0.421 . . . . 10.54 110.687 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.15 90.83 2.07 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.617 -0.801 . . . . 8.95 111.764 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.9 m -148.82 117.55 6.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.972 0.415 . . . . 7.09 111.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -113.94 18.35 17.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.872 0.844 . . . . 5.59 109.242 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.55 -178.19 4.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.348 -1.297 . . . . 2.99 109.606 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.71 23.48 53.02 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.33 -0.938 . . . . 1.61 111.033 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 10' ' ' TYR . 15.7 mm100 -61.25 119.74 9.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.063 -0.568 . . . . 2.0 111.455 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.28 115.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.586 -0.734 . . . . 1.27 109.501 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 8' ' ' GLN . 49.5 m-85 -98.69 150.64 21.58 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.255 -0.884 . . . . 1.14 109.662 -176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' C ' HD23 ' A' ' 27' ' ' LEU . 35.2 ttm-85 -108.26 149.41 28.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.813 -0.63 . . . . 2.31 109.994 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.93 170.95 42.25 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 111.143 -0.783 . . . . 0.5 111.143 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.973 0.416 . . . . 0.68 111.312 -174.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.38 118.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.754 -0.657 . . . . 0.56 110.721 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.58 -43.13 3.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.938 0.399 . . . . 0.76 110.779 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.03 123.59 70.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 1.55 111.039 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.1 mtp -119.19 110.09 16.63 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.566 . . . . 1.42 109.473 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 69.6 mmtt -97.66 -167.92 1.6 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.447 -0.575 . . . . 2.03 109.447 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.93 -26.98 30.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.486 -0.324 . . . . 3.24 111.108 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.65 -44.4 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 2.03 111.227 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.2 p90 -137.95 -170.44 2.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.088 -0.505 . . . . 1.25 110.657 -174.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.66 174.96 34.36 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 0.71 112.234 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -122.82 139.36 54.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.881 -0.415 . . . . 1.08 109.881 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.1 mt -108.78 131.71 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.781 -0.645 . . . . 0.61 110.438 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.86 107.15 8.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.126 -1.065 . . . . 2.3 108.126 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -62.57 149.56 42.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.533 -0.303 . . . . 0.87 110.657 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -51.45 -48.25 62.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 1.58 111.303 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 m -84.4 3.76 34.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 2.04 111.713 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.1 p80 39.96 39.97 0.67 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.124 0.97 . . . . 3.29 111.881 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -88.39 -39.52 14.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.364 -0.835 . . . . 2.89 110.073 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.15 162.8 34.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.48 -0.782 . . . . 1.8 110.107 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 19.9 pt-20 -104.31 127.82 52.02 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.611 -0.515 . . . . 3.37 109.611 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.506 HG11 ' HE2' ' A' ' 55' ' ' TYR . 58.9 t -104.49 128.6 57.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.302 0.572 . . . . 0.87 110.836 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -81.83 114.21 20.3 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.846 -1.07 . . . . 1.06 109.733 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -116.7 145.55 43.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.172 -0.677 . . . . 1.96 109.172 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -109.8 131.62 54.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.392 -0.596 . . . . 1.18 109.392 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.95 -20.27 56.59 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.972 0.415 . . . . 0.75 111.636 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -68.45 -23.28 64.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 1.63 111.118 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -106.76 14.1 27.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.057 0.456 . . . . 2.07 110.723 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -88.45 132.77 34.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.044 -0.526 . . . . 0.91 110.728 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 45.9 ttm -94.96 109.36 21.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.189 -0.46 . . . . 1.73 110.39 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.39 -141.97 12.89 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.738 -0.744 . . . . 1.05 111.84 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -116.65 103.35 52.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.004 -0.369 . . . . 2.14 110.004 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.17 -23.44 39.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.256 . . . . 1.01 112.949 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -86.16 -4.85 59.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.438 0.637 . . . . 2.08 110.51 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -112.15 19.44 17.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.723 -0.671 . . . . 2.18 110.568 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 47' ' ' LEU . 16.8 mt -87.97 157.33 18.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.643 -0.708 . . . . 0.92 111.091 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -131.2 157.37 43.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.783 -0.644 . . . . 2.35 111.166 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.45 121.87 22.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.117 0.484 . . . . 1.4 110.168 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.33 5.09 56.08 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.063 -0.589 . . . . 0.75 112.126 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -73.29 120.47 18.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.073 0.464 . . . . 1.06 111.233 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.25 129.0 39.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.96 -1.018 . . . . 2.51 111.535 174.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.77 142.44 30.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.44 110.315 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.71 135.42 53.96 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.082 -0.71 . . . . 1.49 109.082 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HE2' HG11 ' A' ' 33' ' ' VAL . 11.4 p90 -156.8 159.64 38.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.063 -0.517 . . . . 0.66 111.134 -169.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.2 p -112.61 146.79 37.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.461 -0.336 . . . . 0.94 110.814 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.72 140.18 32.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.973 0.416 . . . . 1.19 110.861 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 -79.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.887 -0.597 . . . . 2.04 110.693 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' HD2' HD13 ' A' ' 70' ' ' LEU . 15.4 ptm180 32.11 63.94 0.25 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.311 1.007 . . . . 5.33 112.34 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -112.94 -69.34 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 5.42 111.196 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.23 127.28 4.85 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.292 -0.956 . . . . 4.76 113.073 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 55.11 25.95 7.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.583 0.753 . . . . 6.38 112.507 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.34 21.11 8.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.974 0.416 . . . . 6.4 111.707 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.2 m -90.73 24.84 2.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 5.23 111.232 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.22 -25.9 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.097 0.406 . . . . 6.95 112.097 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.8 t -108.99 14.44 24.07 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.322 0.582 . . . . 6.02 110.111 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.42 -84.83 1.06 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.594 -0.73 . . . . 4.09 112.551 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.94 -26.2 10.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.766 0.317 . . . . 4.22 110.742 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.1 m -72.8 114.47 10.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.065 -0.717 . . . . 2.09 109.065 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD13 ' HD2' ' A' ' 59' ' ' ARG . 58.8 mt -107.82 124.83 33.67 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.375 -0.83 . . . . 2.3 110.032 -174.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.07 147.81 94.38 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.779 2.32 . . . . 1.43 113.367 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.24 137.99 45.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.125 -0.943 . . . . 0.82 110.289 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -118.47 152.85 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.113 -0.494 . . . . 2.3 110.197 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.6 72.91 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.637 . . . . 2.01 110.356 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.9 t -105.18 111.09 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.8 110.204 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -121.82 141.56 51.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 3.51 110.927 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.6 mtm -74.94 144.74 43.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.473 . . . . 1.12 110.912 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.5 pt? -128.04 162.87 47.34 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.961 -0.755 . . . . 1.67 108.961 173.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 21.8 Cg_endo -62.19 163.59 19.62 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.138 1.892 . . . . 2.15 113.127 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HG2' ' H ' ' A' ' 81' ' ' ASN . 26.9 ttpp -79.93 -179.48 7.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.551 -0.749 . . . . 4.61 110.39 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 54.0 m-20 78.07 9.17 2.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.764 0.826 . . . . 2.84 111.218 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 p -79.61 -34.17 40.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.97 -0.559 . . . . 1.7 110.018 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.57 ' CD1' HD21 ' A' ' 27' ' ' LEU . 10.7 mm -82.76 127.39 70.22 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 115.603 -0.726 . . . . 0.92 109.771 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.59 144.67 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.486 2.124 . . . . 1.03 112.644 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -103.55 131.42 22.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.779 . . . . 2.76 108.895 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.43 125.11 5.72 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.953 2.436 . . . . 1.08 113.018 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.1 92.4 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.74 . . . . 1.1 111.456 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -141.78 129.84 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.587 -1.264 . . . . 1.23 107.587 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.43 -63.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.568 0.581 . . . . 2.87 112.568 -169.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.5 tp10 -95.41 -55.11 3.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.111 0.481 . . . . 2.84 111.017 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.7 t 169.96 161.47 0.06 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.646 -0.706 . . . . 1.42 109.756 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.434 HG22 ' CD2' ' A' ' 93' ' ' HIS . 5.7 m -105.79 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 1.3 112.256 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.434 ' CD2' HG22 ' A' ' 92' ' ' THR . 89.6 m-70 -138.91 172.34 13.0 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.494 0.664 . . . . 1.29 112.268 -171.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.89 163.05 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.878 -1.056 . . . . 1.36 109.399 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.54 177.49 45.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.817 -0.706 . . . . 0.53 111.387 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 m -107.79 161.6 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.046 0.45 . . . . 1.37 110.28 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.13 126.9 26.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.133 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.74 -44.35 56.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.89 111.484 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -171.7 143.96 1.51 Allowed Pre-proline 0 N--CA 1.463 0.18 0 N-CA-C 111.74 0.274 . . . . 3.92 111.74 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.81 159.73 41.61 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.596 2.197 . . . . 2.22 110.71 170.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HA ' HD13 ' A' ' 104' ' ' ILE . 5.0 mp -114.06 91.49 3.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.246 0.546 . . . . 3.32 112.169 -173.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -96.36 -58.99 1.92 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.727 -0.669 . . . . 5.56 110.406 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 58.3 m -92.75 8.94 37.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.234 -0.439 . . . . 4.14 111.713 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.557 HD13 ' HA ' ' A' ' 101' ' ' LEU . 4.1 mp -107.03 32.27 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.424 0.631 . . . . 3.46 110.784 -174.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.7 m120 62.85 97.84 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.929 0.714 . . . . 4.99 112.929 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.65 -6.28 13.43 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.4 2.066 . . . . 4.27 112.606 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -113.3 27.73 9.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 3.94 111.365 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 6.9 tp-100 -135.78 160.67 37.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.986 -0.746 . . . . 5.6 108.986 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' A' ' 32' ' ' GLU . 25.0 mm-40 -54.77 -24.1 21.01 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.251 0.463 . . . . 5.3 112.251 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.32 -18.42 65.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.553 -0.294 . . . . 4.95 110.878 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 108' ' ' GLN . 4.0 t80 -57.33 -21.34 34.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.532 0.733 . . . . 3.19 112.305 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.11 44.83 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.81 0.3 . . . . 1.24 111.81 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 65.21 -176.65 12.42 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.265 -0.493 . . . . 0.94 113.311 172.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 130' ' ' GLU . 48.4 mt -151.01 139.8 20.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.217 0.532 . . . . 0.93 110.917 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 73.1 mt -103.4 135.22 41.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 0.49 109.308 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 125' ' ' VAL . 10.6 pt-20 -86.03 112.43 21.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.858 0.837 . . . . 1.4 109.246 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.781 HD11 ' HB2' ' A' ' 129' ' ' HIS . 16.9 mm -85.27 141.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.895 -1.048 . . . . 0.63 110.285 -170.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 122' ' ' ARG . 34.9 tp -85.44 136.95 33.23 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 116.251 -0.431 . . . . 1.21 110.015 -175.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.47 152.82 10.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.059 -0.973 . . . . 2.29 110.441 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.9 pm0 -58.4 -26.72 63.55 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.043 0.386 . . . . 2.78 112.043 -176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.485 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.93 15.43 22.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.029 -0.268 . . . . 1.77 110.444 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.495 ' HG2' HD21 ' A' ' 118' ' ' LEU . 1.4 tmm_? 64.25 31.8 12.8 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.818 0.818 . . . . 4.14 109.484 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 m -77.18 -83.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.751 -0.659 . . . . 1.87 111.435 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 p -140.39 -169.76 2.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.737 -0.211 . . . . 1.54 110.779 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.2 p -67.97 137.62 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.903 -0.406 . . . . 1.29 109.903 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.9 mt -83.68 -70.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.282 -0.567 . . . . 1.03 110.739 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.8 p -135.88 -85.64 0.36 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.169 0.509 . . . . 1.56 111.714 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.448 ' O ' ' HD2' ' A' ' 129' ' ' HIS . 7.5 pt20 -176.48 137.43 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.247 -0.888 . . . . 2.08 109.489 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.781 ' HB2' HD11 ' A' ' 117' ' ' ILE . 33.8 m170 -124.49 132.97 53.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.68 110.254 171.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 114' ' ' LEU . 15.0 tt0 -86.41 150.3 24.4 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.644 -0.707 . . . . 1.19 110.158 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -123.33 140.81 52.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.289 0.566 . . . . 0.74 111.671 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.49 154.74 20.77 Favored Glycine 0 N--CA 1.454 -0.164 0 CA-C-N 115.426 -0.806 . . . . 0.51 111.987 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.35 -23.75 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 117.154 0.477 . . . . 0.67 111.493 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 15.7 p -81.78 -26.06 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.341 0.591 . . . . 1.35 110.669 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 19.8 m -73.81 -30.0 62.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.41 -0.814 . . . . 1.1 110.001 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 73.1 mt -76.01 60.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.242 -0.89 . . . . 1.46 111.828 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.1 t -42.46 -48.2 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.825 0.345 . . . . 0.82 111.595 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -99.74 35.84 1.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.378 . . . . 2.17 111.167 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 14.8 ptpt -48.23 -25.08 1.37 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.194 1.183 . . . . 1.39 114.194 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -82.24 -11.44 58.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.903 0.383 . . . . 2.46 110.915 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.94 147.34 48.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 1.89 109.904 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.4 mt -80.99 87.28 6.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.701 0.762 . . . . 2.88 110.051 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 143' ' ' LEU . 12.2 tp -103.34 109.22 20.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.659 -1.155 . . . . 0.97 110.223 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -104.8 -177.49 3.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.918 -0.583 . . . . 1.77 110.916 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -66.62 141.46 57.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.295 -0.411 . . . . 1.43 110.104 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.99 -4.23 81.36 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.63 -0.795 . . . . 1.07 113.151 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -91.1 141.56 28.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.757 -0.777 . . . . 1.94 109.64 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.602 HD13 ' OE1' ' A' ' 167' ' ' GLN . 3.6 mt -86.82 132.14 33.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.423 0.63 . . . . 1.79 111.746 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.42 152.74 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 1.16 110.875 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.0 p -112.1 140.33 46.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 1.44 109.389 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 42.5 p90 -163.88 168.09 19.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.809 -0.441 . . . . 0.61 109.809 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 124.12 25.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.695 -0.802 . . . . 2.2 111.438 173.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.0 tt -99.44 140.31 19.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.785 -1.098 . . . . 1.24 110.435 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -166.57 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.765 -0.198 . . . . 1.92 110.759 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.36 -36.73 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 2.76 111.573 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.9 t -74.36 -17.44 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.876 0.37 . . . . 1.98 111.015 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.51 19.89 54.7 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.516 -0.849 . . . . 1.27 112.548 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -139.31 178.23 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.968 -0.753 . . . . 3.61 108.968 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.36 108.64 19.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.251 -0.277 . . . . 0.48 110.251 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -121.3 161.98 21.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.43 . . . . 0.49 110.964 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.5 m 63.84 37.07 9.93 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.712 0.633 . . . . 1.55 109.921 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.8 t -69.15 114.93 6.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.237 -0.892 . . . . 1.26 111.202 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -125.13 118.81 26.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.834 -0.621 . . . . 2.05 109.945 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.94 116.19 3.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.75 110.543 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.05 118.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.506 0.669 . . . . 1.56 111.585 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.93 138.9 36.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.702 -0.681 . . . . 2.94 109.923 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.602 ' OE1' HD13 ' A' ' 148' ' ' LEU . 24.4 mp0 -99.88 150.98 21.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.603 0.716 . . . . 3.88 111.118 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 114.819 -1.082 . . . . 4.04 110.05 175.199 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 111.917 -0.473 . . . . 11.74 111.917 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.05 110.54 22.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.739 0.304 . . . . 10.54 110.898 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.04 -174.65 30.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.288 -0.958 . . . . 8.95 112.47 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 p -85.38 -43.93 13.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.957 0.408 . . . . 7.09 110.821 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -152.47 -178.12 6.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.875 -0.602 . . . . 5.59 110.654 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.72 -21.86 40.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 2.99 111.83 -175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.93 23.26 72.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.884 -0.674 . . . . 1.61 112.324 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 18.9 mm-40 -117.54 122.42 43.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 2.0 111.563 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 t -93.11 122.52 44.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 1.27 108.896 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.09 137.59 32.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.204 -0.453 . . . . 1.14 110.304 -174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -106.62 142.24 36.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.096 -0.502 . . . . 2.31 109.676 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.24 -174.01 34.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 111.183 -0.767 . . . . 0.5 111.183 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -140.81 144.17 35.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.884 0.373 . . . . 0.68 110.8 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.8 mm -63.01 115.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.56 111.021 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.42 -44.36 4.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.083 0.468 . . . . 0.76 110.507 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 23' ' ' PHE . 86.9 t -117.35 123.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.036 -0.529 . . . . 1.55 110.801 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 50.8 ttm -124.12 110.96 15.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.579 . . . . 1.42 109.968 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.3 mmtt -100.68 -174.3 2.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.754 -0.462 . . . . 2.03 109.754 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.06 -20.3 38.51 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.931 -0.577 . . . . 3.24 110.485 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -111.78 -49.02 3.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.089 0.471 . . . . 2.03 111.457 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 12.4 p90 -141.23 -174.12 3.93 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.747 -0.464 . . . . 1.25 109.747 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -156.74 177.48 33.65 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.591 -0.814 . . . . 0.71 112.254 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' CZ ' ' HE1' ' A' ' 21' ' ' PHE . 63.5 m-85 -128.78 139.09 52.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.021 0.439 . . . . 1.08 109.954 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -112.47 125.9 69.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.844 -0.617 . . . . 0.61 110.914 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.8 132.01 43.04 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.776 -0.824 . . . . 2.3 108.776 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 p -84.0 150.13 25.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.219 -0.446 . . . . 0.87 110.199 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 6.9 tp -49.07 -46.85 45.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.788 -0.642 . . . . 1.58 111.828 -174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 m -109.14 30.14 6.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.028 -0.533 . . . . 2.04 110.74 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.8 p80 39.4 57.37 2.1 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.618 1.199 . . . . 3.29 111.389 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -84.16 -35.97 23.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.73 -1.577 . . . . 2.89 109.918 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -173.72 175.22 2.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.14 -0.936 . . . . 1.8 110.108 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 106' ' ' PRO . 35.1 tt0 -103.6 128.57 50.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.196 -1.039 . . . . 3.37 108.196 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 124.37 58.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.648 -0.421 . . . . 0.87 111.043 -174.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.2 112.47 4.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.811 -0.631 . . . . 1.06 109.572 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 75' ' ' VAL . 4.6 t80 -121.64 121.61 37.76 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.624 0.726 . . . . 1.96 110.796 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.94 128.18 44.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.135 -0.939 . . . . 1.18 108.717 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -62.17 -18.56 61.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.981 0.363 . . . . 0.75 111.981 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -60.05 -34.04 72.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.38 . . . . 1.63 111.03 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -95.65 20.79 9.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.934 0.397 . . . . 2.07 111.215 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 93.1 t80 -94.07 139.62 30.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.91 110.871 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.9 ttm -99.33 106.16 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.054 -0.521 . . . . 1.73 110.444 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.56 -150.51 17.82 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.862 -0.685 . . . . 1.05 112.173 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -108.37 104.05 52.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.456 0.17 . . . . 2.14 110.729 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.22 -19.95 28.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 1.01 112.819 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -70.44 -22.71 62.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.437 0.637 . . . . 2.08 110.164 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -96.28 19.38 12.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.348 -0.842 . . . . 2.18 110.343 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD23 ' HG2' ' A' ' 51' ' ' GLN . 55.4 mt -95.84 153.55 17.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 0.92 110.181 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 51' ' ' GLN . 6.0 pt-20 -126.24 162.25 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.969 -0.56 . . . . 2.35 109.935 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 114.58 10.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.017 -0.735 . . . . 1.4 109.017 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.37 4.54 40.64 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.506 -0.854 . . . . 0.75 112.183 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 57.9 tp60 -73.49 133.1 43.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.897 0.38 . . . . 1.06 110.612 176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -86.27 128.24 34.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 2.51 110.799 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 77' ' ' MET . 35.7 m -139.51 160.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.088 -0.505 . . . . 0.44 110.921 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 78' ' ' LEU . 25.4 pt-20 -120.88 140.02 52.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.234 -0.654 . . . . 1.49 109.234 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 75' ' ' VAL . 1.4 p90 -161.78 172.62 15.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.088 0.47 . . . . 0.66 112.075 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 p -131.96 157.86 42.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.684 -0.689 . . . . 0.94 110.77 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.44 149.29 22.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 1.19 111.155 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.72 99.61 7.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.972 -0.558 . . . . 2.04 111.125 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -130.42 76.94 1.76 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.047 -0.723 . . . . 5.33 109.047 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.97 -14.91 57.52 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 5.42 111.254 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.7 172.08 29.7 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.929 -0.653 . . . . 4.76 111.722 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.45 50.81 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.179 0.514 . . . . 6.38 110.63 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -77.73 43.99 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.804 -0.635 . . . . 6.4 110.957 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -81.09 6.41 13.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.813 -0.631 . . . . 5.23 111.021 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.03 -37.77 10.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.176 -0.466 . . . . 6.95 110.926 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 p -105.07 20.12 19.4 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.913 0.338 . . . . 6.02 111.913 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.12 134.61 1.93 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.733 -0.746 . . . . 4.09 111.868 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.31 -46.41 27.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.002 0.43 . . . . 4.22 110.455 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.9 p -110.05 127.42 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 2.09 110.712 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.576 HD22 ' H ' ' A' ' 70' ' ' LEU . 2.4 mm? -67.6 155.27 91.63 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.705 -0.68 . . . . 2.3 111.696 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.09 155.21 66.11 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.854 2.369 . . . . 1.43 112.378 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.03 30.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.82 110.668 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.79 169.32 17.23 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.507 -0.553 . . . . 2.3 109.507 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 t30 60.03 45.54 11.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.636 0.732 . . . . 2.01 109.871 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 35' ' ' PHE . 20.1 t -93.32 114.05 29.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.73 . . . . 0.8 110.359 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 163.28 24.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 3.51 110.239 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.7 mtt -79.63 153.02 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.145 0.498 . . . . 1.12 111.369 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.48 HD11 ' HB3' ' A' ' 54' ' ' GLU . 18.8 mt -119.88 158.54 49.69 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.252 -0.885 . . . . 1.67 109.687 172.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.21 153.83 71.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.125 1.883 . . . . 2.15 111.93 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 51' ' ' GLN . 10.8 tptp -78.94 148.68 32.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 116.077 -0.511 . . . . 4.61 110.839 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 72.01 30.12 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 2.84 110.853 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.3 p -87.63 -11.71 47.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.39 0.614 . . . . 1.7 109.923 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 13.6 mm -84.98 131.56 48.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.315 -0.857 . . . . 0.92 109.627 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.18 150.58 65.85 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.483 2.122 . . . . 1.03 112.412 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -126.92 148.54 65.9 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.403 -0.362 . . . . 2.76 110.206 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.98 127.8 14.09 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.024 2.483 . . . . 1.08 113.625 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.94 94.49 4.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.659 -0.701 . . . . 1.1 110.895 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.86 120.94 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.087 -0.708 . . . . 1.23 109.087 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.05 -62.77 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.544 0.201 . . . . 2.87 111.544 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 6.0 mm-40 -92.98 -55.33 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 2.84 111.733 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 12.5 t 168.91 158.67 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.695 -0.854 . . . . 1.42 108.695 -176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.08 -58.92 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.454 -0.498 . . . . 1.3 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.44 163.61 34.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 1.29 110.803 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -120.87 174.09 6.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.457 -0.942 . . . . 1.36 108.457 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.35 -174.3 46.87 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.027 -1.083 . . . . 0.53 111.606 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.408 HG12 HD13 ' A' ' 148' ' ' LEU . 35.6 m -119.15 162.42 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.008 0.432 . . . . 1.37 110.028 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.6 t -66.39 122.43 17.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.94 -0.573 . . . . 0.69 109.869 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.65 -45.65 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.352 . . . . 0.89 111.61 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -172.98 124.98 0.46 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 3.92 110.835 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.12 147.03 16.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.548 2.165 . . . . 2.22 111.671 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.745 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.1 pt? -78.94 90.79 4.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.499 0.666 . . . . 3.32 111.595 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -97.55 -65.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.14 -0.482 . . . . 5.56 110.588 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.04 1.49 56.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.998 -0.546 . . . . 4.14 110.794 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.9 mp -71.19 -42.55 75.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.723 -0.671 . . . . 3.46 111.161 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 72.42 147.04 0.12 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.638 0.775 . . . . 4.99 111.381 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HB2' ' OE2' ' A' ' 32' ' ' GLU . 54.8 Cg_endo -68.56 -19.87 41.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.845 2.363 . . . . 4.27 111.962 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.88 -14.3 61.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.373 -0.83 . . . . 3.94 110.325 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -96.92 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.949 -0.569 . . . . 5.6 110.332 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.3 -22.63 66.19 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.846 0.684 . . . . 5.3 112.846 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -85.61 15.85 4.33 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.779 0.323 . . . . 4.95 111.268 -175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' O ' HD13 ' A' ' 101' ' ' LEU . 14.0 t80 -50.11 -42.9 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.169 0.803 . . . . 3.19 113.169 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB3' ' HG2' ' A' ' 130' ' ' GLU . . . -76.57 -11.31 59.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.301 0.482 . . . . 1.24 112.301 -169.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.23 150.7 8.72 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.635 -0.793 . . . . 0.94 112.284 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD23 ' CA ' ' A' ' 130' ' ' GLU . 67.3 mt -127.28 147.26 50.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.498 0.666 . . . . 0.93 112.597 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 82.3 mt -111.11 141.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.908 -1.042 . . . . 0.49 109.313 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 125' ' ' VAL . 32.7 tt0 -93.11 109.24 20.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.148 0.499 . . . . 1.4 109.981 -176.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.6 mm -91.74 132.52 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.713 . . . . 0.63 110.154 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.1 pt? -91.83 153.91 19.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.131 0.491 . . . . 1.21 111.008 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.534 ' HB3' ' H ' ' A' ' 123' ' ' THR . 2.8 t70 -55.12 146.88 17.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.32 -0.855 . . . . 2.29 109.063 169.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.744 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.9 pm0 -62.75 -20.01 64.53 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.464 0.542 . . . . 2.78 112.464 -170.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.1 mm? -102.25 13.46 34.6 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.936 -0.394 . . . . 1.77 109.936 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 58.1 80.89 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.652 -0.704 . . . . 4.14 110.378 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.534 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 32.5 m -116.33 -71.99 0.71 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.451 -0.795 . . . . 1.87 109.663 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -146.43 -176.58 5.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.82 -0.627 . . . . 1.54 110.189 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 116' ' ' GLU . 3.6 p -72.38 137.86 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.281 -0.418 . . . . 1.29 110.105 175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.37 -70.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.431 -0.507 . . . . 1.03 110.086 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.2 p -138.48 -87.82 0.24 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.417 0.627 . . . . 1.56 111.193 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.98 139.1 0.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.647 -1.16 . . . . 2.08 108.224 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 117' ' ' ILE . 25.9 m170 -117.32 121.06 40.1 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.455 -0.498 . . . . 0.68 110.448 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' CA ' HD23 ' A' ' 114' ' ' LEU . 9.3 tt0 -78.71 149.31 32.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.736 -0.665 . . . . 1.19 109.849 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -117.77 175.44 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.943 0.402 . . . . 0.74 111.007 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.46 153.09 21.44 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.797 -0.638 . . . . 0.51 111.616 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.7 tp -51.03 -30.54 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.019 0.409 . . . . 0.67 111.516 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.4 p -74.44 -36.91 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 1.35 110.946 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 16.9 m -69.94 -23.15 63.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 1.1 110.145 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.88 59.78 1.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.441 -0.8 . . . . 1.46 111.846 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.2 t -48.28 -41.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.228 0.537 . . . . 0.82 110.563 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -95.95 33.88 1.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.652 -0.703 . . . . 2.17 110.722 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -52.93 -25.09 10.77 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.799 1.037 . . . . 1.39 113.799 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -84.07 -16.92 42.01 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.586 -0.446 . . . . 2.46 111.363 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -76.01 150.05 37.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.12 0.486 . . . . 1.89 110.617 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 142' ' ' LEU . 2.1 mm? -84.96 71.37 10.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.935 -0.575 . . . . 2.88 109.745 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.6 tp -75.72 122.88 24.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.97 110.028 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -108.32 172.12 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.024 0.44 . . . . 1.77 111.758 -173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 146' ' ' GLY . 13.5 tmtt? -70.93 132.82 45.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 1.43 110.366 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.418 ' N ' ' HD3' ' A' ' 145' ' ' LYS . . . 87.56 4.07 80.38 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.47 -0.871 . . . . 1.07 113.05 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.89 152.01 22.4 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.136 -0.626 . . . . 1.94 110.045 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 96' ' ' VAL . 3.3 mm? -77.32 123.47 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.529 0.681 . . . . 1.79 111.513 -172.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.169 -0.923 . . . . 1.16 110.339 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 73.4 m -121.57 152.8 38.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.057 -0.52 . . . . 1.44 110.558 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 162' ' ' VAL . 6.4 p90 -165.49 168.27 16.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.803 -0.635 . . . . 0.61 109.817 -173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.48 122.55 29.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.459 0.647 . . . . 2.2 110.805 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -100.7 137.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.251 -0.886 . . . . 1.24 110.551 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.548 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 31.6 t70 -169.64 -89.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.19 -0.3 . . . . 1.92 110.19 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.548 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 39.1 mt-10 -76.73 -18.61 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.618 . . . . 2.76 110.035 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.5 p -80.03 -18.68 49.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.542 -0.754 . . . . 1.98 110.643 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.77 2.73 2.69 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.61 -0.723 . . . . 1.27 114.082 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -154.89 -161.16 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.262 -0.644 . . . . 3.61 109.262 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.71 115.58 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.337 0.589 . . . . 0.48 110.842 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -128.79 148.81 50.9 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.497 -0.774 . . . . 0.49 109.861 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.0 m 55.27 55.17 7.79 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.038 0.836 . . . . 1.55 110.916 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 151' ' ' PHE . 4.1 m -77.25 141.62 15.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.287 0.565 . . . . 1.26 110.277 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -138.56 119.95 14.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.806 -0.634 . . . . 2.05 110.286 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.513 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.16 103.39 0.61 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.115 -0.493 . . . . 0.75 110.958 174.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.97 118.4 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.381 0.61 . . . . 1.56 110.698 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 119.6 36.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.059 -0.519 . . . . 2.94 110.791 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -118.16 164.23 15.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.261 -0.644 . . . . 3.88 109.261 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 4.04 110.71 -177.557 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.336 -0.306 . . . . 11.74 112.336 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.8 -75.23 0.48 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.583 0.23 . . . . 10.54 111.07 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.46 -18.67 56.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.783 -0.722 . . . . 8.95 112.258 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 p -96.15 39.45 1.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.024 0.44 . . . . 7.09 110.602 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.66 97.67 0.22 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.781 -0.645 . . . . 5.59 111.728 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.9 -83.24 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.183 -0.917 . . . . 2.99 113.068 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.26 -4.17 58.47 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.495 -0.642 . . . . 1.61 111.495 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.54 133.52 35.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.998 0.428 . . . . 2.0 110.977 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 56' ' ' THR . 2.4 p -104.23 129.71 56.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.612 -0.722 . . . . 1.27 109.774 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -113.17 148.72 34.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.279 -0.873 . . . . 1.14 109.881 -174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -110.45 136.42 49.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.147 -0.479 . . . . 2.31 109.907 -177.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.44 -168.2 17.52 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.372 -0.691 . . . . 0.5 111.372 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 149.14 34.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.121 0.486 . . . . 0.68 111.178 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.77 118.99 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.442 -0.799 . . . . 0.56 110.497 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -109.21 -49.67 3.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.76 111.001 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 23' ' ' PHE . 6.3 p -123.51 139.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.032 -0.531 . . . . 1.55 110.272 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.7 ttm -131.76 122.05 25.19 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.277 -0.42 . . . . 1.42 110.993 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -107.43 -170.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.653 -0.869 . . . . 2.03 108.653 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.96 -20.36 25.99 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.438 -0.801 . . . . 3.24 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.83 -48.44 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.063 0.459 . . . . 2.03 111.34 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 53.3 p90 -143.65 175.78 9.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.36 . . . . 1.25 110.947 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.27 173.23 33.51 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.435 -0.666 . . . . 0.71 111.435 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.648 ' H ' HG13 ' A' ' 16' ' ' VAL . 40.7 m-85 -114.16 126.17 54.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.661 -0.866 . . . . 1.08 108.661 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.69 125.66 46.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.243 -0.435 . . . . 0.61 110.527 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.74 119.7 15.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.172 -0.677 . . . . 2.3 109.172 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.45 160.55 24.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.87 110.315 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 13.9 tp -56.27 -46.4 79.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.341 -0.39 . . . . 1.58 111.929 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.8 t -99.58 13.02 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.59 -0.522 . . . . 2.04 109.59 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.555 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 84.5 m-70 61.22 35.56 18.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.42 -0.809 . . . . 3.29 109.599 -175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.94 -58.52 7.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.094 -1.412 . . . . 2.89 111.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.07 178.85 9.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 1.8 109.765 -173.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 131.4 50.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.169 0.509 . . . . 3.37 110.62 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.98 129.9 64.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.888 -0.597 . . . . 0.87 110.464 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -80.91 113.21 18.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.464 0.65 . . . . 1.06 110.446 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 75' ' ' VAL . 26.3 t80 -121.95 132.49 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.905 -0.589 . . . . 1.96 110.13 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -102.26 124.32 47.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.159 -0.682 . . . . 1.18 109.159 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -62.97 -18.74 63.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.476 0.547 . . . . 0.75 112.476 -172.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -59.26 -23.28 62.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.007 0.432 . . . . 1.63 110.618 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.18 20.72 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.081 0.467 . . . . 2.07 110.458 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -85.99 140.95 29.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.91 110.336 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 76' ' ' ARG . 48.7 ttm -111.47 89.32 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.166 0.508 . . . . 1.73 110.425 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.27 -168.97 33.19 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.812 -0.631 . . . . 1.05 111.949 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.482 HD22 ' HB2' ' A' ' 46' ' ' TRP . 4.3 p-10 -98.37 102.75 15.21 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.344 0.593 . . . . 2.14 110.791 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.89 -17.99 13.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.795 2.33 . . . . 1.01 113.513 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -64.32 -25.72 68.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 2.08 110.107 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.482 ' HB2' HD22 ' A' ' 43' ' ' ASN . 84.1 m95 -106.51 23.51 14.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.823 -0.626 . . . . 2.18 111.419 -176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -89.7 152.02 21.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.717 -0.674 . . . . 0.92 109.719 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -141.13 157.81 44.77 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.4 mm? -68.67 118.15 11.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.41 -0.359 . . . . 1.4 110.061 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.77 -5.47 16.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.75 112.296 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -76.31 122.96 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.669 0.271 . . . . 1.06 110.955 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 21.5 mt-10 -64.16 137.41 57.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.693 -0.685 . . . . 2.51 110.656 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 77' ' ' MET . 22.5 m -143.09 148.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.508 -0.553 . . . . 0.44 109.508 174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.33 144.48 43.19 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.931 -0.766 . . . . 1.49 108.931 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -162.61 163.89 26.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.038 0.447 . . . . 0.66 111.939 -174.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 9' ' ' VAL . 56.9 p -120.94 153.51 37.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.715 -0.675 . . . . 0.94 109.742 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.67 156.74 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.745 0.307 . . . . 1.19 110.827 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.89 -174.38 3.3 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.867 -0.79 . . . . 2.04 108.867 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HD3' ' CD2' ' A' ' 70' ' ' LEU . 72.5 ttt180 61.01 41.11 14.41 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.997 0.811 . . . . 5.33 110.218 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -97.81 174.36 6.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.663 -0.699 . . . . 5.42 110.707 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.2 -152.13 17.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.905 -0.664 . . . . 4.76 112.306 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.75 20.3 3.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.222 0.534 . . . . 6.38 110.422 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -99.76 12.51 36.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.599 -0.728 . . . . 6.4 110.898 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.36 6.3 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 5.23 112.332 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 m -92.27 -28.01 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.024 -0.534 . . . . 6.95 109.979 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.1 m -107.06 -28.4 10.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.911 -0.586 . . . . 6.02 110.246 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -94.32 78.21 0.96 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.354 -0.698 . . . . 4.09 111.354 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -72.62 -41.02 66.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.013 0.435 . . . . 4.22 110.553 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 m -122.37 128.46 51.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.584 -0.895 . . . . 2.09 108.584 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' CD2' ' HD3' ' A' ' 59' ' ' ARG . 31.7 mt -109.85 138.44 20.71 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 121.202 -0.199 . . . . 2.3 110.92 -173.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.17 153.16 67.29 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.532 2.155 . . . . 1.43 111.106 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -106.27 147.54 29.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.453 -0.34 . . . . 0.82 111.245 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -126.85 174.22 8.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.495 -0.321 . . . . 2.3 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 58.8 34.2 23.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.869 -0.605 . . . . 2.01 112.232 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 55' ' ' TYR . 40.8 t -78.19 119.74 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.977 0.418 . . . . 0.8 110.899 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 41' ' ' MET . 11.1 mmm180 -124.39 148.72 47.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.675 -0.693 . . . . 3.51 110.35 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.537 ' HA ' HG12 ' A' ' 53' ' ' VAL . 66.7 mtt -69.04 140.95 54.94 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.017 -0.364 . . . . 1.12 110.017 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 31.1 tp -130.61 82.69 64.16 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.389 -0.369 . . . . 1.67 111.502 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.06 116.58 3.97 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.524 1.483 . . . . 2.15 110.305 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -166.22 -21.45 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.904 0.383 . . . . 4.61 111.006 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t30 59.35 41.19 20.1 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.452 -0.944 . . . . 2.84 108.452 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 t -88.44 -5.97 57.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.626 -1.17 . . . . 1.7 110.924 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.4 HD12 HD12 ' A' ' 27' ' ' LEU . 18.3 mm -63.23 119.65 54.65 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.92 109.236 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -66.68 158.98 53.27 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 122.44 2.094 . . . . 1.03 112.125 -172.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -98.2 139.72 21.4 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 115.942 -0.572 . . . . 2.76 110.413 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HB3' ' OD1' ' A' ' 154' ' ' ASP . 76.6 Cg_exo -51.02 134.83 43.59 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 123.113 2.542 . . . . 1.08 112.261 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.76 91.83 7.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 1.1 110.226 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 152' ' ' ARG . 22.0 t -142.82 135.25 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.765 -0.652 . . . . 1.23 109.531 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.92 -59.81 2.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.02 0.378 . . . . 2.87 112.02 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 91' ' ' THR . 16.7 mm-40 -90.76 -56.29 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.31 0.576 . . . . 2.84 111.145 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 13.1 t 151.01 164.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.431 -1.692 . . . . 1.42 106.431 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.512 HG21 HG23 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -106.48 -58.21 1.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.28 -0.968 . . . . 1.3 111.536 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -140.87 158.37 44.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.028 0.442 . . . . 1.29 110.761 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -140.15 126.04 19.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.72 -0.673 . . . . 1.36 109.398 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.47 -140.45 3.21 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.986 -1.102 . . . . 0.53 112.379 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.92 152.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.611 0.243 . . . . 1.37 110.475 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.624 HG21 ' HG ' ' A' ' 143' ' ' LEU . 64.8 t -61.89 132.17 27.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 0.69 110.419 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.15 -49.11 7.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.238 0.458 . . . . 0.89 112.238 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 99' ' ' ARG . 5.4 ttt85 -157.76 126.19 2.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.257 -0.577 . . . . 3.92 111.823 -172.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.15 145.87 24.86 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.802 2.335 . . . . 2.22 111.717 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -93.65 89.97 6.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.325 0.583 . . . . 3.32 112.162 -176.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -98.44 -62.62 1.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.328 0.585 . . . . 5.56 110.468 170.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 3.0 m -86.51 7.35 26.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.425 -0.807 . . . . 4.14 111.081 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -77.34 -42.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.047 -0.524 . . . . 3.46 110.675 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 73.13 146.9 0.12 Allowed Pre-proline 0 N--CA 1.472 0.653 0 O-C-N 123.682 0.614 . . . . 4.99 110.735 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.435 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 55.4 Cg_endo -71.19 0.25 6.98 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.736 2.29 . . . . 4.27 112.412 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.94 -14.52 23.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.039 0.447 . . . . 3.94 110.298 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.427 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 52.0 tp60 -89.45 148.12 23.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 5.6 110.129 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -63.47 -28.75 70.17 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.862 0.69 . . . . 5.3 112.862 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 108' ' ' GLN . 1.3 pt-20 -88.41 16.12 6.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.026 0.441 . . . . 4.95 111.17 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 6.8 t80 -49.58 -33.17 14.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.383 -0.826 . . . . 3.19 111.633 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.56 -16.63 63.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.207 -0.451 . . . . 1.24 111.761 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.53 170.01 46.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.529 -0.843 . . . . 0.94 111.969 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 130' ' ' GLU . 72.6 mt -145.31 144.21 30.61 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.309 0.576 . . . . 0.93 111.613 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.39 138.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.011 -0.995 . . . . 0.49 109.211 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.67 114.75 26.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.643 0.735 . . . . 1.4 110.312 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 129' ' ' HIS . 14.8 mm -91.34 132.15 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.045 -0.98 . . . . 0.63 109.845 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 124' ' ' THR . 1.9 pt? -85.65 152.74 22.87 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.181 0.301 . . . . 1.21 110.438 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.448 ' OD1' ' HB ' ' A' ' 123' ' ' THR . 18.2 m-20 -56.75 151.67 13.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.669 -0.493 . . . . 2.29 109.669 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -62.59 -25.95 68.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.735 0.302 . . . . 2.78 110.699 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.49 5.78 43.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.77 109.987 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 60.94 78.92 0.27 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.547 -0.751 . . . . 4.14 110.643 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.448 ' HB ' ' OD1' ' A' ' 119' ' ' ASP . 22.0 m -121.13 -74.18 0.62 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 1.87 110.606 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.5 p -144.03 -174.71 4.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.75 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 5.1 p -70.92 134.54 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.676 -0.491 . . . . 1.29 109.676 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.68 -69.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 1.03 110.623 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.1 m -136.66 -84.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.261 0.553 . . . . 1.56 111.197 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -175.33 142.38 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.035 -0.984 . . . . 2.08 108.899 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.509 ' CD2' HG13 ' A' ' 117' ' ' ILE . 17.5 m170 -124.1 124.39 42.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.999 0.428 . . . . 0.68 110.678 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 114' ' ' LEU . 9.0 tt0 -85.26 143.74 28.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.247 -0.888 . . . . 1.19 108.758 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -117.13 134.31 54.93 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.181 -0.608 . . . . 0.74 111.348 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.555 ' HA3' ' CE1' ' A' ' 29' ' ' HIS . . . -77.95 153.58 40.16 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 114.945 -1.025 . . . . 0.51 113.11 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.37 -37.52 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 122.545 0.338 . . . . 0.67 111.905 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.6 p -80.0 -32.89 39.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.322 0.582 . . . . 1.35 110.731 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 45.5 m -64.67 -32.81 74.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.263 -0.88 . . . . 1.1 109.934 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.9 tp -78.36 58.38 2.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.452 -0.795 . . . . 1.46 110.846 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 137' ' ' VAL . 39.0 t -44.91 -40.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.64 0.733 . . . . 0.82 110.675 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.73 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 33.7 m-80 -87.87 33.8 0.72 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.317 -0.856 . . . . 2.17 111.283 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -61.9 -16.1 48.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.112 0.482 . . . . 1.39 111.064 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -92.15 -9.13 43.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.795 -0.639 . . . . 2.46 111.285 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.31 166.46 15.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 1.89 110.323 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -98.31 52.57 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.428 0.632 . . . . 2.88 109.753 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HG ' HG21 ' A' ' 97' ' ' VAL . 13.0 tp -60.02 125.48 23.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.828 -1.078 . . . . 0.97 111.591 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -129.95 171.8 12.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 1.77 110.544 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 97' ' ' VAL . 86.5 tttt -70.57 136.02 48.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.268 -0.573 . . . . 1.43 109.564 176.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.29 -9.12 57.5 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.486 -0.864 . . . . 1.07 111.398 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -91.81 123.34 35.12 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.334 -0.987 . . . . 1.94 108.334 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.94 146.87 47.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.049 0.452 . . . . 1.79 110.201 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.17 146.54 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-O 121.285 0.564 . . . . 1.16 111.504 -172.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 p -111.52 145.42 39.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.268 -0.878 . . . . 1.44 109.663 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -165.38 158.0 15.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.914 0.388 . . . . 0.61 110.175 -177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.43 ' HB3' HG21 ' A' ' 88' ' ' VAL . 24.1 mtt180 -125.65 125.26 42.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.399 -0.593 . . . . 2.2 109.399 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 92' ' ' THR . 9.2 tt -99.64 121.85 50.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 1.24 109.876 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 7.4 p-10 -145.71 -100.7 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.533 -0.303 . . . . 1.92 111.155 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.549 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 1.4 mt-10 -78.86 -29.0 44.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.026 0.441 . . . . 2.76 110.373 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.0 t -74.02 -17.51 60.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.849 -0.614 . . . . 1.98 110.915 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.72 21.99 58.97 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.719 -0.753 . . . . 1.27 112.37 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 158' ' ' ARG . 52.7 mtt180 -140.79 -171.4 3.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.997 -0.742 . . . . 3.61 108.997 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.86 107.74 18.46 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.606 -0.438 . . . . 0.48 109.862 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -110.33 161.48 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.432 -0.349 . . . . 0.49 110.109 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.71 36.93 19.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.24 0.543 . . . . 1.55 110.235 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.35 112.16 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.523 0.678 . . . . 1.26 111.12 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.73 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 53.2 t30 -131.14 114.52 15.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 2.05 110.476 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.41 131.18 49.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.75 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.54 107.28 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.959 -0.564 . . . . 1.56 110.501 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? -87.08 115.05 24.21 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.362 -0.607 . . . . 2.94 109.362 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -82.3 129.34 34.84 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.873 -0.603 . . . . 3.88 111.553 -170.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.908 -1.042 . . . . 4.04 111.271 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 N-CA-C 112.04 -0.424 . . . . 11.74 112.04 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.48 80.45 8.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.057 0.456 . . . . 10.54 110.314 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.99 111.98 0.66 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.85 -0.614 . . . . 8.95 111.591 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 m -130.31 6.07 4.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.44 0.162 . . . . 7.09 110.979 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -115.79 162.21 17.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.836 0.351 . . . . 5.59 110.569 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.75 -18.34 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.99 110.586 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.04 22.04 70.26 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.148 -0.549 . . . . 1.61 112.693 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -106.53 124.17 49.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 2.0 111.451 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -90.77 115.29 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.643 -0.873 . . . . 1.27 108.643 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CD2' ' HG ' ' A' ' 57' ' ' LEU . 22.8 m-85 -87.79 139.17 30.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.404 0.621 . . . . 1.14 110.786 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 27.8 ttm180 -100.83 130.12 46.8 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.01 -0.995 . . . . 2.31 110.189 -176.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.63 -177.31 26.99 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.378 -0.689 . . . . 0.5 111.378 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' HE1' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -149.21 151.05 33.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.964 0.412 . . . . 0.68 111.064 -177.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.7 123.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.857 -0.61 . . . . 0.56 111.477 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 25' ' ' GLU . . . -106.26 -37.08 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.76 111.584 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 23' ' ' PHE . 6.4 p -144.82 149.65 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.074 -0.512 . . . . 1.55 109.953 -178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.6 mtp -130.71 107.5 9.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.77 -0.456 . . . . 1.42 109.77 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.22 -168.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 2.03 109.746 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -75.72 -44.2 43.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.159 0.504 . . . . 3.24 110.885 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -102.91 -27.93 12.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.0 -0.545 . . . . 2.03 111.655 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.12 -177.91 6.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.895 0.379 . . . . 1.25 111.756 -172.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.95 160.82 28.54 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.931 -0.577 . . . . 0.71 111.719 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.573 ' HB2' HG12 ' A' ' 16' ' ' VAL . 25.9 m-85 -108.38 135.46 49.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.763 -0.458 . . . . 1.08 109.763 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -102.53 125.12 56.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.995 -0.548 . . . . 0.61 110.304 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 32.6 tt0 -72.34 117.79 14.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.968 -1.123 . . . . 2.3 107.968 173.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 31' ' ' GLU . 5.5 p -66.07 157.44 31.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.036 -0.357 . . . . 0.87 110.036 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 83' ' ' ILE . 17.2 tp -53.23 -36.05 60.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 1.58 111.785 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -110.7 12.61 22.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 2.04 110.054 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.2 p80 40.34 39.81 0.74 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.531 1.132 . . . . 3.29 113.086 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -95.37 -0.87 52.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 2.89 110.472 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB3' HG21 ' A' ' 26' ' ' THR . 28.4 tt0 -156.98 148.08 21.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 1.8 111.248 -170.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.42 121.45 44.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.422 -0.584 . . . . 3.37 109.422 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.4 t -109.47 130.62 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.87 111.44 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 71' ' ' PRO . 14.0 t80 -84.56 120.56 26.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.814 -0.63 . . . . 1.06 110.385 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -124.23 144.96 49.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.367 177.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -116.84 126.92 53.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.716 -0.675 . . . . 1.18 110.101 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -63.93 -20.88 66.19 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.196 0.443 . . . . 0.75 112.196 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.7 t -67.02 -27.23 67.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.62 -0.263 . . . . 1.63 111.517 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -101.93 6.85 41.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.07 111.476 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 79.5 t80 -73.3 129.72 38.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.129 -0.487 . . . . 0.91 110.832 -175.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 57.5 ttp -98.9 93.09 5.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.282 0.563 . . . . 1.73 110.389 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.27 -134.77 4.22 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.607 -0.724 . . . . 1.05 111.466 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -132.72 106.02 12.88 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.721 -0.474 . . . . 2.14 109.721 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.26 -17.85 16.55 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.36 2.04 . . . . 1.01 112.887 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -74.52 -17.01 60.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.338 0.59 . . . . 2.08 110.357 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -101.03 -2.13 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.637 -0.71 . . . . 2.18 110.844 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 13.1 mt -77.38 146.63 36.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.212 0.529 . . . . 0.92 111.736 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.23 173.31 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.133 -0.939 . . . . 2.35 109.66 175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.21 130.04 37.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.237 -0.438 . . . . 1.4 110.449 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.97 4.91 58.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.75 112.918 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -75.4 126.94 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.862 0.331 . . . . 1.06 111.042 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 43.3 mt-10 -72.57 129.97 39.53 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.577 -0.738 . . . . 2.51 110.551 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 77' ' ' MET . 28.5 m -137.92 156.54 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.932 0.396 . . . . 0.44 110.816 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 78' ' ' LEU . 12.9 pt-20 -114.3 138.64 50.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.086 -0.709 . . . . 1.49 109.086 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.425 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 6.8 p90 -165.3 176.76 8.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.958 0.409 . . . . 0.66 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 p -125.67 145.45 50.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.1 -0.5 . . . . 0.94 110.973 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HG ' ' CD2' ' A' ' 10' ' ' TYR . 90.8 mt -73.02 135.39 44.91 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 120.621 -0.432 . . . . 1.19 110.371 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 70' ' ' LEU . . . -80.76 98.52 7.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.531 -0.759 . . . . 2.04 109.724 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD2' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER 37.16 41.44 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.866 1.266 . . . . 5.33 114.318 171.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.78 91.23 4.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.243 0.544 . . . . 5.42 111.012 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.41 30.11 4.12 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.604 -0.726 . . . . 4.76 111.927 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -130.03 -175.43 3.61 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 6.38 109.935 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -79.92 -35.85 37.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.642 0.258 . . . . 6.4 111.439 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.1 m 64.69 8.58 4.57 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.049 0.539 . . . . 5.23 112.032 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.11 -23.7 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 6.95 111.488 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.532 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 7.2 m -93.42 2.76 56.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 6.02 110.439 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.53 9.18 57.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 4.09 112.35 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' OD1' ' HB2' ' A' ' 66' ' ' SER . 17.5 m120 -80.88 54.56 2.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.347 0.594 . . . . 4.22 111.269 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 p -103.5 143.74 32.33 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.448 -0.796 . . . . 2.09 110.279 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 70' ' ' LEU . 1.7 mp -94.01 136.65 23.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.934 -0.765 . . . . 2.3 108.934 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 35.3 Cg_endo -66.01 140.66 61.06 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.019 1.813 . . . . 1.43 111.661 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -58.25 121.22 10.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.493 -0.776 . . . . 0.82 110.593 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.3 148.44 28.99 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.361 0.413 . . . . 2.3 110.842 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.4 t30 59.12 82.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.23 -0.896 . . . . 2.01 110.708 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.49 121.95 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.8 110.253 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -125.97 156.47 39.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.837 -0.431 . . . . 3.51 109.837 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.41 ' HA ' HG12 ' A' ' 53' ' ' VAL . 67.3 mtt -76.91 138.99 40.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.12 110.613 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 54' ' ' GLU . 22.0 tp -113.88 146.0 34.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.631 -0.713 . . . . 1.67 109.255 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.07 155.84 17.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 113.152 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 84.4 tttt -73.35 154.2 40.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.389 -0.823 . . . . 4.61 111.308 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 93.7 m-20 77.36 23.56 0.87 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.622 0.769 . . . . 2.84 110.841 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 m -86.26 -13.08 47.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.863 -0.608 . . . . 1.7 109.512 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 27' ' ' LEU . 3.5 mm -93.71 130.91 33.46 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 108.898 -0.778 . . . . 0.92 108.898 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.07 145.91 80.53 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.673 2.248 . . . . 1.03 112.56 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -124.0 137.54 29.1 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.267 -0.424 . . . . 2.76 110.835 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 82.6 Cg_exo -50.23 141.07 32.24 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.692 2.928 . . . . 1.08 113.352 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.58 95.29 5.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 1.1 111.393 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.464 HG11 ' OG1' ' A' ' 92' ' ' THR . 16.7 m -121.54 171.31 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.499 -0.556 . . . . 1.23 109.499 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.47 -63.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.308 -0.557 . . . . 2.87 111.124 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.03 -54.18 3.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.393 0.616 . . . . 2.84 111.269 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t 172.5 163.35 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.379 -0.971 . . . . 1.42 108.379 -174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.464 ' OG1' HG11 ' A' ' 88' ' ' VAL . 2.1 m -107.18 -59.06 1.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 1.3 111.84 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -148.34 178.04 8.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.573 0.701 . . . . 1.29 111.504 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.42 166.62 23.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.588 -1.264 . . . . 1.36 107.588 170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.49 -165.79 30.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.707 -1.235 . . . . 0.53 112.695 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 148' ' ' LEU . 42.0 t -135.7 141.65 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.547 0.339 . . . . 1.37 110.165 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 66.3 t -59.15 118.99 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.06 -0.348 . . . . 0.69 110.06 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.27 -64.15 1.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.41 -0.359 . . . . 0.89 111.917 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -160.51 158.1 24.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.336 . . . . 3.92 111.862 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.64 177.24 7.09 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.966 2.444 . . . . 2.22 111.038 169.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER -126.78 90.65 3.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.444 0.64 . . . . 3.32 112.029 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -80.01 -20.5 45.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 5.56 109.724 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 56.6 m -72.63 -21.27 61.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 4.14 111.084 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.09 -43.78 8.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.69 0.281 . . . . 3.46 110.352 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -119.04 114.94 34.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.31 -0.404 . . . . 4.99 110.329 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.17 -41.25 0.66 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.509 2.139 . . . . 4.27 114.133 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.36 -37.8 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.774 -0.37 . . . . 3.94 110.94 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -124.7 87.98 2.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.138 0.494 . . . . 5.6 110.091 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -65.78 -12.8 57.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.453 0.644 . . . . 5.3 110.947 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.89 5.82 50.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.444 -0.798 . . . . 4.95 111.052 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' OH ' ' HA ' ' A' ' 25' ' ' GLU . 71.9 t80 -54.98 -52.15 63.98 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.789 0.681 . . . . 3.19 110.548 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.602 ' HB3' HD21 ' A' ' 101' ' ' LEU . . . -114.53 -46.05 2.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.38 -0.827 . . . . 1.24 111.76 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 63.57 174.66 3.08 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.97 -0.559 . . . . 0.94 113.035 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 130' ' ' GLU . 55.8 mt -145.49 138.61 26.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.544 0.688 . . . . 0.93 111.715 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.48 138.02 37.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.686 -1.143 . . . . 0.49 109.767 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.62 121.39 29.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.628 . . . . 1.4 109.408 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 129' ' ' HIS . 4.2 mm -103.36 120.45 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.45 -0.795 . . . . 0.63 109.238 -175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -85.18 139.41 31.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 1.21 110.29 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.73 160.9 3.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.147 -0.933 . . . . 2.29 110.218 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.1 -27.0 68.8 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.19 -0.319 . . . . 2.78 111.53 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.05 12.54 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.709 -0.478 . . . . 1.77 109.709 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 48.59 35.91 6.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.794 1.238 . . . . 4.14 111.854 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 20.3 p -75.47 -67.39 0.67 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.608 -0.723 . . . . 1.87 111.118 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.7 p -139.01 172.81 12.3 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.09 -0.505 . . . . 1.54 111.28 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.6 t -72.92 136.38 25.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 1.29 109.474 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.6 mt -70.98 -69.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.43 -0.508 . . . . 1.03 111.1 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 61.2 m -140.4 -85.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.45 0.643 . . . . 1.56 111.341 172.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -176.5 123.9 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.646 -1.161 . . . . 2.08 108.653 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 117' ' ' ILE . 31.5 m170 -111.91 126.93 55.64 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.631 -0.827 . . . . 0.68 110.618 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 114' ' ' LEU . 13.3 tt0 -88.1 149.06 24.16 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.462 -1.244 . . . . 1.19 109.629 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 38.3 p90 -123.7 175.71 6.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 0.74 110.837 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.443 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -137.44 153.58 22.06 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.625 -0.716 . . . . 0.51 111.564 -176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.0 tp -54.24 -23.26 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 117.154 0.477 . . . . 0.67 111.193 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -80.99 -34.4 33.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.323 0.582 . . . . 1.35 110.674 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' A' ' 160' ' ' ALA . 36.6 t -76.02 -26.0 56.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.231 -0.895 . . . . 1.1 110.377 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 139' ' ' LYS . 80.1 mt -75.26 60.22 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.642 . . . . 1.46 112.27 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.5 t -41.41 -49.07 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.827 0.346 . . . . 0.82 111.863 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.56 HD21 HD22 ' A' ' 143' ' ' LEU . 2.7 p-10 -97.47 36.38 1.5 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.721 0.296 . . . . 2.17 111.53 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 13.9 ptpt -51.55 -22.54 3.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.244 0.831 . . . . 1.39 113.244 -177.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -81.66 -20.84 38.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.081 0.467 . . . . 2.46 111.005 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.24 163.36 18.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.641 -0.708 . . . . 1.89 111.431 -173.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -70.91 100.19 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.804 -0.635 . . . . 2.88 110.276 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 138' ' ' ASN . 7.1 tp -128.11 95.35 4.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.23 -0.655 . . . . 0.97 109.23 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.4 pt20 -130.35 -171.92 2.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.985 -0.552 . . . . 1.77 110.914 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 86.9 tttt -60.58 112.99 2.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.039 0.447 . . . . 1.43 110.833 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.02 -2.8 22.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.602 -0.809 . . . . 1.07 112.789 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.58 135.86 33.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.159 0.504 . . . . 1.94 111.095 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.439 HD13 ' CG2' ' A' ' 96' ' ' VAL . 3.1 mm? -81.07 135.96 35.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.043 -0.98 . . . . 1.79 110.147 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.61 151.09 27.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.11 0.481 . . . . 1.16 110.983 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.519 ' OG ' HG11 ' A' ' 165' ' ' VAL . 75.2 m -117.1 143.6 45.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.852 -0.613 . . . . 1.44 109.702 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.6 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 30.5 p90 -158.68 173.93 15.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.959 -0.564 . . . . 0.61 109.929 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.13 124.97 22.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.499 0.666 . . . . 2.2 111.261 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.471 HD13 ' CE1' ' A' ' 129' ' ' HIS . 12.6 pt -97.2 151.66 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.348 -0.842 . . . . 1.24 109.621 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 35.3 t70 -173.26 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.055 0.222 . . . . 1.92 110.579 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -73.11 -36.5 66.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.957 0.408 . . . . 2.76 111.395 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.8 m -82.36 -16.67 48.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.284 -0.416 . . . . 1.98 111.187 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 66.36 2.08 13.24 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 121.021 -0.609 . . . . 1.27 112.814 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 153' ' ' ILE . 27.3 mtt85 -130.18 -178.94 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.793 -0.447 . . . . 3.61 109.793 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.43 108.86 18.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.48 111.56 -169.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.558 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.4 156.39 27.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.714 -0.675 . . . . 0.49 109.873 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 64.64 41.1 5.51 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.691 0.619 . . . . 1.55 110.318 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.35 114.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.695 -0.684 . . . . 1.26 110.762 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.24 125.51 45.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.377 -0.374 . . . . 2.05 110.44 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.56 120.14 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.77 -0.65 . . . . 0.75 110.616 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.519 HG11 ' OG ' ' A' ' 150' ' ' SER . 13.6 p -136.37 139.94 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 1.56 111.139 -174.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 139.56 50.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.375 -0.375 . . . . 2.94 110.096 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -136.27 167.27 21.61 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 3.88 109.548 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 116.273 -0.421 . . . . 4.04 110.352 178.395 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 112.227 -0.349 . . . . 11.74 112.227 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.35 115.33 12.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 10.54 110.839 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.42 119.65 0.67 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.752 -0.737 . . . . 8.95 112.128 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -109.99 112.11 23.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.144 -0.317 . . . . 7.09 110.144 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.43 159.02 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.034 -0.53 . . . . 5.59 110.8 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.89 91.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.527 -0.76 . . . . 2.99 110.246 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.52 23.56 72.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.582 -0.735 . . . . 1.61 113.206 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -125.25 122.58 37.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.148 0.499 . . . . 2.0 111.732 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.79 123.47 41.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.536 -0.756 . . . . 1.27 109.319 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.62 151.06 22.79 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.649 -0.871 . . . . 1.14 108.649 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -132.54 153.25 51.15 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.726 -0.79 . . . . 2.31 110.828 177.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.44 -153.84 6.7 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.607 -1.397 . . . . 0.5 109.607 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.55 140.84 30.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.942 0.401 . . . . 0.68 111.1 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -64.76 108.42 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.487 -0.779 . . . . 0.56 110.501 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.98 -36.49 9.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.079 0.466 . . . . 0.76 110.812 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.38 122.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 1.55 110.375 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 45.6 ttm -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.87 -0.419 . . . . 1.42 109.87 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 71.5 mmtt -101.66 -167.08 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.212 -0.449 . . . . 2.03 109.992 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -83.34 -35.14 25.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 3.24 110.781 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.94 -36.91 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.244 0.461 . . . . 2.03 112.244 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 22.0 p90 -138.82 -170.36 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.791 0.329 . . . . 1.25 111.413 -173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.1 -169.45 31.6 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.399 -0.68 . . . . 0.71 111.399 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -136.46 142.7 43.6 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.766 -0.457 . . . . 1.08 109.766 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -114.15 120.58 64.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.61 110.237 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -70.65 119.58 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.976 -0.75 . . . . 2.3 108.976 171.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 31' ' ' GLU . 7.5 p -62.16 155.67 23.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.247 -0.433 . . . . 0.87 110.274 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 17.5 tp -55.01 -34.37 63.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.154 -0.475 . . . . 1.58 111.539 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 p -99.04 6.71 46.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 2.04 111.46 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 p80 40.18 42.28 1.14 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.147 0.979 . . . . 3.29 112.112 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -116.62 -16.13 10.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 2.89 110.137 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG21 ' A' ' 26' ' ' THR . 9.2 tp10 -132.18 148.51 52.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 1.8 110.021 -175.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -109.37 128.66 55.29 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.731 -0.47 . . . . 3.37 109.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.477 HG11 ' HE2' ' A' ' 55' ' ' TYR . 21.8 t -123.61 116.55 48.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 120.847 0.356 . . . . 0.87 111.052 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -73.73 122.49 22.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.697 . . . . 1.06 110.184 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.69 124.11 40.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.732 -0.667 . . . . 1.96 110.675 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' ND1' ' HB3' ' A' ' 21' ' ' PHE . 5.3 t60 -101.56 142.35 33.05 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.668 -0.864 . . . . 1.18 108.668 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.42 -21.02 62.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.621 -0.432 . . . . 0.75 112.143 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 22.1 t -61.52 -29.63 70.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.554 -0.294 . . . . 1.63 111.246 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -99.95 17.01 22.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.024 0.44 . . . . 2.07 110.482 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -92.51 129.53 38.42 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.187 -0.46 . . . . 0.91 110.257 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.9 ttp -108.8 91.96 3.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 1.73 110.376 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.05 -130.13 1.83 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.332 -0.849 . . . . 1.05 111.073 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' HD1' ' A' ' 46' ' ' TRP . 36.4 t30 -150.12 111.07 3.28 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.328 . . . . 2.14 110.574 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.34 -16.31 27.89 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.859 2.373 . . . . 1.01 113.385 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.96 -16.47 63.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.686 0.279 . . . . 2.08 111.269 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.471 ' HD1' ' ND2' ' A' ' 43' ' ' ASN . 69.6 m95 -115.04 17.52 16.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.539 . . . . 2.18 111.09 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.35 165.5 12.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.92 110.129 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -155.0 166.78 32.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.742 -0.663 . . . . 2.35 109.328 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.6 mm? -69.09 126.28 29.3 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.82 -0.34 62.71 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.749 -0.738 . . . . 0.75 112.438 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.43 120.42 13.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.007 0.432 . . . . 1.06 110.72 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 21.9 mt-10 -64.34 122.8 17.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.237 -0.892 . . . . 2.51 110.794 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.9 m -141.53 144.73 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.212 -0.449 . . . . 0.44 109.976 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 19.0 pt-20 -116.17 148.13 40.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.758 -0.377 . . . . 1.49 110.274 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -162.92 177.35 9.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.66 112.003 -171.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.69 166.55 16.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.94 111.021 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.15 137.68 35.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.194 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.62 34.65 0.59 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 2.04 111.064 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -88.85 61.18 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.797 0.808 . . . . 5.33 110.073 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -141.69 168.2 20.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.606 -1.179 . . . . 5.42 108.217 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.74 -68.37 3.55 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.881 -0.676 . . . . 4.76 112.608 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -78.93 168.69 19.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.694 0.283 . . . . 6.38 110.576 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 p -67.67 -31.21 71.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.148 -0.478 . . . . 6.4 111.171 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 t 68.15 8.18 6.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.327 -0.851 . . . . 5.23 111.606 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.21 -33.01 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 6.95 110.264 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 p -96.55 5.9 49.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 6.02 110.464 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.32 90.59 0.56 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.965 -0.636 . . . . 4.09 111.713 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -60.79 -47.15 87.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.868 0.366 . . . . 4.22 110.62 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 p -128.99 139.49 52.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.591 . . . . 2.09 109.556 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.66 153.49 70.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.358 -0.383 . . . . 2.3 110.6 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.8 155.8 52.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.929 2.42 . . . . 1.43 111.901 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.71 169.5 9.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.989 -0.551 . . . . 0.82 110.262 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG3' HD22 ' A' ' 74' ' ' ASN . 9.9 pt-20 -158.73 172.2 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.768 -0.196 . . . . 2.3 110.607 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.532 HD22 ' HG3' ' A' ' 73' ' ' GLU . 50.2 m-80 60.51 26.6 16.24 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.674 0.609 . . . . 2.01 110.915 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 38.5 t -70.37 117.66 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.883 -0.599 . . . . 0.8 110.955 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -126.39 157.06 39.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 3.51 110.678 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.505 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.2 mtt -72.4 146.73 46.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.118 -0.492 . . . . 1.12 110.532 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.401 HD12 ' HD2' ' A' ' 79' ' ' PRO . 26.6 tp -119.97 131.23 24.49 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 108.876 -0.787 . . . . 1.67 108.876 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HD2' HD12 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.42 146.13 64.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.001 1.801 . . . . 2.15 111.849 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 19.5 ptpt -59.47 162.83 4.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 4.61 110.625 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 8.8 t30 77.5 2.95 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.447 0.641 . . . . 2.84 110.919 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -81.05 -27.65 35.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.277 0.56 . . . . 1.7 109.655 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.13 116.63 66.84 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.733 -0.84 . . . . 0.92 108.733 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.58 155.09 40.25 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.552 2.168 . . . . 1.03 112.377 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.97 155.03 45.89 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.527 -0.545 . . . . 2.76 109.527 178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.493 ' HB3' ' HB3' ' A' ' 154' ' ' ASP . 17.0 Cg_exo -65.67 143.12 73.4 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.27 1.98 . . . . 1.08 111.215 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.62 94.56 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 1.1 111.214 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 t -140.96 130.62 25.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.571 -0.74 . . . . 1.23 109.254 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.87 -60.51 1.84 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.131 0.419 . . . . 2.87 112.131 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' O ' ' HB ' ' A' ' 91' ' ' THR . 14.7 pt-20 -90.51 -52.43 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.92 -0.312 . . . . 2.84 111.569 -174.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.8 t 166.1 159.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.613 -0.884 . . . . 1.42 108.613 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.54 -52.02 2.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.196 0.522 . . . . 1.3 110.158 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -142.99 168.14 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.306 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -125.98 151.55 46.89 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.417 -1.327 . . . . 1.36 107.417 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.18 -173.31 25.45 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.385 -1.388 . . . . 0.53 112.506 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.44 143.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.465 -0.568 . . . . 1.37 109.465 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.24 123.51 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.604 0.24 . . . . 0.69 110.435 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.44 -38.17 17.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.89 112.033 -173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 12.1 ptm180 -154.23 139.8 12.22 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.606 -0.437 . . . . 3.92 111.869 -176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 4.8 Cg_exo -80.42 167.76 18.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.956 2.437 . . . . 2.22 111.133 170.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mt -118.82 86.68 2.59 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.935 -0.306 . . . . 3.32 111.307 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -102.7 -63.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 5.56 111.994 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 23.1 p -71.88 -26.97 62.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.468 -0.787 . . . . 4.14 112.913 -165.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' A' ' 110' ' ' GLU . 49.6 mt -67.67 -33.59 62.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.404 -0.362 . . . . 3.46 111.738 -173.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 9.2 t30 70.45 134.37 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.476 0 O-C-N 123.866 0.728 . . . . 4.99 110.73 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 105' ' ' ASN . 38.2 Cg_endo -64.9 0.78 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.727 2.952 . . . . 4.27 115.517 -171.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.91 -2.25 58.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 3.94 110.92 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.581 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 6.5 tp-100 -107.82 142.82 37.27 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.586 -0.524 . . . . 5.6 109.586 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -58.63 -23.08 58.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.256 0.551 . . . . 5.3 111.271 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 30.6 tp10 -61.26 -11.98 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.222 -0.899 . . . . 4.95 110.855 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.83 -20.99 25.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.812 0.845 . . . . 3.19 112.122 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.47 -14.53 61.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.407 0.521 . . . . 1.24 112.407 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.3 -178.72 9.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.345 -0.455 . . . . 0.94 113.193 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 130' ' ' GLU . 38.1 mt -152.24 141.01 20.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.292 0.567 . . . . 0.93 111.641 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.5 mt -109.3 134.24 51.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.878 -1.055 . . . . 0.49 109.134 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -86.34 111.04 20.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.67 0.748 . . . . 1.4 109.413 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.646 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -90.78 121.34 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.168 -0.924 . . . . 0.63 109.041 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -90.32 150.81 21.75 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.569 -0.453 . . . . 1.21 109.966 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.75 165.1 3.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.144 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' HG2' HD22 ' A' ' 121' ' ' LEU . 2.0 pm0 -65.12 -20.35 66.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 2.78 110.174 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.625 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.38 14.28 24.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 1.77 110.277 178.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 51.02 29.82 4.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.434 1.093 . . . . 4.14 112.118 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -67.53 0.66 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.392 -0.367 . . . . 1.87 111.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 7.3 p -138.24 -171.6 3.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.578 -0.283 . . . . 1.54 111.175 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.9 p -92.52 129.88 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.364 -0.606 . . . . 1.29 109.364 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.56 -69.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.801 0.334 . . . . 1.03 110.629 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.4 m -139.01 -85.97 0.24 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.147 0.498 . . . . 1.56 110.46 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.5 143.49 0.48 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.873 -1.058 . . . . 2.08 108.596 173.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.646 ' HB2' HD11 ' A' ' 117' ' ' ILE . 33.3 m170 -116.34 124.46 50.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.68 110.335 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -81.94 140.59 33.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.996 . . . . 1.19 109.469 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' A' ' 136' ' ' LEU . 31.6 p90 -115.97 161.01 19.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.195 0.521 . . . . 0.74 111.27 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -119.43 152.24 17.25 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.813 -0.63 . . . . 0.51 111.663 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.9 tp -55.16 -29.42 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.96 0.409 . . . . 0.67 111.241 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -71.77 -33.7 68.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.451 0.643 . . . . 1.35 110.403 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 161' ' ' CYS . 2.2 m -66.77 -33.11 74.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.287 -0.87 . . . . 1.1 109.983 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 10.9 mp -75.94 57.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.769 -0.65 . . . . 1.46 111.923 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.3 t -46.58 -48.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.239 0.543 . . . . 0.82 110.545 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -93.4 35.87 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.465 -0.789 . . . . 2.17 110.962 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 9.9 ptpp? -54.36 -23.69 16.53 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.754 1.02 . . . . 1.39 113.754 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -81.44 -6.26 58.76 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.202 -0.311 . . . . 2.46 111.33 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.45 174.93 4.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 1.89 110.471 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -88.94 17.2 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 2.88 110.507 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.9 tp -46.2 117.73 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.921 -1.036 . . . . 0.97 111.756 -173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -135.59 -179.94 5.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 1.77 110.675 -174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.52 129.32 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 1.43 110.026 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.92 64.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.358 -0.925 . . . . 1.07 112.562 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -91.93 146.12 24.0 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.94 109.575 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.88 134.77 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.181 0.515 . . . . 1.79 111.513 -170.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.2 m -129.72 148.12 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.836 -0.62 . . . . 1.16 111.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 64.1 m -113.77 140.52 48.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.534 -0.757 . . . . 1.44 109.096 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.688 ' HB3' HG12 ' A' ' 162' ' ' VAL . 25.7 p90 -151.06 165.75 32.86 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.144 -0.48 . . . . 0.61 109.794 -175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 -126.91 119.65 27.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.063 -0.655 . . . . 2.2 110.423 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 129' ' ' HIS . 12.6 pt -102.46 149.67 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 109.184 -0.673 . . . . 1.24 109.184 168.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 6.4 t70 -160.69 -93.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.995 -0.282 . . . . 1.92 110.564 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.59 -34.82 27.54 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.767 -0.373 . . . . 2.76 111.519 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.2 t -77.63 -17.7 57.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.672 0.272 . . . . 1.98 110.699 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.61 -14.66 3.25 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.994 -0.622 . . . . 1.27 113.968 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' ILE . 11.0 ptm180 -103.41 175.48 5.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.296 0.548 . . . . 3.61 110.054 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.27 109.84 18.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.142 0.496 . . . . 0.48 110.423 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.67 154.8 33.49 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.464 -0.789 . . . . 0.49 110.354 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.422 ' H ' ' HA ' ' A' ' 135' ' ' SER . 37.6 m 57.82 47.22 15.71 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.932 0.77 . . . . 1.55 111.325 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 151' ' ' PHE . 19.3 m -70.89 128.3 33.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.642 0.734 . . . . 1.26 110.281 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -128.45 125.62 38.86 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.668 -0.696 . . . . 2.05 109.739 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.43 128.12 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.613 -0.721 . . . . 0.75 110.819 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.22 110.94 29.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.124 0.488 . . . . 1.56 111.468 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.542 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 2.8 mpt_? -94.07 126.49 39.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.747 -0.834 . . . . 2.94 108.747 174.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.72 167.59 20.56 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.0 -0.545 . . . . 3.88 110.924 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 4.04 112.475 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.142 -0.383 . . . . 11.74 112.142 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.57 116.26 9.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.096 0.474 . . . . 10.54 111.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.13 105.3 1.55 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.534 -0.757 . . . . 8.95 111.474 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.0 p -113.07 112.42 23.82 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.859 0.361 . . . . 7.09 110.704 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -86.93 169.94 12.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.947 -0.569 . . . . 5.59 110.067 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.91 -21.15 40.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.984 -0.553 . . . . 2.99 110.021 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.84 -29.72 4.49 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.761 -0.654 . . . . 1.61 112.458 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -100.27 118.85 37.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.338 0.59 . . . . 2.0 111.218 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.31 126.56 44.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.857 -1.065 . . . . 1.27 109.229 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -98.55 137.94 36.47 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.38 -0.6 . . . . 1.14 109.38 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 35.0 ttm180 -112.42 143.25 43.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.863 -0.421 . . . . 2.31 109.863 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.27 -170.24 22.74 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.67 -0.776 . . . . 0.5 111.591 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 139.74 42.29 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.662 0.268 . . . . 0.68 110.369 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.94 118.08 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.56 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.08 -56.65 2.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.614 0.245 . . . . 0.76 111.002 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -120.93 160.87 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.154 -0.313 . . . . 1.55 110.154 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 54.1 ttm -141.61 112.29 7.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.268 -0.424 . . . . 1.42 111.035 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.47 175.95 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.499 -0.556 . . . . 2.03 109.499 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -61.75 -34.76 76.4 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.581 0.551 . . . . 3.24 111.539 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -111.13 -47.45 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.205 0.446 . . . . 2.03 112.205 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -130.15 169.39 15.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.162 0.506 . . . . 1.25 111.627 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.72 -174.09 23.56 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.71 111.489 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' HB3' ' OE1' ' A' ' 32' ' ' GLU . 48.4 m-85 -129.04 154.4 46.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.119 -0.326 . . . . 1.08 110.119 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.6 mt -133.79 122.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.61 110.316 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -69.0 119.5 13.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.817 -0.438 . . . . 2.3 109.817 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 p -57.6 141.47 48.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 0.87 109.911 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -50.0 -46.25 52.54 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.227 0.536 . . . . 1.58 110.708 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -85.81 18.05 3.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.656 . . . . 2.04 111.65 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 p80 43.13 36.2 0.93 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.128 0.971 . . . . 3.29 111.907 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -70.05 -50.99 35.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.274 -0.875 . . . . 2.89 110.382 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.43 -174.59 3.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 1.8 110.53 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 23' ' ' PHE . 1.1 mm-40 -102.75 145.23 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.974 -0.557 . . . . 3.37 109.976 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG11 ' HE2' ' A' ' 55' ' ' TYR . 20.8 t -122.44 120.54 61.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.21 0.528 . . . . 0.87 111.21 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -74.2 116.91 15.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.364 -0.834 . . . . 1.06 110.392 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -121.99 151.18 41.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.281 -0.637 . . . . 1.96 109.281 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -110.31 128.86 55.75 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.349 -0.611 . . . . 1.18 109.349 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -64.06 -20.15 65.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 0.75 110.871 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -59.96 -34.83 73.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.555 . . . . 1.63 111.699 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -102.96 -0.54 30.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.028 0.442 . . . . 2.07 110.615 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 54.6 t80 -72.01 128.66 36.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.91 110.213 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.4 ttp -102.21 111.55 23.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.042 0.448 . . . . 1.73 110.239 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 44' ' ' PRO . . . 147.14 -171.87 27.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.687 -0.688 . . . . 1.05 111.429 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.69 105.25 19.66 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 110.22 -0.289 . . . . 2.14 110.22 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 42' ' ' GLY . 10.0 Cg_exo -66.99 -30.34 39.31 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.469 2.113 . . . . 1.01 112.354 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -70.43 -12.16 61.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 2.08 111.19 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -99.95 7.32 44.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.114 0.483 . . . . 2.18 110.58 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.41 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 20.6 mt -88.16 141.61 28.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.183 0.516 . . . . 0.92 111.306 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -120.92 158.41 27.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.393 -0.821 . . . . 2.35 109.274 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.78 114.76 12.42 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.184 -0.672 . . . . 1.4 109.184 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.72 32.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.027 -0.606 . . . . 0.75 112.226 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -65.8 137.39 57.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 1.06 110.67 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.523 ' HG3' HD13 ' A' ' 83' ' ' ILE . 12.9 tt0 -78.63 125.73 29.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.361 -0.836 . . . . 2.51 110.274 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -141.8 155.45 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.176 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -125.1 148.14 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.968 0.413 . . . . 1.49 110.308 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 0.6 OUTLIER -159.34 173.66 15.94 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.975 -0.557 . . . . 0.66 110.81 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 p -127.96 142.81 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.488 -0.324 . . . . 0.94 110.961 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.53 121.92 20.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 120.881 0.372 . . . . 1.19 110.263 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -77.21 -30.34 54.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.529 -0.759 . . . . 2.04 111.485 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD3' HD21 ' A' ' 70' ' ' LEU . 7.5 tpp180 58.44 34.67 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.851 0.834 . . . . 5.33 109.552 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.7 97.1 4.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.211 -0.904 . . . . 5.42 109.921 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.52 -169.06 32.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.954 -0.641 . . . . 4.76 112.777 -176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 65.13 19.8 11.86 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 6.38 111.113 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m -112.74 -0.75 14.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.408 -0.814 . . . . 6.4 109.871 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 14.1 m -70.24 1.04 5.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.649 -0.705 . . . . 5.23 112.246 -174.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.07 -23.6 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.48 . . . . 6.95 110.824 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 m -120.91 9.66 10.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 6.02 110.853 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' SER . . . 176.09 133.5 1.79 Allowed Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.512 -0.635 . . . . 4.09 111.512 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -61.39 -45.26 95.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.127 0.489 . . . . 4.22 110.659 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.4 m -97.64 144.11 27.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.829 -0.623 . . . . 2.09 110.301 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 ' HD3' ' A' ' 59' ' ' ARG . 1.1 pp -88.28 151.93 49.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 2.3 110.865 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.76 150.14 78.9 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.779 2.319 . . . . 1.43 113.357 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.94 147.72 25.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.114 -0.948 . . . . 0.82 109.292 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 10.5 pt-20 -125.98 176.43 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.108 -0.237 . . . . 2.3 110.508 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 t30 63.41 28.08 15.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.627 0.727 . . . . 2.01 109.756 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 17.4 t -66.99 119.0 11.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.808 . . . . 0.8 109.841 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -133.2 140.3 47.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.998 -0.547 . . . . 3.51 111.644 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.466 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.3 mtt -71.6 149.46 45.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.12 110.485 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -145.9 163.31 31.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 1.67 109.445 170.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 24.7 Cg_exo -64.73 161.88 34.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.1 1.866 . . . . 2.15 112.216 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.45 -169.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.51 -0.768 . . . . 4.61 111.514 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.2 t30 78.74 19.74 0.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.202 -0.908 . . . . 2.84 112.444 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 m -93.99 -39.27 10.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.199 -0.667 . . . . 1.7 109.199 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.523 HD13 ' HG3' ' A' ' 52' ' ' GLU . 2.3 mp -84.07 119.54 73.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.639 -0.71 . . . . 0.92 110.399 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.09 161.16 32.83 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.462 2.775 . . . . 1.03 112.565 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -93.12 153.97 41.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.414 -0.515 . . . . 2.76 110.188 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.16 164.1 23.7 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.649 2.233 . . . . 1.08 111.265 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.43 91.32 3.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.33 0.586 . . . . 1.1 111.627 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.47 153.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.953 -1.128 . . . . 1.23 107.953 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 -61.42 1.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.424 -0.511 . . . . 2.87 111.408 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 91' ' ' THR . 9.4 tp10 -92.17 -56.22 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 2.84 111.242 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 3.6 t 167.17 165.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.283 -1.006 . . . . 1.42 108.283 -174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 m -106.79 -54.8 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.578 -0.449 . . . . 1.3 111.111 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -146.7 157.1 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 1.29 110.591 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.89 -179.53 3.72 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.558 -0.904 . . . . 1.36 108.558 171.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.99 -167.6 40.14 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 119.731 -1.223 . . . . 0.53 112.237 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.74 142.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.925 -0.768 . . . . 1.37 108.925 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 122.52 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.693 0.283 . . . . 0.69 110.712 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -72.94 -54.22 9.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.89 109.872 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' ALA . 73.3 ttt180 177.74 130.03 0.2 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.558 0.536 . . . . 3.92 111.8 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 1.1 Cg_endo -85.67 130.51 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.149 2.566 . . . . 2.22 110.392 166.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' CD2' ' HA2' ' A' ' 113' ' ' GLY . 0.4 OUTLIER -128.55 102.48 6.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 112.491 0.552 . . . . 3.32 112.491 -172.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -97.55 -36.42 10.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.095 0.474 . . . . 5.56 111.116 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.3 p -92.66 -46.45 7.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.445 0.906 . . . . 4.14 113.445 -169.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.454 ' H ' HG12 ' A' ' 104' ' ' ILE . 9.3 pt -68.9 -44.82 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 114.576 1.325 . . . . 3.46 114.576 -164.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -138.75 89.55 13.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.401 -0.52 . . . . 4.99 111.907 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 95.9 Cg_endo -88.85 -8.16 5.11 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.909 2.406 . . . . 4.27 112.437 175.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.01 7.19 43.6 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.128 -0.487 . . . . 3.94 110.879 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.401 HE21 ' H ' ' A' ' 109' ' ' GLN . 22.0 tp60 -114.76 142.36 46.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.297 -0.41 . . . . 5.6 110.812 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.401 ' H ' HE21 ' A' ' 108' ' ' GLN . 24.5 pt20 -47.35 -38.9 13.85 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.762 0.825 . . . . 5.3 112.508 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 1.5 pt-20 -85.09 16.0 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 4.95 112.295 -173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.479 ' CD2' ' HA ' ' A' ' 106' ' ' PRO . 49.1 t80 -47.93 -30.78 4.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.161 0.8 . . . . 3.19 113.161 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.44 -35.53 63.36 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.663 0.616 . . . . 1.24 112.663 -172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 101' ' ' LEU . . . 124.12 149.03 7.6 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.501 -0.857 . . . . 0.94 111.698 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.2 mt -131.54 154.4 48.85 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.384 0.612 . . . . 0.93 111.743 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.8 mt -116.84 136.6 53.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.981 -1.009 . . . . 0.49 108.82 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.04 110.72 19.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.574 0.702 . . . . 1.4 109.7 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.0 mm -85.43 130.42 36.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.829 -1.078 . . . . 0.63 109.996 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.12 146.34 26.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.81 0.338 . . . . 1.21 110.333 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.19 165.06 9.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.853 -0.612 . . . . 2.29 110.429 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.533 ' HG3' HD22 ' A' ' 121' ' ' LEU . 11.3 pt-20 -60.25 -25.56 65.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.787 0.292 . . . . 2.78 111.787 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.533 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -96.67 13.92 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.906 -0.318 . . . . 1.77 110.604 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.415 ' HD3' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 39.71 76.67 0.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.399 1.08 . . . . 4.14 112.318 -175.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.2 p -124.91 -68.55 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.144 -0.934 . . . . 1.87 111.237 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 m -124.17 166.64 15.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 1.54 110.477 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.7 p -73.39 133.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.156 -0.313 . . . . 1.29 110.156 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.48 -69.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.601 -0.272 . . . . 1.03 111.045 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -138.06 -85.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 1.56 110.918 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -175.75 137.09 0.34 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.328 -0.851 . . . . 2.08 108.865 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.777 ' HB2' HD11 ' A' ' 117' ' ' ILE . 35.3 m170 -121.32 133.89 55.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.58 -0.526 . . . . 0.68 109.58 172.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 114' ' ' LEU . 12.8 tt0 -90.37 152.87 20.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.589 -0.732 . . . . 1.19 109.884 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -117.97 135.48 54.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.291 0.567 . . . . 0.74 110.838 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.29 151.34 21.42 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.396 -0.82 . . . . 0.51 111.734 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.45 -33.64 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.67 110.718 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.7 t -76.29 -30.22 57.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.481 -0.781 . . . . 1.35 110.203 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' VAL . 24.8 m -76.14 -24.18 54.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.753 -0.658 . . . . 1.1 110.159 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 139' ' ' LYS . 74.5 mt -71.2 58.26 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.443 -0.798 . . . . 1.46 111.459 176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.3 t -47.24 -47.13 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.436 0.636 . . . . 0.82 110.403 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.615 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 35.6 m-80 -92.38 34.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.563 -0.744 . . . . 2.17 111.622 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 136' ' ' LEU . 8.9 ptpp? -61.21 -21.3 63.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.675 0.274 . . . . 1.39 111.726 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -89.06 -2.4 58.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.03 0.443 . . . . 2.46 111.248 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.83 148.76 24.52 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.428 -0.953 . . . . 1.89 108.428 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.95 92.42 3.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.66 0.743 . . . . 2.88 110.077 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 164' ' ' ALA . 13.3 tp -113.31 105.71 13.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.675 -1.148 . . . . 0.97 110.064 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -128.45 -171.35 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.889 -0.324 . . . . 1.77 111.65 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 56.8 tttm -64.01 110.42 2.13 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.31 -0.405 . . . . 1.43 111.138 -175.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.47 -6.69 20.75 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.486 -0.864 . . . . 1.07 112.386 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.56 142.19 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 1.94 110.898 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.31 140.03 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 1.79 111.221 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.65 153.34 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.51 . . . . 1.16 111.772 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -118.29 144.8 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.763 . . . . 1.44 108.983 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.574 ' HB3' HG12 ' A' ' 162' ' ' VAL . 33.8 p90 -158.47 176.86 11.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.016 0.436 . . . . 0.61 110.767 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -135.21 123.8 23.59 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.258 0.552 . . . . 2.2 111.286 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.92 122.7 52.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.261 -0.881 . . . . 1.24 109.332 167.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 4.9 p-10 -152.9 -94.72 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.109 -0.237 . . . . 1.92 110.835 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.493 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 39.3 mm-40 -82.53 -17.32 45.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.539 0.685 . . . . 2.76 109.233 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 -19.06 35.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.99 -1.004 . . . . 1.98 111.2 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.1 6.5 10.18 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.954 -0.566 . . . . 1.27 113.99 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -138.12 -167.51 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.852 -0.795 . . . . 3.61 108.852 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.5 107.6 18.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.415 -0.587 . . . . 0.48 109.415 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.43 155.21 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.188 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 70.4 m 58.7 37.89 25.06 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.833 0.708 . . . . 1.55 110.837 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 151' ' ' PHE . 33.1 m -65.02 117.76 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.766 0.793 . . . . 1.26 110.329 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.615 ' HA ' ' ND2' ' A' ' 138' ' ' ASN . 4.8 p30 -118.1 123.4 45.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.686 -0.688 . . . . 2.05 110.275 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.435 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -66.16 103.42 0.97 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.335 -0.848 . . . . 0.75 110.831 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.2 p -128.74 110.24 20.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.691 0.758 . . . . 1.56 110.86 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 7.5 mpt_? -83.13 114.39 21.29 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.776 -0.824 . . . . 2.94 108.776 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -106.84 167.7 9.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.313 -0.858 . . . . 3.88 110.981 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.884 -1.053 . . . . 4.04 110.376 176.701 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.12 -0.392 . . . . 11.74 112.12 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.92 178.26 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.466 -0.198 . . . . 10.54 110.466 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.63 138.78 27.83 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.922 -0.656 . . . . 8.95 112.415 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 m -140.6 137.28 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.787 -0.449 . . . . 7.09 109.787 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -70.41 118.09 12.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.3 0.572 . . . . 5.59 110.302 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.16 46.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.804 -0.635 . . . . 2.99 111.231 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.89 23.52 71.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 1.61 112.491 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -92.83 119.58 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 2.0 111.392 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.39 122.52 39.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.805 . . . . 1.27 109.163 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.23 137.52 32.48 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.12 -0.491 . . . . 1.14 110.005 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.522 HH11 ' CD2' ' A' ' 78' ' ' LEU . 21.6 ttm-85 -106.44 129.54 54.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.384 -0.825 . . . . 2.31 109.963 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.71 -171.33 22.75 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.795 -0.717 . . . . 0.5 111.765 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.7 148.51 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.066 0.46 . . . . 0.68 111.075 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.41 118.68 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.513 -0.767 . . . . 0.56 110.791 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.85 -37.94 6.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.774 0.321 . . . . 0.76 111.091 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.634 HG13 ' H ' ' A' ' 23' ' ' PHE . 2.5 p -130.99 122.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.274 0.559 . . . . 1.55 110.861 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.99 106.24 18.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.429 -0.952 . . . . 1.42 108.429 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 14.7 tppt? -98.4 170.8 8.6 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.067 -0.716 . . . . 2.03 109.067 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 62.5 mt-10 -65.98 -38.64 89.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.169 0.433 . . . . 3.24 112.169 -170.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -112.1 -41.32 3.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.088 0.47 . . . . 2.03 111.524 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.612 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 42.7 p90 -131.0 -161.53 1.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.052 -0.522 . . . . 1.25 110.195 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.91 -177.57 40.37 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.262 -0.97 . . . . 0.71 112.245 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.634 ' H ' HG13 ' A' ' 16' ' ' VAL . 75.2 m-85 -125.26 130.3 51.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.598 -0.519 . . . . 1.08 109.598 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -102.9 134.08 44.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.267 -0.642 . . . . 0.61 109.267 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.71 143.33 30.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.933 -1.136 . . . . 2.3 107.933 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 p -67.66 -173.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.035 0.445 . . . . 0.87 110.523 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.638 ' CD2' HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -81.96 -47.05 13.18 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.099 0.475 . . . . 1.58 110.658 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -102.68 22.54 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.445 0.535 . . . . 2.04 112.445 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 56.06 58.19 4.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.228 0.537 . . . . 3.29 109.785 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.95 -44.09 5.85 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.48 -0.782 . . . . 2.89 110.714 -172.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.91 167.34 20.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 1.8 110.04 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -103.6 127.81 50.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.062 0.458 . . . . 3.37 110.551 -175.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.546 HG11 ' HE2' ' A' ' 55' ' ' TYR . 12.1 t -110.27 131.5 61.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.87 111.245 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -89.9 123.81 34.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.566 -0.743 . . . . 1.06 110.081 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -124.06 153.8 40.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.214 -0.662 . . . . 1.96 109.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.419 ' HD2' ' H ' ' A' ' 38' ' ' SER . 2.3 t60 -116.11 131.96 56.79 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.939 -0.763 . . . . 1.18 108.939 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 25.8 m-85 -58.7 -27.82 65.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.419 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 69.5 m -65.63 -36.5 83.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.541 0.21 . . . . 1.63 111.449 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -83.85 3.76 32.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.939 0.399 . . . . 2.07 110.981 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 64.9 t80 -83.59 140.44 32.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.891 -0.595 . . . . 0.91 110.091 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.5 ttp -116.52 116.43 27.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.122 0.487 . . . . 1.73 110.334 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.05 -151.49 22.9 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.76 -0.655 . . . . 1.05 111.678 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -105.19 103.55 42.69 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.633 0.254 . . . . 2.14 110.855 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.03 -27.12 25.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.46 2.107 . . . . 1.01 113.119 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.82 1.0 45.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.975 0.416 . . . . 2.08 111.295 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -110.51 14.55 22.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.475 0.655 . . . . 2.18 109.674 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.5 mt -97.61 152.95 18.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.039 -0.982 . . . . 0.92 110.825 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.0 -178.32 6.85 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.754 -0.657 . . . . 2.35 109.238 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.7 mt -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.783 0.325 . . . . 1.4 111.414 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.0 -1.59 24.23 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.922 -0.656 . . . . 0.75 113.182 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.442 HE21 ' N ' ' A' ' 52' ' ' GLU . 25.9 tp60 -74.69 122.5 23.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.866 0.333 . . . . 1.06 110.98 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 27.0 mt-10 -61.59 132.86 54.7 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.609 -0.723 . . . . 2.51 110.373 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 77' ' ' MET . 25.9 m -140.83 148.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.44 110.207 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -114.63 142.71 46.1 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.268 -0.642 . . . . 1.49 109.268 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HE2' HG11 ' A' ' 33' ' ' VAL . 5.8 p90 -162.13 170.82 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.103 0.478 . . . . 0.66 111.559 -175.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 p -125.52 167.7 14.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.865 -0.607 . . . . 0.94 111.182 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.13 153.02 28.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 1.19 109.994 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -96.2 -33.54 11.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.358 0.599 . . . . 2.04 110.969 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.481 ' CB ' HD22 ' A' ' 70' ' ' LEU . 99.4 mtt180 -91.57 56.34 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.324 -0.853 . . . . 5.33 110.498 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -63.06 131.36 48.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.576 . . . . 5.42 110.215 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.43 154.91 6.45 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.883 -0.887 . . . . 4.76 110.883 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -79.41 74.76 6.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.405 0.621 . . . . 6.38 110.823 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -121.12 -0.04 10.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.33 -0.85 . . . . 6.4 110.277 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 34.43 0.35 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.626 0.727 . . . . 5.23 110.036 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.44 -24.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.527 -0.76 . . . . 6.95 110.332 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 m -85.81 -15.53 41.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 6.02 111.214 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.77 51.73 1.62 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.584 -0.817 . . . . 4.09 111.821 -175.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -131.81 86.62 2.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.189 -0.671 . . . . 4.22 109.189 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.8 p -53.93 144.83 17.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.411 -0.813 . . . . 2.09 111.578 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD22 ' CB ' ' A' ' 59' ' ' ARG . 17.9 mt -122.0 138.48 28.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.734 -0.666 . . . . 2.3 110.244 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.68 149.16 37.89 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.445 2.097 . . . . 1.43 111.823 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.48 36.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 0.82 111.116 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 79.8 mm-40 -119.59 143.78 47.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 2.3 110.436 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.5 t30 59.87 80.41 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 2.01 110.846 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.3 t -109.4 122.68 64.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.075 -0.512 . . . . 0.8 110.075 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -133.32 147.24 51.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.576 -0.283 . . . . 3.51 110.747 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.459 ' HA ' HG12 ' A' ' 53' ' ' VAL . 64.1 mtt -66.88 150.37 49.28 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.21 0.528 . . . . 1.12 111.467 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.522 ' CD2' HH11 ' A' ' 11' ' ' ARG . 19.1 tp -147.6 75.96 11.0 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.114 -0.948 . . . . 1.67 110.771 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -90.24 117.99 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.791 1.661 . . . . 2.15 112.716 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -174.05 6.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.117 0.414 . . . . 4.61 112.117 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 t30 57.7 50.56 10.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.027 0.917 . . . . 2.84 108.866 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.0 t -73.64 -10.44 59.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.554 -1.203 . . . . 1.7 109.937 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.638 HD12 ' CD2' ' A' ' 27' ' ' LEU . 6.2 mm -78.22 128.25 78.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.695 . . . . 0.92 109.469 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.1 159.66 48.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.083 2.522 . . . . 1.03 112.904 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -117.55 149.3 44.65 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.73 -0.668 . . . . 2.76 110.382 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.7 149.27 43.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 1.08 111.906 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.04 94.05 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.233 0.54 . . . . 1.1 110.603 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 152' ' ' ARG . 21.6 t -139.24 144.37 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.715 -0.846 . . . . 1.23 108.715 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.2 mt -88.22 -64.12 1.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.476 -0.49 . . . . 2.87 111.872 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 91' ' ' THR . 33.5 mt-10 -95.25 -53.82 3.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.357 0.599 . . . . 2.84 110.676 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 14.2 t 172.0 166.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.769 -1.105 . . . . 1.42 108.114 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -105.66 -58.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.295 -0.562 . . . . 1.3 111.424 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -141.71 171.76 13.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.281 0.562 . . . . 1.29 111.36 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.72 158.09 45.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.018 -1.105 . . . . 1.36 108.018 172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.43 -166.97 28.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.725 -1.226 . . . . 0.53 112.293 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.11 145.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.579 -0.526 . . . . 1.37 109.579 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 145' ' ' LYS . 84.8 t -60.92 126.73 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.627 -0.26 . . . . 0.69 110.846 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.9 -48.59 17.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.89 110.344 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -174.61 143.82 0.86 Allowed Pre-proline 0 C--O 1.235 0.293 0 CA-C-O 121.018 0.437 . . . . 3.92 111.962 175.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.22 177.4 7.21 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.17 2.58 . . . . 2.22 110.659 167.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.8 OUTLIER -118.94 90.14 3.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.291 0.478 . . . . 3.32 112.291 -173.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -98.34 -62.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.362 0.601 . . . . 5.56 110.069 166.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 3.8 p -91.83 10.49 28.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 4.14 111.889 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 47.8 mm -79.38 -22.13 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 3.46 110.48 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 8.8 t-20 73.07 127.65 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 O-C-N 123.817 0.698 . . . . 4.99 111.229 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 -14.74 30.02 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.999 2.466 . . . . 4.27 113.224 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -80.46 -12.3 59.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.382 0.611 . . . . 3.94 109.699 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 110' ' ' GLU . 6.6 tp-100 -83.06 141.36 32.09 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.609 -0.723 . . . . 5.6 109.385 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.77 1.74 14.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.352 . . . . 5.3 111.532 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.52 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 46.3 mt-10 -85.82 12.87 8.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.801 -0.444 . . . . 4.95 109.801 173.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.548 ' OH ' ' HB ' ' A' ' 16' ' ' VAL . 53.5 t80 -55.52 -34.14 64.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.419 -0.809 . . . . 3.19 112.894 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.79 -25.57 66.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.759 0.314 . . . . 1.24 111.844 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 161.08 36.03 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.499 -0.858 . . . . 0.94 111.508 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 130' ' ' GLU . 36.7 mt -143.44 141.47 30.84 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.628 0.727 . . . . 0.93 112.405 -174.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.9 mt -114.16 139.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.494 -1.23 . . . . 0.49 108.817 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.46 136.35 33.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.173 -0.611 . . . . 1.4 110.206 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 129' ' ' HIS . 22.0 mm -105.75 131.81 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.803 -0.635 . . . . 0.63 109.541 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 118' ' ' LEU . 1.7 pt? -85.55 150.13 24.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.559 -0.291 . . . . 1.21 110.559 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.42 166.85 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.468 . . . . 2.29 110.109 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.49 -26.89 63.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.78 110.648 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 1.1 mm? -91.3 11.87 22.21 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.163 -0.471 . . . . 1.77 110.632 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 4.2 ptp180 47.05 32.89 2.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.982 0.913 . . . . 4.14 112.537 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 p -95.59 -73.0 0.6 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.283 -0.417 . . . . 1.87 112.018 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.96 -179.68 3.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.585 0.231 . . . . 1.54 111.488 -176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.4 p -91.36 139.45 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.048 -0.523 . . . . 1.29 109.961 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mt -76.1 -69.99 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.579 -0.448 . . . . 1.03 110.675 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -138.02 -87.22 0.26 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.076 0.465 . . . . 1.56 110.426 168.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.74 146.85 0.46 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.084 -0.962 . . . . 2.08 109.109 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.473 ' HB2' HD11 ' A' ' 117' ' ' ILE . 27.7 m170 -118.8 136.79 53.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.317 0.58 . . . . 0.68 111.119 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 20.6 tt0 -86.66 143.53 27.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.707 -1.133 . . . . 1.19 109.897 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -120.41 140.44 51.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.221 0.534 . . . . 0.74 110.713 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.29 154.04 22.1 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.616 -0.72 . . . . 0.51 112.187 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tp -55.38 -22.0 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.469 0.652 . . . . 0.67 111.013 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.9 p -79.19 -37.19 38.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.749 -0.659 . . . . 1.35 110.212 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 162' ' ' VAL . 14.5 m -68.61 -33.47 74.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.322 -0.854 . . . . 1.1 110.517 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.62 58.52 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.46 111.544 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -48.86 -39.11 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.178 0.514 . . . . 0.82 110.88 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.513 HD21 HD22 ' A' ' 143' ' ' LEU . 3.1 p-10 -84.99 33.16 0.53 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 2.17 111.283 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -61.95 -18.79 61.55 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.123 0.487 . . . . 1.39 111.418 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -76.58 -22.29 54.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.58 . . . . 2.46 110.885 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.45 155.15 17.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.829 -0.623 . . . . 1.89 111.933 -169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.403 -0.817 . . . . 2.88 109.505 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.517 HD21 ' CG1' ' A' ' 149' ' ' VAL . 10.6 tp -145.46 119.52 9.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.644 -0.502 . . . . 0.97 109.644 -176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 11.6 pt20 -133.36 -173.23 3.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.839 0.352 . . . . 1.77 111.355 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 54.5 tttm -61.78 114.51 3.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.43 110.499 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.98 -10.34 15.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.856 -0.687 . . . . 1.07 112.256 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.4 133.12 33.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 1.94 110.508 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.9 142.02 28.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.963 -0.562 . . . . 1.79 111.186 -176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.517 ' CG1' HD21 ' A' ' 143' ' ' LEU . 30.7 m -139.02 158.52 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.315 0.579 . . . . 1.16 111.748 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 8.4 t -115.12 148.01 39.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.339 -0.986 . . . . 1.44 108.339 171.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.64 ' HB3' HG12 ' A' ' 162' ' ' VAL . 18.8 p90 -159.99 163.03 34.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.61 111.035 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -124.36 121.5 35.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.267 0.556 . . . . 2.2 110.71 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 92' ' ' THR . 3.7 tt -101.66 133.08 46.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.28 -0.873 . . . . 1.24 110.224 171.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.561 ' OD2' ' HG2' ' A' ' 155' ' ' GLU . 21.9 t70 -168.08 -88.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.366 -0.134 . . . . 1.92 111.25 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HG2' ' OD2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -68.63 -32.27 72.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.866 0.365 . . . . 2.76 111.323 -177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 p -83.83 -16.38 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.011 -0.54 . . . . 1.98 111.147 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.3 15.05 60.57 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.988 -0.625 . . . . 1.27 112.752 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.421 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 48.4 mtm180 -151.14 -165.0 2.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.462 . . . . 3.61 109.754 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.29 116.27 24.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.48 111.204 -173.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.576 -0.738 . . . . 0.49 109.632 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.4 m 55.02 56.31 6.72 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.744 0.653 . . . . 1.55 111.128 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.64 HG12 ' HB3' ' A' ' 151' ' ' PHE . 10.3 m -80.92 146.1 7.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.984 -0.376 . . . . 1.26 109.984 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -148.1 141.6 25.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.907 0.384 . . . . 2.05 110.411 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.24 24.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.575 . . . . 0.75 111.095 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.53 127.92 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.413 -0.358 . . . . 1.56 110.518 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 1.3 mpt_? -95.65 114.99 26.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.181 -0.674 . . . . 2.94 109.181 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -98.21 114.5 26.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.084 -0.507 . . . . 3.88 110.715 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.45 -0.796 . . . . 4.04 110.423 -178.292 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 N-CA-C 112.027 -0.429 . . . . 11.74 112.027 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.87 106.28 3.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.718 0.294 . . . . 10.54 110.673 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.57 14.24 62.12 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.152 -0.547 . . . . 8.95 112.475 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 t -84.48 99.7 10.87 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.319 -0.623 . . . . 7.09 109.319 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.1 122.13 37.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.004 -0.544 . . . . 5.59 111.239 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.92 -23.93 52.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.106 -0.701 . . . . 2.99 109.106 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.86 -29.24 8.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.167 -0.924 . . . . 1.61 113.116 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -108.85 119.8 40.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.278 0.561 . . . . 2.0 112.138 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.92 118.02 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.178 -1.045 . . . . 1.27 108.178 169.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -87.43 138.28 31.61 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.948 -0.569 . . . . 1.14 110.162 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -106.56 131.62 53.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.533 -0.758 . . . . 2.31 109.286 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.09 -170.8 20.43 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.874 -0.891 . . . . 0.5 110.874 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.96 148.52 32.85 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.68 111.724 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.9 115.39 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.355 -0.838 . . . . 0.56 110.642 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.01 -26.92 12.9 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.873 -0.331 . . . . 0.76 110.891 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.29 140.15 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.687 -0.486 . . . . 1.55 109.687 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.9 tpp -125.43 106.09 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.43 . . . . 1.42 110.32 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 63.3 mttt -112.08 172.45 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.284 -0.416 . . . . 2.03 110.99 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.14 -45.58 79.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.903 0.705 . . . . 3.24 112.903 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.02 -43.04 4.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.343 0.497 . . . . 2.03 112.343 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 43.5 p90 -132.44 168.2 18.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.789 0.328 . . . . 1.25 111.003 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.19 159.93 28.06 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.374 -0.69 . . . . 0.71 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.93 126.87 52.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.574 -0.528 . . . . 1.08 109.574 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.37 124.4 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.323 -0.621 . . . . 0.61 109.323 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 9.9 tp10 -82.3 133.3 35.23 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.968 -0.753 . . . . 2.3 108.968 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -62.82 154.69 29.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.358 -0.837 . . . . 0.87 110.648 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 83' ' ' ILE . 13.2 tp -47.66 -42.68 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 1.58 112.568 -175.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -111.8 18.29 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.274 -0.421 . . . . 2.04 111.811 -174.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.553 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 15.6 m-70 57.46 58.78 3.62 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.251 0.548 . . . . 3.29 110.415 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -96.87 -47.24 5.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.283 -0.871 . . . . 2.89 110.869 -174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -158.22 -174.39 4.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 1.8 111.009 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -102.29 123.68 46.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.043 -0.526 . . . . 3.37 110.753 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG11 ' HE2' ' A' ' 55' ' ' TYR . 17.9 t -111.82 107.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.933 0.397 . . . . 0.87 110.821 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -81.24 123.41 28.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.186 0.517 . . . . 1.06 109.759 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -128.13 134.38 49.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.078 -0.51 . . . . 1.96 110.9 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 125.02 47.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.888 -0.782 . . . . 1.18 108.888 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -60.24 -16.75 36.53 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.292 0.478 . . . . 0.75 112.292 -173.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -59.71 -15.48 20.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.25 -0.432 . . . . 1.63 111.715 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -109.43 12.7 24.47 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.665 0.269 . . . . 2.07 111.401 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -82.11 133.42 35.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.722 0.296 . . . . 0.91 110.223 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.8 ttm -91.97 100.64 13.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.952 0.406 . . . . 1.73 110.613 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.32 -146.02 16.81 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.003 -0.618 . . . . 1.05 112.11 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -112.71 104.74 56.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.689 0.28 . . . . 2.14 110.602 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.82 -5.18 16.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.836 2.358 . . . . 1.01 112.292 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.21 -6.25 46.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.763 -0.653 . . . . 2.08 111.173 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -114.58 14.0 17.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.18 110.924 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.77 148.78 23.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.005 -0.543 . . . . 0.92 110.579 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -145.0 177.22 8.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.928 -0.578 . . . . 2.35 110.107 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 49' ' ' LEU . 1.9 mm? -72.25 123.29 22.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.533 . . . . 1.4 110.944 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.1 1.59 48.31 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.955 -0.566 . . . . 0.75 112.551 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -79.13 123.74 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.812 0.339 . . . . 1.06 110.657 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -74.31 140.87 45.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.808 -0.633 . . . . 2.51 111.186 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.82 154.27 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.893 -0.594 . . . . 0.44 110.684 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.87 134.29 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.648 -0.871 . . . . 1.49 108.648 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.559 ' CB ' HG22 ' A' ' 75' ' ' VAL . 3.5 p90 -164.9 175.89 9.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.527 0.566 . . . . 0.66 112.527 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 p -126.32 173.6 9.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.518 -0.764 . . . . 0.94 111.113 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -108.62 144.72 35.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 1.19 111.019 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.86 37.34 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 2.04 111.439 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -90.39 61.23 4.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.322 -0.622 . . . . 5.33 109.322 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -74.14 -74.14 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.518 -0.764 . . . . 5.42 110.929 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.52 146.89 9.46 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.876 -0.678 . . . . 4.76 111.42 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 179.92 173.62 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.338 -0.986 . . . . 6.38 108.338 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.9 p -70.29 -27.62 64.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.262 -0.644 . . . . 6.4 109.262 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t 68.45 7.1 5.78 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 114.714 -1.13 . . . . 5.23 111.216 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.2 m -75.46 -23.64 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.22 0.533 . . . . 6.95 110.079 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.4 p -104.28 5.2 34.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.564 -0.744 . . . . 6.02 110.902 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.62 101.73 0.2 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.694 -0.765 . . . . 4.09 112.577 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -87.86 -48.82 7.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.056 -0.72 . . . . 4.22 109.056 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.5 133.65 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.36 -0.836 . . . . 2.09 108.775 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.0 mt -114.04 150.25 43.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.671 -0.241 . . . . 2.3 110.932 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.4 148.84 84.7 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.571 2.181 . . . . 1.43 111.762 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.04 156.68 20.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.82 110.566 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.17 166.53 24.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.696 -0.229 . . . . 2.3 110.807 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 55.55 76.53 0.27 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.892 0.745 . . . . 2.01 110.611 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.0 t -115.84 120.3 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.72 -0.673 . . . . 0.8 110.664 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -117.26 151.41 37.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.416 -0.587 . . . . 3.51 109.416 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtm -87.26 143.4 27.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.966 -0.294 . . . . 1.12 110.641 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -130.16 120.04 18.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.345 -0.983 . . . . 1.67 108.345 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.4 116.53 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.431 2.087 . . . . 2.15 116.002 -163.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? 54.59 127.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.319 1.97 . . . . 4.61 116.319 162.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 t30 75.74 30.47 0.77 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.585 -1.189 . . . . 2.84 110.918 167.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 m -94.83 4.5 53.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 1.7 110.886 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 27' ' ' LEU . 10.3 mm -108.21 136.16 19.85 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.299 -0.63 . . . . 0.92 109.299 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.49 156.2 67.13 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.527 2.151 . . . . 1.03 112.003 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.28 146.0 43.6 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.714 -0.221 . . . . 2.76 110.943 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 160' ' ' ALA . 36.5 Cg_endo -67.37 150.33 80.91 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.998 2.466 . . . . 1.08 112.139 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.34 94.14 6.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.052 0.453 . . . . 1.1 110.61 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.6 t -138.11 134.58 44.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.829 -0.804 . . . . 1.23 108.829 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 mt -74.83 -65.09 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.582 -0.447 . . . . 2.87 111.928 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 91' ' ' THR . 34.3 mt-10 -96.49 -56.12 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.19 0.519 . . . . 2.84 111.302 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER 175.9 160.59 0.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.264 -1.334 . . . . 1.42 107.465 -174.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 153' ' ' ILE . 1.3 m -101.53 -54.6 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.352 -0.539 . . . . 1.3 110.18 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -138.91 158.52 44.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.791 -0.448 . . . . 1.29 109.791 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -112.92 155.39 24.82 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.901 -1.148 . . . . 1.36 107.901 170.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.72 177.65 38.74 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 119.674 -1.251 . . . . 0.53 112.012 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.46 149.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.605 -0.517 . . . . 1.37 109.605 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.54 123.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.737 0.303 . . . . 0.69 111.276 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.93 -55.97 4.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.89 111.722 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -151.69 120.79 3.44 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.522 -0.308 . . . . 3.92 111.01 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.08 151.44 67.26 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.059 2.506 . . . . 2.22 111.362 172.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 111' ' ' TYR . 1.7 mm? -86.12 89.17 7.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.266 . . . . 3.32 111.203 -173.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -98.79 -63.98 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.355 -0.538 . . . . 5.56 110.814 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 2.3 p -92.65 10.66 29.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 4.14 111.807 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 105' ' ' ASN . 48.2 mm -83.63 -41.82 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.318 -0.401 . . . . 3.46 111.422 -173.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' TYR . 93.3 m-20 75.05 142.66 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.672 0 O-C-N 123.685 0.616 . . . . 4.99 111.903 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.657 ' HA ' ' CG ' ' A' ' 111' ' ' TYR . 38.4 Cg_endo -67.04 -16.65 49.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.274 2.649 . . . . 4.27 113.464 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -87.44 -5.43 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 3.94 110.786 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.54 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 5.9 tp-100 -87.39 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 5.6 109.656 172.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -77.05 0.04 22.84 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.786 0.662 . . . . 5.3 112.786 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 108' ' ' GLN . 4.2 pt-20 -114.23 15.33 18.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.818 0.818 . . . . 4.95 110.166 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.657 ' CG ' ' HA ' ' A' ' 106' ' ' PRO . 7.7 t80 -66.05 -20.99 66.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.491 -1.231 . . . . 3.19 111.791 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.55 -10.79 55.11 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.023 -0.271 . . . . 1.24 111.648 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 87.04 157.61 31.18 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.473 -0.87 . . . . 0.94 112.176 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 130' ' ' GLU . 59.7 mt -144.03 135.33 25.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.93 111.395 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 mt -106.22 138.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.793 -1.094 . . . . 0.49 109.726 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -89.59 117.15 28.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.593 0.711 . . . . 1.4 110.401 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.2 mm -96.48 132.31 41.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.008 -0.996 . . . . 0.63 109.502 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 124' ' ' THR . 2.3 pt? -86.45 152.79 22.39 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.91 -0.316 . . . . 1.21 110.56 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -59.83 161.39 6.46 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.124 -0.489 . . . . 2.29 111.265 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.41 -23.68 64.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.487 -0.779 . . . . 2.78 111.282 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.38 3.11 54.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.672 -0.24 . . . . 1.77 110.764 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 59.45 88.72 0.07 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.494 0.664 . . . . 4.14 109.759 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -144.5 -77.92 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 1.87 111.378 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 17.0 p -123.83 -166.45 1.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.682 0.277 . . . . 1.54 110.649 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 3.5 p -95.25 126.2 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.912 -0.585 . . . . 1.29 109.729 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.6 mt -65.31 -69.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 120.719 -0.392 . . . . 1.03 110.883 -174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.1 m -137.91 -85.93 0.28 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 1.56 110.485 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -176.43 139.71 0.35 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.649 -1.16 . . . . 2.08 108.151 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.546 ' HB2' HD11 ' A' ' 117' ' ' ILE . 19.4 m170 -117.88 130.19 56.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.69 -0.804 . . . . 0.68 111.277 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 158' ' ' ARG . 16.4 tt0 -85.55 142.67 28.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.476 -1.238 . . . . 1.19 109.435 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 43.1 p90 -117.91 136.09 53.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.31 0.576 . . . . 0.74 110.363 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.55 150.96 22.89 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.508 -0.769 . . . . 0.51 112.312 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.51 -27.95 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.226 0.536 . . . . 0.67 110.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.9 p -76.22 -39.81 53.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.661 -0.7 . . . . 1.35 111.034 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 15.1 p -82.51 -14.96 54.08 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.803 -0.635 . . . . 1.1 110.943 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -79.5 58.28 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 1.46 110.5 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 137' ' ' VAL . 6.8 t -51.45 -35.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.591 . . . . 0.82 110.81 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.504 ' OD1' HD22 ' A' ' 143' ' ' LEU . 6.2 p30 -88.26 21.17 2.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.459 -0.791 . . . . 2.17 111.228 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -54.06 -23.61 14.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.833 0.679 . . . . 1.39 112.833 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -93.04 -1.57 56.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.932 0.396 . . . . 2.46 111.819 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.17 175.75 9.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.204 -0.453 . . . . 1.89 110.202 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.6 mt -91.41 29.1 1.53 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.228 0.537 . . . . 2.88 109.828 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 164' ' ' ALA . 18.9 tp -51.44 115.15 1.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.409 -1.269 . . . . 0.97 112.073 -174.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -122.37 -176.31 3.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 1.77 110.544 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -69.69 130.96 43.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 1.43 109.612 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.67 43.65 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.662 -0.78 . . . . 1.07 112.196 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.99 134.88 34.41 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.678 -0.409 . . . . 1.94 110.218 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 165' ' ' VAL . 92.5 mt -80.19 141.28 35.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 1.79 110.258 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.1 m -124.85 142.81 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.124 -0.489 . . . . 1.16 110.738 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.6 p -100.83 121.81 42.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.784 -0.644 . . . . 1.44 109.455 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.0 p90 -144.06 163.61 33.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.117 -0.492 . . . . 0.61 110.103 -176.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.532 ' NE ' ' HB2' ' A' ' 161' ' ' CYS . 0.9 OUTLIER -137.31 124.2 21.35 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.683 0.754 . . . . 2.2 111.247 176.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.401 HG23 HG21 ' A' ' 92' ' ' THR . 1.4 tt -99.35 134.63 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.627 -1.17 . . . . 1.24 110.353 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 10.4 t70 -153.32 -97.34 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.515 0.191 . . . . 1.92 111.515 176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -25.0 41.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.882 0.373 . . . . 2.76 111.683 -174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -80.58 -16.84 53.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.129 0.49 . . . . 1.98 110.182 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.43 17.67 62.3 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.007 -0.542 . . . . 1.27 113.255 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' A' ' 130' ' ' GLU . 41.5 mtm180 -145.02 -170.65 3.47 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.14 124.23 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.402 0.62 . . . . 0.48 111.437 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 86' ' ' PRO . . . -135.64 157.91 45.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.443 -0.799 . . . . 0.49 110.091 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.532 ' HB2' ' NE ' ' A' ' 152' ' ' ARG . 59.4 m 49.27 61.91 2.89 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.772 0.67 . . . . 1.55 109.954 -171.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 151' ' ' PHE . 53.6 t -90.89 121.83 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 1.26 110.33 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -136.21 132.75 36.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.964 -0.384 . . . . 2.05 109.964 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -60.33 120.43 9.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.75 111.472 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' LEU . 7.1 p -127.02 126.46 68.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.747 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.9 mpt_? -99.91 123.91 44.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.967 -0.383 . . . . 2.94 109.967 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -126.47 166.29 17.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.758 -0.655 . . . . 3.88 109.918 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.763 -0.653 . . . . 4.04 110.38 178.212 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 N-CA-C 112.307 -0.317 . . . . 11.74 112.307 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.92 -64.96 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.603 0.24 . . . . 10.54 110.993 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.32 55.83 0.42 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.847 -0.692 . . . . 8.95 112.439 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 t -146.64 161.72 39.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.264 -0.643 . . . . 7.09 109.264 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.08 -166.28 0.89 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.829 -0.623 . . . . 5.59 109.384 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.48 -29.18 67.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.8 0.333 . . . . 2.99 111.212 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.36 -20.8 8.04 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.089 -0.577 . . . . 1.61 112.767 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -123.78 130.46 52.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.088 0.471 . . . . 2.0 111.524 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.88 123.38 39.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 1.27 109.32 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.83 139.76 37.98 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.917 -0.583 . . . . 1.14 109.798 -175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.443 HH11 ' CD1' ' A' ' 78' ' ' LEU . 37.8 ttm-85 -110.82 148.38 32.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.157 -0.683 . . . . 2.31 109.157 -177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.39 178.35 46.97 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.52 -0.847 . . . . 0.5 112.173 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 145.62 48.88 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.96 0.409 . . . . 0.68 111.17 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -65.96 117.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.419 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' HD22 ' A' ' 49' ' ' LEU . . . -97.9 -42.17 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.078 -0.249 . . . . 0.76 110.914 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 23' ' ' PHE . 2.4 m -124.84 148.63 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 109.949 -0.389 . . . . 1.55 109.949 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.4 mtp -133.79 110.07 9.54 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.973 -0.38 . . . . 1.42 109.973 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -92.69 170.69 9.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.272 -1.01 . . . . 2.03 108.272 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.66 -16.6 60.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.073 0.463 . . . . 3.24 110.034 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -104.31 -49.27 3.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.03 111.651 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -147.74 -179.84 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.796 -0.184 . . . . 1.25 110.621 -175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.69 165.28 28.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.275 -0.964 . . . . 0.71 112.389 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HD2' HG21 ' A' ' 16' ' ' VAL . 49.9 m-85 -118.79 128.71 54.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.894 0.378 . . . . 1.08 110.016 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.8 mt -97.77 125.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.956 -0.566 . . . . 0.61 109.493 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 139.16 36.35 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.806 -0.813 . . . . 2.3 108.806 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -66.34 156.87 33.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.176 0.512 . . . . 0.87 111.447 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.539 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -63.4 -42.46 98.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.786 -0.643 . . . . 1.58 111.143 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 p -97.2 12.27 33.43 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.868 0.692 . . . . 2.04 112.868 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 59.68 58.26 2.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.888 0.375 . . . . 3.29 111.332 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -118.54 -28.14 5.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.243 0.46 . . . . 2.89 112.243 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -169.55 170.61 8.08 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.953 0.342 . . . . 1.8 110.614 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.16 140.41 37.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.862 0.363 . . . . 3.37 110.349 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.63 127.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.043 0.449 . . . . 0.87 110.621 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -84.1 121.51 27.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.898 -0.592 . . . . 1.06 110.776 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -128.05 146.97 50.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.732 -0.84 . . . . 1.96 108.732 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HD2' ' H ' ' A' ' 38' ' ' SER . 2.0 t60 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.297 -0.631 . . . . 1.18 109.297 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -64.89 -19.58 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.027 0.441 . . . . 0.75 111.043 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 20.9 t -62.97 -36.58 83.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.599 -0.728 . . . . 1.63 111.08 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.91 16.85 23.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.865 0.364 . . . . 2.07 110.599 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.553 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 74.9 t80 -75.98 135.9 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.517 -0.549 . . . . 0.91 109.517 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.429 ' H ' HG23 ' A' ' 75' ' ' VAL . 60.4 mtp -98.09 105.93 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.264 0.554 . . . . 1.73 110.961 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.32 -134.59 7.77 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.025 -0.989 . . . . 1.05 111.999 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.1 100.83 51.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.339 . . . . 2.14 110.273 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.26 -12.6 21.02 Favored 'Trans proline' 0 N--CA 1.471 0.185 0 C-N-CA 122.976 2.45 . . . . 1.01 113.133 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -77.17 -13.44 59.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 2.08 110.37 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -102.84 14.63 31.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 2.18 111.359 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 mt -88.67 141.73 28.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.219 -0.446 . . . . 0.92 110.211 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -136.06 170.56 15.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.673 -0.694 . . . . 2.35 109.934 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 15' ' ' ALA . 54.2 mt -74.68 114.59 13.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.01 -0.541 . . . . 1.4 110.488 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.7 26.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.898 -0.668 . . . . 0.75 112.764 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -81.16 116.41 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.048 0.451 . . . . 1.06 111.45 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -64.53 134.37 54.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.836 -1.075 . . . . 2.51 111.328 176.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.4 m -148.21 141.73 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.674 -0.491 . . . . 0.44 109.674 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 78' ' ' LEU . 11.5 pt-20 -114.82 145.17 42.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.506 -0.478 . . . . 1.49 109.922 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 5.7 p90 -166.64 179.71 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.66 111.651 -168.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 p -131.93 170.54 14.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.94 110.835 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.79 142.62 35.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.672 0.272 . . . . 1.19 111.157 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.64 70.92 10.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.317 0.579 . . . . 2.04 110.547 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD2' HD21 ' A' ' 70' ' ' LEU . 2.2 tpm_? -88.56 16.82 6.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.917 0.865 . . . . 5.33 110.02 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -95.09 131.44 41.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.623 -0.717 . . . . 5.42 110.049 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 166.66 12.3 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.547 -0.835 . . . . 4.76 112.87 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -104.9 27.28 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.474 0.654 . . . . 6.38 110.451 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -87.37 12.61 11.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 6.4 111.474 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t -89.26 47.77 1.53 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.084 -0.507 . . . . 5.23 110.49 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.7 m -65.94 -38.18 81.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 6.95 110.541 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 t -114.99 -30.37 6.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.148 -0.686 . . . . 6.02 109.148 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.78 45.73 48.71 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.573 -0.739 . . . . 4.09 114.546 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -80.94 -62.41 1.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.486 0.643 . . . . 4.22 109.953 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.16 117.6 6.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 2.09 110.784 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.43 HD21 ' HD2' ' A' ' 59' ' ' ARG . 1.5 pp -99.75 154.45 37.25 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.479 -0.782 . . . . 2.3 110.011 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.18 146.55 95.96 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.536 2.158 . . . . 1.43 112.457 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -93.83 146.5 23.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.696 -0.684 . . . . 0.82 111.043 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.58 176.48 5.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 2.3 110.937 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.5 32.41 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.635 0.731 . . . . 2.01 110.797 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 4.2 m -73.74 116.62 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.79 . . . . 0.8 111.693 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -123.27 144.66 49.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.919 -0.582 . . . . 3.51 110.302 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.595 ' HA ' HG12 ' A' ' 53' ' ' VAL . 50.8 mtt -74.07 147.06 43.16 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.097 0.475 . . . . 1.12 111.395 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 54' ' ' GLU . 75.7 mt -119.43 157.2 52.14 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.518 -0.765 . . . . 1.67 110.951 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.5 169.95 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.627 2.218 . . . . 2.15 111.847 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -78.08 175.16 10.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.0 -0.545 . . . . 4.61 111.297 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.03 3.04 4.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.307 -0.861 . . . . 2.84 112.234 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.0 m -71.92 -25.73 62.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.476 -0.329 . . . . 1.7 110.62 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.539 ' CD1' HD21 ' A' ' 27' ' ' LEU . 11.0 mm -105.99 120.99 47.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.92 109.954 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.19 158.99 17.74 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.007 2.471 . . . . 1.03 113.523 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -125.87 165.19 28.59 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.608 -0.724 . . . . 2.76 109.899 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 7.4 Cg_exo -69.47 156.16 64.86 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.668 2.246 . . . . 1.08 111.92 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.51 93.6 4.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.917 0.389 . . . . 1.1 111.373 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 91' ' ' THR . 7.7 t -141.88 92.29 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.771 -0.455 . . . . 1.23 109.771 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.82 -37.85 76.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.788 0.328 . . . . 2.87 110.718 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.14 -26.06 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 2.84 110.8 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.462 ' H ' HG12 ' A' ' 88' ' ' VAL . 66.7 m 70.45 113.05 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.831 . . . . 1.42 111.23 -175.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 t -93.66 -24.11 18.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.025 0.75 . . . . 1.3 113.025 -170.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -138.84 160.87 38.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.909 0.862 . . . . 1.29 112.748 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -140.15 155.49 46.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.952 -1.476 . . . . 1.36 107.186 169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.3 -165.69 23.03 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.33 -1.414 . . . . 0.53 112.762 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.85 146.7 24.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.807 -0.442 . . . . 1.37 109.807 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.11 122.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.382 -0.372 . . . . 0.69 110.8 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.3 -67.99 0.75 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.893 -0.594 . . . . 0.89 111.667 -175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -157.34 124.53 2.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 3.92 111.818 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.34 158.64 44.49 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.72 2.28 . . . . 2.22 110.699 169.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.0 pt? -79.53 88.12 5.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.988 0.899 . . . . 3.32 111.758 -174.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -98.31 -63.33 1.14 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.538 -0.755 . . . . 5.56 109.82 169.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.2 p -92.07 -7.79 47.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.688 -0.687 . . . . 4.14 111.454 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 101' ' ' LEU . 91.8 mt -67.76 -42.59 86.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 3.46 111.603 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 71.8 151.5 0.14 Allowed Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.294 0.637 . . . . 4.99 111.25 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.17 -13.1 33.24 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.822 2.348 . . . . 4.27 111.891 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.79 -20.54 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.621 -0.718 . . . . 3.94 110.266 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -85.34 152.83 22.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.745 -0.661 . . . . 5.6 109.581 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -70.2 -11.15 60.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.124 0.488 . . . . 5.3 111.19 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.58 16.92 5.0 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.319 0.581 . . . . 4.95 110.836 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.532 ' O ' HD13 ' A' ' 101' ' ' LEU . 22.8 t80 -50.35 -36.2 31.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.406 1.082 . . . . 3.19 113.77 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 130' ' ' GLU . . . -72.82 -29.04 62.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.152 0.427 . . . . 1.24 112.152 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.39 158.16 16.28 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.078 -0.809 . . . . 0.94 111.078 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 mt -143.35 147.41 34.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.028 0.914 . . . . 0.93 113.258 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.7 mt -113.45 142.65 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.473 -1.239 . . . . 0.49 110.152 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -87.12 117.41 25.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.532 -0.544 . . . . 1.4 109.532 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 129' ' ' HIS . 8.6 mm -103.72 124.08 57.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.574 . . . . 0.63 110.391 -174.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.2 pt? -97.91 153.47 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.229 -0.656 . . . . 1.21 109.229 175.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.07 177.43 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.274 0.559 . . . . 2.29 111.454 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' HG3' HD22 ' A' ' 121' ' ' LEU . 10.2 pt-20 -65.85 -25.71 67.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.417 -0.81 . . . . 2.78 111.851 -175.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -94.23 -2.15 52.92 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.39 -0.596 . . . . 1.77 109.39 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.47 29.14 18.78 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.115 -0.948 . . . . 4.14 110.646 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.8 p -86.1 -38.17 18.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.903 0.334 . . . . 1.87 111.903 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -143.14 166.35 24.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.261 0.553 . . . . 1.54 112.042 -174.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.17 132.37 33.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.186 -0.915 . . . . 1.29 108.68 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.3 mt -75.82 -71.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.017 -0.673 . . . . 1.03 111.242 -174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.0 t -142.56 -87.29 0.15 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.651 0.738 . . . . 1.56 110.427 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -178.11 133.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.03 -1.441 . . . . 2.08 107.984 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.582 ' HB2' HD11 ' A' ' 117' ' ' ILE . 35.6 m170 -109.21 132.77 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.264 -0.574 . . . . 0.68 110.792 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 112' ' ' ALA . 23.9 tt0 -83.8 147.65 27.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.512 -0.767 . . . . 1.19 110.643 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -119.27 151.21 38.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.42 -0.355 . . . . 0.74 110.709 177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.13 150.38 16.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.51 112.194 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -57.09 -26.96 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.217 0.532 . . . . 0.67 111.21 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.7 p -73.85 -32.49 63.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.751 -0.659 . . . . 1.35 110.469 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 14.7 m -87.64 -13.9 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 1.1 110.635 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -73.1 59.06 0.51 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.587 -0.733 . . . . 1.46 111.644 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.9 t -48.94 -42.46 14.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.247 0.546 . . . . 0.82 110.618 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 20.4 m120 -88.36 33.88 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.615 . . . . 2.17 111.727 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -62.32 -19.2 63.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.205 0.526 . . . . 1.39 110.9 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -81.66 -21.45 38.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 2.46 111.896 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.26 169.05 18.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.665 0.745 . . . . 1.89 112.788 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.652 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.6 pt? -85.66 27.94 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.631 -1.168 . . . . 2.88 110.509 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 164' ' ' ALA . 14.9 tp -56.16 113.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.492 -0.777 . . . . 0.97 111.146 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -128.83 -175.08 3.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.472 -0.786 . . . . 1.77 110.207 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.27 136.22 49.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 110.075 -0.343 . . . . 1.43 110.075 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.69 -6.62 74.07 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.839 -0.696 . . . . 1.07 112.679 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.44 141.52 28.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.022 -0.671 . . . . 1.94 109.933 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.8 144.09 32.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.779 -0.646 . . . . 1.79 110.981 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 147.59 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.562 -0.745 . . . . 1.16 111.159 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 33.2 t -110.46 146.04 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.851 -0.613 . . . . 1.44 109.898 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.488 ' HB3' HG12 ' A' ' 162' ' ' VAL . 15.9 p90 -165.96 174.76 9.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.61 110.018 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 127.45 11.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.04 0.448 . . . . 2.2 111.217 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.464 HD13 ' CE1' ' A' ' 129' ' ' HIS . 8.7 pt -95.84 144.72 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.675 -0.693 . . . . 1.24 109.282 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . 5.2 t70 -166.51 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.065 0.228 . . . . 1.92 111.103 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -82.41 -29.24 30.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.448 -0.501 . . . . 2.76 111.843 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.565 ' OG ' ' HG3' ' A' ' 86' ' ' PRO . 59.3 p -84.78 -17.01 39.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.742 0.306 . . . . 1.98 111.529 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.1 25.75 60.24 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.036 -0.602 . . . . 1.27 112.294 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -152.61 178.04 10.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.719 -0.474 . . . . 3.61 109.719 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.27 110.42 19.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.173 0.511 . . . . 0.48 111.115 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -127.28 164.33 21.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.585 -0.734 . . . . 0.49 110.647 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.3 m 60.98 32.12 19.93 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.82 0.7 . . . . 1.55 111.336 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 150' ' ' SER . 10.0 m -64.35 122.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.529 0.68 . . . . 1.26 111.283 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.606 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 6.7 p30 -131.32 125.08 31.83 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.269 -0.878 . . . . 2.05 109.413 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -61.96 133.06 54.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.75 111.189 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 83.6 t -118.23 121.16 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.97 -0.559 . . . . 1.56 111.724 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -91.38 138.9 31.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.963 -0.755 . . . . 2.94 108.963 170.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -120.43 149.38 42.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.358 0.599 . . . . 3.88 111.221 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 115.447 -0.797 . . . . 4.04 109.928 172.697 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.161 -0.376 . . . . 11.74 112.161 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.21 127.33 37.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.558 0.218 . . . . 10.54 110.684 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.35 -78.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.684 -0.566 . . . . 8.95 111.684 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 137.27 7.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.895 -0.409 . . . . 7.09 109.895 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -85.29 172.57 11.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.849 0.357 . . . . 5.59 110.242 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.57 -17.88 46.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.886 -0.597 . . . . 2.99 111.596 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.99 -29.42 1.59 Allowed Glycine 0 CA--C 1.519 0.316 0 CA-C-N 116.288 -0.415 . . . . 1.61 112.787 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.21 126.26 42.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.032 0.444 . . . . 2.0 110.772 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.89 120.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.454 -0.794 . . . . 1.27 109.432 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -90.65 158.67 16.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.34 -0.615 . . . . 1.14 109.34 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 30.8 ttm180 -129.1 143.02 50.72 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.307 -0.406 . . . . 2.31 110.485 -174.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.32 -164.88 24.78 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.117 -0.793 . . . . 0.5 111.117 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.87 154.85 39.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.168 0.509 . . . . 0.68 111.276 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.6 mm -73.41 110.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.56 111.284 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 133' ' ' ILE . . . -97.52 -49.98 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.101 0.477 . . . . 0.76 110.823 176.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.15 123.56 69.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.475 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.0 ttm -119.03 109.11 15.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.835 -0.62 . . . . 1.42 109.574 174.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 5.9 tppt? -98.23 -163.44 1.04 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.234 -1.024 . . . . 2.03 108.234 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' HD22 ' A' ' 20' ' ' ASN . 9.0 pt-20 -79.43 -39.13 33.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.13 0.419 . . . . 3.24 112.13 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.425 HD22 ' HG3' ' A' ' 19' ' ' GLU . 48.7 m-80 -111.92 -35.06 5.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.008 0.432 . . . . 2.03 112.109 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -134.01 178.04 7.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.509 -0.314 . . . . 1.25 110.951 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.39 171.67 36.65 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.045 -0.598 . . . . 0.71 111.703 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -115.93 127.45 54.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.95 0.405 . . . . 1.08 110.085 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.0 mt -98.28 127.33 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 0.61 110.976 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.5 117.81 22.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.653 -0.869 . . . . 2.3 108.653 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.7 p -68.94 156.41 38.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.047 0.451 . . . . 0.87 111.818 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 0.7 OUTLIER -56.48 -47.25 79.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.533 -0.758 . . . . 1.58 110.976 -178.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.77 9.51 27.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.18 -0.463 . . . . 2.04 111.755 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p80 39.28 37.71 0.28 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.449 1.1 . . . . 3.29 112.599 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' HA ' ' NE2' ' A' ' 109' ' ' GLN . 5.7 t70 -98.91 -17.6 18.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.125 -0.943 . . . . 2.89 110.105 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.84 155.39 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.139 -0.937 . . . . 1.8 110.591 -166.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.188 -0.671 . . . . 3.37 109.188 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -108.95 108.56 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.784 -0.366 . . . . 0.87 110.1 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 8.1 t80 -68.58 121.22 15.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 1.06 109.723 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -121.28 128.35 52.27 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.066 -0.515 . . . . 1.96 110.827 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 122.99 41.15 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.521 -0.918 . . . . 1.18 108.521 174.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -62.18 -16.48 53.29 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.097 0.406 . . . . 0.75 112.097 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -57.14 -29.49 63.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.996 -0.547 . . . . 1.63 111.628 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -103.29 24.04 11.54 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.849 0.357 . . . . 2.07 111.638 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' HG3' ' A' ' 77' ' ' MET . 77.6 t80 -86.22 139.06 31.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.91 110.768 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.4 ttm -96.77 97.09 9.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.098 0.475 . . . . 1.73 110.333 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.95 -136.25 8.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.768 -0.729 . . . . 1.05 112.066 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.5 104.94 33.7 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.25 -0.278 . . . . 2.14 110.25 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -17.36 27.0 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.622 2.215 . . . . 1.01 112.226 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -74.35 -8.1 55.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.923 -0.58 . . . . 2.08 110.459 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -107.06 10.5 30.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.728 -0.669 . . . . 2.18 110.597 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.9 142.29 27.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.92 110.306 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -116.1 161.95 18.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.464 -0.789 . . . . 2.35 109.969 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.78 120.22 19.08 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.59 -0.522 . . . . 1.4 109.59 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 133' ' ' ILE . . . 96.34 3.9 59.83 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.964 -0.636 . . . . 0.75 112.01 -176.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -69.09 129.09 38.91 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.956 0.408 . . . . 1.06 110.823 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 80' ' ' LYS . 30.4 mt-10 -71.41 126.5 29.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.386 -0.825 . . . . 2.51 110.637 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 77' ' ' MET . 27.3 m -140.51 157.74 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.242 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -128.81 150.8 50.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.367 -0.605 . . . . 1.49 109.367 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.532 ' CB ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -164.0 175.68 10.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.947 0.721 . . . . 0.66 112.947 -166.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -136.85 166.51 23.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.16 -0.927 . . . . 0.94 109.732 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.5 mt -94.71 147.51 23.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.003 0.43 . . . . 1.19 111.342 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.86 26.62 1.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.04 110.798 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -88.0 61.25 6.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.622 0.725 . . . . 5.33 110.056 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.005 -0.998 . . . . 5.42 110.074 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.41 -171.99 31.33 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.559 -0.617 . . . . 4.76 111.559 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -72.0 113.43 9.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.824 0.345 . . . . 6.38 110.281 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.4 m -141.78 -82.96 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 6.4 110.778 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 15.5 t -91.45 12.83 19.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.438 0.637 . . . . 5.23 110.317 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -76.59 -20.45 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.57 . . . . 6.95 111.018 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -81.71 -8.7 59.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.966 -0.561 . . . . 6.02 110.731 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.14 -66.67 0.92 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.887 -0.673 . . . . 4.09 111.714 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -166.72 -56.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 4.22 110.274 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.96 171.95 17.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 2.09 110.191 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 1.1 pp -125.97 154.4 73.81 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.242 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 58.0 Cg_endo -71.76 158.7 52.61 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.47 2.113 . . . . 1.43 113.057 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.55 155.5 19.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.618 -0.719 . . . . 0.82 110.378 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -134.84 164.26 27.97 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.513 -0.312 . . . . 2.3 111.03 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 62.12 29.27 17.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.488 -0.778 . . . . 2.01 111.095 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 55' ' ' TYR . 39.3 t -73.9 122.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.945 -0.571 . . . . 0.8 110.843 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -126.46 156.91 39.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 3.51 110.442 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.467 ' HA ' HG12 ' A' ' 53' ' ' VAL . 61.9 mtt -72.3 143.24 48.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.12 110.814 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.86 143.33 27.36 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 115.0 -1.0 . . . . 1.67 109.178 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.16 135.33 69.86 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.768 1.645 . . . . 2.15 111.788 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 52' ' ' GLU . 6.4 ttpm? -60.58 149.61 34.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.689 -0.687 . . . . 4.61 111.378 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 77.88 26.05 0.64 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.34 -0.845 . . . . 2.84 110.55 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.8 m -88.37 -30.66 19.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.24 -1.022 . . . . 1.7 108.24 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.25 123.54 73.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.318 -1.31 . . . . 0.92 108.868 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.48 158.17 48.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.816 2.344 . . . . 1.03 113.649 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.63 155.95 46.77 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.709 -0.678 . . . . 2.76 110.575 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 57.0 Cg_endo -69.16 133.94 27.97 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.729 2.286 . . . . 1.08 112.87 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.05 94.64 8.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 1.1 110.334 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 3.0 t -137.22 156.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.928 -1.138 . . . . 1.23 107.928 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.18 -64.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.131 -0.627 . . . . 2.87 111.195 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 91' ' ' THR . 78.7 mm-40 -95.06 -57.18 2.5 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.576 -0.45 . . . . 2.84 112.062 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -179.98 156.57 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 1.42 109.902 -171.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.502 HG21 ' O ' ' A' ' 153' ' ' ILE . 2.9 m -106.12 -54.24 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.968 0.413 . . . . 1.3 110.219 173.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -143.94 177.56 8.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.357 0.599 . . . . 1.29 110.931 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -145.25 168.37 20.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.323 -1.362 . . . . 1.36 107.323 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.8 -170.38 43.31 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.636 -1.269 . . . . 0.53 112.647 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.427 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.9 p -121.62 146.65 26.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.6 -0.519 . . . . 1.37 109.6 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.72 120.23 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.036 -0.357 . . . . 0.69 110.036 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -74.17 -65.54 0.83 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.055 -0.521 . . . . 0.89 111.391 -172.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -169.51 109.39 0.48 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.577 -0.283 . . . . 3.92 110.349 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.56 122.58 7.02 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.687 2.258 . . . . 2.22 110.874 173.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.851 ' H ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -102.39 115.73 31.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.326 0.584 . . . . 3.32 111.091 -176.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -98.51 -64.71 1.01 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 5.56 110.666 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.84 -7.35 40.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.727 -0.669 . . . . 4.14 112.397 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.36 -42.52 90.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.472 0.545 . . . . 3.46 112.472 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -170.73 103.53 0.41 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.473 -0.195 . . . . 4.99 110.473 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.45 -7.37 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.195 2.596 . . . . 4.27 112.801 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.74 23.98 9.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 3.94 110.554 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -128.04 163.85 23.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.797 -0.445 . . . . 5.6 109.797 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 30' ' ' ASP . 39.6 tt0 -74.52 -28.71 61.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.623 0.249 . . . . 5.3 111.523 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.81 15.27 0.68 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.282 -0.417 . . . . 4.95 111.939 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.571 ' HA ' HD21 ' A' ' 101' ' ' LEU . 63.0 t80 -48.9 -32.2 8.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.252 -0.886 . . . . 3.19 113.137 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.65 63.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.856 0.688 . . . . 1.24 112.856 -170.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.65 162.26 13.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.382 -0.913 . . . . 0.94 111.695 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 128' ' ' GLN . 18.3 mt -143.41 147.24 34.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.93 112.015 -171.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -107.3 141.14 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.089 -0.96 . . . . 0.49 109.289 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 98' ' ' ALA . 8.0 pt-20 -88.86 113.18 24.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.542 0.686 . . . . 1.4 110.109 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 129' ' ' HIS . 6.7 mm -94.3 127.98 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.033 -0.985 . . . . 0.63 109.703 -174.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.3 pt? -85.84 159.61 19.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.162 -0.31 . . . . 1.21 110.162 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.84 164.04 8.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.623 . . . . 2.29 110.345 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.5 pm0 -68.31 -17.71 64.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.471 . . . . 2.78 109.744 175.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.577 HD22 ' HG2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -96.07 -17.19 21.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.612 -0.722 . . . . 1.77 110.462 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 20.9 ttm180 71.2 99.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.836 0.71 . . . . 4.14 111.653 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.0 t -154.75 -41.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.992 -0.283 . . . . 1.87 111.111 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 6.6 p -147.44 -171.95 3.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.742 0.306 . . . . 1.54 111.419 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.46 136.4 24.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.039 -0.528 . . . . 1.29 109.756 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.15 -69.51 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.67 -0.412 . . . . 1.03 110.925 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -138.61 -84.8 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.466 0.65 . . . . 1.56 110.841 171.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.454 ' HG3' HD13 ' A' ' 114' ' ' LEU . 1.6 pm0 -175.33 141.25 0.53 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.877 -1.056 . . . . 2.08 108.726 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.601 ' HB2' HD11 ' A' ' 117' ' ' ILE . 32.7 m170 -116.46 133.57 55.86 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.67 -0.412 . . . . 0.68 110.161 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.2 tt0 -86.61 146.29 26.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.682 -0.69 . . . . 1.19 109.656 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -117.02 146.63 42.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.889 0.376 . . . . 0.74 110.155 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -108.83 150.05 17.05 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.757 -0.735 . . . . 0.51 111.744 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.441 HG23 ' HA2' ' A' ' 50' ' ' GLY . 10.4 tp -58.73 -22.49 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.029 0.442 . . . . 0.67 111.369 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 35.2 p -73.23 -37.19 66.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.021 0.439 . . . . 1.35 110.682 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 11.2 p -90.65 -8.84 48.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.116 -0.493 . . . . 1.1 111.733 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 132' ' ' GLY . 54.1 mt -73.45 59.97 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 1.46 111.225 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.1 t -42.34 -47.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.287 0.477 . . . . 0.82 112.287 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.51 HD21 HD22 ' A' ' 143' ' ' LEU . 4.5 p-10 -93.15 34.36 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.737 0.273 . . . . 2.17 111.737 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -59.65 -14.81 15.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.274 0.472 . . . . 1.39 112.274 -176.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -79.86 -16.41 55.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 2.46 110.727 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.81 151.0 20.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.607 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.4 mt -75.68 93.11 3.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.416 0.627 . . . . 2.88 110.076 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.51 HD22 HD21 ' A' ' 138' ' ' ASN . 11.7 tp -100.24 116.98 33.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.159 -0.928 . . . . 0.97 109.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.36 -176.35 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.335 0.588 . . . . 1.77 111.782 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 98' ' ' ALA . 58.0 tttm -65.47 126.14 27.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.981 -1.009 . . . . 1.43 110.117 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 103.71 -1.57 45.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.448 -0.882 . . . . 1.07 113.133 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -91.69 141.35 28.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.094 0.447 . . . . 1.94 111.04 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD23 ' HB ' ' A' ' 96' ' ' VAL . 94.5 mt -82.51 139.4 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 1.79 111.278 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.07 153.51 29.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.211 0.529 . . . . 1.16 111.073 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 22.9 t -112.72 142.34 45.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.468 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 27.1 p90 -158.45 158.21 33.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.61 110.354 -175.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 63.2 mtt180 -125.33 120.82 32.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.04 -0.355 . . . . 2.2 110.04 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.502 ' O ' HG21 ' A' ' 92' ' ' THR . 5.3 tt -102.29 120.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.072 -0.513 . . . . 1.24 110.794 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -159.75 -87.54 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.708 0.289 . . . . 1.92 110.478 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 6.0 mm-40 -75.07 -20.84 59.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.489 0.661 . . . . 2.76 109.822 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.8 p -83.79 -18.24 38.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.232 -0.895 . . . . 1.98 111.249 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.91 5.46 7.47 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.943 -0.571 . . . . 1.27 113.526 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -153.42 -164.12 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 3.61 108.426 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.1 109.14 17.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.407 0.622 . . . . 0.48 111.119 -172.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -120.18 165.16 15.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.26 -0.882 . . . . 0.49 109.944 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 73.7 m 59.02 36.37 24.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.995 0.426 . . . . 1.55 110.613 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' SER . 42.2 t -73.38 110.67 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.919 -0.582 . . . . 1.26 110.648 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -129.38 129.39 44.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.875 -0.602 . . . . 2.05 110.25 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 102.66 0.97 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.75 110.896 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.93 137.6 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.177 -0.465 . . . . 1.56 110.394 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 140.29 45.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.452 -0.34 . . . . 2.94 110.386 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 101.36 2.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.062 -0.718 . . . . 3.88 109.062 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.434 0 CA-C-N 116.061 -0.518 . . . . 4.04 111.046 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.162 -0.375 . . . . 11.74 112.162 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.64 41.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.409 -0.219 . . . . 10.54 110.409 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.23 -88.06 1.58 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 121.064 -0.589 . . . . 8.95 112.344 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -155.96 107.12 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.146 -0.316 . . . . 7.09 110.146 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -104.23 172.32 6.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.621 -0.511 . . . . 5.59 109.621 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.05 -17.31 47.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 2.99 111.312 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.42 18.11 67.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.047 -0.597 . . . . 1.61 112.148 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 8' ' ' GLN . 11.4 mm-40 -130.52 119.8 23.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.322 0.582 . . . . 2.0 111.316 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.29 114.5 30.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.11 -0.95 . . . . 1.27 108.868 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.93 138.22 31.71 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.057 -0.72 . . . . 1.14 109.057 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 11.5 ptp180 -129.04 151.52 49.64 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.439 -0.504 . . . . 2.31 110.385 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.25 -158.95 9.39 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.509 -1.036 . . . . 0.5 110.509 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 139.08 44.49 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.833 0.349 . . . . 0.68 110.629 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.6 mm -64.3 114.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.56 110.948 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.02 -40.05 3.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.463 -0.335 . . . . 0.76 111.249 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 54.5 t -116.92 123.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.615 0.245 . . . . 1.55 110.713 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.5 mtp -123.21 108.14 12.48 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.05 -0.722 . . . . 1.42 109.05 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -106.76 -165.31 1.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.625 -0.509 . . . . 2.03 109.625 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 18' ' ' LYS . 34.3 tt0 -76.24 -46.98 25.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 3.24 111.337 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -101.35 -32.67 10.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.466 . . . . 2.03 111.379 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -148.93 -169.82 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.4 -0.364 . . . . 1.25 111.18 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.37 -176.79 30.82 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.012 -0.613 . . . . 0.71 111.984 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.456 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 84.1 m-85 -131.54 140.31 49.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 1.08 110.442 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.0 131.03 67.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.504 -0.771 . . . . 0.61 109.989 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' OE1' HG22 ' A' ' 133' ' ' ILE . 46.4 mt-10 -70.77 130.39 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.073 -0.714 . . . . 2.3 109.073 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.59 139.53 58.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.761 -0.459 . . . . 0.87 109.761 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.7 tp -52.22 -36.84 53.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 1.58 111.476 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.4 t -108.35 22.75 15.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 2.04 110.93 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 43.47 51.63 6.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.822 0.849 . . . . 3.29 111.856 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -87.95 -50.27 6.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.666 -1.152 . . . . 2.89 110.397 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -160.81 -173.04 3.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 1.8 110.576 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -101.53 129.65 47.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.895 0.379 . . . . 3.37 110.9 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -105.36 122.66 58.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.87 110.923 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -93.07 120.12 33.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 1.06 110.089 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.32 152.71 38.63 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.381 -0.599 . . . . 1.96 109.381 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -111.61 134.17 53.37 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.493 -0.558 . . . . 1.18 109.493 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 24.7 m-85 -63.91 -27.16 68.95 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.333 0.494 . . . . 0.75 112.333 -175.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -68.24 -36.42 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.783 0.325 . . . . 1.63 110.766 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -87.52 7.46 29.39 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.225 0.536 . . . . 2.07 110.894 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 18.0 t80 -84.64 137.31 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.668 -0.697 . . . . 0.91 110.381 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 51.1 ttm -104.52 110.72 23.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.936 0.398 . . . . 1.73 110.969 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.5 -138.01 6.58 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.842 -0.617 . . . . 1.05 111.787 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.34 101.96 14.45 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.955 -0.387 . . . . 2.14 109.955 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.5 -14.43 30.68 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.509 2.14 . . . . 1.01 112.294 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.74 -18.61 63.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.751 -0.659 . . . . 2.08 110.274 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -109.5 9.09 25.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.916 -0.584 . . . . 2.18 110.952 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.3 145.55 29.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.192 -0.458 . . . . 0.92 111.473 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -141.04 160.81 39.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.489 -0.778 . . . . 2.35 109.507 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.59 115.01 4.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.879 -0.6 . . . . 1.4 110.882 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.66 0.05 15.58 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.75 113.21 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -75.64 120.22 20.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.922 0.391 . . . . 1.06 110.638 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.83 128.44 36.29 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.474 -0.784 . . . . 2.51 109.858 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 77' ' ' MET . 15.0 m -139.79 144.4 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.707 -0.224 . . . . 0.44 110.904 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 16.6 pt-20 -118.19 149.18 41.51 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 1.49 109.809 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.65 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 20.6 p90 -168.57 179.67 4.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.051 0.453 . . . . 0.66 111.554 -173.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -133.95 141.9 47.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.575 . . . . 0.94 110.695 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.4 mt -72.52 156.39 39.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.357 -0.383 . . . . 1.19 111.14 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.99 -92.93 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 2.04 110.559 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 55.35 60.2 3.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.548 -0.751 . . . . 5.33 110.608 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -79.86 99.58 7.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.178 -0.919 . . . . 5.42 110.321 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.35 -170.11 15.35 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.6 -0.727 . . . . 4.76 112.199 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -93.58 35.45 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.544 0.688 . . . . 6.38 110.069 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.7 p -80.67 10.26 5.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.246 -0.888 . . . . 6.4 111.913 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 m -71.77 -2.32 17.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 5.23 111.723 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.91 -24.16 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.82 -0.627 . . . . 6.95 110.937 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -116.87 -9.54 11.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.115 -0.493 . . . . 6.02 110.713 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.34 86.3 0.41 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.746 -0.74 . . . . 4.09 111.91 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.92 -45.32 93.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 4.22 110.061 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 p -127.69 125.45 40.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.794 -0.639 . . . . 2.09 109.573 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.6 162.81 42.61 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.293 -0.412 . . . . 2.3 110.819 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.85 152.38 80.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.858 2.372 . . . . 1.43 113.689 -174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 55' ' ' TYR . . . -106.75 124.05 49.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.916 -1.038 . . . . 0.82 109.742 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.36 173.15 6.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.3 111.113 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 m120 60.94 34.44 19.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.942 -0.572 . . . . 2.01 111.394 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 29.6 t -69.18 115.09 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.8 111.181 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -119.36 146.55 45.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.199 -0.91 . . . . 3.51 111.151 -178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.406 ' HA ' HG12 ' A' ' 53' ' ' VAL . 63.0 mtt -78.91 139.09 38.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.566 -0.901 . . . . 1.12 108.566 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.1 pt? -131.87 161.98 59.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.638 -0.504 . . . . 1.67 109.638 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 10.8 Cg_endo -53.89 132.45 49.73 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.533 2.155 . . . . 2.15 112.721 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -69.94 163.96 24.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.93 -1.032 . . . . 4.61 111.306 -174.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 78.16 34.22 0.3 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.294 -0.866 . . . . 2.84 111.472 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.2 m -94.59 -16.9 22.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 1.7 109.057 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 27' ' ' LEU . 6.5 mm -73.07 135.66 79.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.92 109.854 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.81 159.65 50.05 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.496 2.131 . . . . 1.03 112.548 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -124.95 150.12 65.29 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.291 -0.413 . . . . 2.76 110.048 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.42 130.01 37.79 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.555 2.17 . . . . 1.08 111.578 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.95 90.99 5.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.472 0.653 . . . . 1.1 110.624 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.47 136.6 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.494 -0.928 . . . . 1.23 108.494 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.84 -60.95 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.552 -0.459 . . . . 2.87 112.009 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' THR . 10.0 tp10 -90.95 -54.47 3.95 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.875 -0.33 . . . . 2.84 110.81 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 169.16 155.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.187 -0.671 . . . . 1.42 109.187 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.42 HG21 HG23 ' A' ' 153' ' ' ILE . 0.6 OUTLIER -105.75 -58.44 1.91 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.738 -0.385 . . . . 1.3 110.997 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -139.03 147.87 42.66 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.512 -0.313 . . . . 1.29 110.569 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.7 p30 -108.05 125.51 51.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.41 -0.959 . . . . 1.36 108.41 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -133.1 -175.52 14.0 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.056 -1.069 . . . . 0.53 112.321 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.1 t -135.39 146.05 30.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.777 -0.453 . . . . 1.37 109.777 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 143' ' ' LEU . 97.6 t -62.01 121.03 9.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.69 110.828 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.29 -53.22 17.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.89 111.871 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -172.85 154.51 2.84 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.677 -0.238 . . . . 3.92 111.089 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.69 172.24 16.19 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.062 2.508 . . . . 2.22 112.39 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -106.99 88.31 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.25 0.548 . . . . 3.32 111.767 -177.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -100.21 -63.32 1.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.111 0.482 . . . . 5.56 112.028 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.02 9.41 33.36 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.965 -0.561 . . . . 4.14 111.208 -173.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 101' ' ' LEU . 1.9 mp -81.63 -27.88 10.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.426 . . . . 3.46 111.762 -173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 111' ' ' TYR . 78.1 m-20 75.52 156.18 0.16 Allowed Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 123.228 0.611 . . . . 4.99 110.213 -173.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.468 ' HA ' ' CD2' ' A' ' 111' ' ' TYR . 72.3 Cg_endo -91.23 -0.2 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.32 2.014 . . . . 4.27 113.673 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.28 -5.74 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 3.94 111.389 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 67.4 mt-30 -93.67 165.36 12.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 5.6 110.813 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.47 -30.58 61.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.511 -0.551 . . . . 5.3 109.511 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.55 ' OE2' ' HB3' ' A' ' 108' ' ' GLN . 2.4 pm0 -68.2 -4.42 13.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.554 -0.748 . . . . 4.95 111.54 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.576 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.57 -30.64 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.988 -0.551 . . . . 3.19 111.022 176.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.4 -32.36 73.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 1.24 110.807 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.09 145.96 11.43 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.459 -1.057 . . . . 0.94 110.459 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.12 138.83 50.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.69 0.757 . . . . 0.93 111.983 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.9 mt -107.53 135.05 47.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.512 -1.222 . . . . 0.49 109.272 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -90.41 125.97 35.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4 110.263 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 15.1 mm -101.69 138.09 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.571 -0.741 . . . . 0.63 110.35 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 122' ' ' ARG . 1.3 pt? -85.77 154.14 21.8 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.401 0.438 . . . . 1.21 110.016 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.94 -175.88 5.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.873 0.368 . . . . 2.29 110.365 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.9 pt-20 -68.59 -18.36 64.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.652 0.612 . . . . 2.78 112.652 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.1 mm? -109.19 -0.12 19.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.984 -0.286 . . . . 1.77 110.854 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HB2' HD12 ' A' ' 118' ' ' LEU . 31.2 ttm-85 56.57 70.34 0.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 4.14 109.777 -172.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m -118.69 -48.29 2.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.876 -0.602 . . . . 1.87 109.962 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -142.35 169.74 17.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.553 -0.749 . . . . 1.54 111.131 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.5 p -81.14 135.06 25.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.375 -0.602 . . . . 1.29 109.375 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.5 mt -71.12 -70.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.554 -0.458 . . . . 1.03 110.824 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -138.59 -85.45 0.26 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.04 0.447 . . . . 1.56 110.971 170.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -177.16 143.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.329 -0.85 . . . . 2.08 109.065 176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.54 ' CE1' HD12 ' A' ' 153' ' ' ILE . 26.8 m170 -119.58 132.83 55.81 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.192 0.52 . . . . 0.68 111.233 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -95.69 144.01 26.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.033 -0.985 . . . . 1.19 109.454 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -117.92 136.69 53.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.74 111.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -89.29 152.63 22.85 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.605 -0.725 . . . . 0.51 112.292 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.51 HG22 ' OE1' ' A' ' 25' ' ' GLU . 10.6 tp -55.71 -34.66 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.482 0.549 . . . . 0.67 112.482 -175.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.3 t -78.32 -22.48 48.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.382 0.61 . . . . 1.35 110.545 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 3.5 m -89.21 -19.73 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.66 -0.7 . . . . 1.1 110.21 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -79.05 60.07 2.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.327 -0.851 . . . . 1.46 111.268 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.0 t -43.73 -41.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.241 0.544 . . . . 0.82 111.347 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.4 m120 -87.91 32.58 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.948 -0.569 . . . . 2.17 111.38 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -59.99 -26.97 66.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.355 0.598 . . . . 1.39 110.524 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -88.84 -13.8 38.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.193 -0.912 . . . . 2.46 111.392 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.97 175.1 8.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.077 -0.965 . . . . 1.89 111.294 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.73 16.51 17.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.991 -0.744 . . . . 2.88 108.991 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.483 ' HG ' HG21 ' A' ' 97' ' ' VAL . 25.4 tp -43.6 107.53 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.188 -1.369 . . . . 0.97 111.448 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.59 -178.51 3.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.841 -0.618 . . . . 1.77 110.733 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -63.85 135.3 56.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 1.43 110.291 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.85 -7.31 67.59 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.365 -0.921 . . . . 1.07 112.931 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.19 146.42 23.73 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.205 -0.598 . . . . 1.94 109.585 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.56 140.77 29.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.684 -0.689 . . . . 1.79 110.768 -172.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.42 144.87 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 115.139 -0.937 . . . . 1.16 110.731 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.9 m -111.58 143.6 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.146 -0.479 . . . . 1.44 109.878 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.625 ' HB3' HG12 ' A' ' 162' ' ' VAL . 7.0 p90 -157.14 166.6 32.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.146 -0.479 . . . . 0.61 110.116 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -119.22 119.61 34.61 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 120.003 -0.679 . . . . 2.2 109.517 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.54 HD12 ' CE1' ' A' ' 129' ' ' HIS . 3.7 tt -103.78 138.41 28.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.419 -0.586 . . . . 1.24 109.419 167.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.82 -79.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.799 -0.36 . . . . 1.92 111.153 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -38.39 22.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.853 0.686 . . . . 2.76 112.853 -173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.9 t -81.45 -16.82 50.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.842 0.312 . . . . 1.98 111.842 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.15 71.76 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.428 -0.892 . . . . 1.27 112.519 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -133.27 -178.23 4.88 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.083 -0.339 . . . . 3.61 110.083 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.99 108.43 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.48 110.377 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -125.33 161.79 26.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.128 -0.487 . . . . 0.49 110.177 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.35 39.86 11.8 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 123.59 0.556 . . . . 1.55 110.045 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 151' ' ' PHE . 15.5 m -69.58 125.08 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 1.26 111.059 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 46.2 t30 -125.74 117.52 23.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.603 -0.726 . . . . 2.05 109.483 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -69.08 102.67 1.69 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.75 110.43 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.58 130.12 49.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.86 -0.609 . . . . 1.56 110.794 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.56 115.33 27.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.854 -0.612 . . . . 2.94 110.458 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -136.78 167.91 20.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.568 -0.742 . . . . 3.88 109.215 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 120.934 0.397 . . . . 4.04 110.93 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.945 -0.462 . . . . 11.74 111.945 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.55 99.16 6.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 10.54 110.489 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 74.18 1.89 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.781 -0.723 . . . . 8.95 112.649 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -112.37 99.26 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.599 0.238 . . . . 7.09 110.642 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -124.99 124.1 41.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.598 -0.519 . . . . 5.59 109.598 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.17 -39.8 22.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.341 -0.39 . . . . 2.99 110.981 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.14 -29.72 1.88 Allowed Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 116.142 -0.481 . . . . 1.61 112.759 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -119.87 116.86 26.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 2.0 111.171 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.25 116.01 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.436 -0.802 . . . . 1.27 109.13 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -89.09 138.17 31.66 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.822 -0.626 . . . . 1.14 109.564 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 39.9 ttm180 -116.19 132.37 56.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.616 -0.72 . . . . 2.31 109.462 -176.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.73 -157.23 7.81 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.879 -0.677 . . . . 0.5 111.415 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.494 ' CE2' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -146.04 152.92 40.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.989 0.423 . . . . 0.68 110.949 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.0 mm -71.68 114.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.691 -0.686 . . . . 0.56 110.287 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.83 -42.0 4.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.676 0.274 . . . . 0.76 111.45 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -114.19 123.12 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.052 0.453 . . . . 1.55 111.139 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.5 mtt -113.44 116.07 29.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.5 -0.773 . . . . 1.42 109.931 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.71 -177.8 3.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.444 -0.947 . . . . 2.03 108.444 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.19 -45.62 72.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.882 0.327 . . . . 3.24 111.882 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -110.92 -18.21 13.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.964 0.357 . . . . 2.03 111.964 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -153.73 -173.34 4.54 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.251 -0.278 . . . . 1.25 110.251 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.81 -169.99 30.14 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.718 -0.753 . . . . 0.71 111.496 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -130.18 130.54 44.84 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.959 -0.386 . . . . 1.08 109.959 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 35' ' ' PHE . 63.9 mt -90.22 124.03 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.471 -0.566 . . . . 0.61 109.471 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.14 125.17 28.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 2.3 109.482 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.3 p -65.37 144.11 57.3 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.87 109.942 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.649 HD21 HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -52.93 -46.31 68.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.057 0.456 . . . . 1.58 110.946 -174.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 t -92.94 6.57 47.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.105 -0.498 . . . . 2.04 111.542 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 54.46 56.95 6.25 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.013 0.911 . . . . 3.29 109.6 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.39 -33.4 7.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.683 -1.144 . . . . 2.89 110.759 -172.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -142.77 166.49 24.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.283 -0.417 . . . . 1.8 110.911 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.49 126.91 50.92 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.625 -0.879 . . . . 3.37 108.625 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.49 115.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.274 0.559 . . . . 0.87 111.492 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -81.21 120.27 24.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.343 -0.844 . . . . 1.06 110.473 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 24' ' ' ILE . 3.9 p90 -123.21 151.23 42.45 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.914 -0.773 . . . . 1.96 108.914 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -120.36 131.76 54.98 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.083 -0.71 . . . . 1.18 109.083 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -60.33 -24.73 65.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.537 0.569 . . . . 0.75 112.537 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -71.32 -12.2 61.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.668 0.27 . . . . 1.63 111.136 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -109.8 0.48 18.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.07 110.512 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -85.47 127.05 34.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.569 . . . . 0.91 109.998 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 54.0 ttp -101.02 97.77 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.186 0.517 . . . . 1.73 110.597 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.46 -160.34 30.14 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.619 -0.719 . . . . 1.05 111.331 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -102.98 102.94 30.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.805 0.302 . . . . 2.14 110.193 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.44 -24.05 9.47 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.45 2.1 . . . . 1.01 113.633 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.33 -4.28 50.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.531 0.205 . . . . 2.08 111.5 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m95 -113.23 19.64 16.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.386 0.612 . . . . 2.18 110.704 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD21 ' HE2' ' A' ' 77' ' ' MET . 56.0 mt -95.04 159.92 14.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.92 108.976 172.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.13 164.88 28.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.821 -0.437 . . . . 2.35 109.821 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.32 113.28 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.28 0.562 . . . . 1.4 110.017 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.13 4.28 27.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.862 -0.685 . . . . 0.75 112.643 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.468 HE21 ' N ' ' A' ' 52' ' ' GLU . 28.2 tp60 -77.3 124.75 28.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.328 . . . . 1.06 110.41 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' N ' HE21 ' A' ' 51' ' ' GLN . 16.4 mp0 -67.97 126.8 30.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.312 -0.858 . . . . 2.51 111.257 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 77' ' ' MET . 19.2 m -142.9 149.86 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.036 -0.529 . . . . 0.44 109.925 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.02 156.28 42.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.24 -0.288 . . . . 1.49 110.401 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 2.4 p90 -170.16 179.42 3.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.877 0.37 . . . . 0.66 111.292 -169.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.4 p -120.8 172.3 7.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.94 110.683 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.67 146.12 49.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.19 111.528 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.0 80.85 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 2.04 110.091 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -130.85 19.44 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 5.33 110.68 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.35 -45.69 7.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.657 -0.702 . . . . 5.42 111.664 -174.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.48 143.15 20.73 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.478 -0.868 . . . . 4.76 111.788 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -74.41 80.93 1.9 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 6.38 110.491 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -127.58 -5.0 5.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.403 -0.817 . . . . 6.4 109.495 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.5 m -83.76 28.05 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.481 -0.781 . . . . 5.23 111.372 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.1 m -85.66 -29.66 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.23 0.538 . . . . 6.95 110.206 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -121.2 -7.37 9.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.482 -0.781 . . . . 6.02 110.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.69 95.74 1.23 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.659 -0.701 . . . . 4.09 111.726 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -49.76 -65.23 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 122.972 0.509 . . . . 4.22 111.604 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 34.4 m -114.66 120.51 40.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.219 -0.446 . . . . 2.09 110.461 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.631 HD13 ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -84.78 149.61 54.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.802 -0.635 . . . . 2.3 110.238 177.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.29 150.98 42.71 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.57 2.18 . . . . 1.43 112.236 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.36 129.47 34.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.101 -0.499 . . . . 0.82 109.806 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -116.12 143.33 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.915 0.388 . . . . 2.3 111.123 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.1 70.92 0.58 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.362 -0.836 . . . . 2.01 111.21 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 25.3 t -96.14 125.17 49.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.997 -0.547 . . . . 0.8 109.821 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -127.89 149.91 50.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 3.51 111.13 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.448 ' HE2' HD21 ' A' ' 47' ' ' LEU . 66.8 mtt -79.23 154.17 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.12 109.935 175.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.3 147.96 32.99 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 1.67 109.658 169.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.93 162.83 27.41 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.54 2.16 . . . . 2.15 112.975 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.27 173.04 5.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 4.61 111.214 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.1 m120 73.72 3.18 4.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.496 -0.775 . . . . 2.84 110.989 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 m -89.46 -2.39 58.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.351 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.649 HD12 HD21 ' A' ' 27' ' ' LEU . 30.7 mm -110.72 123.39 35.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.203 -0.666 . . . . 0.92 109.203 176.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.49 139.27 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.048 1.832 . . . . 1.03 111.266 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.83 148.51 43.4 Favored Pre-proline 0 C--N 1.314 -0.941 0 C-N-CA 120.821 -0.352 . . . . 2.76 110.427 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.39 130.73 41.43 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.276 2.651 . . . . 1.08 111.932 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.09 93.0 9.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.188 0.518 . . . . 1.1 110.826 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.39 126.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.535 -0.913 . . . . 1.23 108.535 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -59.96 2.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.547 0.203 . . . . 2.87 111.547 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 91' ' ' THR . 57.5 mm-40 -91.21 -55.04 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.714 -0.394 . . . . 2.84 111.281 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 13.1 t 171.02 159.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.42 109.9 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.416 HG21 HG23 ' A' ' 153' ' ' ILE . 1.0 OUTLIER -102.44 -54.93 2.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 1.3 109.788 176.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.577 ' CE1' ' HE2' ' A' ' 151' ' ' PHE . 23.7 p80 -162.93 168.23 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.79 -0.641 . . . . 1.29 109.623 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -114.38 -177.52 3.15 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.137 -0.32 . . . . 1.36 110.137 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.65 179.1 47.82 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.838 -0.696 . . . . 0.53 111.698 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.59 145.27 32.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.833 -0.432 . . . . 1.37 109.833 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.6 t -58.79 123.32 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.365 -0.235 . . . . 0.69 110.365 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.28 -65.96 0.82 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.388 -0.369 . . . . 0.89 111.888 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 110' ' ' GLU . 35.6 ptt180 -157.48 147.55 15.64 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.331 -0.248 . . . . 3.92 110.331 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 7.4 Cg_exo -74.97 154.59 42.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.003 2.469 . . . . 2.22 111.911 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.703 ' H ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -107.1 102.66 11.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.924 0.868 . . . . 3.32 111.628 -176.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -97.91 -64.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.735 -0.666 . . . . 5.56 111.068 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.7 m -93.86 9.84 35.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.154 -0.475 . . . . 4.14 111.803 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 108' ' ' GLN . 1.7 mp -68.78 -44.14 82.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.036 0.384 . . . . 3.46 112.036 -172.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 107' ' ' ASP . 12.1 t30 65.75 138.36 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 122.673 0.389 . . . . 4.99 111.328 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.97 -12.24 6.84 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 123.911 3.074 . . . . 4.27 114.984 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' HB3' HD22 ' A' ' 105' ' ' ASN . 7.2 t70 -69.23 -29.77 67.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.594 0.712 . . . . 3.94 109.634 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.482 ' HG3' ' HB3' ' A' ' 110' ' ' GLU . 51.5 tp60 -93.01 119.46 32.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.661 -1.237 . . . . 5.6 107.661 168.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.596 ' HG2' ' OE1' ' A' ' 130' ' ' GLU . 1.4 pm0 -63.45 -14.46 50.92 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.213 0.53 . . . . 5.3 111.431 -171.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 108' ' ' GLN . 47.1 tt0 -62.42 -11.69 17.33 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.698 -0.683 . . . . 4.95 110.549 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -27.44 55.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.642 -0.708 . . . . 3.19 110.835 174.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.71 62.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.034 -0.53 . . . . 1.24 110.96 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.47 ' HA3' ' CZ ' ' A' ' 131' ' ' PHE . . . 95.96 144.42 16.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.334 -0.46 . . . . 0.94 112.272 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.5 mt -128.99 145.03 51.35 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.699 0.761 . . . . 0.93 112.148 -174.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.13 137.37 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.413 -1.267 . . . . 0.49 108.532 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 8.0 pt-20 -90.48 125.07 35.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.489 0.661 . . . . 1.4 110.505 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 93' ' ' HIS . 44.0 mm -94.97 136.84 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.894 -1.048 . . . . 0.63 110.43 -174.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.5 pt? -100.73 144.39 29.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.63 167.29 9.27 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.104 0.252 . . . . 2.29 111.023 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' HG3' HD22 ' A' ' 121' ' ' LEU . 13.0 pt-20 -60.2 -29.44 68.71 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.575 0.35 . . . . 2.78 111.528 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.502 HD22 ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -89.5 6.15 42.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.77 110.527 178.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 69.72 87.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 4.14 111.793 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.6 p -115.8 -159.07 0.7 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.928 -1.033 . . . . 1.87 109.639 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 p -85.84 -161.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.338 -0.392 . . . . 1.54 109.975 170.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.5 p -64.44 120.41 11.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.011 0.434 . . . . 1.29 111.34 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.8 mt -69.1 -67.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.984 -0.553 . . . . 1.03 110.343 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.5 p -133.28 -86.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.75 -0.38 . . . . 1.56 111.335 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -178.1 129.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.685 . . . . 2.08 109.654 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.471 ' CD2' HG13 ' A' ' 117' ' ' ILE . 13.4 m170 -116.19 129.72 56.44 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.68 110.246 176.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.596 ' OE1' ' HG2' ' A' ' 109' ' ' GLN . 10.4 tt0 -96.77 149.69 21.55 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.071 -0.968 . . . . 1.19 109.958 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 31.0 p90 -117.87 177.11 4.9 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.67 -0.412 . . . . 0.74 110.709 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 135' ' ' SER . . . -134.93 152.98 20.92 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.912 -0.585 . . . . 0.51 111.848 -176.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -52.86 -28.76 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.887 0.375 . . . . 0.67 111.897 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.0 p -77.53 -33.19 54.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.409 0.623 . . . . 1.35 110.436 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 132' ' ' GLY . 47.9 t -72.03 -27.38 62.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.107 -0.951 . . . . 1.1 110.311 177.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.08 59.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.393 -0.821 . . . . 1.46 112.506 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -48.61 -41.99 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.234 0.54 . . . . 0.82 110.257 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 163' ' ' ASN . 14.3 m120 -87.86 32.65 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.759 -0.655 . . . . 2.17 111.414 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -60.59 -21.66 62.88 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.156 0.503 . . . . 1.39 111.264 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -93.14 -6.28 48.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.814 -0.63 . . . . 2.46 111.371 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -88.51 158.06 18.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.76 -0.654 . . . . 1.89 111.188 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.4 mm? -81.36 49.06 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 2.88 110.43 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 164' ' ' ALA . 21.8 tp -76.4 122.84 25.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.603 -0.726 . . . . 0.97 109.937 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 11.7 pt20 -123.94 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.481 0.657 . . . . 1.77 111.732 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.39 121.79 15.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.907 -1.042 . . . . 1.43 109.905 174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.33 1.81 44.31 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.322 -0.942 . . . . 1.07 112.53 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.463 ' OD1' ' HG2' ' A' ' 144' ' ' GLN . 13.3 m-20 -91.07 140.13 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.743 0.272 . . . . 1.94 110.393 173.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.78 138.99 32.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.918 0.39 . . . . 1.79 110.862 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 164' ' ' ALA . 15.6 m -135.97 146.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.212 -0.449 . . . . 1.16 110.823 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.3 p -104.67 133.38 49.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.505 -0.554 . . . . 1.44 109.505 175.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' HE2' ' CE1' ' A' ' 93' ' ' HIS . 5.5 p90 -146.42 163.57 35.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.116 0.26 . . . . 0.61 110.7 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 91' ' ' THR . 1.4 mpp_? -118.54 121.7 40.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.147 0.499 . . . . 2.2 110.194 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 92' ' ' THR . 12.9 tt -100.41 136.95 29.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.696 . . . . 1.24 109.788 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -169.61 -93.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.568 -0.16 . . . . 1.92 110.568 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -82.52 -19.97 37.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.826 0.346 . . . . 2.76 111.254 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.3 t -81.66 -17.01 49.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.927 -0.397 . . . . 1.98 109.927 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.32 23.22 57.54 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.791 -0.64 . . . . 1.27 113.51 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 11.4 ptp180 -156.93 -168.55 2.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.451 -0.574 . . . . 3.61 109.451 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.6 108.3 17.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.897 0.379 . . . . 0.48 110.319 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 135' ' ' SER . . . -117.12 144.85 44.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.154 -0.475 . . . . 0.49 111.368 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 57.9 m 66.17 43.6 2.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.633 -0.712 . . . . 1.55 110.352 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.9 m -65.07 118.7 7.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.622 0.725 . . . . 1.26 110.786 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.431 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 4.1 t-20 -120.86 124.4 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.48 -0.782 . . . . 2.05 109.882 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 143' ' ' LEU . . . -64.07 112.96 3.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.75 111.041 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.86 129.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.944 -0.571 . . . . 1.56 111.021 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -98.47 116.78 31.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 2.94 110.061 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.01 148.59 51.88 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.184 0.516 . . . . 3.88 110.437 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 51.0 tttp . . . . . 0 N--CA 1.435 -1.196 0 CA-C-N 115.387 -0.824 . . . . 4.04 111.229 -178.148 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 111.96 -0.456 . . . . 11.74 111.96 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.21 -178.46 5.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.891 -0.411 . . . . 10.54 109.891 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.62 30.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.601 -0.809 . . . . 8.95 111.8 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -82.74 54.69 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.536 0.684 . . . . 7.09 110.657 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.78 78.98 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.464 -0.789 . . . . 5.59 110.964 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.93 -14.95 40.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.927 -0.579 . . . . 2.99 110.524 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -29.77 3.77 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.932 -0.576 . . . . 1.61 112.445 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -129.54 128.41 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.96 0.409 . . . . 2.0 110.788 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.45 114.65 25.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.631 . . . . 1.27 109.459 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.34 159.31 15.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.501 -0.772 . . . . 1.14 109.267 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.518 ' HG3' HD13 ' A' ' 27' ' ' LEU . 6.8 ptp180 -141.05 147.42 38.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.757 -0.46 . . . . 2.31 109.757 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.09 -169.77 22.06 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.172 -0.771 . . . . 0.5 111.172 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.19 140.26 52.69 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.785 0.326 . . . . 0.68 110.468 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.21 116.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.642 -0.708 . . . . 0.56 110.613 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.28 -48.55 2.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.76 111.355 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 96.2 t -114.45 124.03 70.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.676 0.274 . . . . 1.55 110.649 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 56.5 ttm -126.94 105.55 8.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.272 -0.422 . . . . 1.42 110.197 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 17.9 mmtp -97.94 -161.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.715 -0.476 . . . . 2.03 109.715 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -70.15 -50.63 38.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.3 -0.409 . . . . 3.24 111.912 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 50.8 m-80 -112.24 -34.47 5.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 2.03 111.571 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 p90 -124.82 173.74 8.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.15 -0.477 . . . . 1.25 110.709 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.32 165.74 35.56 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 111.076 -0.81 . . . . 0.71 111.076 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 68.6 m-85 -110.44 126.64 54.53 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.183 0.516 . . . . 1.08 109.791 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -95.7 130.23 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.696 -0.853 . . . . 0.61 108.696 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -80.16 128.75 33.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.534 -0.913 . . . . 2.3 108.534 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.6 p -63.34 149.73 45.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.745 -0.661 . . . . 0.87 110.829 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 83' ' ' ILE . 11.4 tp -54.93 -34.12 62.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.305 0.574 . . . . 1.58 111.828 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.6 m -110.36 22.46 15.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 2.04 111.431 -176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.454 ' HA ' ' OE2' ' A' ' 25' ' ' GLU . 31.4 p80 43.63 45.73 5.9 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.016 0.912 . . . . 3.29 111.369 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.71 -44.72 9.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.919 -1.037 . . . . 2.89 111.337 -171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.82 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.079 0.466 . . . . 1.8 112.07 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.21 121.75 46.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.53 -0.759 . . . . 3.37 110.367 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.19 127.32 64.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.978 0.418 . . . . 0.87 111.536 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -91.83 120.62 32.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.95 -0.568 . . . . 1.06 110.053 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -128.45 138.08 52.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.275 -0.42 . . . . 1.96 110.089 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.417 ' NE2' ' HB3' ' A' ' 20' ' ' ASN . 3.3 t60 -107.6 124.29 49.73 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -63.18 -18.04 63.06 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.626 0.602 . . . . 0.75 112.626 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 -31.5 68.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.679 0.276 . . . . 1.63 110.841 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.05 5.95 46.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.982 0.42 . . . . 2.07 111.4 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 47.4 t80 -75.34 132.09 40.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.313 -0.403 . . . . 0.91 110.047 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 49.3 ttp -114.63 91.06 3.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.959 0.409 . . . . 1.73 110.08 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.68 -136.65 4.28 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.987 -0.845 . . . . 1.05 110.987 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -121.25 96.6 48.04 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 117.023 0.411 . . . . 2.14 110.681 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.39 -22.94 12.03 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.791 2.328 . . . . 1.01 113.013 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -81.66 -5.91 58.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.295 0.569 . . . . 2.08 110.476 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -112.47 18.04 18.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.88 -0.6 . . . . 2.18 110.414 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 49.2 mt -92.32 143.72 26.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.841 -0.618 . . . . 0.92 110.716 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.0 157.96 42.73 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.993 -0.743 . . . . 2.35 108.993 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.598 HD22 ' H ' ' A' ' 49' ' ' LEU . 2.7 mm? -60.84 134.43 57.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.966 0.412 . . . . 1.4 110.511 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.29 -15.55 50.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.716 -0.754 . . . . 0.75 113.032 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -66.0 133.32 50.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.997 0.427 . . . . 1.06 111.434 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 1.8 mp0 -81.36 137.39 35.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.243 -0.889 . . . . 2.51 110.763 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 77' ' ' MET . 23.6 m -144.3 151.54 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.44 109.843 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HB3' HD21 ' A' ' 78' ' ' LEU . 23.9 pt-20 -112.0 144.69 40.93 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.978 -0.378 . . . . 1.49 109.978 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.416 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.6 p90 -161.49 170.71 19.44 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.266 0.555 . . . . 0.66 111.856 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -120.45 143.79 48.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.94 111.049 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.42 143.28 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.362 -0.381 . . . . 1.19 110.875 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -87.37 76.93 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.512 . . . . 2.04 110.018 176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD3' HD12 ' A' ' 70' ' ' LEU . 20.9 tpp180 -91.12 57.68 3.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 5.33 109.614 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -64.35 133.38 52.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 5.42 110.279 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.89 76.77 1.56 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.956 -0.566 . . . . 4.76 113.425 -175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -90.28 -163.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 6.38 109.361 171.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 65' ' ' VAL . 9.9 t -68.13 -22.13 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.09 -0.244 . . . . 6.4 110.749 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.4 m 64.96 16.36 10.5 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.101 0.778 . . . . 5.23 113.101 169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 63' ' ' THR . 19.9 m -99.25 -26.49 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 6.95 111.373 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.7 m -107.72 -4.32 18.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.008 0.433 . . . . 6.02 110.386 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.41 79.52 1.77 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.865 -0.683 . . . . 4.09 112.432 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -66.36 -44.09 84.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.865 0.364 . . . . 4.22 110.888 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -135.85 136.39 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.394 -0.367 . . . . 2.09 110.321 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD12 ' HD3' ' A' ' 59' ' ' ARG . 78.4 mt -110.3 146.09 33.53 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.978 -0.555 . . . . 2.3 109.886 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.53 165.72 31.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.331 2.021 . . . . 1.43 111.808 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.12 141.06 40.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.508 -0.315 . . . . 0.82 110.419 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 71.3 mm-40 -124.22 152.22 43.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 2.3 110.186 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.29 84.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.729 0.643 . . . . 2.01 111.511 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 ' CB ' ' A' ' 55' ' ' TYR . 45.6 t -110.94 124.62 67.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.146 -0.479 . . . . 0.8 110.003 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -118.25 153.42 33.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.802 -0.635 . . . . 3.51 109.792 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.448 ' HA ' HG12 ' A' ' 53' ' ' VAL . 65.1 mtp -97.86 119.46 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.7 -0.227 . . . . 1.12 110.783 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -122.56 104.09 37.26 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-O 121.804 0.812 . . . . 1.67 111.401 176.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -88.95 129.49 2.04 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.27 1.98 . . . . 2.15 112.868 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.5 tttp 79.05 133.13 0.06 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.073 1.138 . . . . 4.61 114.073 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.3 t30 68.96 3.23 3.92 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.444 -1.253 . . . . 2.84 112.891 167.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -78.14 -25.93 47.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.2 -0.6 . . . . 1.7 109.439 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 27' ' ' LEU . 1.8 mm -108.33 128.21 26.09 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.392 -0.966 . . . . 0.92 108.392 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.16 152.08 50.16 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.297 1.998 . . . . 1.03 112.461 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -103.66 142.49 24.7 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 2.76 109.597 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.73 128.13 21.39 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.297 1.998 . . . . 1.08 111.977 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.26 95.0 0.56 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.602 . . . . 1.1 111.502 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -137.54 135.01 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.113 -0.699 . . . . 1.23 109.113 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.2 tt -85.18 -62.0 1.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.659 -0.416 . . . . 2.87 111.265 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -93.0 -56.93 2.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.534 0.568 . . . . 2.84 112.534 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 m 169.12 140.27 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.866 -1.161 . . . . 1.42 107.866 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -93.21 -55.34 3.35 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.174 -0.61 . . . . 1.3 110.638 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -145.96 148.29 32.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 1.29 110.987 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -110.7 161.54 15.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.706 -1.22 . . . . 1.36 107.706 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.28 -176.88 41.38 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.429 -1.367 . . . . 0.53 112.838 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.56 146.69 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.828 -0.434 . . . . 1.37 109.828 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.5 t -58.79 119.47 3.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.316 -0.402 . . . . 0.69 110.575 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' O ' ' HD2' ' A' ' 145' ' ' LYS . . . -74.4 -37.49 63.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.89 111.192 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -177.66 131.46 0.33 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.966 -0.561 . . . . 3.92 110.563 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 144' ' ' GLN . 17.0 Cg_exo -70.96 169.29 20.79 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.437 2.091 . . . . 2.22 111.501 169.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -106.76 90.24 3.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.262 0.554 . . . . 3.32 111.629 -175.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -98.17 -62.99 1.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 5.56 110.212 171.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 m -91.71 5.21 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.385 -0.825 . . . . 4.14 111.19 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.26 -44.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.413 -0.358 . . . . 3.46 110.443 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.505 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 6.2 t30 67.89 153.23 0.13 Allowed Pre-proline 0 N--CA 1.474 0.73 0 O-C-N 123.7 0.625 . . . . 4.99 111.515 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 105' ' ' ASN . 32.8 Cg_endo -65.36 -12.27 34.1 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.551 2.167 . . . . 4.27 112.764 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.75 1.72 25.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 3.94 111.329 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -117.46 149.56 40.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.79 0.328 . . . . 5.6 110.422 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -71.28 -0.25 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 5.3 111.773 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -103.8 13.09 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.271 0.558 . . . . 4.95 110.096 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.475 ' O ' HD13 ' A' ' 101' ' ' LEU . 10.4 t80 -57.3 -35.1 69.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.041 -0.981 . . . . 3.19 112.428 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.54 -22.96 64.47 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.049 0.389 . . . . 1.24 112.049 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.3 163.33 30.63 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.94 111.984 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 130' ' ' GLU . 54.4 mt -143.45 150.71 39.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.93 111.876 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.5 mt -116.3 136.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.981 -1.009 . . . . 0.49 109.748 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -87.57 114.67 24.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.678 0.751 . . . . 1.4 110.009 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 129' ' ' HIS . 5.4 mm -91.0 132.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.994 -1.003 . . . . 0.63 109.076 -176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.02 146.01 27.4 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.779 -0.368 . . . . 1.21 110.438 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.81 -178.6 1.92 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 2.29 110.401 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 121' ' ' LEU . 1.4 pm0 -68.11 -25.14 65.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.895 0.331 . . . . 2.78 111.895 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -93.35 0.71 57.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.904 -0.318 . . . . 1.77 110.476 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 62.95 39.57 10.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.043 -0.526 . . . . 4.14 110.789 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.9 m -104.38 -50.69 3.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.87 111.553 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 125' ' ' VAL . 5.2 m -143.36 166.46 24.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.769 0.319 . . . . 1.54 110.794 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 7.6 p -68.72 137.27 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.356 -0.384 . . . . 1.29 110.995 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.16 -68.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 1.03 110.552 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -137.06 -86.41 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.017 0.436 . . . . 1.56 111.046 171.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -177.24 136.43 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.365 -0.834 . . . . 2.08 109.224 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.688 ' HB2' HD11 ' A' ' 117' ' ' ILE . 27.3 m170 -118.83 132.89 56.13 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.66 -0.416 . . . . 0.68 110.48 174.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.442 ' HA ' HD23 ' A' ' 114' ' ' LEU . 14.1 tt0 -91.25 146.82 23.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.424 -0.807 . . . . 1.19 109.507 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -118.75 142.4 47.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.74 110.967 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.25 150.14 24.49 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.825 -0.625 . . . . 0.51 112.522 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.2 tp -54.39 -43.86 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.126 0.488 . . . . 0.67 111.624 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -71.99 -29.56 64.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.213 0.53 . . . . 1.35 110.124 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 6.0 m -73.07 -24.11 60.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.629 . . . . 1.1 110.495 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -77.17 60.05 1.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.947 -0.57 . . . . 1.46 110.486 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 137' ' ' VAL . 21.8 t -39.96 -46.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.782 -0.644 . . . . 0.82 111.503 178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 163' ' ' ASN . 3.3 p30 -94.19 33.68 1.35 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.409 -0.814 . . . . 2.17 111.537 -173.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.54 -20.04 52.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.723 0.409 . . . . 1.39 111.765 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 141' ' ' ASP . 3.4 ptt180 -75.74 -22.92 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 2.46 110.976 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 2.9 m-20 -93.29 140.49 29.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 1.89 110.893 -172.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 102.41 5.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.648 . . . . 2.88 110.788 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.04 118.44 32.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.97 109.93 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HA ' ' HG3' ' A' ' 100' ' ' PRO . 4.4 pt20 -120.24 -179.03 3.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.707 0.289 . . . . 1.77 111.117 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.55 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 75.2 tttt -65.17 126.94 29.68 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.699 -0.482 . . . . 1.43 109.699 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 116.74 -17.05 13.62 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.533 -0.758 . . . . 1.07 111.352 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -85.5 129.94 34.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 1.94 110.266 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mt -81.72 143.75 31.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.79 110.609 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.11 144.9 35.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.814 -0.63 . . . . 1.16 110.308 176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.0 m -106.61 128.36 54.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.515 -0.55 . . . . 1.44 109.515 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.588 ' HB3' HG12 ' A' ' 162' ' ' VAL . 30.2 p90 -145.26 -178.61 6.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.481 . . . . 0.61 110.165 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -148.63 124.03 10.3 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.311 -0.556 . . . . 2.2 111.019 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.482 HD13 ' CE1' ' A' ' 129' ' ' HIS . 7.5 pt -99.56 153.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.996 -0.547 . . . . 1.24 109.853 172.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.554 ' OD2' ' HG3' ' A' ' 155' ' ' GLU . 33.0 t70 -177.15 -88.75 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.277 0.361 . . . . 1.92 110.293 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HG3' ' OD2' ' A' ' 154' ' ' ASP . 45.6 mt-10 -74.22 -28.6 61.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 2.76 110.535 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 158' ' ' ARG . 13.3 p -78.85 -17.34 55.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 1.98 110.602 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.93 -28.21 0.64 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.135 -0.484 . . . . 1.27 113.111 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 156' ' ' SER . 90.4 mtt180 -120.39 -169.9 1.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.994 -0.372 . . . . 3.61 109.994 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.62 22.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.341 0.591 . . . . 0.48 111.791 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -126.42 155.79 41.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.185 -0.916 . . . . 0.49 110.061 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.6 m 57.55 51.4 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 1.55 111.087 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 151' ' ' PHE . 29.0 m -79.05 145.13 9.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.854 -0.612 . . . . 1.26 110.437 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -149.04 128.8 13.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.359 -0.608 . . . . 2.05 109.359 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' N ' HD22 ' A' ' 163' ' ' ASN . . . -60.04 124.22 19.56 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.385 0.428 . . . . 0.75 111.094 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 99.9 t -132.54 142.11 43.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 1.56 110.342 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -101.31 145.26 29.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.854 0.359 . . . . 2.94 110.258 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -96.22 120.64 36.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.159 -0.473 . . . . 3.88 110.495 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.139 -0.482 . . . . 4.04 110.934 177.261 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.663 -0.175 . . . . 11.74 112.663 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.36 173.89 9.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.264 -0.273 . . . . 10.54 110.264 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.37 83.11 0.55 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 121.022 -0.609 . . . . 8.95 112.375 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 p -134.51 110.63 9.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.776 0.322 . . . . 7.09 111.361 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.27 48.05 20.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.601 -0.727 . . . . 5.59 111.973 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.41 67.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.037 0.446 . . . . 2.99 110.786 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.61 -29.73 8.73 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.884 -0.598 . . . . 1.61 112.469 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -137.07 132.19 33.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.144 0.497 . . . . 2.0 110.696 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.97 114.7 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 108.529 -0.915 . . . . 1.27 108.529 172.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -87.18 141.71 28.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.253 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 25.5 mmt85 -100.76 146.0 27.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.575 -0.738 . . . . 2.31 110.285 -177.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.69 -173.26 33.14 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.224 -1.15 . . . . 0.5 110.224 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.44 145.35 36.86 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.199 0.5 . . . . 0.68 111.196 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.54 101.03 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.561 -0.745 . . . . 0.56 110.61 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.41 -43.82 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.015 0.436 . . . . 0.76 110.733 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.74 122.6 69.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.208 -0.451 . . . . 1.55 110.665 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.0 ttm -117.58 107.33 14.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.958 -0.565 . . . . 1.42 109.788 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.21 170.36 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.159 -0.682 . . . . 2.03 109.159 176.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.66 -32.64 74.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.728 0.299 . . . . 3.24 111.746 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -102.38 -34.85 9.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.147 0.425 . . . . 2.03 112.147 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.89 -172.79 4.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.61 0.243 . . . . 1.25 111.186 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -154.09 173.44 32.68 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.833 -0.699 . . . . 0.71 111.899 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.73 138.71 52.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.832 0.348 . . . . 1.08 110.262 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.4 mt -106.09 129.91 58.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.61 109.807 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.48 130.98 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.013 -1.106 . . . . 2.3 108.013 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -65.86 145.22 56.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.89 -0.595 . . . . 0.87 111.382 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 83' ' ' ILE . 2.3 tm? -52.36 -45.33 65.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 1.58 111.202 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -110.83 31.9 5.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.187 -0.46 . . . . 2.04 111.376 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 p80 43.89 45.38 6.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.785 0.834 . . . . 3.29 111.574 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.32 -48.21 62.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.8 -1.091 . . . . 2.89 110.608 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -172.46 -172.34 0.91 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.909 -0.587 . . . . 1.8 110.858 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.09 122.0 42.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 3.37 110.747 -168.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.58 136.29 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 121.116 0.484 . . . . 0.87 111.908 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -111.12 130.65 55.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 1.06 109.97 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -125.18 156.88 37.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.025 -0.732 . . . . 1.96 109.025 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' HD2' ' H ' ' A' ' 38' ' ' SER . 8.2 t60 -118.68 133.06 56.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.757 -0.46 . . . . 1.18 109.757 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -61.25 -24.04 66.08 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.867 0.691 . . . . 0.75 112.867 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 36' ' ' HIS . 22.9 t -66.3 -33.37 75.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.762 0.315 . . . . 1.63 110.779 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.84 19.58 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.264 0.554 . . . . 2.07 110.564 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.458 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 75.0 t80 -92.98 139.69 30.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.654 -0.703 . . . . 0.91 110.304 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 38.0 ttm -119.5 100.42 7.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.992 0.425 . . . . 1.73 110.108 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.88 -143.05 10.12 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.486 -0.646 . . . . 1.05 111.486 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -115.53 99.38 52.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.789 0.294 . . . . 2.14 110.732 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -81.9 -25.22 3.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.388 2.059 . . . . 1.01 111.918 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.34 -14.29 60.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 2.08 110.315 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -114.39 19.42 16.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.18 111.067 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.458 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 17.1 mt -82.29 169.31 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 0.92 112.202 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -130.77 164.76 24.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.014 -0.993 . . . . 2.35 110.337 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.18 114.87 22.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.6 -0.518 . . . . 1.4 109.6 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.67 3.05 46.67 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.742 -0.663 . . . . 0.75 112.192 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.446 HE21 ' N ' ' A' ' 52' ' ' GLU . 27.3 tp60 -68.3 122.46 18.41 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 1.06 111.574 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' OE2' ' HG2' ' A' ' 80' ' ' LYS . 26.0 mp0 -61.49 127.12 29.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.412 -0.813 . . . . 2.51 111.14 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.1 149.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.761 -0.654 . . . . 0.44 109.913 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 11' ' ' ARG . 21.6 pt-20 -121.22 137.32 54.73 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.344 -0.613 . . . . 1.49 109.344 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 4.3 p90 -155.39 178.05 10.67 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.684 -0.406 . . . . 0.66 111.411 -172.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 p -124.3 141.55 51.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.361 -0.381 . . . . 0.94 111.096 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.0 mt -73.76 119.82 18.51 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.19 109.579 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -77.64 -39.17 46.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.883 -1.053 . . . . 2.04 111.615 -173.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HB2' HD22 ' A' ' 70' ' ' LEU . 7.1 mpt_? -100.27 37.59 1.64 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.224 -0.898 . . . . 5.33 109.526 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.57 -24.26 67.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.417 -0.811 . . . . 5.42 111.067 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.91 17.01 35.93 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.716 -0.754 . . . . 4.76 112.642 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 15.2 m120 -115.74 121.44 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.787 -0.449 . . . . 6.38 109.787 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 p -88.34 87.16 7.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.409 0.623 . . . . 6.4 112.165 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 p 53.95 31.8 14.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.576 -1.193 . . . . 5.23 112.397 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.93 -30.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.142 0.496 . . . . 6.95 110.478 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.1 p -80.43 1.24 29.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.068 -0.514 . . . . 6.02 111.292 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.71 -91.52 1.49 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.934 -0.651 . . . . 4.09 112.072 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -105.98 -53.99 2.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.833 0.349 . . . . 4.22 110.939 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.2 m -134.07 152.35 51.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.136 -0.484 . . . . 2.09 110.676 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 59' ' ' ARG . 3.0 pp -126.89 148.41 65.3 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.789 -0.641 . . . . 2.3 109.777 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HG2' ' NH1' ' A' ' 59' ' ' ARG . 40.5 Cg_endo -71.91 147.76 50.27 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.92 1.747 . . . . 1.43 112.233 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.4 142.07 27.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 0.82 110.421 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 53.8 mm-40 -113.02 156.66 22.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.061 -0.718 . . . . 2.3 109.061 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 58.07 50.68 9.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.576 0.703 . . . . 2.01 110.282 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 20.3 t -80.85 110.7 16.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.846 -0.616 . . . . 0.8 110.064 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 76' ' ' ARG . 9.3 mmt180 -107.98 173.69 6.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.578 0.704 . . . . 3.51 111.821 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.442 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 48.1 mtp -117.46 144.05 45.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.859 -1.064 . . . . 1.12 109.301 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 1.4 pt? -131.56 160.27 68.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 C-N-CA 120.694 -0.403 . . . . 1.67 110.072 175.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 78' ' ' LEU . 60.7 Cg_endo -73.55 160.97 43.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.833 1.689 . . . . 2.15 112.155 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HG2' ' OE2' ' A' ' 52' ' ' GLU . 41.6 mtmt -74.1 173.92 9.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.788 -0.642 . . . . 4.61 112.125 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.52 30.66 2.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.43 -1.259 . . . . 2.84 110.55 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 t -124.39 11.09 8.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.798 0.809 . . . . 1.7 109.324 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 27' ' ' LEU . 40.9 mm -113.12 125.25 30.04 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.229 -0.896 . . . . 0.92 109.157 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.78 158.33 57.73 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.875 2.383 . . . . 1.03 113.268 -174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -137.35 152.73 73.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.629 -0.714 . . . . 2.76 109.779 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 155' ' ' GLU . 10.8 Cg_exo -69.93 150.19 66.82 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.542 2.161 . . . . 1.08 112.545 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.95 92.52 6.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.387 0.613 . . . . 1.1 111.38 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 154' ' ' ASP . 92.2 t -142.79 119.3 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.009 -1.108 . . . . 1.23 108.009 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.82 -63.45 1.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.197 0.814 . . . . 2.87 113.197 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.19 -59.95 1.78 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.728 -0.789 . . . . 2.84 112.529 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -179.52 137.31 0.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.533 0.733 . . . . 1.42 109.525 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -106.3 -42.52 5.03 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.072 -0.251 . . . . 1.3 110.924 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -141.02 140.11 34.24 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.682 0.277 . . . . 1.29 110.422 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -116.97 110.14 17.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.239 -0.652 . . . . 1.36 109.239 173.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -114.53 -171.45 17.12 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.313 -0.946 . . . . 0.53 112.863 -172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.9 p -133.96 143.27 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.327 -0.249 . . . . 1.37 110.327 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.41 124.21 13.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.507 -0.315 . . . . 0.69 110.891 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.33 -59.11 2.65 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.226 -0.443 . . . . 0.89 111.172 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -151.07 129.05 5.84 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.859 0.361 . . . . 3.92 110.802 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -78.18 141.4 18.41 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.675 2.25 . . . . 2.22 111.429 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 98.14 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.239 0.543 . . . . 3.32 112.075 -175.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -95.86 -63.99 1.1 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 5.56 110.828 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 35.0 t -94.2 10.43 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.195 -0.457 . . . . 4.14 111.714 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 47.8 mm -66.88 -39.43 83.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 111.703 0.26 . . . . 3.46 111.703 -175.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 41.1 t30 71.35 123.73 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 123.764 0.665 . . . . 4.99 111.212 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 111' ' ' TYR . 32.6 Cg_endo -64.54 0.93 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.37 2.713 . . . . 4.27 114.335 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -88.27 3.34 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.572 0.701 . . . . 3.94 110.045 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -127.79 142.95 51.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.815 -0.63 . . . . 5.6 109.633 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -69.65 2.46 3.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.63 0.974 . . . . 5.3 113.63 -170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.87 6.01 30.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 4.95 109.767 172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 106' ' ' PRO . 12.0 t80 -56.31 -31.77 64.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.147 -0.933 . . . . 3.19 112.313 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.49 -28.83 69.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.022 0.379 . . . . 1.24 112.022 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.77 164.46 38.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.485 -0.864 . . . . 0.94 111.284 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD13 ' NE2' ' A' ' 128' ' ' GLN . 26.1 mt -146.47 141.66 27.32 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.809 0.814 . . . . 0.93 112.214 -172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.13 132.94 55.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.181 -1.372 . . . . 0.49 108.988 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.93 112.42 21.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.883 0.849 . . . . 1.4 109.593 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 129' ' ' HIS . 11.3 mm -87.56 134.85 26.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.694 -1.139 . . . . 0.63 110.249 -170.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.59 148.04 26.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.41 0.624 . . . . 1.21 110.731 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.64 150.89 14.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.994 -1.003 . . . . 2.29 109.116 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.8 -16.94 64.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.752 -0.379 . . . . 2.78 111.682 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.79 10.82 39.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.677 -0.49 . . . . 1.77 109.677 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 63.4 29.93 15.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.264 -0.88 . . . . 4.14 111.096 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 m -73.09 -76.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 1.87 110.988 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -143.94 -166.11 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.499 -0.126 . . . . 1.54 110.742 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 40.0 t -80.55 138.83 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 122.925 0.141 . . . . 1.29 110.689 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.7 mt -77.34 -70.68 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.908 -0.405 . . . . 1.03 109.908 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.4 m -138.52 -86.2 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.346 0.593 . . . . 1.56 110.457 167.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.435 ' NE2' HD13 ' A' ' 114' ' ' LEU . 10.9 pt20 -178.44 144.55 0.3 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.067 -0.97 . . . . 2.08 108.645 175.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.722 ' HB2' HD11 ' A' ' 117' ' ' ILE . 40.0 m170 -115.46 142.24 46.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.531 0.681 . . . . 0.68 111.282 176.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -89.87 140.76 29.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.263 -1.335 . . . . 1.19 109.176 -177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CD1' HD21 ' A' ' 136' ' ' LEU . 30.9 p90 -118.07 154.97 31.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.82 0.343 . . . . 0.74 111.171 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.48 151.48 18.41 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.51 112.517 -173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.5 tp -52.26 -32.83 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.008 0.432 . . . . 0.67 112.062 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 p -77.44 -38.02 50.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.438 -0.346 . . . . 1.35 111.106 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 42.2 p -80.49 -11.2 59.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.643 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 131' ' ' PHE . 29.4 mt -74.91 59.29 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.549 . . . . 1.46 111.739 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.2 t -45.22 -41.38 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.537 . . . . 0.82 111.128 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 141' ' ' ASP . 20.5 m120 -91.88 34.25 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.778 -0.646 . . . . 2.17 111.78 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 136' ' ' LEU . 3.0 ptmt -64.39 -11.47 33.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.422 0.63 . . . . 1.39 110.832 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -87.52 -22.17 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.527 -0.761 . . . . 2.46 110.834 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 9.8 m-20 -92.86 162.54 14.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 1.89 111.726 -167.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.29 95.89 10.15 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.763 -0.653 . . . . 2.88 109.288 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.9 tp -114.78 107.45 15.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.901 -1.045 . . . . 0.97 109.04 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.92 -177.35 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 1.77 111.456 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -59.59 119.59 7.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.516 -0.765 . . . . 1.43 110.708 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.02 -3.55 31.69 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.564 -0.827 . . . . 1.07 112.904 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -89.7 137.07 32.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.755 0.312 . . . . 1.94 110.655 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 148' ' ' LEU . 2.4 mm? -85.13 139.37 31.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.632 -0.713 . . . . 1.79 110.846 -174.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 141.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 1.16 111.461 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.0 p -105.72 123.37 47.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 172.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 117' ' ' ILE . 37.5 p90 -139.94 164.36 30.2 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.585 -0.524 . . . . 0.61 109.585 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ARG . 6.8 mpt_? -123.65 119.25 29.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.018 -0.673 . . . . 2.2 110.136 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 tt -101.66 137.45 29.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.51 -0.768 . . . . 1.24 109.544 170.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 21.6 t70 -162.13 -99.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.915 -0.314 . . . . 1.92 110.731 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 86' ' ' PRO . 8.8 pt-20 -83.0 -7.08 59.71 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.2 0.524 . . . . 2.76 111.071 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.4 t -93.26 -17.19 23.93 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.043 -0.526 . . . . 1.98 109.769 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.17 15.51 58.76 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 116.052 -0.522 . . . . 1.27 113.955 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -139.67 -177.32 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.44 . . . . 3.61 109.813 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.94 108.22 18.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.252 0.548 . . . . 0.48 110.107 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.504 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -118.03 155.74 29.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.86 -0.609 . . . . 0.49 110.557 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.9 t 56.37 49.3 15.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 1.55 109.699 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.23 110.74 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.038 -0.983 . . . . 1.26 110.608 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.11 124.4 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 2.05 110.126 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 121.21 14.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.208 -0.293 . . . . 0.75 110.208 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 96.3 t -128.31 140.88 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.96 0.409 . . . . 1.56 111.091 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -109.91 122.26 47.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 2.94 109.922 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -99.95 158.84 15.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.238 -0.653 . . . . 3.88 109.238 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 115.791 -0.64 . . . . 4.04 110.403 -176.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 N-CA-C 112.38 -0.288 . . . . 11.74 112.38 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.89 136.93 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.986 -0.376 . . . . 10.54 109.986 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.46 49.6 0.1 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.417 -0.897 . . . . 8.95 111.708 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.4 m -149.12 120.87 8.09 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.765 -0.458 . . . . 7.09 109.765 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -113.51 99.34 7.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.242 -0.435 . . . . 5.59 109.927 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.5 -169.46 2.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.834 -0.621 . . . . 2.99 110.17 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.69 23.35 76.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.506 -0.854 . . . . 1.61 111.423 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -94.85 115.91 28.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.212 0.529 . . . . 2.0 111.763 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' HA ' HG22 ' A' ' 56' ' ' THR . 1.1 p -102.1 121.52 53.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.478 -0.934 . . . . 1.27 108.478 170.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -98.39 155.58 17.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.699 -0.682 . . . . 1.14 109.594 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 27' ' ' LEU . 29.2 ptt-85 -128.82 143.91 51.03 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.104 0.478 . . . . 2.31 110.085 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.16 -171.88 21.57 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.356 -1.098 . . . . 0.5 110.356 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.32 140.34 48.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.271 0.557 . . . . 0.68 111.055 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.575 HG21 ' SD ' ' A' ' 17' ' ' MET . 45.7 mm -65.24 122.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.142 -0.935 . . . . 0.56 111.838 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.24 -18.0 10.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.76 111.321 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.41 HG11 ' HD2' ' A' ' 23' ' ' PHE . 96.7 t -135.54 123.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.395 0.141 . . . . 1.55 111.051 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.575 ' SD ' HG21 ' A' ' 14' ' ' ILE . 85.7 mmm -118.1 111.23 18.61 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.131 0.419 . . . . 1.42 112.131 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.749 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -112.4 172.23 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.514 -0.921 . . . . 2.03 108.514 165.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -82.89 -25.52 32.4 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.49 -0.484 . . . . 3.24 110.958 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -92.19 -50.23 5.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.724 0.297 . . . . 2.03 111.7 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.4 p90 -153.15 151.25 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.994 0.426 . . . . 1.25 111.292 -174.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.91 -178.8 15.71 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.891 -0.671 . . . . 0.71 111.817 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HD2' HG11 ' A' ' 16' ' ' VAL . 94.2 m-85 -131.88 141.83 49.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.345 -0.613 . . . . 1.08 109.345 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.4 mt -124.61 119.78 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.081 0.467 . . . . 0.61 111.581 -170.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -70.83 128.59 36.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.358 -0.837 . . . . 2.3 108.934 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 p -81.2 153.12 27.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.192 -0.458 . . . . 0.87 111.161 -175.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' CD1' HD12 ' A' ' 83' ' ' ILE . 7.2 tp -50.14 -47.73 54.04 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.55 -0.75 . . . . 1.58 111.622 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -104.77 20.88 17.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.585 -0.734 . . . . 2.04 111.023 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 p80 41.48 47.56 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.88 0.872 . . . . 3.29 111.781 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.77 -40.49 22.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.451 -0.795 . . . . 2.89 110.068 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -159.99 179.98 8.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.418 -0.81 . . . . 1.8 109.78 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -114.74 133.3 56.01 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.429 -0.952 . . . . 3.37 108.429 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG11 ' HE2' ' A' ' 55' ' ' TYR . 24.2 t -114.22 112.17 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.461 0.648 . . . . 0.87 111.993 -170.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 5.6 t80 -72.06 119.97 17.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.222 -0.899 . . . . 1.06 110.491 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -124.77 136.06 53.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.197 -0.456 . . . . 1.96 110.621 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -98.97 118.08 34.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.617 -0.883 . . . . 1.18 108.617 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.07 -17.38 39.14 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.26 0.467 . . . . 0.75 112.26 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.6 t -56.49 -24.98 49.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.191 -0.459 . . . . 1.63 111.114 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -107.14 24.24 13.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 2.07 111.021 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.416 ' CZ ' HD11 ' A' ' 47' ' ' LEU . 70.9 t80 -87.41 152.05 22.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.963 0.411 . . . . 0.91 111.297 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 47.6 ttm -116.47 110.88 19.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.871 -0.604 . . . . 1.73 109.89 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.05 -139.34 10.81 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.568 -0.825 . . . . 1.05 112.278 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -122.72 99.75 41.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.535 0.207 . . . . 2.14 110.468 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.53 -20.75 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.272 1.981 . . . . 1.01 112.372 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -74.88 -11.83 60.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 2.08 111.168 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -109.46 14.71 23.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 2.18 110.653 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 40' ' ' TYR . 38.1 mt -93.83 158.66 15.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.92 111.048 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -162.06 175.13 12.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.597 -0.729 . . . . 2.35 109.571 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 mt -72.99 122.22 21.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.849 0.357 . . . . 1.4 111.039 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.08 -4.53 16.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.676 -0.773 . . . . 0.75 112.899 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -86.83 132.96 33.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.048 0.424 . . . . 1.06 111.237 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 80' ' ' LYS . 3.4 mp0 -82.14 143.52 31.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.86 -0.609 . . . . 2.51 111.138 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.0 m -141.48 153.58 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.704 -0.68 . . . . 0.44 110.193 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -113.64 137.62 51.34 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.235 -0.654 . . . . 1.49 109.235 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.518 ' CB ' HG22 ' A' ' 75' ' ' VAL . 1.3 p90 -164.45 163.03 22.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.398 0.618 . . . . 0.66 112.372 -175.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 9' ' ' VAL . 68.6 p -113.3 147.72 37.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.94 110.025 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.2 135.73 46.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.647 -0.421 . . . . 1.19 110.327 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.76 -56.07 7.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 2.04 111.002 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 12.7 tpp180 63.68 13.33 7.29 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.135 -0.938 . . . . 5.33 110.055 -175.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -62.06 141.07 58.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.565 -0.743 . . . . 5.42 109.47 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.97 -37.22 3.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.79 -0.924 . . . . 4.76 110.79 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 63' ' ' THR . 15.7 m120 63.11 12.57 6.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.299 0.64 . . . . 6.38 112.121 175.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -167.91 127.17 1.28 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.967 -0.56 . . . . 6.4 110.176 -175.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 m -72.89 25.15 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.685 -0.689 . . . . 5.23 112.079 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' H ' ' C ' ' A' ' 63' ' ' THR . 20.6 m -78.46 -20.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 6.95 110.99 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -101.9 8.28 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 6.02 110.216 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.89 135.11 2.06 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.072 -0.811 . . . . 4.09 111.072 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -52.08 -54.31 31.85 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.064 0.394 . . . . 4.22 112.064 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 p -98.8 151.02 21.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.418 -0.356 . . . . 2.09 110.909 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 59' ' ' ARG . 63.2 mt -105.24 152.41 39.79 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 2.3 110.333 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 47.1 Cg_endo -69.33 174.98 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.586 2.19 . . . . 1.43 112.134 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.72 159.52 22.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.596 -0.275 . . . . 0.82 110.84 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -130.1 145.39 51.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.709 0.29 . . . . 2.3 111.566 -176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 55.17 85.56 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.047 -0.979 . . . . 2.01 111.823 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 55' ' ' TYR . 43.5 t -115.86 119.38 61.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.056 -0.52 . . . . 0.8 110.623 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -120.22 164.74 15.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.636 -0.505 . . . . 3.51 109.636 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.452 ' HA ' HG12 ' A' ' 53' ' ' VAL . 62.9 mtt -81.12 144.27 31.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.815 0.34 . . . . 1.12 110.653 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 26.2 tp -121.68 129.43 25.19 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.961 -0.563 . . . . 1.67 110.183 -175.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 28.2 Cg_exo -63.83 154.37 70.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.624 2.216 . . . . 2.15 112.476 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.685 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -64.07 168.82 4.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.915 -0.584 . . . . 4.61 111.248 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.9 t30 76.58 2.84 3.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.628 0.771 . . . . 2.84 110.735 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.7 p -86.99 -11.12 51.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.815 0.816 . . . . 1.7 109.191 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.584 HD12 ' CD1' ' A' ' 27' ' ' LEU . 8.4 mm -100.52 132.51 22.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 114.463 -1.244 . . . . 0.92 108.565 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.05 142.04 66.42 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.159 1.906 . . . . 1.03 111.495 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.03 143.28 47.29 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.695 -0.402 . . . . 2.76 110.485 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.489 ' CB ' ' HB3' ' A' ' 154' ' ' ASP . 33.1 Cg_endo -63.84 141.46 78.32 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.117 2.545 . . . . 1.08 112.917 -176.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.07 93.39 5.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.992 -0.549 . . . . 1.1 110.03 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.07 137.01 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.728 -0.842 . . . . 1.23 108.728 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.2 tp -82.65 -61.06 1.98 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.911 -0.316 . . . . 2.87 111.73 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 91' ' ' THR . 39.1 mt-10 -91.45 -55.52 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.453 -0.499 . . . . 2.84 111.082 -175.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 11.1 t 166.43 161.57 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.716 -0.846 . . . . 1.42 108.716 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -105.5 -50.41 3.22 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.511 -0.476 . . . . 1.3 110.788 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.82 145.64 31.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.943 0.402 . . . . 1.29 111.04 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.646 ' O ' HD22 ' A' ' 118' ' ' LEU . 3.9 p-10 -113.41 148.1 36.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.774 -1.195 . . . . 1.36 107.774 171.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -163.43 -163.75 16.91 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 118.973 -1.584 . . . . 0.53 113.225 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 21.1 t -133.94 146.88 30.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.7 -0.482 . . . . 1.37 109.7 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.95 117.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.077 -0.342 . . . . 0.69 110.077 175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.88 -57.0 3.14 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.159 0.429 . . . . 0.89 112.159 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 5.7 ptm85 -138.96 109.46 7.71 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 3.92 111.48 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' ARG . 3.5 Cg_exo -77.36 169.74 20.67 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.154 2.569 . . . . 2.22 111.914 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 111' ' ' TYR . 7.6 mp -88.17 88.4 7.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.229 -0.441 . . . . 3.32 110.95 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -98.02 -64.86 1.0 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.361 -0.536 . . . . 5.56 109.836 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 33.7 t -96.49 7.62 46.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.701 . . . . 4.14 111.117 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.02 -46.05 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.826 0.306 . . . . 3.46 111.826 -170.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 91.5 m-20 60.17 170.05 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 4.99 111.858 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 105' ' ' ASN . 45.4 Cg_endo -71.16 0.8 6.13 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.35 2.033 . . . . 4.27 111.522 166.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.94 -35.02 57.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.459 -0.791 . . . . 3.94 110.994 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 4.7 tp60 -105.85 151.65 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.032 0.444 . . . . 5.6 111.058 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.3 -14.05 62.73 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.796 -0.638 . . . . 5.3 112.217 -175.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 108' ' ' GLN . 43.3 mt-10 -75.36 14.51 0.58 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.191 -0.318 . . . . 4.95 111.518 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.51 ' O ' HD21 ' A' ' 101' ' ' LEU . 55.7 t80 -58.76 -33.49 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 3.19 112.111 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.25 -23.56 65.71 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.178 -0.209 . . . . 1.24 111.532 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.19 153.23 22.06 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.773 -0.727 . . . . 0.94 112.302 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 130' ' ' GLU . 89.3 mt -138.65 142.01 39.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.622 0.725 . . . . 0.93 112.419 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.48 143.88 18.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.521 -1.218 . . . . 0.49 109.964 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 96' ' ' VAL . 11.1 pt-20 -84.63 125.8 32.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.345 0.593 . . . . 1.4 109.586 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' A' ' 129' ' ' HIS . 14.6 mm -104.59 128.15 58.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.63 109.386 -173.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.3 pt? -85.18 156.93 20.79 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.299 0.374 . . . . 1.21 110.597 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.562 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m-20 -56.75 154.54 8.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.66 -0.496 . . . . 2.29 109.66 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.478 ' HG3' HD22 ' A' ' 121' ' ' LEU . 9.8 pt-20 -62.91 -22.42 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.06 0.457 . . . . 2.78 110.603 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.478 HD22 ' HG3' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -95.65 -3.82 45.5 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.145 -0.479 . . . . 1.77 110.221 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.482 ' HG3' HD12 ' A' ' 118' ' ' LEU . 26.2 ttm180 64.23 89.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.272 -0.876 . . . . 4.14 111.004 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.9 m -133.34 -64.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 1.87 110.283 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -168.92 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.472 -0.785 . . . . 1.54 110.398 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 p -92.3 135.31 27.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.718 -0.475 . . . . 1.29 109.718 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -78.45 -70.87 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.566 -0.454 . . . . 1.03 110.767 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.6 m -139.89 -83.96 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.64 0.733 . . . . 1.56 111.43 171.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -175.36 138.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.575 -1.193 . . . . 2.08 109.695 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' A' ' 117' ' ' ILE . 35.6 m170 -118.76 140.48 49.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.252 -0.579 . . . . 0.68 109.703 168.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 158' ' ' ARG . 19.8 tt0 -94.45 145.07 25.04 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.067 -0.97 . . . . 1.19 109.633 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 136' ' ' LEU . 33.5 p90 -117.76 170.61 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.732 -0.387 . . . . 0.74 110.938 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -136.03 152.05 20.93 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.72 -0.552 . . . . 0.51 111.72 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.87 -29.19 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.966 0.412 . . . . 0.67 111.426 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.1 p -74.64 -37.36 62.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.157 -0.474 . . . . 1.35 111.271 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 160' ' ' ALA . 47.3 p -86.46 -11.55 51.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.363 -0.38 . . . . 1.1 110.7 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' CD1' ' A' ' 131' ' ' PHE . 62.0 mt -73.93 59.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 1.46 111.107 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -48.68 -45.81 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.251 0.548 . . . . 0.82 110.839 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.808 HD21 HD22 ' A' ' 143' ' ' LEU . 2.9 p-10 -85.57 31.68 0.59 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 2.17 111.95 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -60.63 -20.01 59.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.023 0.439 . . . . 1.39 111.351 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -76.94 -21.43 54.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 2.46 111.591 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -89.8 175.6 7.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.148 -0.478 . . . . 1.89 110.677 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.87 101.51 12.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.864 -0.607 . . . . 2.88 109.6 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.808 HD22 HD21 ' A' ' 138' ' ' ASN . 11.8 tp -115.48 114.43 25.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.97 110.094 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -124.98 -173.8 2.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.512 -0.313 . . . . 1.77 110.183 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -66.03 136.75 56.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.758 -0.377 . . . . 1.43 110.073 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.41 -9.48 57.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.675 -0.774 . . . . 1.07 111.722 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 38.4 m-20 -89.49 147.57 23.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.099 0.952 . . . . 1.94 110.997 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 165' ' ' VAL . 1.0 OUTLIER -98.04 127.54 44.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.291 -1.777 . . . . 1.79 109.692 -168.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.457 ' CG1' HD21 ' A' ' 143' ' ' LEU . 29.1 m -129.1 152.57 37.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 1.16 111.768 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.1 p -118.98 135.71 54.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.214 -0.662 . . . . 1.44 109.214 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -153.94 161.98 41.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.61 110.948 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 123.96 30.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.781 0.8 . . . . 2.2 111.803 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.7 tt -99.3 129.25 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.201 -1.363 . . . . 1.24 110.409 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 15.5 t70 -160.74 -88.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.976 -0.102 . . . . 1.92 110.913 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 4.6 mm-40 -81.66 -19.61 41.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 2.76 111.25 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.7 p -81.7 -17.57 47.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.238 -0.437 . . . . 1.98 110.496 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 55.73 18.18 16.48 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.808 -0.633 . . . . 1.27 112.842 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 62.8 mtm180 -147.46 -173.82 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.886 -1.153 . . . . 3.61 107.886 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.61 108.35 17.31 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.461 -0.496 . . . . 0.48 109.836 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' ' 135' ' ' SER . . . -115.76 159.95 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.731 -0.668 . . . . 0.49 110.653 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.4 t 59.01 42.26 19.53 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.781 0.675 . . . . 1.55 109.766 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.77 108.81 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.348 -0.842 . . . . 1.26 110.442 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.75 111.33 20.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.387 -0.824 . . . . 2.05 110.143 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.68 120.26 9.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.869 -0.605 . . . . 0.75 110.675 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HB ' HD12 ' A' ' 148' ' ' LEU . 59.8 t -102.84 110.26 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.855 -0.611 . . . . 1.56 110.614 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.67 115.62 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.439 -0.578 . . . . 2.94 109.439 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -91.27 130.71 37.1 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.485 0.66 . . . . 3.88 110.195 -177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.946 -1.025 . . . . 4.04 111.329 -178.444 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 112.168 -0.373 . . . . 11.74 112.168 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.82 132.03 26.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.684 0.278 . . . . 10.54 110.654 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.83 81.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.368 -0.693 . . . . 8.95 111.368 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -149.37 116.9 6.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.738 -0.467 . . . . 7.09 109.738 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.86 109.9 17.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 5.59 109.816 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.12 132.48 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.993 0.425 . . . . 2.99 111.066 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.7 23.42 76.77 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.799 -0.715 . . . . 1.61 112.208 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.91 117.41 30.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.341 0.591 . . . . 2.0 111.018 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.12 121.94 37.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.317 -0.856 . . . . 1.27 109.747 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.37 140.3 32.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.771 -0.65 . . . . 1.14 110.342 -173.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 37.5 ttm180 -101.77 152.85 20.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.776 -0.647 . . . . 2.31 110.002 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.97 -169.09 35.11 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.17 -0.772 . . . . 0.5 111.17 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.9 145.13 29.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.757 0.313 . . . . 0.68 110.581 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 112.16 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.56 110.589 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.82 -25.18 15.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.468 -0.333 . . . . 0.76 111.395 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.614 HG11 ' HD2' ' A' ' 23' ' ' PHE . 2.6 p -156.26 134.02 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.354 -0.384 . . . . 1.55 111.237 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 75.5 mtp -118.85 115.83 25.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.415 -0.587 . . . . 1.42 109.415 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 27.2 mmtm -96.25 -161.65 0.89 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.684 -0.487 . . . . 2.03 109.684 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -76.31 -46.53 27.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.899 -0.591 . . . . 3.24 111.134 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -111.49 -24.61 10.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 2.03 111.626 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 51.5 p90 -143.98 -173.72 4.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.938 0.399 . . . . 1.25 111.109 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.13 -178.36 35.03 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.001 -0.84 . . . . 0.71 111.001 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.614 ' HD2' HG11 ' A' ' 16' ' ' VAL . 67.7 m-85 -125.03 130.54 52.51 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.979 0.419 . . . . 1.08 109.958 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.6 mt -100.03 126.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.976 -0.556 . . . . 0.61 109.542 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.78 127.46 32.45 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.959 -0.756 . . . . 2.3 108.959 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.1 p -63.62 139.72 58.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.34 -0.846 . . . . 0.87 110.729 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 HD12 ' A' ' 83' ' ' ILE . 2.3 tm? -57.2 -36.62 71.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.677 0.751 . . . . 1.58 109.468 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -82.72 6.92 16.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.718 -1.128 . . . . 2.04 112.253 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p80 42.71 53.02 4.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.73 0.812 . . . . 3.29 111.733 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.8 -42.66 3.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 2.89 111.444 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.14 174.5 14.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 1.8 111.303 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.24 126.16 50.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 3.37 109.43 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 90.7 t -105.28 121.41 57.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.282 -0.417 . . . . 0.87 111.86 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -82.15 114.57 20.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 1.06 109.691 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -118.15 137.45 52.96 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.179 -0.609 . . . . 1.96 109.424 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -100.79 127.64 47.14 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.174 -0.676 . . . . 1.18 109.174 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -56.99 -22.87 41.75 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.259 0.466 . . . . 0.75 112.259 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -70.55 -8.99 55.63 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.606 -0.27 . . . . 1.63 111.672 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -116.41 20.15 14.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.387 0.613 . . . . 2.07 109.948 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -102.67 139.24 38.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.91 110.243 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -109.37 136.53 48.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.181 0.515 . . . . 1.73 110.717 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.6 -138.75 13.95 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.019 -0.833 . . . . 1.05 111.019 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -128.67 105.89 18.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.794 -0.447 . . . . 2.14 109.794 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.98 -30.7 38.87 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.843 2.362 . . . . 1.01 112.42 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.38 -18.1 65.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.66 -0.7 . . . . 2.08 111.528 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -98.36 10.65 40.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.079 0.466 . . . . 2.18 110.63 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.0 148.99 24.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.718 -0.673 . . . . 0.92 110.794 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.56 166.12 22.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 2.35 109.887 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.83 115.18 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 1.4 110.195 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -7.16 21.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.253 -0.499 . . . . 0.75 112.002 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.465 HE21 ' N ' ' A' ' 52' ' ' GLU . 24.8 tp60 -71.54 120.24 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 1.06 111.008 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 83' ' ' ILE . 9.0 mp0 -65.13 134.09 53.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.294 -0.866 . . . . 2.51 111.371 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 77' ' ' MET . 18.6 m -145.2 166.42 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.751 -0.659 . . . . 0.44 110.108 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.62 150.02 48.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.03 -0.359 . . . . 1.49 110.03 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . 12.1 p90 -164.09 -179.9 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.392 . . . . 0.66 111.649 -172.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -127.29 150.22 49.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.94 110.617 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.07 142.71 27.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 1.19 110.939 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 77.74 9.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.969 -0.56 . . . . 2.04 110.562 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -102.34 10.15 39.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.186 -0.672 . . . . 5.33 109.186 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.86 119.45 19.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.233 -0.894 . . . . 5.42 111.113 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.41 -132.21 10.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.697 -0.683 . . . . 4.76 112.682 175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.76 27.02 9.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 6.38 109.68 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 m -74.27 79.48 1.83 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 6.4 111.804 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 t 66.21 17.75 10.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.019 -0.991 . . . . 5.23 111.055 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.68 -27.15 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 6.95 110.761 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 t -107.76 21.24 17.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.052 -0.522 . . . . 6.02 110.262 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.56 -132.84 7.72 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.698 -0.763 . . . . 4.09 112.069 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -111.57 -64.06 1.33 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.217 0.532 . . . . 4.22 110.26 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 p -129.29 143.74 50.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.555 -0.748 . . . . 2.09 110.587 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.78 147.88 60.28 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.692 -0.685 . . . . 2.3 109.676 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.91 167.17 25.41 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.632 2.221 . . . . 1.43 112.91 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 55' ' ' TYR . . . -107.19 146.59 31.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.377 -0.829 . . . . 0.82 110.747 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.09 154.55 27.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 2.3 111.027 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 61.87 41.22 11.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.627 -0.715 . . . . 2.01 111.515 170.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' HA ' ' HB3' ' A' ' 55' ' ' TYR . 22.9 t -71.01 118.59 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.8 110.092 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -118.44 154.99 31.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.57 . . . . 3.51 110.237 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.51 ' HA ' HG12 ' A' ' 53' ' ' VAL . 41.4 mtt -78.4 148.47 33.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.963 0.411 . . . . 1.12 110.485 173.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 79' ' ' PRO . 20.0 tp -126.1 141.77 40.6 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.946 -0.57 . . . . 1.67 109.583 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 78' ' ' LEU . 15.0 Cg_endo -58.58 137.81 82.32 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.1 1.867 . . . . 2.15 111.279 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -66.85 164.48 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.694 -0.685 . . . . 4.61 111.861 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 70.44 21.7 5.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.91 -1.041 . . . . 2.84 110.41 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.4 t -89.76 5.14 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.606 0.717 . . . . 1.7 109.744 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.602 HD12 HD23 ' A' ' 27' ' ' LEU . 28.9 mm -101.98 131.47 22.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.832 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.58 145.35 57.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.214 1.943 . . . . 1.03 111.735 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -120.71 149.8 51.24 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 120.866 -0.334 . . . . 2.76 110.851 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 43.0 Cg_endo -68.52 146.56 68.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.67 2.247 . . . . 1.08 112.195 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.57 95.27 5.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.332 -0.395 . . . . 1.1 110.338 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.08 136.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.7 -63.64 1.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.121 -0.631 . . . . 2.87 112.206 -171.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -94.22 -54.63 3.48 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.421 -0.512 . . . . 2.84 111.215 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 t 177.45 163.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.937 -0.764 . . . . 1.42 108.937 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.7 m -106.04 -52.72 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.087 0.47 . . . . 1.3 110.61 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -139.55 151.69 46.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 1.29 110.434 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.596 ' O ' HD22 ' A' ' 118' ' ' LEU . 4.4 p-10 -130.75 128.08 40.07 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.98 -0.748 . . . . 1.36 108.98 173.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.37 -146.32 4.31 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.859 -1.162 . . . . 0.53 112.723 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.467 ' HB ' HD23 ' A' ' 148' ' ' LEU . 12.0 p -142.14 148.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.802 -0.444 . . . . 1.37 109.802 -177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 143' ' ' LEU . 86.2 t -59.95 126.76 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.495 0.188 . . . . 0.69 110.774 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 145' ' ' LYS . . . -70.12 -52.46 23.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.377 -0.374 . . . . 0.89 110.765 -174.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -169.84 137.6 1.45 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 3.92 110.399 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 145' ' ' LYS . 66.9 Cg_endo -76.17 130.94 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.268 1.979 . . . . 2.22 110.989 174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.616 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -72.39 90.5 1.29 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.073 0.94 . . . . 3.32 111.797 -176.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -97.56 -65.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.608 -0.724 . . . . 5.56 111.368 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.86 11.11 25.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 4.14 111.639 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 38.7 mm -73.88 -9.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.378 -0.374 . . . . 3.46 111.127 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 8.6 t30 74.38 128.77 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 115.968 -0.56 . . . . 4.99 111.059 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.11 -5.33 14.4 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.014 2.476 . . . . 4.27 115.816 -168.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -112.85 30.41 7.18 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.659 0.742 . . . . 3.94 110.715 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -116.56 148.32 41.0 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.417 -0.811 . . . . 5.6 109.416 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -58.6 -18.32 29.13 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.843 0.683 . . . . 5.3 112.843 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -84.11 8.33 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.241 0.543 . . . . 4.95 110.842 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.465 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 33.8 t80 -66.92 -27.74 67.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.642 -0.708 . . . . 3.19 112.136 -178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.95 -25.93 65.7 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.749 -0.38 . . . . 1.24 111.501 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 157.74 33.46 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.569 -0.824 . . . . 0.94 111.834 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 128' ' ' GLN . 36.0 mt -141.81 148.06 38.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.467 0.651 . . . . 0.93 112.133 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.91 140.73 27.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.063 -0.971 . . . . 0.49 109.311 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 11.8 pt-20 -87.87 129.21 35.29 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.383 -0.599 . . . . 1.4 109.383 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 129' ' ' HIS . 12.8 mm -104.43 140.67 21.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.827 -0.624 . . . . 0.63 110.614 -170.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 94' ' ' ASN . 1.7 pt? -84.08 146.48 27.89 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.987 -0.375 . . . . 1.21 109.987 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.9 165.47 17.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.71 -0.848 . . . . 2.29 108.71 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.74 -18.72 65.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.866 0.365 . . . . 2.78 111.0 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.95 6.47 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.18 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 55.87 77.77 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.526 -0.761 . . . . 4.14 111.208 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.9 p -117.73 -79.27 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.87 110.89 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.0 p -137.17 -174.5 3.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 1.54 110.793 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 4.7 p -65.17 129.87 29.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 1.29 110.721 176.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.1 -70.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.921 0.391 . . . . 1.03 110.791 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.1 p -135.97 -85.51 0.36 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.068 -0.514 . . . . 1.56 111.065 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.462 ' HB2' HD22 ' A' ' 114' ' ' LEU . 13.6 pt20 -176.51 137.4 0.28 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.573 -0.739 . . . . 2.08 109.763 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 117' ' ' ILE . 32.1 m170 -121.62 125.83 47.62 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.809 -0.356 . . . . 0.68 110.086 171.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.44 149.42 24.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.639 -0.71 . . . . 1.19 109.9 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 136' ' ' LEU . 20.9 p90 -117.74 146.86 43.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 0.74 111.294 -177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -101.8 150.43 18.33 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.51 112.494 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.91 -43.02 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.236 0.458 . . . . 0.67 112.236 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 134' ' ' THR . 3.1 t -77.58 -22.66 50.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.225 0.536 . . . . 1.35 110.203 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 15.2 m -80.66 -18.83 46.8 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.563 -0.744 . . . . 1.1 110.166 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 131' ' ' PHE . 50.1 mt -76.53 60.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 1.46 111.419 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.2 t -41.09 -42.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.291 -0.413 . . . . 0.82 111.592 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -92.05 27.79 2.05 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.159 -0.473 . . . . 2.17 111.994 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -60.34 -18.19 48.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.07 0.396 . . . . 1.39 112.07 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -81.43 -19.24 42.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.309 -0.405 . . . . 2.46 111.478 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -84.48 175.41 9.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.941 -0.572 . . . . 1.89 110.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 pp -104.43 130.32 52.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.754 -0.832 . . . . 2.88 108.754 172.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 97' ' ' VAL . 12.3 tp -139.97 109.7 6.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.97 109.372 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -122.73 -171.97 2.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 1.77 110.956 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.489 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 62.5 tttm -64.59 116.9 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.8 -0.637 . . . . 1.43 110.44 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.71 33.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.603 -0.808 . . . . 1.07 112.877 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -91.49 127.64 37.01 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.106 0.453 . . . . 1.94 110.35 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.467 HD23 ' HB ' ' A' ' 96' ' ' VAL . 82.0 mt -73.73 144.24 45.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.34 0.591 . . . . 1.79 110.889 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.28 145.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.346 -0.843 . . . . 1.16 111.114 -173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.4 m -118.45 148.83 42.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.672 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -163.68 162.93 24.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.53 . . . . 0.61 109.808 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.7 122.05 35.21 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.779 0.799 . . . . 2.2 110.965 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.6 tt -100.89 141.23 17.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.841 -1.072 . . . . 1.24 110.076 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 86' ' ' PRO . 24.8 t70 -171.64 -93.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.625 -0.139 . . . . 1.92 110.625 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 86' ' ' PRO . 41.9 mm-40 -74.01 -33.19 63.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 2.76 111.48 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.1 t -76.19 -15.51 60.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 1.98 110.753 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.65 20.6 39.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.968 -0.634 . . . . 1.27 112.948 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -140.49 -175.05 4.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.841 . . . . 3.61 108.728 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.47 108.38 18.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.216 -0.661 . . . . 0.48 109.216 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 135' ' ' SER . . . -116.26 158.77 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.49 111.218 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 36.8 t 59.34 39.59 22.11 Favored 'General case' 0 C--N 1.334 -0.071 0 N-CA-C 109.273 -0.64 . . . . 1.55 109.273 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -62.25 123.32 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.145 -0.934 . . . . 1.26 110.728 -175.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -132.42 111.69 11.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.28 -0.418 . . . . 2.05 110.187 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.82 109.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.75 110.368 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 77.1 t -89.67 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 1.56 111.364 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 123.06 32.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.125 -0.695 . . . . 2.94 109.125 172.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.44 140.66 46.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.736 0.779 . . . . 3.88 110.993 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 114.52 -1.218 . . . . 4.04 110.332 179.949 . . . . . . . . 0 0 . 1 stop_ save_